{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "gpuType": "T4"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/Nebius-Academy/LLM-Engineering-Essentials/blob/main/topic6/6.1_intro_to_model_tuning.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# LLM Engineering Essentials by Nebius Academy\n",
        "\n",
        "Course github: [link](https://github.com/Nebius-Academy/LLM-Engineering-Essentials/tree/main)\n",
        "\n",
        "The course is in development now, with more materials coming soon. [Subscribe to stay updated](https://academy.nebius.com/llm-engineering-essentials/update/)"
      ],
      "metadata": {
        "id": "OcYH03sKXsfi"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Before we start\n",
        "\n",
        "LLM fine tuning is traditionally a very complex topic, because of so many different techniques and taxonomies: Supervised Finetuning, Instruction Tuning, PEFT, LoRA, Full Finetuning, Human Alignment, Reinforcement Learning from Human Feedback and so on. The situation becomes worse because some teams use different terms to describe the same processes. In Topic 6 of the LLM Engineering Essentials course we try to cover the taxonomy of finetuning of LLMs and give concrete examples how to apply each different technique."
      ],
      "metadata": {
        "id": "DFoRw5UR0Qmy"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### A little bit of history from 2023\n",
        "\n",
        "Historically by `Training Pipeline Phases` people usually assumed 3 different steps:\n",
        "\n",
        "1) Pre-training\n",
        "\n",
        "2) Post-Training\n",
        "\n",
        "3) Human Alignment\n",
        "\n",
        "This was very heavily popularized in 2023 by Andrej Karpathiy and his \"GPT Assistant Pipeline\" tutorial at [Misrosoft Build](https://www.youtube.com/watch?v=bZQun8Y4L2A):"
      ],
      "metadata": {
        "id": "Bm5FMOgsYXXF"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "![image.png](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAABroAAAWICAYAAADqMRSzAAAKq2lDQ1BJQ0MgUHJvZmlsZQAASImVlwdUU9kWhs+96SGhJYQiJfQmvQWQEkILXTqISkgChBJCIKjYEBFHcCyIiIANHQFRcCyADKIiim1QUBTrgAwqyjhYsKHyLrAIM/PWe2+9nbXX+bLvPv/Z56x71toXALI8RyRKg+UBSBdmi0N9POjRMbF03AiApn82wIjDzRIxQ0ICAGKz49/tw10kE7HbZlNa//78v5oCj5/FBQAKQTiBl8VNR/gU4i+5InE2AKj9SFx3WbZoijsRpoqRAhHun+KkGR6d4oRpRoPpnPBQFsJUAPAkDkecBACJjsTpOdwkRIfkjrClkCcQIixC2DU9PYOH8HGEjZAcJEaa0mck/EUn6W+aCVJNDidJyjN7mTa8pyBLlMZZ8X8ex/+29DTJ7BoGiJOSxb6hyKiInFl/aoa/lIUJQcGzLOBN509zssQ3Ypa5WazYWeZxPP2lc9OCAmY5UeDNlupks8NnmZ/lFTbL4oxQ6VqJYhZzljniuXUlqRHSeDKfLdXPTQ6PmuUcQWTQLGelhvnP5bCkcbEkVFo/X+jjMbeut3Tv6Vl/2a+ALZ2bnRzuK907Z65+vpA5p5kVLa2Nx/f0msuJkOaLsj2ka4nSQqT5/DQfaTwrJ0w6Nxt5IefmhkjPMIXjFzLLgAUyQBriYkAHAcg/TwCy+cuzpzbCyhCtEAuSkrPpTOSG8elsIdd8Pt3a0toOgKn7OvM6vKNN30OIdm0ulv8eABfe5ORk21wsQA+AUxsAID6bixm2AyCrDMCVYq5EnDMTm75LGEAEcoAKVIEm0AVGwAxYA3vgDNyBF/ADwSAcxIAlgAuSQTpS+TKwCqwDhaAYbAM7QQXYBw6CWnAMnADNoA1cAJfBdXAL9IGHYAAMg1dgDHwAExAE4SAyRIFUIS1IHzKFrCEG5Ap5QQFQKBQDxUNJkBCSQKug9VAxVAJVQAegOuhn6Ax0AboK9UD3oUFoBHoLfYFRMAmmwhqwAWwBM2Am7A+Hw4vhJDgTzoUL4C1wOVwNH4Wb4AvwdbgPHoBfweMogJJB0VDaKDMUA8VCBaNiUYkoMWoNqghVhqpGNaBaUV2o26gB1CjqMxqLpqDpaDO0M9oXHYHmojPRa9Cb0RXoWnQTuhN9Gz2IHkN/x5Ax6hhTjBOGjYnGJGGWYQoxZZjDmNOYS5g+zDDmAxaLpWENsQ5YX2wMNgW7ErsZuwfbiD2P7cEOYcdxOJwqzhTnggvGcXDZuELcbtxR3DlcL24Y9wkvg9fCW+O98bF4IT4fX4Y/gm/H9+Kf4ycI8gR9ghMhmMAjrCBsJRwitBJuEoYJE0QFoiHRhRhOTCGuI5YTG4iXiI+I72RkZHRkHGUWyghk8mTKZY7LXJEZlPlMUiSZkFikOJKEtIVUQzpPuk96RyaTDcju5FhyNnkLuY58kfyE/EmWImsuy5blya6VrZRtku2VfS1HkNOXY8otkcuVK5M7KXdTblSeIG8gz5LnyK+Rr5Q/I39PflyBomClEKyQrrBZ4YjCVYUXijhFA0UvRZ5igeJBxYuKQxQURZfConAp6ymHKJcow1Qs1ZDKpqZQi6nHqN3UMSVFJVulSKXlSpVKZ5UGaCiaAY1NS6NtpZ2g3aV9UdZQZirzlTcpNyj3Kn9UmafirsJXKVJpVOlT+aJKV/VSTVXdrtqs+lgNrWaitlBtmdpetUtqo/Oo85zncecVzTsx74E6rG6iHqq+Uv2g+g31cQ1NDR8NkcZujYsao5o0TXfNFM1SzXbNES2KlquWQKtU65zWS7oSnUlPo5fTO+lj2uravtoS7QPa3doTOoY6ETr5Oo06j3WJugzdRN1S3Q7dMT0tvUC9VXr1eg/0CfoM/WT9Xfpd+h8NDA2iDDYaNBu8MFQxZBvmGtYbPjIiG7kZZRpVG90xxhozjFON9xjfMoFN7EySTSpNbprCpvamAtM9pj3zMfMd5wvnV8+/Z0YyY5rlmNWbDZrTzAPM882bzV9b6FnEWmy36LL4bmlnmWZ5yPKhlaKVn1W+VavVW2sTa651pfUdG7KNt81amxabN7amtnzbvbb9dhS7QLuNdh123+wd7MX2DfYjDnoO8Q5VDvcYVEYIYzPjiiPG0cNxrWOb42cne6dspxNOfzqbOac6H3F+scBwAX/BoQVDLjouHJcDLgOudNd41/2uA27abhy3aren7rruPPfD7s+ZxswU5lHmaw9LD7HHaY+PLCfWatZ5T5Snj2eRZ7eXoleEV4XXE28d7yTveu8xHzuflT7nfTG+/r7bfe+xNdhcdh17zM/Bb7Vfpz/JP8y/wv9pgEmAOKA1EA70C9wR+ChIP0gY1BwMgtnBO4IfhxiGZIb8shC7MGRh5cJnoVahq0K7wihhS8OOhH0I9wjfGv4wwihCEtERKRcZF1kX+THKM6okaiDaInp19PUYtRhBTEssLjYy9nDs+CKvRTsXDcfZxRXG3V1suHj54qtL1JakLTm7VG4pZ+nJeEx8VPyR+K+cYE41ZzyBnVCVMMZlcXdxX/HceaW8Eb4Lv4T/PNElsSTxRZJL0o6kkWS35LLkUQFLUCF4k+Kbsi/lY2pwak3qZFpUWmM6Pj0+/YxQUZgq7MzQzFie0SMyFRWKBjKdMndmjon9xYezoKzFWS3ZVKQxuiExkmyQDOa45lTmfFoWuezkcoXlwuU3Vpis2LTiea537k8r0Su5KztWaa9at2pwNXP1gTXQmoQ1HWt11xasHc7zyatdR1yXuu7XfMv8kvz366PWtxZoFOQVDG3w2VBfKFsoLry30Xnjvh/QPwh+6N5ks2n3pu9FvKJrxZbFZcVfN3M3X/vR6sfyHye3JG7p3mq/de827Dbhtrvb3bbXliiU5JYM7Qjc0VRKLy0qfb9z6c6rZbZl+3YRd0l2DZQHlLfs1tu9bffXiuSKvkqPysYq9apNVR/38Pb07nXf27BPY1/xvi/7Bfv7D/gcaKo2qC47iD2Yc/DZochDXT8xfqo7rHa4+PC3GmHNQG1obWedQ13dEfUjW+vhekn9yNG4o7eOeR5raTBrONBIayw+Do5Ljr/8Of7nuyf8T3ScZJxsOKV/quo05XRRE9S0ommsObl5oCWmpeeM35mOVufW07+Y/1LTpt1WeVbp7NZ2YntB++S53HPj50XnRy8kXRjqWNrx8GL0xTudCzu7L/lfunLZ+/LFLmbXuSsuV9quOl09c41xrfm6/fWmG3Y3Tv9q9+vpbvvuppsON1tuOd5q7VnQ097r1nvhtufty3fYd673BfX13I24238v7t5AP6//xf20+28e5DyYeJj3CPOo6LH847In6k+qfzP+rXHAfuDsoOfgjadhTx8OcYde/Z71+9fhgmfkZ2XPtZ7XvbB+0TbiPXLr5aKXw69EryZGC/9Q+KPqtdHrU3+6/3ljLHps+I34zeTbze9U39W8t33fMR4y/uRD+oeJj0WfVD/VfmZ87voS9eX5xLKvuK/l34y/tX73//5oMn1yUsQRc6ZbARTicGIiAG9rACDHAEC5hfQPi2b66WmDZr4Bpgn8J57puafNHoAGZJhqi1jnATiOuEEeou0OwFRLFO4OYBsbqc/2vtN9+pRhkS+W/Z5TdH/H4jzwD5vp4f9S9z9HMKVqC/45/gsvMAblU1pX9wAAAIplWElmTU0AKgAAAAgABAEaAAUAAAABAAAAPgEbAAUAAAABAAAARgEoAAMAAAABAAIAAIdpAAQAAAABAAAATgAAAAAAAACQAAAAAQAAAJAAAAABAAOShgAHAAAAEgAAAHigAgAEAAAAAQAABrqgAwAEAAAAAQAABYgAAAAAQVNDSUkAAABTY3JlZW5zaG90u+fJ4gAAAAlwSFlzAAAWJQAAFiUBSVIk8AAAAdhpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IlhNUCBDb3JlIDYuMC4wIj4KICAgPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4KICAgICAgPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIKICAgICAgICAgICAgeG1sbnM6ZXhpZj0iaHR0cDovL25zLmFkb2JlLmNvbS9leGlmLzEuMC8iPgogICAgICAgICA8ZXhpZjpQaXhlbFlEaW1lbnNpb24+MTQxNjwvZXhpZjpQaXhlbFlEaW1lbnNpb24+CiAgICAgICAgIDxleGlmOlBpeGVsWERpbWVuc2lvbj4xNzIyPC9leGlmOlBpeGVsWERpbWVuc2lvbj4KICAgICAgICAgPGV4aWY6VXNlckNvbW1lbnQ+U2NyZWVuc2hvdDwvZXhpZjpVc2VyQ29tbWVudD4KICAgICAgPC9yZGY6RGVzY3JpcHRpb24+CiAgIDwvcmRmOlJERj4KPC94OnhtcG1ldGE+CjL9ibYAAAAcaURPVAAAAAIAAAAAAAACxAAAACgAAALEAAACxAACqyfx5TwLAABAAElEQVR4AezdCbxV8/7/8U+UUpJQQq6pmwiF26CiVFREhpS5FDLlispYyXSTpEFmEaEB1zVW/JCxMqXJmMyzkCKi/t7fe7/7v/Zq77P3Pmftffbe5/V9PGqtvcbveq51dqfvZ32+30rr/ipGQQABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQKDABCoR6CqwO0Z1EUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEnACBLh4EBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghQg0FWQt41KI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIEOjiGUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEChIAQJdBXnbqDQCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggACBLp4BBBBAAAEEEEAAAQQQQAABBBDImcBbb71lNWvWtJ122iln5+RECCCAAAIIIIAAAsUrQKCreO8tV4YAAggggAACCCBQQAJ//PGHjRgxwtX48MMPt913372Aak9VEUAAgfQEvvjiC9t3331tgw02sJtvvtk6deqU3o5shQACCCCAAAIIIIBAEgECXUlgWIwAAggggAACCCCAQC4FHnroIRswYIA7ZbVq1ez555+3rbbaKpdV4FwIIIBA1gU++OAD69ChgzvPLrvsYrNmzcr6OTkBAggggAACCCCAQHELEOgq7vvL1SGAAAIIIIAAAgkFvv76a/v++++tYcOGVrly5YTbsDC3AoMHD7apU6fGTjpq1Cg7+uijY5+ZQQABBIpBYPHixXbwwQe7S6lSpYq98847/DtUDDeWa0AAAQQQQAABBMpRgEBXOeJzagQQQAABBBBAoDwEnn32WTv55JNt3bp1tt1229kBBxxgnTt3tpYtW9qGG25YHlXinH8JdOvWzebPnx+zOPvss23QoEGxz8wggAACuRD49NNP7f7773ddCx577LG27bbbRnraRYsW2SGHHBI7pv5NYqyuGAczCCCAAAIIIIAAAqUQINBVCjR2QQABBBBAAAEEClngtttusyuvvHK9S9hiiy1c42PXrl2tWbNmrpFzvY1YkBUBBR0bN25sq1atih3/mGOOsWuuuSb2uVhnli9fbmvXrrUtt9wykkuM+niRVIqDIFAgAho/q02bNvbnn3+6Gqsb1d69e9uJJ55o9evXj+QqFi5caPp3xhcF1Vq1auU/MkUAAQQQQAABBBBAIGMBAl0Zk7EDAggggAACCCBQ2AIKBKhR8ddff016Idtss43L+tLb/DVr1ky6HSuiEfjyyy9dRl3waLIfMWJEcFFRzf/xxx92xhln2NNPP21Vq1a1m2++2dq1a1fqa4z6eKqIGvvVCL/11lvHxhQqdQXZEYECELjrrrts2LBhCWu666672n777Wf777+/NW/e3P3cJtwwxcJwoGvcuHEuozXFbqxGAAEEEEAAAQQQQCCpAIGupDSsQAABBBBAAAEEildADY3qGu+jjz4q8SJr1KhhCrj06dMn8u6rSjxxBVs5Y8YM69evX9xVn3DCCXbVVVfFLSumD4899pidddZZsUsqa2N31MdTxTRO2vjx410dFRy+8847TRku4bJy5Up3LQrYtWjRwgWJN9hgg/Bmeff5t99+sxUrVtjPP//sAt+q8+rVq12ATxmef/vb3+jONO/uWnYrpMDuhRdemPIk/llX4Et/FARLtyxdutTat28f21yBNf0bQ0EAAQQQQAABBBBAoLQCBLpKK8d+CCCAAAIIIIBAgQsoA+bhhx+2u+++2956660Sr6Zy5cp2+OGHuwbQOnXqlLgtKzMXUBeFN954Y9yO6i5s+PDhccuK6YO6z1Q3mr6UdZyeqI+nemnsurfffttX0XXflqjbz9GjR9vYsWNj22n8ofD9jK3M0cz3339vixcvthdeeMGN/abAhMoPP/xg3377rZv+/vvvJdZmr732suuvv9523HHHErfLxUoFMqdOneqCcuecc05coCTq8+fyXFHXvazH0/PRoUMH0/OTSdEYW3379rXu3bsnDAYHj6XuEffdd9/YooEDB1r//v1jn5lBAAEEEEAAAQQQQCBTAQJdmYqxPQIIIIAAAgggUIQC7733nj3yyCOx7JVkl7jJJpvYgAED3JgtCn5RohFQdt2jjz4adzAtGzRoUNyyYvpwxx132OWXX+4uadNNN7UFCxZYpUqVSn2JUR9vzZo11qhRI1NA2BdlPD3xxBPrZa+cdtppNnPmTL+ZmypYsscee8Qty8YHjeumYNy7775r+jnWH81nGqhIVrd99tnHHnrooWSrc7J8/vz5duSRR8bGjVLQTkH63XbbLfLz5/JckVc+ogMqEKoMK/1MZlo233xzFxDu1auXKSswUfnxxx+tSZMmsVXF/l0Xu1BmEEAAAQQQQAABBLImQKAra7QcGAEEEEAAAQQQKCwBZaQoM0VFDZQNGjSwefPm2bp169a7kIYNG9oVV1yx3rhS623IgrQEjjnmGHvllVfitr344ovX684wboMC/6AuMV9++WV3FR07djQFqspSoj7eO++8Y506dVqvSoka5Q888EAXYApufPXVV9vxxx8fXBTJ/Nq1a92z8vzzz9vcuXNN3ZAGg3GRnCRwEGXqKNuuPEui7vRULwXgateuHWnVcnmuSCse8cHOP/98e+CBB2JHrVevno0cOdI0xqO+q/RMfPPNN7H14Znq1avbLbfc4sbzCq9TEFn/vvhyyimn2JAhQ/xHpggggAACCCCAAAIIZCxAoCtjMnZAAAEEEEAAAQSKU0DjsqiRV2X33Xe3xx9/3D766CObPn26TZkyxb777ru4C1f2jfY5/fTT45bzIXOBRIESBR7VXWQxFjWW/+Mf/4hl6Fx22WVuXKvSXmvUx1M99PyfeeaZ61VJWVrK1vJFgSdlfmm8q2A544wz0hrrKLhPSfOff/65+/l88MEHTV2/lbZsuOGGVrduXVMgQgFtdUW68cYbu7G4ghl1uq4///zTGjdu7LqkK+35othPQb0TTzxxvUO1bdvWdb263ooyLMjlucpQzazvqu4h//Of/8TOoy47g/dAL0Ao++3pp592fxQYDhdl/Y4ZM8YOPfTQ8CrbeeedYwFaHTdRl6Dr7cQCBBBAAAEEEEAAAQSSCBDoSgLDYgQQQAABBBBAoKIJKEPr9ttvd5etBsqlS5fGCNQ9msbqufPOO2ONk36lspGuuuoqoytDL5L5tE2bNvbpp5/G7ajxiFq2bBm3rFg+6NoGDx4cuxwFF7bffvvY50xnoj6ezn/DDTfYtddeu15VFAx64403TF20qSjr8eijj15vu6izVIIZa+udLLBA3frVr1/fatas6bJvPvnkk9jaFi1a2H333VeQP6saz+26666zX3/9NXY9CtTpXkRdcnmuqOse1fF69uxpc+bMiR1O81tvvXXsc3hGXWVqG2V96QUJX9Tdp7ooDQbJtG7PPfe0n376yW1GoMtrMUUAAQQQQAABBBAorQCBrtLKsR8CCCCAAAIIIFBkAv/617/s5ptvdle10UYb2fvvv7/eFSr4NWzYMHvhhRfi1ilQo26qNIYXJXOB5s2b29dffx23Y1mDP3EHy7MPvXv3jnWHF0XXeFEfT1waiy7Z2FTjx4+3ww47zKkqG00B4HDp27evDR06NLy4VJ+VWaXuQhN1UagAc9OmTV0Xcfo5VAChSpUq7jz6OT3hhBNi51QQQgGMQi3qKu/WW2+1F1980apVq2adO3fOWkZpLs+Vj/djr732coFS1W277bZz5unUU5mN6rbzrrvuittc2WF6Tn3Zd999Y5mJJ510kusK16/L56nGL1OXq/r38YMPPrAvv/zSNMaggsjK4lTGZHmVfK5beZlwXgQQQAABBBCoOAIEuirOveZKEUAAAQQQQACBEgWGDx9uEydOdNto3Bt1S5WszJgxwwYOHGg///xzbBM1sk+aNCnjbBEFeJYsWeLe7t92221t1113LXXAbMWKFbZo0SLTGDBqnFUQpRBKkyZN7Mcff4xVdZtttllvzK7YytBMafyUoafGaDU+KyPv0ksvjR1VwRRlKeme+ACLurJUF3dRlJUrV7oGb90jlf79+7tnqbTHjvp4vh4dOnRwDdn+c3CqDK5Ro0a550xZd+FuPbVtnz59XFA4uF9Z5o866ih77bXXYodQNpOCzqpnsgDzu+++awcddFBsH2VztW7dOvY51Ux5Piep6sb67Anoed5nn31iJ/DPe2xBihl9dyj4HAzea7w6fef4csABB9iHH37oPvbq1ctlffl1+Tb94YcfTF2G6t+9119/3dStZ6KiMS71c5pJKc33d/D42axb8DzMI4AAAggggAAC+S5AoCvf7xD1QwABBBBAAAEEciRwySWX2OTJk93Z1C3bm2++WeKZFVBStoga2nzJJItFb59rHCqNCxbMVFGGynHHHecyanz3cP74yaaq60UXXWQaJ0Zjx/iiwNkFF1xg3bp184tKnC5cuNAeeeQRU3dvauxVAEHddalbvU6dOmUtcLbLLrvY6tWrY3VTI7ECjyWVsvhpXB3dKxV5v/XWW+5adf0KYCYab6c0jbiJ6v/vf//bzj333Niqp556ymUrxRZkOBP18XR6ZfM0a9YsVpMdd9zRli1bFvtcr149mzt3rj355JNJM4qizlLRGF3qDlGZTAo8KKMsWYDLV1TB6uCzr8Z6jY2WbinP5yTdOmayne6rnhcFWDRulILz2SxRnU+BFXWZGRxDLZv1Do9TNmLECFPXmeGiQPhnn33mfjb08/H222+7IHnwZ8Xvo+/h4Jh37du3j3WPm8+BrocfftgF4dQ1Y6qi72x9d6dTyvL97Y+frbr54zNFAAEEEEAAAQQKSYBAVyHdLeqKAAIIIIAAAghkUeC8885zb63rFDVq1HAZPalOp4CIGt2VSeXLhAkTrGvXrv5jwumjjz7qxmj65ZdfEq7XwsaNG7v6bLzxxkm3UQOwzjdmzJi4YFl4h0GDBtnZZ58dXhz7rIbviy++OGUW1W677eYaa9VInm5REO+JJ55wgUN1d1W9enVTBpca2ffYYw/TGDY77LBDXIAu1fhcZfULBjB0HeqKS43y3bt3T+oYVWO0GoKfffZZx6cA36xZs9KlTLhd1MfTSRQQ0s+DL8pEUXeF6qbMF9Vby5977jm/KG6qLgLVVWB5lnDAQg3j6pIu3RLlc6Kfg+nTp7su8BRIXr58uQvUKTNN2YJdunRxXRGmW7dE2+nnWN2v6udJGUS1atWKbaZxt9Q9q4IzKgrwqsvJ/fffP7ZNpjPZPJ+y6W666SYXTP34449N3ckqs1LfrQqiZrPovApu+VK3bl3baqutTJm+MlVQXuNw6Y/PzPTbJpoqaKwXGnyXmtqmY8eOse5xlVV6zTXXJNq11MvK+rzpOVH3pcp6TadoTDx1qbnZZpul3Lys39/ZrFvKyrMBAggggAACCCCQpwIEuvL0xlAtBBBAAAEEEEAg1wJ62/7xxx93p1UjsMbjSqcoI+fUU0+NBWo0Xsn//d//mRpHExUFfdRdXTCLK9F2WnbOOefY+eefn3D177//7rKS1JifTrn33nvXy+BQg6HGFlOgTGPLpFsUpFJDsLpHLKkow0H1X7x4ccLN1Ch62V9jPAUznNSYrO6xko31EoWf7o+61vNFDa8KBKpBPVFRA7WCBApqlqUo+08ZRf7epwpApjpX1Mfz5zv55JPtmWee8R9Nz9g999xjCpb4okCWAjfJujFTQEJB2PIs/r76OmQa6IrqOdHzrGdcAa6Sir5/FMwpbdHP2gMPPOB2VwBL90xFyxJ9jyh4o/ucKjPOHSTBX9k6n75TlWEb7PoveHoFd5U9pO/AKVOmuO+1KLtpPeuss+yxxx4LnrLU8z169HBdbIaNDz744Nj34uGHH+6ye4Mn0XeEfn5eeukl0wsRbdu2dc9QMFgW3D44H8XzpjHG1DVouOj7WfVVl6UKqG655Zbu5QVlWuqlhVQliu/vbNUtVd1ZjwACCCCAAAII5LMAga58vjvUDQEEEEAAAQQQyKGAurJTBocv7733nlWtWtV/LHF6+eWX2x133BHbJtkb+mpUVlDMBzq0gzJMBg8e7DK49Na/ujP0mV5ap8b5cFGA6owzzrCZM2fGrVKATg3cGrdJjZ3azheNnaLu93xR11GqS7IuGtVtohrCFfzx9fH7aqp1amRO1sCsbuMUGFJjdCZl3333dcdNtE9UfhqDKxi00rhoCsr5oow1dZOnDDY1tiubRNeroi68dI80/pOCg8rwUPeOmiorTPbKblDDtgyVJVa/fn23r8aA810yqhs2NWKre8nSlqiPp3ro+po3bx57RlU/ZbwpWKnG+WRFWTbqFs+PW9eoUaP1ns9k+2ZruTID9bPli+q39957+48pp2V5TvzB1bCvIFc6gWQ9Q2rET1ZHdbGpALOyPJW5pecyWP75z3/Gvi98tqCeawUmgl2DBve54oorEmZIpTqXjhHl+XydVJ/bb7/df0w4VYBd2UMKkisrTQ76LgqOq5VwxzQXBsfPSnOX2Gbq1lOZqgpoq7tXdfuZqOj7R8+XSufOnd0LB347dRurFy/UPWiwhMf5Cq7z81E9b8FMUX9sfTfrO0dZuaUpUX1/Z6Nupbke9kEAAQQQQAABBPJJgEBXPt0N6oIAAggggAACCJSjgDJ8lMHhiwJFels9naLggN5w90EddX342muvxTUIap3eyv/iiy9ih1QQRF1WKUDlS79+/WzGjBnuowIkCoaES3A8Mb9OWVZq+P373//uFmkMMY1j5INd4UBXOAjgj6OG2auuuspat27tFmn/N954w2699VZTpkVwDDB1uaaurcLBGnkooyd4rTqYAodqJFUwJBjs8+fWtFWrVq6br+AyzUfppy7HdC8SFfmrG8dERdejLuZ+/PHHRKsTLttvv/3c2G9y07g86u5NpUWLFjZt2rSE+6SzMOrj+XMqiyTY5aAyUq699lq3Wg33icYv00qN16Vn+bn/dWWoZ1rBwOCz7c+Rq+l9993nxq7z58t0jK7SPif+fLq/GpspmPUmj0MOOcQFURUg1Z+hQ4fGAq0lBQgVmPZdXeoeKasuWOR/4403ukXqElFdZCpomyxTURsGM7+Cx0p1Lm0b5fl0PAWBFUgJF2UK7bzzzqbgvH72FEjSCwB77rmnqYtDFQVnlWFY1vLrr7+6exO8Z+FjKpCtrmUbNGjgxi/829/+5rJbleGk7/50irpC9T8rCqwpwKmiFwT0HfTVV1+5z8G/FBxXsDZZ95tRPm+JAo66NnVpqkBTpj/XUX5/R123oDHzCCCAAAIIIIBAoQoQ6CrUO0e9EUAAAQQQQACBiAWUwaNAji8KNinTJ90ycODAuIZWjfMSzIBR5oECUb506NDBZS4Eu3tSUOuEE06INYxrm3DDr7KGFCQJNsSGMwL8OZTNooCWurtSAEOBCl8eeeQR14Wi/6ypgj9qKA93s+W3UZabsjiWLFniF7ljKggWLMFGci1Xo+hpp53m9lUXVyrKfNI4RTLyWUBargZ6ZTqEG1Kj8tM5lKGW6N4qk0bBkOA90fa+3H333TZkyBD/Ma2purB89dVXXfd/J554YmwfZeYce+yxsc+ZzoTHnyrr8XR+BTUVMA0GKG+44QYXLNF6ZRxeeOGFmo0rPntINjLyRYFjBQPKq6jhX91D+qIu/DReUrqltM+Jjq+AhQLZwTGc9KwrqKXgVrCoTvq59kVZOQqkhEvw5+r000+PC+Jp22AAXD9HCgj5YIrWK3CvwJu6pPNZmvpuWLBgQVxQXtumOpe2ifJ84W4mdXwVZaPJTNejogxUBbz0c9WtWze3TH8ly36NbZDmjF4QUCDSFwXn9b2pDC0F9JXBqpcBFHQqS9H9U3BYpV27djZp0iSXNanAsr4bkxVlmapbxXDXrlE/bwr4KaA1Z86c9aqin3f9XB144IHrrUu2IMrv76jrlqzOLEcAAQQQQAABBApJgEBXId0t6ooAAggggAACCGRRQF0BqoHZFzXaK/iVblFmk8bU8kVZMGq0VFGjsjJ71CWVLwrkKNtCGUzqikxBNjX2BgNYibI2gt3V6VjKItDYPsmCUytWrHCN2OHA0QsvvOCCar4+Ckio4TXcHZpf76fK1lLDrxqbVXRcdXPmz6+MC3Uh5jO2dDyNA6ZspnBR92PqjitcFKBQMM+XKP38MRXo8o39WqaGYzkmCoD5fZJlqmm9ghfK9FCQyDdUK9CgwKEyPoKBVJkoY1DjuZW2RH081UPBXWWT+KLrUWaiD04qEKbgwsKFC/0mbqrgl35+dK3K8vFF3espA668SnhsqsmTJ7ufw0zqU5rnRM++ft6DAUMFNa+++ur1gqgKGoeNNIafAufhEvyOUrbm+PHj4zYJBk/iVvz1QUEuBb31cx7OiNF3T8OGDeN2SXUubRzV+fQdpWCPfr6CpaQxCsPft1GNCRcOuCnIpm5toy4DBgywhx56yB1WLzQo+HjkkUfG/RuhgLsCWwq+BYvuozKIfcnW86aAksYmVPA6mMnrz6uMOmV4KSOtpJKN7++o6lZSvVmHAAIIIIAAAggUkgCBrkK6W9QVAQQQQAABBBDIooAyYpSF5YsyW+69917/scSpGmqVvaGu2nwJBroU6FEjdyZFDZkadyacOaDuyoJv2Wc67pCvg8YjCzbgahwhNb6mUzTWl8ap8uWee+5xXaDpczi4oKwPZXOFixpn1VivsZ/CJdx9YJR+/lwKRHzyySf+o4W7doytCM1orCXdZ3Xhp0CQMkvUXaQPWqlB+Msvv3TZasp8UMaMApzqWs13I6mgnzIcSluiPp6vR/jZUnahurEMFgVmFOzy3XQq40VZQ9tss43LNDnrrLNim59//vlxwd/YihzNqHs7ZSD6EsxO88tSTUvznIQDuBrbSN0oJsoUVGaMArvBom76NJ5RuCjooswfFQWsgl2tallw3Cd99kXPqSx8dp3GfvJBeG2juvmuSv0+qc6l7aI6XzhopWMHu8zU53C57rrrbNy4cbHFek71vJa1KDir4I4vyp5SwDrqop8NfVeqNG3a1H1fBL+P9AyMGTPGdc+owKcycH0J/1xl63nz59O/NwpmL1u2zC+Km+6+++7u5/yggw5a798rbZiN729fgbLWzR+HKQIIIIAAAgggUOgCBLoK/Q5SfwQQQAABBBBAICIBvV0fDPQoU0ndZPkARrLTqHHy7LPPdllNwW2UHaQGQJXjjjsuNtaWxjnR2FYa/ydZUXaDsjUSnVtdealevijwkO64MH4fTcONy1deeaUFu9YLbhueD2YjaJ0a5dUwqxLsvk6ZQOoWTcGQcAln/wTXq3swjS/kS5R+/phhx3CWhN8uiqkyiRTw80XZOmq8Lm2J+niqh7IZlcUTLMka+dXFpjLKFOBT0NMHUNQVpbp48wG9jh072h133BE8ZE7nVf9g4K00wZDSPCfBLv30M6yAlAKi4aKf4yOOOCJhtkzw+8Pvp++EUaNGuY8KgGvsvM0339yvdpk1fgy42MK/ZsLdqCrIrO8mZcWo6B4q0Bssqc6lbZXJE8X5LrroIhds8+dXFp3uXTgL1a9XsFndQH7wwQd+kQv+h7uEjK3MYCY8Tpi+h/R9FHUJf4cGj697o5cH/L1VMCc4HpuCr/oO8CVbz5s/vqbKNJaFsrtmz56d8JnVfVMQLtylYTa+v6OqW/A4zCOAAAIIIIAAAoUsQKCrkO8edUcAAQQQQAABBCIUUMBq//33j2vAS9bIqawdvUWvrBxtE+xuUFUKdyumsZ98t1xq2FbDssZY0hv9ygxSF2dqpNU4M2ok1J9E2R86trpAe/nllzXriu82zn9Od6psMY3X40u6XXSpy8OTTz45NvaQGqOV4eQbpS+++OJYJtz222/vrtOfw0917X369Ikdwy8PToNjpEXp58+h7A9diy/qSlDdu2WjhLMFZRTsIjDTc0Z9PHVDqe4o/TOq+qixXcGWZEXBrPA4QdpW4xv5rtbUJae6tUwU6Ex23CiXz5w5My6bsDQBxtI8JwrC+ExFNf7rWQ4XrT/ppJPiuqoLbqPxkRR0CZbwz2y4a0iN6+W7zfT76RzqqjBc9D2kQJlKac6l/aI6XzA4ruPqRQAFuurVq6ePceXTTz+1Sy+91GUR+hXqQk9dDkZRzjzzzLjnXi9AqCvWqIuyaZVVGy76DtLzIgNf9O+N/m344Ycf3CK92KAXCPx3braeN3/+8FQBRmX06h6F/+3TtuqKUxnNyiRUycb3tztwgr8yrVuCQ7AIAQQQQAABBBAoSAECXQV526g0AggggAACCCCQHYFw46MPtqhR/+OPP7b333/fBXXUDdjSpUsTVkKNv+qKzI9ZpY0UQNP+KuriTRkxyQJZbqMS/goGkvxmGutLmStqVE+3KECnBm5fVC9l9dSuXdsviptq7K3bb7/d/fGZINogHLRR4O3+++93+2psKp3HN8hqoYJcCvIEx8dSUEVdJwbHRAs20Efp5yr211+9evWKayzX+GQaDycbRQ3zytDwRd0YqiFY46uVVNasWeOCT8rsCI6dFuXxfvrpJzc2UDA7RnVS923KxMi0XHbZZXHdMioYnGh8tkyPW5rtlWmooKwvwWfKL0s1Lc1zoq4d58+f7w6tzCsFBPSMq+ieqqtAjWW2atUqt0x/KXNM3yu+6J6/+uqrcT87ygxTgNiXU0891QV99Fndp4a72NPzpfG3gs+O3zcYXEoU1CzpXFGfL5xdquPru0NBp0aNGlmtWrVct3mvvPKK67rRd5vpryX8HeSXl2Ya7r5TXSSqW9qoi8bjUnA9WPSsKGNK33fhou5fFbj1JRiAy9bzpsw//fFj9Plz+6n+DVT3kepWMRzw0rOoFzm0bza+v6Oqm78WpggggAACCCCAQKELEOgq9DtI/RFAAAEEEEAAgQgFlNGicUY0BpKKGuiVbaUGPTVQpyrq/kvZE+GuBI8//niXAeb3VyNzMKjjl6czfe+999brGsrvp2CVgjXqSk5ZAAom/fzzzy7LQ5ke6vJr8ODB1qpVK9e9nMYO+vrrr/3urosuNS6r4VvZWF999ZUbx0pdZ6kBNtgwr53UNZ2CX8FxxNQF4m233RY7ZosWLVxD8bbbbusCaRr3THXzRW/9q6F0u+22c2/+q8FeRYZq6Nc0Sj9/XgVAguMgTZw40Tp06OBXRzoNd4emgyvQqcBkw4YNrX79+u75UjBRz6CePz13yrRSA/Jmm23muhXUM6OgYZTH0/OkDIxgUXd78+bNM2VkZVrCwaVE43xleszSbq+garA7TmWt3XrrrRkdrjTPibpIDJ5Hz7CyNNU4r+CGxnALFgU+1XWmMkEXLlwYW6WxjTp37hz7rHVdu3aNfQ4GutSFoLoSDJaSgowKxmt8MBVl5ilDKBicL+lc2ifK8+lFAmUCvv322zp0xkUvDuhnKIoSzI7S8dQtrXeK4vg6hq5XXXyqq89gUTAr2MVpcJ2+I4PdnarrQ70coJKt501jhKmLWQWqdC4frA3WS/MKkl9//fUuoBtcpzHc1NVmNr6/o6pbsL7MI4AAAggggAAChSxAoKuQ7x51RwABBBBAAAEESikwYcIE122XAgoKBKnhUW+eqwFaGS6ZFAUs1Ih9+umnu0BNon2Djcpar8DQyJEjrUePHok2jy1TcE1dnKleGpfFN0Qr6KRghxrOMy3qAstnjqghXBk4pSnKclBWSjBbS8d57rnnXLZUOsdUN12qg7oeUwlmg+mz6qZAQ9R+OnY4e++cc85x48toXdQl3Ehd2uPLSdlAypILNnqX5XjK3FKQIVhKanAPbpdoXsFV1dMHhtUlpwKl5VHUvaga2X1RMERBkUxKaZ4TBSkVdFq9enXKUzVp0sRlKSmTUj/XCoL70rRpUzeWnv+s76tgN3rBbks///xza9OmTSyzpnXr1nHjXvlj+KmCSsEgmgIH6s7Ql5LOpW2iPp/MlK2WabArWfeo/joynbZt2zZu/ERl2qmbviiLAlz6Hg4WBZGU2Rb+PvXb6CUF1c0HSRUcnT59uludrectOD6d6qXgmrJxq1Sp4qsVN1XG3THHHBNbpi5L1Y2p/r0JBgvL+u+fThBV3RJlO8YugBkEEEAAAQQQQKCABAh0FdDNoqoIIIAAAggggEAUAhoXRY3XZS3KmlImjMbMUrZSSUUZTOqqyo+J47dt166d63JQ3R0q60PZVWoYfPPNN12DvOZ9N11qlFaGhy9qsFewIziukl9X0vTyyy+PC0RddNFFJTaIh4+lLDAFn5Qdk6ioQVaNuOHsr/C2O++8s2vYD2Zi6FoUNPTXpIZdNf5nw08Nrwqg+aJMtuCYZX55FFMFJHVsdeVV1qKAhLqqjOp4ysS466673FhaqpsasRUgSjQ+Urp1D49r9e9//ztpEDjdY5ZmO/2MBLtfVFBa3Y8mCyYkOkdpnxMFcBWMDmYvho+v5/umm26KZYCqS1D9XPluTrW9stIUzFHRsRTw1jhVKuFu9RT4UH2VoaXgqr5XSirKdtPxVfRdojHMfEl1Lm0X5fl0PH1n6OdQwfJ0iwLucoiqKAtJ2Yy+BLPm/LKyTnWdCgb7FxX0M6fuLdVNY0lF3v4ebbXVVnH1zMbzJltl1QaLsoYVxFUmqoKzetb0b5Qy/OQ2d+7c4OYui1dZxlH/+xdV3VL9jMRdDB8QQAABBBBAAIE8FiDQlcc3h6ohgAACCCCAAALZEFCju+/yKd3j161b1xSYUeOeuuJr2bKlbbHFFunu7rZTA7sCAOoOMFFRRllJGSA6p7o3CxY1lKphUWOJzZ4922VZqLs5NaT6MVOqV6/uxrhRN3nqWjHY9Zk/lt7EV0BJjZrqLi9c1KCpQFvv3r1TNsZq3xdeeMG9+Z8o2KW3/DVWkjKo1EVeuGicMDW669oUkBw6dKjbJGq/Tz75xHVV6AOJCgwouyabRd2AqatHH8jL9FxqEJ81a5brYlL7RnU8GSjooQDQiBEjXOZIpnULbj9lypS4oKGCo1qW67Js2TLXKO+DTcqg1NhomZSyPCcKtCnwpOwnX5TNooCGsmMSBYs1tpd+NhTs0v1+9NFH48be08/psGHDXNBL3UTutNNO/tBuquw5ZUoqEJ+qKGCmrvoUANRxw89/qnPp+FGeT8dTdq2yumSmP8pg0neagn0at0vPf7BbSHUVq++TqIq6XVX3qyry14sRO6QYS68055atz95T8CqdDE19p+t+yUc/q+FxIqN+3jSuoOrof34yvU69vKGXNvSdH/X3d5R1y/S62B4BBBBAAAEEEMhHAQJd+XhXqBMCCCCAAAIIIJBFAXWpprFwlixZEjuLAi5qzNQfNaYqQ0tvrivbSPOlGasodvDAjAIcyljItCu3Zs2auXFYdtlll8DREs8qQKSGSTWo6217TTMp6gZLY0XpOGoA33zzzU3dz2V6HHV9dv/997s3/WVep04d56lu8lJlC+n8ahhVQEBjePkStZ/ug8YM23HHHe28887zp8nqVI3VarxXkOGzzz5zwU01qKsxWEFJBRVr1arlApUKOirLT8FRze+9997WrVu3uPpFfby4g5fyg7ovVEDYj7emw9xxxx1uTLdSHrLUuyljSsE71UdZL2p8z7SU5TnRz6KCZQpKqOtRn72Zqg561vUzp5+/cFEASF2sKlOmrEVBTn1P6E+iEuW5dPxU50tUh+AyZSAqq9GXqAPUul+XXnqpG9dQ39XpfOf6umQ61b9BehlA3VHquzadoqxgGSiYqWm4RP286aUFZcwpYJVJ0Xeaxg7r2bNnbLeov7+jrFuskswggAACCCCAAAIFKkCgq0BvHNVGAAEEEEAAAQTKIqCsAY19pcZFBbM222yzshwuo30VQNJYLMocSDYejRqd1SCucXYU5Grfvn3GgaaMKlVAG+NXGDdr5syZLjPJZykqeKBu4CgIlEVA2Wx3/dXVpoqCKQoWMc6S48jqX+ricty4cfb666/HsoUTnVAvhqj7WY3VpSzicMnG93dUdQvXlc8IIIAAAggggEAhCRDoKqS7RV0RQAABBBBAAIEiE1DWkrpXU3aPGgCVzaPAm7oQK03mSZHxpLwc/FISlesGGrdHWVTKPlKgS12AUhAoi4C6ddSLAioa50pdO1JyJ6AxGPVzrQxFZaYqyKifa2X9Kgs6k5/xqL+/o6xb7kQ5EwIIIIAAAgggEI0Aga5oHDkKAggggAACCCCAAAIIIIAAAlkVULbQe++9586hceX8eFpZPSkHRwABBBBAAAEEEEAgzwUIdOX5DaJ6CCCAAAIIIIAAAggggAACCGh8L43bp65nVa699lrr0aMHMAgggAACCCCAAAIIVHgBAl0V/hEAAAEEEEAAAQQQQAABBBBAoLwF5s2bZxMnTrRPPvnEjed2xBFHxFVpzpw51rNnz9iyWbNm2S677BL7zAwCCCCAAAIIIIAAAhVVgEBXRb3zXDcCCCCAAAIIIIAAAggggEBeCHzzzTfWtm1b++WXX1x9KlWqZDfddJN16dIlVr9Ro0bZ+PHj3edNNtnEFi5caBtssEFsPTMIIIAAAggggAACCFRUAQJdFfXOc90IIIAAAggggAACCCCAAAJ5IaDsrFNPPTWuLpUrV7ZbbrnFOnbsaO+8845pTC4FxFTatWtnkyZNitueDwgggAACCCCAAAIIVFQBAl0V9c5z3QgggAACCCCAAAIIIIAAAnkh8O6771rnzp1t7dq1cfXZcMMNrU2bNvbaa6/ZqlWrYusuv/xy69WrV+wzMwgggAACCCCAAAIIVGQBAl0V+e5z7QgggAACCCCAAAIIIIAAAnkhoG4J1T1hqrL11lvb7NmzrWrVqqk2ZT0CCCCAAAIIIIAAAhVCgEBXhbjNXCQCCCCAAAIIIIAAAggggEC+CyiAdfXVV7uuCpPVdeTIkdazZ89kq1mOAAIIIIAAAggggECFEyDQVeFuOReMAAIIIIAAAggggAACCCCQrwJr1qwxBbNuu+02W7duXVw1W7VqZffee69tsMEGccv5gAACCCCAAAIIIIBARRYg0FWR7z7XjgACCCCAAAIIIIAAAgggkJcCL730kg0fPtw0fpfKTjvtZNOmTbM6derkZX2pFAIIIIAAAggggAAC5SVAoKu85DkvAggggAACCCCAAAIIIIAAAiUIrF271p566in75Zdf7KCDDrIaNWqUsDWrEEAAAQQQQAABBBComAIEuirmfeeqEUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIGCFyDQVfC3kAtAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBCqmAIGuinnfuWoEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAoOAFCHQV/C3kAhBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBiilAoKti3neuGgEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBAoeAECXQV/C7kABBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQKBiChDoqpj3natGAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBApegEBXwd9CLgABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQqJgCBLoq5n3nqhFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBghcg0FXwt5ALQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQqpgCBrop537lqBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQKDgBQh0Ffwt5AIQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgYopQKCrYt53rhoBBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQKHgBAl0Ffwu5AAQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEECgYgoQ6KqY952rRgABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQKXoBAV8HfQi4AAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEKiYAgS6KuZ956oRQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgYIXINBV8LeQC0AAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEKqYAga6Ked+5agQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEECg4AUIdBX8LeQCEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIGKKUCgq2Led64aAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEECh4AQJdBX8LuQAEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAoGIKEOiqmPedq0YAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEECl6AQFfB30IuAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBComAIEuirmfeeqEUAAAQQQQACByAXWrVu33jHDy8KftUOiZeEDJdomnWXpbJOoDon2C9cp3f0SHSu8zH+uVKnSeqeJetl6J/jfgqjPU5bjJapjWY6XaN9E52AZAggggAACCCCAAAIIIIBA4QkQ6Cq8e0aNESgqgbVr17oGTt/Ap2n4j7ZRCS/P5HNw/+A5/TGC6/0yv12idcFtSlqv7VT8sfx+wWlw//B2wXXBffx2ydYHty1pXvv7Y4W3Cx87vF14vd9f2yVa55eVNHU7/u8vHa+kbZOt98coaX2ydeHlqY4V3j782e9fmutIdqxEy8PLkn329Um2PtXy4HVEcazg8fy5Ey3z65JNM61LonNkeox065LoXMn29cszrUtJ58j0WL4OfhreP51z+X2YIpDPAj7w5aeqq5/302D9g8v8vJ8m29ev99NsHK+kYwfX+Xk/TVXnRHVNd99U2/ljp9rOr/fTZHVO53ipjuHX+6k/ZvCcwfngdn7eT5Nt54+Zaju/3k+THS+4Pnzs4Do/76e5Pl7wvOF6pqpLcF8/76f+WMFjBOeD2/l5P021XaJjp7tvou2iPF74+Prsl/n54Ofwtfpt/PLwZ7/cT8Prg5+D2wTntU2iz4mW+eMF9/Hb+anfJtlnv9xPS9o+uE1wPnj+4P7BbYLz4e21TsXvG14f/vzfrdPb3h/XT/05kn32y/3Ub1+WOvh9w8dM9tkv91NfB32mIIAAAgggkC0BAl3Zks2T46qhSn+CDdR+PtHUN1Br6v8Ej5Fon+Dxg+v9vF/vjycaP+/Xhafp7Jtom/Bxgp/9fPDcwWWaD3/25whO/XxwWy0r7XWFz5vo+OFt/LnDy8P1SHYsvzw49fP+2OHPWk5BAAEEEEAAAQQQQAABBBBAAAEEEIhGQIHADTbYIGHQ2i/3wcbgtj6AmGzq91Ut/TZ+mf+c6TS4vz9ucFlJx/Pb+f20rV/m9/Prwsv9+vDUb+f3S3TM8D7+s/YN7hdc7uf9en8evzzZ1G/n99N2fpnfR+vCy/y6RFO/bUnHTLSflmnf4H5+O39Mffbrg8v8dommfju/n7bxy/z2Whde5tclmvptSzpmov20zO/jZv73l18eXObnw+uCn4Pz2t5//vPPP2316tWxP2ov3XjjjWN/VH9KfggQ6MrhfVCg4LvvvrPPPvvMli1bZh9++GHc9Ndff81hbTgVAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIlEZg8803tzp16iT9U7duXdtxxx2tSpUqpTk8+2QgQKArA6xMN/3+++/tscces3vuucfef//9THdn+yIQUPTfv5mgqf/jlwfXBZclW57pNto+WFJ9Dm6r+VTbZ3t9edenvM8f9i3v+pT3+fEo+ee5vO9PeZ+f54PnI/gMhp+H8OfgtpoPr8/25/I+f/j6yrs+5X1+PArr+yP8vOhzuOeB4OdM5xMdz58znWOF909nn+A2/lx+GlyXzny65/fHD28f/pzOOYPblLR/snOmu39wu+B8+JzpnKek/YPr0pkPni9cl3T3T3c7f67g9qU5Z7r7+/OVdI6S1gXPk2w+eI7SHKu0+wTPm6xu6Swv6fzpnKOk/Utz/nTOGTxuac4fPEdp9w/WIZ35sp4zeI6S6hw8T3Cf4HxJ+we38/Oa+vlgzzlaps/+eP6z376kdX4bPw0f1y/XNLhO5wp+Dq5Ptq4866dzUxAoBoGNNtrIGjdubHvvvbc1bdrUTevXr18Ml5ZX10CgK8Lb8dtvv9mUKVNsxIgR9ssvv6Q8sv5Tveuuu8b+NGzY0BTlVSR4iy22sMqVK6c8BhsggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAdAI///yzffvtt/bNN9+4P5r3n4PzP/zwQyxwHTz7hhtu6Nr61cb/xRdfmLpB9GXbbbe1du3aWdu2ba1NmzZWo0YNv4ppKQUIdJUSLrjb1KlTbfDgwcFFcfM777yz9enTxzp27Gj16tWLW8cHBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQKDwBDUe0aNEimz9/vvvz5ptv2ueffx67EGV07bHHHla7dm2rWbOmC5Zpm1WrVrlttP6ggw6yHj162H777ed6BIvtzEzaAgS60qaK31AR3QEDBthTTz0Vv+KvT//4xz/s0ksvdamIqbpCWW9nFiCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggEBBCnz55Zc2d+5ce+WVV2zOnDn20Ucfxa5DQa8jjjjCJcTMmzfPxRd8YGz77be33r17u6DXJptsEtuHmdQCBLpSG8VtsWzZMjvuuONcumFwRadOnWzUqFG26aabBhczjwACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAhVU4OOPP7ZZs2bZzJkz7fXXX3ddHVarVs26devmAlsrVqywyZMn24wZM2zNmjUu8+ukk06yvn37uiGOKihbRpdNoCtNrvfff99FUpcvXx63x5gxY1wENm4hHxBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBgIDG65o2bZrdf//99tVXX7k16rLwzDPPNA2BdNddd9m9995rP/30kxu7S8Gufv36GRleAcQEswS6EqAEF3333Xd2+umn26uvvhpcbA8++KDrojBuIR8QQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgRIE/vjjD3viiSfsjjvucGN7adNmzZrZ4MGDrXHjxnbnnXfa7bffbj/88IPVqVPHhgwZ4jLASjhkhV5FoCvJ7V+3bp1NnDjRLr/88rgtpk6dai1btoxbxgcEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAIFMBjeWlnuM0npdK586dXWCrVq1aNnbsWJflpS4NO3ToYCNHjrQtt9wy01MU/fYEuhLcYqUP6qH55ZdfYmv1APXo0cMqVaoUW8YMAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIFBWgRdffNGuuuoqW7JkiW288cZ2wQUXWK9evWzp0qU2cOBAl/ml7C4Fv1q3bl3W0xXV/gS6Qrfz8ccfd/1h+sXK3rrtttts00039YuYIoAAAggggAACCCCAAAIIIIAAAggggAACCCCAAAKRCqxdu9YmT55s11xzja1cudI0ftf1119vtWvXtnHjxtkNN9zgznf++ee7OAaJOf/lJ9D1v8dQfWJecsklNmXKlNiDqf4xO3bsGPvMDAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCCQTQH1OjdgwADXnaG6KpwwYYIbUunll1+2s88+277//ns3Zte1115rVatWzWZVCuLYBLr+uk0rVqywY4891hYtWuRu2oYbbmh6YOrVq1cQN5FKIoAAAggggAACCCCAAAIIIIAAAggggAACCCCAQPEI/PnnnzZ+/HiXyaXMrSFDhljv3r1NQbBTTjnFFi9e7IJfStjZZJNNiufCS3ElFT7Q9fXXX9uRRx5pn332meNr0aKF3X333VatWrVScLILAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIBCNwOzZs61///72008/uUDXsGHD7Ndff7UzzjjDtK5p06auu8OaNWtGc8ICPEqFDnR99dVX1qNHD/v444/drTvwwAPt5ptvtsqVKxfgraTKCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggUGwCH374oZ188sn20UcfuS4LR48ebevWrXPdGM6YMcOaNWvmgl0VNYGnwga61F1h9+7d7d1333XP/N57721Tp061jTbaqNh+BrgeBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQKGABjct14oknui4Lu3bt6ro0VLDr1FNPtWeeecYOOeQQN5aXujmsaKVCBrr++OMP90BoHC6Vbbfd1h555BHToG4UBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQCDfBNR94fHHH28LFy604447zv71r3+5bgzVc92CBQvs4osvtn79+uVbtbNenwoZ6Lrooovsvvvuc7hVq1Z1Qa5GjRplHZsTIIAAAggggAACCCCAAAIIIIAAAggggAACCCCAAAKlFVi+fLnrrW7p0qU2dOhQ69u3r33xxRcuo0s92U2ZMsV1ZVja4xfifhUu0HXvvfe6qKa/WRqTq0uXLv4jUwQQQAABZaEwrQAAQABJREFUBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAgbwU++eQTO/TQQ23lypWmmEfLli3tueeec+N41atXz2bOnGmbbrpp3tY/6opVqECXUveOPPJIW7NmjXM87bTT7JJLLonalOMhgAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAlkTmD17tvXu3dsNyfTkk0+66ZVXXmm33XabHXHEETZmzJisnTvfDlxhAl2rVq2ygw8+2D766CN3D/baay974IEHrHLlyvl2T6gPAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIFCiwOjRo23s2LHWrl07u+uuu1yST9euXe3dd9+1O+64wzp27Fji/sWyssIEugYPHmxTp051961GjRqmCOf2229fLPeR60AAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIEKJPDnn3/aMcccY/PmzbPhw4e7DK+33nrLZXRttdVW9vTTT5viIcVeKkSgS31T9urVK3Yvr7rqKjvhhBNin5lBAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBApN4LPPPrNOnTqZgl4am0sJPgp6TZw40c4880y74IILCu2SMq5v0Qe6fv31V5eep5utokHZpkyZYpUqVcoYix0QQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgXwSuO++++yiiy6y1q1b27333msrV660tm3buukzzzxj9evXz6fqRl6Xog90jRo1ysaPH+/gqlSpYjNmzLAGDRpEDskBEUAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIFcC6xbt8569uxpc+fOtXHjxlm3bt1s8uTJdskll1j37t3tuuuuy3WVcnq+og50ffHFF3bAAQfY6tWrHeqpp55ql156aU6BORkCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggkE2B9957z7p06WJ16tQxZXFttNFG1r59e1Nvd/q8ww47ZPP05Xrsog50DR482KZOneqAa9eubc8//7xtuumm5QrOyRFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBqAWGDRtmd911lw0cOND69+/v4iOKkxx//PF29dVXR326vDle0Qa6FKVUH5R//PGHw1b/lKeffnrewFMRBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQCAqgeXLl9t+++1nlSpVspdeesmqV69urVq1shUrVrhuDTfbbLOoTpVXxynaQJePXEp78803j93UvNKnMggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBARAKjR4+2sWPH2rnnnmsDBgywMWPG2PXXX29Dhw61vn37RnSW/DpMUQa6Vq5cac2bN7dVq1Y5bd1M3VQKAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIFCsAj/++KPL4tIYXa+88or98MMP1rp1a2vUqJE9+eSTRXnZRRnouu+++0xdFapUqVLF5syZY1tuuWVR3kAuCgEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBDwAsOHD7eJEyfaiBEj7Nhjj7VjjjnGBb2effZZ22mnnfxmRTMtykDX0UcfbfPmzXM3qWvXrjZhwoSiuWFcCAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCCQTGDZsmV2wAEH2O67726PPfaY3X333TZkyBC7+OKLrV+/fsl2K9jlRRfo+vbbb123hWvXrnU3ZdKkSdauXbuCvUFUHAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBDIRMBncc2aNcs22WQT151hmzZt7N57783kMAWxbdEFuqZMmWIXXHCBw69du7a99tprVrly5YK4GVQSAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEECirwLRp02zQoEHWv39/GzhwoLVt29a+/vprW7RoUdHFTIou0HXqqaeaIpQqPXv2tJEjR5b1eWB/BBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQKBgBH766Sfbe++9bfvtt7dnnnnGBbumT59uDz/8sO21114Fcx3pVLSoAl1r1qyxJk2a2KpVq9y1021hOo8A2yCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggECxCZx44on2/PPP29NPP+16v7vwwgtt6NCh1rdv36K61KIKdM2ZM8dlcekOqc/J+fPnW5UqVYrqhnExCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggEAqgcmTJ9sll1xigwcPtvbt21vnzp3tsMMOs/Hjx6fataDWF1Wg67rrrrNx48a5G3DIIYfYjTfeWFA3g8oigAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAlEIfPXVV9ayZUvXVaG6Ldx9991t6623tmeffTaKw+fNMYoq0NWjRw+bO3euw1XQq3v37nkDTUUQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgVwKHHzwwfbOO++4rgtPPvlkW7BggS1evNiqV6+ey2pk9VxFE+jS+FyNGze23377zSpVqmTz5s2zunXrZhWPgyOAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAAC+Spw7bXX2g033OB6w3vppZds6tSp9sgjj1iTJk3ytcoZ16toAl0aj6tbt24OoFGjRjZz5syMMdgBAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEECgWAfWCp97w9Kdhw4Z25ZVX2ujRo+2oo44qlku0ogl03X333TZkyBB3Y/r06WPDhg0rmpvEhSCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACmQqoNzxlb9WqVcuuuOIK69u3r/Xv398GDhyY6aHydvuiCXQNHjzYpdxJ+tZbb7VOnTrlLToVQwABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQRyIXDSSSfZ7Nmz7fbbb7dTTjnFDj/8cBs7dmwuTp2TcxRNoOuwww6zt956y6G98cYbtsUWW+QEkJMggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAvkqcOONN9o111xjw4cPd73hNW/e3KZPn56v1c24XkUR6Fq3bp3rW/L333+3HXbYwUUmM5ZgBwQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEECgyAReffVV6969uxun68knn7TatWvbCy+8UDRXWRSBri+++ML23Xdfd1OKLeWuaJ40LgQBBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQRyLvDbb79Z48aNbfvtt7e1a9faV199ZW+//XbO65GtExZFoGvOnDnWs2dPZzRkyBDXx2S2wDguAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIFBIAt26dbMFCxZYgwYN7L333rN3333XqlWrVkiXkLSuRRHomjZtmg0aNMhd5NSpU61ly5ZJL5gVCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggEBFEhg6dKhNmjTJBbdWr15t6s6wbt26RUFQFIGusWPH2ujRo90NmT9/vutfsijuDheBAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCJRRIJgwpEM9++yzttNOO5XxqPmxe1EEui655BKbPHmyE/3444/zQ5ZaIIAAAggggAACCCCAAAIIIIAAAggggAACCCCAAAJ5ILBkyRLr0qVLrCYzZsywXXfdNfa5kGeKItCl8bk0Tlf9+vXtpZdeKuT7Qd0RQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgUgFfv/9dxfY+uOPP9xxH3nkEWvSpEmk5yivgxVFoKthw4b222+/2WGHHWbjx48vL0vOiwACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgjkpUCHDh3sgw8+cHV7+OGHba+99srLemZaqaIIdG2//fbuugcPHmxnnXVWpgZsjwACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggUtUC/fv1MXRaqEOjKs1vtA13jxo2zbt265VntqA4CCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggUL4CI0eOtAkTJrhKPPbYY7bHHnuUb4UiOntRZXRNnz7dmjdvHhENh0EAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEikNg2rRpNmjQIHcxTz31lGlYqGIoRRXoev75581ndxXDzeEaEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIEoBObMmWM9e/Z0h3rppZesfv36URy23I9RVIGuJUuWWI0aNcodlQoggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAvkk8Omnn1qbNm1clRYsWGC1atXKp+qVui5FFej6+OOPSw3BjggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAsQqsWbPGGjRo4C5v2bJltsEGGxTFpRLoKorbyEUggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAiUL+OGfiilxiEBXyfectQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAUQgQ6MrT21iMNyZPqakWAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIFKhAMcZTyOgq0IeRaiOAAAIIIIAAAgggUCgCb731ltWsWdN22mmnQqky9UQAAQQQQAABBBBAAAEEilKAQFee3tZivDF5Sk21EEAAAQQQQAABBBDISOCLL76wfffd1w1yfPPNN1unTp0y2p+NEUAAAQQQQAABBBBAAAEEohMoxngKGV3RPR8cCQEEEEAAAQQQQAABBEICH3zwgXXo0MEt3WWXXWzWrFmhLfiIAAIIIIAAAgiUrwDZ5+Xrz9kRQCC3AgS6cuud9tmK8cakffFsiAACCCCAAAIIIIBAHgssXrzYDj74YFfDKlWq2DvvvGOVK1fO4xpTNQQQQAABBBCoSAJkn1eku821IoCABIoxnkJGF882AggggAACCCCAAAIVXODTTz+1+++/33UveOyxx9q2224bmciiRYvskEMOiR3v2WefZayumAYzCCCAAAIIIFDeAmSfl/cd4PwIIJBrAQJduRZP83zFeGPSvHQ2QwABBBBAAAEEEECgTAJ6i7lNmzb2559/uuNUq1bNevfubSeeeKLVr1+/TMfWzgsXLrSuXbvGjqOAWqtWrWKfmcmtgO7zK6+8Yo8//ri9++67tnz5cvv+++9tzZo1VqtWLWvevLl16dLF/alUqVJuK8fZEEAAAQQQKAcBss/LAZ1TIoBAuQoUYzylqDK6PvzwQ9twww3L9SHh5AgggAACCCCAAAIIFJLAXXfdZcOGDUtY5V133dX2228/23///V0ApGrVqgm3K2lhONA1btw469atW0m7sC5LAlOnTrUxY8aYgpupSsuWLe2mm26yzTffPNWmrEcAAQQQQCDrAmSfZ52YEyCAQAUSINCVpzfb3xilGqvffwoCCCCAAAIIIIAAAgikJ6AMqwsvvDDlxgpytWjRwgW+FPxSECydsnTpUmvfvn1sUwXV+vTpE/vMTPYFVq5caRdccIE99thjGZ1st912s//85z+20UYbZbQfGyOAAAIIIBClANnnUWrm57Heeuste/HFF23ZsmX2ySef2Lfffuu61K5Tp47rYaBBgwa2yy67WNOmTa127dr5eRHUCoECEvDxlI8//riAal1yVYsqo0tdb6irFQoCCCCAAAIIIIAAAgikJ/DDDz9Yhw4dXPd16e3x36122mkn69u3r3Xv3r3E38H9AO/+2AMHDrT+/fv7j0yzLLBixQo7/PDDTQHHRGWLLbawLbfc0t3/7777br1NBg0aZGefffZ6y1mAAAIIIIBArgTIPs+VdO7P89tvv9ngwYPt4YcfTuvk6smrdevWds4551izZs3S2oeNEEBgfQECXeub5MUSf2OWLFliNWrUyIs6UQkEEEAAAQQQQAABBApFQG/NKstqwYIFGVdZXdtpPK9evXqZgibh8uOPP1qTJk1iixU0UfCEkhuB0aNH29ixY+NOtsEGG9gpp5zi7tvf/vY3t+6PP/6wBx980IYPH26rVq2Kba9x2vSGNeN1xUiYQQABBBDIsQDZ5zkGz+HpLr30UrvnnntKdUa9cDV06NBS7ctOCFR0AR9PIaMrz54Ef2MWLVpkNWvWzLPaUR0E8kNAaeD6+dDb1xQEEEAAAQQQQCAscP7559sDDzwQW1yvXj0bOXKkLV++3F555RV79tln7ZtvvomtD89Ur17dbrnlFjeeV3DdmjVrTN3N+KIAy5AhQ/xHplkWCN9Xne7KK690Qa5Ep9b/qQ499FBbu3ZtbLXu/zbbbBP7zAwCCCCAAAK5FCD7PJfauT3XP//5z7SzuRLV7LLLLrOTTz450SqWIYBACQI+nkKgqwSk8ljlb4wa8jfbbLPyqALnRCCvBXyXQXp79+abb7ZOnTrldX2pHAIIIIAAAgjkXkBdwGg8Jl/CwZB169bZ/Pnz7emnn3Z/3nnnHb9pbFq5cmUbM2aMC5TEFv41s/POO5syhlSU/aVjU3IjoLek9ba0L3vssUfKsbpOOukkmz17tt/Fpk6dai1btox9ZgYBBBBAAIFcC5B9nmvx3JxvwoQJ7sUqjb911FFH2Z577ml62Uovav/888/29ddf25dffmnz5s2zxx9/3H766ae4ih1wwAGmri0pCCCQmYCPpxDoyswt61v7G/PGG28k7C4l6xXgBAjkucAHH3zgxt5QNfXLw6xZs/K8xlQPAQQQQAABBHIt0LNnT5szZ07stJrfeuutY5/DM99//73bXllfH330UWy1Xqy5/PLL4zKG1GjhGyYIdMWocjKjAKPGUXvzzTfd+ZThpaBmSeW8885z3Rj6bSZNmmTt2rXzH5kigAACCCBQLgLhLGWyz8vlNkR+0s8//9y23XbblMfV75sHHXSQaVwvX3bbbTd78skn/UemCCCQhoBeYNxhhx3clgS60gDL5SY+0PXaa69ZnTp1cnlqzoVAQQgsXrzYDj74YFfXKlWqmN7A1hvXFAQQQAABBBBAwAvstdderptCfd5uu+3cuEx+XUlTNTZcffXV671Nq+ywpk2bul333XdfU4a5irKFrrjiCjef73/p7fGXX37Z3n//fdOLQ3qjeNNNN7UWLVrYGWecYRoQvRCKuiHU+Gu6V7onVatWLbHa4aDn9OnTrXnz5iXuw0oEEEAAAQSyLUD2ebaF8/v4ass65JBDYr0EqLbKWj/11FPzu+LUDoE8E/jzzz9jQ9sQ6Mqzm+MDXXPnznXprXlWPaqDQEqBTz/91DS4qt6APvbYY9N6kyXlQQMbaKwF/TLgi8bYYKwur8EUAQQQQAABBL777jvbZ599YhBHH320jRo1KvY51cySJUusd+/ernsZv+3xxx/vAmD6rG5lPvzwQ7eqV69eLuPLb5dvU40D8uCDD9qMGTPs9ddfjxurKljX0aNHuy52gsvSmVcXPPJShpveXt51111tk002SWfXnGyjTL1mzZqZ/gPsy1NPPWUNGzb0H5kigAACCCBQLgLhFzHIPi+X25Dzk+pFnX//+9/u90rfQ4Aqod+j1GNRPv0elXMcTohAKQTU44O6llch0FUKwGzu4gNdDJKcTWWOnS0Bvd3cpk2bWGNCtWrVXEORuvWpX79+JKdduHChde3aNXYsBdVatWoV+8xM+Qg89thjds0117gA5+DBg+OCkeVTI86KAAIIIFBRBZ5//vm4rgZHjBjhXr4Jeyj48dlnn9myZcvcn7ffftuNmaDP4XLBBRfYmWee6Ra3b9/eli5d6ubzOdD18MMPuyCcgj2pyvDhw93vbKm28+uVHTZ27Fj3cpMfr0zrlGV/3HHH2YABA2zzzTf3m5fb9M4777TL/hrY3Rf1mPHqq69apUqV/CKmCCCAAAIIlIsA2efrsxdL9nn4yvS7ktp51UOAuiZcuXJl3CZbbLGF6XeWJk2axC3nAwIIpBZYs2aNNWjQwG1IoCu1V0638IGuF1980XWzktOTczIEyiigQTOHDRuW8Ch6w3e//faz/fff33UXk6qbmYQH+WthONA1btw469atW7LNWZ4DgXAjkvqZvu2223JwZk6BAAIIIIDA+gI33XSTKbjlS926dW2rrbay2rVrW61atWz16tVuHC6NjaD/GKUqygjSizXqMlmlY8eOrvs/zR9zzDHuRQ/NR1XUGKLu9fT/gU8++cR1wai3e9UIokBNly5drHPnzklPpwCeAk1qTEmnaIB0nWuzzTZLZ3N79NFHTS+1/PLLL0m3b9y4scsk23jjjZNuk+0VaixTUHLFihWxUxVSV5OxSjODAAIIIFB0AmSf//9bWszZ5++9957961//MvXatWrVqv9/0f+bU09Ihx56qA0dOtS23HLL9dazAAEEUgsoS9L31kCgK7VXTrfwga7Zs2fHBlLLaQU4GQJlEFAj0IUXXpjyCApyaTwIBb70R0GwdIveoFajhS8KrPXp08d/ZJpDAY3vMXLkSJs5c2bcWTt06GATJ06MW8YHBBBAAAEEciVw1llnmTKNoyg9evRwL/EEu5HRWKEaM1Tl8MMPd5lNwXMpUDVhwgR76aWXXDCobdu2du6558YCZcFtw/PqXlDbKsBVUnn88cdt9913T7hJshePFOhTfVu2bOn+n6EGlerVq5sy8NXQkk554oknrH///nHjSSTbT2OPnH/++clWZ3W5GpMU1NK4x74ow+zpp592AUO/jCkCCCCAAALlIUD2+X/Viz37XJn/zz333HqPmF7C0u9kemHKd7m23kYsQACBtAR+/fVXa9SokduWQFdaZLnZaN26dbHg1jPPPMOXXW7YOUuEAnoTR0GOdLrICZ5WY2z17dvXunfv7hpbguvC8+oeUYPA+zJw4EDX4OI/M82+gAJcyqTTG90aED5cCHSFRfiMAAIIIJBLgeAYWpmet169erbHHnvYP/7xD+vUqZPtuOOO6x1CY37NmzfPLVdm1S233BLbRm9oq4tDvbkbLMExvoLLg/MKIinIpbcSUxVlpimgtffee6+3qcYX0ximwaLfnfQSigJbpS36/4kGSA92Vahul5TdpQwuvfCk7gx9ppfWqQEr10W/h+olqPnz58ed+sYbb6Rr5TgRPiCAAAIIlJdAoWefy60sGegVJftcv08qwzxcNB6X1unF7wMPPDDtrPrwcfiMAALmsiV32203R0GgK4+eCDUY+/9MM0hyHt0YqpKRgP4RV+PCggULMtpPG+tNW43npbde1D1PovLjjz/G9Vt89tln26BBgxJtyrKIBTRmyfXXX580wOVPR6DLSzBFAAEEEMi1gN7o0390Er2I4euirvoUmFFf7upN4W9/+5vrMnyHHXawGjVq+M2SToNv5yqopoCTigIr/fr1s6+++sp9Dv6lMaE08LiCP4nKtGnTTOOABeut8a4OOeQQdz1bb7216Y+6ttFYYip6czGcVa3lV1xxhd1+++2ajRVd13nnnefG4dJxMy2///67KTNNLxz5oheUND5n8Hi6/hkzZrhNND6rstpyWd5//333e2g4I648s8tyef2cCwEEEECgMAQKOftcwmXNQNfvTomGvSi27HP1DBB++Sn8hG666abudzS1hQV/pwpvx2cEEEgs8PPPP8d6uiDQldioXJbqbQifsqr/IGbSnVu5VJiTIpBEQN3UPPDAA7G1ejtaXdwtX77cDcCpt4y/+eab2PrwjN421tvRGs8rXIKDDGrdKaecYkOGDAlvxueIBZRuf9ppp6X1ljmBrojxORwCCCCAQNoCixYtisvaUXfJyszSW7N6e1ZZ5HqxTIGn0pbTTz/dDSSu/du1a2eTJk1yXRmqMSM8uHjwHArAqUvFDTfcMLjYBcgUNAqOF6buERXUUnArWDReWPB3KGWBKWgXLAr2Katrzpw5wcVufpdddnEvCOnt4UxKeDxO/VuvYFqwy0MFtU444YRYsC7Xvw/odxU1HIbvAeNyZXKn2RYBBBBAIBcChZp9LpsoMtD1e0pFyD5XtvvFF18c+92opGdL2V3Kvt9oo41K2ox1CCAQEggmRBDoCuGU58dgoCvRf1rLs26cG4FMBPTWbHAA9CuvvNJlavljqJtOvfWscRL055133vGrYlO9yTJmzBg3MGds4f9mFBD23eborRcdn5I9AXVJ2apVq1hXRMEz6e1uDZ6qLiR9yXXDlj8vUwQQQAABBNStrrK9fVGwSN0jR1kGDBhgDz30kDuk/s3TG8lHHnmkqdtCXxQAUmBLgbdgmTp1qhsjyy/T7zNq2AhmSh177LF29dVXxwWRtP2SJUusS5cuflc31XhZwX+D/UoFuzT4+d133236vStc9txzT/f2sBraUhV1Rag6Bq9Pv6fp33/9frDxxhubeqMId2msl5x69uyZ6vCRrFfDkH4fVFdIwaIMMzUwURBAAAEEEMgXgULNPpdfVBnoFSn7XL8/KatLvR4tXLjQ/VmxYkXCx7Fjx47upW8yuxLysBCBhALqttx3506gKyFR+SwMZqroP4r6DygFgUIUUKNG8C1izYffSA5el76UtI0aRD766KPYKjUSXX755XFBMq3Uz8ZPP/3ktiPQFePK2owauMIZphrAXo2H3bp1c7+06S12Xwh0eQmmCCCAAAK5Frj55ptdgMefVxlUGnMryhLMXG/atKnLWA92lacXcvSyjn5fUSDqkUceiZ1e++qFIF9efPFF0/hdvmgsrfvuu2+9IJfWq6tmNTAFi86lsbOSFf1+deGFF5q6H05Udt99d1efgw46KGmWm7LsFXjLpLRs2dKmTJmS9JiZHKukbRUoVGa/zMKFcVzDInxGAAEEEMgHgULMPpebXlaOKgO9omafy1EvIOn3smuvvdZlx2lZsDA8R1CDeQRSC2gIHfXeoUKgK7VXzrZQ3/d///vf3fk0cHOyPvxzViFOhEApBfTsqptCle22287UiJNO0eDrakjxY134fZQdpoYkX9QI5N98LqTuaPTl+/LLL5vGj/jggw/syy+/NPXH3KJFCzvjjDPW68rIX28+TC+77DK755573P08/PDD3fgXqruK3k4i0JUPd4k6IIAAAggMHz7cdfviJdQtjrorjLIEM7rCx1XgSP9eatxRFQWagllNyoyaPHlybLdLLrkk9ln/rv7f//2f1a1bN7bez7z55pt2xBFHJMzOevzxx2P90vvtg1ON+yUHZXfNnj074TH0QouCcIm6NDzuuONiY21prK86derEvZgUPJfm1Z3j+PHj3e844XVRftaLUuqq8JVXXok7rLqlVJbdySefHLecDwgggAACCOSDQKFln8ssGxnoFS37PNGzp2dBL+yoFx1flM2l3x/1+xYFAQRSC2h8ZLWrqhDoSu2Vsy3UyN+wYUN3PnWHss8+++Ts3JwIgagElJYdfHaPPvpoGzVqVNqHV7c86q/566+/ju2jN52DbxIH+7PWgPDK+srXol9YHnzwQTcwuwZsDQ4yH6zz6NGj7aijjgouSjkvI3kpu03jjqiRapNNNkm5X2k3UNZplSpV1tv9+eefj8u6UyOZxu2gIIAAAgggkGuBM8880xT48SUbv1OrK0R1vRwuynbWOLvBhgm9tasXgHwDhgJF6rrGd0mjsbgWL17sDqV/x7V/uGi9XuwJdh0Y3Ea/NynAl07RizZjx451Y4Ul+p1EXSPqDeOaNWvGDqeuQBRUUlGwTb+z6N9+jceq7qf18pEy93Wd+h1Af4Jjd8UOFMGMuvpRYEu/WymTLTiumQ4vV9VfXUlSEEAAAQQQyEeBQss+l2E2M9CLPfs81TMYttX2etGYF3ZSybEegf8K6P8iSohQIdD1X5O8+FtvMzRq1MjVZfr06da8efO8qBeVQCATgXDQY8SIEaaxJsJFYyh89tlnLmVbadtvv/22zZs3L2HXOhdccIGp4cqX9u3b29KlS93HfA50KTNTQTjfOOTrn2iqBio1VKVTlBmmRioNbOrHKtN+atzRW9d609y/SZ7O8cq6jRoUg/dH2V1qZKIggAACCCCQa4Fw98nXXXed62YnynooiKKXV4JFWUTKmNp///2Di938aaedZjNnzowtDwbf1AWwugJS0THU1aKywlQUxFGXfNdcc42tWrXKLdNfyqzW7xi+6N/8V199NRY803L9fqA/1apV85vFTfV71Lhx41y3iuGAl7p6VBDL76tr8v9p3GabbVx2V7YCWXGVDHxQwFD/P9Lvlal+r9LYaMqOq1Wrlm211VauKxONJRYMQAYOzSwCCCCAAAI5FSi07HPhZDsDvVizz9N9sDT8g15G8uX000+3iy66yH9kigACJQh8+umn1qZNG7eF/z9LCZsXzKpKf/0HaP2Rlgum+mbBcXDCA1UX0GVQ1QoucNNNN7lGCM+g7nfUyFC7dm3X4LB69WrX3Y3G4gq/hev3CU6bNWvmAjrBTCIN0Knu/1SOOeYY1wAU3Kes82oYUmOK3qzRmBvqhlGZUltssYVrJNHbzp07d056GgXxFGxSl4vpFL01rXNtttlmKTdXavvgwYPd90WyjRs3buzedNbg8Lko+r5SnXzReCQaF4OCAAIIIIBArgWCGVI6d9TjHOjfePUB77to9tenYJYagRIVjdGlfxt90e8I5557rvt41VVX2a233upXmTK+lBGl30UUTFM3x8GiF+H07+5hhx3mBjP36zSOVvB3E40RduONN7rAm87lg2d+ez9Vo8r111/vAmx+mabBjHxl1uv3FF/Uxc4pp5ziP+ZkqnMqkFiW0qBBA1NDUqdOnVz2Wa6DdWWpO/sigAACCBSPQKFln0s++PtVtjPQCzn7XMNw6GUidePcunXr2EtDJT29+p1Pv/t9+OGHsc369OnjumGOLWAGAQSSCqh9uW3btm49ga6kTLlfoTc19Qaiit7e1JciBYFCE9BYCXobOYqizCCNsRDuji/4S5bealZ2U7DoF4UJEya4N44VQNYXnhp5gsGy4PbBeTUqadvgoPLB9X6+pPEw9MuN6h0uCvapvhqgfYcddjB1cVS9enX3y086jS1PPPGEayjT9aUqGuheY23kokycODGuyyRlsSnTjoIAAggggECuBfRvvv6z40ui3xP8utJMFeAKj6OrIJJebvHdEYaPq+7JVS8ftFKwSi/UqKirDXXJrBeBUpUmTZrYpEmT3MtDCvoo+OOLxjINvmCj69a4Xiqql4Jr/fr1S/q7kLoD1MtDvlStWtUWLVpkG220kU2bNs0GDRrkV7nMs5EjR8aNzxlbGZjRC03qdlHXrbHJwr/PBTZNOauMrM8//zzlduluUL9+fTvhhBNcNn2uXgxKt25shwACCCBQ3AKFln2uu5GNDHS1a+iPzyAP3/VCyz5Xzzt6UdvnYOi69HKNun3W72lqDwoXZbL985//dBn2wXV6CYlumIMizCOQXEBBYv1/SoVAV3KnnK8JBro0iHWirk9yXilOiECGAsHxszLc1erVq2fqLkdvSusXgh133DHhIfSWsbo5VNHby3qL2ReNX6E3pObOnesXuWl4nK+4lf/7oECSglxqkEpV1B3O/2PvTOCtnPb//5Uk13CVMtwM3VCZRSophUSmJDKPFaIMCVFpoqgQUkijDJUhMiVD/hkyZY4y1CXj5YokQ+Xvve5d+7fOc569z7TPOfvZfb6v1+mZ1rOG97Pbz9rrO6HQIm9FVAhBSNL3UIgXi0IIxVZphDwUXbt2dRNBfz8LbXhS4cFFGEMUfij2EK6FYY38PeWxJeF8mIeNUEhMhCUiIAIiIAIiUNEEwjkCbfPu7Nu3b9a6wXx99913T72PMaLBwMeHH0/XEIot7+2Mp7ufx1B+woQJzmDEL4zE1YGiDK95PL4QQp4zVwp/zBE+ervttnPXjz32WBfO0B387x/CDjJPIycwiy3rrruu/f77786CmP5E507Mi5hj0C8WW+bPnx9W56yVMXCiDP0idyjKMRRsL774otunfiQ6XytQUTEO8CCbPXt2oZIsImFAxLyMxbLly5e7PxSIYb7XQjf+78Spp55qV199dbrLOi8CIiACIiACWScQGu5Sea57n9PH8vBAzzfv85deeik2bQf8ECL5bLvttm6uxnyNuRxzm6ghT4MGDeyJJ55w87T/3ql/RUAEMhHAC5SoDUj42yjTPUm4lvjQhfww82FFsNbE1VUiAkkiwIsar8RorodwDLzcWRAhfAwvd17022yzjfNw8os3Yfm4fbyF5syZ4y6xYIPCCSHHBdbKX3/9tTsO/yHvxUMPPVTICtuXwVqZXGBh37GAPvzww92YSLLO31VXXeXyiXEfi1phzg1f1+DBg+3OO+/0h27L2Hr27Oksh9NZfBe4IThgkYgFLhZtvLCARc6OsC7G7pPYY6nMIlNFCPkyWHzzwoIdedQkIiACIiACIlDRBMaOHZtSXKCEevrpp90cI5v9CL2pUF6FYQnTtcP8goUtcpLy7va5Rn153tl4TYWLHcxdmGvgjYVSKyrMe/Dg5gcdYyW8MeGEEIzm8PjKpDyL1hceM29BYYVnF0LIaDyg4uZYXEfhlMkrDWUUIRdLKyjQmP9h0OSF+SQWzywIxQmW1Xiq8Td37lwjfn9U8BTDWEgiAiIgAiIgAhVFIGne53ApDw/0fPM+x6uExfZwTamknym83++++27nAVbSe1VeBNZWAgsXLrS2bdu64UvRlUOfgp9++sl5s9AlLRTn0INRV4pNgEUIFENeWBxhYQYPrTp16li9evWclxYLN2UREnNi4YKgEEYxTGgcQh3+/PPPaatGCYfVNRbMobBQhOIozBnGYhRKLZRboeCK/u2336ZOeWvn1Im/dlD4nfGXV9e8efPC026fxRgWsojBXFzh+2DAgAGp4kyeUKSF4Q5ZIGMByk+qKIMHWUVING8GCezhJBEBERABERCBiiaAYgcPLuYDeHinU4KUtV8LFiwwvLv23nvvAu/jTPXiEYVihtDFbKNC3wmdjBKMhQ7vKRUtFz3+/vvvXTjBmjVrFriEcuf6669PhTAscDHDAUozLLcJrRQK7cA0bn4TlovuMyegvrI+C54pls/8ZmJOV9K5xttvv+3uR1nHs4PxSSedlNYIKjoOHYuACIiACIhANggk0fuccWfbAz3fvM9hxBrMlClTbPHixam1Gc4XR/C2x1CJKEcSERCB4hPAkNDnKpaiq/jcyr3kjz/+6EKh0BCL2CVZCC/3zqkBESgGASyJcbv3gqKoc+fO/jBrWyybH3zwQVcfCh3yYRFSJ7TyRQnEIgjKt1CwJsaq2AthbsgbEXpLnXjiiTZkyJBCC1csarVr187f6rZYcftQROEFlF1Dhw51idPjrKkJe4SHl48jG94b7hOKkP6FY8MS/MgjjzSskMkrwaIP7L2Si/vJnRFdoArrzeY+4/e5Rqg3U/6ybLarukRABERABERABIomQEhDwgqThzScK0TvxCiJ3x/k6vKeYdEyzJvIBYbnHD8q4wSDIpR05BtGGYWXd1mNnOLa0TkREAEREAERSCKBpHqfwzqbHuj55n0efhZZ3yWdBUZOeHrhVY6nOYY2oeBBz5wLA2483Ih2JBEBESgZgdDpQoqukrEr19LLli0zkkwjd9xxR2yIknLtgCoXgTISuO2225xyx1eD91R5WKNccsklhtcQQlJPEsNjAe1l++23N+I9o0xCEfXII4/4S8a9hPnx8sILLxj5u7yQS+uee+4ppOTiOp5YhDgMhbbIn5VOsHru3bu3s+iJK0O4UvqDm23cIhD5x1C6lURQ5N13332x9ZWknuKWxbob5ZaXp556qsxW274ubUVABERABERABLJDgBykLLbgMfbVV19ZtWrVbPPNN3fe6+TvYr8kQjhDLJZZvEEBhiUyoZP5PVPccNQlaU9lRUAEREAERCAfCCTZ+xz+2fRAzzfv86I+n8zF8Exn3rTppps6w+Wi7tF1ERCBzASI2nDUUUe5QlJ0ZWZVoVdZrG/UqJFrk3w3hE6TiECSCAwcOLBAuDwsWAhXmG0JPbqidaM4wjLIh+9B0RR6NuEdhSu5lz59+qSON9lkE3vmmWdiF3rIU9GhQ4fYXBdFeTBhPQ0Lcno8//zzsXVgxYMSLurJSUgdn2uLRaPatWvbkiVLfPcLbbEEuuWWW4yxVJSceeaZBZR95fXcK2o8akcEREAEREAEREAEREAEREAEREAERKBiCMj7vGI4qxURyEcCrNfiEYlI0ZVDT5i493vttZfr0ahRo1xoshzqnroiAkUSiHr2EF6Q3BXZFsIhklw+KuS8ePLJJ50yyF/D2ggF8g8//OBOoSx65513XCJ4TqBQJr8XgrKJ+6PC9dNOO61A+MCwDPm4UPIVRz7++GO76aabXK6wuPBBhEYcPny4bbzxxq46vhP4bkBQtN1www3GJBCPtg8//NCFXCSPGGNEScZfmLvL3VjO/xDq8aWXXkq1glXWtttumzrWjgiIgAiIgAiIgAiIgAiIgAiIgAiIgAhkIiDv80x0dE0ERCCOwOuvv24dO3Z0l6ToiiNUSedCRRdx9Nu3b19JPVGzIlA6AnhOhQnKSYBOgtFsC/m4yDMRCmH/8Jjaf//9w9Nu/+yzz7ZZs2alzocKOP6fvfXWW+4adRBuEa8w5I8//nBhDK+77roCsZSxFJgxY4Yrwz94j7322msp5RnncEXnr3r16hwWEsIG8f+csIpRhRfhHlFkcS/j8V/UhBXCu6uiFVmFOh85EX0eL7/8stFXiQiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiUB4FXXnnFOnXq5Kr266fl0U5F17nOX54bf1Z0o9ls77vvvkt5v9x4443G4rFEBJJEIPSOot/du3d3ea2yOYbVq1db48aNXV6usF6UWYQhjBOUSeTq8kLow4suusgdXnPNNS4nnr+GxxdeUSipUKaRwyKUJk2a2NSpU13813fffTd1iVxahx56aOqYHGGjR492iira8sqzVIH/7eDhxf93FGyhHHfccTZixAiXP4w8Yl769etnXbp08Yc5scULbcGCBam+YE1BiEWJCIiACIiACIiACIiACIiACIiACIiACIiACIiACJQHAYztTzjhBFe1FF3lQbiUdf773/92C/jczgI3C90SEUgSgVatWhXIH4XnE2H6silhLjtfL0qkhx9+uIBHlb/GFvd3+uaVViirpk+f7op8+eWXdsABB9ivv/4a3hK7T3L1SZMmuWTreI+hdPKy5557uj74Y8ZOnFikatWqhnLtnHPOsfXWW88XKbANv5i5sP7669t7773nPMcuvfTSVFm8zoYNG5ayVkhdiOzgjUbIRcZMXrKNNtooUiJ7hzvvvHMBjzc85EhILxEBERABERABERABERABERABERABERABERABERCB8iBA5KuTTjrJVS1FV3kQLmWd33zzjbEAj7CQTRg4iQgkiQDK2VdffTXV5a5du1rfvn1Tx9nYWbFihe2+++7O44r6UBzhDdWwYcOM1aPY6tWrlyuzxRZbFOjnhAkTXI6tTE6hKMrGjBljeHwhK1eutEMOOSQVVpBz5M7abrvt2HUhGwlnGArh/FCq1a9f3ymC1l13Xfv999/t008/df3B3TaUxx9/3FAi4d05f/788JK1bt3azj//fNtll11cn/j+QDGGco0vefapG8HTDI+z8hJCLf7000+p6t9++23bdNNNU8faEQEREAEREAEREAEREAEREAEREAEREAEREAEREIFsEmAt9tRTT3VVStGVTbJlrOvrr7+2pk2bulqGDh2a0kaWsVrdLgIVRmDs2LF29dVXu/ZQQD399NNWt27drLcfelOhvArDEqZrjDxYhFb84IMPnIcVObJCQTmE59QXX3yROo33FAo0vLFQakUFz6ULLrjAKbsY78yZM22nnXZyxe666y7n8ZVJeRatLzxGoYbSCs+ujz76yE455RTjOyJOyOWVySOtWbNmLtxi3L3ZONetWzdDKYdsttlmLuQj7CQiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiUB4E5syZY6effrqrWoqu8iBcyjoJMcaCNIKywGsjS1mdbhOBCieAUgcPrp9//tnOO+88a9CgQbn1gZxQeHftvffeVqVKlWK1g1cU+bBq1arlttGb6P9nn31mKMEI9ee9paLlosfff/+9odipWbNmgUtz586166+/PhXCsMDFDAcozcgdFnp10gZM582bl+HOwpf22WcfV1d5PgvCP06bNs2WLVtmbdu2tebNmxfuiM6IgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIQJYIPPPMM3bWWWe52qToyhLUbFTDYvG+++7rqho0aFBKG5mNulWHCIhA5RHAjfbmm292nk54lqWTOnXq2MEHH+ySKHrPsLDsqlWrXB4wPOfwTIsTwiGioNtvv/0MJdeBBx7olHBxZXVOBERABERABERABERABERABERABERABERABERABJJI4KmnnjJS5yBSdOXQEwwVXf37909pI3Ooi+qKCIhAGQj89ttvLh8XHmN4cFarVs0233xz22qrrYz8XewXVwhnuHjxYvv8889dvrIaNWrY1ltvbXvssUcqj1hx61I5ERABERABERABERABERABERABERABERABERABEUgSgSeffNLOOecc12UpunLoyS1dutR5YdClfv36WZcuXXKod+qKCIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACFQ+gccff9y6devmOiJFV+U/j1QP8Mxo0aKFO+7Tp4+dffbZqWvaEQEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERMJs5c6Z1797doZCiK4c+EZ999pm1bNnS9ah3794pbWQOdVFdEQEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREIFKJfDwww/bBRdc4PogRVelPoqCjfMw9t9/f3fy0ksvTWkjC5bSkQiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAjkJ4Fly5bZRhttZFWrVs3PAWpUIiACWSHw4IMP2sUXX+zqkqIrK0izU8mSJUusVatWrrJLLrkkpY3MTu2qRQREQAREQAREQAREQAREQAREQAREQAREQAREQARyl8Ds2bNdOpeNN97YJk2aZI0aNcrdzqpnIiAClUpg+vTp1qtXL9cHKboq9VEUbHzx4sXWunVrd/Kiiy5KaSMLltKRCIiACIiACIiACIiACIiACIiACIiACIiACIiACOQfgRtvvNFGjhzpBtawYUObNWtW/g1SIxIBEcgKgalTp9pll13m6pKiKytIs1PJp59+agcccICrjNiSeHVJREAEREAEREAEREAERKAyCHz++ed27733WpUqVezEE0+0OnXqVEY31KYIiIAIiIAIiIAIiMBaRODmm2+266+/3o14nXXWMdZLmY9KREAERCBKgN+rvXv3dqel6IrSqcTjTz75xA488EDXg+7duxt5uiQiIAIiIAIiIAIiIAIiUNEEvvzyS2vRooWtXr3aNV29enU744wz7NRTT7Wtt966ortT6e39v//3/2zy5MlWq1Ytu+aaa2zdddet9D6pAyIgAiIgAiIgAiKQNAIrVqyw119/3XbYYYe0RlShoovxvf/++y5fV9LGqv6KgAiUP4EpU6ZYnz59XENSdJU/72K38PHHH9tBBx3kynfr1i2ljSx2BSooAiIgAiIgAiIgAiIgAlkgMHHiROvfv39sTTvttJO1bNnS9t9/f2vSpImtv/76seXy6eTOO+9sLMwgw4cPt06dOuXT8DQWERABERABERABESh3AgsXLrTjjz/efvjhB+ehRYjCo48+ulC7w4YNs1tvvTV1ft68ebbVVluljrUjAiIgAp4Axoj9+vVzh1J0eSo5sP3oo4+sTZs2ridnn312ShuZA11TF0RABERABERABERABNYiAmEIiEzDRsnVtGlTp/hC+YUSLB8lVHSxIHPTTTclcpi//fab/fTTT7Z8+XJbuXKlW2T69ddfnefeZpttZttuu6281RL5ZNVpERABERABEch9AkSumjZtWqqjRLWaMGFC6tjvDBgwoMD5OXPm2D//+U9/Wds8IKBoCXnwEHNkCHyH8J2BSNHlMOTGP4sWLbKDDz7YdaZLly4pbWRu9E69EAEREAEREAEREAERWFsIYGlLpIHvv/++REOuV6+ede7c2Y499lgj3GG+SKjoQqFHiIxcE54VoX3mzp1rb731VsrTjmf573//21lP//777xm73ahRI8O6OhcWkx599FEjuTRKOfIX+xDvGQdQyosV2VYpu6jbREAERGCtIjBu3DgjVyg5Qhs0aLBWjT2fB3vAAQe4fFt+jIcddpiNGTPGH6a2l19+ud13332p41deecW23HLL1LF2kk8gnFsrWkLyn2dljuDOO++0wYMHuy5I0VWZTyLSNi68bdu2dWfPPPPMlDYyUkyHIiACIiACIiACIiACIlDuBFCOnHXWWfbOO++UuK2aNWu6fF6nn3664SmUdAl/jKMMmjFjRqUNiRCKH3zwgfHbAUM5/tgvqVIy3QD23ntve/DBB9NdrpDzKOqOOeaYVI44PAdhznPItlRkW9nuu+oTAREQgaQQmD9/vntPYbRQVJ7LMHwy84mnnnrKateunZShqp9pCJD/dd999y1w9eSTT7YhQ4YUOMdBjx497JFHHkmdX7BggW244YapY+0kn0A4t05ytITkP4nkj2Ds2LF29dVXu4FI0ZVDz5MfrIceeqjrEYsCgwYNyqHeqSsiIAIiIAIiIAIiIAJrG4FLLrnE7r///tSwsaYlb8J//vMfe/nll+25556zb7/9NnU9uvO3v/3Nbr/9dpfPK3otScfhj3G8nQihU1GyZs0ax5oQL1g0v/vuu7Zq1apyax6vPJ5rZUpc6Ez6hQKuRo0aWe1aRbaV1Y6rMhEQARFICIG77rrL+vbt63q766672mOPPZax56eeeqrxzvOC1+1uu+3mD7VNKIHx48fbwIEDC/S+e/fuRjjDqGBo9cwzz7jTKEY/+eQTW2edddyxvLCjtJJ5HM6tczVaQjLJrn29vu2222zo0KFu4FJ05dDzDxVdvNi9NjKHuqiuiIAIiIAIiIAIiIAIrEUECBn38MMPp0bM/JR5qpc///zThcl7+umnjb8PP/zQX0ptq1ataiNHjrQjjzwydS5pO+GP8fXWW89mzZplf/zxh1t4Wbx4sf3888/G+Q022MA22mgjF/axTp06ZRrmF198YShhHnjgAcMKurTCAtHmm29uKB3xrsMqnn5y3i8aUTcKtdWrV9suu+ziwk+Wtr1s3McCZ/g583W2atXKSDidTanItrLZb9UlAiIgAkkhQC56ctJ7wWBjk0028YeFtvvtt58tXbo0dR6Fxw477JA61k7yCDC/aN26tX322WcFOo8CtGvXrgXOcXD88cfbvHnz3Hm8+t588023Ly9shyEv/gnn1pUdLSEvgK7Fg7j11ludISYIpOjKoQ8Crrjt2rVzPTrppJNS2sgc6qK6IgIiIAIiIAIiIAIisBYRCBcaGDaLDltttVVaAoTPowxeX0uWLEmVq1KliotWEKe8SBXKwR1yWrHYdsghh1hR+a3C7tevX99mz54dnirxPnlJXnrppSLvI6zf1ltvbRtvvLHztAsXkZo2bWr33HOPoWxMmhCG5Prrr7eVK1emuo6ijvBX2ZaKbCvbfVd9IiACIpDrBHiHhoYwvNsyGYOEii7mDxiF51Pez1x/XuXRP8IPX3jhhYWqTpebqUOHDqn3fehpLi/sQggTeyJUdFV0tITEQlPHYwnccsstNmLECDQusfkAAEAASURBVHdNiq5YRJVzkuTRJGJEWFRggUAiAiIgAiIgAiIgAiIgApVFAAtLwhQi22yzjb3wwgvF6spvv/3mci6QZyMUvMP23HPP8FS57pNnjAU1LMk//vhj++qrr5wVOQqgbt26xeYJoVyvXr2cRaAfe0k7WbduXXv++edLeluqPJbPKMviQhSitILh/vvvby1atLDdd9/deZNx89y5c+2UU05J1cPvCX5XJFUIi3nHHXe4zx2LnIR5P/fcc8tlOBXZVrkMQJWKgAiIQI4SYAGShUgvhMdFeZFOyBX53Xffucvbbrute7elK6vzuU/g119/tQMOOCDWO52QY97gPxxJ+/btXcQAzoXePvLCDiklez9UdFVUtIRkE1Pv0xG46aab7IYbbnCXpehKR6kSzr/33nt2+OGHu5Y7depkWDZIRCATgc8//9yFtMHKCavfTFZRmerRNREQAREQAREQARGIEmCRicUmL8cdd1zKWs6fy7QlWsEZZ5xh33zzTapYuqTjqQJZ2Pnhhx9cuL8nn3zS3njjDReSL65afhB17NixwCUUTPvss4/hmVYSIQQg1qgNGzZ0CkGUTSzOlUXo2+uvv56qAm+m/v37u7CIhEeMk4ULF1rbtm1Tl/DmwjK+uLJixQqnoEQhecIJJ6RyqnA/SrdXX33VeK5eEUeuFUIhSkRABERABEQgHYExY8bYtddem7pclKKLd6n35sWogxxfkuQSiCo6w5Gkm6eg/GK+gbT+K+ThpEmTUrfJCzuFIpE7lRktIZHA1OkiCfCbDmUXIkVXkbgqrgBxio844gjXID9svTay4nqglpJEgFwNWPGy0IBg5cpiEiGBCF8jEQEREAEREAEREIGyEIhazbJIhWFNVJiLEN6PXFX8EWIIhQj7Ubn88svtvPPOi5425sGPPPKIy92Agg1FDiESt9tuOxc2MJPld1gZoXEGDRpULEUVCdGZO4VCXqzmzZuHp2L3N9xwQ2vcuLGzMsa7aq+99rK///3vsWVLe5K+dOnSxc3xUDIeddRRjkum+shdgRW0F/J70c/iCnnWOnfu7IrjOfb222+7Nnk+eLmFoad8nXEKQ3+tsrd4aT300EP26aefuhxxzJ3LU7LVHvnSUJ6GOdTKs9+qWwREQATKk0BU0YXHc92/PJ/jhO8/DEe8sL6h/PWeRvK2ixYtch5bcR7qjObRRx+13XbbrdDAUHD6BWvmNTfffHOBMvLCLoAj5w9yIVpCzkNSB0tNIFSm+++NUleWQzeu81cy7D9zqD8l7go/JPkBixx99NEpbWSJK9INawUBQgFh1RsnO+20k7Vs2dKFtGnSpImRu0EiAiIgAiIgAiIgAiUhEF2Y2nzzzW2LLbawGjVqOKUOoWjIw8XfH3/8UWTVeEqRW4HwJF5QQFx55ZX28ssv+1OxW8KboCA78sgjY6+jbLv44osNT6TiCPmsCMO46aabFiiOBTlebHg2ZRKUeX/7298yFamUa1HlJIo/Qv4UV0JFF/cQ9pHFpGOPPTY2jCJlTj/9dKdcZD8UFrWmT5/uOJM3jDCQKDDxTMMLDGttQhGWRfj8EPaIBVO8BUNlIxbfQ4cOTRmFobibMGGCmx+Xts3ybI/PHP/nnnjiCbe4V61aNcNjDkPI0047rbRd1n0iIAIiUOkEQmt7OoO3da1atWL7xSIlSg4vffv2ta5du/rDEm9//PFHZzSwySablPhe3VA2AszNjjnmmFQIQmrDOAijHC8YOe2xxx7+MLXFgMh71/MOHDx4cOqadkpPgCgLeMrx/4KIUKwdposSUPpWCt7J5yBXoiUU7JmO8oXAddddZ6NHj3bDkaIrh55qaIGJwiuMYZxD3VRXcoRAXBLOuK6h5CIPBYov/niRSUpOgFwjP/30ky1fvtyFUSBcJAt8vLRZsCE80brrrlvyinWHCIiACIiACOQogfPPP99Z2maje4TlxkDH/5jm/Xn77bfbyJEjjXdscQWPHDzLyBcWSjoDIJRyGJA1a9bMKUNYWENBhSc87/I4mT9/vjF23uutWrVyHvTXXHONETIa4V5CBOaizJw507p3757qWkkVXc8884ydddZZqft9fel+NKK0RJmEx1koLGJedNFFzkMvPB/df+yxx5wyJ3q+uMeXXHKJ3X///a54GN6Kc1yLCoraZ599NvU5jF4v6ri82ps9e7b16dOnQJjPsC94HuKBSLif++67z30mi+vlGNajfREQARGoDAJXXHGFEaIOQYmPl086j1XCDp9zzjmpbhKyjtB1ofA7nHWOdHX4soT/xQgCwZDgwAMP9Jfydpstz+JsAIoaTDEXY07Wu3fvVPXpFF077rije+dRsEePHs6rPHVTFnbKw3M6l9hHEZGzltBurCOG3nUYAZ100knOWKxmzZrR24p1XNS4cylaQrEGpEKJI8BvEQzfkHS/WRI3qL86nHiPrjfffNN96QMfy71bb701ic9Bfa4gAuSfOOigg1JWLsVtlh/FhKTBMpeFGok5hu+//75LcovC2XvAwZgJAVsWFjIJ1tI33nhjgTALmcqX1zVc/6dOneoUchdccEG5T+Yrur3y4qZ6RUAEREAEChMgcTgeLKWRLbfc0oWiIWzeIYccUuD9yLsV62zmvnHCD20UEvxQ+eWXXwoV4RqL/eFCP4oAcn6Esu+++9r48eOz4nlFyEXaRFCU4dFVEsEqmQUGFGQo9vA8IjQjWxYIfv75Z8PLDEUg42eeVppQ1MwBLrvsslTXCNuHVXRxhZCTodIKA6lwrHjUEU4RDzusglmw5HmE8vjjjzslV3EUmIwfJWW6PhLxAsXmBhts4H7A0l4oF154oaHMQxo0aGBPPfWU6y8LaSyExglW4XEeUkW1RV3ZbM/3jf7ceeed/jB2i2IXD8QBAwY4rzQ48HkMc+jF3qiTIiACIpADBM4++2ybNWuW6wkeuIQuTCdR7y+++0LjFjy38eDmexDDjPCdF60TBQmKFOTwww9PWfxHy5X2GK/nXXbZpYA3cVF1ldXbuTw9i4vqe0mu46lPvlKvVOE9zmfglVdesUsvvTRVVZzBC2svKLq8lNWrz9dTVs/pXGFf0s8dRkv8P4mbU3s2fI4Jd81zikpZx530aAlRHjrOPQKEtyWSAyJFVw49n1DRRSgPr43MoS6qKzlGgIUiJnfvvPNOiXvGIgrxrgk3g0fS2iBMbFisYZEJKzL+2Pcu8WVlwGLDgw8+WNZqSn0/SjpCA2Alj6CwY/GHxajykIpurzzGoDpFQAREQATiCfCjlPcHFq/pBMUMP4x32GEHl0sL72YWo1jEIodVOokqY3w5cnLgObXffvu5U7zP8K664447DI+XMEo5oe9Y7CLsChKnLKAPPXv2NJRgWKyWRcj7NW7cuFQV9Ku48yfyqjK3X7ZsWer+onbwwp8yZUpRxQpdx2Iey3kvJc3RRRhKvNjiBAt7wkxmkmnTphlKwfBzA3sWGPk8odzj76qrrkop0Bo2bJhaAI3WjUIU5RUybNgwO/744wsUCUOV8DxQdqKMy/QjN/T8Cisrqi3KZrM96sNLC2VsVPA23H777Z3BFZ8b8pcwp9t9991TYTUJT05oSIkIiIAI5DoB3gHvvfee6ybveO/dFdfv8LuYNQvet6HnVmiEU5ThCeFxvbEG8wUUBMUVFDJ875I3FK+wqFeZnxdgoIIBCOGVvcFsujay4e1cXp7F6fpcmvPMe3jmhCz2gqHGmWee6bywQ49r5nf169f3xdyW9ZnQAIZ37wknnFCgTEkPsuE5XRHss/25w/gIha9XOGbihqF0+Gx82WyMO8nREjwHbXOXgP8+poeZfgPk7gjie5Z4jy7+43fo0MGNDstXftRLRKAoAuFLh7JYULMQwKQCKxp+8GMpnE6YHBI6KIyDna5s0s6zyAID8lUwYSCRenFe8KUdJ5blUWvy0tZVmvviwlnSJ5RvhG7KtlR0e9nuv+oTAREQARFIT4AFKRYpvLB4w/wUDy0Wi3i/oJgKF5982aK2WFfzozsUlCvEVvehDcNr7GOcgjcNeQW8hPNlFHMotObNm+cvp7Z4+mA9fPDBB6fOlXRn+PDhNmrUqNRtzC/+8Y9/pI4z7UyePNn69euXqUiha+RDe+211wqdL+oEiqbQUpoQfuRFKK5g7RsX5poFJ5Rm6cI9Uj8GMHiihfnaDjvsMKfUQrkVCn0K56csxKA0jUq44HnuuecWUOJRlnB/XiGIoguF0Jw5c1LVEKoSxRthM70lM+EWMRJjDhxKUW1RNpvt+bCQYR/YxxsNRaBXpGIMiXEbn4n27dunihNNwHuzpU5qRwREQARykADf73guI+G7O9pVQg2i0PDvkWhZIq2Q4ykU5isY3sQJcxa+P72g9Ip+9+NtRh5JDDn8mgjviDAnKF4u5LD0ntZ44UZzRuF9fOKJJ/qmCm2z5e1cHp7FhTpbhhOst2CUwrP0gnLz7rvvdnNG1ibwyPOCdx8GUqGwUO2fBecJc+3XSn254nhh+7JxxlD+mt8Wx3M6m+wr4nNHqGbmNuEaGHMHvLv4P8l6DtEG/Pwo3bwim+P2vNmWNVpCWJf2124CPuIBFKToyqHPAtYdeGMgbdq0KWA1mkPdVFdyjABWF2HidVw28dTygvUzCw9MzPj78MMP/aXUFktbJg/hZC51MYE7xADmpc2CDNZEpRVyc7CowGSYxQasx5nkcj5c2EOhhtU5kwXCQlaWRBPQ+36weMgiW7alotvLdv9VnwiIgAiIQHoC0UV4Ft6z9Y6bO3euC2fjW8cj7IknnnBhiPy5uC0Wvix6+UUr5i8sdHjlGMouYrTzzgu9v3xdeMPg4YU1eEnl+uuvt5tvvjl1WzSUUupCzA79Jix53JwEBRALdFzzi4Aoa1D64SFXUonmpkIJhHdYSQRFl1/04D7mPYQWilOA+XpZRKGdcIws+A0ZMqSQcgxlJR5uoaTLv9GtWzdjcRCJy2GM8ovPTpyg5MJ7kM9XdJErzoK8qLZoI1vtkfcV74BoVIF01tS0zXyf614U6t6T0FYERCCXCfBeIJSwl+22284Znnz99dcu3D5hZjF8+PHHHwt4AFEeo97we49oLG3btvVVOc9XFvPjBENX8oOGgtFM6HVFxBcf/YRQuswp+J1PDinWE0IZMWKEC+2LoQseXj6Kii+z6667unelPw632fR2zrZncdjPbOyj8CM3lxfCG/Oe9sYbhFQmh6eXOMMh0kpgKOOFtC6880IJjVPiPL592Wx6TmeLfUV87gj/yDpQOC/DGIkxhFEO8NYnLx6CIvfFF1/06FLbbI07VeH/dkIvHE6VJFpCtC4dr90EMCj0a55SdOXQZwGLh44dO7oekSRzwoQJOdQ7dSVXCWAtE1ovsx+1mg37zg9qyjAZIDyNFyx0edGESjJ/LWlbFlaKE5aASS4vcxaY8IDDkstL06ZNXUiFcBLgr+Xylri0LMax2OeFSSWThvKQim6vPMagOkVABERABAoTIIQ2SiMv5GREAZMNwfAmVJqx4BFa92ZqI5q746677ipg9cu9zHNYpFq8eHFsVSxGsXDGYllouBJb+H8nMQgiF6cXPLjDHGH+PAofFtLwdgvzHJCvigU6DI6Yd2BIQ/6JTTbZxN2KYu6rr75y8xE80PA6Ko3g4YPlrRe80EpqyITCKpwT8fsE7pkExR8Lf15Y1CQ0VZwHGB5nLPqFQpi+uMVKFKyTJk1yRVFYPfPMM+FtbtGRvGJRgTEsuAeJLnjSNx8i099bVFuUI39ZNtqLKq2omwVZPAfTSVTZSphP8p9IREAERCBXCaAM4h3v82SVtJ9EniH8oJeokoTf/ShW4uSkk04qsGiPIiua8iFUOFAHxuco3fBoD0Pwcg1FFwYKGGp4gxvOh4IHLuEWQ8m2t3M2PYvDfmZjn7kR4Qm9sRFrKeSTDD3LmbeRc8sLzDFMCSX6zmbNIVRwUjZUdMV5fFMmarTFOaS0ntPZYl8RnzvWkwf8FS7Sy0EHHeTygYbzMpRazCP8Z50yceGUszVu3xe/LUu0BF+HtiIAgfAzKkVXDn0mwuTPvED9j7oc6qK6koMEcC/2sY+9u3VxusmCC1a2JAAPhR/e0XAA4fVc32cyTYzn0D3b95mJFmPDDb5FixYuz4FfSIpal2eyCvL15eqWyTmhT1l0ql69uvtxwOSvvKSi2yuvcaheERABERCB/yMQtYBNp9j5vzuKvxdd5I96o2eqCYVYmA8T5QhKkqjwo50+Y91HWBy/6BKWw0MJa/HihDRkkYV+emHxBA+xULBKZ0EOBVtlzeVRSJ5//vmpbpVGGcICEIt1XvCKatasmT+M3YY/MFHeoZBCmRcV6iX8UNzziEtIf8stt7jFRepBKYnhTriIGOZqCdvCmjy0BmdeiILTGwKhuPMGhv6+otqiXLbaI49amKOGzyLPLp2BFfN2xvPxxx/77jqFbibjtlRB7YiACIhAJRGILraXtBt4moTexNHQ+SyUR722aIPQv3ivhIJnUdRQIapwwLsIY5FoOepBoYaiDSVMOkGpE3qvlYe3c7Y8i9ONobTn8RziPUV4SS/MJc/4K6y0F3hgVEIYQy+sZ7E+g8e+D2FMCGJyyXthbZR5VShFeWGXh+d0ttiX9+cOr3yMlsgv54X5BYZPzZs3d4ZYeLYzl/VKLsqlWwPL1rh9X/w2asBTkmgJvg5tRQAC3guX3wqhQ0fS6SQ+R1dotcCXko83n/QHo/6XHwFeXHvvvXeqAaxMsTQqrhA6honHN998k7oFa1wUYLx82bIYRZzs0OqGCQqTP+73iiUWDwjtl0loh3sIS0B+DyatPtxQpvtKeo2FizAmNB5N5GbAQiVde9EwCHGWvpn6UR68MrWnayIgAiIgAiJQngRIqo7iwQvKpXDO4c+XZstCEHH5vRQ3LCJGKVgK+9wd/Gjn/Z1OOeDrRzlADgIUCeEPen8d62wWy/ACSieEQybsoRcWaTCaCeWpp55yFsb+HJbjWJBXpMyaNcvI++ClV69ehfKh+Wvptlj3wtpLnLW1v+a3LG4RaghhfufD4PjrbLl+2mmnFVh4Ca8zJ2VRLJToZwVPwzDsYZj3xd9HG9HcKVxDweY93EvTFnVkq70wxAr1Mofm80mu3ah8/vnnbh4e5h5DycoClUQEREAEcpkA6wl4ZZVWWHNAQeUF45Uw52WcgQRrFYS5Ix9XKMVRdKFMCb9rw/tZR/AhhjlPegMMQ0Kjhahipzy8nbPlWRyOraz7zMtQOPp3LPWRx5T5COskRBXCy4I1GtaC4iSMQhOdy8SFYS7KCztqVEWbZfWczhb7qKIr2587/s/xf68kgkETc664SAfZGne0P2WNlhCtT8drLwHyzmGYR7j1Tz/9NG9AJF7RRZgVwtAhhNIIX5h585Q0kKwSiOZISpcAFWXU0qVLnYUxVsZM+pg0xoX0YeGJxa0wrBALSD4HxrvvvmssmsTl+oqzjmXAuPazwIQFFhNPL9RLSAGss0PrXH+9tFtydHXp0sV5M/FSJqdDOgWXb4OQAmGCbxa0SF5bXMkmr+K2WZ7l8NLCYo2XBJY/0cW8bLadrbZYvGRiFjc5y2Z/VZcIiIAIrA0EoqGRsbqMWkeXlgOeVigavLAYQh6mGjVq+FMFtsuWLXPhVkj+7j1yKEDieHILeGGOwR/ezHHyySefuDxbhFCKKrwIy0h+q3T3RvscZ0UehlXEY5y5UlFKuLh+luUcHm4oA72kU/r463FbrKjDhT5ya/gcJnHlOcccirkUwnsYpQ1GUAgLYPyuIccDizteWCAkvKAX5oJY4YfM8Aw766yzfBGnSPTGV1hrR8Np1q1b17BSrlatWuoevxMql+hbqMilTKa2uJ7N9uIW4MjJxhy8YcOGTkHKPB3vAizZybURSvSzH17TvgiIgAjkCoGowsL3i/BpGA6QLoBwvYSZ3XTTTd37K7TG5z0ahgGOKrr4Lo1GoyHMMAvoUeHdguFL+FsxqnCI3pPueMMNN3Qe43vssYeLJuPnFN27dzfC83opD2/nbHkW+z5mY+sXmUtbF0pD2HmPdOYQfp86iVaDx1coRXlhl4fndLbYl/fnLgzbyWcVY5rw/1XIkX0UbfD04bSj17M17mi9SYmWEO23jnOPAGvU06dPd6Hfw+gHudfTkvUorxRdaNPRRkpEIBMBwrKEMakJEYOlEgtFWBATQocXGn/e+jlTfcRORhnF4kyouOEecl6hkGCRK1RWhfWxMEKer1CwNmXiEyY1D6+zzyQXxVI4iY2WKe/jqNKQhRfc6Isr2eIFW76gsf4iPwZhKVHSYeHEBAUr5jBOeXH7Fy2HAguraBaE8OILLc6ZcJCXBQUpwo8Cwk4QUqA0Up5tMUnk/wGLcFiJsbDF4hVWfCzuSURABERABEpHIPTQoYbo4k3pav3vXbxfCO0TepST74pFfr7DSVRPknregxiCsbAVKkiopU2bNk75FS5YsbA1evRo974iJ4hXtET7yg8gFsJYSAkF45h0nvGE3EMx4wUrZRawvGBkwyLM8uXL3am99trLGYz46xW1jc5n6BMLRCURFGVhvizyNeAVn0kIkRi2w8IKISGZ1+ARRv6xUJo0aeJ+62CMhBGVl2g+Fq6FCejJyeEVXcwvWHwJhfkKuY7jhLxgfgESi0887kJDqExtUV822+P/ADlgoh4Hcf2OO0deDfLMSkRABEQglwmgAMJ4FI8eL8wn+C5HsRUV8oXzHvOCwj/MKcTaAvd7iSr9+U7lnZFuvSLqoZxJ4YABMAYaUeG3MV7dPqQv8xnC9iHReUQ4l8qWt3O2PIuj4yrt8bhx4wqtAZWkLt7jzL3CPF38tg9TL3AdtqEU5fEdGrdwXzY8p7PFvrw/d8xB/f85vNkxxOL/FQZdKI/5vBL6mPUu5mr8hf/PQs7sZ2vc0XqTEi0h2m8d5x4BH9oeg0WifeSLJF7RhcUeIeIQfvyx2C0RgUwEsHKJLtJkKp/pGm7chPfzP/ijVq1+UpkusR/KMZQj4QQE6+wePXqknWiG/SEpPHkyKkv8+Hz7JVV0ZYMXE28W5sIE8L4/4TYuREN4vTj7sGaig6DAIikswrm454AClUUv//lwhYv5T3m1hcU2i4zhQmnYJbwFCB+BFTQTYbzSWEiViIAIiIAIFE2gVatWzlDGl0TJg3d2tqQseTswumHxKfT8oV/00eeW4ho/evD48vk4o30P595cW3/99e29996L9QbCaAgmXggxh6EF4Q5RxmE8gve8F5RuLC5UtETDJKEMQSlSEuncubMzePL3FGeOxqIJi1UYWRUlWMDjpYRhVtQ6H8t8LPS9RMN0E4OfvBwIykXe7d6SvqiIGCyAhsZC0WeUqa3yaA9meKuVVNmFIjhcCHYw9I8IiIAI5CgBvvPxzPZCKgOMIeIEJRa/yxHe43hihxI1OMATlvIozbjG+4stwu9Xfg+GyiqMYTAy8JJO4cB8gu9njDGigrEFijovoRc03mmEMfaSbW/nbHoW+z6WZYshDIbOcXk3fb08azyVYYOyj7UODGu9wJl1qFCiRsQorYjYE0p0/SU0hKFctj2ns8m+vD93rO/4dTuiJjAPzKTICrlG97M57mjdSYmWEO23jnOPALkVWcPFO7Sk8+rcG83/9Sjxii48Zk488UQ3Iqxe0G5LRCATgXQuxJnu8ddYoCHcC581rH3/+c9/+ktuS2jDUGnFpCT8wiCcHZMNQtmgaMCThsmkF5QiTDZCayosRvDuwiIEzzEWzLynF9fC8DXUgxUKZdDIk4QbryMsT9jiXUaMbBaYUL4Q7oaFr9Jat+JBSd+8ELYPS5jiSll5oRREycU4ixLGP3HixLT9I8wknn54yLHwFhe+x78IaMtPyHm+TOrTLVKR7yLOS6qo9rLZlmdDXwhhlUm22WYb5xk3YMAA55EGBxRe2coxk6ltXRMBERCBpBNgDsC7zUt0AcGfL8s2GlamqLqwmsbbKBq+xt/HPIDQd6HwA5/5Uv369Z1iBU8eDCBYCGN80aTyvI+Zp0SFewixhKd1UcLcCKOU0i4qFFV/pussZhCyxgt9+OijjwopBf31uC1eT3g/ecHTLsyp5s9HtygvMTDJtOCFshAFoV/kJBQlz9MvyFAnShyUOQh1kbuYPFVINIQmhoH0l+dKSMq4Z+du/N8/obcAxliEOvFSVFuUy2Z71MdiF3znzJnDYbGEzzkcJCIgAiKQ6wTwXt1+++0LvBcWLVrkDEvi+o4xA+sECO8JlGJRia6BYMHPOx5PFR/mlXcCIXPx+sag1wtrGKNGjfKH7js4GpqX8G18J2O8ElV0EV2F39ehsF6BxwxCuxjMsNiKZNvbOaroo42yeDJzf2mF99DNN99c4HbWjFA6EmkI4/3mzZu7CDLhfCiq5OG3OXlgQ4kaIrHuFOZmo2xRXtjZ9pzOJvsoA8aTzc8dEXswfPISpyj014raZnPc0baSEi0h2m8d5x4B5vT8DmBt2OcMzr1elrxHiVd0hT9M4xb9S45Ed+QzARYGmJR5K9a4saIE4gc/Ma9ZMMDiicV/wtX5BYa4+zgXtVwOy2EdTZiAdMIEk4UMLFW9xFlfU49PVh61OOZeJpKh9ZevK92WhRASlZZGmAiz4OalpDm6ysKLxSQWkMJniQUb1mY8Y5R7/JFw1SsbsYoi5nmcsBjpLcmGDRuWyv0XlsWyDYs2hLCIWNMw8Q8XmsLy7IeeX+G1otrLZlu0yyIa1mNRYQLNDylywvG5QZGL8pSE7UwmEXnLRqnpWAREQATiCYRx831IY+YP2RYWM/DqQUHF93dU8PrBC+eMv6yyefdlEryT+TGfSdGS6X7mRvzoxrMrTljQKUrBgOcwxiheURNXT3meI8wTi4CeQVGJ1+P6grU1oQr9giE/HLHIL47wewbFE95WXlho5NnhYRenpCS3F15jzEH4rGGdz2KZFz4fWHszJgypot7ZeNQR8oj5blGCwoxQUswZqDc6rqLaov5stkd9LMYxv4MZf4R5xFjJz92Z04VhIdMZHlGXRAREQARyicAPP/xQIIcWiiAWztPJkCFDjBC2CO+DuFwrvJN4Z/j3XFxdPqQhvwH5LeiNb3nPoyChH0icwoE+oChAcRa+s1hLwYglmscomus7jAzDmgbv5HSGpGHfi+PtnG1P5rD94u6zZsE7mfdlKISUxpAlzsg2LBf9TKCo5B0YKsN4V4c5wuNSuxTlhU2b8M+W53Q22Zf35y4M1QwH5mGsC4VKX85HhXQnKAmYh7C2htIgm+OOthddQ8vVaAnRfus49whgNMb3M04BhCbPF0m8oisMNcJLjhe4RATSEcBSKHS7Z1GGiRgeWnXq1HGLAHhphbkr0tUVdx5Pq3CRwZfBywklUDgR8df8NhqOiMUSvG/Ce1gIOeWUU1LKHcqEygsmTlGrHV9/ui2WQ1FL7nRlo+ejkwFC+JGzrLhSWl5MjFEChjnUWIBBqYVyKxT6gyebl3RW56HiidjWoQLP3xsmxkXRhVIotCZmwQjlG5NY73XHjw1eGt5CzddVVHvZbCsaYtL3AU80mDEWhIVKFkz5TBAywouMCDwJbUVABEQgMwEWkAjPg/c0Px7w/i1vYUECQwUWpJgz4K3Nu7Akc5m5c+c6ZZQPYVjcPvOOw/L6+OOPT3sLCxMY8sQp5Phhxb0svmFoVJnCQhOe3XigMScryrgprq8oc8hBwlyyZ8+ecUXSnuOzg7KMkFMskmB0VZw+4MnPs+a5R4WFlh9//NEZAEWvlfQYBR6LnH6hM3p/Ntui7qLai7YfPSafHGEWvZRE8ejv0VYEREAEKoMA7wO8eni/I6xfeGPLuP5E1wD47cn7NSpEY8H7KzQUpQy/YTFIad26deoWb+nvT2As6g1nmG+ERpH8ViSyC+8i+k5qEd6HeCmxXpBuLhTm4sLDi9+mXrLt7Zxtz2Lfz+JuJ/5lzBMNNchzxRgoGlI6rk7SNRxzzDEFLhHdijWsUPjc8D5GmBNiGIUixAvPJ5PHty/H3C1bntPZYl/enzvYwHj+/Pkeg9vy/4L0J35eRmQm1hWZM7M+x743csLIzCudszXuAp3564C2khAtIdpvHeceAdY9ye2HgSRrrPkiiVd0EaaDcBoIi87Zyr2ULw9Y4yhIILrgzyI/MamzKSi6vJKDelkQQEsepwDz7VKeCQcWNl6Y8OAtxGQFC1VyK9H/cGIa9TxisYNEsn5S7Otiy6IXi0hcYwEO4f8Mk2YsrUoj0dxUeIYxjpJISXkxwaGNcIyEL8WKLFQK0gfCNuDhFko05I6/Ru4KlGAI4RZuueUWfym19S+C1Ilghx8I/HjAMjoaIpBnR2iIUIpqL1ttER+ayZlPrOr7kCl3SDQ2N5+pW2+91d+qrQiIgAiIQJ4SYF7NogsLKuF8IzpcFlZIws1iVqb5jb8P63IsxbEIZyEMK+OOHTu6OoqyYvZ1aCsCJSHAgiILiwgKWeaE+qw5HPpHBEQgAQT4PYbxBYad/JZkITKd4NkT5lLEEDOaYsHfyyI+YQS5h9+veKvw2zdqWMFvRwxL8STjvU3YYowhvVx99dUuZxT3YdAbzgXoM+991h9QdqUTFARn/OV5jiEMfYr+bs+2t3O2PYvTjSvuPPMePH68kNqAiCvR9Qt/PboNDfz9NdYeqDcUb7Tjz8WFaCyOFzb3Z9NzOlvsy/tzR9hqDMu//vprj7DAFk+6TJ6GUS+6bI27QCf+OkhCtIRon3WcewTOPvtsF/EKw/eogjf3elv8HiVe0fX888+n8t8QrgxtpEQE0hFgAjV06NDUZRSjKHuyKShhsMj1wkKOjz/tz0W3WH2gqCmJ8BIldxITz1DIV0V+LsIGoNhiQrrjjjumwgVgqcIki3wZWFfx47+0QogBckl5IXY3yrmSSEl5RSd55B4hhGLcJDGaL4N+EaaPED5RQelJkncEZRWJWqMSzb3ir8MZFj78D7lLQhd3+key91CKai9bbUWVVvShqJBM0djhWOsz4ZOIgAiIgAisHQSYS7C4hXcRcwYUBMwnWLQif1e42FUSIijPmLdE5y4lqUNlRaA4BDDoYQ6E4HmAsZhEBERABJJEgN/tvDfTedL6sVCG6EYYOCL81uU3b1kFA1PW13hnY/gYFYxnMc5l8b+0QhsoDvBkjhMYZNvbOa6duHNl9SwO6+R5MFYWlFmPCsM7huUy7Z9++ukFosk8/fTTbp0nvAflFN5xKGyYq5FTM85jPhte2OXpOZ2JfXl/7lDy4s2GkqokQiQh1k3SeTAWp65M4w7vT0q0hLDP2s89Ajh98D3Cd0Vpo3zl3qj+Cjv614vjz1zsWHH7hLUKX/hIpvw7xa1P5fKbQDRPETmWojkLykoAl/sw9E+cpU20DRKgY7GEYBVVu3ZtI/ZuOsFDB4+jaKzrdOXL6zyKQty4vZRGIVJSXmFIP8aPQipuwY1n0KFDh9g45HjY7brrrr7bbgvPESNGuH0m81g0RMMARZP4+gqwnCL0ghcmsdRPTjgERScKz1CKai9bbRGCEUWbF6zteG7pQiSwuMlYwtjuTPJY3JSIgAiIgAiIgAiIQBII4HG4aNEi11Wif2AFLhEBERCBfCXgPV0YH0aXYbi6fB1zksZFJBzeSXhQ4ElXGiEUsc/nSQqLkoZILk2bme7JZ89p1nMwliH3Lt6PcYICmnCGGDSj5DrwwAMr1JBL0RLinorOlYTAmWee6QwjeF/w3sgXyStFF6HBcOuWiEA6Aj7Znr/+4IMP2t577+0Ps7LF84VcF14I/1PUZIYcXj60HMoZFCOED2JChGcWYfpQNBD/mh/u/MV5MPk2K2pLrG4ma16wGCI0YEmkpLzCWN4obZ588slCzZEMlHAAYSjIsBAhElB6hoJ3HPm1vMSFT2Ai48M++nK0Q6jCqPAcvftvadrLVlvkbAuT3qJERdEV9+OHBLbklsGAwIusoD0JbUVABERABERABJJAAItoDCCxbEeGDx9ewNM+CWNQH0VABESgJASWL19u+++/v/PAzqcFy5IwUNmKJbC2eE7jHbd48WJjrQQFGGFEt956a+dFGQ35WbFP4L+tKVpCZVDPjza9lyjROsjnly+SeEUXHjksIiPpQpK5i/pHBP4iQMLz0AWZEG3Ens6m+C8LXyfu/oTVzCRMSv/1r3+5InzJ4N2VC4qsTH3mGmERsALwkk7p46/HbUvKq3379qlEiXheobTx3lnEA8d76brrrjPcub3gNUZoQS94auGaG3o14Rl21lln+SLWtWtXp/TxJwgFEQ1zWbduXadcj8v5ECqY6B9eZKFkai+bbcWFLiQnG0pfFoFIVMzEjRcboRtZHAqFnCrnnHNOeEr7IiACIiACIiACIlBpBMgVM378eBfOivkaxkWhMNdnzu/lqaeeKlMoIV+PtiIgAiKQywQwnCUE4Prrr5/L3VTf8oSAPKfz5EFqGGstAe90sM022xgpYvJFEq/oChfaSbgZeiLky0PSOLJHIPQGotbu3bs79+/stWBO8RPmgOKHOK7lmeTkk08u8MWCkqRLly6ZbsmJa3idEQ7GC7Gm77jjDn9YrK13l/WFi+JFeMSwDaxomGRhXYP3XJjklTqbNGlihI8kye67777rmzHyooVJe7kWxh6PKrrIVUI4wVDikrv669OmTUt9tnBrf+eddwrEHs/UXjbbwpr58MMPT+ty7/ubbovSFYsliQiIgAiIgAiIgAhUNoFvv/3WWrVqZb/88ovrCkZPhJBu165dqmuEoiZENMKiL3OuJBiQpQagHREQAREQARHIYQLynM7hh6OuiUAxCfgUOtttt52LKFbM23K+WOIVXaFXRL49nJz/9CSwg/wwDnNf4elDss5sik/o5+vEpfuSSy7xh7HbUClCAX60Dxs2rMgwK3gwEaYP5U7Lli0LKFJiG8rySbT+KOm8oBDxucb8uaK2JeVFGEcUTiStLUpIyouXEu7lhO9Dgehlzz33TCUp5xxhDsMwlr1797Zu3br54kbC1hYtWriEwJwkFnOY+ypV8H87xHIOFWkjR44sYHGcqb1stwUzvNXSxZeO9t0f6zvVk9BWBERABERABEQgFwjgnYUxUih46GPA1KZNGxfyGyMsFGIIeW2ZC0pEQAREQAREQASKR0Ce08XjpFIikGQCPuJZvXr1jGh5+SKJV3Q9/fTTxkI5UppF9nx5kBpH8Qgcd9xxxkvbS9Rrx58vy5YEoSiuvBAiLsz95M+H2z///NOOOeaYVE4nf40f5+eff75Lconn0jfffGPvvfeevfnmm06hxL4PNYdShR/5FSkotbAC8IK1LDGMw5CA/lq6bWl44UlFji24pROUmlj4+rjJK1euNDzOfIhI7sMjDWUOQl0oC4m9jMSFtZw+fbrz0sJD65FHHnHPxRVO8w8LLbSBkLuMHGZeimovm23RJqEc+SyWxOuVsJ5wkIiACIiACIiACIhALhBYuHChMyQiJ0UozM0wSHr99dcLhK8eNGiQESZbIgIiIAIiIAIiUDQBeU4XzUglRCAfCHTq1MnI6ZhvaaASr+iaPXt2KsRbviVQy4f/OLk2hrFjx9rVV1/turXeeusZilLyLGVTPvvsMxeq0CugUIjgWVSUoCAiRurXX38dW7R69eoZvZiaNWvmQvTF3lxOJ8nthHeVVzjxRUnC75JIaXmhZENJhveTFzzhyDt18cUXO6WWP++3b731luFhh7KL5z9z5kzbaaed/GXn9dW/f383HsJPYtkQFfI+1KpVy3bYYYfopULHKM0Il4kCEI+y6OeAc5nay2ZbdI4whnh1wYw/PAE32GADp+wjbxdW0mFYyMGDBxt51yQiIAIiIAIiIAIikCsECEtIeMKiZKuttrLnn39e+WqKAqXrIiACIiACIvA/AvKc1kdBBNYOAh07dnQGYvXr1zd0K/kiiVd0hV/CW265pdNG5svD0TiyTwCFTN++fe3nn3923i0NGjTIfiN/1YiC4u677zbyxvXs2bPYbZBAFq8b7i+J7LPPPkbuqvIaT6a+4DV17bXXWtOmTQ1PK+9Bleme6LXS8uJ5oij75JNPXNjGXXbZpVjtwxmlWM2aNaNdcQqgH3/80XbeeedC10pzAoUnVsb8xQkKp2y1V1Rbce2H52688UYjxKKX4ippfXltRUAEREAEREAERKAiCKDAGjJkiAtVmK49woATlkUiAiIgAiIgAiJQPALynC4eJ5USgaQTIJUP0cIw/n/yySeTPpxU/xOv6Jo1a5adffbZbkC1a9d22sjU6LQjAgkksGrVKpc7Cu+zdDmVUJqg1CFPFEquAw880CluEjhcdTmHCOBdNnHiRNcjPN4WLFhg1apVy6EeqisiIAIiIAIiIAIi8F8C5KpFmcWc2UcX8GyaN2/ujM7wqpeIgAiIgAiIgAgUn4A8p4vPSiVFIKkE2rdvb0S9wsj/iSeeSOowCvU78YoutI7nnHOOG9hmm21WKMdRoRHrhAgkiADhDAkPSAg8FGA1atRwuegIgVcaz6kEDV1drQQChHV8+OGHXcu77767C+1YCd1QkyIgAiIgAiIgAiJQbAKEsyZ3K1boCKGnyZeLEaREBERABERABESg5ATkOV1yZrpDBJJE4IgjjrB3333XdtttN3v00UeT1PWMfU28ogut47nnnusGiRIAbaREBERABESg5AQOPvhgW7Rokbvx1FNPTeWzK3lNukMEREAEREAEREAEKo7AmjVrXH6BX375xdq2bSuDsIpDr5ZEQAREQATylIA8p/P0wWpYIvAXgXbt2rkoTnvuuWfK4D0fwCRe0fX4449bt27d3LP4+9//bu+8804+PBeNQQREQAQqlAD5vRo2bGirV6927Q4fPtw6depUoX1QYyIgAiIgAiIgAiIgAiIgAiIgAiIgArlDQJ7TufMs1BMRyBaBQw891KXLadSokc2YMSNb1VZ6PYlXdD322GN23nnnOZAbbbSRvf/++5UOVR0QAREQgVwj8Oqrr9r48ePts88+s65du1qHDh0KdHHevHkFErY/9dRT1qBBgwJldCACIiACIiACIiACIiACIiACIiACIrB2EZDn9Nr1vDXa/CfgIzo1btzYHnjggbwZcOIVXcSRPP/8890DIWfRggUL8ubhaCAiIAIikA0C3377rbVq1coI54Oss846NmbMGOeq7OsfMWKEkXQWwWiAWL1K4O7paCsCIiACIiACIiACIiACIiACIiACIiACIiACySdw0EEH2ccff2xNmjSx6dOnJ39A/xtB4hVdM2fOtO7du7vhVK9ePZWEOG+ekAYiAiIgAmUkgHcWXlyhVK1a1W6//XZr06aNffjhh0ZOLhRiSOvWrW3SpElhce2LgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAgknMABBxxgn376qTVr1symTp2a8NH8X/cTr+h65JFHrEePHm5E1apVs48++uj/Rqc9ERABERABZwBA/F3CDYSy7rrrWosWLez111+3FStWpC4NGjTITj/99NSxdkRABERABERABERABERABERABERABERABERABJJPgKhPS5YssebNm9u9996b/AH9bwSJV3Q9/PDDdsEFF7jh4KHwySef5M3D0UBEQAREIFsECEtIeMKiZKuttrLnn3/e1l9//aKK6roIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiECCCGD0/vnnn1vLli1typQpCep55q7mlaKLvDNoIyUiIAIiIAKFCaDAGjJkiAtVWPjqf88MGzbMjj/++HSXdV4EREAEREAEREAEREAEREAEREAEREAEREAERCChBPDk+uKLL/IudUniFV0zZsywCy+8MPWxQtGFwksiAiIgAiJQmMAff/xhKLPGjh1rf/75Z4ECvOjuvvtuq1KlSoHzOhABERABERABERABERABERABERABERABERABEUg+AXJzffXVV0aurokTJyZ/QP8bQeIVXQ899JBddNFFqQdC6EJCGEpEQAREQATSE3jxxRdt4MCBLn8XperVq2fTpk2z2rVrp79JV0RABERABERABERABERABERABERABERABERABBJLYJ999rFvv/3W2rRpY+PGjUvsOKIdT7yi64EHHrCePXumxvXxxx/beuutlzrWjgiIgAiIQDyBNWvW2OzZs+2XX36xtm3b2oYbbhhfUGdFQAREQAREQAREQAREQAREQAREQAREQAREQAQST2Dvvfe27777zq0FEvEpXyTxiq7777/fLrnkktTzWLhwoVWvXj11rB0REAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERWNsJNGrUyP7zn//YoYcearfffnve4Ei8omv69OnWq1ev1AP54IMP7G9/+1vqWDsiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIisLYT2GOPPWzZsmV22GGH2ZgxY/IGR+IVXeSUufTSS1MP5P3337eNNtoodawdERABERABERABERABERABERABERABERABERABERABERABEVjbCey66662fPlyO/LII23UqFF5gyPvFF3vvvuubbLJJnnzgDQQERABERABERABERABERABERABERABERABERABERABERABESgrgZ133tlWrFhh7du3t5tvvrms1eXM/YlXdE2dOtUuu+yyFNC3337bNt1009SxdkRABERABERABERABERABERABERABERABERABERABERABERgbSfQsGFDW7lypXXo0MFGjhyZNzgSr+i677777PLLL089kPnz59tmm22WOtaOCIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACKztBOrXr2+//fabdezY0W644Ya8wZF4Rde9995rvXv3Tj2QN954w2rVqpU61o4IiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIrO0Ett9+e1u1apV16tTJhg8fnjc4Eq/ouueee+yKK65IPZBXX33Vtthii9SxdkRABERABERABERABERABERABERABERABERABERABERABERgbSdQr149W716tR1//PE2bNiwvMGReEXX3XffbVdeeWXqgcybN8+22mqr1LF2REAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERGBtJ7Dddts5BCeddJINHTo0b3AkXtE1ZcoU69OnT+qBvPTSS1anTp3UsXZEQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREYG0n4BVdp5xyil1zzTV5gyPxiq677rrL+vbtm3ogL7zwgm2zzTapY+2IgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIwNpOwCu6TjvtNBs8eHDe4Ei8omvy5MnWr1+/1AN5/vnnrW7duqlj7YiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIjA2k7AK7rOOOMMGzhwYN7gyDtF13PPPWckVJOIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAj8l4BXdHXu3NmuuuqqvMGSeEXXpEmTCjyQZ5991rbffvu8eUAaiAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiUlYBXdHXt2rVASqiy1lvZ9yde0TVx4kTr379/iuPs2bOtfv36qWPtiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiMDaTsArus455xy78sor8wZH4hVdEyZMsAEDBliVKlVszZo1NmvWLGvYsGHePCANRAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQATKSsArurp162a9e/cua3U5c3/iFV3jx493SdPWW289++OPP+yJJ56wnXfeOWcAqyMiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiUNkEvKKre/fudumll1Z2d7LWfuIVXePGjbNBgwZZ9erV7ddff7XHHnvMdt1116wBUkUiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIikHQCXtHVo0cP69WrV9KHk+p/4hVdd955pw0ePNg23HBDW7Fihc2cOdN233331AC1IwIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAJrOwGv6LrwwgutZ8+eeYMj8YqusWPH2tVXX22bbLKJ/fTTTzZjxgxr1KhR3jwgDUQEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEykrAK7pQcqHsyhfJG0VXjRo17IcffrCHHnrI9tprr3x5PhqHCIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACJSZgFd0EbaQ8IX5IolXdN1xxx12zTXXWK1atey7776zBx54wBo3bpwvz0fjEAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREIEyE/CKrssuu8zOP//8MteXKxUkXtF1++2325AhQ2yLLbawb775xqZNm2ZNmzbNFb7qhwiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAhUOgGv6Ordu7d169at0vuTrQ4kXtF122232dChQ+0f//iHffnllzZ16lRr1qxZtvioHhEQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQARFIPAGv6OrTp4+dffbZiR+PH0DiFV1jxoyxa6+91rbZZhv7/PPP7d5777XmzZv78WkrAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiJQCQTWrFljf/75Z+rPH/utv+aP/TbuPN3318Nt3Pm4+/05tuH9JT0f1x71xZ33dZelPV9HtN9x7eVCP/xYfb/XWWcdC/+qVKnijv3WX/PHbBG24Tlfjm143pctznlfR3i/P+fv99f8eX/st9k4n67Pvg9Vq1a1dddd19Zbbz235dj/cd7v+3Jxx5SjPokIRAl4RVffvn2ta9eu0cuJPU68omv06NF23XXXWd26dW3JkiU2ZcoUa9myZWIfiDouAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiJQeQRWr17tFCFs/f6qVasKnQuvp9sv6X0oCbjHt5uu3rjrme6j3ri6/LmwvnRlw/P+vvBc3H7lPUW1LAIigAKsWrVqTmHmt+uvv36Bc/58pq2/huKN+9nyx/nwWngc3fflwy3KuKigIP3jjz/st99+c5c22GADp9iLltNx6Ql4RddVV11lnTt3Ln1FOXZn4hVdt956qw0bNsy23357++STT2zy5MnWqlWrHMOs7oiACIiACIiACIiACIiACIiACIiACIiACFQEgZUrV9qyZcts6dKl9umnn9rHH3/s1ozYX7x4cUV0QW2IgAiIgAiUE4FNN93UdtxxR9thhx3cFr3AFltsYdtuu61tuOGG5dRq/lTrFV0DBw60M844I28GlnhF16hRo2z48OFWv359W7RokU2aNMlat26dNw9IAxEBERABERABERABERABERABERABERABEShM4JtvvrGFCxfayy+/bDNmzHC52wuX0hkRKDsBH66OmsJ9X3N4zoeLi57z50tzT9y9YT3sh2X8vt+G18Nzvo50131Zvy1JuWzXHVdfSfrjx+C34b3lUTd14p1Umq27qQz3+3aLWw/eoHhQ8ff777+ntv7+pG0POOAAO+SQQ6xRo0ZOERbnOZa0MWWzv17RNXjwYDvttNOyWXWl1pV4Rdctt9xiI0aMsJ122sk++OADGz9+vB100EGVClWNi4AIiIAIiIAIiIAIiIAIiIAIiIAIiIAIZI/Av//9b3v77bfttddes3vuucd++umnElVO+KunqWhCAABAAElEQVSGDRtagwYN3Nbv16xZs0T1lKSwX2z2W+71+34b1ufP+W268v56dBtXV1wd/r64a+E5X186xUB4nrLhcbr9aDnfRvR8eH+ma2G5cD96T7p2ouXCOsL98H7ti4AIVCyBn3/+2TBs+Pbbb932s88+s7feesv9ff/990V2huhvRx55pHOOqV27dpHl872AV3Rdc801dsopp+TNcPNG0bXLLrvY+++/b3feeacdfPDBefOANBAREAEREAEREAEREAEREAEREAEREAERWNsILF++3F566SWbO3eu3XXXXUUOv3HjxnbMMcfYXnvt5cJZkQdGIgIiIAIisHYQ+O677+yNN96wV155xUV8w0stTvDyOvPMM61du3Yuv1hcmXw/5xVdQ4cOtZNOOilvhpt4RdfNN99s119/ve2xxx7OsueOO+5wrol584Q0EBEQAREQAREQAREQAREQAREQAREQARFYCwig3HryySft0UcftTlz5qQdMSkrWKREuUVuFnnepEWlCyIgAiKwVhIgBCNKr+eee87GjRsXy+Ciiy6yU0891WrVqhV7PV9PekXXddddZyeccELeDDPxiq6bbrrJbrjhBhdz880337TbbrvNTXby5glpICIgAiIgAiIgAiIgAiIgAiIgAiIgAiKQpwRWr15tL7zwgk2fPt1mzpwZO8r99tvPrfW0adPGttpqq9gyOikCIiACIiAC6Qh8+OGHNm3atFilF3mqzj33XKtTp0662/PqvFd0DR8+3Dp16pQ3Y0u8omvkyJF24403Oiue119/3UaPHm2HH3543jwgDUQEREAEREAEREAEREAEREAEREAEREAE8o3AsmXLbOrUqTZ58mRbunRpoeGRi52QSkcffbRtsskmha7rhAiIgAiIgAiUlMAvv/xi9913nw0ePNjWrFlT4PbOnTtbjx49rEaNGgXO59uBV3QRJe/YY4/Nm+ElXtGFkgtlV7NmzWzevHk2atQol1wub56QBiICIiACIiACIiACIiACIiACIiACIiACeULg+++/t9tvv92mTJliK1asKDCqqlWrOuPl008/3fbee+8C13QgAiIgAiIgAtkiQA4vPIkHDhxoK1euTFVbpUoVI6Tfcccdl7dhcb2iC70KuS3zRRKv6CJsIeELmzdv7pKUkrOrffv2+fJ8NA4REAEREAEREAEREAEREAEREAEREAERSDyB3377zcirPmbMmEIKro022sh5b2FNv+WWWyZ+rBqACIiACIhAMgig8LrnnnusX79+BTq8//77u3RJtWvXLnA+Hw68oivf9CiJV3ThYsdDadmypc2dO9d5d3Xo0CEfPnMagwiIgAiIgAiIgAiIgAiIgAiIgAiIgAgkngDrNX379rUlS5YUGMvGG29sZ511lnXp0kXhCQuQ0YEIiIAIiEBFEsDDGEOMW265pUCzd999t7Vo0aLAuaQfeEUXYz3qqKOSPpxU/xOv6BoxYoT7ALZu3drmzJnjNK0dO3ZMDVA7IiACIiACIiACIiACIiACIiACIiACIiACFU9g+fLlNmjQIJs2bVqBxtdbbz0jPGH37t3zPhdKgYHrQAREQAREIKcJfPbZZ3bllVc6hxrf0V69ern31TrrrONPJXrrFV233nqrHXHEEYkeS9j5vFF0HXTQQfbMM88Yii9iaEpEQAREQAREQAREQAREQAREQAREQAREQAQqh8D8+fOtR48etnTp0gIdICIPyq969eoVOK8DERABERABEcgVAg8++KBdfPHFqe7gZDN27FirVq1a6lxSd7yi67bbbrN27doldRiF+p14Rdfw4cNt1KhR1rZtW3vqqaeM406dOhUaqE6IgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiUP4HJkyfbwIEDbfXq1fbnn3+6BsnD1b9/f63ZlD9+tSACIiACIpAFAl9++aWRO3LBggWuti222MKee+4523DDDbNQe+VV4RVd5M085JBDKq8jWW458YquYcOGGW52hx56qD355JN27bXX2oknnphlTKpOBERABERABERABERABERABERABERABEQgEwEUWyi4Jk2a5BYCWQz89ttvbaeddjIsx+vWrZvpdl0TAREQAREQgZwisGrVKvdew4ADwaPrrbfeSrSyyyu68FDDeShfJPGKruuuu85Gjx5thx9+uD322GM2ZMgQO/nkk/Pl+WgcIiACIiACIiACIiACIiACIiACIiACIpDzBFBy9ezZ02bMmGF16tSxjTfe2D788EPbf//9nZIr6RbwOf8A1EEREAEREIFyIzBu3DgXdpcGNttsM3vllVeMfJNJFK/oGj9+vJEOKl8k8YouPLjGjBljRx11lD3yyCN29dVX26mnnpovz0fjEAEREAEREAEREAEREAEREAEREAEREIGcJ9CnTx+bMmWKNWzY0GrVqmUvvPCCtWjRwiZMmJAXOU1y/gGogyIgAiIgAuVKAK+ufv36uTbatGljKL+SKF7RNXHiRDvggAOSOITYPide0TV06FBnGdShQwd76KGHbPDgwXbaaafFDlYnRUAEREAEREAEREAEREAEREAEREAEREAEskuAsISsz9SrV88aN25s06ZNs5133tmmT59u5OaSiIAIiIAIiEA+ECDXJAoihP2zzjrL7SfpH6/oIsxw69atk9T1jH1NvKKLUIW33367HXvssXb//ffbgAED7Mwzz8w4aF0UAREQAREQAREQAREQAREQAREQAREQAREoO4Gnn37aunbtajVq1HA500eNGuVCFxLCcPPNNy97A6pBBERABERABHKEwJo1a+yQQw6xRYsWuR49+uijtttuu+VI74rXDa/owgu7ZcuWxbspAaUSr+i65ppr7I477rBOnTo5i6GrrrrKOnfunAD06qIIiIAIiIAIiIAIiIAIiIAIiIAIiIAIJJfAkiVL7IgjjrBff/3VevXqZSNGjHBhCom406BBg+QOTD0XAREQAREQgTQEfvnlF9tpp51SVxcsWGBJykPpFV333HOP7bfffqlxJH0n8YoucnKNHTvWWQ3de++91rdvX2dJlPQHo/6LgAiIgAiIgAiIgAiIgAiIgAiIgAiIQK4S+P333400Eu+9955deOGFNnXqVPvmm2+cMXLbtm1ztdvqlwiIgAiIgAiUmcDSpUtTSiLC9j733HNlrrOiKvCKLnQpzZs3r6hmy72dvFF0nXLKKS7pKclPzz777HIHpwZEQAREQAREQAREQAREQAREQAREQAREYG0l4FNJtGvXzlauXGlz5syx7t2726WXXrq2ItG4RUAEREAE1iICTzzxhJ177rluxCNHjnTGH0kYvld03XfffbbvvvsmocvF6mPiFV2DBw+2O++800477TSbPHmyXXHFFakPWLEIqJAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiECxCcyfP986duxoW2yxhZ188skuZGHjxo2dV1fVqlWLXY8KioAIiIAIiECSCRx33HH26quvuiEkJYShV3Thid2sWbMk4y/Q98QrugYNGmTjxo2zM8880yZMmGCXX365nXfeeQUGqQMREAEREAEREAEREAEREAEREAEREAEREIGyE1i1apUddthhtnDhQsP4eOjQobbOOuvYrFmzbJtttil7A6pBBERABERABBJCgDC+O+64o+vt1ltvbS+++GLO91yKrhx9RAMHDrTx48e7vFzk6iL5aY8ePXK0t+qWCIiACIiACIiACIiACIiACIiACIiACCSXAGswrMUceeSRtnz5cheykPzpp556anIHpZ6LgAiIgAiIQCkJvPLKK9apUyd394wZM6xRo0alrKlibvOKrmnTplnTpk0rptEKaCXxHl0DBgxwnlznnHOO3X777XbJJZfYBRdcUAHo1IQIiIAIiIAIiIAIiIAIiIAIiIAIiIAIrD0EUGy1bNnSfv31V5c64qqrrrK99trLHnjgAatSpcraA0IjFQEREAEREIGAwD777GPffvutO/Ovf/0ruJJ7u17RNX36dGvSpEnudbCUPUq8oqt///42ceJEF65w9OjRdvHFF9tFF11UShy6TQREQAREQAREQAREQAREQAREQAREQAREII7AjTfeaCNHjjSMjWfPnm1LliyxmTNn2q677hpXXOdKSGDNmjUW/q1evdr+/PNPd459rnHs931ZX4Zt+OfLs0XCY39PeN6fS1dHeL4kZX27/p6wTX8tXR/DNsOy6c5Tt28n3Pry6eoIy2azL769sP6i+hK9J45XUXWE7aUbjz8fLcsx4UhRXvs/jqPn6Je/zjauTNy50tzn20639e3HbTOd8/UVtwzlov2POxc37ui56LHvQ3H65Mtm2sZd8+fCNuLOFadv3BeycAeRf/gs/fHHH7buuuu6v8jlvDpcsWKF7bzzzm5MI0aMMHJ35ap4Rdf9999vKOjyRRKv6MJ6aNKkSS5c4S233GIXXnih9ezZM1+ej8YhAiIgAiIgAiIgAiIgAiIgAiIgAiIgApVO4JdffrF9993XLVqy9jJkyBA75phjDOVXvguLtYz/xx9/tO+//96w1l+8eLFT9Pkt5yVrLwEUA4hXEMQd+2thuXDfX/fb8Fq476+zDc+H+2GZ4pYL7+czn+6PclwLFXJhWX89PFeS/fD+aBvhNV8n5yTJILDVVltZzZo1rUaNGu5v0003Nf78MVuO69SpY5tvvnkyBhX0knRKjzzyiDuTy15dXtGFN3bjxo2DESR7N/GKrn79+tnkyZOdguumm25yCi/ydElEQAREQAREQAREQAREQAREQAREQAREQASyQ2DKlCnWp08fO/PMM+3ZZ5+1L774wm39gll2Wqn8WlBYLVy40D788EN766237OGHH678TqkH5UoAzxT+qlat6rxO2PceKH7fbzkfV5ZzXqHk9zn2+wzA74fn2Q//wjLZOk+dSLTdTOcpi4T98fvpzof9pYxXRPltqLSK8yajXKbzXEei9eDh6P9WrVpVYJ+ynPPbcN/fwza8z58Py4b7XPf9dB3SP+VCoHbt2rbHHnu4v9133934Q0mWy8Ln4p///Kfr4g033GAdO3bMye769/aDDz5oe++9d072sTSdyhtFF15cfIC6d+9ul156aWlY6B4REAEREAEREAEREAEREAEREAEREAEREIEYAkcccYS9//771rt3b+fNdfTRRxsGx0kWFiUXLVpkr732mr3++usuHCPhp4or66+/vu24446pv/r169sOO+xgW265pW2wwQaFqvEL+X7rF8wzHWe6Rv/jrhenXn+vLxs9zlRvtGz0mHvT1Rsty3H4V9S9YdnofvTe6PVsHBd6qDohAsUggBIQJel6663nFKooVfnjODwf7qcr48+H27CeuDrSlQ3Ph/thfeH5cN+Xob1QVq5caUuXLnV/n3/+ufk/zrG/bNmysHjsPt+t1IsnrRcYNmzY0Fq1amWtW7d2nkj0IdekW7du9vjjj7tu5apXl1d0PfTQQy7PZq4xLG1/Eq/o6tu3r911112GFxfxL8877zy7/PLLS8tD94mACIiACIiACIiACIiACIiACIiACIiACAQEPvnkEzvwwAOtWbNmbnH2hRdecLm5sLBPmuCZ8dJLL9kTTzxhs2bNcqEIM42hffv21qRJE7cYyCKr94LJdI+u5S8BlGn8oTRDwmO/H7elvD/PfeEx58tan6/Dt+GPK6uPtBt6eLHvPcL8vi9T3PPch0TLZzrPNf8X3ufPsQ3Ps4+U5DxlkWg90TZcIf3jQsB++umnxnsl3JLz8ffff08RQqmGBxfKrGrVqrlngqKMnF8IIQ4xuDjxxBOdAix1YyXvMAYMIJAnn3zSdtppp0ruUeHmvaJrxowZ1qhRo8IFEnom8You3OZxn0e5dd1117mEqFdeeWVCH4e6LQIiIAIiIAIiIAIiIAIiIAIiIAIiIAK5RWD06NFuzeX888+3MWPG2C677GKPPvpobnWyiN588MEHRj4SLNi/++672NK77baby0NGLjKUWxtttFFsOZ0UAREQARHILgGMEFB+LViwwHkPv/fee26f3IgIii+MDfD0QpmE0uvnn39215o2berC6rZt29Zddycr8R/ekfStVq1a9sYbb1RiT+KblqIrnkuln/WKLpRbJELt2rWr4eUlEQEREAEREAEREAEREAEREAEREAEREAERKDuBE044wV5++WXr3LmzjRs3zvr3729nnXVW2Ssu5xp+++03p5Ajtzv5tqLCwikhsA499FBr06aN1ahRI1pExyIgAiIgApVEAM9Ewsvihcs7aN68ec4jjO7UqVPHqlevbnzPExYRqVu3rmGQccwxxzjFmDtZCf/Mnz/fOnTo4FrGay0a3rESulSgSa/oIgflnnvuWeBakg8S79GFguvuu+92yq2rr77aunTpYv369UvyM1HfRUAEREAEREAEREAEREAEREAEREAERCAnCGBlj3X6P/7xD9t8883tlVdecYuOHOeqYElPmos777wz1nuLPFqnn366W4jceOONc3UY6pcIiIAIiEBAgPfR888/b9OmTbNnnnnGhTHEYIF306+//uqUYOQHrFevnuEcgwFDZYlXJt1xxx12yCGHVFY3Ytv1fXvkkUdsjz32iC2TxJOJV3RdccUVds899zhrooEDBzqLIiyLJCIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAmUj8Pbbb9tRRx1lhIR69tlnrX79+i6/VdlqLZ+7WQTFGHrkyJH2n//8p0Aj5Mtp0aKFM5Bu1aqVy/dSoIAOREAEREAEEkPg+++/twcffNDuvfdeF/KQjqP04j3ghffWNddc4xRh/lxFbVGyffTRR67t1157raKaLVY7XtE1c+ZMS2KuzXSDTLyiq3fv3u4DPWjQILvqqqvsjDPOMBReEhEQAREQAREQAREQAREQAREQAREQAREQgbIRmDBhgg0YMMDlriJ0VPfu3e3SSy8tW6XlcDcLiVjwL1y4sEDthIxq166dC2e18847F7imAxEQAREQgWQTILwhnsYTJ0602bNnF1B0MbKaNWva8OHDK9y767nnnnN6Cvrwr3/9i03OiFd0kWuT3JT5IolXdF1++eV23333GWELyc112mmn2eDBg/Pl+WgcIiACIiACIiACIiACIiACIiACIiACIlBpBC6++GJnNY+SaMGCBTZ9+nRr0qRJpfUn2vCKFSvs2muvdaEKWfD0UqVKFTvssMOM/hOqUCICIiACIpDfBL788v+zdx5gUhRbGz5IEhAEFREJkpNkEUFAsgSVnDNKFhAkKIqCCclRBAFBgpKjZJAgEiRIkizhgqKYABMiXvzvV/evvrXN7E7qmemZ/c7z7E6H6urqt3umu+urc85FlUcSXl64N5jWqVMngY4Ar69w2F9//SV58+ZVu1q3bp0UKFAgHLv1aR8UunzCFP5C/fv3l/nz58vbb78tCGPYunVrJXqFvyXcIwmQAAmQAAmQAAmQAAmQAAmQAAmQAAnEFoHq1avLuXPn5M4775Q//vhDDh06FLaOQm8kDxw4IM8995xqn1m2XLlyyrsLucVoJEACJEACiYvAlStXlOAFj+Rff/3VOnjcGyZNmqTuZ9bCEE5oQcltjjm6XatWrZLChQuHkEB4q456jy64yyMB3fDhwwWiV8uWLWXIkCHhpci9kQAJkAAJkAAJkAAJkAAJkAAJkAAJkECMEcCI9IIFC0rKlCnV6PgqVaoIOg7dYAhThYg+Zj6WbNmyqbQWyMtCIwESIAESSNwEIHi98847MnXqVAsE8jUiDG/mzJmtZaGa0CmXUL+bwhdqoWv16tUSSwNCYkboGjlypPTt21eaN2+uXNZDdYGyXhIgARIgARIgARIgARIgARIgARIgARJIDASOHTsmNWvWtA71pZdeks6dO1vzkZi4ceOGoB0Y9KwNebiefvpp6dOnj6RKlUov5icJkAAJkAAJKK9f5HD87LPPLBrbt2+XrFmzWvOhmNi/f7/Uq1dPVX3mzBnBvcoNpoWuNWvWSCzlrox6oQviFuJDjxkzRsVdbtq0qfLucsNFwzaQAAmQAAmQAAmQAAmQAAmQAAmQAAmQQLQSQKL6Z5991mr+smXLpESJEtZ8uCeuXbumhLatW7dau86SJYuMGzdOHn74YWsZJ0iABEiABEjATgD3MIS71YZ7SY4cOfSs458YmKFzRLrJe0oLXWvXrlVe244feIQqjHqhC6N1Fi1aJOPHj5eePXtKkyZNZMSIERHCyd2SAAmQAAmQAAmQAAmQAAmQAAmQAAmQQGwQmDBhgiCCDgzhC48cOSLJkyePyMFdv35d2rZtq0JO6QZUqlRJ9QchfxiNBEiABEiABLwRuHjxopQtW9YqtmvXrpCGMdSiEtIvde/e3dpvJCd0myh0RfIseNj3888/L4sXL1bxNnGxNGrUSEaNGuWhJBeRAAmQAAmQAAmQAAmQAAmQAAmQAAmQAAn4SkDnRUd5eHJhNHwk7ObNm9KtWzdBmCVtrVu3ltdee801oaB0u/hJAiRAAiTgbgJ//vmn5M+f32okBnHccccd1ryTEwhdiBCG8D7esWOHk1UHXJcWutatWycFChQIuB63bRj1Hl29e/eWJUuWyKRJk6Rr165Sv359GTt2rNs4sz0kQAIkQAIkQAIkQAIkQAIkQAIkQAIkEFUEWrZsaeU0gTfV66+/HpH2v/nmmzJ16lRr3x07dpSBAwda85wgARIgARIgAX8I/PLLL1KkSBFrk1OnTkmKFCmseacm5syZI8gPBvvXv/7lVLVB1aOFrvXr18cR/IKq1AUbR73Q1atXL1m6dKlMmTJFOnXqJHXr1lVu6y5gyyaQAAmQAAmQAAmQAAmQAAmQAAmQAAmQQNQSqFq1qnz11Veq/cOHDxfkRQ+3zZ8/X/r372/tFikr0JYkSZJYyzhBAiRAAiRAAv4SOHz4sDz55JNqM3gtQ2Nw+t4Cb7HatWurfZw5c8YVXsha6NqwYYPky5fPX2yuLR8zQte0adOkQ4cOUqdOHUEMaRoJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkEDgBIoWLSpXr15VFaxYsUKKFSsWeGUBbHngwAFp2LCh/P3332rratWqyXvvvSfJkiULoDZuQgIkQAIkQAJxCeCeMmTIELXwueeeE6RJctKQX1KLSVu2bJGcOXM6WX1AdWmha+PGjZI3b96A6nDjRlEvdOECRIzoGTNmSPv27ZUKO3HiRDeyZptIgARIgARIgARIgARIgARIgARIgARIICoIQFzKkyeP/PPPP2qE+9GjRyV16tRhazsEtlq1ask333yj9lm8eHGZN2+epEqVKmxt4I5IgARIgARin0DNmjXl2LFj6kDff/99waAKJ00LS9AvqlSp4mTVAdWl2/PJJ5+o+3xAlbhwo6gXunr27CnLly+XmTNnCuJFwxUQ+bpoJEACJEACJEACJEACJEACJEACJEACJEACgRH46aefpGTJkmrj+++/X3bu3BlYRQFu1a1bN1m1apW1/48//ljuueeeAGvjZiRAAiRAAiTgmcClS5ekdOnS1srt27dL1qxZrflgJ7Sw1L17d+nXr1+w1QW9vW4Pha6gUTpbgRa6kNitVatWAgUWLoc0EiABEiABEiABEiABEiABEiABEiABEiCBwAj861//kscee0xtXK5cOfnoo48CqyiArTCgGf09sKRJkwrCJhYuXDiAmrgJCZAACZAACXgngHvcgAEDVMFSpUrJggULHMunVblyZUF+roceekiWLFnivTEhLqGFrk2bNknu3LlDvLfwVR/1Hl09evRQDzxz586V5s2bS40aNWTKlCnhI8g9kQAJkAAJkAAJkAAJkAAJkAAJkAAJkECMEUAYJwwmhqG/ZejQoWE5QniSlS9fXv744w+1vxEjRkiTJk3Csm/uhARIgARIIHESuHnzptSrV08OHjyoAED06tKliyMw4MUF4SxJkiRy7tw5R+oMphItdG3evFly5coVTFWu2jbqhS64/MF9ff78+dK0aVOpXr26TJs2zVWQ2RgSIAESIAESIAESIAESIAESIAESIAESiCYC6OyrU6eOanLfvn0FA43DYbpDEPuqW7eujB8/Phy75T5IgARIgAQSOYH9+/crsQsYUqRIIRs3bhQtCgWDZtasWfLKK6+oKuAtHWnTx0ShK9Jnwrb/Z599VlauXCkLFy6Uxo0bS9WqVWX69Om2UpwlARIgARIgARIgARIgARIgARIgARIgARLwlcC+ffukQYMGqvioUaOkUaNGvm4acLlDhw7JU089pbZHPq4tW7ZI2rRpA66PG5IACZAACZCAPwS6du0qq1evVps4pTPs2LFDeUajUjcJXbjH5syZ0x88ri4b9R5dOjkp4lviAQwxLz/44ANXQ2fjSIAESIAESIAESIAESIAESIAESIAESMDNBPbu3SsNGzZUTZw9e7aVryuUbcYA5t27d6tdYAR8xYoVQ7k71k0CJEACJEACcQicOnVKqlWrZi1D7i7kqQzGTp48qaLQoQ43CV1bt26VHDlyBHNorto26oUurbIuW7ZMuRZWqlRJZs6c6SrIbAwJkAAJkAAJkAAJkAAJkAAJkAAJkAAJRBOBL774QurXr6+avHbtWilYsGBIm//5559bubgYsjCkqFm5ywj8/vvvkixZMkmZMqXLWsbmkEDiJIDcXGvWrFEHX6JECYHuEIz98MMPUqpUKVWFm4SuTz/91JHQjMGwcXLbmBG6kKcL7u0Y7YNRPzQSIAESIAESIAESIAESIAESIAESIAESIIHACJhhBHft2iWZM2cOrCIft4K4deDAAVUaXl2ZMmXycUsWI4HoJIDvGHLSnThxQvLkySNjxoyRwoULS5IkSaLzgELYaoiBCP8GT9Pz58/Lzz//rP6uXLkif/75p9x7773SunVradGihcqtFMKmsOpEQMDM1YXDDdar6/r165IvXz5Fzk1C17Zt2yR79uwxc0ajXujSCitiZ9auXVsqVKggc+bMiZkTxAMhARIgARIgARIgARIgARIgARIgARIggXATMEMtHT16VNKkSROyJpw5c0alosAOevXqJb179w7ZvlgxCbiFAEKDQrgxLXXq1FK6dGkVKvT+++9XneO5c+c2iwQ1DYHo5s2bghx4bjYIAxC+IW599tlnavrvv//22mR4oY4dO9ZrORYgAW8E4FADMRrmRK6uBx54QNXlJqEL361s2bKpdsXCv6gXujp37ixwocdfzZo1VcxMqKw0EiABEiABEiABEiABEiABEiABEiABEiCBwAh8/fXXVl6Sc+fOhdTLpH///jJ//nzV0CNHjsgdd9wRWKO5FQlEEYHixYvL5cuXvbY4V65cUqtWLdXvWbRoUa/lPRWASIT0Lxs3blQhEidPnixI/xIOe//99+XChQvSvHlzyZ8/v8dd4vdm37596g/eNBDXfRG27JXBs2vPnj32xZwnAb8JfPjhh/LSSy+p7ZImTaoEV4jPgRqFrkDJ+b5d1AtdnTp1knXr1sn69evl8ccfl7Jly8q8efN8J8CSJEACJEACJEACJEACJEACJEACJEACJEACcQhcvXpVdKd6KEegw7skZ86cat8dO3aUgQMHxmkHZ0ggFgn8888/8uCDDwpC8vljWbNmVSH6mjVrJunTp/d505UrV8qzzz5rlR8/frwgXGgghvx9P/30k1SpUkUgACRkH3zwgQwaNEgVueuuu1T/bcaMGdX8pUuXZOrUqfLJJ58IvDr9tbvvvltQ17///W+BGH/jxg3JkCGDFQLV3/pYngRMArgHPvTQQ+q6wvIBAwYIIssFam4UurZv3y74TYkVixmhCz+KcCMsU6aMNQooVk4Sj4MESIAESIAESIAESIAESIAESIAESIAEwknAFKBCKXTB+6JRo0bq0NCBjs5rGgnEOgF4K1WuXFnlmzKP9bbbblPekxBvErJUqVIJwvT16NFDfPEyefPNN5WopOvcvHmzwFPMX5s9e7YlRiOf2KpVqxKsAnmzPv30U6sMBLciRYrIN998I0888YRPHm0I5wjHhooVKyqPMOQLxF+KFCmses+ePatS2aBfuHr16tZyTpBAMATatm0rW7ZsUVWUKFFCli1bFnB1bhS6EBo0S5YsAR+T2zaMeqELo33gzYUfaNwgEMd24cKFbuPM9pAACZAACZAACZAACZAACZAACZAACZBAVBEIR8dcnTp15ODBg6pzH14ZNBKIdQLwPHr66actAahevXpSrVo1yZMnjxKf4CV1/vx55aW0c+dOWbp0qfzwww8escBLaty4cSqnl8cC/78Q4QNff/11NZcuXTqVeyhJkiQJbeJxHdp56tQpa93hw4cF9cVn5cqVE4Ql1AZHBRznzJkz5dVXX9WLb/ksWLCgCq0IcatUqVKSPHnyW8pwAQmEmoAp7EKERlhNfzwpzfaF435q7i+had0W/L74IpQnVJeb1kW90NWhQwfZsGGDujk89thj6sdv8eLFbmLMtpAACZAACZAACZAACZAACZAACZAACZBA1BHQnWGh9OjS+wgmlFrUgWWDEzWB6dOny2uvvWYxaNOmjbzxxhvWvH0C3l/wilqwYIHqA7XnroIwNmLECGnYsKF9U2se+bHgvQGDWAXhKxCrUaOGHD9+3NrUm0eIKXRBKDh27JjcfvvtYgoIurJkyZIJPGgaN24sELpoJBBpAsgtV758easZU6ZMEXwHAjF9rwvl/dSXdiFsao4cOVRRCl2+EAtjmWeeeUYlUkRMSfx4lixZUo10CGMTuCsSIAESIAESIAESIAESIAESIAESIAESiDkCoe6Y+/777+Xhhx9W3E6fPi3o6KaRQKwTQF4qhBLUhhw56Nf0xdBJ/s4778iSJUvEFLzgnTVq1CiPYtfPP/+sHAN0OMTBgwdL+/btfdndLWVGjhwpEyZMsJZ7C4GIHEc//vijKp89e3bZtm2bmkZne6tWreSzzz6z6po8ebLUqlXLmucECbiBACLI6Rxy0CES8kRMqL2hvp8mtG9znRmWeNeuXSoMqLk+mqej3qNLC11QIBGvNdh4mdF8Mtl2EiABEiABEiABEiABEiABEiABEiABEnCKQKg75l555RWZNWuWam6kR7k7xYz1kIA3Avawfcg1ZYYD9LY91u/bt0+Q/+r333+3isMLau3atda8npg/f770799fzyrvMP3dthb6ODFp0iQZOnSoVdqb0FWgQAG5du2aKo9IXPDk0vbRRx/JgAED9KxqOz25LByccAmBQYMGyQcffKBaU7RoUfn4448Dapn+zkX6XgfBW+fn+/zzz+W+++4L6HjcuFHUC12IaYv4rjgxjzzyiBQrVkxWrFjhRtZsEwmQAAmQAAmQAAmQAAmQAAmQAAmQAAlEDYFQd8zp+lu2bClDhgyJGi5sKAkEQwBeTLjmtSHHFXJd+Wvw6urdu3eczb788ktJmzZtnGXt2rUTCFIwdHDr6TiFfJyxC11bt261wqDZqzA9R7AOwpzpyWYXutasWSOFChWyV8N5EogogfXr10vHjh1VG+B1jO9YqlSp/G6Tvt9FWuiCJ2ju3LlV+yl0+X0aQ7sBXG03bdoke/fuVW64RYoUkZUrV4Z2p6ydBEiABEiABEiABEiABEiABEiABEiABGKcQKg75nT9sdbZFuOXBQ8vSAKXLl2S0qVLW7Xcf//9gkhVELuGDx8u3377rdSpU0cQxSpNmjRWOXMC4QC7deumBv7r5fAMO3HihCAXlrbffvtNihcvLjdu3FCLevToIX379tWr/f4cPXq0jBs3ztoOnmX33HOPNW9OoEMfXlzaBg4caAkGWGYXupYvX67aqsvzkwTcQODq1avquoRwC1u0aJEVctef9un7XaSFLvwW5MmTRzV99+7dkilTJn8Ow9Vlo96jS49KwA8r4jrDxXX16tWuhs7GkQAJkAAJkAAJkAAJkAAJkAAJkAAJkIDbCYSyY+78+fNSoUIFhSDSHX9uPw9sX2wRgEiF3FXa8ubNKxs3bpSKFSvKuXPn9GK56667pHPnzqqTHV4Y+Pvuu++UR8nixYvljz/+sMpiolGjRipPl7lw6dKl0qtXL2vRhg0bJF++fNa8vxMINQiBCgZh7eTJk4L8YJ4MYRTRfm0I2VipUiU9e4vQtXDhwjgCoFWQEyQQYQLIHXf06FHVCoQyRIQ5fy2U91N/2vLXX38JfnNge/bskXvvvdefzV1dNuqFrrZt28qWLVvkiy++UD+GOFGe4tG6+iywcSRAAiRAAiRAAiRAAiRAAiRAAiRAAiTgMgKh7Jh79dVXBR3fMApdLjvxbE5ICdg9uuBxBW8mhBVE/pxArEyZMjJjxgxJnTp1nM21gwAW5s+fXxCGLRjr1KmTrFu3TlWRI0cOQejC+Mzu/YWQjdmyZbOK2z26Jk+eLBAU7Pbnn38qce/AgQNy5MgRuXjxohL84K2WJUsWQd9ww4YN7ZtxngQcI2Derxo3biwjR470q+5//vnHCvEZ6fvd9evXLbEbEfIyZszo17G4uTCFLjefHbaNBEiABEiABEiABEiABEiABEiABEiABCJEIJRCl667du3agrw/NBJILAQg1JQtW9Y63EceeUQWLFggdevWFYg5/hhyBnXt2lV5bWHatMuXL6s0L/AEg/Xr10+6d+9uFvF7+oknnlCiEzYsV66c5d3lqSLkNdLCGrzT4KRgen/Zha4qVapI+fLl5e6771ahFiFqoSP+2LFjypvN0z6wDJ5lx48fl6RJk8ZXhMtJICgCEKJ79uyp6ggkbZKZFyvSQheEY4jesIRCj6oCUfYv6oWuNm3aqNED+/fvF9wYcubMaf2IRtm5YHNJgARIgARIgARIgARIgARIgARIgARIwDUEtBgVio45XTc6u9FhTiOBxELgzJkzUrlyZetwkYoFeX8gdvXv31/g/eHNkIcLYQBffPFFq9Pavs306dPltddeU4shMG3fvl15QNnL+TP/4IMPCjypYDVq1JApU6Z43BwCVbNmzazcYJ7K2oUujxX5sBBeYPAGo5FAqAiYoXbhNYkwhqZo622/prgUivupt/2b669duyYFChRQiyA+Q1iOFYspoQujIeACi7i2NBIgARIgARIgARIgARIgARIgARIgARIggcAJaDHK6Y45M4zT6dOnxe6JEniLuSUJuJ8APJRq1qxpNRT5upYsWaLm4TnSt29fQR4du2EbiMLZs2eXQoUKJZhbB98xeEhBVINprzF7nf7M2z3R8PtQvXp1FUbw119/FXTmf//993L16lX5+eef41Tdp08fyyNGrwhE6IJnGBjAIwXpa0qWLJkgB70vfpJAsAQQYhRekrCdO3fK/fff73OVv//+u/rOYgOn76c+N+L/C5ptodDlL70Ql2/durV8+umnyrX30UcflcyZM8umTZtCvFdWTwIkQAIkQAIkQAIkQAIkQAIkQAIkQAKxSwC5gpAzCOZ0xxzqe+yxx0JSt6qU/0jAxQQQLqxBgwZWC0uUKCHLli2z5nfv3i2dO3e+RSxCn+esWbOs/DrWBh4m0FeKPlNtQ4cOlebNm+tZvz/xe9CrVy9ZsWKF39tig/feey+OuIdlvghdEMEhMEDcqlChghK2GKIQ9GjhJtCqVSvZtm2b2u28efPihB/11pZffvlFEPIQ5vT91Nu+7espdNmJuGheX2QHDx4UCF2ZMmWSzZs3u6iFbAoJkAAJkAAJkAAJkAAJkAAJkAAJkAAJRBeBUOYU+eCDD2TQoEEKSKQ7/aLrrLC1sUDALkJByIEnl2mXLl2S5557TnmOmMvvuOMOmThxogpbaC63T3fo0EE2bNigFiOHFcS1dOnS2Yv5PD9jxgwZPHiwz+XtBdeuXSsFCxaMszg+oQvtrFevnvJIgycaQsXRSCDSBIYMGaIEW7RjxIgR0qRJE5+bBA9HCNqwSN/zEHoUIUhhSAUFL8lYsagPXdiyZUv57LPP5NChQ0rdR1zJrVu3xsr54XGQAAmQAAmQAAmQAAmQAAmQAAmQAAmQQNgJXL9+3fIcOXfunF/5SLw1tl27dmqQMjrY0NFGI4HERGDdunXSqVMn65Dz5ctniVLWwv9M3Lx5U8aNG6f+zLxd8GiC6NSmTRuzuDX9448/SunSpQVeWDCEMIRQFYyZnfyB1AMvNTgnmGYXuiDsoa158uQRCHo0EnATAYQX7d27t2oSPuHh6KvhO4kQpbBIC10IM1q4cGHVlgMHDkiGDBnUdCz8i3qhq0WLFiqZ4uHDh6V8+fJy5513Wm6EsXCCeAwkQAIkQAIkQAIkQAIkQAIkQAIkQAIkEG4CZsJ65PlxMlwY8usgn89TTz0l77zzTrgPjfsjgYgSQCQqiL3a0NGMDuf4bOPGjcq7C54YprVt21ZeffXVW3LczZkzR15++WWrKHJ+9ejRw5oPZMIuzuk6brvtNuUdAs8rfK8hUqVPn17at28vEMi1HT9+XFKlSqVn1add6Ao2vGKcyjlDAg4TOHLkiNSuXVvVijCguF59te+++07lyUP5SAtdZhhFRMjD9zVWLOqFLlxYO3bskC+//FIJXWnTplUeXrFygngcJEACJEACJEACJEACJEACJEACJEACJBBuAmYej9OnT9/SmR5Mex544AG1+WuvvRanwz+YOrktCUQLAbPDXLf55MmTkjJlSj17y+dXX30lHTt2FIjOpiFv1fTp0wXhCbWhA37SpEl6Vl566SWV88taEMAEvMtKlSolP/30k7V19+7dVZs8dZQjPxhCNGo7e/asQBQzzS50jRw5Uho3bmwW4TQJuIaAOfijevXqMm3aNJ/bdvHiRSunV6SFritXrkixYsVU2xEhD05DsWJRL3Q1a9ZMxavFTQI/7hgdAOGLRgIkQAIkQAIkQAIkQAIkQAIkQAIkQAIkEBgBM7zRqVOn4nSkB1bj/7bSQhdCQelwTv9byykSiG0CP/zwgxKNzKP0lMPKXI9pfCcRMk3n3tLry5UrJzNnzpTkyZOrRQMHDpTZs2fr1SqMIXIK5ciRw1rmaeLGjRtKyEJIUVM402XROY5Ocm1Hjx6VNGnS6Nk4nxDBPv74Y7UsWbJkArHcbnah68UXX5SuXbvai3GeBFxDoGTJkuo7gs+lS5f63K7z588r3QIbRFrounz5siAvIAwR8oLJ3acqcdG/mBK6HnvsMTX6YefOnS5CzKaQAAmQAAmQAAmQAAmQAAmQAAmQAAmQQHQRMEd9nzhxQm6//XbHDkALXbt27ZLMmTM7Vi8rIoFoIADvKIT40zm00ObVq1erEIDe2o9cXRMmTJDRo0eLmberZcuWgjxaMHhKwsvLNHhTFSxYUOXdy5o1q0DUwnccHlrIHwSPEwhwaBs8tCA4dejQwfLkRFtz584dZ58JeaFBtJo7d65qAsQwiGJ2swtdcGYYNmyYvRjnScA1BLTDzd133y1ffPGFz+2CR2OlSpVU+UgLXT///LOUKFFCtYVCl8+nMDwFmzZtKngwwg9mxYoVVczozz//PDw7515IgARIgARIgARIgARIIIIE0MGBDgl8mtP2ZXoenzB8mst83d4s59T2ntqt6/a0Ti8zy3haptfbPz2V9bQsvu08lfW0zJft9bmwb69O0n/+JUmSRIX5MT8xrf/QaaXXYRs9r5fpcua8WUav18vwadajl+tyCdXjT1l7PU7sU7cdOYTi+0MZjCrHej2NT8xjeXzLzPoUIP4jgURCwOwMO3bsmKROndqxI9dCl9MCmmMNZEUkEGICZcuWVeKS3o2vQpcuD7ELof60IcIV8mDBVqxYEXROLtRTtGhRgRiFNDGmFwjW4d5oD6OI5dogur333ntqFp5mCL1oN7vQVb9+fRk7dqy9GOdJwDUE+vfvL/Pnz1ft8UewwvVftWpVv7cLxYFD3IZHGgypoPD9jhWLeo8uU+iqXLmyesHfs2dPrJwfHgcJkAAJkAAJkAAJkICNAEQBjCp14x/Ejb///jtO2zwtQ9sxkhZl8aen7Z9Y99dff8VbDixoJEAC4SOghTJ86j8tlDk9j3rROajrd2JetxGful69zNM8REla4iUALw8dVjChEGWBENJClz8dhYHsh9uQgFsJIBfV7t27VfMQOgzRqe644w6/mtuvXz9ZsGCB2gYelxCOYXh+fOGFF2TRokVqPph/EJ4gQOGZ89FHH7XEuSeeeELefffdeKueNWuWvPLKK9Z6T7mA1q1bJ506dbLKdOnSRQYMGGDNc4IE3EZg/PjxMmrUKNUsf+5f+G4+/vjjfm8XiuM3hS6kgvL3dycUbXKqzqgXupo0aSLw4MLoIghd6DTYu3evU3xYDwmQAAmQAAmQAAmQQIAEkMQeIVHwh1AoGMmG+Pz4w7SZzDrAXXCzKCCAjnJ0oGvPGUzrP7sHjV6uP72t1x30Zqc9tvW03Cyj1+uy+LQLCgmVxzFpryS0EX96Xn+ay8wy5nqzjLlcn1bt6WV+Ylr/mV5j2Mac12X0p6/rAq1H16/3h0+9TH/Gt86JfWIfMLwPooMP8/rT0zKsw3J//nR9+tOfelXjYvhftmzZVBguhOLKlSuXZMiQQeV8QOctRgrjE8nO8V2jRQ+B77//Xh5++GHVYCdHfWNQB64VmD8dhWoD/iOBGCEwZ84cGTx4sHpmef311wX9m/4a7qvjxo1TnlM5c+ZU4Q/NOiBETZs2LeBnbjwbrV+/Xv2uo97ly5fL0KFD1QAt5AnDb318hn7amjVrWqu3bNkiaKNp8BpFGhrkHsMzEUIdlilTxizCaRJwFQEIyxCYYf7cvzBYpFatWn5vpzZw+F8oB7E43FS/q4t6oUuPgIB7bpUqVeT69et+xcj0mxg3IAESIAESIAESIAESuIUAxCzE+EasciSWP3fu3C1luIAEYoUARClf/3DMvpb1VC4xb2+KZfGJZOZys7wWvrTIpj/N8nqZ/oxvHc6BLqM/4ytrLsc0yuMP4hg697WHJupMbJYiRQqV36VAgQKSP39+0Z/Iz4Rrn+Y+At9++63V6exkHo8//vhD5QrCEfvTUeg+QmwRCQRHAPcFDJoINv8d6sDvKMQiu+EehO/yhQsX5Ouvv5Y///xTDe5JmTKlCkcKsQoDEVAOA9MuXbok3333nZpGeLO6devGqVLf27wNXEB9xYoVk19++UVtv2nTJnUPiFPZf2YOHDgga9asUX26jzzyiH0150nAVQS2bt0qbdq0UW3y5/6Fe+iTTz7p93ahOHhzEIvT3tqhaK8/dUa90NWoUSNBqEK4AELounbtmuzfv98fBixLAiRAAiRAAiRAAiTgJwEIW/CqX7p0qXo59WdzJLIuVKiQ6uRCUmx4Atx7773qJdufeqK1rO4gMDvE0RmAP71MT+tPcxtdFsev1+tlwW6v6zTr9VanWTaY7c39mHWayzGt1+lpzOPP276dKqf3762+SJdTQPgvIgTQ+ZeQlyBGyGuvQj1t/8T6QJfp7Zyqw96ZiWsbo4HREfrNN9+od3GM3Mc7OZKt+2tI6F6qVCnlOYTPIkWKKD7+1sPyzhO4ePGiII8Q7ODBg5I+fXpHdgKPbzwHwPzpKHRk56yEBEggbATefPNNmTp1qtof3hvuu+++sO2bOyKBUBAwPRX9uX9B0NWisT/bheIYIGaXLl1aVY3jcTL/Zija60+dMSV0VatWTbm74gGMRgIkQAIkQAIkQAIk4CwBhBWBsGXG2/e0h8KFC8tTTz2lOivRkZVQWBNP23MZCZBA8AS0QKg/UaOnab0Mn2YZvdzXZfbynrbTZfSn2uF//ul5+6cnDzft+eNpHeozl9vnzXUJ1WOWC6QObEMTlccF4e6Q/wEdPMjPgjBV3gy5IpCwHflfKlWqJPA6oEWGADxAypcvr3aOAcV33XWXIw2BRwm8+mCR7vBz5IBYCQmQgEcCeHdAaEJ49ELoopFAtBMwRSJ/7l/79u2TBg0aqMP3Z7tQ8MJAJe09SaErFISDqLNhw4YqJ9fJkycFQtfVq1fVA3QQVXJTEiABEiABEiABEiABgwA6t7p162YlnzZWqcmOHTuqjjAkrEcuFhoJkAAJkAAJ2AlAyDxz5ozq7ESH5+7du+O9r+htkdurTp06gkguJUqU0Iv5GSYC6IxDJzUMoYnhfeeEIcwacrnBIt3h58TxsA4SIIH4CSAnLwYwcNBC/Iy4JnoIIAR13rx5VYP9uX/hmQfpl2D+bKc2cPifGZYYqaBSpUrl8B4iV13Ue3RBDYUqeurUKalevbpKsIhRYzQSIAESIAESIAESIIHACSCfzMKFC+XFF1+8pRIkie7cubOUK1eOL6230OECEiABEiABXwmcPn1aPvnkE/W3d+9elcsMHnUQuOA9hIGs2gsMoW7btm0r9erVi6lOGV9ZRaIchMnKlSurXeP8ZMyY0bFmPPDAA6quSHf4OXZArIgESIAESCBREAjk/rVr1y5p2rSp4hPp+54Zlhhhp4PNEeimkx71Qlf9+vXVyKKvvvpKHn/8cZU0EYnUaCRAAiRAAiRAAiRAAv4TgMA1ceJEGT169C0bT5s2TYWT8pTo+pbCXEACJEACJEACfhDAqP8VK1bI3LlzVb4vbAqvH/whFzc6ieAJBAGsQ4cOSvSClwAtdAQgRCIXOgyj0TNlyuTYzgLpKHRs56yIBEiABEiABAIkEMj967PPPpOWLVuqPbpJ6EKEvFjytox6oQujuRBOBw9gELrgfof4kjQSIAESIAESIAESIAH/CHzwwQcyaNCgOBsVKFBAsDxz5sxxlnOGBEiABEiABEJFYOfOnTJ9+nTZuHGj3Lx5U92DkLPrjz/+kOXLl8vvv/+uwuj16dNHmjVrJkmTJg1VUxJ1vegAQ+QcGIRGJ58FAukoTNQngwdPAiRAAiTgCgKB3L+2bt0qbdq0Ue2PtND1zTffyKOPPqraggh5yKEXKxZTQleNGjXk66+/tkZ/xcpJ4nGQAAmQAAmQAAmQQCgJHDp0SJ566qk4u0DH1jvvvBNToQziHCBnSIAESIAEXE/g7NmzMmXKFFm8eLFcv35deRS1bt1aLl++LB9++KH8+eefUrRoURk2bJgUKlTI9ccTbQ1E7g70s8AgPt5///2OHUIgHYWO7ZwVkQAJkAAJkECABPT9C+F9fR1os3nzZmnXrp3aY6SFrgsXLqj82mgMhS51Stzzz/ToqlWrlkrohlFHNBIgARIgARIgARIggYQJIBRU3bp14wwSqlSpkrz//vuSLFmyhDfmWhIgARIgARIIE4FLly7Ju+++q8IaQvDKkSOHCl0IL6N169ape1b37t2lR48evH85eE4QLadmzZqqxu3bt0vWrFkdqR3nMF++fKquSHf4OXJArIQESIAESCDRENBCFwaL3nnnnT4d94YNG1TYZRSO9H3v/PnzUqFCBdVupIJKnjy5T8cQDYWi3qMLnTMHDhwQqKi1a9dWIQxxkmgkQAIkQAIkQAIkQALxE1i/fr107NjRKoCcJ4gdniZNGmsZJ0iABEiABEjATQSQQH3MmDHKwwv5utBRU7ZsWRXm8Mcff5QSJUoob2SnBBk3HXsk2vLll18KQkbCtm3bJtmzZ3ekGfDIK168uKor0h1+jhwQKyEBEiABEkg0BLTQtWPHDsmSJYtPx41BOZ06dVJlI33fw/4fe+wx1RakgoqlAa5RL3TVqVNHDh48KAhpAKELLnc4STQSIAESIAESIAESIIFbCSDMU+fOnWXLli3WymXLlqnOQWsBJ0iABEiABEjAxQTgaYSckp9//rlKot6+fXtBZJdNmzZJ+vTpZcKECVYnjosPw/VNM0MbI78IPOmcMAiWEChhke7wc+J4WAcJkAAJkEDiIaCFLohXyGfti61evVq6du2qikb6vnfu3DmpWLGiaguFLl/OXhjLIJ8EHr5wnEj0egAAQABJREFUkiB0nThxQnl3hbEJ3BUJkAAJkAAJkAAJRAUBs2MJDS5fvrzMmjXL59jiUXGQbCQJkAAJkECiIPDPP//IwoUL5a233pIrV65ImTJlpEiRIjJjxgx1/K+//rq0bNkyUbAI1UHu379fkC4ChvwiuXLlcmRXiMJTtWpVVVekO/wcOSBWQgIkQAIkkGgIaKFryZIl8tBDD/l03CtWrFDhlVE40vc9OAshXQHMnzxjagOX/4t6jy5T6HryySflyJEjSvRyOXc2jwRIgARIgARIgATCSsDsVMKOketEhyMKa0O4MxIgARIgARJwkADyd/Xp00eF1suYMaPK3TVlyhT55Zdf5MUXX7RGUDu4y0RT1RdffCH169dXxwtvudy5czty7KanWKQ7/Bw5IFZCAiRAAiSQaAhooWvmzJmWYOTt4BFB5bnnnlPFIn3fg7hVuXJl1RYKXd7OXJjXQ9w6fPiwUkNN0StJkiRhbgl3RwIkQAIkQAIkQALuJPD1119LuXLlrMatXbtWChYsaM1zggRIgARIgASimcDNmzdl3LhxMn78eEmRIoX07NnTyts1ePBgQWhDmv8E9uzZI40aNVIbbty4UfLmzet/JR622LVrlzRt2lStiXSHn4fmcREJkAAJkAAJxEtAC13+DBxdvHixPP/886rOSN/3TKEL3l233XZbvMcabSui3qMLI5G1F5fO1xVramS0XVRsLwmQAAmQAAmQgHsI/PTTT1KyZEmrQZ988onkyZPHmucECZAACZAACcQKAYQG0h1JAwYMULm6rl69Ku+99548/vjjsXKYYTsO5EBr0qSJ2t/69eslf/78juwbYRDbtWun6op0h58jB8RKSIAESIAEEg0BLXSNGDHCukd6O/gFCxZIv379VLFI3/eQl6tKlSqqLUgFFUvOQlEvdCEvFxLRQoFE7GjEkI61RGrevixcTwIkQAIkQAIkQAKeCFy7dk0efPBB+fe//61WI5dJ6dKlPRXlMhIgARIgARKICQIbNmyQLl26SMqUKaV3794yfPhwSZ48uSCXhq9J42MChAMHYXpeOekNvmrVKunWrZtqYaQ7/BzAxCpIgARIgAQSEQEtdA0aNEiefvppn4587ty5KpwyCkf6vmemNIh0W3yC50ehqBe6atWqJSdOnFDJ0xA7GjGkccLwIEsjARIgARIgARIggcRKAGGcGjRooAYBgcHYsWOtPBuJlQmPmwRIgARIIHEQgKgFz64MGTJI8+bNZeLEiYKOqZUrV0q6dOkSBwQHjnL79u3SokULVdOaNWukUKFCDtQqgoE3ffv2VXXFWiebI4BYCQmQAAmQgGsJaKEL97EePXr41M45c+bIyy+/rMpG+r538uRJqV69uiva4hM8PwrFlNDVsGFD2bt3r+CEYfQWjQRIgARIgARIgAQSK4G3335bJk+erA4fI9sRwolGAiRAAiRAAomFwNSpU+XNN9+U7NmzS/HixQVhDWvUqKHCGMZSmJ5Qns9t27ZJq1at1C7ghVW4cGFHdjdr1ix55ZVXVF2R7vBz5IBYCQmQAAmQQKIhoIWurl27Wl5a3g7eTfc9OAzpcM6xdg+OeqGrZs2acurUKRWuEElSkSwVJ+z222/3do1xPQmQAAmQAAmQAAnEJAHk4dJhFEqUKCFLly6NqdjbMXnSeFAkQAIkQAKOExg8eLDMmDFDcC+8fv26HD16VIlfrVu3dnxfsVjh1q1bpU2bNurQ4A1XpEgRRw4TOdOGDBmi6oq1TjZHALESEiABEiAB1xLQQhfuj2+88YZP7cSzCJ5JYJG+7x0/flwN/HFDWxQQB//FlNCFJKlIloqcXalTp3YQE6siARIgARIgARIggeggcPHiRSlbtqzVWHTqpUmTxprnBAmQAAmQAAkkFgLIUYmBH1u2bJGKFSuqCDAI7Yt8Uzly5EgsGAI+zs2bN0u7du3U9vCIK1asWMB1mRsinPKYMWPUokh3+Jnt4jQJkAAJkAAJeCOghS443IwaNcpbcbVee5ljJtL3PegmcBxyQ1tUIxz8F/VCF0IPnD59WuXlatq0qSBZKjt0HLxCWBUJkAAJkAAJkEDUEEDnXYUKFeTrr79WbXYycXzUQGBDSYAESIAESMAg8Msvv0idOnXk7NmzaiDIzp07pUyZMjJv3jx6OxucPE2aHuLLli1TnnGeyvm7zAyvHOkOP3/bzvIkQAIkQAKJmwAGyvzzzz9Sq1YtK1WANyJu8mSm0OXtbEVwvSl0NWvWTPDQeuTIEbnjjjsi2CrumgRIgARIgARIgATCT8AcKTZo0CArfGH4W8I9kgAJkAAJkIB7CKBTp169epI0aVK566675MKFCzJy5Ehp3LixexrpwpZs2LBBOnTooFqGMMglS5Z0pJXIz4V8JTAKXY4gZSUkQAIkQAJhIvDggw/Kb7/9pjzF9b3M267fffddGTZsmCoW6fseHIQg0sEi3RbVCAf/Rb1HF5KnYWQW8nS1aNFCtm/fLocPH5Z06dI5iIlVkQAJkAAJkAAJkIC7CcCLq1y5cqqROXPmFIQbSpIkibsbzdaRAAmQAAmQQJgI6ETwd999t1y9elUyZMggyEHF8L7xn4B169ZJp06dVIHFixdLqVKl4i/sx5p+/frJggUL1Bax1snmBwYWJQESIAESiEICDz/8sHz//feCz0WLFvl0BBMmTFADbFA40vc9OAjVrl1btTvSbfEJnh+Fol7oql69urpATp48KS1btpTPPvtMDh06JHfeeacfGFiUBEiABEiABEiABKKbAEaq79+/Xx3Etm3bJHv27NF9QGw9CZAACZAACThIAGGG2rZtq8St5MmTy40bN+S5556T559/3sG9xFZVa9askS5duqiDWrhwoZQuXdqRA+zevbt8/PHHqq5Y62RzBBArIQESIAEbgStXrqjoZcmSJbOt4Wy4CSBVwPnz56VQoUKC+6QvNm7cOBk9erQqGun73pdffilPPPGEK9riCzt/ykS90FWtWjUVduDEiRPSunVr+fTTT+XAgQNqdJY/IFiWBEiABEiABEiABKKVAAb6YMAPrG/fvtKjR49oPRS2mwRIgARIgARCRuDixYuCPoTff/9d7QPeXDt27JD06dOHbJ/RXPGqVaukW7du6hDmz5+vcps5cTzPPPOMbNy4UVUV6Q4/J46HdZAACZBAKAkgjCy8a9OmTSszZ850LF9iKNscy3U/9thjyukGUVS2bNni06GOGjVKxo8fr8pG+r6HSHhPPvmkK9riEzw/CkW90FW1alX55ptv5Pjx42p0Fi6wL774QhCOgEYCJEACJEACJEACsU4AI9Tz5Mkjf//9tzpUhHNOkSJFrB82j48ESIAESIAEAiIwbdo0eeONN6xte/fuLb169bLmOfE/AitWrLAGz8ybN0/Kli37v5VBTOm0E6gi0h1+QRwGNyWBqCCAd4ShQ4eqtiICROHChaOi3W5uZLiZjhkzRsaOHauQFChQQBBWlhY5AlroypQpk+zevdunhowYMULeeecdVTbS9z1Ewnvqqadc0Raf4PlRiEKXH7BYlARIgARIgARIgATcRsBMFD9p0iQr3rbb2sn2kAAJkAAJkIAbCKCDErm+T58+rZqDQbK7du3iIBEPJ2f58uXSs2dPteajjz6ycoF6KOrXogYNGsi+ffsEIbj0efCrAhYmARLwmcCSJUsEgj7s9ttvV5Gw0EFPC5xAuJnCEwgeQTDkYD5z5ozcdtttgR8AtwyKgBa60qVLJ/CO8sUgNuNdHRZpoQuR8OrWreuKtqhGOPgv6oWuKlWqyLfffivHjh2T9u3by6ZNm2Tv3r2SMWNGBzGxKhIgARIgARIgARJwJ4F8+fLJ9evXVePOnTunXn7c2VK2igRIgARIgATcQQCj4REGShuSxNepU0fP8vP/CSxdutTydvvwww+lfPnyjrCpVauWHD16VFKlSqWi8zhSKStxnABCfEKMTJkypeN1s8LwEejfv78g9Ki2kSNHSuPGjfUsPwMgEG6mptCF5h45ckTl6wqg6dzEAQIVK1YUvHf7M1jjrbfekilTpqi9R1roQl5veHfCIt0W1QgH/0W90FW5cmW5dOmSekjScZ7hNsjRCQ5eJayKBEiABEiABEjAlQTM+Np4cK5Ro4Yr28lGkQAJkAAJkICbCCDsL/JTICE7rFKlSirviZva6Ia2LFq0SPr06aOaMnv2bMEodicM/TjwSIB3CfKt09xFAGGt+vXrp84NwmMjbBrC3cGThBZ9BOC5AQ8Obd27d1fnV8/z038C4WY6fPhwmThxotVQeCFnzpzZmudEeAlooQt7hVcyBC9vhpDJCJ0Mi7S4RKHL29mK4HpT6OrQoYMgfM/nn38u9913XwRbxV2TAAmQAAmQAAmQQOgJPP300/LJJ5+oHZ09e5YhLEKPnHsgARIgARKIEQKrVq2Sbt26qaNBJxVC6aVPnz5Gjs6Zw1iwYIHVIT5z5kwlCDpRM3J9Xbx4UXkKnTx50okqWYeDBBo2bKgiJZlVpk6dWkqXLq3Ezvvvv18QUSB37txmEU67kABE/QcffFDgnaetWbNmMmzYMD3LTz8JRILp4MGDZcaMGVZLt2zZIjlz5rTmORFeAqbQhQEzadOm9doA8xxGWuj64osvpH79+qrNkW6LV3B+Fogpjy6EHkAIgp07dwpuvDQSIAESIAESIAESiFUCN27cEIyyhb300kvSuXPnWD1UHhcJkAAJkAAJOE7g3//+twrFB8EFNm7cOCuUj+M7i9IKEe4MIbpgH3zwgWCgsRNWvHhxuXz5ssqLdurUKSeqZB0OEtDnx1uVuXLlEoShrFmzphQtWtRbca6PAAGkeilTpkycPTdv3lyQLyhUht/WuXPnKo+jqlWrhmo3Eas3EkxfeOEFmTdvnnXMdPCwUERkwhS69uzZI/fee6/Xdrzyyisya9YsVS7S4hIG9iBXJizSbVGNcPBf1AtdCDHwww8/qPikFLocvDJYFQmQAAmQAAmQgKsJbN26Vdq0aaPaePDgQY5Cd/XZYuNIgARIgATcSAAh2caOHaua1qhRIxk1apQbmxmxNn300UcyYMAAtf/p06eLU53WBQoUkGvXrkny5Mnlq6++itjxcce3EvDkrXJrqVuXZM2aVVq3bi3wFqJn5K18IrVk7dq1twyGa9WqlSBfUKgMOcCQ9xD26KOPKk8khCm122+//SbPPvus8ux85JFHpH379lERnSISTHv06CErVqywECLHYZo0aax5ToSXgCl0ffrpp/LAAw94bcDLL78sc+bMUeUiLS7t3btX4LkLi3RbVCMc/Bf1Qhcurp9++knF1u7SpYusWbNGtm/fLrjJ0kiABEiABEiABEggVgnUqVNHIHAhQTjD/sTqWeZxkQAJkAAJhJIAksmjTwGG9AcYJU/7HwF0yqFzDobcItWrV//fygCnIKTAE+jmzZsqrwnym9DcQ+Dvv/9Wnnvnz5+P06jbbrtN5eiCt05ClipVKhUSCx3zjLSUEKnwrEOIwnfffTfOztq1ayevvfZanGVOzsDD79ixY1aVEEDffPNNa15PjB49WnnS6vknnnjilrbqdW76jARTM1x90qRJVV4onTNv5cqVAu/bX3/9VXr27ClVqlRxE66YbIspdK1fv17y58/v9ThNr7xIi0vwQsPgHlik2+IVnJ8Fol7oQjJUuLwjGXvXrl1l9erV8tlnn0m2bNn8RMHiJEACJEACJEACJBAdBNBJlCNHDtVYjJps3LhxdDScrSQBEiABEiABlxFA6DWMjodt3rxZiTAua2LEmoMwSwi3BJsyZYrUqFEj6LZcv35d5XdCReiwPXPmTNB1sgJnCCAsNjrU4aEAq1evnlSrVk2FyoY4ifMFAQwCMVKGLF26VEVY8rT3u+66S4kY6LOjRY5A9+7d5eOPP47TACzr169fnGVOzeAagscmBFNtEEnRV1uwYEG9SH3qqFzmQog2RYoUMRe5bjrcTAGgadOmsmvXLsUC3639+/er6QMHDqgQdFqAxgDIZcuWSaFChdR6/gsNAUSXQ35sGDztihUr5nVH+M4h7yUs0uLS7t27rf6DSLfFKzg/C8SU0AWXV/wo+uo26CcrFicBEiABEiABEiABVxBA0luMeoQxdIUrTgkbQQIkQAIkEKUEkJsLngWwt99+W1q0aBGlR+J8s2fOnCmvvvqqqvi9995TuZiC3cvVq1etfE7oANedhcHWy+2DJ4DwlKanD0Jkv/HGG/FWDDED/W/ovN2wYUMccQMbQRgbMWKEFSIr3oq4ImQEEEoSoqRpoczte/z4cY+CuCdxDR6i9qgUQ4YMkZYtW5rNdd10uJkCQP369eWLL75QLCA6Y1AGDLnQXnzxRTWt/2H9kiVLJEOGDHoRPx0mYApd+P1D6E1v9vzzz8vixYtVsUiLS/Beb9KkiSva4o2bv+ujXuiqUKGC4EHp0KFDomOWbtmyRXLmzOkvC5YnARIgARIgARIggagggLAUy5cvV22N9INyVABjI0mABEiABEggHgIIsYVQWzAkZ0feLtp/CZjCx+TJkwXeb8HapUuXpHTp0qoahN6CdxDNHQSmTp0aJ8QcUoIgNYgvhufRd955R3Wwm948OMfIfafzwfhSF8s4R8CTmARxH956obBVq1ZJt27dbqkaXlpwTNCG0KXw/IKHp2mI1GUXbsz1bpgON1Mcc926dQXeW7ASJUoory1MQ2hGaEi7IbQePHJpoSFgCl3grEMgJ7S35557zjpvkX5/h3cgvARhkW5LQswCWRf1Qlf58uVVHFLkqNCdPgw3EMilwG1IgARIgARIgASihYBOeIsHZowOo5EACZAACZAACQRGAOGAH374YRWCDTmF7N4PgdUaG1shL5f26EGeH+1NHszRoVPNDGcXa51swbCJ9LamBx/akiJFCjl16pRfzdq3b5/qeP/999+t7RCybu3atdY8J8JHAH2mFy5ciLND5HMqU6ZMnGVOzUDshBef3SB4wiMJYfdgZug0s2yHDh2scKnmcjdNh5spjt0MsQuRBd9VbRCoISZfu3ZNL5K7777b8gCzFnLCMQKm0OVrWF/tnINGRPq+R6HLsUvB+YrKlSsnuIFC2dbq6KZNmyR37tzO74w1kgAJkAAJkAAJkECECfzxxx9WjHs8pGbOnDnCLeLuSSA8BNAZbf5hr+Y8Rgfrefs6vdzXT3N7s169vbleL9PlPK3TZdDRgz+E69LTKK+nPX2a683tdFlzvV7mz2d822NfntaphfxHAjFGoH///oLOXxj6Fhjy6b8n2PTwQQf2U0899d8VQfw/ceKEPP7441YNCF2of2+shZyICAHkuzfDxqVLl04OHz7sd1sQNq13795xtkPY7bRp08ZZxpnQE4D3JLwoTQtluhecd5x/TzZhwgSpU6eOWjV48GCZMWPGLcWeeeYZK1zqLStdsiDcTHHYGBygxRF4d40fPz4Oje+//17lUcR3+Pbbb1deyl26dIlThjPOETCFLvO6TmgP8HSExyNMn8uEyodyHQb0IAQnLNJtcfo4o96jyxS6evXqpZJhfvLJJypZptOwWB8JkAAJkAAJkAAJRJoARsR27txZNSPWHkxDwRbig7c/iBBI4qzLYR7Tepme1+sT+vSnLtTvb93xtctel33eU5vNtprtsG9rn/dWF9br+uzb2uf9qQt10iJPAB3SWnDT054+IbZ5Wq6X6fXI4aKn9Tp86mUJrcc6s6x9+2DW2+sy5+3Tuq325XreyfWeeJj1J7Q+Ph7m9pG/wiLTAiSTx2hr2OzZs+N4HEWmRe7YK/JyIWcODB2r6GAN1hCNR3d2o64zZ86oXE7B1svtgydghpVEbdrDEWLX8OHD5dtvv1XnDmJEmjRpPO7wxx9/VKHrkANGGzzDIHDiNzEhw/6RexbpSbJkyaIGdt1xxx0JbeLouhs3bki/fv2UFxvCw7355puO1o/KMFAf3ymEIEdH88CBA619IOQjPJ3AAM9L+fLlk8KFC0vGjBmtMv5OFCtWTK5cuWJtps+ptcDhiapVq8pXX33lsdbGjRvLyJEjBZzhUYZrxW5PP/20DBo0yL7YVfPBMg3kOi9ZsqT89NNPioO33HmughWjjTGFLngw6nxXCR0u3t+1Z2uk3+F37NghzZs3V82NdFsSYhbIuqgXuh599FHlnrl//34VugeJ3ZAEEzcEGgmQAAmQAAmQAAnEGgGEDcKo2Pvuu0/MToRYO07zeCBwoGMAoVeQywOjv80/Ty/K5vacJgESIAESCI5A8uTJJXv27ILQufjT0/hEx2l8nd7B7TV8W2M0PMIXwgYMGCAcCf9f9ghXOGzYMDXjVF4fe8iy06dPS7Jkyf67Q/6PKAE8Tz300ENWG/LmzSsbN25U+WfMXGoIP4dO2+LFiwvEGfx999136vkUfXKIPmBao0aNVGg1c5k5/cMPPwiur7lz56q69DpcFy1atFDeYTrknV6nPy9fvixbtmyRlClTqvBuEO4DNR0lSm9/5MgRcVpoA08IhTAcH4Rf7ANiYt++feX48eN699bn6NGjA85xlj9/fvnzzz+tutq1ayevvfaaNe/khPk7inpz5sypntf1PvS7y5o1a+L9jfVXxAE3DFQ4f/68Es7AEtEucJ+qUaOG5MqVS+/esc9AmQZzneO7+Ndff6ljwKAMXCtOG87f0qVL1eADeO8iRGMghkFs+B4G810MZL/h3MYUuiCIe8qTZm9Px44dZf369WpxpMUl5F7Ebyss0m1RjXDwX9QLXWXLllXJCxHrtU+fPrJo0SJ14eCHh0YCJEACJEACJEACsUZA5+d66623pFWrVjF1eOgoQUcK8kEgrAo6S+xJqmPqgEN8MNqbBJ/ak0MvM+e1B4j+RLNM7yk9rT/t6/VheFofyDJdn7kfX+vxto2uW9eHT2/T9jrNbXR9/CQBEvgvAXTGoVO7fv36kilTpqjCou+vTz75pEycODGq2h6qxpr5dsaMGSMNGjQIele4v5udgvD+gJBKizwBu0cXhCx4HkEsgIdRIAbPHYSoS506tcfNP/74Y0HoULs4ZhZ+8MEH1TNhqlSpzMWydetW6d69u/zyyy9quaeQbnE2SGBm1qxZt+SG8iTC4ll14cKFghBxEFd+/vlnJVQhJxI8r5BLqWbNmvHuyRS6UAieFRAY8LuJuj1Z27Zt5fXXX79lFcqvXr1aMPAfz85gDG8jCBRFihRRHnQ5cuSwnnNQQSjzc+G53cwdDM81hHWDJ6A2dPRjOcRJT9a0aVPlPehpnbkMnqAvvfSS15yKhQoVUh6GvoZdDRXTYK5zCFy4t2qDFyBEE38NzCZPniy4JhCi9M4777SqQJjat99+2/qeQ4TF99bMp2gV9jCBAYmTJk0SiJgQTuDFCW9E3E8hXsaamULXK6+8Isgt583grYgIdLBIi0tmmNpIt8UbN3/Xx5TQBRfjBQsWKFdAJLukkQAJkAAJkAAJkEAsEcAIOYyOhGEEaPr06aP28PAiiZfyQ4cOqT+8HJtJlH05sHvvvVcwuEn/waMff/F1pvhSJ8uQgL8EtFCmt/N3Xm+nP83tzWmsd3pe71N/JlR/QuucaJtug/lpjgaObxrl41vny3Jzf8HWZe7PXpe5H7OcL9PmtuGaRqc2PDROnjx5y5/pHeBLeypUqKBG7yPtgHm8vmwbzjLoMEdnJCzWOn4C5YhOaoQagwXjVWLuHx3dZictngXQKUqLPIGLFy8KBpNre+SRR1QfGwQk5K7zx9BR3rVrV0GKEUx7Mog08E6JT+Axt+nZs6ca3G4uQwczBCpt6LjHc6W/htB+6NBHyERtnkSzffv2qeOBwJWQIQ8POvk9GTq60eGtDb85+O2J7zcHIjAECIT9M+3YsWOKB7zOPBneEQYPHqzaq9cj9yCOAQObQmHt27eXTZs2WVVD1EYoWIgo2iBkQSjEO40n8zbQAPcmhFQdO3asX4PhIP4NHTpUsmXL5mm3almomAZ7nSNkIUIXaoOXrc6vpJf58qmdQ1AW1zvODQwOI1hnNwxWwfn05tWIqGovv/zyLbngdH3aixCC3bx585QQGwpPO72/cHxWrFhRDc7Evl544QUlpnrbLwRrLfDG9333VodT67dt22YNmI10W5w6Jl0PhS5Ngp8kQAIkQAIkQAIk4HICeJmtXbu2amW0PZSikxz5GTCCDA/XGIVr7zi340eyenQ0lCpVSoVqtK/nPAmQAAmQgDsIwCMBnh/wFoBwkZCh4xsd4LfffntCxcK+zvTogHexm0W5cMFBODkIXDAIXvbO9kDaoTv29bZ4NnDbtaDbltg+4fFRuXJl67ARzhOd4BhQDq8rb89t2BCe4/B2ePHFF9VAJKsy2wQ60CF4miIX8mJhP/DgQhhDXH/a0wvrli1bFqcWhAwzRZRAhS57PQiTCEHKDJcIsQK/Xb5EGkA7PvjggzjihG64PXQnBulDYNEGzyN4h8ATCR52EIHt3rEQHfFd1KHs9LbePiFiQmgIhUGMKV26tHU+kWMN3mrmu4un/cLbB+Hyfv31V7W6QIECsm7dOk9FBaH/cM3Ag82T4XyBFd6R9HVjlsM6HL8nkSVUTJ24znE8pmcVRD54TZuGAZAQ8uD1CK8tT4MHzNCcGCSIQQe49urVqxcnvKVZ7xtvvJGgRxbWT5s2zdzklmmIi3j/g/AKLzG0DefBDJN6y0YuX2AKXfhd6N27t9cWw5MZ4i9+IxGCP5JmelZHW5+CN25RL3TBDRqJDDEqASoqviy4AeHGSCMBEiABEiABEiCBWCLw6quvysyZM9UhRcNDKTpE8OKIka34w0jh+AwvcOgYwUs4XnLxEkAjARIgARKIXgIIZYR7VkIj70eNGqU67ELlYeAPPaRD0J2HyIGJfDKJ3RCuEOcPNmLECGnSpEnQSOzeA8hJZA9JF/ROWEFABNDpbYbdQ0f0kiVLVF0QspEXyJO4gm3gsYmcfRBo4HGfkKEOdBSbz4UI3QdPFdP7C3nA1q5dq6rKmjWrIK+MaehgR0e7Nk9CF4RV9BGmS5fOyjeny+MTXqsIN2gKbvZ8dBD60N9oeiGhncibi+NFTij84Tldi1bxCTYQ0XHsngzHi3B8CRkEJXg9mexQHjnKENEAgpF5LGZdjz76qBIQzWVOTSPc6/Dhw63q8FuB3wwYcmV5yj2GdQh1h/OuPV3AFeK3eR2gHAwDKSCE2g3RLhDSHdcgDF5f+D2fMmWKwNvIFGgRXhLXMoQ4baFi6tR1bhcLwRrXgGkQAHX+J5wHeM7ZDZyRdxGGUJubN28WCKsJvVOanl/2+pDrbfr06fbF6h0ud+7cSpiEtyTCaEKkLlq0qMq5jA0gisKzL1rNFLq6deumfh+8HQtyYuE3DNc2wqJG0jDgVIeUTOj8R7KNge476oUuuFLjR2zv3r1qxAhGfSTkJhwoKG5HAiRAAiRAAiRAApEmgJdmhPerWrWqxxeLSLdP7//ChQuqYwThCON7eNZ5DNC5gOc5N3Ry6vbzkwRIgARIwHkCyKOD3Cx4Z7cb7gPjx4+PqLgEYQ6d1jB0wKEjLrEbvLgQvhAWaLgsO8MPP/wwTmf+0aNHJU2aNPZinI8AAQwgN/Ow2b2o4I0EMQZ5qUyDyAOPSISP9sXg1TH4P94d2vBcC9HKHOSEDmHkotXikqdnX7swZxe60KmP6xaGzmVcaxCETIMgsGvXLmsRPNrgjaUNA7YgwmGAvTZEV4CoheM2DR5w8G7V5mkQPjyNPKVaQWg6PDebDHQ95qcpaGA5jqtTp04Cbx3tGfnbb7+pc4R2ak8plIW4gXPoSUTC+kANfbIIDWiKb8jvp/Ni4TcfHn52015F9hCU8KbLkyePvbisWLFChbo0V0BwwHmOL7wehEywwbnXBuENIpi2UDF16jrHwAtzkAG8GBH1wjTzGLp06SIDBgwwV6tphBecM2eOmsa1AAFKC4xYeM899yjBZtCgQZZHHEJnIhyoPSy83TNXVfqff/AOw3cD9cPgfQdPPIjfiNKhzf7bopdHy6cpdMEDE9ewN9O/NfgNwnUZScN5RyhFWHzv6pFsXzD7jimhCyMf8NCELxyUYhoJkAAJkAAJkAAJxBKBBx54QB0OXugwitRNho4IjA5D5wDCIeiOCbONCAOFXC14sEZHAsUtkw6nSYAESCDxEEDH1/PPP6/uF/ajXrlypeqAsy8Px7y+z3oKDRWO/bttH/DIQIc1DHmCMCI9WIMHADwBtMFbIb5Oal2Gn+EhYIazwh6LFy+uvF/MvSOcHoSDnTt3movVOYSnCbzzEzIIPXgW/PHHH61iEF4gisDjCN598MJBv575LOnJSwXrIZZoLzNT6IKwDgHdDGFnHxQPQRteatqwPfatQwXCMwptNQWc5s2bK8HeLkhBSMHgLdOQf8ysX6+D0GW2C8/DaJsnAUxvg094x8DLTntsIQQc8lVVqVLFLKamESquZcuWtyyHdxq4OGnwuoMAqi1t2rTKGUELbxDCIHIcPnxYF1GfEL8QxtYUJLECoffsLLHczCuEeYhh8AjzFKYP67XBYwviFu47MFxvCPWH351QMXXyOjdFCbQfntL27xk4QliF1alTxxqgoBb8/z8IYODlySBywWMOTO3hCPGdMEVsfLewf3A1zVMePb0eXnRYr81bLjZdzq2fptAFzyjTszS+NiPcKIRmiIba8zO+sqFebl5TFLpCTdvP+jHKCm6oe/bsUcnvoE5D5S9WrJifNbE4CZAACZAACZAACbibgO6Ac9PoZ7y8olMSI751XhaEEMELHjoxsB4vuggHhRFvnkZoups6W0cCJEACJBBKAvZOUr0ve+eaXh7KT32fbdeuXRwxJpT7dHPdZqgreON56jj3t/32Tu0vv/xS0DFOizwB5EaCd5A2dG7je2g3CEwI74c/MywcBJvB//HU0iGx7NthHsIMriV/DClLkKbEU948eHp99dVXqjpT6DJz7ul9wVPl6aefVrPopIdABKFDG7xKTa8Tu1iE8NofffSRR6+rfv36qVxmui58InwbcjTZDeLZ+fPnrcUNGza0cuFZCz1M2MN+wkPHPF96EwhhEDsgItvNl/CI9m28zWtPFV0OnngIJWga3l3AVouS8GpBZ/v999+v3iOeffZZq3ifPn3iiCJ6xcaNG+WZZ57Rsypnmi+5kbABcg3ietU2e/ZslfcqVEydvM7t30v0e+MaMs0Mb493LXjF2U0LLfbl+P1FaEH9jmb3IMM1r8NCYlu7aIVlZqhKzNsNYYrx/dKG6wPXSbSaKXTh+jfDdsZ3TPCWhdcsBFZP3834tgvFcoStxHMOjEKXwuCef3ANxs0Oqqh2d8UXFG6QNBIgARIgARIgARKIFQJIfq1H07nlgRQjKzGCDbH00bkBLy2MqsQo38uXL6sHeXR24KUUIwVpJEACJEACJBAfAeSsgLcyQvRqQ6QWdHCHK7QdvAjQIYuc33p0vG5LYvyEFxe8K2BvvvmmtG7dOmgM8JZD7i9tCIsFgYIWeQJm5ydakyFDBpVrNb6WQXiAdxdC5ZkGz310vHsKkafz1KA8vtcIZX3u3Dlz8zjT8BzBYCrk2PJkeMZEO2AIs4aQYBhkhdBuZ86cibOJ/l5DnIPgAwFBG/KMQZwwzQz1hv1DPPCUfwzh2TCgyxT9dD12LzIsR3g3bKMNnjQQ87yZ7vNEOQwiw3fHHooR6+xiMpZpy5Url8rNpOeD/cTvJLyJTIvPKxfhKDHoLW/evEp40sIKQmGWKlVKnTfUU61aNXn//ffNKtW0XWDx5zcJgpjON4fKIEBCiAwVUyevc/A0hUCEXYSHmmn4jiDULAx95MhRdtddd5lF1Hua/TuBApMmTRKEudQGobRw4cLWvRgiIcRYbQiLCPFLGzwR0UZP33eUwTss6teCNJYhXKg99CeWR4shd5l+H4eAZd7T4jsG/b3Hb4nduzG+bUK1HNd/+/btVfX6OEK1r3DXG/WhC/FjiI4VKM76B4pCV7gvI+6PBEiABEiABEgg1AR27NghCJcCi/QDKcLWIOwQXt7xMoWOQeQ1QWfk119/rTou8PCMePHp06cPNRrWTwIkQAIkEEME0BGHgROm2T0tzHVOTut0CKgz0vdaJ48r0Low6l7nssHAloQ8dXzdh/YSw/MDhAHkQIKgQos8AXgZmB3eaBGEI09iim4tOq/xvGfvQIfHCcJU2sPKIReVDnkGcQid6AiZCM+a48ePqzCB6ADH4PXq1aurP3uYQL1vfNrDrGGwFcLzeep4xjWHvkN48+jcc6gDHhYQ+ewiFlhozwt05sP71G5Yj++FGYrRLAOvCTNUJ9bBkwWDxbTBy8OXAWHm7xO8T8HNblgGrzUzp5i9DI7DW5hE+zae5hEKEIKLPp8oA4EE7wfxGURI9OHaDYMc4N0JQ/hKhBa0X3d4z3jhhResTSGmmh5e1grbBFjjvUQzgSCDQXr4DBVTJ69zhBtE2EFtELTgnWWanY2n8I8Qeu2iNK5dT2H38N2EWAazX8O6713vH2I1hK777rtPL7I+kbd54MCByntPL8QAFoQmjWYzhS6EXdUhfhM6JpSDOO1tAEFCdTi1DqK99m6NtWedmBK64IaMvBBQ6RG3lkYCJEACJEACJEACsULAzJMRyQdSdB68/vrrKrk1XpjwgolnL4R3wQtjs2bNBKMmfXlhj5Vzw+MgARIgARJwnoA9TBVCXGFZKL27EBIKXhywSN5rnacZWI3wmJg6daraGJ316PAM1vAMAW8NdGbDew+eLXbPg2D3we0DIwDhAoPJTfNFFPn111/Vs589zCHCnSGfEDyttJkdxPhOw8snISFLbxffpz1EIXL/QcTSooZ9O3gRmZ4lWI9rEl5odkOoPQixMIhk6MyHkAND/fBqgXD7+++/q2X4B68NDL7XhmsbqVZMbxfsC2H7tEHIwIAxb4acVnPnzlXFsmfPrsQ5s16IXPBUM/N/ob29evVSnlS6/vjEDb3el8+rV68KPFnsLAPN5YeQlzNmzLB2jWl77jG7xyGuH3iUxSeUIyzltGnT1J/pKQxxS+cUCxVTJ69z+70QQhM840wzhQssh/gMgUkb8moVKVJEz6rPHDlyqNCkdjEaK00xyy5e2j3rUB7XY7du3aRAgQLKQ/fs2bMqwge+/zpcJcrBTP7/XRJ9/83zC7FXDwhJ6Ei0mHv33XdbImJC5UO5zrymYu1ZJ+qFLghauGnC7VH/MC5evPiWm3MoLxDWTQIkQAIkQAIkQAKhJtCoUSP1ooyXkq1bt4Z6d7fUjxfa/v37q9Gs6JxCRwI6JiDA/fnnnyrkCjoKkBScRgIkQAIkQAJOEEDII3TK4n1fGzqb7R12el2wn2Zukljr/AmEDcQteOXAzPxGgdSlt9Hh4CAAIGQZvAbQ8UeLPAHk3oIQBK8bbRASMLDJm8E7DwITPLTMEH7I62bm5MI8Bkdp89Rpr9f58nns2DFB2MH4DF6JEGvjC49Yvnx55eHlSWwzPRpRP0R2eJkhtBu8sL799ts4uy1durQgDCHyY5mhyRAS0WwjvIvM3F34jiHXmDczhWeUfeSRRwTvB1myZFGCz4cffhiHPXIvrVixQrJlyybwMILYAcNxQHwLZtAAQrwiooNpCMmGtDJ4T/DXzFBq2NZTni9cl8iThsgS2hCKEQILxBh4uX333Xcq/xnuGRBBTRES2yAsIsQvCJewUDF18jqHlyIGEmqDyIXvjWm43p588klrkV3o8uQp7UlM1BVgYCPyzsHggQdPJHg+wnAeINrguxeIQdzOmjVrIJu6ZhtT6IIga4q08TUSvwFg5gahC4MStFgaa886US904cca7qz44uuHMLg8I3cXjQRIgARIgARIgARihQDiyOPFGqEkkN8inIaHcrwwIfxE8eLFVWcXEjpjNCpeojFiEIl49UtjONvGfZEACZAACcQ+AXSMo+NQm68hq3R5Xz/R4YMOLFisdf74ysAsp6PmYJlTzNF5ik5UeGNcvHhR9u7dq/I0mfvldOQIQEjAedHmq9Cly5u5grAMogdCEmozO9CxDM+Ow4cPlyZNmugiHj/hQYUwgRCXEBZRd7qj8KOPPirffPPNLduhX3DhwoXqesNgLbuhsx3CeXweQeCAMKoY0OXNihUrprzXUJfdywzPzvCC0WbmFcOynj17Sp8+ffTqeD/x3O3J88zTBoisgM53hImDmZ5LmIejgM7Rg3l/DR47yJ9mWqdOnSyPWHO5L9PwQkNbtScewleaAxx0HTgmtD0QgygIDzzTCy5UTJ28zvH+BUFWG/K5QVA1DaEzzchmON9m7jR8P1AHxGwYvC3NPFtmXZi2C8h498Q7qDZ8NxD6zl+xK76Qm7reaPnEb9D58+dVczENb3BvhryBCJnpBqFr/fr16t0ebY61Z52YErp0bF78oGBkA40ESIAESIAESIAEYoUAXgxgTnU0+coFL4AYKYkRkXihwUsiXmSRiwsdCBC8MJKURgIkQAIkQAKhJIDwaDpsGPYDrwkzz44T+zbDO8Va508gfMzwVRjUgkEvwRo69dHpD08MeBnAAyRTpkzBVsvtHSKA3D84JzB46GBQuSkq+bIbLWai7O233646d/V28PZCyDud/0cvh2jy7LPPKu8xeBrBawc5mxDaEh4gmNYh0OAZAS8pbQjnh4590yCwIQ9Q3rx5lQcKnmXNHFvYBwbJewsZCGEFg+pNLzVzP5iuWLGiTJo0yfKQQpg8hDMzf0MQVlA/y5t8sD3aZuaewjJPBg9X5C6zeynZy2JwHMQ202sGebTgjabzaaHNKBOoQTBBmEbk0oIh0hYGJHjK0+TrPuy5y5YuXao80ezbDxgwIEGRxl4e4i1EPZwTu4WKqdPXuSnmwvsQ30uTNfYHwQWiGGzUqFHqnc08Xoi+uPbgoQVPP2+emq1bt7bywPXo0UP69u1rVqeuQ1y7eFf01fAeibZFu4E1xD4MQvUkPHo6PnhtItSnG4SudevWqfd5tNP8nfLU7mhbFlNCl3Y5hbKNC41GAiRAAiRAAiRAArFCQL8cIyyJOaovlMeHh2C8wMAQcx/hbDCSFB2BEL0QfsgcFRnKtrBuEiABEiABEkBnHu4/OuwXIrygM9QpQ+dtzpw5VXWx1vkTCCOIW7Nnz1ab4p6PgS7BGnLjQHCAwIDwZ/DagPcGzR0E4JkAjxk83yEktTdPK0+txvcUA6EgRuH7BK8w006dOqVC0yHMnCeDOJaQF5W9YxmdzXg+1SER0ZGPnDkIU6cNZbp37668MOD5gudbX687CG0QCEyvMXiiIR8R8tJ6ElCQ2wuiLn5HIAJBdCtYsKBqDjxB0OmthTuIDvAI88W2bdum8kt5ErsQ7QqhXrFfiJR2w3mAYAEW8CrD4LlgDJ56EENwrQwdOlQJfsHUN2/evDiCHwQqLPNkEHog1CEEI3LL2Q2edRBE2/0nryDOU0IWKqZOXucQUsFYGwRYew4z8IAXLr5/uEdiMIHd8HsLbz+803kziGa1a9dWoepRt6drFGEM4dWF7wb+4HEJkRnvrcjbBc8hM38VHFRwjUa7QejCdQdRG78nyFftzeAdisEdCNsLAT+SRqErkvS97BujGfAl2rFjh+j4ufghxA8ijQRIgARIgARIgARihYAWuvBih3A/oTa8COHlFS/ykydPlnvvvVeFJ0RoEXSA+Bo6JdTtZP0kQAIkQAKJjwDyAKEjHYZQg1qMcYKEvt9S6BJ56aWXBANsYPCi6NKlS9CI0fG8efNm5akBr55wPdcE3fBEVAHCx6EDG4JTMIY68BzpKf8VPIsgNnkKT5fQPhFNAH1/9pyw8MxBrit4gsFbCZ3KThrEAwhUp0+fVh5u8IbxJccVjhMM0LltGo4b3y0Igch7648hTB282NBpjnOVMWNG5b2FvEmml4+nOq9cuSIQYCD+IPy4mwzvGIjOpXOJoW3vv/9+HMHSU3vhWYPjgoCHaw2sIWKCu68WKqZOXef4LuGeh3OHdzJ4V3k6fxCbkFfZm6eir1wgxkI4xl8gNmbMmDgh9/0RdQPZX7i2waBTXHPwNIcAiOPyZjqvlxuELgw2waATWKw960S9Rxdi3eLmghEWSHCJESP4wYdbJ40ESIAESIAESIAEYoWA7njDS22gLxu+ssA+EI7kt99+U6FY8uXLp8Jf4GUNnl3Nmzf3tSqWIwESIAESIIGQEMC7P/oAYPDywkh2J0zfb2Ot8ycQNmZeH4RW017egdSlt2nRooXqv0GfDQYs448hkDWdxPUJYQJhLKdOnRpvrh8880JUQk4hiFzwYvFHwEhcRKP/aOFpAo807dHnVMjUSJJJzNe5mecRno3w4k2RIkUkT4cj+4bQBZELoixE4zVr1nitF79hCP3vBqEL7dUDV2LtWSemhC64ccKdM5whfbxeySxAAiRAAiRAAiRAAg4QCFfHGx7akfcEYhc8tzA6FMmH8WDuVCeXAzhYBQmQAAmQAAmITl8AFGPHjlX3q2CxhOt+G2w7w7F9//79BakhYJhGDqVgDTlaEG4MggXCayHcXLZs2YKtlttHOQF4qpw9e1blGIIwgNBzyDEFbwlfPKei/PDZfIMA3kEQmg+eSRC64MEUK5bYrnOdkxHnr2jRoiqEZyycS4hWCB+KP3hlIkSjN0PkOXgfukHoQhjTrl27qiZT6PJ25sK8Hjc9uGvi4WjYsGHy7rvvCmIKI14mjQRIgARIgARIgARihUA4Ot4QlgVhDDCaEl5bSEKP3AxIAI4E9HjZpJEACThPAJ16OvcCvCkLFy7s/E5YIwnEKIEGDRrIvn371NFt3LhR8ubNG9SRhuN+G1QDw7gxwmMtXLhQ7RHTyO8TrGEwzcGDB1XuF3S2ffrppyqfS7D1cnsSIAESIAF3EahevbqcPHlSNQoh8TE4JRZMC10I7ZgpUyYVjtfbcSEsJ/ISukHoWrVqleWhTaHL25kL83oownfeeacgeeDw4cNl4sSJKj43Yl/SSIAESIAESIAESCBWCISj4w2jJ+HFhdDQCxYsUB1aEL2efPJJmTBhgsccC7HCl8dBApEkgCTWSGgPQ04UdPzixZlGAiTgGwF9j0TpEydOBJVbSNcVa50/vpGMWwq5gxYvXqwW9unTR4UUi1vC/7maNWuqPDO1a9dWeU22bNmiRsT7XxO3IAESIAEScCsBiEAI64f8YrARI0aoAZRuba8/7ULo3WvXrqm8cPA+xXO7NytVqpT88MMPrhC6Vq5caXlox9qzTtSHLjSFrpEjR6pOmJkzZ0qlSpW8XWNcTwIkQAIkQAIkQAJRQyDUHW8IpYEwhYibjrjd6NhCAuESJUqosEUpU6aMGlZsKAlEGwEzPBjajveaxo0bR9thsL0kEDECyOeSP39+a//BdNyE+n5rNTIKJnr16iVLly5VLYUYj/lgrXLlynLp0iWpVq2ays+0efNmyZUrV7DVcnsSIAESIIEwEti9e7dMnz5dzp8/ryJ/INS9abt27ZKmTZtaixDez7xPWyuicEILXWh6qlSpVK5Jb4dRsmRJQb5rN3h0ffzxx9K9e3fV5GCel7wdcyTWR73QVaRIERW7F+opha5IXELcJwmQAAmQAAmQQDgIhLLjDSPtGjZsKPv375fRo0fLPffcI+3atZO7775bENqAniXhOMPcR2ImULduXTlw4ICFAC+f/fr1s+bDNYFcAzt27JC9e/eqjouff/5Z8HflyhWVGB55MhB6pkWLFjGRTDxcXLmf8BA4fPiw8kDG3uCJ9NxzzwW041DebwNqUAQ3MvOrQOTSnqfBNEmHfMLgZIhon3zyieTJkyeYKrktCZAACZBAGAl8//33UrFiRfnjjz/UXpMkSSKTJk2SWrVqWa3QffRYcMcddwju0bfddpu1PponkG/r+vXr6niSJk0qn3/+udfDQeolPE+7QehasWKFFYqYQpfXUxfeAohfj06YrVu3qo6ZcePGqaSFSGxKIwESIAESIAESIIFYIRDKjrdZs2apfFx4fkIo6Bo1aqgE0B9++KGUKVMmVhB6PI7ffvtNhZs4cuSIGmGOF7D27dtLwYIFPZbnQhJwmgBy4z344IMqobWuu1mzZir/sJ4P1Sde0iGwQdxCzmNMI1+YN8Oo3bFjx3orFlXrMXASv4UQ+t966y1BxwUt+gi8/PLLKmc3Wo70BtmzZ/f7IEJ5v/W7MRHeADm50CEGg+iF8IXBWunSpQW/e8irDu/xDRs2SL58+YKtltuTAAmQAAmEiQC8s5C/2bRkyZLJe++9p7x1jx8/rgZGQRCDYWADoq/FimmhK3ny5Oq5WecJTej4oF/8+uuvrhC6li9fboUiptCV0FmLwDpT6EJ4HbxwwXWyatWqEWgNd0kCJEACJEACJEACoSEQqo63q1evCnKbIuzTxo0bZdCgQWp0dTCj4UNDwNlaEU5j7ty5KkwjOvtNg9gFT7ZChQqZizlNAiEh8O23394iKDdv3lyGDh3q+P6+/vprwcs4/uDBefToUZ+ELXtD4Nm1Z88e++Konsf3HR5tsFjKIxHVJyWAxt+8eTNOvqdz584JRpr7Y6G63/rTBreUffbZZwW5PGAQvfr27Rt005AHNE2aNILQT8gHunbtWg4uCZoqKyABEiCB8BFALkzkW8Q91zQMEipfvryKDKCfqbD+9ddfl7Zt25pFo3paC13Iq4tcXXim9mb6OdMNHl0UurydrQiux+jHjBkzChKYQuSC2PX+++8rBTmCzeKuSYAESIAESIAESMBRAqHqeHv77bdl8uTJqgMrZ86cKtwT8nJhlHWseTRcuHBB5QNZsmSJnD59OsHzM378eEE4ORoJhJoAOnk7d+4cZzetWrVSXkVxFgY4g1w4U6dOVQL2mTNn/K4F0TPwvoUQpxANbty4oULHm6EW/a7UhRvoDgg0rV69eoJIIbToJICR5PBMhg0ePFh56fpzJKG63/rTBreU7dq1q6xevVo1B6IX8gkGa/iuISTyww8/rHKAIi8oltFIgARIgASih8CECRNUCiFvLc6cObOKwhZL+Z610IVBGxg0eujQIW8YpECBAkoUc4PQtWzZMiu8Mz26vJ668BbQD0lIYIoOiVGjRqkXuccffzy8DeHeSIAESIAESIAESCCEBELR8YbcO8iVgRcPJKWtU6eOIJQfOp1iJV8GOuUxGh1hGH31QEHojUWLFgkEP1p4CeBczZ8/X4X2QJisxBCOfNiwYfLuu+/GAY0cea+99lqcZYHMfPPNN/LEE0/I5cuXvW6eOnVqwYs7ci4gWTg6JvCXIkUKa9uzZ8+qsHAIaVq9enX13YqV82UKXQipNmfOHOu4o3kiMX6ncL7atGmjOtYwffDgQUmfPj0mvRpC6uXIkUOVi7XOH68H76EARHiI8bBu3brJCy+84KGUf4vwfJE7d251j4VnNTyoEamHRgIkQAIkEF0EkEZoyJAhggEm8RnC4jdt2jS+1VG5HM/BeMdMmzat/PDDD4IQ+N4sb9688tdff7kidCHyYyLvJizWnnWS/OdB7h9vJ8PN602hS6vJU6ZMsUZwubntbBsJkAAJkAAJkAAJ+EogFEIXPBZGjx6tcm4ghvrs2bMdy8Hh63GFqhzyDCHfDgQEvIDEZ+jcb9mypSBUHDr0kSvkkUceUTmT4tuGy0NDAB5CDRo0UJ5D2AMEWIw4jPWR/t27d1dCs0kVy/r162cuCmga+RBeffXVeLdFLjrkTYC4VapUKUGuAV8t1s6XKXRB5Ma1F+0Wa+fIn/Px008/ScmSJdUm6GBDR5svhnsHRBhYrHX++HL89jKdOnWSdevWqcVdunSRAQMG2Iv4NY/uJ3iPQ9gqWrSoGoSCgTaYppEACZAACUQfAQg+uMcieoBdYkCIWuzPz2kAAEAASURBVAw2RFj4WDK8KyLSQbp06QQhyI8dO+b18PBsgWeMDBkyqJy4XjcIYQFEN+ndu7faQ6w961DoCuGFw6pJgARIgARIgARIwCkCTgtdeNDGywfCLeAFBB2ByLsDL3nEG49Ww8M6Rp8j9CLix8dnOFZ4zSBE3J133hlfMS4PIwGM7H/xxRfj7DFXrlyClzG8FMaqNWvWTHbu3Bnn8F566aVbwhnGKeDjDMTrgQMHxikNj0XkSWjcuHFQeXFi7XyZQhc64hEaP9ot1s6Rv+fjlVdeUQMesN2OHTskS5YsXqtAvkp4NMJirfPH68F7KNChQwc1AASrIHq9/PLLHkr5vgij2TGqHSIk0lDgNwq5QpC3i0YCJEACJBC9BLZv366iEej3LzzDIw8jwl/HmmmhC+8neFY4efKk10PEsyVymrlB6MJ7MvJxw2LtWSfqhS6MQkRIjU2bNsnEiROViow8E7Vq1fJ6kbEACZAACZAACZAACUQLAaeFLghaEHoaNmwo169fVyHI4N2F+Wg1jCQcOnSoGi0X3zGgM+3pp59W4dzQ4U9zD4FPP/1UWrdufUuD4G0E77z/Y+88wO2oqva/v0epnwoaSgiBBwQCH0WUKgldDIKCdAgJIZAAoURKEAg1hBqKIL0FAiSIEFrokGgggHQBFZFuQgkoIQQ0IM/j/e/f/rvGffadmTNnZs6958xd63nunXOm7NnzzpyZPetd611VNSQAwxdksi2pE1XUiKyFzH3ssceipsp6V6ra+fKJLjLbyGIhSpl6fkg2IuvK/MUWW8x87WtfMz/4wQ8yEScR8N3woWrnqFEIyVSmDhS29957G2pS1rN//OMfURZp1Zw/9Y49bjnPy+nTp7tFBxxwQCfiPG6btHmCL7JPEIpknSKhJNl3advqMkVAEVAEFIHWRgAiB3WMf/7zn4aSQtSwqqJttNFGLnuNeluME19//fXUw2Q8LrLIrUB0IdE/evRo1+eqjXUqRXQhTYPG/eWXX26233771ItMFyoCioAioAgoAoqAItBOCJRNdDG4ZZA7btw4M3bsWDf4njZtmvnKV77STrDU9BVHGXJVofGSRf0xMmc0ajxEp7W+Q1ZSc3fBggVRx3r16mWef/756HvVPmy66aZm9uzZNYdF3SscwWXYTTfdVCM3RsYjwYJlWBXOFxkm77zzjpO+53NW69evX5TpknWb7livCueoCG6+9B73Ee4naUaWs8joVc35k3bcScsIiCEwBiO7iyy5Ika9QJ7Dm2++uZOIvO6661wGNtKpaoqAIqAIKAKKQDsgQBDN//zP/7gxBRlsb775Zmq3fVnkViC6br31VnP00Ue7PldtrNP2RNcaa6zhIumIMoLgIooXwouiy2qKgCKgCCgCioAioAhUBQEhusgsKKpzTrQdTiW0xbfddluDU/3cc881e+yxR1vDJdrn/kH07t3bSRnyUqHWHAQgB1566SXTt29fA95FjSwMau6ShYSM5o9+9CNDbZh6Ri025Mlee+01F1mJZj7a+ciLHHzwwS1L4hIV+sEHH9QcHpk48puvWZDjS0h03X///VHGSo7mOm2S93x1aqgLZxB5yws+L/dz587NtWcicynC3g7WjueoLFyRUiKbCzv22GPNIYcckto01wM12rCqOX9SDzxhITKnIuNJdtcpp5ySsGa22ZJlR0Ykv6EJEyYYHG7cB9UUAUVAEVAEFIF2QECILmQZ//SnP5m33347tdsi28tKrUB0ISkptYCrNtZpe6KLdPcVVljBEIF85ZVXmjPPPNNccsklZocddki9yHShIqAIKAKKgCKgCCgC7YSAOL2RRygquUfBXMiDLbfc0jzzzDOOTHjyySfNwgsv3E6QdOrrVlttFRtRt/XWWzvN+BVXXLHTNs2YQUYAUX6QLN1lECcvv/yyq8FGXRoyeJBbSzLkpBhHUyuFzDe/rhNRiE8//bRrD3KUTJa1117bae7PmjXLIGf1yiuvuOtn6tSpmbOFIKKoIcS+yRpgTN+okR2AzjxZSs8995zTvo9rI48sZ6MYxu03y7x1113XzJs3L1q1T58+nWp2RQtzfAiJrirWw2nkXHEN46CIy/5Mg5ffNPUVCLTkWkUSsug9pRXuFWnHXIVlBHZQJwTZIO6FEF+cyySDMJfsoqo5f5KOOW0+crIQ7xj36VNPPTVt9brL3n33XVcflDEIvyMyDsvMYK3bAV1BEVAEFAFFQBEoiADjBFRQILr+8Ic/OKIrbWzh1/9Uoqsg+HU2rxTRReTnGWecYS6++GInT1Pn2HWxIqAIKAKKgCKgCCgCbYOAEF1kqxQlpCZPnmyOP/54VwieKLSDDjrIfW8bMBI6CrEDSYPzODTIwd12282RMquuumq4uO53XlAWWWSRVAcpjTz77LNm8ODBrj3UBiDZ6hlyFygSIH2x+OKLu8j2QYMGGQiPRg0nLfWdIJAgqMQ4frIajjzySIOefGgEjQ0fPtzNZt0XX3zREWO8vJH5ApEVGuTRH//4R3PttddGi6iTSw2oLOZnCuSRgbvzzjud9GYWwgLnLE7aLJYXwyxtx61D4B7Xl1gZzmRpi2lIdLVa9gQZHtTo4XdAsCJSjlktz7kSR3u9fSB5iiOD7B6k1pBGXWKJJept5s5ls+4V/s6L4Oa3k/VzWfuDeMIZlOYQytqnrOuNGTPG/Q5Y/+67746kCeO2h4AX2VAluox7nkmNv6FDh5rTTjstDrbM88hKJ8gGOWFqrROszPOqf//+mdvQFRUBRUARUAQUge5EYP3113d1W5dZZhn3zlRPcUXqU9LnViC6CDA55phjHIRVG+u0PdHFSzGOH4rdEQ10+umnm4suusj89Kc/7c5rXvetCCgCioAioAgoAopAqQgI0QUZgpxbEUOqAMkCMo7mz59vHnzwQZelUKTNVtkWsuvwww83r776amKXtthiCydfJc7MxBX/s4AMGAgiCEakm+TFIG67UaNGGbKaMKS0IbCSDHIDJQKIoS+//LJmNaIEkXbab7/9MjsAceDSNwpAJ9laa63lMqAWW2yxmlV8oosFSADi2IYc9AkzfyOIKjKq5HhZBomIpHg9+/3vf2922mmnaDXINa5tpvWMjBzOB+cli3396193MohLLrlk3dWLYBjXONjdd999huOFpIbIJIMLMmedddZxMqQrWfkusk3Eys5uCIkurjcIydC4HiEuX3jhBSfD8t5775k5c+aYzz77zGXCcL533XXXcLO63yGw2CfHCQnsk0W8v5111llORpWGOP/U7KF+Tz3Le66o/4aDAqdDmpH5yvlqxMq8VzQLt6Tjaeb+wBriH9lMHCrcS8kK/clPfmIgT5ptPOOo1YVxj5a6FHH7pV7bgAED3KKqOX/ijrfePIIueB5gZRBd3Ae32WYbs8suu5hll13WXReTJk0ym222Wb2u6HJFQBFQBBQBRaAlECD4iaAmnmOM8esprnz66adu3EPnW4Houvnmm52cM/2p2lin7Ymu1VZbzUlIPPTQQ+aaa65xEUZEsfovzpw4NUVAEVAEFAFFQBFQBNoZASG68jhfw+NGMoh2MCSdpNB8uF67fodcuP32212mkRxn3LFQuwlSTJyaceswz5dExPGd1qaPLTJZ4iAM24asYbxKbat6RvYdWXdpBpmCAzeJlPK3/dnPfmZGjx7tz3LkFCSeGCTCYYcdlvjys9BCCzmCAsnLKVOmyGYGAi0u+yta4T8fkDtk/C5GrTjUGbLYxIkTY+vE8OIIphCYkCpLLbWUIyoghrPUtSuKYdh3rhNwJmsyziDexo4da4444ohoMceABCNEZ1kWEl1kGUK09erVyxGs9I9MRPqbdv1ATnBuG+0bGMg1AoF14403ukNjXngdsgCnwW9+85tUqc2i5+r55583hx56qDsWiG/wQBlk9uzZrm9cMxCvjVqZ94pm4JZ2PM3aHwGpJ5xwQqc6dNIXyWCkfgWOF84Fz6UyDbIWkh+DYLv33nsTm4fw4zxiVXP+JB50yoI999zTcJ/HkOvkd1LECEaBaKddJJ8I9rjhhhsMv0M1RUARUAQUAUWgHRBolOhCbeQ73/mOOzQlupp7hitFdFHIdNy4cebCCy80O++8c3OR09YVAUVAEVAEFAFFQBHoQgSE6MIpnVZrqV6XcCZSr0kc2lWRLUw6bhx0SOuRsQS5FGdkd4wfP94QQBUaGUvIlvlG1gtZQnGG1BlyamKQB3FZITj2TjrpJFmt7jQtCwFSAOJIzimNIbdGdhfOXWShCASTTC+WIfvnGzW4dt9992gW14hP6CEpN2LECLPmmms6hzWkB4QExMf2229fg+1TTz1levfuHbUVfmAbCEHJYkLCjP4Izsgmnn322Y40IxOIffmGYzwkZzfZZBN3nuOw9rdN+lwGhn7bZEWBJ7+3RozjwNlfpoVEV962k2Qp650vyGS53pBphODk2oKU9CUb/X4hj5aU6VP2uZL9HnvssRH29Qht2cafln2vKBO3eueI4yhzf4IL55Fg1DSjThPSeJC+ZPPxe+c3wH25TCM7lZqUGEQnRG+ckQ38wx/+0C1SosuYPfbYw3BPx5C/JQOziHFvRH2H2l+Q/ZSduP76652cYZF2dVtFQBFQBBQBRaCrEBCii/cdxhSvv/66kzJM2v/cuXPduxnLW4Ho4t3wuOOOc92t2lin7Yku5FFWWWUVJ7mDEwP9/QsuuMClwiddYDpfEVAEFAFFQBFQBBSBdkNAiC5qJiE5mNckmlq2R8KQzKaqG3JUZAIhC4dcY2hgSkYRRINvZHUMHDgwmsW4E0d7nOEMxCnoG05TpC1842WHGiV+LTEyCJDWon4NRBAyX3//+9/9zWLHuBApRMIjMyeGQxfizpcBhNB84IEH3Cp9+/Y1jz/+uKzupm+//XZiRH09MlSkMKVBcCRDK8nIpLnnnnuixWB27rnnRt/9bK9zzjnHRf5HC+2HOOc59ZSOOuooAwnmH7e/XdLnsjCU9qkZhiSbf05YxnUAgYJ8iU9KynZMqVPDy2eZlofooo4bmY4QUxDAvNBThyDO6p0vrkWR8IRcgKSEOE17sfYzv/x9ln2u/LYJmCRwUiyNDJF1/GnZ94oycat3jjiOMvdHe7yX+/X7mIeRXcl9lICAefPmOQlPiFAinUVOcqONNjLUkivTqCkI4Y+l1fQmmATyHku7Rt0KPeCfTxAiY0gQQhEjexQJVGR5kTElSJnrBKleNUVAEVAEFAFFoB0QIGgQFQuILpQY6tXQ5p1OAnhagejy3w2qNtZpe6KLQTIvX7y4EwFGJBiD2Dz68e3wY9I+KgKKgCKgCCgCikDPRECILiLzs9QaSkIJhyKR+xiZYbTXKDGQ1HY7zCer6bbbbnOkF9F3viHHB7FC7RCxO+64o0ZaLs3RR7S7TyDhxIuTJvSj6NgPDj7IIf884PBFslAyYViPDKoZM2bUZIjJ+JflGG2RQeFL9dEnJKcg0WSd0AENLmRxhQbBAV5+e+E6ZOeQoSWG5CHkV5xBHoCvZHNBMHJMfnaF75QfOXKkGTNmTE1T1FiC0BI5LX8hxAz7lowMf1nS57IwlPb9/jOP8wqJye9O6ushpQbhiUMd4ksMHMiu868FWZZ36r/MJrXB/siog9yiVg7nPatEoX+8cecL2Tpq8GAcH7XJOOdiSEySTXXKKadEWYf8FvnthBl6ZZ8r6QNTyFZk1MR+97vfmT59+sjXutOy7xVl4lbvHHFwZe5PpE9D0MjiO/nkk6PfO3UtILwgUf0a23FZp2FbjX7nPsg9GkuT4JOMI9armvOHY2rUuF/jxMOQG+QZWcT4Xe21114uC5n7//nnn+9qrfsBJUXa120VAUVAEVAEFIFmI8CYmSA73s2yEF3UPd5www1dt3iP5/27O23y5MnuPZM+VG2sUymii5R3Bs7nnXdejfRKd148um9FQBFQBBQBRUARUATKQECILhyDZFvkNZxKF110kducgvB+BkPeNttxO0gfnNpEk4eShtTVor4WFpJSOMPDrC3WQxKLyHffePmBtAjNdyizjCwz6kqFRtYPxJrfBmQJmUsY5BSkhJ/5BWFBtgyZQUQaUh8Hp7OQXGwXlyXFfIgukTfkO0QHtWziCDCW+0ZW4Jw5c9wsyBLIldDIxoHYIepRjCyafffdV7666cEHH2yowYTtuOOOLvvCffH+QXYhoYUEpJBm3mKXHQJOUmvHX+Z/LhtDMlSI2JSMLWTYrrzySkNdrNCQaxs8eHA425SdZZlEdOFkhnigb5y/kFTq1LGEGfXOF+TX/fffH7s1JBfXPyodYaYe126/fv2i7co+V1HD//ng3xuZxflBVi+rlX2vKAs3+l/vHLFOWfsjY5aMVTIbfYurDSjL77rrLsNyMTIiL730UvlaypTrR+5lTCXDNWxcMo6YXzXnT3isWb5zj2DcgYXZt1m2D9d59NFHnWwhmb08o/Dd1MsCDtvQ74qAIqAIKAKKQHcisO666zoZe971GDfEKXj4/Xv//fejd71WILoIQON9FKvaWKdSRJfUOkhyQPgXmX5WBBQBRUARUAQUAUWgnRAQoouoMZzDeQ1nIk5F7MQTT3RR1XnbqsJ2M2fOdE5gP6vGx0XGl3KsED9rr722fHVTSA0cs35NKxYkEV3UkiWzCcPRh5xkUsYUMlo//vGPIzKHGmBkWGEQKGeeeab7nPUfhBr1b6iLFRqk2axZs6LZKCSglJDFRo8ebaZMmeJWhWyDnPOztFhAhhoRhGJkbXAsYeYQgWsEsGEQINOnT5dNOk3J6kJj/q233uq0jBmcK655sgXijrlsDMEALMR4iSSbKzSuGUg8zm9o9aQiw/XrfQ+JLshSyC2wLVLvT/Zb73xRq8wna2U76tyRsUg/sFD6k35DmoqVfa6kXZlCeiOBL4bE4re//W35Gk05dzg0Vl55Zff7lQVl3yvKwo3+1TtHrFPW/kLSirbrESQhyXjGGWe4rCu2LdMg2uU3x/06jtyVjCP2WzXnTx4sybQjyw0jmINzVcSQ/kW2UDJckcxEqlfkIou0rdsqAoqAIqAIKAJdgQByyyh3kJGeheh69913XRAifWsFouvGG290fgD6U7WxTtsTXbx8IFFClKC8XCjRxaWqpggoAoqAIqAIKAJVQkCILjKHkmrlZDlePzobJzNkQ7sbMnDUc8FpCeGElEQjxrZHH310tInvlJXxpSzEiYtchW84x3GShwbhgzxiSLCAObJ1YmRc8cKUZGQlvfnmm27xGmus4WrT8sWXSuSYl156aUOtrSQjy4LaNGTyxJl/bbA8KdMsblvG4mSEiCFFd8ghh8jXTplxECxkVMRlzNBHovwxsIMUTMtiJFsNUoJz9cgjj0SkYLRz+4EMDgioUNKwbAxPOukk1w/2jUwh8nthjTaWUbMKB2+c8X7D8ZRlIdFFjR0yBcuyeufLv379fYbObQgkiEmy9bBQjr7sc+X3hc9XX321Of3006PZcb/Lzz//3Ml0QqzyexJClo3KvleUhRt9q3eOWKes/SE1yjUnxm+PmnzcD+Psiy++cCSHLyULgb3ccsvFrV5onk+233777VG9DL9RyThiXtWcP/5xZv1MhrBI8DYS/JDU/oMPPujIf565SJSSmUv2Hs9uNUVAEVAEFAFFoB0QQIabWlu8e2UhumbPnm023XRTd2itQHT5Y9bKjXWs1Edbm42k67A1Adwx2BPVseKKK3bYKNW2PibtvCKgCCgCioAioAgoAiECjHH4s9IH4aKGvm+00UauHVvntMM6GBvatlVXto5Vd0zgY52qHVb2rqGu2uyBaHvaGDVqVLT91KlTa5ZdccUV0TI+2GysDktM1Kwj54qprT9Ts74l5Tqta4kv107Nit4XW88k2sZmZEVL2E72ZaPjO6wEY4clSDqsJFSHrdXlsLCZOx2W4OmwpJJbHm0c88HK6EXtxfU9ZpNoFsdlM3Oi7S1x1/HBBx+45TZTp4PrTfrK1JKs0bbhBysBV7NuI+fTyiJ22BphHSuttFJNG7Jvmy3VYaXVol2WjaF/LdoMuWg//gdLxnXCQ/onU66rssxm0dVgYaURy2ratVPvfK255po1++cYbdZkbB8s2Rqta7OQatYp+1zVNG6/2Gy8aN/00WZ7hqt0WCd9zTpWqjJap+x7RVm40cF654h1ytof51auY6ZWyjPxuWUzSDuGDh1as74lPOhOU8z/Ldho5th92AzSqD+xK/SwmTbTKsKD50xRs6Sna8+S/R1WstB9TnseFN2fbq8IKAKKgCKgCJSNwFprrdWx+eabd9g6lu45ZgOhUndhA6SiZynvSN1tNlAr6k9396Xs/bd9RheSEUSJoeMvxdTKjlJsBzZZ+6gIKAKKgCKgCCgC1UZAMrqQVerTp0+ug6UWlUhx2QF6VAcpV2MttBEScGFRX/CiBpklfFz9IT+bgAyg9957z0XgkQFEZL9vfiYJmVRkOohZx62reUU0HsuGDx8eZVshVThs2LCaTB0yd5AeFGO/m2yyiXyNpvQPyTpk9sgEEkNmiwwzstYwsrH+8Ic/uM/2BSvKOOCaePzxxxMlEN0Gdf5RK2vGjBnRWmRpWed39L3eB2piiawi69In+k7Wy8cffxxtjkSaZGxFM70PSBXuv//+0ZwDDjggkteQmWT/8OdjJcuYvvHGG64WnSUfauqTsYwoTCQG2bZsDJFRpFYTxrViiceaTBayRTjPfi00spiOOOIIM2LECLcd/6zz39WsimYU+BBmdNFHajaVZWnni3pN4O2bJSFd7Tjql4XmZ8SBC1KhYmWfK2lXppwrfr9icSoh3Bt++ctfulXIRnnllVei81vmvaJM3Ohs2jlieZn7i5Mu5LdAhicZqUj9kBHHs4x7A7X7fCPrit9IM4xaU2SuYsjnjR071n32/0nGEfMqF+XsH2jGz9ttt52T12V1ZAylxmfGzTutJtcHEsFI9lKnkYxoJH3VFAFFQBFQBBSBdkCA92iyuZBpz5LR5Y8RWyGji/EXstZY1cY6bU908aLEBcZLkLzEkf6OtIWaIqAIKAKKgCKgCCgCVUFAiK4nnnjCLL/88rkO66OPPjLrrbee27aMWhu5OtGEjZBAQn4wyXCoQ2pQCwqyj3pcNnosdnVkmi655JKaZaGkF23169fPObnFSUvbjEWR2oPcEQvbwzG+7bbbyuJOU6T8kIfiHM+ZM8egof7hhx9G6/mydjYDyzz22GPRMkgCnyyJFmT8gOOX+ili1157rSMK5Xu9KfrzyLkJJnHrr7baao4opDZZkkHk+TJWcUQXjlFIRMgPSCJIkThDDg1pSaTTfBOyrWwMkb5DAk9s4403dnVtOJ8SmOdfe9SpgozjvPPbhHDAkKJEprRRGU7Zrz+VdySZZzMEa8hYmZ93mna+/Bd7af+6665zNcLkuz+12Wbm5z//uZvFbwrJNKkjVva58vfLZ58E4Tu11aRQN9+5vvntSj0/ztcdd9zBosjKuleUiRudSztHLC9zf9xjIffDmoXsJ4tB2Pft2zfLqg2v849//CMi70PpSWmMe4XNinVfq+b8kWNsZGrVc6JzWQbRJXUMTz31VNeNU045xdX9YkyipggoAoqAIqAItAMCBAIS4Ih8IfWzraKEiQvgkmPhfYTgS6wViK6JEycanr9Y1cY6lSK6iJ4kQpGi3LwIqSkCioAioAgoAoqAIlAVBITogtiIq2uU5TgZhJPlhFFHxa+plGX7Vl0HQogofSvrWKiL1MlCISCsYQURQaaVT1CEO5IsBByptEO2EQZRgZMZpz1G5hkZaGI4EadNmxatL/PjpkS/E4EHuYP5pADfIdnOOeecGqKN+aF9+eWXhkwx8LLyehGRQHYafRHjmKlr1YiFRI+/LTXUqAtHfd00+/vf/15TOycuA8mvJ0Y23JFHHumyQMiyiTOyRyB4xKib9cc//tH1R4gVlhXFkIw4MuOy2FJLLWUgfbheMD8bjO9km0A+FrWQ6CJzIq6mXN79pJ0vyCFqEpBFiQ0YMKCmflO4T8gRfhNifqZH2de77EOm1LfbYost5Kvp3bu3oY4YZCQ1o6xsqXnnnXei5X7fZGZZ94oycaNvaeeI5WXvj8xVsjIbJbt4zpH12Ewjo5b++UED/v64R1mJPjeras4f/zizfh44cKD5y1/+4lYPAzeytuGvZ8tMGGo4Wslgd18gQCMue9LfRj8rAoqAIqAIKAKthEBIdEFkJb2D0O9XX301qhPcCkQX7x+8Z2BVG+u0PdHFYBg5DCKv/EHTkCFD3AnTf4qAIqAIKAKKgCKgCFQBASG6kNpbyWa05zEizqyWuNvU1sZIzSzK0353bkO2GpJiZPnj1G3EIKMgO5CLE0Iq3P7Xv/61IyLEYS/LISvOP/98l8kk82yNL5elI9+RwkKyC3v++edrJJoYv9paaU7WC5IsySDfxo8fb2y9lGgViDfOJ236RqYCGQmoHnBstlaWI3XIWCFbAoJHsq4gFa688kq3ORhAJoghNYZDshHjWFBWQMbDN6IcueZ8GUh/uf+Z44KAo3AzBr5htD/fyXjyDalE2ifbjghLziXHSbbK008/bWytMH91l2HFi2qZGHL8tpaUSTuXdMLWLDMUgvYzV7iGf/jDHxqmGKQL6xQ1X4qNtiC4IbrLsnrni2xLri3OB0QQ12Wa7bPPPhHZwW+JjE2s7Os97APXChl4c+fODRd1+s51w70G8jm0su4VZeFG/+qdI9Ypc3+0x2+Aewjkb1brikxjPzMwzrkDDnLNxS3PeixVWY/gGIJkMDL1yKQtYmQpI1vI84yAELIm+ewHIhRpX7dVBBQBRUARUASajQAllJZbbjknx8x7WD2iyw/kUqKruWenrYkuBuw4eoiCvPvuu6Oo1tNOO805KpoLnbauCCgCioAioAgoAopA1yEgRBd1ZKTOVqN797NNHnjgAVfntNE2Wn19xodkTVGThjpNkAb8IQlHXSReLsjQgDgCUxzbEENorNczXmTI6uBlBYILiUKys0J5OfaHwxaChQwhSJZlllnGNe+TjcxAxmnDDTd0NVCIcCdzRLLB2JZ6tEhdIKMmbfj9xAFJgBdZbXGGzKItkBy3yM37/ve/b3DMY7NmzXL7EhIMUmLdddd1yxr5B1HA8VOHB2IQAurSSy+NZDOztAXBg6QG5xM5xfCax1lKJgDL8xjnDOKPzK4yMaQvM2fOdNllcWQX+4NQJVsuzBxkW+QNIXe4BsiwE/18luU1zgdZgEjuQcyggsF5L9PqnS+ua34zq666at3dQnBC6NJX2vWvwbLPVdgZ6g9BrKYZ1yKSL3JPjlu3jHsF7ZaFG23VO0dl74/2kDHkfknGGH9kkSJbCnbU7XrooYccAc66WFe8x5N9S+YuRmarSGO6GfafnwGpRJdxMqM8SzF+l2Q5FjGRS+J3RnaxKvIUQVO3VQQUAUVAEegOBAhgRJacd0reJ3hO+vWgwz4x3pBgxVYgupCnFwnhqo11lOgKrz79rggoAoqAIqAIKAKKQAsiIE5VnP5kg+QxyK2DDjrIbUrtmyWWWCJPM7pNBgQgKu6//35HdPn1psI6QMhkkQEkBiGHY5iMJF6gQhJN1vOnEGtkTuAUb8Qg2CDXfClB2sAJDMF21FFHNdJczboLFixwTuTPPvvMEVxxpE7NBjFfcIx/8sknUU2dcBUIJZylYNqIIS3Cce+5557RZmViSKNkFUIoQXbizKVgNdlbZEQgiZdm8+bNc+QbL9G8QJdhL7zwgrset956a0fultFm2Ea98xWun/YdspUMsLgMy7LPld8PyEky6f72t7/5s91n7pdcM5CUZZ0XGk66V3TqQIYZabixeZnniPbq7Y910oz6eb6MZl5yPW0f4TIyksggwriHQLj5BiEIiY5VzfnjH2fWz37dOT8DOOv24XrUMETiFlKZDFiyPbuC4Az7od8VAUVAEVAEFIG8CPDuRCkB3tMYYzPejxuzSvt+rVTGk7yHd6dNmDDBjBs3znWhamOdtia6iBDlJZwoPwbFIjPAycqqjd+dF5buWxFQBBQBRUARUAQUgawICNFFDaXVVlst62Y16zFeIlsEq9qgtuZAW/hLWKML+bO11167cI9xlt91110GJyJEWZzxAoZsHHWSILkgPcgaa3ejpg9OU7LlQmlJ/9ggDpEGRCILyZHQejKGIRat/r2Z5wr5GbJ+cErw+yD7bdddd3XXTlqh8VbHrBX7R9YmGT4YBPTLL7+cWszdrVjwn1+DK+7+W2XnTx7oIH6pX4dtu+22NRl4bmaD/8iKPuuss1yWL9nG1IEkqnzYsGENtqSr50GA+xsZp2Rwc38jwxJHLeOCLBm3efap2ygCioAiUDUEeBeHj0A5g3c7VCzi5KzluCHDfvrTn7qvrUB0XXPNNS7IhA5VzSdQKaIL6RcdKMnPSKeKgCKgCCgCioAiUCUEhOhC6snPwGnkGO+44w5zxBFHuE2qNqhtBIfuXNeP6KMfzZCQRN6NFy4k4CAEyA4jm4jgsCwZYt2JT5F9kx1ARCXyIUikQUog94iGPvKJcdKPSfvrqRgm4dHK85t1riBNcQRXgQxu1fNHdhwEPSblCJrd1yeeeMIMGjTI7YaahMjX+kbNwjPPPNPN0uekcfUSIUWwgQMHumAK9yXnv0suucSce+65rjYkmb+MSZBoRapVrXkIfPjhhy6TGaI3yQiA4fzUyzpO2l7nKwKKgCLQUxAgMACFFYJ0eLerN17wFT1ageiS7GrOV72+t9s5bWuiC81vNNK/+93vugHybbfd5iRWxo4da/bbb792OxfaX0VAEVAEFAFFQBFQBBIREKKrCDGiRFcivF22gGwr5J/EOCfrrbeefNWpIqAIKAI9BgEyLF999VV3vPvss4+TtGv2wbM/9otR64/6db4JEcO8qjl//OPM+nnTTTd1QROsv8022xgy3ooYUpVIVtIOUqGQnSeeeKI54IADcjdLO9RGoQaiWmcECADZaaednBRw56W1c/y6nbVL9JsioAgoAoqAIADJRVYXahnU35LMZ1keTp999lmnDsD8ViC6rrrqKhf8QH+qNtZpa6KLCFUuLuoaEJkizhuNCOJSVVMEFAFFQBFQBBSBKiEgRBd1n9Zcc81ch0b0OvUwsKoNanMB0g0bffDBB2ajjTaK9ox0hDhdo5n6QRFQBBSBiiNAfS/q0BG8ipHls8ceezT9qKm/tsEGG7j9XH/99WbLLbes2acQMczU56Qx/fv3d7XdwAO52+uuu46Pue28884zF198sQF7ajgeeuihZsyYMWbkyJENt0mNE8Y0f/nLX5zsHgQaUsCahflfKMl0Ri4rSdL4v2v+9xPZCXnqav63Bf2kCCgCikC1ERCii+cNzyACCtLs6aefNrvvvrtbpRWIripnr1eK6BK9bYrHjhgxIu0a02WKgCKgCCgCioAioAi0FQJCdN1zzz1mnXXWydV3JbpywVbqRgRqIXfR0dHh2j3nnHPMnnvuWeo+tDFFQBFQBLobAZw61157rasFRLbOzjvvXNOlJ598subeV0SWt6bhOl9w/Pfr18+tFUd0CRHDCkp0GbPJJpuY9957z+G11VZbRTXV3Iwc/8aPH28uu+wyM2nSJEd0QXAdc8wxjvBqtDlq5xEl79viiy/ugknI1EOylnONQ7Knmk/cggHyxeBGbRlqVUJoTZ8+3fzyl790UsfUmHnqqacakvrtqdjqcdciQL3UG264wSy11FIuU4RMl+60uXPnurqt9EdNESgbAdTlKCXA+xwS2simp5k/5mkFouvyyy83Z599tuty1cY6lSK60PcuI/U97eLUZYqAIqAIKAKKgCKgCHQHAkJ0TZ061dVaytOH22+/3Rx55JFu06oNavPg0V3bkE1AVgF29NFHm1GjRnVXV3S/ioAioAiUjgD1gLbYYgvzz3/+07VNxDNOle222y7al08ofe1rX3M1LtIKuUcblvBBnqc33XSTGTBgQE2L1Oci0hnT56RxNcx4XpF5R/Yb5GARO+OMMwySSTfffLOZP3++OfDAA3M/Bylh8fHHH9ftDg5Jrj1kg6kF11OMwBqkCGW8wXFfdNFFLsMrxICano888ohTS1prrbXCxfpdEaiLAGoTyIhiXZWhG9cprvuDDz7YTJs2zcmZXnHFFe7eFbeuzlME8iKw0korGe6VXG+QXK+//npqU3590FYgugg4IfAEq9pYp62Jri+//NJFxFLXANlCJbpSf1e6UBFQBBQBRUARUATaGAFxzJHBjmxzHnvwwQedU4ltqzaozYNHd22z1157md/97ndu9zgGkKNUUwQUAUWgKgiQnRXWXKKGEgQSdZ5eeeUVQ00uCDGsDAKlEezkeUrwx/rrr1+z6bhx46I6VPqcNGbDDTc08+bNM0hNkiVFXbMiJvjeeuutjugaPny4C8A54ogjGmqWKHqcjOJYz7px37593bXHc3jJJZfMullbrsc4g+MUI4OLOq9qikAzEPCJLmrCkSXYHYbyBZKoYknkrizXqSKQBwHGESiskCXOWEHqjSa1NXPmTDNkyBC3uBWIrirXI60U0UWEMxGxJ5xwQuTESbrIdL4ioAgoAoqAIqAIKALthIA45gjuIcgnjz3zzDNmt912c5uqAy8PguVsc8opp9TIPxUhL8vpkbaiCCgCikB5CFCvguyZf//73zWNImW16aabOrk5n6CA/Nh3331r1m3mF3mexsklUgYB+S1Mn5PGEYGcqwULFpjNNtvMSQ4WOTfUUycrjLHMJ598YoYNG+ZUeUaPHt1Qs0TRI6U4a9asmu3ICiSDUGq/1Sz0viy22GJOThP/ERKHzTQc77/+9a/Np59+6o6VWmddYWTV4MwUQ/2oUZxlW50qAvUQ8ImuMu4V9faXtPz00083V199dbT4t7/9rSGrU61cBLrrvlbuUeRrjUALMrrIECZz/d1333UBPGmtkTE7dOhQt0orEF3UyiSzHqvaWKetiS6iilZbbTU3+CIa6+677zaHHXaYOf74481BBx3kTpj+UwQUAUVAEVAEFAFFoAoIiGPutttuM0jf5bF33nknkmmq2qA2Dx7dtc29995rDjnkkGj3u+yyi7ngggui7/pBEVAEFIF2R8B3oqQdy3LLLeck0xZZZJG01UpdJs9TahH17t27pu0xY8YYJA0xfU4aF1hDxPpnn33mxg+CTQ1oDXw58cQTXVYYajwQXTj+8OH8/Oc/z9wKyj7777+/oSYQRvYImYLUv8ShDaEKAfb222+77GlINV++z9/Rt771LZd5QrZaM+yFF14wPOOFeOM6J7gFUqDZFtYwKyJ93ey+avvtj4BPdKE8wXXeHTZhwgRD8ARGDbqXXnrJkd/d0Zeq7rM772utgCn3c541yOcSwPD++++bP//5z6ldg3AlsANrBaKLTMfzzz/f9adqY51KEV2SosrglKKmaoqAIqAIKAKKgCKgCFQFAXHMIfez0UYb5TosIqClKHvVBrW5AOmmjZCBQi6L84EtvPDCTvKCKHQ1RUARUASqggARzNS8Qqowyc455xyz5557Ji1uynx5nlJTY6GFFqrZB4TLLbfcYpBarFdcvmbDin7BkUdmHqTUJpts4mprFTnU4447zvzqV78yBHzwLBw8eLDz3eDDyWrXXnutOfXUU6PVIctOO+206Hv4gWctpBjn9eGHH46evbIexBjZTxBDZRvHyjH7hoOUQO1vfvOb/uzSP1OfCwcstvTSSxuy+nWcUTrM2uB/EPCJrpVXXtnMmDGjW7AZNGiQoR4SBgEO8aVWLgLdeV8r90jytSbv0xC6PBs/+OAD8/LLL6c2Nn36dBegwUqtQHQhLfqLX/zC9blqPoG2JrqILOrXr5+Laia6+b777nNFB4899tiaKNnUq00XKgKKgCKgCCgCioAi0AYIiGMO+RucF3lN2qnaoDYvHt21HfUDCNISe/PNN10UunzXqSKgCCgCVUCA7BvILKSkkPvxrX///mby5MkGubmutLTnILWiyABC2i6NoOvK/nbnvtZdd133bProo4/c2IMxSBETIpFaUTgIITmp50amV1bjWkKeTIy6W48//rh8TZ0y9kHOD6JJgk3YAAKI6PayyS4INurRhbbFFltEEpnhsrK+r7766ubzzz93zVGra/z48WU1re0oAp0Q8IkuAgioC8z9n4CBt956y2WFMp9769e+9jXzgx/8wCy//PKd2ikyY+7cuc4/LBmUY8eONfvtt1+RJnXbGAS6874W050un+UTXR9//LHh+fjHP/4xtR8EWYwYMcKtQ6bhH/7wh9T1m70QJZELL7zQ7aZqPoG2Jrp4aPPwpkDqlClTXCFvMrmOOeaYmuKDzb5AtH1FQBFQBBQBRUARUASajYA45m6++WYXVZ13f9JO1Qa1efHoru0gtpBbwtFHgfj7779fI62762TofhUBRaDpCEBEkIVD/S6MrBYybMg06WpLew4io0dJhK9//et1HVdd3e/u2N8666xjkNtD+m/jjTd256xIP4466ihDkDJOPzK6dt99dzN8+HBD7a6sRo0vf32yol977bWsm7v1nnvuOUdA+bXieBZDwJVtEHOQaNQ5E+vVq5d5/vnn5WtTphwP9WOws88+25DpoqYIlI0AJWWQRt92220Nn7MaSQvcB8o0iHj8wWIQMnK/l3k6LQeB7rqvldP7Yq34ZZR4NvIuh0RmmkH8HnjggW6VViC6yOYiqwurmk+gUkQXgxJqcxElxABVTRFQBBQBRUARUAQUgaogIC9q1McYMGBA7sOSdqo2qM0NSDduCNn17LPPmh133NEsuuii3dgT3bUioAgoAs1HAAk8HJs43wcOHGj+93//t/k7jdlD2nMQfwJ+BWo3/f73v4/ZumfNWmuttRzphwQessnIJxexww8/3NXu+c1vfuOcgzvvvLPZd999o5o6Wdp+7LHHnOShrJvXaUhW15FHHinNuClR+ZCcZduHH35orrrqKkPfed7/6Ec/anq5DUjK+fPnu0OhHstPf/rTsg9L2+uhCCD7evTRRzsHOVlUeWyllVZy9RnzbJu0DTWQqIWEEUwhn5PW1/nFEOiO+1qxHpezta8uN2fOHEPABHXL0oyARimxlPeZldZ+o8vOO+88Qy1VrGo+gbYmuoiIWWONNaIBlzCk3HBHjRrV6HnW9RUBRUARUAQUAUVAEWhZBMQxN2nSJLPZZpvl7qe0U7VBbW5AdENFQBFQBBSBHoVA2nOQ7KJp06a5TDMCEXq6IUe25JJLmnfffTcqGVEEE8mYo34bGV2QL0j7+VKE9dqnHopfq7RPnz7md7/7nZOCQiYTUo4AEs5lEpn697//3ZW7eOqpp6LdkRlGxmE9KU2px0IUP9JrZE4hxdYqhlwcEnHrrbeek9SiX9Qg22OPPVqiiziFqd131113GSQVfdlKJMGefvppV+8G+TmyftZee+26mZ8QepCUHPsKK6zgSI68B9vq59c/ru7oK+cFVS3k2hox5EGp3YUPl3M0ZMgQs+KKKzbSROq6n332maGmINcAhk8Y33CZ1h14h/1vxu8n3Id+T0fA5yLIZoT4qpehi1w9svWYEl3p+BZdqkRXUQR1e0VAEVAEFAFFQBFQBLoAAXHM3XDDDYbaDnlMNMXZVomuPAjqNoqAIqAIKALtjoA8T+Oeg2QXzZgxwwh50u7HWrT/OKWRl5w1a5YjTqhfVsQOPvhgV1udzCaIoh//+MdOUg9pvawGSbX++utHq6+22mqOnGRs9Pbbb0fzycojQw/nN+Mf/oi+hxBBPlFk/WSD3XbbzUkMyvdwikQVUk+/+tWvaup7ffWrXzV77723yw5jn80ysifAn2zwHXbYwWy66aY1u6IGHmTWM888Y6hb9t577xmpVYSD1Zd0q9mwgS/UlZk6daq7HjgPEHzLLbeck4dDuo4smnoGkQwJiYHdiy++6NqhbYiJuNp4yGzF1U8j63LMmDFuG78GIATkscce21AWW3ef33q4+cub2dd61xmkN/UV6xkk8wYbbGC+973vud8gxOsSSyxRb7Pcy/ltUGNRjOxhiNIyrJl4N9q/Mn8/cfuud/7jtsk7r6x9kS0OkcpfVxjPDgIckPPl2Qi5ihxumnHflIScViC6CAq59NJLXZfjxkJpx9Lqy9qa6PIvLvS9H3roIVfIdPTo0eZnP/tZq2Ov/VMEFAFFQBFQBBQBRSAzAuKYozbFlltumXk7f0WiAInOxqo2qPWPUz8rAoqAIqAIKAJJCMjzFPktMl98Gzx4sJOXI9Ng5syZ/qIe+RlHMaQB5AoO6zvvvLMQDtQoQYmHDCyILiT8IGfIOMpqZFX4GV0QWWQHQbIIsZO1LVnv+9//vrnuuuvM4osvLrNqptRtgygKyTF/JWQeIdAWW2wxf3bmz2B8xRVXmJWspBvXoU8KUA/nrLPOio4Pgoj+br755lH7EFubbLJJ9N3/QE0wcIYgpJ8QuY0YfTv++OPdeUvbjjHmIYcc4oi4pPV8Rz3rPPHEEwaHN0QjZGSchfKWOLZx0l544YWJ29BO1rImXXF+446LeRw/58Q/30nrMr9oX4teZ2SzcB3xTpFmf/7znxN/T2nb5V3myxauvvrqzj+cty1/u6J4+23xmWscCVjIfkgSpB8hjPmNElSw3XbbuftiuJ18L/r7KXr+pR9Zps3cF9ff5Zdf7moc805LRi7Znz/5yU/M0KFDs3Qv9zryPs1z46233jKQ7AQYpBnPKOEpWoHoGj9+vLnssstcl6vmE2hrosu/uCg6CGM/YsQIQ4FTtJ/VFAFFQBFQBBQBRUARqAoC4pjDsbH11lvnOixepnBUYVUb1OYCRDdSBBQBRUAR6HEIyPP05Zdf7iRtt+eee5onn3xS67v856ogWwrSD1JQCKUiFwz+Gvw2SAZ++umnZptttjG77LKLueCCCzI3GxI6RNUT+IwMYr06KeFOIIzIMiMThM9xdt9997lI/CQSxt8GRyaB13mM7aZMmeI2hcC68cYb3WfmxbW57LLLGmqdiWwiDtesgVA4WsnW4w/nMPsjMys0iMMrr7zSEUrIc2U1ss3I0kOiLrTp06eb/fffP5oNkYCkZdK4FDIakm/33Xd32/zrX/9yGWGPPvpo1Ebah8mTJ3fKfvPXb+b55TqHHCb7DfIyPD/jxo0zEyZMcOeQ3wYk4SKLLOJ3r+ZzGX0tep3RIWTayBL8yle+4lQmON9nnHGGmT17tusvdeiQAe0q+/jjj132mPxGsxKc9fpXBt7+Psj64V4DwZVm9957r/tdxq1T9PdTxvmP61fcvGbti2fICSecYAh6iDNIz1NPPdVwr7j55pvd7z9LtmlcW3HzkMmEnCawgGcjvwNfBjduG78mZCsQXdyfIQqxpHtv3HG0w7xKEV3CbFNQ1E9ZbYcToX1UBBQBRUARUAQUAUUgDQFxzPFCjGMoj/nOoaoNavPg4W9DABX1WFZddVUXve4v08+KgCKgCCgC1UFAnqdIplF/yjdIF5yRZWYE+O232+dVVlnFPReRk/vOd77jskmKHMN+++3nyBmetxBdW221lSOoLrrooszNkiXAdmLUC4IMguwi68qXsJN1wil1uCAdjjvuOHeuw+XyHSLpgAMOqMkaImCI/eDoRMYQOUPJ9ErKeuNaw7FIthdZW2QfhEawtmTMyfVHVsxOO+1kPv/883B19/20006LshfIciJjDidwowYeP/jBD5zzmDpKGHJtHDvygHGGTCNkG+NJOX5/PZbhZA4dzNTgEtKK9ZEA4zjFkGWE9CE7DEc2WNEWBvEGMUlWoG+QlJB1OKD5/fqZfUgeIn0YZ2WdX3CHvCDrTbLsXnrppZrMNs49PktkJbFrrrnGcP584xoZNGiQPyv6XFZfi15nUYeCD0hFcr4xMiP9cxqsWvrXa6+91hEbNIx83eOPP154LF8W3nKwkGb4qbMQxmT3TZw40cnFyvYyLfL7oY0yz3+9+1qZ+5Lj5zfDbyfNINjJmBs7dqzLfOUewrXpS96mbV9vGdnIPA8heLnOIafJUk4zP2ChFYgu6iQSxIBVzSdQKaJLmG1uHpBdaoqAIqAIKAKKgCKgCFQFAXHMIV8zcODAXIdF1BmODKxqg9pcgPxnI6JOieInIhRnD5HlOJbUFAFFQBFQBKqHgDxPIVuQivJtxx13dDWDIDFwTPZ0g6SAdCH7bZ111jH33HNPIUikBhoZIZASkAJITUmtkCyN41hE8lAM5yXR8hjyUNR5IpI/NLYZMGCAy1CDRFlmmWXCVWq+0wZ1vwgSEkNeD8knP/uLOmAPPPCAWwUSAyd7aBBGlNrAqI3CmCM0X0oKGbPf/va3jihJG6+Bn2R+SXuQKeBBVkijRvYU1z2SlagmxdX1gggjewcsMUglzudVV13lSDafaOT3xTlB/lKMOmpJtWbBErIoycjimDRpUs1inM04tMk+xKjBxu9YyK4koqus8ytKU+wbggLnP2QLJCpEqG/nnXeeI/lwipPhJX2UdciuiztvZfWV/ZR1nUmfZSrZafKda4LruNnG9YbSBQQ4JhmeRfZbJt70AxIeIhAyWox7CDUKuReRTcnfySefHBGEZFuGhC7bFvn9sH2Z57/efa3MfdF3srQgNUPj3Y2gDMj5efPmuWcVQQOQUfw+MeRukYwsw3hfJMOZ+y+1BalHF3ff9/fFNUCmIdYKRBf3cO7ZWNozxq3QZv8qRXTBuBMhVCRdvM3On3ZXEVAEFAFFQBFQBHoIAuKYY1BKwe885keXVm1QmwcP2YYXD15AxHhhRiKyKw0JnhtuuMEstdRSzoGEDIaaIqAIdC8CyL3imOJ3qVYdBOR5irM5rFVEfRRInTJk+qqAGPWiIP3AhMybouTfkCFDXO0zyAAckP3793eklUSWZ8GMjB0y78TCLCoyHiBM+P36hiOZ5ywkThZjHACBIkagEJkEOFXFcG5yTOLAZp04R6zvEB45cqQZM2aMNBFNfRIHggBiccaMGdFy7kM4y0855ZQogwpiirFdXG2xcGwDuYYzmEw6xoBIbYXSX2Q+IN3J/qdOneokG6MO2A8QVNR1EblEfxmfX331VZcxwvUixphVHKrMI/uLaym09dZbz9U48/H116GOFySGYM0yyMu4aweCDqIOfCBR48bNZZ1fn+iiT1yf9BUSw+8ryyC6trSZhNxncMrHGRl0ZMv5VlZfabPs60z6SZ29Sy65RL66DJfw/hotLPED4+d99tknajEtKy5aqc6HMvFGThWC/Msvv4z2uv322ztSK5QLJTuVa0eM+y33X9/y/n6kjTLPf737Wpn7EolTOQ6ZEpgIQSikKr8fflsEMiBnKxY+J2R+nulHH33ksu34LbM/CO56NT3JKOP+jbUC0XX66acbgmexqvkE2pro8nUxuWgYBBAhNGrUKBfF486Y/lMEFAFFQBFQBBQBRaACCIhjDskbXpDzGM4LiSKu2qA2Dx6yDRJIEgnKPF5ARbdc1mn2lIhOiTrEWUDReDVFQBHoHgSo84E8FpkRSNJw38WhUdSI3ifCH+eWZNcWbVO3bxwBeZ4+8sgjBiLHNzKmyfL1s4T85T3pM5kS4APhAnFBZtf9999fCIK9997bRb4TBc8z7/vf/77LUheHW5bGQ8d2HCkJgYNsVignBUED8VHv94wzebPNNnO1laRPZGAgqwc5hwwdEoE4X30yIylbi/uJkIRkG1188cXSbDSFAEvCF5IL4gZ55VC6i37EkXfIQZ5//vlR+2Q6ff3rX4++8wG5PTLkGBPirMXRLlKDOG4h8cTYN/2Lk12UdZjiBIZYEiIH3CA2fXIMosuXOyS4h0ymOAJM2vbl6ZjHtck2fruyLtP58+c7AtDPvpPlZZ7fkOjimuPQGT7tAABAAElEQVTag3ANDRLmjjvuSK3ng2+T2j9iZfaVNsu+zqSfXGu+BCnScXE12mT9sqZS94/2uDYhGiES8lqZeDOW4D7iZ4UiTYlsXEjoco8N3++SfNt5fj+CR5nnv959rax98Vvmns29xbe0JBcySVku1mjmsGwXN6XmHmME3h/JDIdkYzyRZjfddFMU4MB9mPtxd5r/HKmaT0CJru68snTfioAioAgoAoqAIqAIZERAHHNE0hIlmseQwRlmC/RiVRvUuoPK8c+vWyabIyfDS2hXmk90EZ1IzQ81RUAR6B4EkGc79NBDo53jvPMjg6MFDX4gml8c3DjLiRpfdNFFO7VCQCf7h2QjgwHVktAp1mkjnZEZAXmeQmSK3JlsLIEPEDAQCz3ZIHCQqVt33XXNn/70J4eVSPTlxYVgG4JucOriUN5ggw2c7Bi/hayGnBc1kcQgeeLqUtF/nqX8+XJ6kCpkag0dOlSa6DQlS6jRcQDXDCQFsnWhkXFw/fXXu9kQRpTdCI26VXHkCE5RZLjYDiMTyw+GwYEqMoJ+m5CHRO2LxRFdsixuyu9j+PDh0aJGSoRQE8sfxyCvKLWraBDnPySbWJK8oCxnKteOzIMwIgssj5V5fkOiC4c8QfhxBinH/V2MTDzGfJxDMeTZZKzOvDL7SntlX2e0iV144YVO+vv/fzNOelNIU5nHFPKHzD/uLRDGRQzCAUk6kYAsQ5GhTLwh+3inEIPA5FzHPc/DDEy2IQMT5bLQ8vx+pI0yz3+9+1pZ+wpJK46FeyCBgUkWEq9I9fnEfdJ2WeaTdUdQAAFLPM+oIcg7dppxDzzxxBPdKq1AdPlSo1XzCbQ10UXKNRq2vCQQGQeDymDlsMMOi7Qv0y40XaYIKAKKgCKgCCgCikC7ICCOOWRBiCjOY77ztmqD2jx4sE0YIcy87hhL+kQXL7BhDQr6paYIdAUC3Cdw8POuRTQsjqOeZr6kC8eOAyPOYdcoLshskT0hhtyS74iW+aGTmOAGghzUykFAnqdxslDiQKTuz+TJk8vZYZu2gkMaRyuSTxBdOKalzlTeQ8I5CVHD72DBggWR/JOQQFna9YN2WP+b3/ymQR4sySBsyLDxCQbWRQ0IR21cxo9knrEe9VeoNUVtnCSD3IDETsokYRlENwYRRv2iUJ5OSNZwH2SYk2kuxnnBDwZ+GPcLiKLQGEcgHSYWJ9Upy+KmoXOZe5UvERe3jcw78sgjo7ppzMNZz7UkBrmD5JcYzxyIwjQLt4Es5dzksTLPb0h0Ze0PfUdKEyIZslYyA8MxaJl9pW9lX2dyvCGxSrYjNZJ8+/zzz53c5FtvveUydBr53fvtyOfwGqc+H1lQRaxMvH3pPu4NENxxtQH5Ley88841hLwcA1mL/N59C38LWX4/sn2Z57/efa2sfSH16pPBZLQxVo27d3OcX3zxhbtnUptaDEIqlIqUZY1O58yZ44KQfvjDHxrITGoQxgUv+O3yWz/ppJPcrFYgugj2kACTyvkEbGRL29onn3zSseKKK3bY1E93DJboct9twbu2PSbtuCKgCCgCioAioAgoAnEIMObhz0b1xi3ONM++CLk2aEeto8M6izqsMzPCRDC2tSS6HB770hb1w2aOdPn+dYeKAAhYZ0uHdWZH16LNdumwDu4eB46twxNhYB1MHdYBWRgDW9y+w5JlUbvcb6z0Vod11nZq29a9qFmPdW0dnk7r6Yx8CMi93pINnRqwznaHvQ2g7bSsp83gmgUr61Tt4F6wzTbbFIbA1tZybVqHd8fHH3/sPlvHckPt2swkt52cR6a0l2avvfZahyWjOm1nsy06rFO006aW3IvWtSRZh80Y6bAEW4fNtOywUfwdPLNtEEDH6NGjO2yWm1veqRFvhg3Mjtqjv5Zk9Zb+/4824KVmHdazGQCd1mMG50SO35J1seswXpR1mNoso9j1kmaGfea+mMWstGSHJbWifXPfs/WJajYFd79vVuawZnncl7322qtmG0v+x62WaV6Z59cSqDX98o/LymTGLgMTSzxGfZX7DttyTflWZl9pt+zrTPo6ZcqUmmO10peyKJrabMyadebNmxcty/PhrLPOqmnPygznaaZmmzLxtlKEUf+snGfNfuQL9zObmRit518/fI77fef5/cj+yjz/4T0ivK+VtS/ugz4uVjaw4/3335dDqpnaTNEOnt/++la2sGadol/effdd1z5jNZtp22EJr7pNWlIp6pOtu1Z3/WavwHUlGDV7X13dPoxx21pIdPFA5URZ3du2PSbtuCKgCCgCioAioAgoAnEIyGDUSrXELc40b+LEiZUd1GYCIFgJLAVXfwoh2NXmE1222HtX7173pwg4BGzEbKffBM7huXPn9iiEfIfq/vvvX8qx2wyWTthy37E1fTq1D6Hg35P4bCPXO62nM/IhINjaCO9ODVgpPYd9Wee90w7aaAYEEFjZTIMOW5/LETtFuy8EDSSazRp17VtJuoaatbJRnX4fcYRx2Kit89Jhpfg6bUvgNP3xzWb2RetBQkB0FTGbVRa1B6a2PkpNc+LbkmuTqZX6iyXh2NB3/Npsr5q25EtICFpJNlmUaWqzsGr6DA5pzwKISysl5q4V/zjiyIfQEZ0loMJmddT0h31APGY59+EBl3l+k4gumxHdYTMNO/WZfocBVT4eodO8zL424zoTbMPrJW4sbeXkIjwgQ0MCVNrKOrUZU1F74Lrbbrt12Gyxupvze4coiSO5y8Tb1uOL+mcziTtsbcKob/SB9zJ//M8xcN0wlT9bg7ATTv71wnpZfj/suOzzn3ZfK3NfIWnPMROoyJiVgJU33nijg75wX4V4EuxkGncPik5Ejg/vvPOO24eV0HUBTEkkpt/0hAkTon61AtHlP0P8flbhc1tLF9ofjkuFFVkB0T+lIN5xxx3nZwnqZ0VAEVAEFAFFQBFQBNoaAZFauuCCC4yNiM51LMjfUAgbq5xMQYOIIJ+CpIZfIFqasC9EnQpCy7JmTW3Uo0H+BltooYUMNUisA8DYlzeDxAuSS8ynngE1HtCFRypDTREoEwEbOBgrTWXJVyexVOa+WrUt68h1dYOk5gfyLtTIKmrIDx1yyCGdmllnnXWcBI8sQL5qjTXWcNI7Mo+pvuP6aBT7LM/TsG4QrdpofsM1gMwktVp6svGctASXq0WCdCGyT3H1YhrBSCS3eLZZR6+xTl4nAXXLLbdkbobfCPWq5DfKhnEylHENWieekxhE7o/PYtTR8Wty8R3/khiSUyNGjJCvDU+tg9vYrIJoO5sJENVrYeabb77pxiTRCvYDslJJ0rHgRU0fjJpjNuPTjQ3cjP/8Q74LfAUn63SPagT66yV9ZjtqCn3wwQfRKki4ch9DSo3fERJe1NpCFgxpLhnHyAaWtDc2E6xT3TLuqf61hIw045o0o64TUmFx1qdPH8M4iuuC80r9N+R3GTvxBxbHHHOMK3vC9mWe3zjpQmTqqNNlHeIG3H2zWT6GcaZv1DPjmsQ4n9RTo34XVmZfm3GduU7af8jv8fsWo46eL51ps2CMJQTceWEd6qtRZ62IUc+Ma8c36l9x3SMH2bdvXzeWtplj5qOPPjLU9GLcbzMInVTkkksu6Z6t/LZFBq9MvKkLZUnNqHvIVXINIz/63HPPGUu2Rcv4QL0xZAi5ZrhniPEs4pkkluf3w7Zln/+0+1qZ++JehISzL/0sWGSZPv744+5ayLJulnVmz55t4CGQlKVuJdcbz6A086U9W0G6kGca92ysaj6BShFdXLzoqY4cOdKg4ammCCgCioAioAgoAopAVRAQxxzFdW3EYq7D8uu+VG1Q2ygg1MpAWz7O0IGPK+wet27ReTj6cITw8s/nrMYL/MMPP5x1dV1PEciMAC/j3Gek/gsb9urVy9WUydxIG6+IkwmHqBjkn9x/ZV6eKfUV4wqnh/V6nn76aUMB99BwxEl9h3CZfm8MATmfOOBDxzkOfBzk1MLknPVkgywQIgrH+7LLLuvq1RXBBFwhZah3xTOPZ5mVoaqp55SlfQgYP1AlK9Elbfu1ZZhHEMkrr7wii41PJDGT36nNvjTUGEszAlQgBXFg28yQiHzCwc5xihGYDXktBgmA41TqNDEG8WvSyHoyxeHrO74vvPBCV+NHlsuU6xuCCKNGlk8uyTppU8g2yP48xljVlhWJCAS/DZtZZ6idJkY9SCvZJ18TpzhmITcgCho1SGybGeI2K/P8xhFdkKYQJlxTjO/EbIaJIeghrOVGjTkrWy2ruX7SX6zMvjbrOqOf/KYJihHr3bu3IcAOpz5EKOQe412xpGtWlmeZTp06tXBNLvZDLTF+b/S1TLy5RxFUR9BAPaNWGzXLqDno13NiO5vVZaiZJ5b391P2+U+7r5W9L7C0mdYNk1087xnHlWm8Q9uMW0e+8XsOA5bi9gXhCfGJtQLRZTO6DME+WNV8Am1NdMHKczNgAEERwieeeMLYtHNz0EEHmeOPP96dMP2nCCgCioAioAgoAopAFRAQxxyO0nqOlqTjpZA4TmysaoPapGOOm4/Th4jaJEcJBY55aWmWURyZgtmcAzIH8pit7WNsfdo8m+o2LYwAUca809h6MobrBGcpDrGNN97YOUWJ9M5qRdqy0mAuCpmMhkUXXdQ5VAkmFMNBjbOaaGmcWVWyYcOGRc58shdsXZ5SDu/II49MdObjdJeof79AuL9jHFu2poI/Sz/nRECep7Z+Tk2WDc2RTQfJS2YCWRY92cSBbyXrXIbJ0ksv7bJUimBCVD5EEE5xnsGQLz4BkbVtyGBIYYx7pK13FJFKWdsgIwqnNsZ97i9/+Uu0KVlBZM9bWaxoHh+slKuxcnnGSk8ZsjPIdoIEJJuFwGs+S9CKnxVIe/ityATA4oKWbr31VpelxX0eBz77SLN99tkncuCOGjXKjSvC9SFcJDMxJPPCdZO+E0SeRrqF20FCknHiEzzhOj72LCNL7Nhjjw1Xi/0OzhwvGTqN2Lhx48y+++7rNinz/HIdQ5RINhvXM5lKkKPsx0rhOqKH7CGuN7Ik44zsEH4bGPceyY4qs6+03YzrjHa57hmrZBnXkn0HQUD2VREDe64bWx+sSDNuWyHeysYbshhylnaTDIIQUpB7CsYziN+P/67mB90U+f2Uef45prT7Wpn7Ahd+Y9wryJbMahDu3G/LNCF1eZ5xHYdEZNy+IHptTTm3qBWILjiTyZMnu/7411lc39ttXqWILgY3PETCFNl2OynaX0VAEVAEFAFFQBFQBEIExDFXhOhCQoTgIKxqg9oQr6TvyF/gvCJ6VowXFP87DiaCqYoaMts4OvzIXfa/4YYbNuygoZ2VV17ZOWFXWGEFM2TIEENkcDONF0qcZESRMsYm+k8M5wJORlsbw8kiEZVPJgSO0DTDKcg2YIP0ItkCSDF2lTXjmOh7keOydU3Mbbfd5uRPkLKRiP4QEzIyd91113B2zfcy26pp2PuCTBWyW0SqL7zwws4hy3nMYhB3tni5c1ZAKHEtp1kRXNPaTVqGxBX3A7IysCTncdL2afOR5YK8jDOc9mSZsl9IBaKkQyOS+ZRTTgln6/ccCMjzNE4KGOkzzoOckxzNV2YTfg+QLRAXOODJNCgaGU+QCYQSslY4SVeyQRuQBHfffXdDuDGWgRRGbgwCI08AEPuHUIAI4vkaSk8RcMCzFnm+OIMcS8vU4LdMhqgYWRr8htkvmVUQ6aGR+bLUUks5Cb5wWfgd0gxyBLKAtuPGLUgfQ7iJXLOtCRQ2k+k7vjb28cwzzzjZt3Ajrg32w30dsrie8RzhniikYKPjLsYgTz31lHtuEvRD9ghEHs94eYYi/bfEEku4cQbPTl86kv6VeX4lkAyigue5/0zkfsK9H+lPyK4kgyQFP4JUQgntMvvK/su+zuSYLrroorqkAtc916Hch2XbItPLLrvMSWQ2Sn7KPpEGf+ihh6LfZNl4Q85CTnGdijGu57dCEEwcKcx7CZmOvK/RP+6Rcl0V/f2Uef7r3dfK3BfY8R5FRitY8se4kt8+1xPvRZxHXy7S1u0ytqaZwF7KVGQZuf/y3MgSrME1SoYr1gpElx/AUDWfQFsTXbzI8SJCyiApd/yAbCFT9+Llv4iXciVrI4qAIqAIKAKKgCKgCHQjAvJCyCAZ0iGPHXXUUe4FfJFFFomkbPK0087b+HXKOA4cUUTN+vVd0xwuOIvAjxfUNHv22WedbA3rsE+ps8FLWf/+/dM2dctwlmywwQbu5YnxLrUMcNhkNXTzOQ5ehnGaQybhZOE64oU6zsEWto2sEFkkGM7EF1980bVD22Sk+TJPsm0SGYPjBociJAcOKjHaRXqcF/1vfetbMruhKU4tzke9c0KjZR4T7RU9LmSUcNJmcc4QEYwTLMnKbCtpH8wPa2LE1RtJ2p5oeonETZPfLIpr0v7rzScK/4gjjohWQx6UfhY1MuQguMVwquOAFiMrDqft/fff72T4Zb4/xVGDw0atOALyPKVmJYowvkG8QEQwX2pa+st70uf58+e77GZk9CC6cM75davyYAEZghOZGl0YvwWctyHJlKVtCAScnhBORYw2eH7EZZdwbyaDAF9TI8bvHZmqMHuHMQCBHmS0lGEQRWSApWX7IhdHJjtZI2nrZe0PEmKoK/EsBzOe3YwvsjyD/X2AKRkFXAOMT4sa/eG3Sz84ziz9KfP8QgwzpilyPXIMjDPjAoDK7GujWGe5zmgTopHrjGd4aIxh8ddC3nAvKdsYC0J6QABzzYMjBBFjdkhPyFj6wHr0j0AaSGw+M8b2pSPpW9l4c20yJufex/mVrNB6ONAPruVwjFz27yetH/XOf5n3tXr7SusnywhgITtPLO2dTtZpdMo55L2O8S/jNt7XILjTzJfL5fxL9mbaNs1cRibkzTff7O7h/ni0mfvsqrbbmugiJRbmlBspLLISXV112eh+FAFFQBFQBBQBRaCrERDHHLIHEAN5DOkxBuS87PkZTHnaasdtiEgmOluIFiIAH3zwQedgJtJSDBkKspNCI7MJQoYsFrIr/Do+4bpkgvByhSFtQSQfhhwJdTpwBqQZ0YpSiDxtvXAZUYbIUXCsaYaTDecd9VKSzCeFWAdJPRz2yIAIhuG2EBkQN74RhQpW1HtJMl74eUnknGQx8INA5HomEpFzwjkjYjstcrOsY6KPRY4LxyrXkl9zIe24xcEcFw1eZltpfZBl/rXNPDJgpk+fLosTp2GhehyCZHYw9a0Irn47eT5DJIpUIQ5qIoPLMK5t35FLpiROD5xyYuyL+TMSJHlwEFIjSK04AvI8jSOPZRmycGRp9GTzS0WQbUIABpkJRYxAC5yEkt2IdOFqq63mMnOKtNvMbXneca9G+plnc5xBrPAcgxSE5MIJmoVoiWtL53UtAu10ftuhr/y2GYcSFMVvgIAyMuqoF8dYrZ2sHfBuJzy7oq9kzU78T+YqRCcqEmVfd1zjZKQSuPHAAw84yU6RwU06Rj/bsRWILt7LyDjm2cW7Y5WsUkQXUXCkrGuh3ipdonosioAioAgoAoqAIgAC4nwjQhiyJo9JNkWfPn3qEiF52m/lbYhAhnDyaweMtbJH1JFA298vgp6UxUFBaXkZgIRKcniBAy8/shyJPkgiMWp+UOODlwsCtihAz3mV2h1hrRDZLm0K2YH8ElGMX3zxRdqqNcvYN1kLcRJykBcQemIQEIcddlii7CUvlBCxSH6JEaUPMYKzoJ5lLUbP+UGGk2jcOIOswIFNVCjRihyjZLCVcUzss+hx8RIeJ0MHCU2GIY6hlWxmCRJWXGtcE3HZBvSlzLZor57xW/HrYUBOxmX3he0gd+gTRzi8fXkZ1i+Ka7jPRr6jFkJUrlyrkN9c72UY9xmkysSQf0ORRGomMh8ii3oWIrsl68oUEpeaUmrFEZDnKfcRyh74Jss4ZzwjerL5gcUQXWRG1AuiqIcXzm6CE8gwwsiYBHPu6+1gZKMR/c7zmnsF92xqFSIbKPV12uE4tI/xCLTT+W31vjaSbR9/Nlprbqvj3VpodV9veJeQILI8srhZes7zi2cZ41gCJpH35X0jzXg/I9sMawWiS+q8EWwmGdZp/W+nZW1NdJHCSYrplltuaa6//npXJ4AXay3U206XoPZVEVAEFAFFQBFQBLIgIM63IlrjBAQRGEQEte90zbL/dl4HZxROZOQExYi6RjKHaNPbb7/dZdfIMuo9QDL4JpLZ/jwcf0nyKzjMfemWehlaIiFB+/VINL8PfGY/kAhkzMQZcifLLruscy7GZVWxjBc0IYOkDWpw+aQV8lJC3rEO2WAEmJEdBulExCRtiXGN0S8hDpiPGgNRhES+I2OInKH0KYvGPdf/NddcI7uInULaIa+Fk5oi4PSL4yOTrugxscMyjgsyTjKH5CB4Ub722msbzuQrsy3pCzKVEKCQWNQK8aNhIbWoSwC5KsZ9Bfm9JGMbyF+kezB+d0gtIsspVgau0laeKdhDkGL0j8wVSOqixjvrRhttFP0OhPhGtgYck4zMRKQUP/30U7cKtTxwqKgVR0Cep0iwQsT7Jsu4d/X0cgi+v4XsjDKILqLgkbkScpznCrJ3PWlM4l9v+lkRUAQUAUWgPAQgoCSQolmZ2Ty/ILkGDhzoArh4p7zppptSDwJpd955sFYguhj/EFxFkKJkWKceQBstrBTRRWFMpFS0UG8bXYHaVUVAEVAEFAFFQBHIhIA435CFIzMrj0FMvPTSS07iDXm+nmI47JG5E4OMQfKuV69eblZYl4eIdbLefENijRcasTSyUFQGZF2mvHThJEwyzuuECROixWR9Sf+imQkfkJ6Ik1Gk7gWZYryAYRATtEsWDdHzQjqwbOmll3YRkL5j/+2333YZZywP7aCDDnLSNOF8+U42FdlqZNKJMU6nxpwvVUc7yH5gRMWnyWKFtaGkXTKdOB8QfkhtrbPOOo5EIZJTJCIhGnihK3JM7K+s44oj7MgGQN4O4srHSI4zaVpmW7IPP/sKuTyIYt8kElTmcU3x0p9kZDDec8890WJI93PPPTf6XhauUYMNfuC3gNSYZGxuvPHGpp4MTdZdkIXlSw76xw5m4vAP2+Mexe9lxowZbhHXRJzUY7idfq+PgDxPIblw9vgmyw4++OCa2o3+Oj3lM/UdCRAgm5nADrKQeb4VMX5nSHZK0ARBDzx/5Dov0rZuqwgoAoqAItBzEWAsSVCQBGIxzmTMVbbx/CJ4C1KN96nNN9/cZemn7ee8885zktWs0wpEl6gzEMhGtmKlzA7q29bswKtjxRVX7LDRbu4YLNHlvlsZkLY9Ju24IqAIKAKKgCKgCCgCcQgw5uHPZh3ELc40zzqYXBtWKz/T+lVYyUaJd1jHpTtu8LNZSx02q6fm0Gyt12g561jCpGY5X2zWV806NgOr0zoyY9CgQTXrWuJFFiVOrSO8Zhsb8Z64brjASnTUbMsx2CjGDpsJEq4afbcO8w77klaznSU3ouV8sCRRzXLa5c9K63XYl8iadcMvXKeyPlMrA9ZpG5t11WEz56L1WCfJbL2zaD2/XStR0sE7gZgl8jps1kuHzW6rWd8WGXerFDkmGijruGwWW4d9+a7poxyXfXHusBJ/ckh1p2W2JTuzmXpR32zdKJkdTW3Ng2g5/eb6TbLnnnuu5jdoa6nVnDO2KwvXpD7Um2+zOGuOx0bm1tsk03KbzdhhZShr2uZaFmM/ct79KdcAZjOKapZbZ4RsqtMCCAjWtgZXp1ZkmXWQdVrW02bYTF13/XFvtlnKHbb2VGEIrBpPh83iitrh+WjlZaPv+kERUAQUAUVAEYhDwAZadNgAuY7tttvOvZeF69hAxZoxkw0kClcp5buMgXk2MmYQTiKtcRu4FPXNKmGkrdoly2ydYNcfWyOzS/bXlTupVEaXfYkyu+yyi4uCFNmJSrGSejCKgCKgCCgCioAi0GMRkChz6vr4dZMaAaR///5OMohMG0vuNLJpW65LNhHSYMgOijFGJGNGDFm9k08+2ckYyjwk9IjOI9uCaHMMmb3jjjtOVnHZKHFRgqIwEK1oP5BBhmRemp1//vmGQsViSO/F1c2S5f505syZNXXbVl11VZex5svN+evLZ2SpOEaRWCRjBMk6Ig3FkJUSaUHmEdFPNiDzk4z1N9tsM0M2gBhtk1HINYgcHhGQ1Pzy6xHFZQ6x/fz5851UOf31La2mF/r8LBfz6xvlOSbaKfu4FixY4Gqa8Vu0L4DS1WhKRhoZXmRT1LMy22JfZLNQLwvbcccdoyhUN+M//8h6mjNnjvuWJNtCdC2/QT9aNMxKLRtXv49ZPyPBKTWC+N3wXvmNb3wj6+aJ65GtSNaiGFKnSKhScw0j6tiSsAZZON+413AOLrvsMpfVJcuQkbQOHvmq05wIyPOUZ0HoN5Bl1glkjjjiiJx7qMZmSNKSDbvNNtu4jC6uV18COM9RUnaCZw7SnRjPW54Jfh3LPO3qNoqAIqAIKALVReDDDz90ShHyToLENGod/pgozJpibJVU37YIUiI9TYYysrtI8tqArdQmfXWRVsjoYnyDoknWOrupB9diC9ua6PJT6SnCjBTLzjvv7OR8eIFSUwQUAUVAEVAEFAFFoCoIiPPtpJNOcnWR8hwXtU2F3EBqrMr25ZdfOrkKxodiyBEeeOCBTs4OHP761786p90nn3wiq9RMkQ6U7SEjwF4MssdmpshXN4U0g1ARSSZZmIXo8osUsx31m8KaWcxnH8ggIkvIywk2bdo0V6PWfbH/eHnBSZvFfM141r/xxhsdySfbQljNmjVLvhqbDWjYJs2uvPJKY7OA0lbptMxmvbg6Wry4hhaSViz35d/C9fkeEodIOA4ZMsStmueY2LDs43Kdsf+efPJJR6K+9dZbMqtmynUGaYd0Zhw+/spltQX5Sw1kDOJ0+vTp/m7cZ5E94QtEJmRuKLd5/PHHdyKRb7vtNkeYSoPNwlXarzflnRJnvkjd4LigtlsZhuQj50SMa5Br0TcbGezILkhBDIlTZNy4XyH3iOyjGJj7BK7M12ljCMjz1Gbfulp0/tayLK5+l79eT/iMxCD3Zu49OAx5rkICFzECbXj+IoWIIY1IjRD/d1Kkfd1WEVAEFAFFoHoIWKUDV/fXPzLGnowhCcZABpqaXBBiGEEVMo71tynjM8+vH//4x24fjNd4Rl599dWpTfNeRF+xViC6Dj/8cCfz3mhd6NSDbJGFlSK6KMBtpVQMhXvRqldTBBQBRUARUAQUAUWgKgiI881KWXUa6Gc9RslkYbwkBXGzbttu61GzitpVeY2B/2GHHRY5mUOiC/Llu9/9bk3zF1xwgYGwCo0XMQr9ppEUvCBZGa1oU7KdyOjx7fPPP3ea8BAi/gtcSATRDi97WQxCzMoyRqsSmUi9KzGuFcbYYmCK4zPN9t5776jWFnWnqL9Cbawk41guvvjixAyaMWPG1BR55jqGAADXOPviiy9cFpFfXBkn6nLLLedWz3NMbFj2cfl9J7MNcpPrzMroxWZ4cdwQHdQESLMy2uJ8EBmLcd1C+H7rW9+q2S01pEaOHBnNs3Ke5pBDDom+h1mQvNiT4RRmKjYT16gzKR8mTZpkTjjhhGiNsggOMuLIyvKN65YacqFRm46sMish44hkyEVs7ty5xkrGRSQczhy/ll/Yjn7PhkC/fv0M94k44l6eteH1nK3laq1FVvQmm2ziMn8husBMgj/yHinZ0mRZSxYjJDMZrWRDqykCioAioAgoAnEIUKOUuli+EgTroTRh5W9d4KLU5WV+qB7AvLKM5xeBjQRuMGanX0JiJe2DdzMhw1qB6CJoivdH3tMIuKqStTXRRco7A3+JulOiq0qXph6LIqAIKAKKgCKgCPgIiPONDAlfCstfp95nWw/JOZTiotjrbdtOy3EEF8nuRyoOJ/9SSy0VHTbEE8SXWHgeyOLipYeMqzgjCt5vL1yHLBdk6sQmT57sXtzkO9MwmvGll14ySyyxhMuEwikrRjbO8OHD5WviFMlDqy/vovRZCeKIF0mfQCIDhfXE6h0H60nmIJ9RWyAD7NFHHzVTpkxxEZc4TyGdkKyCtOEvTVqETDoIIDGIMwiD3r17y6xoOnv2bAMZTISlGIQh508szzGxbdnHJf0JpxB0ENEcY/hCz7rItFBgGxm8epa3rZtvvtn411ScZB4OBcheyURacsklnfzfMsss47K7ILDIABFDmhOZvtC6Ctdwv/Ldl5NhXvjblvUamfKeiiyoL7dJZh6ZoElGRhkOm9CIGpbsF7I4kRcl60stPwKcC1vD0MmpXnLJJTUNybNW5CNrFvawL7ZWpJObxYmHYw+JVD/wIQ8cZNSSRc3zC4NIK4NAy9MX3UYRUAQUAUWgfRDwg7DSes07BgRUs8ZKjMOQ9eZ5xjsS4zSkptOMZJxrrrnGrdIKRNeoUaOMrRnbEtllabjlWdbWRBcpibYgaqSH+cILL7iXJyJY/YjYPMDoNoqAIqAIKAKKgCKgCLQSAmU436QNanxR66uKhkY6JFdczSM5XqLX1lhjDbP66qu7WlNI80mUHevE4fPmm2/W1EqyxYcdeYJzn2UQS0wxpAqp/WILD7vv/OMFiBehJCObh23EIDLCGmC+zCBST8h0QEqF2yJ5RjbJN7/5TWmuZjpv3jz3ssULF45LsTgH/7777ltDGpHFY4soyyaxUyL2kYXE6AvZKmlEVmwj3swwY41F4E/2EOcRso8sN1uE2smUCPEiTYTHleeYaKvs44IU5U/qNUl/ZfrGG2+4um28iIaEF1lBEIeybZltsX+kCv1agAcccIAjEKVvMoWchaQV43xz3SIX49fG23333aMMMVlXpmXjKu1mnUKMItkpRoYJvz8CA9IMEg8ii0w3vx4eTnzqRvsZhbRz1llnuazAtDbjlo0dO7ZGShFZRQI91fIjIOQqZGQo4yvPyfC+kX9v7bslgQNEylNnD6ILchAHXxELiS7qNpZBoBXpk26rCCgCioAi0B4IQGAhA8g7UJIl1fxNWr/R+cI9UJ+WdxyCuPw6y3Ht+WO5VsiiIniTIECC5iSYKq7f7ThPia52PGvaZ0VAEVAEFAFFQBHocQiI8w1JPr9mSyNASBtsTztVs7AuE8eH3BtkFFkmOLBxquHA9okXMlN88oaaIb6cn+BEppeQWcyDZEACi5ctIVfIyLjpppuc3JtPVO2www4mzByQdpmKMoHMo5aYL6dGZD1OWRyNGI5aighjZIIQFf/BBx+47/yjvhdEEJkLnPc5c+a4WltI+JEd5ct7sD6SaBBfobwiGV/IGYpBJFJ0Oc0GDx5sHnvssWiVInXlaITjgyQMa59FO6jzgZfQvn37RmvlOSY2Lvu4kLmEAIXooa4a5yrOIEyQxSTDyzefPCqzLfYhsiyyvySii+sS6Um5/mV9f4ocHy/TUlPOX8bnsnEN26/3/dRTT+1URJz7A/cOft9cO5BaEMQQW9T0IiuRrC0ISO4vSBQiPQjxjASMXxyd/X/jG99wWW5JGKT1kd8f16xYXJ0vWabTbAhwv+Qccu2GNTzkOcn9l/twTzYCFrg/ka3MPcGXHMyLC8SZT5iFxFfednU7RUARUAQUgZ6BAGMyyCyCFMPARt7zUMXw3/PKRkXe2RhLEGSHekWcdL2/X7/2bSsQXfgCeK9gfMrzvUrW1kQXL/M4LESrXNIHdfDffpcoNSf++c9/umgupty4iIwk1VSmfOavmTes9kNOe6wIKAKKgCLQUxAQ59vPf/7zGgm9Ro5f2iirBk0j+27mujibyVDz5e3YH2PEyy+/vCbbIq4fOO/8elsQWJAq4ZiDzBo0zcOXKr9NyQKASEIyT6QMeanhRSJOmozt37Y1rNB6F0OWj74TaQc5hXTcO++8I4vdCxUvVmJkeRAtmMd22203l33mSxZKO2SqTZs2Tb6646dOVJrdcssthutUDPKMF1Kf+JNl/pTx35/+9Cfz/vvvOzkQpD3EcEqTYdQo2cU1j2yib3mOie3LPi6/VhjYUy8NWVKy9eKMl+m99torWsS4mChMxspltsUOIHMgfMXSZNz8ugOyvkypdXfnnXe67EmZF07LxjVsv953ftdIuBQ1fu+Q3GAHgeJbSFz7y+p95t2Itvl9YEjycE9Qy48A54csUJxUyHT6Js/JIvUw/fba+bM8lwjU4PkF0Vs08jskujgXkMbc+9UUAUVAEVAEFIGsCBDIRrASsusYQX6MKZE4b6YJ0UXNYsZjvEcRbJlmvgx7KxBdBEMip40qhkgJp/W/nZZViuji5DAIIyqQVEa11kCACE8inYmAhpwkotifIkGZFgWa5yhwIvXq1cv9UQ+Dz9zsmCLjI6SZkGhM+cOx5c9jPfkeOrvy9KtK2+BU9P+ItsbxxzScH35PWy9tmbQT7ku+s5ztZQre8lmmLJc/fx6fs6zPvvjDcSmf5bvMk6ksl+8ylfXDKX2QdcKpv6701XVY/3UZAtwfkMrCASJTPq+wwgruvkJEt94nuux09MgdifOtCEklbVTNgTdx4sROUoxkACEjEUfehBcQdaeQGvPtiSeeMMsvv7w/y33+9a9/bXD6h/dixhu85PgObtE/l0YefPBBJ7Un3/0pY6GNN97YzJ07158d+5nsM15OwnvOmDFjnKM9dqOYmTh5yRQhUyzJIKx4aRTjxciv3STz/SnPWfB8/vnn/dkOGyII11prLVf8mPEgTlNeGHlZ5bOMCeMKO0Mesv8ZXv2tmh3EfIl7+cxzTDRd9nHRt2eeeaam10j/kTlIJhFjVsa0YMI4+umnnzZPPfVUzfpIVIJnmW3JsZJpgXQZxrXNPuKM+jrU43r22WdrFjOGRhaO40mzsnFN21fcMsZcXNNIQRY1InqRsIF4FIk3iEsyHONqymXdX1hXjmxOsjrV8iEwcOBA5xiLy96V52TRTNR8PWutrbjv8Pvlmobo4p5dtGh9SHTRfhntthZy2htFQBFQBBSBrkCA97GHH37YJU7wbIdEarbxfkOwIYk3jM0J5EPyOs3IEp80aZJbpRWIrpEjRxrk6HnXQIqxStbWRBeECQ4BClgjtcLgi7R6XrTQQFfrHgTQpcdhxIs7P3oISHFadE+PunevvOQLWRZHsPHyyws+xpQbtT/ls/9dlrO+fJZp0royP64dokMhUZjyos86aoqAIpAfAZyTu+66q9lggw2cQ9vPSMjfqm6pCBhHsoIDNXEOP/zwXJCIA4/ot2FePahcjbXQRkTUkQUkNnToUBfhFxJBsjyc4oQmUMo3CC3ajTNecMiwIrsIgosXHIoShy9XRL9DDuAsJKuJcRESikkGMVcvIpBoRYg9OZdhW2T9kNnGOIwo+dB4oYFE4vxT36qeUb8MqUIZy5H9su6669bbzLz22msG5zzj9TgjeICM/iQDe85BaIxZwB3JPP4478jBgQdBCA899FBNzR2KP3M9+Jb3mGijzOOiLhTO9LxjL643SELGl2W2JVhxHZEpSf+Qz+PaSzIIWq51smQYl0LYXXrppZnJmDJxTepjvfnISPJOye82jzGm5/oDJ4L8qBsN0X722WfXZGvmaZusI59gjstEytNuT91GpPiodRdKgsq9FZkhsj97sjWD6AqlCsm8hlCXiPyejLceuyKgCCgCikDrIyABkvh7CPLKwkH4wYitQHShIPHAAw+4OrO8S1TJKkV0EQVK9O6gQYPcC0WVTlSrHwuOBn4kRCrzQ8cJgeFgog4GL7tEe6JtjzwQU0gVMdbD8UKkIwXc+Yv7TLFnqR1Be7xU017an+yTdaWuhexXp4pAWQjgyMDBQeQ1U/nO1P/zl/nryvr+PFk3bh7rM58/fj/+Z/ku07h1/PX9z7KNTJO2jVvOPJkvv9Oy8O2udrhn4ER94403XFF5pvIZKaGsRh0VHMVE/ZBZqqYI5EFAnG/U8kHiLI9JG0iN4YStiq2yyipuXMHvi2CntAylpGPed999azKFkOujtlBRY7xDxBz3RZyraUbGEvKFcQQV0hJ77rmnkw5EzjCLIfcnYy7uz4yjkD1r9B6NLAd69yuvvLIjWrPsm3UgDMjAalRmbcMNNzRnnHFGqtxdUh+oZeXr5CcRc3mPqezjmjlzpiM3G33JZIwARlwTYmW2JW0yxieIza9hJ8vC6YIFC5z82GeffeYILnT/G7HuuF7C/kHS8dzH8Y5UKGQsWEMmIsPI+wq/RdbjdyoqFXwmw4rMl2YYYw4CPOfPnx81P2HCBCfPGs3QD5kRIOMUR9Xqq6/uyEl/Q3lOjrVSsH5tNH+dnvKZ+oCMX4lcJ6iY+wEkbhELiS4i8CHIIbvVFAFFQBFQBBSBVkcAnzeBzd/73vdcwBnv1LxbpxnBSiKV3ApEF5La+O95dw4VONKOox2WtTXRxUsI0Z4MjihCh67z9ttv77Trx48f3w74t3UfecGbYaVjKEpOJDTRnjhOyGbgB4+DHDKKjK5XX301Olbmr7rqqi4aGL15Cm8TUZynOHPUaMEPZDPxcu7/8WLrf5fPrMux47iC0JPPMk2ax3y2YXv+iIyWz7INGNJO+J15/LGcZf4fhy7kgj+Vz+DNeWHKH/NlWfg5XB5+99dnWVq74bbh+lm2lTZkGtfvsF2/j3Hr+8uT2mUdNUWgEQT4LfPij6QUEl9pUalITOGYxOGtpFcjKOu64nwjm4usrjwmbUAGEX1WFUNyjLEGg3YyrPIYznwk7XDk4djLi3Geffvb4FikzhdORZ6VjHV5mULBgAzxdjPGPnfddZcbqyfV1+J5zL1xwIABBpJr6623dsee51jJQJpoM94wCApktpqBW9nHRR0xMvpwvjPmSzLkNLkWqNX1f//3f7GrldlW7A6aOLNsXJvY1S5vGocENQIlE7JqErRdCSi/H7JfIe95n/VNnpNVy3z2jzHrZ56r3G94BvFOX0bm1eabb+6CVHnGYWQYQ3IRSKamCCgCioAioAi0OgKoZqBiQH1nZP8Ilhw3blxqt33Z9FYgug444AAX6MN7M+8eVbJKEV28yG633XbOgUjBa7XmIMALKEWlKZCOMwYj4plsOqIc+ZEQBS3ZDjgXkLghk4E/0jtVyqs550ZbVQQUgdZBgIh2avygGe3Xt/F7yMs9Wci89CvB6iOjn+MQEOcbdZ+o05XHpA3GSX4mSJ62dJvmIgDZAdHFX1UMZyaR+zhLGU8ybuzbt68bJ/LSV4ZBBECsYQRU3X333WU0m9pGmcdFkBhyYTh9CepjHI3cJZl4KCSkSV+GnSyzrbDtrvheJq5d0d+u2AfXxnXXXeey7CC6GrkeuqJ/7bIPyeDlNwXh5Zs8J+NkT/31esJnArcIKsahBzFVRuYVWctkb6LGgxGoTBAEbaspAoqAIqAIKAKtjgBS9Cj2IH/MsxGZY+SO04x391tvvdWt0gpE14gRI5yfaumll+5UYzftONphWVsTXcixoE+OPA2Fjhkg4TTMUgiuHU5Oq/URhwvOAmpH/PWvf3XdkyhjBqakYUoBdV7Gicblj+jc7szWajUctT+KgCLQMxHgGUXWCfU/QiNCn6ganl9lOXvDfej39kdAnG+HHXaYyzzKc0TSxnnnnecG6Hna0G0UgVZGgOwDURLIIiXSyseifVMEFIHmICAOnrhIZnlOKtFlavwrZHSJfHeRs7Lllls62U/UeDCpl/b2229XKrCjCEa6rSKgCCgCikDrIoCKD34bZL1JuMGPQ/BRmqEUctttt7lVWoHogpwjQYWAKTLUqmRKdFXpbDbxWBiInnDCCU5/lN2sv/76LrqLSCzqThCVS5bWTjvtZNA8R6O+ShHITYRWm1YEFIEehgAyh9w3b7zxRkM0kG/U3Tn44IPNsGHDlPDygdHPDgFxvlHzCJ3vPCZtUMeI57WaIlAlBJCFRg4biWfs3HPPdS+iVTpGPRZFQBEojgDP0XvvvdfVW4PA8U2ek9TAGzJkiL+ox30WxRwcekStlyExuNVWW7nadrSNUdcO6SeyFZGxVVMEFAFFQBFQBFoZAer8ooyChDjBzPhvjjvuuNQuU2P7jjvucOu0AtG1//77m+nTp5tll122k08q9UDaYGGliC7qo5DdRQohkcpqxRGAwLrkkkvMxRdf7MgsdMwpIMsgV2Qevv3tbzunLJIGmolQHHNtQRFQBHoOAgQRXHHFFWbq1Kk1B01kDcEFvPxr0EANND36izjfsgymk4CSNqgFxPWlpgi0EwIEB1AbdtasWS56cuedd67pvrx4ysyHHnrIrL766vJVp4qAIqAIOATE4YTqCD4E3+Q5eeaZZ5rBgwf7i3rcZ78GOoQgUoYQUkUMxRdkWXEOYgTK/v73v3fZYl/96leLNK3bKgKKgCKgCCgCTUdA3jf69evnVCSyqK340uqtQHQRWP3b3/7WSaNzPFUyJbqqdDZLPpa//e1vhh8sFz0vARQHnz9/vou4Yld8P+igg1zBdq0tUzL42pwioAj0KARwGhCgQXSxb9TuGj9+vKvL4s/Xzz0TAXG+8ew9/vjjc4EgbVx66aVOLihXI7qRItANCHz44YeG2i5SA5YgAOrFUp9XjPsowVkYSgNkIOgYVdDRqSKgCAgCUhSeDKKQuJHn5Nlnn+3qqMo2PXHKPRRpwb333ttAdEF8ITFYxLbZZhtXpxHSDCO7nBrfBNJSk1BNEVAEFAFFQBFoZQSE6FpllVVckMbhhx9ukCZMM2psE9zMewn+dclqTtummcvSapU2c79d0XZbE13vvvuu6d+/v6vLdeWVV7oIIymWSh0ptfwIMJBFZ3TOnDmuUDjFwuUlYNNNNzWw0RtvvHH+HeiWioAioAgoAp0QQB8ZfWc/uhg5w9NPP91FvHbaQGf0KATE+ZZFBzwOGOTcyMLGyCT0CYK49XWeItBKCJCdxbXvG9H/vAPgOOW+SU0uCDGMOjDXX3+9v7p+VgQUAUXAIYD8L/WlMak97b7Yf/KsJdBor732ktk9copPYIcddnCZbXyG+ArxahQY/DXU94bYwlDjIVuXe7jW9W4UTV1fEVAEFAFFoKsRQN2M8QGKZzzPRo8e7Xzkaf049NBDzT333GN4d1lkkUWU6EoDq+CyShFdFJ6mAPWuu+5qfvGLXxSEpudujiMBImvBggUOBBjnf//7364uFy8FSnD13GtDj1wRUASajwCSsWQk8Cd1Ztgr9REojL7ooos2vxO6h5ZEQJxveYmuzz//PJJxu+qqq5zcc0seqHZKEYhBgOj/H/3oR25M6i8mI4MgrGeffdb84x//iBaNGzfOEK2opggoAopAiAC1NH71q1+52SFxI8/ac845x9XgCLftSd+pnYXMMUEEEF0vvviic+oVyZTlPu7X+qLOCdHxRLdrGYSedHXpsSoCioAi0J4ICNG14oorOjl1ssRRQ0szSg/cd999LnN5oYUW6naia+jQoeaRRx4xyy+/vHniiSfSut52y9qa6HrnnXfMgAEDXEQykckMmIjoJP2dIutqjSMwZcoUc8wxx9Q4V/v27etqxWy//faNN6hbKAKKgCKgCORCAIcCafCSTUsj3/nOd8zVV19tevfunatN3ai9ERDn2/Dhw83JJ5/c8MF8+umnZu2113bbTZgwwY2ZGm5EN1AEuhEBAgCy1OFdbrnl3MsbEZNqioAioAiECCD/O3nyZDc7ieg699xzXZBRuG1P+k7tLGpo4RBjXArxxbiUAIO8hk+B+lxEwWNExeM0RBYRyVk1RUARUAQUAUWglRGAGBo0aJAjiVCaGzNmjBk5cmRqlyk98MADD7igZZ6h3S1dOGTIEDNz5kyzwgormMceeyy17+22sFJE1+uvv+7qRVGY+sILL2y3c9Ht/YXkIuVSjJRKfqxoiWoGgaCiU0VAEVAEug4BshOIOkbPWaxPnz7mxhtvNKuuuqrM0mkPQUCIrv3228+MHTu24aP+6KOPzHrrree2mzhxotlqq60abkM3UAS6GwGiD88888waidewT5qJESKi3xUBRcBH4IQTTjCTJk1ys5KILkh1ZPV6sj3//PMG3wrZsRBdEF9vvPGGk17Kiws1v3wJROp/Pf74427eN77xjbzN6naKgCKgCCgCikCXICBEF8HHlPuh9EQorx525MADDzQPPvigWXzxxQ11hrub6Bo8eLAjuMhKg/CqkrU10TV79mwnVUJUEMWoGXRtvfXWLurol7/8ZZXOU9OPZdq0aYYIcbE11ljDZcWtueaaMkunioAioAgoAt2EADVozjrrLNPR0eF60KtXLye5s/rqq3dTj3S33YGAEF04nJBla9QYiIv88A033GC22GKLRpvQ9RWBlkDgyy+/NJBZZLjKfVE6Rv1eMjWKSGtJWzpVBBSBaiJw0kknGZ6DmE90+bUsKYVASYSebM8995xTyxk2bJgjuiC+CC5GdimvIYXoZ4ZJVDmyiEsuuWTeZnU7RUARUAQUAUWgSxAgOIMgjaWXXtr87W9/cwGoBKKm2YgRI8zDDz8cSfR2N9ElQSb4Fx599NG0rrfdMiW62u6Uld9hah5QFFaMFMxTTz3VFciTeTpVBBQBRUAR6F4E0HRGyvBf//qX6wgDqzvvvNMgL6vWMxAQogsJIeq1NWoi+cx2EAHUNVJTBNoZAV40GbMylsW+/e1vm1tuucW9eLbzcWnfFQFFoLkIIP97/fXXu534RBckumTMUwqBkgg92Z555hmz2267mf3339/V54L4olzEwgsvnBsWMsR8wkzqhPw/9s4E/qpp/f/LdAmZJSFDZBYyz5IMpWSWMRQSMkWZQhTKEFKReR5yzWQoGSLCNc9cmYdCZvfe7/+81+//HKvdmc/5nu/ZZ3+e1+v7PcPee+21Pnufvdd+Ps/zecgWW2yxxUpuVxsKASEgBISAEKgGAkZ0cc+aPn26fy7nXpbLuI8+8cQTrnnz5r5UEBK+TWn4/clMW2GFFbzce1P2pdL7jjXR9emnn7ott9zSde7c2Y0cOdLrRSPDQ5TQiBEjKo1VXbaHLFaYtYXjLN8PtC6B0KCEgBAQAjFAAMku0uL/+OMP31uyb8eNG5eODIrBENTFMhAwooui8IMHDy66JepqmFzhbbfd5jbddNOi29AGQqDWEPjf//7nIyR//fVXH7i1wAIL1FoX1R8hIARqDIEzzzzTIeGLhUQX86u2bdv67ymFACmTZHvhhRd8nTIi0cm4gvgisKCcsgYQZ2E7ZKlPnDjRk18oFsiEgBAQAkJACNQyAkZ0Lbzwwu7HH3/0yjtkSOUyMqMnTJjg2IagmqYmuqw+JkGC9KueTERXPR3NEsaCwwvHF4b8IzKQMiEgBISAEKhdBEh5p5gp8jrYjjvu6EaNGuW1nmu31+pZJRAwoguZn3PPPbfoJsMMbrJeTMaw6Ia0gRAQAkJACAiBGCNAJug111zjRxASXRDmq6++uv+ewFkCaJNszz//vNt77719kBVE15QpU3x9xGbNmpUMC+3RLrJNBCYg9/Tkk0+6l156Sdm4JaOqDYWAEBACQqBaCDzzzDOOGlfcw0geufDCC31QSK79W1DHoosu6oOWm5rosnuxiK5cR60JljEp3WqrrRwFTa+44gr38ccfu2222cZ17drVXXbZZU3Qo3jtEt1xq2V2/vnnOxhdmRAQAkJACNQ+AtSVoL6E2cCBAz35ZZ/1Wp8IGNFFxBg124q1N954w2fBs93dd9/tNthgg2Kb0PpCQAgIASEgBGKPAHUux44d68cREl0///yzW3PNNf33Irqcmzx5svcR9O7d29foCgmqUk8Cqwvy+uuvu4UWWsjXCadeOCTaUkstVWqz2k4ICAEhIASEQFUQMKKL7Obff//dFVLTE0UWamGRufzbb781eUbXXnvt5cjabtOmjQ82qQpwVdpJrDO6okTXJ5984gur77LLLu7yfNsocQAAQABJREFUyy+vEoTx3E3o7OIEh4GWCQEhIASEQHwQCGV35pxzTi9huN5668VnAOpp0QgY0UVgCgEqxRr1L3bddVe/GfXddL4Ui6DWFwJCQAgIgXpAAPnfq666yg8lJLp++uknt/baa/vvCZwlgDbJRv0O6nigJEBGVyWIrmhNLmQRUSvA4dayZcskw62xCwEhIASEQAwQMKJr7rnndv/5z3986aR8GeBkgLHdEkss4cgeb+qMrj333NMHmFCXlNph9WSxJrqixJZ9tgyvejpQlRwLjPOqq66abjKc3Ke/1BshIASEgBCoaQSYVDFhwumAQYI8/PDDqtdV00etvM5RLLahocHLCF1wwQVFN0a0NJNa7L777nPt2rUrug1tIASEgBAQAkIg7giERNeHH37ocFZhM2bMcOuuu65/j2IMfoUkmznzjjzySE90QXwRMNu8efOSYYlKFZIt9uijj/rssVatWpXcrjYUAkJACAgBIVANBOzeOMccc/hn80LmCwSNcA9t0aKFI3u8qYkuq5e5yiqrOLKq68nqiuiKZnjV04Gq5FjQHYdBxsKJfSX3obaEgBAQAkKg8RH47rvvfG3Fr7/+2u+MKNlzzjmn8XesPTQJAmhoU5ut1Exsi8ym8w8++KBba621mmQc2qkQEAJCQAgIgaZEgDqXY8aM8V2gfiXyQ9j333/v1l9/ff9+5MiRablf/0UC/z399NOOuqB9+vTxRNezzz7rTHKwVDh69erlxo8f7wO1ll56aZ8t9sgjj3gH4DLLLFNqs9pOCAgBISAEhEBVEDCiy3Y2evRoXzfdPmd6tZpYZC6TPd7URNfuu+/ua2O2bdvWZ1Vn6nNcv4s10RWtyfXpp5+6Lbfc0k9ImZjKZkeAH+B5553nF9x5551uo402mn0lfSMEhIAQEAKxQSAkL+i0ai/F5tAV3VE0tMnkIwJr+PDhRW8/ceJERyFcDKcSgS8yISAEhIAQEAJJQ4A6l6NGjfLDfvPNN92CCy7o33/77bfp+pVXXnmlDyZKGjbheJ966ilHEFXfvn090QXxhYThIossEq5W1Huywx566CEv4bTccsu56OeiGtPKQkAICAEhIASqjECU6Lr66qvd9ttvn7MXVhOLzOUffvihyYmu7t27u5dfftmtttpqPqs6Z+djtrCuiK5p06a5LbbYwk9ImZjKZkXgrbfecjvttJP/cuutt3Y33HDDrCvokxAQAkJACMQSgTAyGfLigQceSMvwxHJA6nRGBJAW+PPPPx0RWBS9LdaQJTj00EP9ZsgEMbGVCQEhIASEgBBIGgJDhw515i8IiZuvvvrKbbzxxh6OQiK06x03C5A5+uijPcE1adIk9+qrr7pFF1205KHTFvLJEyZMcGSqky1GljkkWuvWrUtuVxsKASEgBISAEKgGAlGi67rrrnPbbrttzl2bVCCZy8gkN3VGF3W7qd+N74gA2HqyWBNdH330kT+ZKPo2YsQI99lnn7nNN9/ckzkWoVVPB6ucsfzxxx9uk002cdOnT/fNlDtBLacv2lYICAEhIAQqiwDXeAIZkKPFqD1xwAEHVHYnaq3JEUBagGNNBNYll1xSdH+o4XbEEUf47SC9IM5kQkAICAEhIASShgB1LqmpgU2dOtUXh+f9F1984TbddFPeemnDHXbYwb9P6j/IqIMPPtgdc8wx7rXXXnMQX0SAL7744iVDctxxx7lx48b5miDMQ8gWu//++x3ZY9QilQkBISAEhIAQqGUEokTXTTfd5NXlcvV5t9128/MNMpkpP/HOO+/kWr3Rl4noanSIS9uBiK7CcTv//POdyTkOGDAg7egqvAWtKQSEgBAQArWMwJQpU9yee+7pu4ikzOTJk938889fy11W34pEgAys3377zTExvfTSS4vc2vkIaiKpMYukLroRbSAEhIAQEAJCIOYIXHjhhe7yyy/3o3j++ecdtaIwC5zl/VVXXeU6derE28Tak08+6Xr27OmOPfZYn9FVCaLrpJNOcnfccUdaQtkyvGh7xRVXTCzWGrgQEAJCQAjEA4Eo0XXbbbelg2SyjcCIpeWXX9598803TU50kTBEAswaa6zhCIatJ6urjK7PP//cbbbZZr4IHFIDsv9DAKbYotHmmWceX0C2WbNmgkcICAEhIATqDAGLkmVYCmqos4ObGg4T0V9++cVZJnuxI6R+2/HHH+83U+R0sehpfSEgBISAEKgXBIYNG+Yuu+wyP5xnn33WLbvssv79v//9b7fVVlv594XU3KgXPLKN44knnnCHHHKI69evnye6CJIJM+CybZfr+1NPPdUR/Y58Ybt27Xy22L333qsAnFygaZkQEAJCQAjUDAJRouvOO+90G220Uc7+GdFFQAcyyU2d0dW1a1d/X19zzTV93cycnY/ZwroiukxqAFJnzJgxMTsUjdfdvffe2xGphjGx7N27d+PtTC0LASEgBIRAkyEQ1pYgoIG6E/POO2+T9Uc7riwCTER//vlnx8TUHHTF7OH22293/fv395swQUc6QSYEhIAQEAJCIGkIDB8+3Jc+YNxhJtHHH3/sttlmGw/H2LFjXceOHf37pP577LHH3GGHHeaDZJhTQny9+OKLrkWLFiVDcuaZZzrqmSBf2L59e58t9s9//tORPdamTZuS29WGQkAICAEhIASqgUCU6OIett566+XctRFL1Kb88ssvm5zo2mWXXbwk8VprreXrZObsfMwWxproohZJhw4d0hI+IrpmP/vCwvPNmzf3hNeCCy44+4r6RggIASEgBOoCgbDAOtI8e+21V12MS4NwjonozJkzXZcuXdK1RYrBhQhqAl6w5557zlEMVyYEhIAQEAJCIGkIXHTRRWkJYMiblVde2UNg/gU+XHvttd7XkDRswvGOHz/e9erVy51wwgk+eArfAlLZSy21VLhaUe+pI4ssJME31BA3NQLVDi0KRq0sBISAEBACTYRAlOiizuQ666yTszc8v7/++ut+voEaXVNndHXu3Nm98cYbvt/0v55MRFc9Hc3IWBoaGtxOO+3k3n77bb/k0EMPdWeccUZkLX0UAkJACAiBekJg+vTp6YiiVVdd1eGkkNUHAkygf/zxR7fzzju7K6+8suhBEUFNJDUW1iQpuiFtIASEgBAQAkIgxghccskl7uKLL/YjeOSRR9zqq6/u37///vvpLC7umdtuu22MR1l+1x999FGvBnPiiSf6yG/mlOXOHy644AIfrHPjjTd6mUgklZFWJnusbdu25XdaLQgBISAEhIAQaEQEokRXOI/Itlue3/HNk9FVC0QX/XnzzTe9hDBSwvVksSa6PvjgA7fddtu57t27OyarpP8RFUTRWKKEkm5hNtccc8zhpQYkB5D0s0LjFwJCIAkIDBo0yEciM1Y5DurniK+77rpuxowZPohl1KhRRQ+MuRGR1Fi50kNF71wbCAEhIASEgBCoEQQuvfRSR1YX9uCDD/qMad6Hta2vv/76tIwhy5JoOO8OP/xwd9JJJ3miC+Jr8uTJrlWrViXDAcGI7+aaa67xvhyyxe666y4fmEWAlkwICAEhIASEQC0jQG3PHj16pLtYiL9lxx13dATTrLDCCjVBdJEU89Zbbzn8C9TJrCerK6LLapNsv/32juKxSbd99tnHT0TBAf1rdLBlQkAICAEhUP8IhDUmjj76aEckriz+CKy//vru+++/d6XWIh05cqQ7//zzPRDlFpOPP5oagRAQAkJACCQVgREjRjjqdGFhbQ2irXFGYSK6nC9Qf+SRR7qTTz7ZSxdCfJUrfXz55Zc7pLVHjx7tsYZEu+OOO1whEfH+wOifEBACQkAICIEmRCBKdE2YMMFnauXqEs/vyCMvv/zyNUF0MddhzkNtMeZB9WSxJrpMWmC33Xbz0gMiuv4+NT/66COvKY58IXb22We7gw466O8V9E4ICAEhIATqGgFLR59rrrkc9wRZ/BEol+gKHXuvvPKKW2yxxeIPikYgBISAEBACQqBIBC677DI3bNgwvxWyeRtssIF/T70K6lZgJq3nPyT0H9luffr0caeccoonuh5++GGHg2/ZZZctGZExY8a4c8891zEn6datm88WE9FVMpzaUAgIASEgBKqMAAEf++67b3qvTz/9tGvdunX6c6Y3KM8RjAzRNW3aNPfuu+9mWq1q34noqhrUxe0oSnR9/fXXbqONNvK62mPHji2usTpbm4k7E3gM2cIXXnihrKKxdQaPhiMEhIAQqHsEcBoQJYtxD2jZsmXdj7neB4gj7ttvv3WlZq4TvY5jCXvttdfcwgsvXO+QaXxCQAgIASEgBGZDwLKKWHD77bf78ge85964yy678NbddNNNbsstt/Tvk/qPAvV9+/Z1AwcOdK+++qrP8KI2yXLLLVcyJFYvlDnJHnvs4fr37++PASTaGmusUXK72lAICAEhIASEQDUQiBJdhUj6duzY0RNc3D9rgegiwwy5ZgJp77nnnmrAVrV91FVG1zfffOM23HBDr/WM5nOSjcK5FsFP8XomqTIhIASEgBBIDgI//PCDLy7KiJGI2WuvvZIz+DodKcE8BPVQn7SUeQ6yhcgXYkStN2/evE6R0rCEgBAQAkJACGRH4IorrnAXXHCBX+Hmm292W2yxhX9PtvOuu+462/fZW6rvJRSoRwL71FNP9RldDzzwgJs0aZKPSC915LfccosbMGCAGzJkiK9xgizibbfd5km0Nddcs9RmtZ0QEAJCQAgIgaogECW6XnrpJbfkkkvm3HeHDh3cl19+6ZZZZpmaILrIMCOrrB7LHMWa6Hrvvfd8VPPuu+/ui8kS5Uy0MyfQtddem/Mkq+eFEFwQXWbHH3+8O/bYY+2jXoWAEBACQiAhCKy99trup59+qssiowk5hLMMc+ONN3bINJc6zxk8eLC76qqrfJsUn11ggQVmaV8fhIAQEAJCQAgkAYErr7zSDR061A81rMX18ssvu+7du/vvb731VrfZZpslAY6sY6RA/THHHONOO+00T3QRPPvUU0+5FVZYIes2+Rbcdddd7oQTTnBnnXWWO/jgg70sIlgjk7jWWmvl21zLhYAQEAJCQAg0KQJkcO2zzz7pPhRSEgAfPQGrrVq1qgmiC4UYOBWShbgv15OJ6Kqno/n/x3L11Ve7c845Jz0yJqRkdcmEgBAQAkIgWQgg40uNRuyTTz7xUrbJQqC+Rrvpppu6L774wm2zzTYOx1yxNmjQoHQgEFIFzZo1K7YJrS8EhIAQEAJCIPYIjBo1ymcUMRDmSkgKYS+++KKX0+M9WUbcd5NsFKgnYPb000/3so4QXxMmTHArrbRSybCEWWK9e/f22V1keZEtRoCWTAgIASEgBIRALSPw/PPPu7333jvdxUKUUnh+Jzln6aWXrgmiC4WYDz74wJd/uvPOO9NjqYc3sSa6SLMj3Q5tZzSev/vuO592B1OK9nNS7cADD/SRVox/iSWW8BP2OeecM6lwaNxCQAgIgcQi8O9//9tttdVWfvxPPvmka9OmTWKxqIeBE1n++eefu6233trdcMMNRQ+JiOwbb7zRb0ed03/84x9Ft6ENhIAQEAJCQAjEHYHRo0e78847zw9jzJgxjloVGDVNTeo5rN3lFybwH3U7+vXr58444wyf0VUJouvRRx91EFwnnniil0Wk/hfykQrOTeAJpiELASEgBGKIQJToKiSAFJ/MjBkz3FJLLVUTRBcKMR9++KFDMYba7vVkdUV0ff/9976QWqmRzvVwYP/66y+fvfXrr7/64aAxfumll9bD0DQGISAEhIAQKAGB5Zdf3m9FNk/Pnj1LaEGb1AoCm2++ufvss888eWmEVTF9O+WUUxzyQBgT27nnnruYzbWuEBACQkAICIG6QAAZX+R8MWpXdu7c2b8PnVc4fnAAJdnuvvtuRxkE5pCvvvqqI8Or3MCpiRMnuoMOOsiTXJBd1P+66aabHJle7dq1SzLcGrsQEAJCQAjEAIFwrkB3C3muphbozJkzfS2vadOm+fpYTTlUEoQoe7TJJps4AnvqyWJNdMGaEn215557umHDhjkRXc5NnTrV7bbbbulzFFzARyYEhIAQEALJRKBLly7u9ddf92nyTMpk8UVgyy23dJ9++qljokz0c7GGQ8mkCT7++GOnbO9iEdT6QkAICAEhUA8IhETXiBEjXLdu3fywnn32WdejRw//nvvlRhttVA/DLXkMYT2tf/3rX27cuHHu8ccfd6usskrJbVptk169evnaX5ZtTrbYuuuuW3K72lAICAEhIASEQDUQCLO/55hjDsdzNa+5DGWW3377zS2++OI1kdEloivX0WrCZSK6Zgc/lGFgKRNJit3JhIAQEAJCIJkIWCFxRo+UoSy+CCBZSK01JsqWmVXMaKizQTQ2pnOhGOS0rhAQAkJACNQTAmFN64svvjgdKPr000+7/fff3w8Vkoci7Uk2yD6CZKj3CtFFhtdjjz3m2rZtWzIsL7/8suvevbuj3AJ1xan/hRwz85P11luv5Ha1oRAQAkJACAiBaiAQEl0opJDRlc+o+fnHH394oovn8Pfeey/fJo26HCU8CDr6RU3SerJYZ3S9/fbbbscdd/Q62hdeeKGbPn26nxyVWruiHg7sEUcc4R5++GE/lOWWW84988wz9TAsjUEICAEhIARKRMCyndn8rbfecgsssECJLWmzpkag3AnpUUcd5Yu9Mw4RXU19NLV/ISAEhIAQaCoExo4d68kb9o8fwepyPfXUU56A4XtInQ022IC3iTXkG0866SRPSEF0Qf6NHz/erbrqqiVjwlx0p512cnvvvbe74IILRHSVjKQ2FAJCQAgIgaZAYMqUKWnltGbNmjmScPIZEoGUGlpsscX8c3hTE13lBtDmG29TLhfR1ZToN8K+rX4HTe+xxx5u+PDhjbAXNSkEhIAQEAJxQsDqdJEFRDaQLJ4IlCsxcPjhh7tHHnnED15EVzzPAfVaCAgBISAEykfg2muv9XWnaGnIkCFpucIJEya4gw8+2O/gnnvu8fW//YeE/qNuR//+/X09s9dee80XrGcesfrqq5eMCJHvHTp08HKRyEaeccYZ7vrrr3fCu2RItaEQEAJCQAhUEYEXX3zR+9vZZfPmzd0bb7yRd+9IITc0NLhFFlmkJoiurbbayvcDDuGWW27J2/84rVBXRNeMGTO8rjMHrJQi7XE6cJn6+tNPP7l11lnH/3hYPnToULfvvvtmWlXfCQEhIASEQIIQMKKLiGUil2XxRADHEA6ijTfe2Dubih3FoYce6mtrsJ2IrmLR0/pCQAgIASFQLwhcd9117swzz/TDQT4PGT3siSeecIcccoh/Lyk95+WMTj75ZHfuued66UIyvMoluj7//HMfdIUyD2UXOA4cD+p/tW/f3mOvf0JACAgBISAEahWBl156ye2+++6+e2RovfLKK3m7SoY49bEXXnjhmiC6yq39nXfATbiCiK4mBL/Suw5/bLT96KOPutVWW63Su1F7QkAICAEhEDME+vbt6+6//34/uUKLWRZPBDp27Ojef/99XzME+aBi7aCDDnITJ070m4noKhY9rS8EhIAQEAL1ggAZRGQSYYMGDXI9e/b076k/ddhhh/n3Irqcj/IeMGCAz3pDupA6Hg899JBbc801PUal/DNJbeSYOQ4iukpBUdsIASEgBIRAUyEwderUdG3PFi1aODK88hmBHPPMM4/PAOM5vKmlC7fYYgs3bdo0B+F100035et+rJbXFdH1ww8/uHbt2tXlgSrkrDINbdalBsvrr7/u5pprrkI21TpCQAgIASFQxwiEjhsRHPE90J06dXLvvvuuj3gm8rlY22+//dK1O3UeFIue1hcCQkAICIF6QeCGG27wtaEYz2mnneZ69erlh0agaO/evf37e++916vF+A8J/XfzzTe7gQMHeqUYiC4ksB988EG31lprlYzIL7/84tZYYw1HvRKkESEakZJUTbSSIdWGQkAICAEhUEUEXn75Zde9e3e/x1atWrnJkyfn3fv666/v5p13XrfgggvWREaXlT2qR0W8WBNd0UKmP/74o5fug5lkUpY0Q47q8ssv98MuVdYoaZhpvEJACAiBJCCAtO3aa6/thyqCI75HfIcddvDFbpkoU8uiWKPw+/PPP6/MvmKB0/pCQAgIASFQVwiERBcZS0cccYQf38MPP5x+TyY8ZQGSbER5n3rqqe7888/30oXU8XjggQfSc8pSsPnPf/7j2rRp40lEyMSzzjrLXXPNNY5M9Q033LCUJrWNEBACQkAICIGqIYBU4a677ur3t8IKK7innnoq777XXXddn5Ay//zz1wTRRd12pIS33nprx5yonkxEVx0dzWOPPdYhsYChLW6643U0RA1FCAgBISAESkTA6nQRJELWryx+CFDP4u2333brrbde+n5fzCjQEkfmmGiyppZLKKbfWlcICAEhIASEQCURoJ43mVzYSSed5JB4xshW6tOnj39fLqHjG4n5PyMECaglowvi67777vMqOuUMbeWVV/ZkFxl0IrrKQVLblosAqlBkWMw999zlNqXthYAQSAgCIdHF/Yz6nvkM9bnmzZu7Zs2a1QTRtemmm7ovvvjCmYxwvv7HaXmsia4333zT7bzzzm6fffbxUUYWsU4KHtFGSTOL1Gbcw4YNc3vuuWfSINB4hYAQEAJCIAsCRnRRX4GJjSx+COy0004OopKIMKKgizUiz5iYM8l+4403it1c6wsBISAEhIAQqAsETJKPwRx//PGOgFEMEufoo4/278uV6PONxPxfSHS99tprDoKwEpKOqAwsuuiibtKkSe7ss892Y8eOdXfeeafbaKONYo6Yuh8nBJB2R6qUeTH14ggkk82OACQ3GK200kqzL9Q3QiCBCPCb6Nq1qx/56quv7h555JG8KNh9b7755nPUTKfudlOaiK6mRD/HvkV0zQpOhw4d3Icffui/VATarNjokxAQAkIg6QgY0XXMMce4E044IelwxHL8nTt39gQVUkpIKhVrtv3iiy/u0BaXCQEhIASEgBBIIgIExSJZiEFyQXZhkDjMk7CHHnrIrbnmmv59Uv/h/D/jjDN8EC1EF8QXCjLlEgIQWg0NDe7FF18U0ZXUk6sGxn3xxRe7Sy65xPdktdVWc2QYymZFgIwPHOJzzjmnGzVqlENGXSYEko4A98NddtnFw1Doczm1LXkGR1mlFogu6mR++eWXDh6BOpn1ZHWV0TVz5kxfGBWtSQqlJs2YcE6fPt3fhIj4JiVSJgSEgBAQAkIABKzgKA8rZHXJ4odAly5d3Ouvv+5rYxDQUqyZ9OESSyzhpk6dWuzmWl8ICAEhIASEQF0ggK/glFNO8WNBthD5Qoz6l/369fPvidAmUjvJhvNr0KBB7qKLLvLShRBfYESt0HKMmiDff/+9D94555xz3NVXX+3uuOMOR51xmRCoFgIjRoxww4cP97ubY4453EcffeR9adXafxz288EHH7jtttvOd3XVVVd148ePj0O31Uch0KgI8DzOczlWaO3sNdZYwy211FJunnnmqQmii4CTr7/+2v++qZNZTxZrogvZHaKT9913Xzd06FD3888/+6irpDrxKOpKcdflllvOPfPMM/V0nmosQkAICAEhUCYCRx11lC8gTgFU6jzJ4ocAEglIJRBhTqR5sdaxY0cvk8Ake8qUKcVurvWFgBAQAkJACNQFAgT8nHzyyX4sRxxxRDq76+67705nd4nocg7nFzW0yHxh/nHddde5cePGufbt25d1HhB4g2wTajSSLiwLSm1cBgIh0UUzKEZRr0v2NwKmosU3OOjfeecd1TP7Gx69SygCxkUwfDKjbr/99rxIEDiz9NJL+99PLWR0bbjhhu6bb75x+AeQD64nE9FVJ0fzr7/+chTBw+qxmFydHCYNQwgIASHQZAiMHDnS17OkA//+97+brB/acekIdOvWzb366quOiLCHH3646Ia23XZbH63KJPv5558venttIASEgBAQAkKgHhDAKdW/f38/lF69ernTTjvNv6dO1IknnujfI2OGnFmSDecXRBTybhBdZHhBBm6wwQZlwdK9e3cvoUy2yHnnnecJtbvuusvheJMJgWohcMEFF7grrrgivTvmxsyRZX8jEDr0+XbChAmq1fU3PBV9N23aNK9MhkwkyRzLLLNMRdtXY5VDAAU1amdjW2yxhaPuZz5jPsExnWuuuWoio4v7+Lfffuu23357n1Wdr/9xWh5rosvSBXv06OGGDBnifvnlF+/8KZRRjdOBytdXy2ZjvYMOOshPSPNto+VCQAgIASGQHAQouHzYYYf5AYvoiudx33XXXd0rr7zipZQKKXobHeWWW27pPv30U9eqVSs3efLk6GJ9FgJCQAgIASGQCASQyTO5wp49e3p5PgYeEmBIdCHVlWS76qqr3ODBgx2ZLxBdEF+QgUgelWP4b5599llHnRNkESuVKVZOn7Rt8hBAljOsTTNx4kS34oorJg+IHCM2n6utguwrpWJq2SZNmuTrCSLVfu6553pioZb7S9+ohQZh8t///td3db755nMHH3ywO+CAA9yyyy5b691PXP9QxyEzGSOQlHtYPmvbtq2jZjoyqbWQ0UVm9nfffec6derkuNfXk4noqpOj+cMPP7h27dr50Zx++ulpZ2adDE/DEAJCQAgIgTIRCDXWRXSVCWYTbW5EV6kFs5F25kGKByYcTDIhIASEgBAQAklEICS6DjzwQEedKCys3UWAEI6pJFtIdEFKVaqWFoFX4EsGDYoDN9xwg/vnP//pqDmeBKPcBJJRM2bM8HJwRPkvsMACSRh6TY0R+dKwbvELL7zgWrZsWVN9bMzOkJWCQsThhx+eVbIxSnRBeqMwUcuG8gVJENiFF17o9tprr6p2F0lWrmdWh5Df+h9//OHL7gwYMCDjbx2i5Mwzz8zYTyTvCFbcaqutfJDBvPPOm3E9fVk9BEKiq1CiaJVVVkkT6bVAdFFbjHN0hx12cGPGjKkeeFXYU6yJLiZbu+yyi9tvv/18ynuSM7p+/PFHt8466/hTZvTo0Wl2uQrnkHYhBISAEBACMUDg119/TRdVF9EVgwOWoYtGdOF4w0FUrJkWd+vWrd3TTz9d7OZaXwiUjQCBWdS/mHvuuctuSw00PQI6nk1/DNSD0hAIJQrNl0BLyA8NHDjQN/rEE0+kSwOUtpf4b4Xzi4yIyy67zGdfQXyR9YaCTjl2zDHHuHvvvdfLoJEldtNNN7n77rsvHbhbTtu1uO3//vc/XxuVOurUSMWP9dtvv83SVYKQ+vTp431bsyzQh0ZD4Oijj/bnne0A4qceCUcIVQgtnh0Y4z/+8Q8/F0O2jL+tt97ak82GQ/gKadOhQ4f0V5AxhxxySPpzLb4JiS6enS699NJG7yZEFhjfcsstDsI0m/Xu3dudeuqpsy0OgyxmWxh8Acm18cYbe+IL8gsSrKmMMf/0009u5syZ/nqG5OLvv//us9IWX3xxx/MmMn31aO+++67PhGJsnTt39gEb+cbZpk0bB9nF/UBEVz60ylsuoqs8/GpmayP56ND999+fJr1qpoPqiBAQAkJACDQ5AqTLYyK6mvxQlNQBI7qYJD/++ONFt2GRWyussIJ76qmnit5eGwiBchDAwcIDfvPmzd3111+fmMj9cjCr5W11PGv56Khv+RCgHtQJJ5zgV9t7770dtXqwG2+8MV2v68knn3Q4ppJsBNBSQ+vyyy/35AzEFxkwZIiXY6eccorPnnvwwQc9yYWTl/drrbVWOc3W1LZIkEFo4fzGP0NGfSGGlOPuu+9eyKpap0wEIGwgtDEc8pA6yIrVk3HuofgE2ZXNCD6aOnWqW2SRRWZbhfM2/L1TwxCCsJYtJLoggyDSG8vI1uI6yT2F4J98ttRSS3myO7oex2e77bbzGTbRZbk+r7TSSu7QQw91e+yxh0PusFJGps+bb77pAyOpD21ZZPQTcpTXP//8M+fuyNC9+OKL01lMOVeO2cL333/fdezY0fe6UDKVY4UcMkQX1xrUdprSOD7Tp0/3STKcw/VkdUV0WbQ6DDdyBEky0t9tIv7iiy+6Fi1aJGn4GqsQEAJCQAgUgICIrgJAquFVjOjifo8Drlgj85sMcCbaFJOWCYFqIsDD7iWXXOJ3War8ZjX7q33lRkDHMzc+WlrbCNx9993u+OOP953cc8893bBhw/x7JPRwCmPcJ7lfJtmuvPJKN3ToUB+tTo0unGGVqNFz9tln+3pf+GxwEPNK7dGmzE4o5zhz3vDHHIvMLLIaCCoz+bRi2t5///19Fl0x22jd0hCA5EY+E1tsscV8HdzSWqq9rSBajzvuOJ85WUjvuB4ee+yxs60alkhhYd++fdP1DWdbuUa+CIkunPnICFbayGIaNWqUv45FszNz7QtS6owzzsi4CgQS5CsEebHG+Us9r4MOOsiRTVWocY1Cho8Mpffee8//8R6iqxJGHahx48ZVoqmaaiMsCRHOIXJ1kvp/3OP4bdYC0bXuuut6wnKnnXby53KuvsdtWayJLiZbXbt2dTYZ4ALDgzPFUZEjSJqZA/Ojjz6q2xTRpB1TjVcICAEhUEkE7D6hjK5Kolq9tozoKpWosge/Uomy6o1Ue6pHBKjrMHz4cD80IqaZryJzIosnAjqe8Txu6vX/IYDjDScw1r179zQJH9ZJEdHlPMF1/vnnOwgvfC84dpHm2nzzzf8PyBL/QywihwjeSBZyPMhUJ2M9jkYmGo7vQqxVq1aO+fhCCy3kM5yJ7h8/frz7+eef/ebm2yqkLa1THgL89l9++WXfSKlz6/J60HhbW9ZkuAfmXiukVB1wtH/66afhIi9liKw5hElof/311ywSrtTXs2CAcL1aem/PO/QJcmHixIkV6x4JBtdee63Pcs2UwUV2HPtkjgvOZnzP+QbJxW8/m5FpDPlvRs04Mo7JvJk8ebIPwCCLLJvNP//8PiCBel6ZjOsN7UyaNMlLLFKDjTE1ltXb78pw4vhuu+22/mOPHj3ckCFDbFHWV677a6+9tuM3VQtEV7t27XwW4s477+zv8Vk7HsMFIrpieNCydVkOzGzI6HshIASEgBAAAd0n4n0eGNFV6kMbcglEGZcqfRhv9NT7pkYgJEboC5Io1OuSxROBWj6eyOxwbq288srxBFe9bnQE7rnnHtevXz+/n27dujnOZ+yaa65xZ511ln+Pc5T7bZLtiiuu8E5WCC6yDEaOHOllwJADK8csU4z2H330UU92xZlYzEV0IYkHMYiTe7PNNnM4rqP21Vdf+WwM5LAGDBjgDj/88Ogq+twICPDb536BNVbmTyN0O2+TkMiWpWorU1cPGVKC3XC0k8EFyRwa2UTU4Ioa2xgZQtbQ4MGDo6vU1OeQ6Jpnnnn8NcbIBWojQSrzfbNmzfxcAcnAZZZZJu8YPv/8cy8TSAZU1KhjRoYgBBNkE0kY77zzjvv6669929xLCpnzWv1Cax+swdysoaHBn7MEBvDHPqIGqYaCwi677JJeRN/JxiWbuVAZ1fTGwRuuZ6iHMUYyx5ZcckmPI9+Hsp8QahB9a665pscsaKIu3oZEF1l0ZCnnMo4bJDPqKkg+1gLRZUovhdYYyzW+WlsWa6KLmxI3J7vY4rzBiUOx9ZAFrzXQG6s/cmA2FrJqVwgIASFQHwjoPhHv42hEFxPlUmps4fTlQY+5EtHDMiFQTQSISMWpaYZc0NJLL20f9RozBGr1eFIPp0+fPr4GApko++yzT6MhO23aNO84IjNx3333LchR1midUcNFIYCUlcl0hU6eq6++2p1zzjm+Le6z3G+TbNTmuvDCC32GAEQX13DqmGXLFigUK5OIpG2kmPndPvvss172r9A2amm9TEQXTuCePXs6ZK0ykVvR/ptjGAe8rDoIINn11ltv+Z1ts802vn5odfbceHshWyd638NnSu03CBAzSAhqwb3yyiv2lVtuueXcM888k/5sb8whzmfzvdqyWnqFQPjss8/cDjvskLd+VNjvtm3bOuqO5jIyWpEdRF4wNAhSSA4wqoSFcpq0l2+ujMQg6zAn++STT9JdYF5Cv4wkY47y3HPPpZdne0MtLuRXqadLFlmY+UeJIDJ6w/MoWzv1/j1Yb7311n6YvXr1Stf2zDZufm9ktyEXCG9RC0QX2WU//fST69KlyyzPZ9nGEKfvRXTF6Wjl6ascmHkA0mIhIASEQMIR0H0i3ieAEV2tW7f2xYGLHQ3RhDhS0AenFoZMCFQTgUGDBnm5F9unsiUMiXi+1urxxHH30ksveVBxLuMACqOMo2jjyOG6uMQSS0QX5fxMRPQWW2yRliaiCPzBBx/snUo4iWS1jcC9997riJzHdtxxR0/k8H7MmDHp+kjIeHG/TbJZZgi4QHRBfEFSmYOvVGysRhrXERzrZCa88MILBRFCpe6zMbeDWIBgMOvUqZN3PC+66KL2lV5rEAEIW5NzDzM7G7ur1EIiA4ZMqUoaWSNk8SBHZ8ZvlUzVTOQEtfFOOukkW9XLSZMhBNkR2qabbprOAjrwwAPTwQDhOk31nlpJJ554oj+O3M9LsXwBhGSdEhgR1uJiXnHUUUf5zDiOZaUM4szGkY14zLSvP/74w2fsIQcbGvc6CA3IPMvKC5dzXkC+8FtgTgNhZ2Q790CkVM0g0yDiZM4TgJbZTHDVySefnBMWsOf3zvHlPKolootrBvf2erK6Irr4cfMD3mCDDXxKZj0dqELGIgdmIShpHSEgBIRAchHQfSLex96IrmIefGzEOHJNgglJD6KnZdVFgKjIF1980XXs2NEtvPDCvkj9G2+84TuBBAjyHvVcs4qHwNtuuy0NepydmulBJPhNLR5PHAk8C1pdDBw4OBMyGeseeeSR3sGOUw9pNiL6CzWcSZkkntieYAIcIDiOqB0ddRoWug+t13gIhETX9ttv78jkwjgPrNYGBAz32ySbSZReddVVnuiC+Lr++uuL+q1kwo9gG+T5cFBzXyR7jsySaH2gTNvW4nc4wnv37p3uGjV8kDKT1TYC66+/viMjBiuGwEGOjkywH3/80Wfycs0vRJaO/ZBZdemll/K24tlRSBEeffTRvm3+kUHCd2TnZDLGju+UZwQzMiyjBBy1iJBqwwqRabO2GvuVez1qXnYMC90fJBXPRKuttpq/xkPmZAtq4HoHIR9iRGAL0oBkBFbSvvvuO9e+fft0k2SDRiUo0wszvOGcJOCG89Nsv/328wRYGATEMjJOmcMg25jt3H333XcdpL1ZJeozWltxfyVz0GpVEjRDbbVchqIKyipcc3799deaILosE7lr166+Zmau/sdtWayJLiZDOH3spiSia3l//llUStxORvVXCAgBISAEGg8B04ZmD6Tb54pwb7xeqOVyEDCii2wBJH6KMZtgsw0T2wcffLCYzbVugQjgPB86dKij3gZZAiZXRMQpEiK//PKL+8c//uEfKiliHT44Z5KWKXC3sVgN50tYD4IH8gUWWCAWfVcnZ0egFo/nl19+6ahDYkbtCMvusu/s9YEHHvDR2PYZhz6/wUKNWhennHJK3tUhuZD7gfjiD4eorOkRCB3CEBIQExg1qJC8xOIspecHUIF/OORxzEMEktHF7wSSF8d3OWaZApDN+HTIvIxz3caoXByZMvzucxnzAebj1M5hjsYfc/VFFlnEZ1XgiM5myKxxfuLEpu5qIYbkGtdDfEUQ8Dhc68EgYPjd4pQnaIixIdPWqlWrvMMDO+TuMO5pEK+5DAz5TXD9Z75nRlBFjx493HHHHZeTrEUmjOwZC8ZgDmTSidZWOa977LGHJ46tDTK5IDJyGfc9q1PGemRXRs8prpEWNFJLRBe/Here5TNwhtAjmwb8OfcJOMtnEPJHHHGE/13auvwuuV+0a9fOvqrY66RJk9JSgzTK8wTnctQ4fyBaqDfGHzXDpkyZ4t9H1yUoiYwjsDrssMMcJB0EGuRGNoLL2rBSQfaZTFxwlDmf4UimI8Z1IySYM+HDdYbfFUQm1/5ayOgiwJJ6dSK6Mh2xJvwuSnSFJ8+4ceOasGdNs2tF6jcN7tqrEBACQiAOCNg9kr7idDdZgjj0XX38PwSM6OLhPZTIKQQfq2PKushS3H///YVspnWKRIBC3k888USRW/29Og4UjnM9WogNMi885CWVcIdkuf32293MmTO9fFocI/+rdTxxDE6YMME7syCuchmO+LD4+m677eYuvvjijJtQ4J0sFTP2QfR7oTZjxgzvQCw2kpx9UOcDhyQOJ1nTIMA9sG/fvn7nSHshx4dZTSreU89kmWWW4W1ijawFfkNjx471RBf3qEpkK4V+HDKbX3755VjPTaNEFzXgcKqHRlA260HykcH2/vvvh4tneU8GDiQFpE3UyIBDKhGiBWnEO++8czZiItwGmazzzjvP19YxciZbTXuW0x7ZjGShI6GGMxznPtdfMlgI4mks4zeH87UQEoJ5Lb9XsjAhCUNjjgHBQ420bERI+FzEtqeddpqj1k4245rRv39/n42RbR36DhnQrFmzjKuAK+SkGYTLPffcYx/LeoU0DSVFC1VvCOVal1pqKX+/jQYhoURg5yvnngUDlNXhyMalnHuc20YcRJqb5SNEECRoMYa8JARAKFfYokUL//uI1m7kt40EJL8ZAth4zoL0zEVWZ+rLlVde6cktW8b+OCb8zvlNcM5znPmLnvO2TfjK7xxSttRn/ijxlum6Fu4vSe/DwKoBAwZ4QjTX+O05nGMCucTvycjjXNs15jKuEZBu1ZRtbczxhG3XVUaX3ay42InoCg+z3gsBISAEhEDSEWBSxQMYpkyKeJ4N3bt3986gUoguJrJMaDGiGZFtklUWARx1HKNyjBoAxx9/fDlN1Oy2YYFt5KlwdCbRiJCFgLGIbjJ+cB7Y7zMumFTreBrBj5Nn9OjRziJoM+EEWYVsjxlR/p07d7aPs7ziuCfLEltooYW8E79Y4pXofgg/CLZijd8AReKJji/WGVbsvrT+7AiEGX3UJbn55pv9SlaTig+QEoVkhczeev18A8kF2QXpwnlu7/NlieRDACcykpFcC8nEwRFNZkJcjZqT/JbNkGUkoxtCnCwtstU4n0Knua2b7XXVVVd148ePn21x1BmO0/2hhx7KmCE9bdo0LxHJ/kNDphVJttCmTp3q+vXr55314ffR9ygCoAxQrCFXzL0OeTbInqhULNdjrssQa2SekIWSTfaV+yf3hkKuvQMHDvQYRPtLkEKY1QZ5A4mTycCXjA0jCjOtY9/lkjFDNpwMITPuV2eddZZ9LOs1Kqc7fPhwH1BRSKMQJxDOZOuYEkG43c477+zPYb4Ddwjv0MDliiuu8FmGyLJBuHEuFUqwlHPuMfemVhbkJvvlen7uuec6zn2MgBKuMcUamVQQr2ZkWkICI48ctSiByXLIThQ4IL64BvBHbU+IDsjFKJnINoyDe1MlbK+99vLShPmytnLtKwwIYT0RXX+jhTykBSIgAclcMJdx7Ucqk20IchPRlQut8pfVFdEFq226l5WKjCgf4uq1oIyu6mGtPQkBISAE4oZA+ED3r3/9y0ujxG0MSe+vEV1LL720l/kpBg/qCBBhiBFlzMOKrLIIEPlMsFUoR5htD8gXEh1N1DaSN9QK2GGHHbwWfjbHTra24vK9nb/0l6wWSIkkWibJO/AgSI+o3bhYNY5nNEsiXzAjjtszzjjDQwhpxb0uW2ZA6MQiWh0HaylGXYa77rorvSlOQgq2cz2g/5zn33zzTXp59A1R5hB41POSVQ8BnPU40jHIU6sfiAMXqT5MRJdzOMtNrhBSwWQMIanKMRy+4M59j6h2ZLXeeeedcpps0m3JDiVLtBxjLhASKUijhXK/1namfXXp0sUTDbYOr9TTgTwKyTXqgELmILUVEuwQORATZKbkM66pkCohSRRuQ60yMlsgmOy6xrkTZttCAiCRBxGAIY15zjnnhM1klW1jJTIwTz/99FnWz/UhkywhEo7WP7aFxM0UrETNKjK9wmPDPJrsLgIIuadz3YDgwXLNsSF0yZ4AZ+Z6EAkQmpUw8DbCnvYqWWMQqTuk8TAy+rhnmUFcci2FyAzNakOF32V6X8lzz9oPa4hyjwX3YoyMS8rjhMYcgblCJrvpppvcqaeemmlRxu/C4IpwhbAWWvh9Ie+Ze6y99tqerOS6anWZC9k22zooD3Cem+Fjz/a7t3WS8kqgk8k4cu0ncCmXWcAp8to8k9cC0YWUNtetTOR1rrHEYZmIrjgcpQL6SFSLyW2oRlcBgGkVISAEhEDCEKBmkNULQKM/nwRUwuCJxXDNsYyMhT1wFtpxnK4mo5PPWVxom1pvdgR4KORBkAhKoqxxCFGk/vXXX0+vjMOE2j44tZJkYR2IXI6gesckKgVj4w3l0+y7Wn6txvGkDg2R/Wb8ZnCGZ4sSJ5LeslWXW2457+izbcNXroc4KCyrbtCgQV7iKlyn0PfhPtkm6vAgipssPpy6/GVy5jMunKyhI7jQ/Wu90hDAuUp9KIwIayL1Mctg4j2O20zZDSxLig0bNswXqYdEhqyA+IJo6dSpU1kQIEmKUxZZOUgRVAcgpuNqRPRD/hRqrVu39nXOcGwTqI1EGcQHzlCkCblm4KzOVNOP+p4sY14fGo52SCZIFKS0kNALjSAppP7MOWvLqCcGMRAG6XBNIhuWTGO2448gAiMMyExgbhM1c+byPfMfjilBB8x5IIRC49yCQIFQhhSx67Gtk62eLNdvssFwFpuBI2NnDFxjyXqDgAmN3zYZhGZkuZGpZEZGEoRhaChGcW+GmDVDdpbsr3AORwYf9ZywfHV0aQvZM+5RHPdKGTKNkHIY2BeS7VbovslWJGsRA2s71zlPGXv0XGQ9jjvzYXv24LuoVfLcC9u27ED7jqyvkNi177O9Mu9g/mGWT9qNeQdzgUINbHgWX2KJJdKbQEjzewt/h+mF//8NwXGQq1wzSHLgOsJ5tELqeSNThlh0+2I/Q5ZzLTFTjS5DwrkwgJjgJlQOcpldG2uJ6OI6znmHf4E5aD1ZrIkuk4ixgohEWbRp0yZnFEU9HbxwLJbNxnciukJk9F4ICAEhIARAAEfClltu6cFQlHI8zwkjungwxhFSjIWRZ9lqMxTTntYtHAGLiLctcBjipEmaUdvDiq4z/qhsUpLwwFHMeRFG2uOE4dkmLlaN44kjFedlaEh5ZYuA33zzzX2BdtbPRRxGo5QhH00ZI9xXIe9DCUfWf/75571TONu2OEdYB8cIclFmZFrgnMsXFWzr67U8BEIJsTD4I7xeE1BCYEmSLSS6CNjgM7JbEC3lGKQGfhvILhz/kNf8LuJqkKaQp7kMBycEIUSBBSjnWj/XMu6lkEQQhGY4z6k7B9mRSaoQR2Y0axiiAuImrPcD+QOpBbkVGnPHMDuV8Zokuq1nzlz7jCQd20CaRR34nEvMBbiXMEfNZEgcI/MaWjQrGhlNzsmQeKIfZDiF6gX8liFrrFYTRDbybmaZCFzq0REIYca+yD7jem327LPPuv333z89PtZB6rPahvS1jZffE/KgYT/L6Q9yi1wzMY4Z8zfOMfALz8HoPiBukOJDVjBqlT73wvYvvPBCT+rad8U89+JTZo4RZvAxBq5V2Yzzbffdd08TwdnWC7+PPgsgHRlKLUN8c52FmKZWJNcMsrT4nVfLICKpPWZG9jrXAZnzWftG4kZJ9Ez4WAkJMpkJVqiFjC7Oc2qH5apnm2kscfhORFccjlIBfeRBGUYWE9FVAGBaRQgIASGQMASQhunQoYMfdTlOvYTBVlPDNaKLCECcB8VYmNEXRq8X04bWLQ0BcxTa1kl1niIRZHPUfNGxhlVjvOJQo+4CD5kffPCBj6ymRhMZrzgrMzlksvWjnLZw/uGcQ16IGhLIAYW1O7Lts1a+r8bxRB7pvPPOm2XI2eSDwDN0wHAsySLIZNRFMelMnEf2PtO6+b7D0UGGAZYriyzaDlkXjM0i4205keHUUZQ1LgJkX5CJgIUZpuH1moCSSmZcNO6IGqd1cxgjFQfRxWd+l1yvyjWc4JAP1DrhtZzfYbl9KXd7yKJMAUiQKkgFQmCXS25F+whRQ8B3GDARXYfPZJpQ+zPqIMeRTwBcmK2EpCvXpShBArEGIRVaJjnAKNEFwQABk0mFYOjQoT7jJyp5F+4DSdFoXUYy15CKMyNwARIxaoyP8YT7DuugQnqFddWixAOSXuATZoZBppF5SyYi8otk/SA/GJJ4hWR3RPtaic+Qk2EAEb+nSp1zxx13nJdXpp8QeWQw4hwPseGc4TcNYRNapuPTGOdeuM8wYIHvi5FxZJ4aSloiNc58sRCDwOCPGkwQG7xaPSayDENjHgqBZRath8XxPPTQQ21xk7xCbCHPbMbvzoJm7bukvnKckZfFyJTNl5FvWcwEZDFnrAWii3pzzEUhaU2yuV6Op4iuOjmS4aSC6MDoRKZOhqlhCAEhIASEQIkIIDdijoknnnjCyx6U2JQ2ayIEjOgqJfOD+hc8mGM4BHjwlFUHgdApg7SIZTVVZ++Ntxce2nBoEAmOgz+fQwVdf7JZMGofROtxNF5PnZsxY4aXccK5DUkcOqXC/fKgxwNfLqtkW7n2k2tZsdjnaqvUZdU4nmRzReWxotKA1v8wQ4fviPq3a56twyvOJ4gky2DI5KwN18/1Hicf2UBmZFhAlBRqXAsg3XD0mxVa18TW12tpCITZgtSvxMmI4aRGwgyTzPPfeNx4442e6AKfUaNGzUZ6eMCK/EfQDZldXFOJLLeMkSKbqYnVIWOMMII4hQSAKCHjJZqRVMkO48CHrAmzT8L2qWMVyr+Gy9iW640ZY0CqLEpysZysDrI7QiMjz6Ty7PvQJ8V3ZP9AKGUyJJ7DbCBIQWrF0Aezs846y18j7TOvNhfmPWQT19FMfWY5WUdkySAhi5EdY5KO4TWAZVEnfqZAC9bLZcyvIeeawhcXlfqljh5jKCZ4J9vYwlqU3D9x1KMUYsa5QMYg11LuqWFtObaNyvo1xrlnfeGVvpBlY5aN9ON3Q+YbmVKcSxj3Y65NoZUT9MBcg7lM+Ftp1aqVl+wM98F1dciQIemv8mWRpVdsxDdkCEIOmxVC6Ni69f5qxBXjLCTL2WplU5+NZ6FaILpWWWUVhzwrgRqQw/VksSa6eFBlEsEDAjdBLlRJlS4Mf2hE7Yep2/V0wmosQkAICAEhUBoC6OR37drVb4yzN5Puf2kta6tqIWAP96UQXaF0Jc4MHsRl1UGAiExq82BIn/DwWgkjg4X6Bx999JGPJOThqRqGlBCa/dTBMOcR+yUylTofZGtlMnugYlk55EKmtnN9x4M6knBGsuVaN5NTLVy/km2F7Rb6vlTsC22/mPUa+3hCRkIiWbaU9Q1prlBKx74Po9lxmFKfJFMtL34z/fr1s818RD5RraVYtN4aGQpkEEQNZ/5nn33mPv74Y/9H4AlZBnyOGr+hPn36RL/W5wojEDq5yUIwkoXaOyNHjvR7w9cQ1lCpcBdi0RznNJkIN998s/9NgQ+fw9pGpQ6EzBD8FtxHQgKi1Paaajsc2VxDLICC6wsZMNUw7mtkn4SEke2XYBKCSrJZGIRDVjNBcJkyGLnvMP8M7/fW5oMPPuiopWUWJbrs+3yvBAGRNUiGRIhlput9mEVLu5DUECzZDKlI5klYWFuMudhRRx2V3izqrO7Ro4dDlhCjf9Q2DuVm0xv+/zeQepdddpkDy1xGJg8kDPcEMqMsCDHXNoUs4zykD7RrhrQk46JuWDkWZnRF2+H4Q4QboYsEaViviAygMAOP7Rvj3Av7hQwlQTFmmc4RJNvAnvswuFk2HL9jyLywBtyJJ57o563WXqGvEK1kU0Zrc2ZSNWD+GUpeZiPnCt13JdaL/kbOPfdcL9NZibbj3gbXXLqpU9MAAEAASURBVJNuJTOf60wuI6CD84rrNWoQtUB0UeuN60axQVq5xlkry0R01cqRKLMfPARy08eQYcn0YFfmLrS5EBACQkAIxBgBIpMtUyHThD/GQ0tM1wnuwfFGjQW07Ysxe5BjG2QTwojZYtrRusUjgEPQ6mVkerjN1iKOGSI8KTJN1DXFxc14iCfy04q3E+BELYlQbsXWrdQrD/9kOhApmy16nH1BQuCcCo2IQYgRs9NOO8316tXLPmZ8ZR933nmnl5yBqGWuSwQ4RC8OJ2SUcjmIwAbnDFJwhRhFvokyXmSRRWZbvZJtzdZ4AV+Ug32m5svFtpTjmakfub6LOsts3WyRpzjNeQbCkOnl95DJCJA0iTSySKj5Varh8IcIMMNJjAQb12h+rzjScIzyhzMhnyG9SCaanuPyIVX+co67XYNC5zfXVa67GDXzuN4k2QwP5gyQx5zvEIFhLZlS8SF7BxIF496FszyOFpU6I7AilMSLjgkyCCc6jlKyvri/QI5w/Qjv89Htop/JPGFukE1WjaxbrlEtW7aMbuo/h3MTgt8IgosacxfIslCiLlzHAs7tu1xEFyQ+RGnUmL9ApJr8YJgdF3XAZmqf3yjbZwvgI/gAcgkLM2miWcBk47I/szBrGaKPjG+CG5Bzg7ggg486ZvjgyJ7iL1tmmbXJsULizOQm6TvPZ/m2s+3zvXJv45iExj64pkWzlMJ18r0PA7bCdQkE4LxhTmYGIQomOPYxSEKuHWEgfmOce7Z/Xsnag2Ay4/yIBoOF9wDWo4/2+wsDZ1hGVhyEYceOHfmY17gmcL6Q2WYEeLgR82jOqdAIcIE4Nhs3btwsGeP2fTVfw4AQ9lsq4VfNPldrX1y77ZqT6fyK9sP89dSPJVCxFogukoR4HiDzGFnierJYE13mtOvZs6cbNGiQnyQgmwJTWuhDbb0czFA6g/RbihfKhIAQEAJCQAgYAjzkWaR5LUyerV96LRwBI7pwxJOhV4zhAMYRjPGwx6RcVh0EmJfaAz/ES5hNkqsHoVRM6ASMauZbGzjYkUaBDKq0QWzg6MDJU4hFH/qIOsdpZIazi7ol2QxCF5xCaZxM60ajycN1iLAkWjpqkBA4WHGqQSLiqCEDiDpZ2ZxNlWwr2p98n8vFPtp+JbAt9nhG+1DIZ8jQTI5v5Aghg0Ijgh0C3ywbkcrvkMwRI2ozkbLWRiGvZANUKkMTRwPna2P8fgsZS9LWCWW+IOEt65aIdRyamIgu5+s1IX/Gb44aXdRvqpR8FXWr7J5C0AL7iaNxTWV+ZkZGEqQ1pAxkN9dw/rhOQY7wPpvhw4E0gHxFJjIb0fruu+96QsPkErO1x/YEqEAeRY3AGwuaQmqPa5llZ0HMQ25yr2YcZtw7yWw2I4sHWTcjMTIRUazLdoccckhaWcK25zV6vYYkNLnDaDAC4800FvZPzT0k8riXm0HUcW21jDcIRc5jjN888xqzqMwj8y6rKwpBRnZXtjmCtZHvleAdyILQKi0nj8QkWfd2n7N9UYeU50BIpqivkHMSfyKklJE9th2v9vwRfsc5QxZepgCrqOxw9LmzMc69sG9Rwg8nPudBaBBRl156qf+K4BLISzuPn3rqqdmyITn2zFuppbr88suHTTnUtTjXeDZj3/wmLBBtlhVTH5iDktFN7a/QyIIjwMcMKTkCe5rSeKbA125Wbdlx228tvnJt5/qE8bvORyTbvJnsQYIURHQ17lEV0dW4+Fat9bDIPHIYPLDLhIAQEAJCQAgYAjw0WoRppsLAtp5eaxcBe9DkIZTIw2IMp0inTp38JiFpUkwbWrd4BEyT3bYcMWJEVmk/W8de0cU3h5I5e5jj4TDiASuT5ZMqyrRNvu94WD/yyCNnq5WEQ4BzCQcSjr7woT5a2Dga8Z4pmtX68dBDD3mSiwLJ+YzfAiRUSKLZNkQ1W+aOfYeDDGmYYufJlWzL+oJDhOwI6kIQbR11erBeJbC3/fFaKWyLOZ7h/gt9TwQ0juJMWQRkJ7zwwguzNDV27FgvT2lfZsta5tgjD4ThpMNxGRaDt+0LfQ0lsQrdxtZjHEiZQrztsMMOvkaILdNr4yMQEl0Eytq1ArkrMmYxso1Mjqvxe1SbezDiD7ljCAI+I89mUtjl9DrMYIjeM8ppt9rbRrMeKrX/TM557osQsZBXlhXE/iDIIXq4poXOcusLgQAEd+C0JnsZs2Nr60BykJUEQcI9/csvv7RF/hVHLs8PHHsji1gAQWnZ1ZmILsglnkEg+qLnDZnZlkFpO4N8gITAyKShFqjdsyEjuF5mM+qFci5xXcc/RrAE2RNm4W998uTJswTcUMsMssuMbDmyvM2iRJh9X8wrc8CwFg79hOw1gqWYtnKtC1HDvC0kKW195k0EvnEuQRxOmzZtlnst50f//v3TRA/zEO5TURlhyCwkCDMZmUxIVJtFg7wa49yzffHKtZu5slm0r9Qt5jyaOXOmX4U5JLLGoXG8IfIyGfcFjh2/FUiLKDaZtrHv+J0OHDjQPqZfwyw3vswk25leuUpvODcJSDADMwsEse+S+go5bEoVPKuZulo2PCwxhXkj16ZaILq4HvL7hmQlsKKerK6ILh6KKCSItm9YALGeDli2sYTRLRTkZKIiEwJCQAgIASFgCIROnWjBZVtHr7WNgBFdYURqoT2GIDFHRKhFX+j2Wq80BJiT4cgxI2Ia53YhRiS11YohKhtHLJI3FmGcqY3GIDHDWgq2T7ICUVOwhzwcUTiwjOyKOi2JdOUh3gwnXZcuXexj+pVIZOSNQqkXHEDIZFFHB5kg/pCV4ZzGQtmxdEOpN5B+V199dfiVnx8jZwNxVYxjqZJtWYeQTTPZPB4ww5oWtk4lsLe2KoltocfT9l3sazbZQmsHZ25YcwSHlkmg4cTjPQ7S0JBTQtLQarUQ3Q4mpRpOZs7J8FyNtoXDkBoO1EEgArx169YOR+wKqUxCPatF0aru5zCbg+OBYxhDdg7iFIOMziRl6hcm5J8RfxAckBt8LiZgIxdMp5xySjo7M86ZAmS7MZZKGvM8MqPD2lNcF8l0jhJQ3BNZFxkq7sEEkpB1l+naRACNSbrhP8Lpmi1wJhwP/jVqGJGNgvM/JIRCNaVMRBdZgJBGUZKK6yFZ2Yw1NLLMyPgxC53I/CZDsox5Lb/laPaSbRu+kpHDGCwDCYInlLODCOQ8N+P+ENaDJDiCe3U0M8jWt1ey4bhHcpyoTxVm6ZIlR7aVGcEuprZh31XqFbwhlCxrsph2CYwzwt8k18LtyfxDQSvbPAoSDYk2O1chScl6MWuMc8/a5hW5YPZvRmAJMp7ck/kdQa6GtcyyBV/xu2K+Wcj5ZfsKXyE/bG5i3zOXh2CIGv2l32bMayzjzL6r9itEL79dM+ZdzL9kzp8TXHMxZFCZD+Yy6nJBGDMP5XdRC0QX3An3CTIVM8nK5hpPrS+LNdFFSijpnKRBI/XAQUoq0RUWmWcSGp0w1PqJqP4JASEgBIRA4yLAw6QVuCcDIl/R1MbtjVovBQEjunho5iG6GIOIsJoaIrqKQa68dUPZD5wkHLdCHdwhyQHRBUFGVLQZknuQQsyB0YrHkF8h28+in23dUl+JhIYQCB1m2SSmiADGSUQfILLCqGsycELnEA4UyzC0vuHcYl4f1jKCHMPJgCMvNLJ9wihtMpWsKLStBxEBoZUpup0MORxYRK8XYpVsy/YXEl1I4YTOL9apFPa0VWlsCzme7LdUC2ULIayog8A1zIxznuc/LOr4jNZ0sW2ikcnlOhjDayr7QAqKcx5HBpHeOLJ4LuV3L6s9BJALs3MI8tEyNyDwrb5bWLOl9kZQnR41JtEVZnUwP+V+FkeLXg9zjYHrATJ4BIlw3nEfR3YYRzx/3Osh66PSctzHcDhHHe5cayBkQuKf/bM+WTQQCqFFneec62S5EgiQzXDAQxLY3IX7Ide6MOiG6ytkPv2DnLNMIhz9ZMowbvaBQ5W+QSDTb5P+iu47zG7B2W/ZOciJhrWNyDSEVOH8sX1G2+IzvjEcuWHADd8jhUt2DwYRRpYXxwGjv8y72WdozKGRrWXOASZk9HA/gNCABOC9yVNG50tRsg9ZeY5hYxr3SIhPAh5zHWfrA/2BzOZehoErx9TOPeZ4BG0RZJTLQplGznHk+kKr9LkXtg3+zF0LybSCoOAZOZssJeVymKNBVBRikH9kUPJ7ZZ7LPMBw55xhvprJmLuEGDFHZC7UlMb53KNHj3QXwAiCJhvBmV4xAW+Me2CokO0W+Jdt6FwnIHyp88Y1R0RXNqQq9H3qRxdbS10IGlKRIA2pCakfQyqCxX9ORbvGdkyldjwVnejHDh4p/flSm9F2QkAICAEhUKcIpB400/eJVOHgOh1lfQ8r9XDvj2HK6Vv0QFOO7vTxTzn/i95eG5SGQCp7Mo17KrK3qEZS8ibpbZnfhX8pmZWG1EOSby+VgTDLspRMZVH7ybVyKrNhlrZTkdANKamXrJukpBobUkTVbMtTEayztMPn0NgmFU09yzopp2cDc/uopcjCWdYDl5TEU3Q1/zlFADakIs8bUg642bZhu1RWWUOKjMy4bfTLSrZF2ynHSbpPKYma6O4aKoV9Y2Cb73jONpgivqC/KedoGpuUnFRDdH8pQjTdYkqSKL0uxzSVmZNeFr5J1WJJr5fKsGrgXC3HUuoh6fbYbyp7sJzmtG2VEUgRXenjx7XHjOsFx5O/cs8RazPOr3Z/SZET/hwHl1S9nYoMKeVMT2OdcsRXpM2maIRrViqL2Y8leq9J1etq2H///RtSRFFDKki7ISX1W1IXU5lIaazs/GQekCKbsraXqhvUkKoH1ZDKvmngmsd1NUXazLZ+iuRtSMn6ztI+40iRWQ3ZnhdSpE4Dcxr6kspqaEhlr6fbTWVA+++Zq4bfs0KKgPDf5fNXpQK3G9q3b+/bSRED6bZTpMMs/cQfiDEvSDnkG1IBBunljCFFSjXQn5STOd1G+CaVNZ9en7FwXQjtvffea0g5p2dZx/DnleMbfo6+TwX4hM3598zBWS9F3jWknOWzLW+sL1Ikm/8NM7fifE1l6Xm8UoRVA/5TcOJc4BhFLTz/+N0WYszfOIcYK8clk1X63Av3kSJIcx4b+sX5kcqiCjfL+J7fbYpUbUjJQTakMgobUkoNHkPmH6mgtIaLL764gfl+ikxs4HdnliJhZ+lDSvbPFs32yjI7f/hNffzxx7OtU+0v8DGH1zSuJ7K/EbDjVcg5lMri8seXuSi/i2y/ib9bb/x3dmy5JtSb1VVGV+rguBVS0gNEHKDNniT78MMPfRokYyaaJOl64kk69hqrEBACQqAQBEIJDuTQLLunkG21Tm0gYBldRJAiiVeMMTewiFi0+alVI2t8BEL5QaL4TBKrkD1HozttG6RXkPJBDg2LRpMjjUM0aSUsWhybyOxM9bDy7StawyQqn0o2RSiPQi0txpEpwpZMLK5noSEfQvZcNiOCHGmplOMg4yrI8FDEnujbfBk4lWqLTDVklDCOJRkmoVUK+8bANt/xDMdR7Psw04ZtqQdEVDzyWBaxzzEi0hjpqVDykUwJvo+eN9RGIJIWWS8M6RjL2vFflPAP6aMhQ4aktyxGljS9kd40GQIp8tSlHM5+/2RwcB3FwrosZGZwvU2yke3DfOGuu+7y0oV8Tjl1faZLubiEEnjIwyJfGGdDTjflOPT1LPFL4ZMimyMqo1rKGKMZqZyXZFBHM5lLaZtt6C8KQfiUUA2wbKV87X3//ff+nhn1PVG7k6yP+eabL18TWZeTQYSsYij9F85l2TCUNeRzimTwssZILJKZZFloLMtk3BPIGCO7okWLFi7lyJ/tN88YyRjj3l+MkXlO1mI0a419kmXN+UF2VFMa2XDUB80376GPPHdwD04RkLPdY7ONgWw4rhdkLvKaySp97tk+6CvZiJkysciaZO7AvK8xr/FkloEX5+WSSy7p5aqjvxXrLziQwcVvh/Mtet7YetV+JZuTDHgy5Jg35ftNVbt/Tbk/rvcYmaDMP3MZcoXIo/Kcwdy1FjK6rP9k7YXz2VzjiMuyWBNdpHbiBEixol7WhItDUomusMg8xUO5mciEgBAQAkJACBgC6Ixb8dtK1VewtvVaHQSM6EKWzuoTFbpnpDeom4Qh1xatXVRoO1qvOAQoxm11Y1NR3d7pUWgLyItaPaFwGx46Q/kdnEEQNcgJYRRxt2MdblfKe8hRHEtmODpKeciFBEDqx4xi1kgfmYUyjUgMQXbgdIoafUG2iDl/1JCeAYdshswIzm2cq9TjydQGEnknnHBCXknDSrQFgTNs2DDfXZxMOIRCB0ilsG8MbPMdz2zHoJDvcTxR+wODsOKYI3OF44djbIbkFA5InoHM+L3hqIwaxCo4mLEO65ZjRgBYG5xbyBXK4oEAMrAHHXSQ7ywOSO6RWCibidRs6GT3KyTsn0k53n333Z7o4nOl7jGQFNSMwrLVyEkY3FmHyz2Hex8ECSQODmdkAZNmUanafPf9SuHDPIv7ErLL2ebfEJoQhAQaQXIRUFEIgVSpPqqd2RH44IMP/LMvpV04FhANzI95DoLgq4ZxvjBnYt5eKWK6Gv3WPvIjYEQR83dkZ3MZMrIE8fHsA9HF3DXTM16uNiq9zPpPoCG1FOvJ6oro4sBwsKhhwMUkScYFlGhHjNplmZwDScJDYxUCQkAICIFZEbguVZfrzFRdEwznKoEisnghwMMZzjgiZEPnbiGjCLN+mGRDNMgaHwHmZuYUwYEPiVKo8UBMZGdoRLwT+R41HGA8aGFkKeCEr4RRJJ0aEmZkRaWkW+xjwa8UaqbGgVn0GhTW44BsSskl2arpV5zOjJ/snExWzLhxfhDFzfMCDsSopWRpXEoOsaBI31LborZIWJOGDCH2a1Yp7BsD23zH08ZQymtKSiideUf2IFmEWJRci7aNE+vpp5/2dW+iy4hGhiA2I+gjJQ1qH0t6jRJvKTk3H7ldUmPaqOoIhEQXDiq7fnJuEBiElUrsV30wjbhD5o3MHzm/cRbzefjw4b6eYrm7DWtYkjVGtrksOwIEZ5A5QEBHUuuxcw6mJIfTIDFXYM5QTSMTg+xwnNUQYBCP1EhLSQGWFAhUzb4ndV/M85gjiHhM6hnQOOM2oqiQ7G/qchGgxXMh2bO1RHQVG4jZOGhWtlURXZXFs8laC2/6pFVHi3Y3Wce0YyEgBISAEKgJBIhCpKg4htMPJ6osXggY0UWR8lTdgKI6j3OEIuCYiK6ioCt5ZeRSkEszIiVVq8ETXV999ZVDwuKHH37wRBbSNSukpLeJ9LMC9MicELgVGutQTDxTFGoot4UTLMx8Cdso9n3o9LVtU7UcfHZWMc4lCjWjwGBGf1O1l+yj69atm49U5wscEZAalp2Vqn/iZQyRgTTpOtYj44mMADOyoQj2Cotk44TiL5t8EjJNZLiSdWfHydoDf+S6bNtKtsU+ohJ90cLjlcK+MbDNdzwNw2JfydAKpTFT9YHSWTdILG2wwQZeAihTu6n6ce7GG2/MtGiWLB1W4HcJkclvKpdx7tEnzq3o7y4qLVkp53+u/mhZ5RAIiS4c1WTKYJD5t956q38vost51RwkViGcceZx7ea3w/2sXAszzbnWkgUjEwK5EAiDu1mvVDnlXPvQMiEgBIRAIQgY0cUzuT2/Zdvus88+89meBLSlaivWFNF1wAEHpH1E2foft+9jTXRZdDIPyky6sKRmdDE550EWK0Qj1K+of0JACAgBIZAYBK644gp3wQUX+PHWQy2ExBy4YKBGdOFwJaK0GAvr9DDJJntEVnkEiLhOFfz2tRwgl4ngK9SIBjaZQ+QskC4MDakipHAyWViDD/mc1157rSKSWzy8IfGSydCjX2ONNXx9Kcb966+/upkzZ3ryjkw0iIn+/fv7CMaQaKWtcO7OZ+pYhFmGyCOyX8glJLkhBkODqKA+SaoouM8ysGWjR49OKxzwHXJY1CSEBOnXr1+aPLP17ZWsLOpHRBUhyHw1ecFKtsV+wyA1PkeJrkph3xjY5juejKcUQ1IyrNODVBS1ucwuv/xy72S3z+FrrtqTUZlBtkMWEbK2bdu2PhofUgvyGWKLrEFkZiCrIUCRTiSTkfPWiNQwU472+vbt66gfJ4sHAuG5RnYMv0eMaxbXFgynOlLBSTYLoiCoAIwqSXQxj6F2JTZ+/PiaqUmT5ONd62P/+uuvfaCC9RMZ7mxzFFtHr0JACAiBxkDAiC4yPKO1YaP7I4tryy239DXSWb+WMrqyqYVExxCnz3VHdBGZh9RLpSJZ43IwkVtAtgajCDPp0zIhIASEgBAQAoYATlorBIz0zCGHHGKL9BoTBIzoIgMIx3wxFjr1cNCGMl7FtKN1syOAA/D+++93M2bMyL5SjiUtW7Z0BHFhEGRbbLFFOsuImg+33HJL1q2jUc6VrHdCTSuIAkinYo0aIjhIkfhhPGbUSTBnMt9BKkDsUXg+n0EIkmFAFgZ9s2A3toMUsfpOfA7rXEFQHHfccV6yLlsB+CiBQ4QmWQyQy5Vsi75BplCk3CyTLGQlsG8MbPMdTxtTsa8Uww5JeK5bYdYV5wfShlHiE8IKktJIqOh+IZDLrclFm+uss47/HVK8niL3n3zySXpXnB/IYcrigcCkSZMcUcwYxDrZWxhkJYEDGEELzZo18++T+i8kurgWUsOMoCkyGsu1b775Jp3Fxb2Pe6BMCORCgHnIyiuvnK6xWalzMdc+tUwICAEhkAkBI7rI0MpnrEPQHdKrBDOK6MqHWHnLRXSVh1/NbD1lypR0vRUm7vajq5kOqiNCQAgIASHQpAggNUM0PHbqqae63r17N2l/tPPiETCiC2cukmvF2IQJE3ztJrbp3Lmzz3IpZnutmxsBnC842//888/cK2ZYuuCCC3pJNqQlwxpNd955p3e6kqGFoz5fEWuctswBMZz6J554Yoa9lfYVQVS0SbZLMRZKz6FNbxluRD5CKoWOTTLWINTIDstmkAuQtDimsd9++81LcYYPmeE8eI899vByhmF7ZKJBqpHJA1kGvhw3HjyZTxvZaNs89NBDHvtKtkXbjJPoTkgjLJv0XSWwbwxs8x1PP6gi/yGrCrlglqnAN3W4Dj744DTxChEBMQEJlc34fVIPDXm0cs1IZLL9OF/Mohl59r1eaxOBkOjiHLLzjusm114MR5RJl9bmKBq/VxBbSIISQADRxfwRGVmTQi6nB2T9ch3GRCqWg2SytkXClmxbjN9rJYIYkoWgRisEhEAlEDCfe/gMkq1dAqN4hkH+nWd4EV3ZkKrM97EmuqhFRTRR+GCR1Iwuw4LTAs3xFVdcsTJniFoRAkJACAiBukAglK9Cmueoo46qi3ElaRBGdOGYxylfjIU1dZhkG+lZTBtaNzsCEEDI6eXLelpllVX8HI2HI2T/qAPVpk2brJIXzO+WWGIJH8Gcfe//twTChGw9SCQygch8qqQxNkggir+TaQNphYOYullW3wqZr4UXXtiTfpyvYdF4CCrqA5plkmKE1CGjwggx1qVm12qrreazsSBCooZ89zHHHOM178nUIqvO6ofhoCUjIRd5Fm0v/Ayh9sorr3jt/Uq2ZfvgOJFhS/+efPJJt9JKK9miWV7LxZ7GKo1tIcdzlkEU8MGucay65JJLOmr4ZDKOOVl9EJTICZI5WIghb4jUVbGErbXN+YXEGscprHvJ91xjw+wz20avtYkAhCkF2LFQDvj44493d999t/++kLobfsU6/gexddNNN/lgizfffNMNGDDAkXnZo0ePioy6GEdhRXaoRmKPACQrgTIY86iHH3449mPSAISAEIgfAsXcv5ArRJEAyXVUWWqJ6DrooIMcgYn1ZHVHdEHw8HBL9GWSjIdXm3AStZ3tQTlJmGisQkAICAEh8DcCgwYNcjiWMRw5xx577N8L9S4WCJgTGCKDCXMxhnOWwCCMSfZll11WzOZatwAEyAIg0v2///2vj1JfddVVfc0qnOo47cm4CusNFdBk0avg+IcI5a8aBgEDSQMZxT55zWbggrQbdVlatGjhI7GRgIsa7aFlT8Qj2W5kslkGV3Td8DM4s//FFlss/Nrh0CZbCsKqGIO8IEAglOiqZFvWF0i9H3/80Tvs7LtCXovB3tqrJLaFHk/bdyGv1FG75557/KqNdZ2ClEX6EGKY4uDIIXKskamEqCXLD7KW9cgaoCbMV1995d+vv/766ZrIYEm2C/Xo+vTpo/pChRzgGlonrFsZZkmH5yDXKkiwJNvAgQPdzTff7AMIILqQWD3vvPPcfvvtVxFYinEUVmSHaiT2CBAcct1116XHgTxyocEO6Y30RggIASFQJgLF3L+s9nK3bt080YXkfLHP8mV2d7bNrf8Hp1QSUNSoJxPRVSdHM5RfIKKQiGGZEBACQkAICAFDwKJy+VxpWTPbh14bFwEjunDmh7VhCtkrWTiHH364X5VJ9ogRIwrZTOsIgbpBgLky5/3UqVPTGWiZBrfMMsv44vZEjVtmWHS9SrYVbTvJn5F/IcsNApTrVdLrIyX5XGjssYdEVxg8QhAQjnOMqGtI0CQbGVzUh6QGHkQXEqAEAFg2XDnYQDITEIIVIv1Uzr60bf0g8OCDD/rgAhvRbrvtlq5BbN/pVQgIASHQ2AgYUVTI/YvgvQ4dOvh6vwTR1BLR1bNnT0dAdD2ZiK46OZph7Q2itm3SWCfD0zCEgBAQAkKgTATCAutHHnmkj8ots0ltXmUEwhpBhUyqw+6FjoFdd93VZ9aEy/VeCCQFAerCEFnJQyeZPWRskGG29NJLO+p38b5Qq2Rbhe5T6wkBIVA+AqEaCq0RPEIQCTKo1KPCuEaQ7ZVkI4Pr1ltvdcwhILqQvh48eLDPUC4XFzJ3qVOISSayXDSTs/0PP/zg2rdvn5aK5h7O+ZMrozw56GikQkAIVAsBI7oKqedJ4Mx2223nunfv7q9XtUR0HXLIIV5GvVq4VWM/dUd0IdkHyZM0rd6w9gZR29kiUKtxUmkfQkAICAEhUHsIhHI8YW3L2uupepQNgXKILuoW9e3b1zfNJPuSSy7Jtht9LwSEgBAQAkKgrhF47rnn3L777pseI+Q38qvcJ7lfYiK6nM/guu2223xZCIgugqbOOeccd+CBB6axK/UNcrIE3mDUf2zZsmWpTWm7hCFAnWGyDM3s92uf9SoEhIAQaEwEqE9MjUCMe1lUNj26b7K4Onbs6MhAhRirJaLr0EMPdWeccUa0y7H+LKIr1ofv784/+uijrnfv3v4L6pNRz0AmBISAEBACQsAQCB8K61GL2cZZz6/lEF1EqBOpjiGBeNFFF9UzVBqbEBACQkAICIGsCESJLpMpDOdK1M9A1jDJRgbX7bff7oOIIbpOPPFEX7Se4vXl2sSJE521Q8bYWmutVW6T2j4hCEBsQZJS35IAb4LcldGVkIOvYQqBGkCAGq+bb76578nzzz/vVSFydQtyq1OnTo5neUguEV250Cp/WayJrsmTJzv08yF4qD2CJTWjC3ILKSqM6Ja1117bv9c/ISAEhIAQEAIgwL2SoAiM2grUWJDFC4FyiK577rnHkdWH0c7w4cPjNXj1VggIASEgBIRAhRAwP4I1Z9J5PE/zXI2ZnKGtk8RXk71GMQai64QTTvBF6wmYKtfwWUAsYtdee62vX1Jum9o+OQhAdr300kuua9eubr755kvOwDVSISAEmhyBMCMZKeRll102Z5/eeecdt8MOO7g999zTvfXWWzVFdB122GHu9NNPz9n/uC2sO6KrTZs2bpVVVnFMxpJkoSTRfffd59q1a5ek4WusQkAICAEhkAcBCo0++eSTfq29997bXXDBBXm20OJaQ6Acouuuu+7yDirGxCR72LBhtTY89UcICAEhIASEQFUQIAKbuZAZ0dXzzz+/O/zww9N+hGJrYVpb9fQaEl04544//nhftJ45ZbkWzkuGDBnievToUW6T2l4ICAEhIASEQKMjQBbpEUcc4fdTCNHFHGPHHXd0e+21lw8aqaWMrnosaSGiq9F/AtXZQShJ9M9//tOtt9561dmx9iIEhIAQEAKxQIAsrqefftr3VRk9sThks3WyHKLrjjvu8LU1aJRJ9oUXXjhb+/pCCAgBISAEhEASEIgSXZA4CyywwCzZ7yK6nA+QgZAaP368d84dd9xxvmg9xevLNSQRkUbEjj76aC+LWG6b2l4ICAEhIASEQGMjcNVVV7nBgwf73ZAh3qpVq5y7DIku5htkSJM13pS2/PLL+92L6GrKo5Bh36atTeTVwIED/RpJzegaN26cY+KJ8b59+/b+vf4JASEgBISAEAABIpdx7GDdunVzI0aM8O/1Lz4IlEN0hQ4lZfTF55irp0JACAgBIVB5BKJE1+uvv+4WWmghh8MHUgcT0eV8Btfdd9/tHnvsMe+YQwKZovUUry/XbrvtNnfyySf7ZjQvLRdNbS8EhIAQEALVQuC0005zN954o9/d1KlT3RJLLJFz15BbO+20k/fHQHLVEtEVloLKOYgYLYx1RpeIrr/PtDvvvDMdBUXU1YYbbvj3Qr0TAkJACAiBxCOw2267OSZiWOfOnd3IkSMTj0ncACiH6LrlllvcgAED/JCpb3r++efHbfjqrxAQAkJACAiBiiDwwgsv+Oxma+xf//qXW2SRRRy1KiB1MBFdzgfSEkT7+OOP+7oixxxzjMPBByFYroX+C9RoUKWRCQEhIASEgBCodQT23XdfBx+BWUZ4rj6/8cYb3v/CdgTWiOjKhVb5y0R0lY9hTbQQRkQRtb3JJpvURL/UCSEgBISAEKgNBHbZZRf32muv+c5QDHXMmDG10TH1omAEyiG6brrpJnfqqaf6fTHJHjp0aMH71YpCQAgIASEgBOoJgSjRRWH5xRZbzCHJ98QTT/ihiuhyjgyue+65x2OCY66SRBd1xZEsxBZeeOH0HNV/oX9CQAgIASEgBGoUARTUvvvuOzfnnHO6Dz/80L/m6irkVpcuXXwtSvwxIrpyoVX+slgTXRR9o2gpReAsSjmp0oU333xzWr4R0mvTTTct/+xQC0JACAgBIVA3CFAAFX1obLvttnPXXHNN3YwtKQPZc8893ZQpU/xw0fWeY445Ch76DTfc4E4//XS/PnMnCr/LhIAQEAJCQAgkEQHupdxTzUx66OCDD3YTJkzwX4vocu7YY4/1mVZPPvmkd8xBTBE0g9RRuQahGNb6eumll9ySSy5ZbrPaXggIASEgBIRAoyHw7bffug022MC3j+QxJFY+g9wi6Hi//fZzZJDXEtEVloLKN464LBfRFZcjlaefoQMLeaLNN988zxZaLASEgBAQAklCAHLrgw8+8EPeZptt3PXXX5+k4dfFWEOi6+OPP84bPRYOmuNNXQ2MSfZ5550XLtZ7ISAEhIAQEAKJQSBKdL344ouuRYsW7qCDDnITJ070OIjocj6D69577/XkH465vn37+uBaHGPlGpiTqW4mH4YhoVchIASEgBCoVQQIhiEoBltxxRXTcwb/RZZ/kFtdu3Z1+++/v3v11VdFdGXBqVJf1x3RtfLKKzuyuh599NFKYRSLdq677jp35pln+r5SFG+rrbaKRb/VSSEgBISAEKgOAltvvbUjCwgjGAKHgixeCIRE10cffeTmmmuuggdABt9ZZ53l1z/ggAPc4MGDC95WKwoBISAEhIAQqCcEoiQLUoYtW7Z0Bx54oHvqqaf8UEV0zUp0UYfkqKOO8ko6KOqUa8xjtt1223QzZJ1TI00mBISAEBACQqBWEbjooovcpZde6ru34YYburvuuitvVyG3unXr5ngGRypZGV15IStrhVgTXc8884yPSj7yyCPdKaec4oFIKtE1duxYd/bZZ3sMiNomWl8mBISAEBACQsAQQNJ2+vTp7vfff/d1HKnnKIsXAiHRhR743HPPXfAArr76anfOOef49XHk2fuCG9CKQkAIFIzADz/84BZccMGsv9F8ywvekVYUAkKgJASQydt9993T206ePNm1atXKO6EmTZrkvxfRNSvR9c477zj8LieffLLr06dPGrtS38ycOdOttdZaboEFFnC//PKL22233dzFF19canPaTggIASEgBIRAoyOAMgpcBIYc4eWXX553n5Bbu+66qw+m4T1yh009x1h++eV9v8NSUHkHEpMVRHTF5EDl6+ZVV12Vjs4muyuMjsq3rZYLASEgBIRA/SNAxNGff/7pcLCiK3333XfX/6DrbITlEF3hPEFEV/YTA2mJ5s2bu5VWWin7SloiBHIg8Nhjj/n6NZxHBJ+tt956s6ydb/ksK+uDEBACjYJAlOii9veyyy7rg2jNgdXUTqhGGXiRjVKT67777vPSTBBdOMT69+/vM7uKbCrj6muuuaYnumbMmOFwuj3++OMZ19OXQkAICAEhIASaGoH//Oc/bu2113a//vqr70qhJJGIruoeORFd1cW70fZ25ZVXuqFDh/r2kSeiFotMCAgBISAEhIAhsO6667r55pvPffnll4731FyQxQuBcoiu0aNHp+tyUYPEssDjhUDj9vaLL75wZD7OOeecbtSoUW6HHXZo3B2q9bpEgIyESy65xI9ttdVWm01OPd/yWgCFB3l7riAClawLmRCoJwSmTp3qM4hsTE8//bRr3bq169Gjh4P0wkR0OV+T6/777/dyjhBd1OY66aST/PeGXTmvO+64o3v//fdd27ZtHe0T5U42rEwICAEhIASEQK0hEJU9puY1GV757OWXX3bdu3f3dUB5r4yufIiVtzzWRBcTUoq5kTpPCj22yiqr+IJw48ePLw+ZmG1NuuSFF17oe03UdqdOnWI2AnVXCAgBISAEGhMBomaXXHJJX6eL9w8++GBj7k5tNwICIdH1wQcfuHnmmafgvYQBMRTQtXpdBTeQgBXB1AKFVl11VZe0uWQCDnFVhjhixAg3fPhwv6855pjDUYcG8tQs33Jbrylfx40b54477jjfBQIkkHJbaqmlmrJL2rcQqCgCUaKLulwrrLCC22effRwyhpiILucztx544AF/DYCI6t27tzvxxBMdmV6VMPw4zEe33HJLh2/n5ptvdltssUUlmlYbQkAICAEhIAQqigDze+bxiy++uPv+++/drbfe6jbbbLO8+7As8p49ezrei+jKC1lZK4joKgu+2tk4fGgeM2aMopBr59CoJ0JACAiBmkAAx/1yyy3nPv74Yx8U8sgjj9REv9SJwhEIiS4ioP/xj38UvPEVV1zhLrjgAr8+k+xBgwYVvG1SVqQw8M477+yHC4mIU6+YOmhJwUnjzI1AOCdnTc6rMEMh3/LcrVdnKdJkYR3HYcOGOa4/5drXX3/tHQNkb+i3VS6a2r4cBCy62tqYMGGCl6zde++93fPPP++/FtHlfEAxRBQk1Ntvv11xouuiiy5yl156qb/3PvTQQ55g79evnx0WvQoBISAEhIAQqBkEunTp4uf1q6++un8lw6tFixZ5+2eZYIcccojjfS0RXdTePOWUU/KOIU4riOiK09HK0ddQBgW5nZ122inH2lokBISAEBACSUOAmkOQXWQXQHipDkL8zoCQ6HrvvffcvPPOW/AgLrvsMoezGmOSfeaZZxa8bVJWfOONN1znzp3TwzXHZ/oLvRECBSAAoQyxbIbTfOmll7aPnnDOtTy9YhO+6datm3v11VfTPejbt6+XK0t/UcIbfk+Q7A0NDf4eRD1hZMs22WQTN9dcc5XQojYRAqUjECW6nnzySdemTRtnRBfZmJ988knpO6iTLXGAQUBRtwyiq1evXu6EE05wxxxzTEVG+PDDD/u6X3vttZe744473Oabb+5uueWWirStRoSAEBACQkAIVAoByj8gcU8JiM8//9z99ddfs8yVc+1nypQpPmDs0EMPdbwX0ZULrfKXiegqH8OaaAHnFU4sbOTIkbM4amqig+qEEBACQkAINBkC//vf/7ysb7t27RzybEhQ4XSUxQuBkOh69913fc21QkcQEl1Mss8444xCN03Mejx0EKlnVqgcha2vVyEAAmRLXnvttWkwJk6c6K+/9kW+5bZeU71CRCFv+8svv6S7gJzb+eefn/5cyhuk1QcPHjzbpsi/QDDz29twww1nkXmcbWV9IQQqhIAVhrfmCP6hBILdZyFfCQxKuh1xxBEOMoq6ZRBdhx12mDv++OPdscceWxFoPv30Uy9bCPGN4gBZn6+99lpRGesV6YgaEQJCQAgIASGQA4Hrr7/ePz/zHD127NiiAjNeeOEFR0AH91Dei+jKAXQFFsWa6EIv/oADDvDa0UhsYEmt0RVGj+LM6tq1awVODzUhBISAEBAC9YDAn3/+6e+P7du390TXwgsv7GVo6mFsSRqDOeAYM7J6zZo1K3j4SAMhEYQxyT799NML3jYpK0aJLiTmyGyRCYFiEKBu8G233ZbehAfali1bpj/nW55esYneELFKllVo++67rxs6dGj4VdHvp0+f7usY/Pbbb1m3bdWqlc/6Yn/NmzfPup4WCIFyEYgSXdRkJOt9jz328LJCyNcSGJR0O/zwwx1S188995yfd5ARjrSg1fArFx+IdeamBGSR4UmACbKp0WtQufvR9kJACAgBISAEykEAooo5PcGiZ599ts9GHjBgQEFNou5AxjhZ0bRBQAdZ42SPN5Utv/zyftfUyuTZpJ6s7oguNN85YI899lg9Hae8YxkyZIhDshCTYyYvXFpBCAgBIZAoBIjMX2ONNbzjgNpOSN5ZsfVEARHzwdoEm2EQWT3//PMXPKJQ4jhpRNcff/zhfvrpJzdz5kyHk33OOed0v//+u/vvf//riwm3bt3aS6d9+OGHrkOHDmlMkXfEqScTAsUgcPTRR7v77rsvvclbb73lFlhggfTnfMvTKzbRG5zaOLdD23///d25554bflXSe8hkZBB5uM9l4AXZxe9vmWWWybWqlgmBkhCIEl2c99Tc2G233dzUqVP9PAmJ4KRb79693aOPPurnjATYID9KNhdZXZUyHH8QjbRJQM5RRx3lLIi5UvtQO0JACAgBISAESkXgiy++8BlcKB5ss802Xk1t9OjR/4+9M4G3amr/+PInmaPQa4jMQ6hIIkPmkKHIkCJkJkOGqFSkDCFjigbJ8FJKg3nOPGZ8qQyVJFNm4eX+93f1rmOd3Tn3nHvPtPc5v+fzuXdPa6/ht/c5Z+/1e57fYx00sqlTRFc2KOWvjIiu/GFZ0pqQAkESBBsyZIhp3759SfujxoWAEBACQiA6CHz//fcG2cJddtnFIHmHkQhVFi8EfKIrPHmeaSTXXHONdYShHJNKvXv3znRKLI5/++23NhnwtGnTrE66y1u2cOFC8/XXXxuWRDRWZ82bNzcQgZyL9rqz8847z0BK5GJTpkyx3umQbOQ08Ym0XOrN97lx6We+x12I+iBnnnzySVs18mcQqL7HZqbjhehTTepEohAZdN+6du1q+vfv7++q9fp///tfM3HiRDNmzBjz9ttvV1vPMsssYw455BCbJHuNNdaotqwOpkdAn+8lsQkTXcjz4RDEOzT5u4iYhtipdPOJLp4f+S7gt4w8XfkyJ2vKby7zGETWkRdMJgSEgBAQAkIgCggMHTrUKhugiEJQDcTV66+/brJ9NsXBGBlwflM5VxFdhb2qsSa6nn32WXPMMcdYz8Dzzz/fIlWpEV2ETqITiuEJdeihh9p1/RMCQkAICAEh8M0331hpGHIgMFFBhAsTObJ4IZAL0eXn8owj0UVUIlFs3L942fPHOkRXPgzppJEjR1pC2NVH5Il7vnT7arKcPn26jQ4gcgyDSGOCn8nUKFlc+hklzKrrC9IkvMRi9evXN0yo+5bpuF+2FOvc95MnT05qOtfPQlJl3gafY6LfXJ5h71DS6korrWSl0phkh/ySZY+APt+psQoTXVOnTjVbbbWVJVY5RlQhDiWVbi7aiu80fnOPPfZY6wACKZUvA+f99tvPesbzm87kIdJO5JOVCQEhIASEgBAoJQJI7OKoSE5JOAjWURuoSb5z5H9RKkAxAdIrSkRXOUZRi+gq5Scmj20jrzN69Ghb49VXX20T3eWxelUlBISAEBACMUbA5VzZZ599LFlAdEkmT/oYD7dsu54L0cWzwU033WSxwZusV69ekcaJfB28CJCPlQkvJM+IBCmUbbjhhlY6aeONN040kavEI7lGevbsmaiPFdp54IEHzGqrrZa0v5QbcelnKTGqSdsuIoRzuN7hF+FMx2vSViHK4nEalra9+OKLl5AzzFfbfv7ABg0aGD6Dr776qmFiIWw4NF522WXK3xMGppptfb5TgwMB6OdghNzdZptt7D6OkSPuvffeS31yBe3ldxDvdX6HiXArBNHF7/32229vJYWZBCQCfeDAgeboo4+uIKQ1VCEgBISAEIgiAi+88ILp1KmTYR4FVQaek/l94ncqW3N1nHLKKTbnpYiubJGrXTkRXbXDLXJnEUKJBAh21VVX2UR3keukOiQEhIAQEAIlQWDu3Llm5513Nvvvv78lupB0e//990vSFzVaewR8oovrR5RDtubLkTGRxMR1FG3evHk2Gf348eMNeui1NSTj1lxzTZvHjMlzpCWQomK/LyPHBBsRV2iun3DCCWajjTZKEGpdunQxSEPX1iDpqCNsu+22W+KZLXysFNtx6WcpsKlNm0yeM1GOIYtJFJ9vmY77ZUuxvvfee9uISb9tyCgkBAthkMGQMRgRNUTWkMPr/vvvN/fee68hItk3Pr+cw2SBLDMC+nynxihMdD344IOmWbNm5qCDDrKOQPXq1bMe16nPrpy9/C4+8cQTlnyG6Aqr6eQLiQsvvNB+3nk2YfIQBQLnxJuvNlSPEBACQkAICIGaIoCaAE5rd911l3UEw3EUie8DDjgg66qef/55S46deuqpBtJLRFfW0NWqYNkRXWg6N2rUyD6Q1QqRmJ7EQyEfPOyKK66wYZExHYq6LQSEgBAQAnlG4JNPPrGTBkywQpBAJij3RJ5BLkJ1PtGFpzke59kazwboi2NMEF900UXZnlrUcsg6IO+QyZABXHfddS0G3333nZWTcOfssMMO5u67766VxBke/T/88IOtKleii0rIPYJ3+m+//ea6ZyDeoiYdGpd+JkCM8AoSXE7yjITVd9xxR1JvMx1PKlyCDZwicI7w7d///nfBoqiI0Lr99tttc8gSktPMGZKl5M8bNWpUgoB2x/Covfzyy2v1OXd1VMpSn+8lrzRR7ZBaziCkIaYPPPBAOwFF1K0jrF2ZSly6nILkdeW5kd/FQsgcOVmntm3bmpkzZ5rPP//c/k7WxKGnEq+PxiwEhIAQEAKFQ4D37Xbt2lnZeRyxeIZHdpv3uFVXXTXrhskl3blzZ3PaaadZootnkE8//dT83//9X9Z15Lvg+uuvb6ssxG96vvta0/piTXQ988wzS4TPVyrR5byguAEU6l/Tj4HKCwEhIATKGwEeyPDSJ38jRBcTibNmzSrvQZfh6HyiCym/VVZZJetR8mwwbNgwWz6qRBeRVUiTpZIoZAIcb/tdd93VRidCSNWpU8eOx708ODByiWzfcccdE5FkeK4zCZ+rffXVV2b48OEGb77lllvO5iHJJhqFyEsm/5j04/OKBCnXHCIPj0Ci0/JpcelnPsdciLq4R2fPnm2rxrnghhtuSGom0/GkwiXYaNmypVmwYEFSy0QFuRfipAN52Bg0aJC59dZbbU3LLrusvd/D1fKbhUw7n3XfIOX4XtNkuI9K6vXafr5T1xb/vWGiC0lZcjXioc3EVhQdEkqBuk908SyJXBO/P2FZ3lz7RnQ10c5EcvO9SVQ3TiKHHXZYrlXrfCEgBISAEBACtUIAuV54B541N9lkE5ufq1WrVgYHsJqYi66HVOJ9MEpEV6Hy8NYEn3yXFdGVb0RLVB/J0u+77z7bOpMyTM7IhIAQEAJCQAiAgEv0fcQRR9gJnP/85z/Wi0joxAsBn+hC8gBppWyNyAfIFqwQk1TZ9iNTOchYEtE7Y7KRCe4999wz7WT2Rx99ZHXT3TlEc7Vu3dpt1miJXBIRkBgvN5deemmNzs+18MKFC+0E3yOPPGLeeOMNw+RfKrv22mstcZ3qWDH2RbWfP/74o/2O+/PPP63CAzmyim3bbrut+fbbb22zqcjSTMfT9Rfyie9yIg5Jgr3FFluk/UykqyOb/U2bNjXff/99oujaa6+9RM6uxME8rPTv39+MHDnS1pQpiobPxXnnnWfIM+kMsouoOchwmRDIFoEw0QWx0qJFCyvxjEOQiK7FSB533HHmqaeesr/LEF3kKSmUswyRh8gFEwnLxCJOHW5+I9vrqnJCQAgIASEgBPKBgHOk5LkYeWMcKZEsxEGL38Ka2LPPPpuQ/qVeEV01Qa/mZUV01RyzSJ5x7rnn2okROsekDJMzMiEgBISAEBACIOAmdAiZhyCJgi60rkzNEfCJLq5pTSQTmDxiEglDNoFI8CgasprdunWzkU8dO3a00lKZojXCuVbchGVtxrfHHnskpNOKTXQhncUznCNJqus/5ACa8aWwKPbzrbfesnKcSGtVVVUlYIEQ4l4nQqBYhsfnH3/8YZs788wzLTHjt53puF+WdSL7yJFFHis/2hFihxftc845x9SvXz98Wq23UcdYtGhR4nzuM+63QlmvXr3M2LFjbfWMg2tZnRFtw28ZZKsz8ghdcsklbrPaJdGwkyZNsnKn5P/i+2WttdayEWv77ruvKQU5Wm2HI3SQqLAJEyZYZwAk/iAZ42o8BzEGZ+SEI5rRSYuuvvrq1tnAHa/UJZ9/cpPgeAHRhbxwofJ8IlW600472e9P8mrOmTPHQG5vvvnmlQq/xi0EhIAQEAIlQACHOaR0URTA4QKyC9UPno9fffXVGjua4bzBeyXvBUR3iegq7EUV0VVYfItW+1lnnZVIdt2vXz+D95VMCAgBISAEhAAIMEHRoUMHOzHOgxUTiTy4yQM+XvdHLkSXnwen3LS4nRyEu5ou14rbrslyr732SkinkQPoyiuvrMnptSqLZCNkBd6C2Ri52ZC9qAnRmU29mcpEsZ9EvN18881myJAhSSRQeCwoHyDNkckgkpjwBl8mWcn/BhFCdAcTr0yC8+KbziC4ILKc9e7d25x44olu007gVnc8UfB/K5MnTzYXXHCB+fXXX8OHEttNmjSxzm7LL798Yl+6Fcb30EMP2d8AJDFXWGEF+/IOYbH11lvbXAGNGzdOIgsLmZ+LfvrOeiuuuGIiv1m6MbAfQhMinAg+Z9wH5FFIZ0RqktP4pZdeSlfE7t9yyy2tM4BPglR7Qi0OIknKdcs2KjfX+zLbLoIRMpLcA0jU+f3DUQIvZr4HMJ4fyJ2GFGccLUx0ufuczzdR73ze/ejiOI4xH31mYo4JOvKRQHTxu3jSSScZCOpCGJ9jvOa594he5XM+ePDgQjSlOoWAEBACQkAIpETgxhtvtL89hxxyiHU2Qy2E/NaplBpSVhDaGWWiK5VTXqj7sdsU0RW7S5a6w9yceCdieDTi2SgTAkJACAgBIQACL7/8skG2kAlXSC4mb5B7I1+QLD4I+EQXUUzIfGVrRAqNGDHCFi83ogsywCcxciG69t9/f5vHDqDcy42PMRPOTMS98MILlnwgp8jZZ5+dyBfml812ffTo0VaeMVye60sf0IJn4pkIA4gJPrelSF4ctX5CKvG8C9GZjd11113VRqDgEMC1hOCqzkhGvdVWW6UsQjQe0oTOIEqZGHaW6bgrxxJCiud77rlM1r17d9OjR49qizF5Txlk2VIZxCnOcmDgjHsQXPKdD87Vz5IIUzDFIE9wwsjGHn/8cfub5iL4yF/35JNPmjXXXDPpdIgZcitAhv7+++9Jx6rbgPy74oorrARmdeXCx1555RXrfEi0GGTbQbmYAABAAElEQVQRMmy+ue9iCFSiVxl/3bp1/SJJ6/m4L5MqrGaD+2PcuHG2BATWnXfeadfZl+r+atiwoZW1yxR1W02TJTtEZJ9PjDqii6g+iFTuo9dee61k/YtKwz7RBTnuniUh8Qthv/32m0FCmJyUGN8JTBA2atSoEM2pTiEgBISAEBACSQgwR8LzAc5XPFfyfOl+l5DyrU3OWiKjiZDmeR0ZwyhFdInoSrr8pd/wWVH02jHkNngQeuKJJ0rfwSL2wH9JDHuPFrEbakoICAEhIAQiiADRCS6BOEQXxBe5XniAk8UHAZ/o4jrWRK7Mz4NTbklnmaAk6sUZ0lo+2eD2Z7PEexxJCgzPfibInTFxzfMWE9m+8dkaOHCgvytpnZcZJsyJuCFaYtlll0067qSh/J3IY5C3CGKrWBaXfoIH5AW55h599NEkeJgUZYL+559/tgSNiz6hEPnfyG2WyiCVIHiyIUKINID0S3WPzZ49OynCBXKlffv2iSYzHXcFeZHGMcEnuZo3b27vcyKBkDFEztBFenEMgjedQYxzbztJxXTlwvu5D++9997w7rxuQ1b6721EjVRH/PiNO9LI7QtHYSL76Bw8XBl/yXcoZA3XxWHpH+cY408lZ0hUC6QoUWIuqikcJcRnnrGtu+66ttrbb7/dEF3rG98NyMGlsnzdl9Sd6fNNGV8hhHfqxx57zEY3Qbj7cpaUdRbX3NBhoovPFLJ5++yzj3UEEtG1+Arjvc6kHM8cfDYLTXTRKs67TLw5q+6725XRUggIASEgBIRArgjwnHzQQQfZZ58bbrjBSp87Rz/ew6+++upaNcFzPaprPGfBY4joqhWMWZ+kiK6soYp2QbSy0bDGeOFiWyYEhIAQEAJCAAR4oHK60MjPEI3CJA8eSrL4IMAEEyQlxnVETi1b69u3r52cp3y5eW45OQmHRS45upz3OnXhvcfLDQZRwLPVl19+abf9f0sttZTNWwPZkMqYaGfCGEOSievomy8r6fZDQiPpBgkGeVMMi0s/wcLP6+SwIQKnXxCR5KQByeXEy6oju9JNlqK9Tx4vZBCdgfkBBxxgkLEjfxN/KCYQFYWRMyZMsrGfaCmiAp2F5fQyHec8XrKJFPziiy9cNeawww6zMpr+veA/+0Ok8L2eyogiwzPVr49ykEkQqT/99FMSoebXwcQ/BEAh7fjjj7ces64NIpiIXszGGBsRj47A43NDxLIjiMMkuKtzgw02MJdffrlp3bq13cU9wnfq8OHDDZFiLkqMg0jYIStKvjdn5BLi3sAgPpmw4HugZ8+eS+CF7BokI5KJkOLufnR1ER3oItrcPpb5vC+pL9PnmzJEIJJoHeP3BQ9kJBwhAtOZH/mVrkwU94eJLhfxuffee1tCB5LTOT1Esf/F6lOXLl1s1Cy/gRBdTPQRidinT5+CdsERbDRCBDOR2+kiaQvaEVUuBISAEBACFYOAe1/m2eemm26y+WB5HyTamGeitddeu1ZY+EQXziP8piIXXUjFhEwddZFp5TYvYMcdPMjH1oKbpWq99darCl4gEmMIvM+qgkTiie1KWQkeOC0W4BG8oFTKsDVOISAEhIAQyAKBYOLO/kZcd911VZ07d7brQe6ZLM5UkSghEEwwJX7rg+iiGnUtmJRKnBt4o9Xo3KgXDiazE2PjOSiYnKx1lwPyIFFXMNFm6wkIk6pgUjuxnzbCf0H0V1UQfZOyXf8ZLYj8WqJMEElS5V9bv+5g0rUqIMmWOKcQO+LSzwULFlQFUo5J1yCIrkkJSZCby5bbaKONqgKHsCXKBFEKVRzzMT/llFOqAlJoibItWrRIKsd9EbaAiE4qE5BhSUUyHadwEMmXVEfgAVoVkCNJ9QRRukkYUCad+deVcQbRSVVBFFFV8NKeOCUgu6oCMqMqiBZLajsgb6uChNyJcoVYCSK6ktoMoo1r1EwgqZd0fkAaJc4PCKqkY4w/mLivYrzpLJCsqeLz7N8TAUmUVDyIGEw6HkSOVQUkZtI1cecHhFXVV199VbXddtslneOOswwIu6T6831fUrl/H6T6HqJM4CyZ6CPXnu9Av59BFGMV37cB0ZvYz+cnIP44PVYWRN8lxsAYAwlU23/mEdhu2bJlrMZTqM76z4xBNLPFJogQL1RziXrnzZuX9H0URBUu8T2YKKwVISAEhIAQEAI5IhBEE9vfuMBxrirIAWtrc+8R11xzTU61B9H9tu5AWaIqcMKz6+neG3NqqAYnu+e7cpsXAAI81mJrIrr+uXS84LobNWCe/zmgNSEgBISAEKh4BB5++GH7GxEkVk1MXNWUKKl4ECMAgE+G1PT6BbLGieeEcnugvf/++xNj8ycsa3PJAvm6RF08W3322WdVTO66ZyyWkCxB1E7SPvYHERspm4Q4cecHspEpy0B2QUYG3nWJsu4clkFEThXPvYW0uPQzyDWXhFEQUVItcfHDDz+kJGsgcIJooKS6gsiulJOpkBj+9WA91eco8PZMKse2b5mOQxiE7zeIqUDqxBIMvIQHnpdLECqBvJ7fTGJ94cKFlthyfd94442rgnwDieP+yrRp05L67s6BnCuk+fcdbd522201ai6QbEzqN0SMM8gLNw6WkBiBPKU7nHbJ96tPTHENfHIsTHQxKR9E3SW15doNIk6rgoiulMdcmRdffDHRl0Lcl1Tu45zue8gn+l3f3JL7MsjRZPsZSEYmjQdyMG4WRHQljSGIfLdDCDy37f4ddtghbkMqSH+DKESLB98lOJFwPwSRswVpK1xpIEOcdI2CnHHhItoWAkJACAgBIZAzAjhZ4cQTqEJU8XyA8VzMe1mgspDkHFabxnynYxFdtUGwZueI6KoZXpEt7XvcBVqike2nOiYEhIAQEALFR8B5KAX5gaoCmSg7cRBIsBW/I2oxJwR8oosIgppYORNd4ckw7vfaWiAXmJhY40UErz430cuSSdBApsxWz2SxfyzImZSyWT+aLpPqAGQZL1R+vf46BBuRSYHMXsq2ctkZl376nwOwCaTuajXsMLETSEqmJLmoPMgFvMQ14V4IG9fGv14uSsSVy3Sc72j//GzWwSPd/RAmgYOcc64rSUvIlf322y9l24HEX1LZfG8MGjQoqd1OnTpl3QQkJlGPPk4+0eUmFtxxPGmzNbx33XksA6mZxKlhost/D/PPYT0cDcpESiBxmFT3qFGjEnUX4r6k8mw+3+nIOiL9HMlFXeHIRCIM42ZhosuR0m3atLHXBhJcVlXF55H7+Pvvv6967bXX7Hog7VQ0aPzv3i222KLq888/L1rbakgICAEhIATKHwGUIpzj27hx4+yA+c1jH86N+XD4Qp2D39Igd68iuopwSy1FG5m0G6N6PHggtbkLunfvbgLZCttNNPPRUA+8FaPa7YL0y+lnUzlYgIlMCAgBISAEhAAIBB7vNvlpMNFlc06QW4Z8IbXVmRaqpUHAz9FFHhpyx2RrAdFlAm9oW9x/bsr2/CiXmzJlijn99NMTXST3TiC3lNiuyco555xjHnjggZSnkB8EDOvXr2+PBy8+Sfm2dtllFzN27Nglzg0iKQ15ejDy+JALyNWxROFgB7mieMYdM2aMQcc91aN6MOFnn/fIJ5Mvi0s/AwkrE0i7JYYdeGEacjPV1Pw8X+Qr5N1hzTXXXKIa2mrfvn3K60BuJT9vTPheJOfTvvvum6gz0/FgUjmRa4sx8RkPogoT54dXgkl5w3VLl2+R73zuI2y55ZYzgVybzc0Vroe8TORnSmVBNJO9H1Mdy8c+Pm987pyRhwzM043JlZszZ44JyGabH8vtY+lfE3Jr+e9EAwYMMLwzZWPh7wLyKwQyffZUP0dXNnW5MlxTrkfTpk3NpptumsgLxzgCeRxbrBD3JRVn8/kmDwU5I8I2dOjQpNxzgdyOve/JWYEFBKIhB16cjBx+5OFzRj5Gxu8w4PmI56RKN/edRE6zWbNm2e9CclkGUX1FgWbRokU2RyHtY0Gknc2DV8q8JkUZuBoRAkJACAiBgiPA81zgMGZ4Jjj11FNtrlXeu8iDy3xJII1u8wLn2hFyNZMrlbl63jeUoytXRDOcD9EVV0N6A1bU18us1BxdRx11lMUCPMjBIhMCQkAICAEh4BAgRwi/D8FETpWTJgomCd1hLWOCgB/JQs6Xmpife8XPbVqTOqJaNhwlk0tku4t45PPi/yHbFcacKJpgwjpRDm/zVPmM7rnnnkQZ6nzooYeyhpIoCiLHwjmpXN/4PDsd+awrTVMwLv088sgjk/CsbW5aP4IpIKNSokIerrCUoMOe5SWXXJJ0HtfWP853r2+ZjpMXyZ2PXCG5uQLSsyogcqv23HPPKu4xogLJS8V9H87d5bfF+kUXXZSoLyBiw4ftNpFK4Txlrg9uWdO8WSkbSrOT3GBhyc6PP/44ZWk+c0TJISua6jPBZ8W38D19++23+4fTrtOGjwnShf5nOxzR5XBiefPNNycw9/dThy9v6ryHKcP1dFaI+5K6w1ik+h4KR5/RN6KBUxk5k9z4wp+DVOWjto/Ptus/S+YVMBdRu+OOO0atyyXpj/u+5XcmcNKwmKW7JwrVQXIm+lKimusoFNKqVwgIASFQOQggZe2ilnnOds/UqB/wXHDggQdW/fHHH3kBxL2r8o4aNenCcpsX4ILFWrpQRNc/nznkVtzDejneqP+MVGtCQAgIASFQUwTIEcJvRBBtYidMWf/0009rWo3KlxgBn+hCZqEm5k94+w5CNakjqmXd86B7DsplEi6I3Ek8T7n6mIT3Zct8HALvvKTyQaSdf9iuuwTErr7LLrtsiTJMogfREUvsdzsCT/qqIDIl5eR+EJVQ7bmujkzLuPTTv5cdpryg1pSMcS+a1ME1dpr84MSLLY4BEEuuDZZcA3+7WbNmSQRIWCovnG8q03HIKFc/RIh76c507dIdJ+eYqw8ZTp+s4Rzua6T0XBmWyGM6iRW3P5fPVLq++fvDBLO7liTqhvRiggBpUOQiXZ/CSwgiP48W9bt8zq4smH733Xd+00nr5CEi9xqOk+4clkhK+paO6OL+CLx0k8519QTRfX4ViXyZHEd+0Vkh7kvqzvT5RgbS9dUtdw3y36XLacY94cpxz8TNwkQXn02MMTOunXbaKW5DKkh/o0B0MbAgGjVxv3F90v0mFwQEVSoEhIAQEAJlhQDPl0G0lv1dIWjEPeuQr3ODDTawjoxz587N25h9ouvggw+27YafyfPWWJYVuWe4cuQPYi1diIRE4NFn5ZiCnAo2dq1SpQsJt3zllVcsBkGSahPoWWeI5dNhISAEhIAQqBQEkFsLJqXMVVddZWWxkHMKogQMklSy+CDgSxcGSeFNw4YNs+58QA6YgPC05YNIEeOem7KuIMIFg+iLJDkypOKQjKupBaSCadGihQkmwpNOrU62IsgHZnjucobc2dlnn+027RLJpXbt2iX2IV3B59G3QLPdIB8XTLLa8305PL8c0lGBN7tBAs+3jh07JuQR/f01WY9LP2fMmGHSSTYiNxZEpZiNN97YSg3++uuvJiA/TEBM2L/gRdZccMEFJpjENkhc+vcJsnLUiyxbkPfLzJ8/Pwm+li1bmiD/kwmICONktCgQeH6atm3b2rJInQUTw4nzunXrZpAPdJbp+NFHH22CfEeuuD2XOmprSPUFZFvidGS/gjxMVuY9iOgxd911V5Ik48orr2y4pxs1amSCSDYTRHHYc8EmyM9TK4nIROPVrHz77bdmn332Md98840tFUStmSCKwwQklwkmAqo5c/EhZPMCAnmJ/vGZDiJzTOAYkKiD373TTjvNSu8FBKcJ8lUaZBCRIkVWEBkb3/baay8TRIJZ2VG3P5V0IVKLwQSJCXII2XvElWUZkHAmIMv8XSYg7qzkHzuRYUM2Z4UVVijIfUkbmT7fSBYi2+dbkDvMcC1SWRCtmJBbpP/IYq600kqpikZy3/vvv58kx8g15vOPBC33w7rrrpuQEY3kAIrUKb7P+N4CL35/ggk6+3vLd0uxLSC3TJAPL9Esv/18hmVCQAgIASEgBLJFgOd83oOZD0FKOoh4t8+PH330kZVhRpaZ58HWrVtnW2XGcgHRZeUQkakOHI+sRDfPuMh1l8rc7ycS30gqlpOJ6CqTq8kLHvk6MPJU8BIvEwJCQAgIASEAAkxW9evXz06qMYlKThQesjbZZBMBFCMEfKIL55Z//etfWfe+Z8+e9kGeEyBi/Jw4WVcS0YLc0xAEzmo7QQnBFUjHuWrsEsKJF6F0LyIQJ4HUVYIUgQy5//77k+pg8j6QXUrs41qgA++bn3eKtrg+6MPXqVPHL5ZYDxMmdevWtRPlyy67bKJMTVfi0k/GxQto//79LSlV03FyjclbCJHCxD45YDIZL8J33HGHWW211WzbPnkVRHXZe4Q6Au9PE0ROJaoLIogsOeZ2ZDrukwecQ043HBRwaKvOIIOYiIacY6LeEQ4QL+TTycZWX311+1uxzTbb2OL+dwY7+A3BwTAXC2T9bI467jUISIgocofR7yCiqEZV/9///Z8lJk455RRLyqU72f3+pTte3X5IQXKXhT//qYiugQMH2u+hDz/8MCkvW+Axa/OGhXOOkZ8B0sAZ9yT3ZiHuS9rI9PmeN2+evXfJEYgxweOcI+yO0L///Oc/CYKXQ5D15LKLi4WJLghhyFY+v3xOIXt90jku48p3P91zB7kQIbog+smBiaNAKSzsXAKBG/5slaJfalMICAEhIASijwDPb8yX4/CLYxzPOTzb8+zFnDpL9zyXz9FEmegqNwdYrlusia5AqsYEUhdJEzaVGtHlT5C4JHr5/GCqLiEgBISAEIgvAkzg4H0b6EKbadOm2Yl4EqzymymLDwJuwoke15ToCiTMzL333msHW25E1wsvvGACjfXEhWQCPMhttcTkdKJAmhVefpjkx9MPg2QicirT5wRiy0XSE2VHtJ1vgYKEJR+YPMUC6UgbVeOXYUKdiBnfiE6CiNl0003tSxhRE4GkniHygjZcJL87hwidJk2auM0aL+PSTzcwrjvRdEQD1cQuvfTSBPkDCQJhxtjTGUTm0KFDE9FCeHoSNRjklkqc4kcWEC0GaYBxL0JK+qR0dcfpR4cOHSwZlKg8WGnTpo19Mef6El1FhBIRQG+99ZaNOmGdewMjuowoMwwiFvKEe7s6C/JRWQIPktgZuBLh4vAFBwjG2hrOFSeccEJtT0+cR7QeEVKB1IyNTEscqGbFj2itpljiEFFgkHpc51TGdwTfFQ5XMJ4wYYIlJrmGRMEQIbbqqqsayMtACjFVNTaiCMIFI8KL9zmsEPdlNp9vvsvwNua7BkIh0/dJly5dDPc+FjdFEYgb7iNnRHdyvSH4iMqDoOR5qdLNPXeAF97nQc4SS+gyEVgq839z6QO/97k4eZRqHGpXCAgBISAEiofAZ599Zp0IcUhCwWPkyJGmXr16NrKfZ0rerwoVNPLwww8bHLMISAmkkiMV0SWiq3j3YFYtiej6Bya8q95++227Aw/gIOn8Pwe1JgSEgBAQAhWNAJO0V1xxhZVGQ/oF+S0euPBkksUHATfhRI+ZRF1rrbWy7rxPdKWS18u6oggWDPLNWULIkRVEvwR5dmrVUybyXbQO5JUvS5iuQiIgghw1hggHIj+YDAwb9fbt29cSKkhvh2VDkRelXTeG8PmZtiE/ID2I7MrF4tJPN0YIBwg/PCX5boNgWn755S0B4SJTkIPjRTbIt2W9NX0ZSeqBMGNy35FT7COSCoKTz0oqsoNoHKQ+ILsgRCdPnmzr51z3fcs6Bmnhy79lOs6kLRETSOqlMiKgqotCC0eRMVnPu4EjZfw6uV+QAmMsqaIiIE/5DIAzJNUll1zin16jdYigsKxnpgrWXHNNAwkH2YvsImNr0KBBptNSHodw5P6GUP7666+XKINHLyRh165dM5LbnOxkIfnsjR8/PnH9OUaEHdEvfEdDdqUzCEraoz9IG/rES77vS/qQ6fNNGX5biO6DUMxkkPd890HoUjeRj3GxMNHlJEgdEY2kjyPx4jKmQvTTpUfg943fNr4/cSwZNGhQIZrLuk7nHe9O4DuZz7BMCAgBISAEhEAYAdQ5evXqZdUEcChjXoRnYJ7VUD7AwYVnb57teAfIt/E8TUAK7+NBHlwRXfkGOFSfIrpCgMR1M0hEbj076X+q3A9xHZf6LQSEgBAQArkjcOONN9r8PXgsI2VFmD6RKltvvXXulauGoiHgE11M2hLxk63hQQbBiZUb0cWYHHnAZDjEApPPtTUmQCEFkBtkAjcbe/PNN23uLCaIyaGVyiBSkGdLRzBDSBDtBWFVE4NoQUaK+yMfFpd+phsrpAyEIS+qRKZk88JKefLyMJGL7J+LnErXhttPtBP1169f3+2ycnxE50BYQdRAmJL7yhlyfdUdpxz1kkcK0qEmtv3229t7IRxBhGwdOQjwVoWEWWONNWwOIt4f/GizVG19//33diwQf/44UpWtbh/t4pjH58sZ5Frjxo3tHxE066yzjv1eI7KMdUjLQhjSNIyLe4XPONcPUiqbe8XvD7nfILchH2tr9AHi0slN+vXk87509Wb6fLty2S6JJORzxl+cLEx0OaKRaD7uD+5LyPNKN5/o4vuD7ww835kkLLXxW+miIOmLi8ordb/UvhAQAkJACEQDAWTpcTQkSh1iixzJLtcjjodEM5GPlnzMBIvU9Dkw21FOnTrVPtcjC46qDr9fvHOEpbGzrS8f5VyOLkV05QPNPNahiK5/wMQD0L04hhNf/1NKa0JACAgBIVCJCDDxTv4MQvTRpCZ6BM8mcsvI4oNALkQXEStIaGHlSHTF5ypm7ilRBMiMvvHGG8ZFJaU6CyIAaTlk0ohWKrbFpZ/FxiVf7UGA8D2N9CzRFKkMcgFSDrk1SC4ixwr1kp6q/Zrug+RDqg9yCTKruminmtat8kKgJgiEiS6cJYhOc0TXBhtsYB2DalJnOZbt2LGjlcpF6gmiC4z4zSF3XRQsnHsOGdHbb7/dRiVGoX/qgxAQAkJACBQfARyFxo0bZ6OPcR7jPYm5EJy2eL7GsRAHF55HyUGLFHMhDQdjZBGR0iYiOUpEV7mlNOA6xjqiy2m9+xM23Li8+EOCVZIhq8IDKIamPB9WmRAQAkJACAgBEBg8eLAhquuOO+4weC+xREZq2223FUAxQiBfRNe5555rPdhiNPSK7Cr5lZhYxONv/vz5NgcJEUJEnhDNx3oULC79jAJWte0D0WFIdCIVxws6El0QRUjF5RK9WNv+6DwhEHcEwkTXzTffbGX5kMfk+xZ5WRyDKt1c/siPPvrI/h7hXMuzyFVXXRUZaIgW3WeffWz/XKdw7kFutVBRoa4dLYWAEBACQiBaCCBlSz5eHAbJ34gEN7KBKGDMmDHD8B787rvvWkWDm266yTqKFXoEIroKjXBy/SK6kvGI7dZee+1lZUUYABqjfLBlQkAICAEhIARAgFwKeC0hWYiTCJFdeDkRASCLDwI+0fXiiy9ax55se+9HdInoyhY1lRMCQkAICIFyRCBMdDHZdeCBB9pccOTHE9G1+Kofeuih5vXXX7eTgzhekMculzyYhbyXcOLy8wgywUlOFqQWc81fWch+q24hIASEgBDIHQHy5uLcS95cIrratGljA0CI0MYpj9955kOQXMZpg/mRYuV2pE9nnHGGlUckT7oiunK/3tXVIKKrOnRidGz33XdPeDGhOXrZZZfFqPfqqhAQAkJACBQSARKrIn9FjiaILreO57IsPgjkQnSRJ+j++++3gxXRFZ9rrp4KASEgBIRA/hFADhTSxhlR7+SQa9mypVmwYIGIrv8BEyeiiy6jcMNcCNfQWcOGDW0O806dOikC1oGipRAQAkKgTBAg9yi/4bznonqw6aabWkKJOXKMnFjkMoYIa9CggSW/+L0vppEjjMgynC8eeughEV0FBl9EV4EBLlb1sNVImmCdO3e2H+Rita12hIAQEAJCINoIIGc7atQoM378ePPYY4+ZYcOGmXvuucfstNNO0e64epeEgE90vfDCC1a6LKlANRs+0dWjRw/TvXv3akrrkBAQAkJACAiB8kUgTHSRF/Hggw+2ke5fffWV2WijjazUc/kikN3IOnToYOWfkE8loot0CeTtwms+qoa3PpOeXFPf6tWrZ/OLde3a1cr/+se0LgSEgBAQAvFCgN8k8muSjgEJW1IYkW8KBw1ybz3zzDPm+uuvt6QS27xHX3jhhUWL4vLRJOcu7969e/c2U6dOFdHlg1OAdRFdBQC1FFXusssuZs6cObZpvJUIw5QJASEgBISAEACBPn36mDFjxpiJEydaouuWW24xY8eONfx2yOKDgE90Pf/886ZRo0ZZdx5yC7lKTERX1rCpoBAQAkJACJQhAumIrhYtWpivv/7abLzxxhWX8zvVZW7fvr158803zaxZsyzRRS4s8nZdc801qYpHah95xZAyfPnll5P6tcwyyxjSPhD5hcPXUkstlXRcG0JACAgBIRBNBJAkfOWVV6wDL867f//9t3X8PO2006ysLoQXxBfzHkT4YrvttpsluJo0aVKyQUWZ6DrnnHMsQVgycArQcKyJrscff9x069bNJpM766yzLDybb765ZXKffPLJAsAV3Sp5SCNkEzvyyCPNlVdeGd3OqmdCQAgIASFQVAR69uxpI7jwIEIXGo1qHgB58JPFBwERXfG5VuqpEBACQkAIRBeBMNGF1/chhxxitttuO/PNN9+YTTbZxEo9R3cExekZmLhcInjP77333tZb/tprry1OB3JshUlR5oUg5sjLFjYchtq1a2dlK7fccsvwYW0LASEgBIRABBD47LPPrMMuTrtOyQyJwpNPPtlGY0+fPt06dE6ZMsX8/PPPNqKL36tTTjnFbLvttiUfgYiu4l4CEV3FxbtgrZFnZf78+bb+qCaILdjgVbEQEAJCQAhUi8D5559v7rvvPvPII49YXWjkXEaPHm2cdnW1J+tgZBDwia5p06aZ9dZbL+u+kZcL6UpMEV1Zw6aCQkAICAEhUIYIhImuIUOGGKKXmBD79ttvRXT975r7RBeTi0RCIWd43XXXxequgPB69tlnzciRI+0yVeeRvcIBbNdddzWtW7c2q6yySqpi2icEhIAQEAIFRoDv7Hfffdc6nBDgwm82+1xELipmq622mnXgnTx5spk7d67tETm4mA/neE3ekws8HEvSEZyDyg6Oxy5Suk6dOoVuOm3966+/vj2miK60EJXmgCK6/sHdJc5lT9R1s//ptdaEgBAQAkKgGAjwAPPAAw/Yh0UerpigGDFihJ2wKEb7aiM/COSL6CJfFwlxZUJACAgBISAEKhGBMNHFcxEEjiO68BRnrqHSzSe68Kjfc889LSEIMRhXYxw4f+H88+WXX6YcxtJLL21QCkLK0v2tvfbaKctqpxAQAkJACOSOwBdffGGQ5ufvxRdftDLC1Ep+Lea7N9tsM1O/fn0rpYt8Ifk0sbp169o5DZxV2rRpY0pJHtkOpfiHnCL5w5DTJepMRFcKkPK4SxFdeQSzlFU5mQX6QPK9uMgJlBIztS0EhIAQqBQESH5KyPzTTz9tH66QcLntttsMuRZk8UHAJ7qee+454zyxshmBH9EloisbxFRGCAgBISAEyhWBMNHFuzPv0M2bNzffffednVAj/0el28EHH2yQhEK2EIJojz32sBKPSD3G3f766y/z0ksv2edjrvX3339f7ZAaNmxomjVrZgmwLbbYwt4jjRs3tpOw1Z6og0JACAgBIZCEwC+//GIjtt5++237G8PSpeLxC6644oqG715yZ/7000+JQyuttJJVpkGeEAcMtqNsUSa6mCNwqaCijGFN+hZroosHkhNPPDFJgqdSc3S5h3IuPkx2nL2sanIDq6wQEAJCQAhkRoAErURyIXc3adIkc/XVV5thw4aZtm3bZj5ZJSKDgE90IcHDBEu25qL6KC+iK1vUVE4ICAEhIATKEYEw0YUD0GGHHWaJjIULF1oy49FHHy3HoddoTD7RNXv2bDuxyD4ksMvJ/vvf/5r33nvPECXA32uvvWZ+/PHHGg1xzTXXtPcN81H8bbjhhmattdYya6yxhiFCzBnyW/z9/fffdpfb9pfVHct0rl9PqvVMdac6x+3L5VxXR6mXEJyMg2vOH9tuybq/7e936/7S1ePqdEv2u7oYb3g/x90fxzEfF7cdXlZX1h1z57jtVPW6Y35Zt88tOSZbjAARReG/pZZayu7js80xt806+/zt8Ln+tjufpTvPrbu6XHl/v3+M/UQx8Ye0X7brlF122WXtOeF16mQf7bB0224Z3sd4wwaZNWfOHDNjxgyb6xGnCXI+1saQliW6lqhr/sipSB/iYijr8C7et29fg9RilCK6RHRF7C4S0fXPBWnatGnCC6kcHz7/GanWhIAQEAJCoKYInHTSSYYJGzxXSeJ65ZVXmqFDh5r999+/plWpfAkRENFVQvDVtBAQAkJACJQNAmGia/DgwVb+371TE7FDXtNKt4MOOsjgaU9+LoiuNoEsFPtuvPHGsoYGEoIJ2o8++sh8+OGHiT8i22RCQAgIASFQGARWWGEF6yiATCEOAyydZGFhWixOrUjlQij169fPOh2L6Cos7oroKiy+Rat9q622SoRyHnjggeamm24qWttqSAgIASEgBKKNwAknnGDzc7366quW6Bo4cKD9neD3QhYfBHyi65lnnjEbbLBB1p1XRFfWUKmgEBACQkAIlDkCYaKLSHcS2G+zzTbmhx9+MCK6Ft8APCe+8847VrYQomu33XYzlTzX8Pvvv5tvvvnGRnsR8YWUFkuwmTVrlpk5c6ZdEsEjiz8CLmqGKJZMf35Zf51IF3duqv2gRBn/zyEX3pdu29Xhlq5cqu1U+1x5t3Rlwkt3nKU75tb9bVcu3T5/v78ePs8dc0t33LXpli4KjaX745zwur/PP8dF16Va8lmmLMdcZB7bqdZTne/2parH1enq8pep1l15t/TLMLao29Zbb22Yt95oo41MvXr1zCqrrJJYss7fyiuvbKPIoj6WmvZPRFdNEcutvIiu3PCLzNmEbvLgRSj1AQccYG655ZbI9E0dEQJCQAgIgdIicOyxxxqIEbyHCJ0fMGCAlZ0hAlgWHwREdMXnWqmnQkAICAEhEF0ERHRld218oosIp1133dW0a9fO3HzzzdlVoFIpEXAT5yzdn5sQd9uuDPvdPrfulq5MqqXb58r6JAHrkC6OKPC3/XU672+7dbffbbN06+mOuTL+krIyISAEhEC5IzBu3Dibcql///42ouuNN96wThHITJbKXK7vHj16GPK5l5OJ6CqTq0lYJw8zixYtMvvtt5+59dZby2RkGoYQEAJCQAjkikDnzp1tfi7kZ3jQuuyyywyJxA855JBcq9b5RUTAJ7qefvppm/8h2+YV0ZUtUionBISAEBAC5Y5AOqILj3MidHAiffjhh8sdhozjg9R69913bcQSRNcuu+wip9qMqKmAEBACQkAICIF/ELj//vttjuxLL73UPPjggwaiiwhgcqSVykR0lQr5DO2Sb4S8I35SdQgfEtU9+eSTGc4ur8ObbLKJ/ZD8/PPPZt999zXDhw8vrwFqNEJACAgBIVBrBI488kibn+v99983PGihD33ttdeaQw89tNZ16sTiIyCiq/iYq8XCI4AawRVXXGEbgnxH1kQmBISAECgkAmGi66qrrjL8xrp0AE2aNDEPPfRQIbsQi7pRiuHZ8bPPPjNz5841O++8s83vSp5XmRAQAkJACAgBIZAZARFdmTHKZ4lYR3SJ6PrnVkDnFD3ThQsXmn322cfcdttt/xzUmhAQAkJACFQ0Ah07djTk5yKh9n333WcuueQS4xKvVzQwMRu8iK6YXTB1NysEkFMl4hBbbrnlzHPPPWcaNmyY1bkqJASEgBCoDQJhouvKK680OAVBcOE4KqJrMao+0fX555+b1q1bSz2mNjeczhECQkAICIGKRYD5l/PPP9+q6kycOFERXQW+E0R0FRjgYlVPQvr69evb5Kh77bWXGTFiRLGaVjtCQAgIASEQcQTat29v83ORKPuee+4xffr0MS7xesS7ru55CIjo8sDQatER+OWXX8zrr79uNt54Y6uekK8OXHDBBebf//53ojqR8AkotCIEhECBEEhHdCFZyHcdkV1Tp04tUOvxqXb//fc3YPXpp5+aefPmmZ122sm0bdvWDBs2LD6DUE+FgBAQAkJACJQQARFdxQVfRFdx8S5Ia+Tmaty4sVlrrbXM/PnzzR577GFGjRpVkLZUqRAQAkJACMQPgYMOOsiQn4uJirvvvtv06tXLSoUdddRR8RtMBffYJ7qeeuopQzR3tqYcXdkipXKpEPjoo4+srBfKASSwv+666/KW4+/ggw8206dPTzR7xhlnWK/HxA6tCAEhIATyjECY6EI+lWciR3SRq2vKlCl5bjV+1ZH7m+//Tz75xHzxxRdmxx13VJqE+F1G9VgICAEhIARKiECUiS4/FVQJIcpr0yK68gpnaSojtwGTXeuuu65BUqBNmzbmjjvuKE1n1KoQEAJCQAhEDgHfI5eIrp49e5qBAweao48+OnJ9VYfSI+ATXeQiJbImWxPRlS1SKpcKAeQ2eElzli+nKpy1kAgjgsIZ8mHIiMXVkF4cM2aMWX311c3ll19ull566cgNJQ59jBxo6lBZIRAmugYNGmQ6depktthiC/Prr7+abbbZxkyePLmsxlybwYjoqg1qOkcICAEhIASEwD8IoFyBgsWAAQPMhAkTIiVdKKLrn+sUiTXl6Fp8Gf7880872YV8Id76u+22m33BjsRFUieEgBAQAkKg5Ajsu+++5uOPPzZIF/oPWl26dCl539SB7BEQ0ZU9ViqZXwR2331369HvaoU8Hzp0qNus9RIlglatWiWdT1QF0RVxNRcRQv+jKhEbhz7G9fqr3/FAIB3Rtfnmm5vffvtNRNf/LiMyhTNnzrTPkO77WvnA43GPq5dCQAgIASEQDQTuvfdec+GFF1oHOIgupOBnzJhh6tatW7IOrr/++rZtEV0luwSpGxbRtRiXRYsWmc0228xssskm9kF0l112MWPHjk0NmvYKASEgBIRAxSFA7sa5c+da+Rk/dP6YY46pOCziPGCf6HriiSfs736241FEV7ZIqVwYASdX5e8nGpSo0FztkUceMSeffHJSNZ07d7Yvgkk7Y7Thk0iHHHKIuf766yPX+zj0MXKgqUNlhUCY6HJR7ptuuqn5/fffTdOmTc2kSZPKasy1GYyIrtqgpnOEgBAQAkJACPyDgIiuf7AoxlrZSRdC+DRq1MgwAVQphrwCMgv88dDeunVrm4OlUsavcQoBISAEhED1CBCNsWDBAvPBBx+YcePGmR49epj+/fubrl27Vn+ijkYKgVyIrnPPPdeMHz/ejqccPbcidaHKrDMjR4603xf+sPKVRwuJwltuucWv2n4v8f0UV/NJpKg6n+XaR3IXER38008/me7du9v8wHG9Xup3ZSKQjujCcfSPP/4wzZo1Mw8++GBlguON2ie6vvzyS7PDDjuYvffe29x+++1eKa0KASEgBISAEBAC6RDwU0c88MADiuhKB1Se9ovoyhOQpazm559/tvkNSJr77rvv2iSxMMYyISAEhIAQEAIgwGTrDz/8YN555x3DwxXRPX379jXHH3+8AIoRAiK6YnSxyqSrf/31l839OmfOnKQR9e7d25x44olJ+2qzAWEWzoOTLxKtNv3Jxzk+idS8eXMzceLEfFSb1zpy6eP06dNNhw4dDPcGhuwKY6ROmRCICwJhoot8ekSTkvea/NdR/ewWG19f+hqHqZYtWxpUAkaMGFHsrqg9ISAEhIAQEAKxREBEV3Evm4iu4uJdkNZ+/PFHA8nFA/lbb71lcx3gZSkTAkJACAgBIQACO+64o0Hmlt8IJiTPOuss06dPH9OtWzcBFCMEfKLr8ccfN0gsZWt+RBcRfURhyIRAJgTc90W4XL5yTx155JHmpZdeSqr+4osvXkLOMKlAxDd8Eon8uc8880zkepxLH93Luj+oDTfc0DpRrLbaav5urQuByCIgoiu7S+MTXV999ZXZfvvtzZ577mmI9JUJASEgBISAEBACmRG4++67zUUXXWQGDRpkFVaUoyszZrmUENGVC3oROXfhwoVWXoEHz9dee816Wt1///0R6Z26IQSEgBAQAqVGAKkZvO95qEKKB5IjXxEZpR5bJbWfC9EFuYVsJSaiq5LumtqPFXIc2VNydIXt1ltvNfvtt194d423kcAiGbNv5LQit1VczSeR6tSpY8gp/Oeff5qPP/7YfPrppwYlBvYvv/zyZqWVVrKTxuuss05Rh5tLH5977jnTpUuXJfq72267mTFjxiyxXzuEQBQRCBNdAwYMsPc15PTff/+tiK7/XbR99tnHfm/NnDnTfP3116ZFixZWqnTUqFFRvKzqkxAQAkJACAiByCEgoqu4lyTWRJdLYH3++ecbZE6wSszR9e2335ptt93WRnK9/PLL9gHU5eEo7u2k1oSAEBACQiCKCGy33XZ2YpXfCJKrn3nmmaZXr17mpJNOimJ31ac0CPhE12OPPWafedIUXWK3iK4lINGODAgMHjzY3HjjjSlL8cJGTthcbeeddzZz585NqgZVglatWiXti8MGeX0+//xzQwQE69kakZlEaBbD8tXH2267zVxzzTXmt99+S3S7QYMG5s0330xsa0UIRBmBdERX48aNTVVVlX23njBhQpSHUJS+4Ywwe/Zs65DwzTffGJ4ncYAYPXp0UdpXI0JACAgBISAE4o7AXXfdZVCsuOKKK2xEFwEqH330kVluueVKNrT111/ftl2OubtFdJXstspfw867ihws06ZN04N5/qBVTUJACAiBskAAaVuiB1588UUzZcoUc/rpp9vw+VNOOaUsxlcpg8iF6OIh1kV7K6KrUu6Y2o+TKCsitshVk8r4HkE2O1cj3wt5X3wjYsi9fPn7o7g+a9Ysw2eLieDvvvuuVl1kYv3ZZ5+t1bnZnFSoPiJjNnz4cPP888/bF/W2bdsa/aZkc0VUJgoIpCO63HcPTqQiuozxiS7nXNumTRtzxx13ROEyqg9CQAgIASEgBCKPgIiu4l4iEV3FxbsgrbnEsDx0kgdAyXMLArMqFQJCQAjEFgEmpMmdwgTyQw89ZE499VRz4YUXmtNOOy22Y6rEjvv5jJBD23zzzbOGwSe6yNdFnjaZEEiFADKnHTp0MNOnT08cbtasWdI2kaFNmzZNHK/tCnV8//33idPXXnvtJXJ2JQ5GbAWckA1n8rcmttRSSxnk0fj8NmrUyHTu3Nmst956Naki67Jx6GPWg1FBIZBHBMJE12WXXWaOOeaYBMlO5NIDDzyQxxbjWdVee+1lo27xPBfRFc9rqF4LASEgBIRAaREYO3asVdO58sorbSqBKEV0+Qp5pUUpf62XHdGF/AeeWMWSAMnfpah9TeRO2HHHHa3HFeNm0oAJCJkQEAJCQAgIARAgH0vDhg3N008/bVLJ/gqleCCQC9HFQ+x9991nByqiKx7Xu1S9HDp0qJXWcO0jI0jOrJ49e7pd9jkzH0QXkuPkAnPWtWtX079/f7dZ1OUnn3xibrnlFislssIKK9ict0cddZSBfEtl8+bNMzvttFOqQ0n7VlxxRSsrjiMahCGRIvXq1UsqU6iNqPXx3XfftffOnDlzDDJo5Chba6217Lsbko8bbrhhzlAQaUYkDtfzwAMPNMhjyoRAGIEPPvjARq1CPCNVGCa6yEWlVADG+EQXUat8jykfX/hu0rYQEAJCQAgIgfQIiOhKj00hjojoKgSqRa7TvcQiGcIEJp77SMrIhIAQEAJCQAiAgJ+/kkggcnOVox5zuV9tn+ji936LLbbIesgiurKGqqILvvTSSzbCyEkWInnKd8Yrr7xiuIecTZ061Wy11VZuM+WSOoggfeutt8zMmTMN5BHkGMQDz6r/93//Z5DtY5LZWbb5uagbKU5k8yBNmICFNCFP1BprrGEnsHkuzsYg2m666SZz6623mj///DPplKWXXtrsueee5rjjjluC1CI/FVEfv/zyS9I54Q0iRxh7Llbb8Razj9WND9KJ3ATcX9UZThlEGkNQpTPq4lpx7xx99NFJpCG5wwYNGmSIZMOWWWYZM2rUKLPrrrumq077KxSBTEQX0Zrjxo2rUHT+GTbff8w1fPjhh2bhwoWWrOfzdOedd/5TSGtCQAgIASEgBIRAWgT4zezdu7e56qqr7PuLIrrSQpWXAyK68gJjaSvhBZ/8XAcccIB5+OGH7cQXEwsyISAEhIAQEAIgsPHGG5uNNtrITlg/9thj5sQTTzTK0xS/eyNfRNc555xjzj777PgBoB4XFAEUAniW9HNN9evXz5I8TPjyneEMBQFUFNIZ5A7l33///ZRFVl11VUPd/n2IvOobb7xhIJeqM8pwHs+/1Vk2ZByECNFq77zzTnVV2WMQNSeffHJSuTfffNPmPKTPRDlA4l1++eVW6ouCJJlG8isXy3W8xehjuvGB77Bhw8yQIUPM77//nq7YEvvBkYTdSDuGjfvKERD+hHv4HnXnEc381FNPWSLU7dNSCIjoyu4e2GOPPcz8+fMN3+nIzOKswLwD3ukyISAEhIAQEAJCIDMCIroyY5TPErEmuiB1SHp8wQUX2JdMgKlE6cLPPvvMvlzj/Qgmm2yyiY3syueNorqEgBAQAkIgvgiQD4boH5wgnnjiCXPCCScYkR3xu565EF08KxEtg+nax+/aF7rHRAwdccQR5vXXX0801bp1a0PyZKS9yFXDfePs2WeftRE1bttfkturY8eO5o8//vB3Z1xHhvvee++tthzfYZBc2ZAmyAOOHj3aSgWmq3TMmDGmT58+6Q4vsf/MM8+00bBLHPB2kP/QjYNILiaIa2v5Hq/rRz76+Pbbb1syiqg/IqyWXXZZV71dfv3119apgoi+VFa/fn0rqTt79mzz66+/LlEEggocw3KG5BecOHGiLU+0Ms4bYAxh6ctg+hU6WTp/n9YrGwFHdBFZ+vfffy8hXdiyZUvrdV3ZKBnjE10//PCD2WabbSyhz2+DTAgIASEgBISAEMiMgHvfuPrqq+2zxauvvmojpXmGLpWR8glTjq5SXYE07YroWgwMEh677767Ofjgg+0kpvPaTwObdgsBISAEhEAFIYAsWONA4onJicmTJ5snn3zSHH/88Xay2J+4riBIYjvUXIguf2JbRFdsb4GCdZzoGXJzOYNk4DkbKUCMnEd+9BUSdKlyV3377bemXbt2hugw3+rWrWvl+3766ScDqZbKyHd1zz33pDpk95FjjvuYSWlnSNMRhYbkHbme+LvkkksS5NLmm29uI1ldeX9J5FqbNm0Mk7fOeJ5G2pU2kOoCE3JJ+XbdddeZDh06+LuS1i+99FIzYsSIxD4iqhyOiZ1ZrOR7vH6T+egjkcGQTBhSLBClvkGsQ7CHDccLot4gUjGivsBo+PDhNseyL2WJDOWDDz5o1llnnUQ1JPImlxoGruSexNkPwiyd+ZFf6cpof2UhkIno2mGHHRJ5LSsLmeTR8p24YMECA14//vijlZ3ls3v33XcnF9SWEBACQkAICAEhkBIBEV0pYSnYTkV0FQza4lU8a9Ysmz+gffv2luiCmUVSRiYEhIAQEAJCgEllHCBIII4XPJOCXbt2Nd27d0+SIhNS0UcgX0QXhIVIzuhf72L1kO8EclA5ggHyiEgactQ4c5Ibbhs5vdVXX91tJpY++cFO6oI4IgoHGT/s559/tvKI+++/v4H4cgZpgYcj54SNKLHDDjssKYcW50NqQW75Rr+/+uqrxC6iopo0aZLYdiuQaj179nSb9lkassVvn/xbSBa6CCIKQwI+88wzafNu4a1Jzi9n6UhBdzzVshDj9dvJRx/9a43CxkUXXeQ3YSZNmmSIgPMNeUdIKvKppbIZM2bYe4VJdWf77ruvJcHcdq9evRKyadwz5HvjejjjvoQQ7du3byJSrE6dOlaeMtdcaa4NLeOPgIiu7K6hT3TxfU1uxkxOCdnVrFJCQAgIASEgBCoDgSgTXb5CXrlcjbIjupDtw1PQeRiWy4Wqbhxo/++zzz52AoB8BHg94rEvEwJCQAgIASGAxBeyvi1atDDjx4+3E4LHHnusnYA877zzBFCMEPCJLqJtiGLJ1pjQd9EyIrqyRa38yxF5BWG0cOHCxGD79+9vyXC3A7IcQsmXqoI4J0oGEsKRSORv2W677RIRW0jZkZ8J6auwPf/88+boo48O77YRFERS+Eb75ITxo8SOOuooM3DgQIPsmG9u8trfl05u0CdMKE8EUqtWrfxT7Trt0x4knDOIu3PPPddtJi2vueYac8MNNyT2MdZUuaYSBUIrhRqv30yufaSuU0891TrYsX7QQQeZG2+8kdWETZs2zXTu3DmxTa5IvrfCEoeJAv9bISqQ+wrpQwziEZlER45BqlFPKoPk4jrSFnKFt99+e6JYprxyiYJaqQgEyB/Idx/59YgqdPKWTsqH7wIn91sRgKQZpE904aTA9302MrNpqtNuISAEhIAQEAIVh4CIruJechFdxcW7IK2hS9+2bVtz+OGHG4guPE3xzpUJASEgBISAECD3Cfm5nAwPnu8iuuJ5X+RCdBFt4aSGqpukjycy6nVtEPjzzz/tsyOycc6QIyQCi0gmCAfk4Mjb5cv7ubIsiahx548bNy4pShQiibrCBpEDMcJEc9hOPvlkG0Hl7w+TYkyyci+HSS7OQWceyT/fiGh96qmn/F12HSUE13c08iHJUtVJYfqKRKKLenOOA0tUGuwYMmSIQd7QGc/k4TxTHAMHIphw0PM1+gs1Xtcflrn2kTogP++44w5WLbEUdrJz+SBtgeBfTQj2a6+91lx//fXuVENEIcQqRv43n3R0hVZeeWUbeQfJhb3yyiv2/nbHuWecXKLbp2XlIiCiK7tr7xNd/C7gYCMSMDvsVEoICAEhIASEAAjwvMxz8+DBg22OLp5RmccvpdKAc+xRRFfE7lG8+fDq8y9MJUZ0Oe9VtPEhutCzZyJTJgSEgBAQAkIg7IH73HPPmS5dupjTTz89Zf4UIRZdBHIhupBfcxE5Irqie42L2TOen3OJWODl7IwzzrDfJfS7T58+Bo9FDJnCd955x5CbK2xI15FnKZVBCIWdtfzIq1VWWcWqFqy55ppLnP7WW28ZyCtHRvkFeD5Gcss3otLI0+WMHIbkMkxnTPiSFxerLvfXbbfdZgYMGJCoJlW9ixYtsk5qn376qc0T5ggjTirUeBMdClZy7SN1EcHFCzu21FJLWdKwfv36dpt/5NZCItcZmPDbk40hrfrAAw8kikJUQlhi/nVIFAhWyKdGhI4ziESu+W+//WZ3QZ4deuih7rCWFY6AI7qIGOReUURX6huCPIZEV4KXiK7UGGmvEBACQkAICIHqEBDRVR06+T8W64guNPeRzUCH/bTTTrPoVCLR9e6779rE3506dTJTpkwxq622mmEiUyYEhIAQEAJCgEgMJm933nlnS3Q4OSl+N/n9lMUHAZ/oSpd3KN1o/Mlz5WdLh1Ll7B8xYoS59NJLaz1gyAZIDj9Pl0+m4iWY6lmUfccff3xSrq1wJx555BEbher2Q14wyYoRncrxsHH8mGOOMd988034kN0mLyGSjM7chK3bZkl0GmQwbaQy5AtffPFFe4jIN3JvpTIkYn1ZQ+rk+9c3JNbJceUMUrBevXp2sxDjde24Za59pB7yuPm/IbfeeqvZb7/9XBNLHMeT9YQTTkgcT7fCbxQ544g4xCAikGl3udOQTsOBwzeuPURF2PyovfA9EC6r7cpCIEx08X3IfdS4cWMLhOT5Ft8PPtEVuXdq6QAAKntJREFUVgiorDtGoxUCQkAICAEhUDsERo8ebXPHIh2O8oQiumqHY7ZnlR3RhVwFHn+PPvpothjEvhy69UjAoIMP0YV0B7InMiEgBISAEBACRCwQubDbbrvZaAsni4WjCHmbZPFBIBeiq3fv3lb+i9GK6IrPNS9ET0eOHGlJrlSRT669FVdc0UYtbbbZZpb4mTNnjo0Ccschq/r27es27dLPA7feeuvZyCxHTlAAkgtpQiZLnRFxg6Rdt27d3C472eyTFgcffLCZPn26PU7kEM+6LjoLMgRJOiLEIK+cHXLIIVbGzm0TafTaa68lyBLyfTGRHTb6Sx/5jBCV5oxJcSTCHcFCZBmOZqmMiDRIFWdXX311koQe+31pvjp16pgPP/ww0bdCjNf1xS1z7SP1IFXIfeAM4o7vGWfhNiAHIehxyEtl5HgjpxZ/LgqLchCoXBPsxx9/NFtvvbVdd/8gJsi/lSr3lx9lyD1DZJ9MCIDAe++9Z+VI+cwT0QURjqyzI7p22mmnRF7LSkaMZ0dkbMGLzyXRrC1btrTSS5WMi8YuBISAEBACQiBbBER0ZYtUfsqJ6MoPjiWtBakWXujxQuPlH51/53Fa0o6pcSEgBISAECg5AkjOkE9mjz32MKNGjbK/D0QmpMqFU/LOqgPVIpAL0eVP+J555pnmvPPOq7YtHSxPBPAkvOGGG5IGRwTTqquuapADZAKTCV4me/18VeEIqO222y5JWo4KkaZDEs8ZeQEPO+wws84661iCg8gmn1zDMWvSpEmmUaNGZtttt7UkBudCskFKscQuv/xyM3z4cLvOP/bvvffednL6jTfeMPPnz08cY4UxIMmIE5hPRg0bNszKBVIGYmnfffdlNaXRJ2Tu6PuXX35pSeKvvvoqUTaVxKI76J7L3TZ5yoiodDZv3jzb9k8//WR3MfYJEya4wwUZb6Ly/63k2keqcYoSru4w0fXXX39ZMnHBggWuiM1VRjQxpBNRf2ALifryyy9bRwyfrOSkvfbayxJfEJwY0pFEE/rG7xq/b6kMr1nytmFLL720ldNcaaWVUhXVvgpDwBFdEM0Q5hBdvEuTMw8T0bX4hvCJLiRXcX7YfvvtDTkZZUJACAgBISAEhEBmBHyi6/7777fPvaQgcu86mWvIfwmXo8tXyMt/K6WpUURXaXDPa6u85Hfo0MF6j5IHgHwI6eRU8tqwKhMCQkAICIHII8BEIhPOTAzjKc/vA4RJePI18gNRB+11c7/vqXIOVQeRiK7q0Cn/Y3///beNwHI5tNyIIRLIbZQqGsaVYblw4ULTrFmzxC6inUii7JNh5IclIiIbQ/IQgsLlxPKjwTi/X79+Vr6OdaKvIDeYZM1kTZs2tQmfiRpirNz3zug/eaMwp4bgjrVt29Y88cQTljxz+9ItGTNa+7vuumvKIp999pmNoHUH//Wvf1mMIfYgdJD4+/zzz91hM2TIEJtbzO0oxHhd3W6Zax+pB5lICE9nXEMihX3jGnMta2OQpETq+VGBkITIQHI/Y61bt7YRfenq5x7l2joLY+32a1l5CDiii+++P/74w96nfH85oivTvVUpiPE9x/c/xLaIrkq56hqnEBACQkAI5BMB9zyMogNOWLwPiOjKJ8LJdYnoSsYjllt4vfIyiHwIRBcei2h+yoSAEBACQkAIOIkuoheIiuDB6ogjjrD5YXyZKSEVfQT8iK6aEl3kx2FyHlNEV/Svdb576DwJ/XoPOOAAG93lEwn+cX/dOVX5+1APIOLJ2e+//25lUsNROe64WyIxDgm17rrrul1WGgsyHokszEmtugK8IBJx4UeEuWNuyTmQds47Epktvvdmz57tilj5RDwY33zzzSRyiXxT9J9oo+r6j2Qh5At5tNIZk+Y4FyAbm8m23HJLK6fnE4ack+/xhvuRjz5yLXbZZRczd+5cWz3RgryPhO2iiy6qlowKl0dSkhxd6SLu8IQlSov3HSICydlVnXXp0iWRL07ffdUhVVnHXEQiDqJ89pFi7RpIjjqiy+U1rSxUlhytT3SB06abbmpVAsjzJxMCQkAICAEhIAQyIyCiKzNG+SxRdkQXL8+bbLJJykTV+QQuSnX5k5Z4qiLv8eqrr0api+qLEBACQkAIlAgBJiGZsGFilklg/zdDRFeJLkotm82F6GISD7ID02SvhaGi/rVq1SpJ4g+JLoijMMGSDhSX288/jjwg9fo2bdo0K4uaiixiQpl2yX8FYRQ28jdxb5Iv54QTTjCQs7698MILluAgqscZz7zkjDnnnHNSEiPk9qI9yC4kynAIQ6oxTNwhw4UcF96VSCXyPUk/MNpg8nvPPfe0kbBIPGYy5CEhfqoz5A/5TDrpkHDZfI43XDfb+egjhCXfLZBeTz31lJUmTNUWkaiUxTkPOd2wEYFH5BVEA9czk3F9iAokN3Mm4zeQ3z/udfpA1J9MCDiii+hUIpW4j4no4nOJiehafI9AZv/www9W9hOCnHmWVNK1i0vrvxAQAkJACAgBIRBGQERXGJHCbovoKiy+Randl6HCsxFN/Ndff70obasRISAEhIAQiDYCTqLqwAMPNDfddJON+D388MNNt27dkmS9oj0K9Q4EfKKLnJxbb7111sBAaowcOdKWP+OMMxJ5a7KuQAVjjQCOYBA3DRo0MIMGDUpJCmUaIJPAyBM6Q+qPSc+wIWl3zz332HxK5L5ZY401bPQWEWTI+FVn33//vZk5c6YlO5D6CxuECjmdPv74Y0OuJaJ5XARXuKy/TaQYhFX9+vXt7nCOqokTJ9poNHfOjz/+aKUZIWCIWsumDXcuS4g+IsxSkTr16tWzUbUQcKnG6NeTr/H6dbr1fPUR4pGJcKLTsjGijLnO3I+QT1yTtdZay16fbM6vTRkm6IkA408mBEDAEV3ktib6M0x0QfCMHTu24sHyiS6+zyGXw3kFKx4kASAEhIAQEAJCoBoEeAfnXfy6666zeYRx2JJ0YTWA5Xgo1kQXsj1IjPia8JUY0YXHZ6dOncwpp5xiJTyQFUCSRSYEhIAQEAJC4JNPPrH5bQ4++GDrwU/Eb8eOHVNGTAitaCOQC9F16aWXmhEjRtgBnn766eaCCy6I9mDVu7wiQMTSjBkzbEQSkTC1McgMJOMgNohuOvfcc2tTTSTOCefoqqkUaDaDmDVrlrn44ovthDokG9Fvhx56qM2XmCknWjb156NMHPqYj3GqDiEQRiBMdBFBCpnPXAImomsxYkS2/fTTTzavIeQ0+DRv3tzgHCCrbARwxMDBmvvCLcPrNdmmDv6olz9yMfLn1sP7Xa7GVOX888Ll3DG/Xr8Otz9czm2nW/rnuTJuX7pluFx4253n9vMsgYMIf26du9DfZj28z5Vl6a/7Zf06UpVz+9z5rrzb77bd0pXzl/56deU45sbgyvn7XD3uGNtuX3iJgwvlkOl2Di+plhx35dwym3KUkQmBTAiI6MqEUH6Pi+jKL54lqQ2ZmM6dO1vSD+lCvNLwVJUJASEgBISAECA6Yq+99jIdOnSwXkR+Xkc8mGXxQSAXouuyyy4zt99+ux2siK74XHP1tDAIuEluV/sjjzxiJQ3ddj6XTFC5SZh81pvPuuLQx3yOV3UJgXfeeccQ6b7CCiuYX3/91Uql+kQXuanuvPPOigdKRFdxbgEIHiLmIIaIQPXX2cc2+9062+G/XM4N18V2pvocKVUchCqvFffc4JYgAPHllqy7bbtT/0qCANcHkswRachkQ36Fl65MqiXlw/tT1eHqDJf1t1Od5x9n3S8TPuZv++Ug/2S1R8Anuu677z6DKtv7779v1SlqX2tuZzrp9AsvvNByCbnVFq2zRXRF63rUqjfIyPBgTl4DvKuc11WtKtNJQkAICAEhUFYIfPjhh1amjCiuwYMHW2lbogqOO+44069fv7Iaa7kPJheia8CAAea2226zEBENz0OtTAhUKgL/+c9/bE4oN/4JEyZYOS63raUQEALljUAmogvpUXK6Vbq1bt3aSrGS7xBigxxmzZo1MzjXVrohcYsMK9HO4T/2L1y40EZSv/fee5aUigtebiLcn/B2+6qbaPcnxcPnZns+dbgJdZbuz5E9bptleF94O10Zt9/VxXmp9rn9/rHq9uX7WLb3i4v6csSXi/5yS3fcbbul2+8v3bpfJtU+d5ylW6dcprJ+Gb8sY/Xr8ut0627pn+fW053POXxv+X8QuP426+n2cb5/jPVs9mWqk+P0vdwMqW/y4JJrlXy2yHMjM05eXtb5W3XVVVPm6S03LMLjQVUFdZUhQ4ZY6cIoEV2+Ql6433HdFtEV1yvn9fvpp582Xbt2tcm2eejkoQpPVZkQEAJCQAgIAfSf99tvP5sT5qqrrjJvvPGGje7idwOtaFl8EPCJrsmTJ5ttttkm685ffvnlZvjw4bb8qaeeamWfsz5ZBYVAmSGwYMEC07Jly8SoiHbce++9E9taEQJCoLwRcPKl5N8jX11YulBE1+Lr7xNdTPBusMEGpmnTpjZdQnnfIf+MjnGT7xbCCg98nqtZkvsxasYkMrkl3R85EFOts49oRogr/pDTdesQNjIhIATyjwDfJYsWLbJ//O78/PPPNfrjHIIa3HkQb3E0vn/I8UvOR5ZunTy+5fr9I6KruHeqiK7i4l2Q1p588klz/PHHm7PPPtt6V5H4mocvmRAQAkJACAgBXswPOOAAc9RRR5krrrjC5nBs3769jQTGs0gWHwRyIboGDhxohg0bZgdLTs+LLrooPgNXT4VAnhFgcoAXbOdRixPAEUcckedWVJ0QEAJRRSBMdPXp08c6jrocXW3atDF33HFHVLtftH75RBffl40bN7ZONjjblKsxGf3RRx+ZF1980cpLvfLKK4borZoaJCqkIPcUElHrrbdeYgnJhJFygrqJCEu1dPtcxJjbZslkt/sNq2nfKA+5RT/Cf8svv3xin1tnLG7dlQ9v+/uJzJIJgSghwOca+c/ff//d/vnrbp9bho+Ft105twwfD2+7ckiCFsogiPhMu8/lcsstZ9fZ9v9S7U+1j3NS7YcQdwZp9/nnn5s5c+YkHACYd2C7NtagQQOz3Xbbme233960aNHCbL311paAr01dUTtHRFdxr4iIruLiXZDWHnvsMXPiiSeaHj16GKRX8FLF00gmBISAEBACQsBN5pDLkaieN99804joiud9kQvRBck5dOhQO3ARXfG8/up1fhHgJRrnMOy8886zEuD5bUG1CQEhEFUE3LORi+iC6CIVAAQ4JqJr8ZXbaaedEvm/y53oQtJ2/PjxBhLvyy+/XAxA8L9hw4Z2whdyiT9kx3yrV6+eletq0qSJ2XLLLQ1LIhSQ6yukMXFPfjkILxcdks0yXRkm5/NlbsLdTbCHJ8zr1q2biCJj3UWVcZ7/l2o/+/zzKZ9qH/sLfQ3yhVcc6+H+c7nc3JJ7CEci/tjn/vxtd9yVdeemKxve79dFHe4PMsmts3Tbbkk9xTLuO+5R7vtMy1Rl/H3+uqsr1T6OIbMZJfvmm29sAAbfrS4S9tNPP13iO9T1mTFwvZzx+7z77rub/fff3y4h0+NqKEeQL/v666+30oU4UkAKIudYKnM5uiRdWKorkKbdqVOn2qRp/oXBY4YHC5JKV4o9+uij5qSTTrIv6eTomjdvniEni0wICAEhIASEwFtvvWUOOeQQc8wxx9gHrPC2EIoPArkQXVdeeaW55ZZb7GBPPvlkc/HFF8dn4OqpECgAAv7nicnJhx9+uACtqEohIASiiAA5pw4++GAjoqv6q+MTXZRkYgwv+ylTplR/YkyOQhRBbN11110G8hODnMERgiUT5jNmzDBffPFFYkRrr722lb7dYYcd7JL5p3KQ24JAIMIMTPhjvbptojlqUpb6i21cF5eLiyWRZm6fywfmjrtj4f3+edkcc/WkOi/VMcpBIvMHeQSRyjLdNscy/XGuq8fVFd5mv9vnt+XWs2mj2NczU3tgCcEJYRJeQg6F94W381VGBGv6KwXRThqFV1991bz22muGeQlHboEb368uOnTu3LkJhzT2kYqBPOM77rhj5Ei99CNefEREVyaE8ntcEV35xbMktfFijnf2BRdcYCC6Zs+ebR/IStIZNSoEhIAQEAKRQuD111+3D4XHHXec6devn32g9ImvSHVWnakWAX9iftKkSVYSp9oTvINXX321uemmm+wenGN69erlHdWqEKg8BPr27WtGjx6dGDjP0M2bN09sa0UICIHyRcARXSuttJKNiCFHFw5BLqILL3L/+6F8kah+ZEwoMgmJGgCGdCERSzgcx9mI5h01apQZO3aslQ2E/IC4wmEacueJJ54w33//vR0iZGirVq0Medt22WUXs+GGG8Z56CXrO6Qh5Bj4su4ieVyEjr/016srlyraJ9W51dWRqnyqfRBAcTZIBIg2lu7PbbMkKs7fdmX889KVS7ff1eHXm2077tzq2qcuR1ZBblFWFi8E+H2B9HruuefMtGnTbMCG+6w1a9bMOldAYL700kuJSFtkYPm9RnJ8lVVWicWARXQV9zLFmujCk+j000+3eSYgejAePDbbbLOK8sr0I9uQLiQcdObMmcW9k9SaEBACQkAIRBIBHh47duxoTjjhBJtsXRFdkbxMWXUqF6Jr8ODB5sYbb7TtIHfcu3fvrNpUISFQrgi452c3vg4dOpjrrrvObWopBIRAGSPgnoV8oqtLly6W6GDYIroWX/ww0bXBBhtYmb6HHnoolnfHd999Z6Pbx4wZYwk8ZKPatWtnuA+YaCU3F7baaquZvffe27Rt29aSW0ymyyobARfh5CKeiIZy6+5YeOmOhyOn/HKUgWh1kWZM6vMX3k61L1ymuu3KvnoafVwQIHqWQA5+Y3Cw4LNCpN1BBx1kNt10U4OTCql7IMv53u7WrZv9K6UEYDbY3nbbbWbAgAHmhhtusNKFL7zwgnn33XdLStRJujCbK1eCMiK6FoOOV/eZZ55pZYgguiC5Pv744xJcETUpBISAEBACUUPg5Zdfth5PjtxwXsxM6PDAJYsPArkQXddcc419uGa07l6Iz8jVUyGQfwTw1ifpNZ7bGBOZSFQxUSQTAkKgvBHIRHTtscceNuKnvFHIPLow0RVXp2KIBuQJiW4nz9bqq69u89UyifrAAw+YhQsX2mgWrvvhhx9uWCo6JPP9oRJCQAgIgUIhAOk1btw4c/fdd5v58+fb5/Ndd93VKtXwvH7nnXfaiNwGDRqYCy+80H53R/UZPspE10UXXWQV4gp1HUtRryK6SoF6ntt88MEHTffu3a13Ng9qeCJ98skneW5F1QkBISAEhEAcEcBjqFOnTvYBhgcZl4C9c+fO5vLLL4/jkCq2z7kQXUSqDBkyxGKH91ufPn0qFkcNXAg4BFCG8HPN8PyMxI5MCAiB8kZARFd21zdMdMUxHzpqNz169LB5YcjzQm42omiYQ0FGj6gAnq+6du1qGjVqlB0wKiUEhIAQEAJFQQCHNCK8RowYYSO6aBSpcdIyfPDBB9YpBQlE5GevuOKKSMrLiugqyq2SaEREVwKK+K4QxXX22WdbSSqIrvfff9989tln8R2Qei4EhIAQEAJ5QwC9a0it0047zXo7iejKG7RFr8gnupigQbs8W7v++uvNtddea4uL6MoWNZUrdwQgtshZ+MMPP1g5LuRSouoNWu7XQuMTAsVEIEx0kbOPZyVyNGF77rmnGTlyZDG7FMm24k503XfffYZr++uvv5qtttrKrLPOOuaZZ56xsoVrrrmmlfXmukN2yYSAEBACQiDaCKBUc8stt5hnn33WdhTCiyhc5Miff/55K3NIHmqUa6L0PC+iq7j3lYiu4uJdkNbGjx9vzj33XNOvXz8bev/OO+9YoitKH+yCDFyVCgEhIASEQEYEeKE/9thjrcTteeedZ/iNOPDAA83RRx9tBg4cmPF8FYgOArkQXeTnIk8X5vK1RWdk6okQKB0CkF2vv/661f8nD4BMCAiB8kcgFdHFcxE5QDARXYvvgVatWpk///zTRkOxZ+ONNzZEdT366KOLC0T0/6JFi2xaB+ZJmBP517/+ZSULf/nlF7t+6qmnmqOOOsrUrVs3oiNQt4SAEBACQiAdAjju4sDJPAdGXk1+n+655x7z888/2/yKyPZHxYnBJ7pwwICUY06mXr16tv+l+OdydEm6sBToV9NmqhxdcU+QWs1w0x66//77DZOXl156qSW6yL8i6ZW0cOmAEBACQqCiEHjqqadsaP9ZZ51lnSJEdMX38ueL6Dr++OOth3N8kVDPhYAQEAJCQAjUHgGS3Ldv395OgjEpRtSPT3TttddeViap9i2Ux5lxJLoWLFhgiFznede3VVdd1aob4PwlpwYfGa0LASEgBOKJwGuvvWYdd/lNJ6/i3nvvbWbOnGlmzZplHVdGjRpl1l133ZIPTkRXcS9B2UV0VSLRBSN8/vnnm8suu8wSXXioffzxx0qgWtzPkloTAkJACEQSgSeeeMJG8JxzzjlW5lZEVyQvU1adyoXouvnmm81VV11l20HTnChwmRAQAkJACAiBSkQgTHTxm0g+UxfRxWTZ7bffXonQJI05THQh7ch8y2OPPZZULiobOPsiRThv3rxEl5j8hMREAQeySyYEhIAQEALlgwA5FydNmmQGDRpk5s+fb5Cl5Xv/iy++MA0bNjR33323jfYq5YhFdBUXfRFdxcW7IK0RntmzZ0/LZI8bN87w4A6DXadOnYK0p0qFgBAQAkIgPgggL3PSSSfZyN8zzzzTvPvuu6Zdu3Z2QocHQll8EMiF6Bo6dKhN0MtoSbjev3//+AxcPRUCQkAICAEhkEcE3njjDdOhQ4dERBe/iUjZiehKBnmHHXYwf/31l5V35Qj4IHf0+OOPJxeMwBaOvkcccYT5+uuvE70hl+kVV1xhczAmdmpFCAgBISAEyg4BpGmvvvpqM2bMGPP3338bCDAM4mvChAkljezyiS4U2cihjvxiKZ0vJF0Y0Y+ApAsXX5i77rrLalDzEAfRRZ6BGTNmSHM6ovetuiUEhIAQKCYCjzzyiDn55JNt5O8ZZ5whoquY4Oe5rVyIrmHDhiVysiHbg9yxTAgIASEgBIRAJSKQiejaZ599DBNTlW5homuzzTYzjRo1MqgFRMm+/PJL68TlSC4cfong4vl36aWXjlJX1RchIASEgBAoIALIGaJkM3fu3EQrRCNDdq288sqJfcVcEdFVTLSNKbuIrsaNG5smTZqYqVOnFhfJErZ25513mt69e1tJIoiuV1991Xz44Ydm+eWXL2Gv1LQQEAJCQAhEAYGHHnrIkHT7wgsvtLkJFNEVhatSuz74RNfEiRNN8+bNs67IPWBzwjHHHGPljrM+WQWFgBAQAkJACJQRAjiGHnrooYmILpw/iAaCyMFEdC2+2C1btrRe8UwcYptvvrlZZ511zJNPPrm4QAT+//bbb2b//fe3OcrpDvlYbrnlFtO0adMI9E5dEAJCQAgIgWIj8NNPP5kePXoYlG2ctWnTxowcObIkzg/Dhw83l19+ubnxxhsNqYeiFNF18cUXW6cQh1M5LGNNdE2ePNngne5fmEokugjN7NOnjw3THD9+vHn55ZfNBx98YFZcccVyuEc1BiEgBISAEMgBgfBvpYiuHMAs8am5EF3kGiGXJyaiq8QXUs0LASEgBIRASREIE138Ph5++OEJomvfffc1TExVuoWJri222MKstdZa5qmnnooMNN26dUtIKbZo0cJG4tWvXz8y/VNHhIAQEAJCoPgIIF04ePBgc9NNNyUahz84//zzE9vFWhHRVSykF7cjoqu4eBektdGjR5u+ffuaa665xkoXvvTSS+b999+3HmoFaVCVCgEhIASEQGwQePDBB0337t1t5O+JJ55o3nvvPXPAAQfYXBRI3srig0AuRBcebC4vV5cuXcyAAQPiM3D1VAgIASEgBIRAHhEgQumwww6zjqHk9RDRlRrcqBNdfrR6q1atbG6WunXrph6M9goBISAEhEDFIeA7ezJ45s933333ouLgE13k6HruuefM9OnTzWqrrVbUfviNuRxdfuCQfzzO6yK64nz1/td3N3l13XXXWaLrhRdesDlYVllllTIYnYYgBISAEBACuSCAHvXZZ59tLrnkEnPCCSeI6MoFzBKfmwvRdccdd9h7gCEcffTRiXxdJR6SmhcCQkAICAEhUHQEkPrv2LFjgujC+YNtJ12oiK7Fl2T77bc3Sy21lE2NwJ4tt9zSNGzY0Dz99NNFv2bhBp1CAfuRK6RPyy67bLiYtoWAEBACQqDCEUAykOguZ0R1r7HGGm6z4EsRXQWHOKkBEV1JcMRzwzHU119/vYEdfv75580777xj6tWrF88BqddCQAgIASGQNwSQtCUhd79+/cxxxx0noitvyBa/olyILidzTK87depkBg0aVPwBqEUhIASEgBAQAhFAIEx0kTuDCC8RXckXJ6pE16JFixLXih4rbUPyddOWEBACQkAIJCNAuh/eh7Gdd97Z3HXXXckFCrgloquA4KaouuyILsLvtt56azNlypQUwy3PXS5k/4YbbrARXVEIgyxPpDUqISAEhED8EMAB4rzzzjMkWj/22GNFdMXvEiZ6fMQRR9g8nOyYOHGiad68eeJYppWxY8eaXr162WJHHXWUkWxlJsR0XAgIASEgBMoVgVdeecXm5CKnNdKFAwcONIceemiCPGnbtq0ZNmxYuQ4/63GFia4mTZpYL/hnnnkm6zoKUXCjjTYy//3vf23Vb775pmnQoEEhmlGdQkAICAEhUCYI/PXXX4acji7HJIEihxxySFFGJ6KrKDAnGhHRlYAivis8hPNwTpK9cePGGR489cAX3+upngsBISAE8onAfffdZ5Oukn/imGOOEdGVT3CLXFcuRNfdd99tLrroIttjIsOuvPLKIvdezQkBISAEhIAQiAYCYaKLKOcOHTqI6ApdnjDRtdVWW1lS6dlnnw2VLN7mrbfemohKJw9ts2bNite4WhICQkAICIHYIoBjyzbbbJNwlEACtxgpf3yiizl7fkPfeustU79+/ZJhqRxdJYO++oYnT55szjjjDOMnT6vEiK6hQ4daz+xbbrnFSheiT/3GG2+Y1VdfvXoAdVQICAEhIATKHoF77rnH9OzZ0zpEkJvpvffeMwcccIBRVE/8Ln0uRNe///1vc8EFF9hBU89VV10VPwDUYyEgBISAEBACeUDg5ZdfNvwWrrDCCubXX3+179Lt27dPEF377befgVCpdGvRooVZeumlDcQghnLOaqutZlCQKYXNnz/ftGrVyjaN8xZOXDIhIASEgBAQAtkiMGfOHLPLLrvY4qijoJJSaBPRVWiEk+svq4iuqqoq07hxY8vQQoJVit188812woqHcSSqnnzySfPaa6+ZNddcs1Ig0DiFgBAQAkIgDQLoT+MQglQd5JaIrjRAxWB3LkSXi+xjmIcffri5+uqrYzBidVEICAEhIASEQP4RCBNdRDkjYeRydInoWox5lIguN9fj7obZs2e7VS2FgBAQAkJACGSNANHA3bt3t+UfeeQRs8UWW2R9bm0K+ipszNkroqs2KGZ/joiu7LGKbMkbb7zRDB482MASM5H1xBNPGBLsNmzYMLJ9VseEgBAQAkKgOAjceeedpnfv3tYhAqJERFdxcC9EK7kQXcgk9OjRw3arY8eO9rmhEH1UnUJACAgBISAEoo6AI7qWX35589tvv9lnpIMOOshsvvnmtuv777+/QTWl0i1MdCH5VK9ePTNt2rSiQ0OaBuekQ0SZk10qekfUoBAQAkJACMQegU022cT88ccfdhyFdpzwia6opBtyv6G+Ql7sL+r/BiCiqwyu5A033GCuueYac9ttt9mIrscee8wmq19rrbXKYHQaghAQAkJACOSCwJgxY0yfPn3s5ACRPGhRt2vXznTq1CmR4yCX+nVu8RDIheiaMGGCOfvss21nDzvsMPvcULyeqyUhIASEgBAQAtFB4KWXXjLkq1xuueXMokWL7DPSgQceKKIrdIm22247U6dOHTu3wKGmTZualVde2Tz//POhkoXd/Pzzz03r1q1tIyIhC4u1ahcCQkAIVAICP//8s2nSpIkd6rXXXmsOPfTQgg07ykRXr169zEknnVSwsZeiYhFdpUA9z20OGTLEXHfddWbEiBE2ouvRRx81PLyvvfbaeW5J1QkBISAEhEDcEBg9erTp27evJTYgOER0xe0K/tPfXIguX6KBB3ke6GVCQAgIASEgBCoRgRdffNHKOdetW9f8/vvvNsoZJyAX0UUuU/JfV7qFia5mzZqZFVdc0bzwwgtFhQZSkvkNbPr06TZPWFE7oMaEgBAQAkKg7BA47bTTzNSpU+24Pv74Y7PMMssUZIwiugoCa9pKy4ro+vvvv80GG2xgPY0mTZqUdtDldoDJquuvv96MGjXKEl0PP/ywffhcd911y22oGo8QEAJCQAjUEIGRI0ea/v37W4eIDh06iOiqIX5RKp4L0UXu0jPOOMMOp3379gYnGZkQEAJCQAgIgUpEIEx08T5NpJCIruS7IUx0/T975/JK3RfG8cerTpQZSrmV60wdIQPJLbdEZsQRSUb+BAbuZOqSUCL320AyIGTgUq5F5koppibo/PquX1vn3fGSs/e57e9T72A7+zxrrY99nPWu73Ox2+2Cco/g5ylDmUKHw6GGa2lpUeW4PTU2xyEBEiABEghcAihdrH3vo9UDvmPMMApdZlD92ieFrq/Z+M0r6M+FPl3T09OyuLgoW1tbqm52XFyc36yBEyUBEiABEjCHwMTEhHR1damACDRaZ0aXOZw94dUdoQvRaohag+E5QIAMjQRIgARIgASsSAAZSSjhbLPZVI8OVEcpKyv7OPBCdtfw8LAV0fy1Zm8LXU6nUwmQt7e3al4nJycSFRX11xx5QQIkQAIkQAK/JQBxC+1/YHd3dyqY47e+vnofha6vyJjzc78WupC11dbWJlpNSatmdKEpK5qzog/L0tKSbG5uChu0mvOBoVcSIAES8DcC6N/Y3d0t6OdYVVUl19fXgj4UdXV10tvb62/LsfR83RG6tre3pbW1VfHDc4DngUYCJEACJEACViSAHlPYB6H/1Ovrqwr+KCkpodClexjS09MF5R21soH6a93thl/i8FGLsKf4aDheOiQBEiAByxPQzkYAoqOjQ5qbmw1nQqHLcKT/dEih6594/OPFgYEBVUN8dnZWCV0QAPf391UZR/9YAWdJAiRAAiRgFgHXjRUELm0zR6HLLOLm+XVH6HI9LKqsrFSZ4ObNlJ5JgARIgARIwHcJaEIX+nG8vb2p4A8IXampqWrS2C8hkNTqphe29Ndm80HJ7bOzMzXMzMyM5Obmmj0k/ZMACZAACViMQGJiotoLREZGyvHxseG9ulzPY1ZWVtR5/fn5uYSHh3uNdHx8vBpbSxzy2kRMGDighK7393dJSEgQNElF03WrWF9fn4yNjcnc3JwqXYi17+3tKRZWYcB1kgAJkAAJfE5gdHRU+vv7VUAEmqtfXV0JhI76+nrp6en5/E38qU8ScEfo2tnZ+YhQ4wGeT/56OSkSIAESIAEPETg8PFT7IE3oQhuA4uJiCl06/nphS1/KUHe7oZc3NzeqbCGcRkREyOnpqQQHBxs6Bp2RAAmQAAmQQHt7u6qQBhKohoP9gJFGoctImt/7otD1PSOfvwMHlePj47KwsKCErvX1ddnd3ZWkpCSfnzsnSAIkQAIkYC4B9JgYHBxUARHoP0Ghy1zeZnp3R+hCAExjY6OaHgTPkZERM6dK3yRAAiRAAiTgswRQ5t/hcCjhBMGy2CsVFRV9CF3MfP7/V6cXujIyMhQz9Moy21BCCj3IYaxCYDZt+v8pgcfHR3l+fpaUlBTDsz5+OgfeRwIkYCwB14BQZHfjfN1IcxW6VldXVWIKspURxOEtY0aXt8h/M66+R5dVM7rQewWq8+Liovq3trYm+KAmJyd/Q5AvkwAJkAAJBDoBRCkPDQ2pDRs2bpeXl6pXFw548P1B8x8C7ghdBwcH0tDQoBZbXl4uyPSjkQAJkAAJkIAVCWhC158/fwR9vvGdWFBQQKFL9zB4S+jCuU5WVpY8PT2pGU1NTUlhYaFudrwkAc8SQNBYU1OTOJ1OiY2Nlfz8fCktLZXs7GyPZBve39/L/Py84O9WbW2tREdHexYARyOBACXw8vIiaWlpqmenzWaTi4sLCQsLM2y1FLoMQ/kjRwGV0YX62qitabfbZWNj40cAAuGmzs5OmZyclOXlZSV0oeYnenFoNcYDYY1cAwmQAAmQwO8IUOj6HTdffJc7QpfWjwTrQmYfSh7TSIAESIAESMCKBLTgj6CgIHVojUOovLy8j/8/V1VVqb5dVmTjuma90JWZmSlghjKCZhp6l1RXV6shQkJCVJBWaGiomUPSNwl8SwDB5Z8FCaLPDqolVFRUCD4jEKKMtoeHB8nJyRGIwDB8LlCpAYGLMTExRg9HfyRgOQI1NTVydHSk1o3gFwSGGmUUuowi+TM//wEAAP//OuNRuwAAQABJREFU7J0HuBRF1oZLV0VRMBAMoD8KGDFnMaMYEFSUVcwJzCgqICqKillRVAyYM4hiznFVkhmUIOacFQTz7s5fb7GnqWkmd8/cnplznufeTlXVVV/3dFef74QFUlZMlcrDDz9sjj/+eHP66aeb3r17m3//+9+mbdu2Zv311zcPPvhglY6q+G4PHjzY3HLLLeb+++83o0aNMvfee6958sknzRprrFF8Y1pDEVAEFAFFoKYQGDZsmBk6dKi58cYbzY477mjeeusts8cee5iDDjrInHvuuTU11lofzD777GMmTJjghsk8h/lOoTJ+/Hiz7777uuI77bSTGTFiRKFVtZwioAgoAoqAIlBTCLz44ovm4IMPDsbEO3GbbbYxq622mtu3++67myuvvDI4Xq8rG2ywgWnUqJFhDoFssskmBvXRa6+9VlZILrvssgD/bbfd1tx2221lPZ82rggUgsBPP/1ktthiC/P7779nLb7CCiuYQw891PTs2dM0adIka7liD9x6663mrLPOylgNvd9WW21ltt56a/cb5TdbDvnvf/9rPvzwQ/Pmm2+a999/33zwwQcOi80339yde7311jMLLrhgOU6tbSoCZUfgqquuMpdeeqk7D9/MF110UWznvP766835559vrr76aqe3f+GFF8wbb7xhmjdvHts5im3o//7v/1wV4VOKrZ/k8gso0ZXky1NY384880w3+XvggQfMPffco0RXYbBpKUVAEVAE6gKByy+/3FxxxRXm5ptvNp06dVKiq4qvehSia+LEieaf//ynG70SXVV8E2jXFQFFQBFQBCIjECa6MAZCUaxEVzq0YaJr0003Nf/5z3/M66+/nl4w5i0MsjDMQlDuH3bYYTGfQZtTBEpD4J133jHHHXec+eSTT3I2sPjiizuyi3u3VatWOcsWchA936mnnpq3KCQXv1OeZ/xFNX7//vvvzUknnWSmTJlifv31V/PHH39k7QNKewwIjjrqKLPIIotkLacHFIEkIgDx1L17d9e11q1bm7Fjx8bWTZ/oGjNmjHn++efde7RFixaxnaPYhpToKhaxCpVXj665QA8aNMjcfvvtzott5MiRhr/HH3/crLXWWhW6EnoaRUARUAQUgaQiIFaxWAJut912SnQl9UIV0K8oRBdKqb322sudBc8+lHoqioAioAgoAopAPSIQJrowBurYsaMSXaGbAc/xxRZbzIwbN84dqQTRNXv2bLPuuus6Qo2TPvPMM2bVVVcN9Uw3FYGGQ4BIUkRWQAc3adKknB1ZaKGFXCQNSKooSu2ff/7ZGSz++OOPOc8XPrjKKquYww8/3Oy9995m0UUXDR/OuY3in8hZP/zwQ85y4YOrr766M7KMSrKF29VtRaCcCPz9999m7bXXDjw2X3nlFbPiiivGckolumKBseBG1KOrYKiSWxBXwzvvvNNA/EFy3X333ebRRx91P9Lk9lp7pggoAoqAIlAJBHDBxxWfsC+EfyHcxJ577uks7s4555xKdEHPERMCUYguCVlJV/DsQ6mnoggoAoqAIqAI1CMChA065JBDgqFjDET4LfXoCiBxK2Gia7PNNjMoA1GAl0t8EhJigDCJCyywQLlOp+0qApEQmDFjhtPD8a2VS5ZYYgnTt29f99yB/CpF8K7CQ2zy5MlFV19mmWXMgQce6L7/mjVrlrc+5yD84pw5c/KWzVRg4YUXNv3793dEWabjuk8RSCIChCyUUL2kfhAj0ah9VaIrKoLF1Veiqzi8Ell64MCBAbkF0SWkF5ZQKoqAIqAIKAL1jcAll1zi4kFjdUj+CXHLR8Fz9tln1zc4VTb6KEQXFqfdunVzI95+++1dbs8qG752VxFQBBQBRUARiAUBwgaRR0cEYyCILvEcInQeOU7rXcJEFxj9+eefzmiqXNiIgRbt77bbbmb48OHlOpW2qwjEgoDkQ6YxSKR27dqZV1991eWzC5+AZww5kiGNS5GTTz7Z3HfffUHV5ZZbzlx88cWG/GEo6CHxv/vuu+B4eKVx48YGpTv5vLLJ559/brp27WrwIsskPBeOPvpo0759e4MHJnm7CK3ImMOCrpJQhiqKQDUg4L9/IIaHDBkSS7eTTHSdccYZplevXrGMMymNKNGVlCsRoR+4QfNieeyxx5xH1x133GEeeughQzJIFUVAEVAEFIH6RoBEqtdcc40zgiBWu4SwQ8EzePDg+ganykYfheh69913TZcuXdyINbF7lV147a4ioAgoAopArAg899xzaXmf+H4mLJ8SXekwNwTRdcABB5iXX37ZdQSDLN/zLr13uqUIJAMB0cfRmw4dOji9HDm8Ro8e7fRz4dB/eChSpxQCqE+fPk7XJyNHEY9CXiSVSpm3337bPPvss+5v+vTpcihY4lFG/mbIrExCqEPqZxJycPG7zORlSVQpvLjI5SVCOZT85AdWUQSSjgD3Pfc/ss4665hHHnkkli77RNcDDzxgmIPgrdyyZctY2i+lEcnRpURXKeiVsU44Rxdu9FhPkDSVm6dehJfJqFGjzBNPPOEIL8nXxcRURRFQBBQBRaC+EbjwwgvNtddea+666y6z5ZZbukkVcdoJfUGCb5XqQSAK0TVt2jSz8847u8Eq0VU911x7qggoAoqAIhA/Ar4yi9YJ/b/RRhsFRBchnlEE17s0BNGFsa54kmg6hnq/A6tj/HhoSe5bSCQ8nEQgfS6//HIXSYHcXr4QJu28884zxYQy9L8FaGvChAlm+eWX95tNWyenF2Xw+oJ8E1lwwQUNIex9koxjYW9XKY+nWufOnV2dRRZZRHbPt/zoo4/M/vvvb7766qvgWJMmTRz5J4r14ICuKAIJQwBSesMNN3S94j7n+7mY32e24SjRlQ2Z8uyvKY+ueiW6+vXrZ+69917z5JNPOosRYoyPGTMm+IGW59bRVhUBRUARUASqAYHzzz/fWdLh+bvFFlu4sBI9evRw1kpnnnlmNQxB+/g/BPyPW5JgF2PQ8t5777kPVJoiXAnW6yqKgCKgCCgCikA9IvDMM8+YI444Ihg64f8xlhWPLiW65kID6bT44oubsWPHuh3MI3///XdD3s9yyDfffOM862h70UUXNVOmTIlFyViOvmqbioAgcMEFF5jrrrvObaIcf//99+VQsIT8wsBQvBXlAEaIKMHJ4VWIMPcnTCGy4oormldeeaWQai7kKN+E6Ap98SNB/fXXX2aHHXYwn376aVCEUIeDBg0y//znPwv+LUJ2kdtI+kljhGrEOF9FEUg6AtyrX3/9tesmRjGE6IwqI0aMcKQ2ufz4hlePrqiI5q6vRFdufKriqMTpffrpp51H1y233GLuv/9+Z5VWFQPQTioCioAioAiUDQEsBZlcocQht8LEiRPdxwoKHj5cVKoHgShE1wcffGA6derkBstHNR5+KoqAIqAIKAKKQD0iECa6MBqF1BGiq3v37s4Lox6x8cccJro6duzowpIRGq0c8tJLLwUeJvUWpacceGqblUGAUH4333yzO9nSSy/tQgdmOzPG6aeccorLbSVlmJeTJzCf54jvbUJdDBfJKVSoTJ061YUC/fbbb4MqeF9BgCEo4f32ILnwdi3GsE4aluhbss3yX//6l2nTpo2/S9cVgcQh4IfuhMDeZZddIvdRia7IEBbVQE0RXVggwLbiaohHU71I37593Xhhm7HYv+mmm1w84E022aReINBxKgKKgCKgCGRBgNjtN9xwg7Oiw0KJ8BUQJiQdJSazSvUgEIXo+vjjjw0hCxEUVXy4qigCioAioAgoAvWIAAaifvL1++67z6y77rqB5bYSXXPvijDRhUJ+9uzZZtKkSWW5bVD2S7SBgw46yBASTkURSDoCp59+usuFTD+XWWaZvB6P5M0lF52E6KQeynW599nOJD4RzHHC0/fs2XO+ov/5z3/MF198YZj780f4tVdffdWthwsPGDDAHHPMMc5TE0ILj00RQi7yLCxVIAgg10SGDRtm9thjD9nUpSKQSAQgeyF9Efl9RO2oT3ThRYnunt/ksssuG7XpkutLKFHN0VUyhOWpKFYCvFh69+5t6pXoOuGEE5z7I/F0Ibp8hWZ5kNdWFQFFQBFQBKoFAYkbj7UyidaV6KqWKzd/P6MQXZ999pnZaqutXKN49uHhp6IIKAKKgCKgCNQjAk899ZTTH8jYye/doUMHJboEkP8tK010kTMIo13koosuMuQwUlEEko7ASSed5CIq0U9CffrkTra+T58+3Xlk/fLLL0GR4cOHm9122y3YDq+QcxlyS6Rly5ZOUY4X2ZJLLmn++OMPl4eLXFykdcknG2+8sdMfLrzwwmb8+PFpv7c4oj9gTIBRgQjebGussYZs6lIRSCQCwjPQOYhk/zdXaoeV6CoVudLqqUdXabglqlafPn0MrPALL7zgXlR+iKpEdVQ7owgoAoqAIlBxBCScBtbKfNDIhwwGIhiKqFQPAlGIri+//NLlaGO0Gie/eq659lQRUAQUAUUgfgTCRBc5M9Zaa62A6CK/zNChQ+M/cZW1GCa6MJiZNWuWmTx5cllGcuSRR7q84zRebC7SsnRIG1UECkAAj6jHHnvMlST8IPm4ChFCqEIGpVIpV7xp06Yudw8EViY59thjzaOPPprpUNH7yLlFzjDJDXbllVeayy67LGiH7d133z3YLmWF+hLmdLHFFnOeZQsssEApTWkdRaBiCOABufPOO7vzEQ0FT+OookRXVASLq19TRNeff/7p4mpvtNFGgUVFcXBUZ+njjz/ewDq/+OKLjugimSWeXSSLVVEEFAFFQBGobwQGDx5s/NyN48aNc9ZJKBNOO+20+ganykYfhejyE7wT2nj06NFVNnrtriKgCCgCioAiEA8CeBYwDxJ55JFHnKdBu3bt3C4luuYiEya6tt56axdu7Z133hHoYl0S1uytt95ybU6ZMiVQwsd6Em1MEYgZAT+nD03PmDHDNGrUqKCz+F6MVMCLEW/GTLLddtuZjz76KNOhvPuWW245s/baaxt0pTvttJNZeeWV0+oQKpQcWiKEJ11qqaVks+jlzJkzXW6v//73v64unlw8d1UUgaQjILwC/YzrvlWiq7JXXYmuyuJdlrOJZQcxeyG4cGkmyTzuxiqKgCKgCCgC9Y0A1nq33nqry+VIDsuxY8ea/fbbzxx11FFm4MCB9Q1OlY0+CtH1/fffu49bhoxnHx5+KoqAIqAIKAKKQD0i8MQTT7h5kIz98ccfdwazQnTtvffead4NUq7elpUmutBffP755y4cG/lLVBSBakDgsMMOc55Y0tc33njDNG/eXDZzLn/88UcXaYE0LAihD19//XXTuHHjtHrkzlpzzTWNEEdpB/+30aRJE+eZynOM/DsrrbSSWXHFFU2bNm1cu5nqyD5/DIQyhKxbcMEF5XDRS/SSp556alCvkBxkQWFdUQQaGAGcRoiGgnfla6+9Frk3PtGFkwrenBMnTjQQ0A0lmqOroZDPc16JnSk5uoR5rTePrqOPPtowOX/llVcc0UVs3zvuuMNgcaWiCCgCioAiUN8IDBo0yNx+++1BCBjeFfvvv7/h3eF/gNQ3StUx+ihE108//eQsKxkphOeYMWOqY9DaS0VAEVAEFAFFIGYE+HZmHiSCpwHKYSW6BJG5y3XXXdegPGfuiGyzzTYGxfy77747t0DM/0XxpiGWYwZWmysrAkcccYRTXMtJis1Fdcopp6RFWsBwfdddd5Xm3JLfXJcuXYJ9eIzhmYXus1WrVmaVVVZxXlqlhgYcMmSIueGGG4L2n3/+edO2bdtgu5gVSDmeFd9++21Q7e677zYdO3YMtnVFEUgyAuTmIgoO8umnn0buKr8tfmOEBMWDXImuyJDmbKCmPLpIvrjaaqvVnaUyVvlYpWGlj+XE1Vdf7ZSavFxUFAFFQBFQBOobgTDRhffvgQceaPAG7t+/f32DU2Wj94kucnNiaV2okFNjnXXWccXXX399R3wWWlfLKQKKgCKgCCgCtYQA+XTIqyOC0glFsSh21aNrLjJhoot8JXiIE1YwbsFTRcKpkT/okksuifsU2p4iUBYExPBcGufbC/KrUGFO36dPn6A49z6/AV9Qjh933HHBrjPPPNPgJRWXjBw50gwYMCBo7vLLLzfdu3cPtotZoW9+XqP27du7sIXkL1NRBKoBAXQko0aNcl19//33zSKLLBKp20p0RYKv6MpKdBUNWfIq9O7d25BQd/z48QZLiauuusq9WJiIqigCioAioAjUNwJnnHGG8/IVYoT468Rh52OpX79+9Q1OlY0+CtH166+/upAnDBmCjPtBRRFQBBQBRUARqEcEHn30UWfwI2PHewFvIiG6evToYS699FI5XLfLMNFFjiC8NKZOnRo7Jv485aSTTjInnHBC7OfQBhWBciBw4YUXuvQh0jYhOEklUoj88ssvBmL9vffeC4pnIrquu+46c8EFFwRleIaRcysuITwb/RDBU4ww58V6iF122WXOa0XaYalpVXw0dL0aEMDzinsZmTx5sllyySUjdVuJrkjwFV1Zia6iIUtehV69epmnn37aTJgwwXl0DRs2zNxyyy1m++23T15ntUeKgCKgCCgCFUWA8L533nmnIdwvCosXX3zRHHzwweb44483hMpQqR4EohBd4vXOaPHswjJURRFQBBQBRUARqEcEwt4RzI3IZaNEV/rdUEmia+bMmW6eSg8gGSEbVRSBakCAcOB9+/YNuorn0ltvvWWaNm0a7Mu08tlnnznDw0mTJqUdxuO0Q4cOafvOPvtsc/PNNwf7XnjhBeeFGuyIuAKBvckmm6S1Qqg1ooAUInPmzDF8cz744INpxffYYw+DflJFEagmBO69997AILiYnHvZxugTXZDUor9ffvnls1Up+34JFYxRNJxCLUlNEV3Egl199dXdA3r06NG1dJ1yjgWX5WeffdaQsBWPriuuuMK9BDt16pSznh5UBBQBRUARqH0EBg4c6N4NYvnHh9EhhxziQmScfPLJtQ9ADY0wCtH1999/B7lH+HjmI1pFEVAEFAFFQBGoRwQk17eM/eWXXzYrrLCCEl0CyP+WlSS6yP21wQYbuDNrvvHQhdDNRCMAYbX11lubVCoV9DMbEUUZct5hmE4ZQnb60q1bNxehyd/HOqFW/bk75Bo5d+MU/zuDdvHmgrwiDGMuzy6iS0HEffnll2ndgTjDmytq2Le0RnVDEagAAhIBh1Ph7diyZctIZ1WiKxJ8RVdWoqtoyJJX4bDDDjPPPfec+wGSo2vo0KHmxhtvNDvuuGPyOqs9UgQUAUVAEagoAqeeeqrz9hXrQMLzHHrooS4kDKFhVKoHAf8DVEJRFtp7P/fFmmuu6XJ7FlpXyykCioAioAgoArWEQDgnDknnl1122YDo0hxRc692mOgiYszXX39tpk2bFvvt8NNPPxlyiCJPPvmkWWONNWI/hzaoCJQLATE+l/blHv7Pf/5jPv30U0OeH8IT4vH04YcfSrG05VprrWXwJFliiSXS9rPhfwOwTVg1P9Qg+6IKuQoz5RaDgCa38xZbbGEaN27sTvPNN984rxSMBiACwsJvmTxdUUO+hdvVbUWgEggQnneXXXZxp1KPrkogHu85lOiKF88GaQ3LfKxB+AHi0cVLD8a4c+fODdIfPakioAgoAopAchAgsTAJhh9//HHDBxSGERhInHjiiWlhNpLTY+1JNgT8j9xiiS7aJMk7hBfKIz7AVRQBRUARUAQUgXpEIEx0kQKgRYsWSnSFboZKEl2zZ88OwrXFYUEfGopuKgJlRQCPRPRvP/zwgzsPpPBXX33lSC2iKuSTvfbay5x77rlm8cUXz1h01113NVOmTAmOlSPXMt8I5MaDvMokeGbxLUEkLbzYsgnfK+edd55ZeOGFsxXR/YpAohHwQ3nGnaNLQxeW/9LXFNH122+/OeXNpptu6iwhyg9fMs5ArhXiir/55puO6CKm9YgRI8xOO+2UjA5qLxQBRUARUAQaDIH+/fubUaNGOQ8ePHkIdYvVIbHkIbtUqgcBn+iSnGvF9L5du3aGj+3VVlvNWWEWU1fLKgKKgCKgCCgCtYIAXhUodEUgVpo1axbkvFGPrrnIhIkuUiMQnmz69OkCXWxLP8TyBx98oEry2JDVhuJEYPjw4U7vBqEFOYvH1qKLLuo8HWfNmlXUqRZccEEXhemoo44KwnZma2CbbbYxn3zySXC4XLmvILsGDRrk8jsHJytwZZllljGDBw82u+++e4E1tJgikEwE/vzzT7Pqqqu6zs2YMcM0atQoUkc1dGEk+IqurERX0ZAlr8JBBx1kiCFKwktCF1588cXmuuuuC1wtk9dj7ZEioAgoAopApRDo16+fM/6QEBoSloKwhb6Sp1L90fOUjkBUoguC648//jDt27d3hGfpPdGaioAioAgoAopA9SLwwAMPpBn7YDC61FJLKdEVuqRhomuHHXYwn3/+uQvBFioay+b//d//uXYI9aaiCCQNATEWjNovDM8Ii9azZ0/TqlWrgprr0aOHefXVV4OyvXr1MmeccUawHfcKXq/XXnttQWFK8fTabbfdXH8wGFBRBGoBgTjfRz7RRToJ8tqNHz/e5QZtKKxkfDxHeJ7UkijRVQNX84ADDjAk0J00aZLz6LrooovcSwn3ZhVFQBFQBBSB+kYgTHQ9/fTTbjJz8sknmz59+tQ3OFU2+qhEFx59v/76qwvNRK42FUVAEVAEFAFFoB4RGDNmTFr4Zr6jmzRpokRX6GYIE13kAIeEwsK9HCKKNyW6yoGuthkVgTBBXkh7LVu2dPNuvEOIPLXZZps579FC6vplRFHOPkICQrq1adPGL1KWdfSMfDPwm+QPg7nFFlvM5TTk/HiabbnllkHurrJ0QhtVBBoAgTjfR/L7vfLKK40SXeW/mDVFdKG8QYnDy4MwTfUi++23nxk7dqx55513HNF1wQUXGFyqsapQUQQUAUVAEahvBE455RQzevRoZzm0+uqru2Xv3r0N+48//vj6BqfKRh+V6FpnnXUMYVVWWWUVl9uzyoav3VUEFAFFQBFQBGJB4P777zd4touQ+6Zx48Yu/wz7NHThXGSU6JI7RJeKgHHhv7t162amTp0awNG0aVNHOEH6rLTSSs5Da4UVVjCtW7d265BCcUgqlXIeU3PmzDHHHHOMC0MeR7vahiKgCGRGIE6i68Ybb3Q5+IYNG+bypqtHV2bM49qrRFdcSDZgO7g8jxs3zrz77rsudCGJH6+66irDS1hFEVAEFAFFoL4RwHPrvvvuczmZCF3HxEqJruq8J1C8TZw40XX+kUceMRBXxcgGG2xgSJbNxzghj1UUAUVAEVAEFIF6RIB5EfMjkWnTprk8OyuvvLLbhWEJ6QDqXcJEV+fOnc3HH39s3n///bJAE6disSwd1EbrHgFyckGMk18LMouQpyqKgCJQewjE+T5Soquy94cSXZXFuyxnEwtvLEvuvvtuM2TIEINLpCaBLAvc2qgioAgoAlWFABbLWC6Tm4uwGeTqOvLIIw0hDY877riqGku9dzYq0bXxxhub7777zlmcEopERRFQBBQBRUARqEcE8HTHs10E4mahhRYKPLqU6JqLDAY1Sy65pEuTwJ6ddtrJfPjhh+aDDz4Q6GJb/vXXXy6HKA1q6MLYYNWGFAFFQBFQBIpEAA9KDEORTz75xCywwAJuvdR/SnSVilxp9ZToKg23RNXyia577rkncIncY489EtVP7YwioAgoAopA5RHo27evIRcFsdzbt29vnnjiCXPUUUeZ/v37m2OPPbbyHdIzloxAVKJr8803N1999ZWzQCXksYoioAgoAoqAIlCPCNx7773O4EfG/tFHHzkPDVFsKdE1F5lKEl0//PCD2XDDDd2JleiSO1OXioAioAgoApVGgFx0RMJB3nvvPefxHaUPN910kznnnHPMFVdc4XQxGrowCpr56yrRlR+jxJfo0aOHefXVV8306dOdR5f8gPbcc8/E9107qAgoAoqAIlBeBE488URD8uTnnnvOtGvXzsWFPvroo82AAQNcjPfynl1bjxOBqETXVlttZT777DND7oDx48fH2TVtSxFQBBQBRUARqBoEfKILS20stn0L7n333ddcdNFFVTOecnU0THTtvPPOLmwhXl1xC15inTp1cs0q0RU3utqeIqAIKAKKQKEIzJw50xC6F5k8ebLzbC60bqZySnRlQqV8+2qK6CIx41prrWWwWB45cmT5UEtYy3vttZd5/fXXzYwZMxzRNXjwYDN06FDDfhVFQBEoHAFeaEsssYQLXVJ4LS2ZVAT0es69MieccIJ58MEHzfPPP2/atm1rHnvsMUdwnXrqqQbCS6V6EPCJrkcffdSsvfbaRXV+u+22M1itL7/88mbChAlF1dXCioAioAgoAopArSAwatQo59nOeAhZKMSN5ORQomvula4k0YU+Q/QXSnTVyi9Nx6EIKAKKQPUh8O2335pNNtnEdZx3U4sWLSINQomuSPAVXVmJrqIhS16F7t27mzfeeMNZVxG68MwzzzSXXnqpwdNLpXQEJk2aZJo0aWJWWWWV0hvRmlWDAPmLevfu7a75bbfdZtZff/2q6bt2dH4E9HrOwyRMdEGQELJw4MCBLoThvJK6lnQEohJdO+ywg5srLLvsss4TPOnj1f4pAoqAIqAIKALlQACjWDzbkUaNGjmDUdaV6AKFeVJJoovIA4cddpg7uRJd866BrikCioAioAhUFgHeQVtvvbU76bhx40yrVq0ideDmm282Z599trn88stdvnQNXRgJzryVlejKC1HyC5CL66233nKWaHfffbcZNGiQueSSSwwKMZXSECCHCZ6BCy64oLnuuutc4t3SWtJa1YIALx1i5iKrr7664eWjUr0I6PWcd+369OljHnroIfPCCy844v6RRx4xxx13nDnttNPMkUceOa+griUegahEFyGHpk2bZpo3b+4MZBI/YO2gIqAIKAKKgCJQBgQwDsWzHVl88cXN1KlT3boQXT179jQXXnih21fP/8JE1y677OLyleAdHreQT5a8sogSXXGjq+0pAoqAIqAIFIoA0dJ23HFHV1x0KIXWzVTOJ7rQMz755JMmDgIt07kK3SfznTPOOMP06tWr0GpVUa6miK7Zs2ebDh06mC222MIwea0X8Ykuxs2NevHFFxuS6KqUhoAfI5wkhE8//XRpDWmtqkHgyiuvNJdddpnrL7H6JSl11QxAO5qGgF7PeXCEia6HH37YHH/88eb00093XozzSupa0hGISnR16dLFvPvuu6ZZs2bmzTffTPpwtX+KgCKgCCgCikBZEMA4FM92pGnTpuadd95x66L4UaLLwWHCRNeuu+7qDGY+/vjjuQVi/H/LLbcYUjAgSnQ5GPSfIqAIKAKKQAMgwJxgt912c2dGF4xOOIoo0RUFveLrKtFVPGaJq9GtWzdDmD0mnEzaUV6SPJfY4iqlITBlyhTDRB5ZeOGFzfTp0zVvU2lQVk0tnxih09wD5OtSqU4E9HrOu26QWpBbL774oll55ZWddxfkVy1a78wbdW2u+UQXudYw7ilGxDCGsLwQXiqKgCKgCCgCikA9InDXXXc5z3bGvswyy7joKKwr0QUK86SSRNewYcNcnnHOrkTXvGuga4qAIqAIKAKVRcDPGVnKN3e4t2LIMXToUOdEoR5dYYTi3a4pouuXX35xidk7duzoCJ94oUpua127djWTJ082n3zyifNkwzrtggsuMPvtt19yO53wnqEAxPJdJA53VWlLl8lEAC/I4cOHB52bMGGCWX755YNtXakuBPR6zrteSnTNw6La16ISXSR5Z+Lu5yOpdky0/4qAIqAIKAKKQLEI3HHHHc7gh3okmefdiAjRxXc039P1LmGii+9jjAHRO8Qt5557rrnxxhtds0p0xY2utqcIKAKKgCJQKAKEFcSzG3nwwQfN+uuvX2jVjOWU6MoIS9l2KtFVNmgr17A/4ZR44+edd5454IADKteJGjuT76rK0MCVkJgqtYsAoTJ4AYmI94ts67K6ENDrOe96kY+LvFz/+te/TJs2bdxk7YQTTnD5HI844oh5BXUt8QhEJboIaQyJT/7JcoQdSjyA2kFFQBFQBBQBRcAicPvtt7t5EGBg2Ma7EVGiy8EQ/Ksk0dWvXz9z7733uigqH374YdAHXVEEFAFFQBFQBCqJAI4OhxxyiDvl6NGjzSabbBLp9D7R9cwzz5gnnnjCjB071rRu3TpSu1Eqy3ynFqP8KNEV5c5ISF0/VvaoUaNM//79zZAhQ8yBBx6YkB5WXzfCRBdh0HbffffqG4j2uGAEBgwYYEaOHBmUnzhxolluueWCbV2pLgT0es67Xscee6x59NFHzUsvveQUOA888IA58cQTzZlnnmkOP/zweQV1LfEIRCW69t9/f/PKK6+4caq1dOIvt3ZQEVAEFAFFoEwI+EQXiiYUTogoftSjay7wYaKLnCV8J5djDnHkkUcawjn5oSTn9kL/KwKKgCKgCCgClUPgqaeeCnKZx+H0cOutt5qzzjrLXHbZZebZZ59VoqvMl7KmiK5Zs2a5hKlbbrmlIe52vcjOO+9s3n//fYPlE1ZQWEPh+n/QQQfVCwQFjfPPP/80hLecPXu2+f33351F+x9//GH+85//mGbNmpmVVlrJ/OMf/3BtgeX2228ftMtD6bDDDgu2daX2EJDwbjKyqVOnmsUXX1w2dVllCOj1nHfBwkTXmDFjTN++fd1kS59r83CqhrUePXqYV1991XW1lHjhBx98sMvVRgPlUFJVA4baR0VAEVAEFAFF4LbbbnMGPyBB/lIiOSBKdDkYgn9hostPmbDAAgsE5eJYgVyEcOSb/OWXX46jSW1DEVAEFAFFQBEoGoGHHnrIkNMcwTBmm222KboNv4ISXT4a5V9Xoqv8GJf9DD7RhVvlKaecYs455xyDQqte5Mcff3TxwpkUv/322y7/CGP/+eefzffff++Wf/31V044iLt6+eWXu4+dr776ymy++eZBeTBFcR5F8KjA4w6ijYemT6RFaTfuutXSz7jHjcL/ueeec81CeEJ2xv0BF3efy9VeLdwDej3n3R3HHHOMgRTh+Yjy4L777jMnn3yyOfvsswOX/HmldS3JCEQluvDgw4oMUaIryVda+6YIKAKKgCJQTgRE6cQ52rVrF3wDCNGFB/T5559fzi5URduVJLq6detmJk2aZNZaay3z+OOPVwU+2klFQBFQBBSB2kNA9OqMjLCDUXW3MudQj67K3Cs1RXTNnDnTrLvuumarrbYyd955Z2UQTMBZOnfu7HJt4NV1//33m5NOOsmQn+bQQw9NQO/i7cKvv/5qpk2bZt577z0zY8YM98c6RFccsuGGGxq8HeRekjbJcYOnXKkC+da9e3fnPUYbjRo1cnly1lxzzVKbLEu9aulnOQYvuWtou55DZtTKPaDXc96vJEx0ycSt3gwi5iFSvWtRiS4JCwQCSnRV732gPVcEFAFFQBGIhoDky6CV1Vdf3RCmCFGiy8EQ/AsTXUJGkeeTfJ9xynbbbWc++ugjs9lmmznj0Djb1rYUAUVAEVAEFIFCESBC3GmnneaK33jjjWbHHXcstGrGcuJFfumllzrDGs3RlRGm2HYq0RUblA3XED86FFYQP7UWkuq///2vGT9+vMstQ84kYoL/+9//LhvYq6yyiiHx4N9//+2s++RERxxxRJCwWPYVsySu66mnnppWhXNxvZZeeum0/Q25US39LAdGe+65p3nzzTdd03IflOM8SW+zVu4BvZ7z7rSjjz7aWcaSm2nFFVfUELfzoKm6tahEl4SxZOBKdFXd5dcOKwKKgCKgCMSEwE033eQioNBchw4dnOc760p0gcI8CRNd5KzGKA5CSkL+zysdbW2jjTZykVh22GEHw/VRUQQUAUVAEVAEGgIB3xjm+uuvN0RRiyI+0fX888+n6WaitBulrsx3zjjjDNOrV68oTSWurhJdibskxXeoU6dO5ssvvzTTp093XkInnHCCI2UgZ6pVGA8KdzzUCCNYqjABb9mypWncuLHLw9WiRQuz2GKLuYm5H5YOQo1cXYRKILQT0rZt24BUO/DAA82QIUNK7YYj6mgjLMR6JeZrUuSll14y1dDPcuAlH260TRjLBx98sBynSXybtXIP6PWcd6sp0TUPi2pfi0p0MT+QZ5sSXdV+N2j/FQFFQBFQBEpFAAttcloj6623niEfByKKHw1d6OBw0XKaNGliMJZCZH5dDqJrjTXWML/99pvZY489zLBhw+Z2QP8rAoqAIqAIKAIVRgByS8IXX3PNNaZLly6ReoDOd9CgQeaSSy5xjhWE5xUj5EgNR6gs8x0luiKAWI6qDz/8sMubdPrpp5vevXu7PExMVLfeemtzxx13lOOUiWyTeKFff/21C+knSfOq/Wbt2bOnGTduXF68CQHYunVrwwT8p59+Mp999llQZ9NNNzV33323WWihhYJ9xaxgwTZr1ixXJSrRRSM33HCDISbr77//HnSjWbNmgRdRsLOBV6qln3HDtMsuu5ipU6e6ZrfddluD1UW9Si3cA3o95929Rx11lPHd48kV2L9/f0feZyK259XUtaQhEJXoIt8koSuRcoQdShpe2h9FQBFQBBQBRSATAsx1xYgRTyKMKxFR/BxwwAHmvPPOy1S1rvaRFsInuiCh3nrrLZfLuNRv7GwA1gr2eLwtscQSadFhso05KftJD8H1RLeioggoAopAvSNw1VVXGcIMIldffbXp2rVrJEiU6IoEX9GVa8qj6+eff3YWWfVGdBHP+ttvv3VK+jD5V/QdkYAKeFatuuqqgTeV3yUmYEJmbrnllgYyauGFF3ZFXn75ZcNHicjFF19syNNTqmy++eaBN9lBBx0UWP2V2h71vvvuOzNixAjH3i+66KLOBRYldC75/vvvHelHDrYPPvjAkZpNmzY1EHl4asQdNqLUflKvIfqaC7tijvHcEA8HrBWvvPLKYqrHVjZuDEttr5R7NTYQYmgoKdczhqFEbiJMdI0cOdIMGDDAKXD8Z2bkE2kDZUfAJ7qwBMMLuRghhC7e0siHH35YsiFIMefUsoqAIqAIKAKKQNIQ8IkuPydUrZAtceHdEEQX+UQlN0pc46hUOxiWkRuXaDEXXXSR2XfffSt16pLOM3nyZJeHnJzn7dq1M5dffrkL5elHvimpYa2kCCgCikAVI4CDgugDWaIfjCJKdEVBr/i6NUV04dFDyLGkhYMr/rIUVwPvE5TZU6ZMMY888og57rjj3OSQSWK1yl577WVef/31oPt4Pp111lmGMI1YSGUSJmidO3cODuHN1bFjx2C72BVJiEu9gw8+OIjjXmw7pZSHtMWy8MknnzRvvPGGmyxnamfo0KEGrBpSktrXX375xbz77rsu3xp5ici7lUs22GAD8+OPP7oicRGbuc7nH4sbw7jb8/tayHqx2BfSZrFlGvJ6FtvXcpcPE12Shw13fELzqFQPAlGJLry9xeMd44lFFlmkegavPVUEFAFFQBFQBGJCwA9LhPEkiecRJbrSAW4Iouukk04yhFquRvF1GMstt5yZMGGCSTJp5PdX8CblwyabbOKiJK2wwgrOAJmUDnEKejvIwObNm8fZrLalCDgE4r6/4m5PL1PyEbjwwgvNtdde6zp6xRVXGPK/RxEluqKgV3xdJbqKxyxxNfBcQLH9zjvvuES6WBFhtY23T7UKObrIMYbXE4q9bt26ZSW4ZIyECfCZdogiQlGUKoSExOIdqSTRRf6Uc845JyBdcvX/7LPPNoccckiuImU9lsS+Ek5j4MCBLmddKpUKxt+qVSvnxeLfI8FBu9K+fXvz119/uV3HH3+8IcRXJSRuDONurxgMSsW+mHMUWrahrmeh/atkOYweIM0JB8vvACMAfiMXXHCB2W+//SrZFT1XRASiEl2DBw82JNdFyOtJzkoVRUARUAQUAUWg3hC47rrr3DyIcfshy5XoSr8TwkQXyr4333zTRRmRqCrpNUrfEuyrNQXDv//9b0cKEZ0GIRKN6BJKR6W8NYmUgx4pn2AwSlj4nXfe2UXUyVc+23EwQkf17LPPujCJ/A75/akoAnEgEPf9FXd7jJHnA0anyy+/vDPij2Pc2kb8CJDDk1yeCJ6u3bt3j3QSDE15txF17F//+pfT2xORbKWVVorUbpTK1f7OzTV2JbpyoVMlx7baaiuXSwrXc0IZMXkgLBWEVz3JSy+9ZPx8Myj88fArVXbYYQeDxTtC2AHCD5RTeOn17ds3SIac71wSL32ppZbKVzT240nsK1Zhw4cPN1hcMCnJJv369XNej/5xCC6IEZFCPrA4B7luSCJJbjgsffA2xPuwRYsWwceAtBlexo1h3O2F+5trOwr2mdqNim0p1zNTP2plX5jowmqZkDBYKpEPUaV6EIhKdJGPhHBNCDkJF1988eoZvPZUEVAEFAFFQBGICQEstZkHITvuuGOg0BLFTxz5mWPqaoM20xBEV7UaYpEznTCYInwP+hFqZH9SlhiEEgKb/FzFCPnR+X2gHylWD/Hoo4+aY489NjhdHCHBgsZiXvnmm29ctCQMp0vRKf3999/OuGzZZZfNGZUo5m7XdXNx319xt8fFIe8T+Z+QLbbYwt0jGPeHZc6cOe63Qt48UpYceuihZsEFFwwX0+0yITBo0CCDFxYSRxQtJbrKdKGyNFtTRBdhxwhXhVXIbbfdlmXItbebcAuzZ882kyZNclb7KDUzKfNrb+TpI5KwjbI3KtG16667unCQtEfi3WHDhknTbokyHmJl7Nix5rfffnMhM0888cQgZ1ha4QI2br31VheeMVx06aWXdudn4tymTRvn4k9IAV6IDfWyS1pfITYOP/xwA9lZiKDo53cjIs8O2c4XU51wklxrCK5c8thjj7k455nKxI1h3O1l6nOmfVGxD7cZB7bFXs9wH2ptO0x03Xnnneb000+vitwBtXYtoo4nKtHFs+2aa65x3SC0KwYTKoqAIqAIKAKKQL0hwDccltUInip4liBKdDkYgn9hogurdubq5Qh/LNgnifwgHPsLL7zgFNIQV7kEo+OuXbsGRcAKT4CkCroMUjWEv2fRLxBuESPKXEJUADz8iIRCiMNCxDe4ojzY5ksvUEi7cZf55JNPnP4FbzfGiTF5sf0888wzA50k3jvPP/+8QYdTDoGQGTVqlNMJ9unTxxCZqB4l7vsr7va4JnhFTps2Lbg82YwqIFd8/WOXLl2Cb7igsq6UDQE/rzX5uvbee+9I5/L1L+gs0ROqR1ckSHNXtpYcVSsPPfRQyrr6pWyMbTeGH374wW3b/DpVO6ZSOr755punrNu5q2rDUzkM7ASxlKaqus7IkSPd2Lkn+LOT8EjjsQ+zoL3evXuntWVzoqWswjE4Lue04cDSyoU3bHjFlLV+SlmLjNSff/6ZdtiGR5yvvX322SdlrazSylViI1c/OX+S+mon6alevXrNh52djKZsWMcU13HllVdOO24959JgtJPZtONjxoxJO+5v2JdSynp/pZWX6x9err322lnvw7gxjLu9fPcAmMSBfTmwLeZ6+uev1XWeX9ybX3zxhRuitU5y2zwzVaoLAZtLIXj2WKKq6M5bK8Kg/syZM4uurxUUAUVAEVAEFIFaQMBa1AfvQ5vfOhiSzOWtQVCwr55X1llnnZTNeR1AYMkbh9sff/wR7ItrRbB/6qmn4moycjs25L0bL990NgR4zvYskRHcU4zFkg85yzfkQWuomDrggAOC/lpyJPXwww+nrLd/imtrvZFSNuxi6rnnnktZZX9qww03DMrKdZIleigbiqug4dhQYEE7HTp0SNmoIAXVq3QhG+Y76CfjtN4YRXfB5kFOa8Ma4hfdRiEVbOqANF0HeoopU6YUUrXmysR9f8XdHr87dFTy22FpDdnd7y58MTLptyyZHi6m22VCwOaKDK6TjeIU+Sw8Q7jeNmxlykZgc+uffvpp5HajNCD34YgRI6I0k8i6JpG9KrBTvIy5ONYCy9WoV6LLevqkrDu1w4CJIZhY9r9AFGunmPXScWOXH+xrr70WaXAQptIWJIIIkwmboDU4JmVYWku0lI1bLkXnW9q8Y0G9sJLZ5uUKjkmba6yxRsqGmXKTzfkaK+OOXP3ktEnqqw3BNh9uNu9QasaMGQFCNn9d2gQwTHShMBbMWVrvwKCuv2ItpdxkxC/LZMVasqVsCJSU9SJMTZw4MbXTTjsF7XXu3NlvIliPG8O428t3DzCQOLAXQOLEttDrKeeu9WWY6OJDi3sYzFWqC4GoRBdzA3l+Wc/H6hq89lYRUAQUAUVAEYgJAYxC5X1oozQErco+JbrmQtIQRJe1dg+uR0OuQGzJ/cDSei/l7I6NrhGURyeQZIOim266KegrY7Nh+3OODeIL0stGiZhPUU99jErvu+++nG1wEINfwfSwww7LW76hClhvjqCf9Nfmfi+6K9abL62Ncj1TbO7ltPPQXxvhKmXTKhTd52qvEPf9FXd71pNrvmvF9bLexfNBb9OozFfWegXNV053lAcB9HvyrCrk2ZavF1w72uP3qkRXPrSiH1eiKzqGDd6CjdmasiEbXT+efvpp9wOyeYoavF+V7gBKW3kYsXz11VcjdYGJnLQnXoIo0Ndcc81gvxz3l9Yd2Xm6ZDq5Tx6cf/75aUVs+MPUP//5z4xt29jxKa5tpSRXP+lDUvr67bffzkc8hb3vBDMbztNh27Zt2xSej75MmDAhDfdMloQQnNT1r/VRRx2V+uqrr/ym3LqN5Z1WLpPnRdwYxt1evnsgLuwBLG5sC7me8120Gt6hRFftXNyoRJcN1RQ8m/BMVlEEFAFFQBFQBOoRAd/w45RTTgkgkHl+PsV/UKHGV8JEl8xDfv/999hHLtjbvFaxt11Kg6JXkX5h3IhHRjbxFaO+F1y28g25Hwt+GRdLmyuo4O4QOYPfTNgzBXIvl0IYAys/ysrNN99c8DkrWZCIJRiRCz42j5nTfRTbB5vHO2iDtvCaK4fgTSd99Zc2JF45TpfYNuO+v+JuD+Dw8vSvkazbsIRpuNqwoRkjCNn8hWnldKN8CKDnk+uT67lWaA98ouuYY45xbfMsbUiR8alHV0NehQznDnt0obThYvneNxmq1dwuvItwJ0eeffZZh4GN6Vpz48w3IFxK5cfKMqo1GNZ90h6hBnkQQSjKPpa4GttcXmn72D9+/PiM3fUfmH6YDCkMWWETHzrPMP88sr7bbrulCItQbsnXT86fhL6GrdG23nrrlM1XlxWeWbNmZfSOs/HB064h275gxYbnpFwHlgMGDEgxCQkLoQL8cqxfcskl4WJuO24M42wv3z0QF/blwDbf9cx4MWp4Z5joEovTe++9t4ZHXZtDEwUTz5VMBHq+UfuKDchqFUVAEVAEFAFFoB4RwChU5ut+6HnZp0TX3LuiIYiupIRdk5QQck+wnD59etafC2SRlE06ySDfAtLfdu3aZR1XtgMQkkSfkTZYEtUkm4TTTDS0kjdbP23enLQxoZspRSTSkuBTTg825verrbZaWr8l4lMpfa/GOnHfX3G3B6Z+yFy5L1hCEvuRNogQ5B+XdSL4qFQGgcMPPzy4BqV4dIZ7KdHHWCrRFUYn/u2a8uiqV6Jr4403TuFBguBSzoPQJsyL/25JeIsPPPBA8DACA4jQKOLHZe3WrVtqyy23TGvfJm9NTZo0yZ0C0kpeQCyzhY5koiTlbJLQrN2DKNtmm22CslJHlpBrTL7LFde60H4ygIbsa9gDrtS8bOEPmTBJGp7wkjstE8kFHli4yXWSJfdKLokbwzjay3cPxIV9ObDNdz1zXYtaPBYmuiTufBzxpmsRrySPySe6SlEEybXn2ZTJGzXJY9e+KQKKgCKgCCgCcSHghxXzFdkyd1eiay7S6667bpq3j+SwxrgubhHsP/jgg7ibLqk90mNIn2T5zDPPZGwL4yEpwzLpnhfh7y/yZZUiKID9cbP+yy+/ZGwKY3QpS2i9pEo4bGGpeZHIxSPjZcm3cz757rvvXCoEjGSJLoQOilxqECR4muUS7sFzzz3XkY3kliOtQj1J3PdX3O1xLXxDev/eYP2hhx4KLtdZZ52Vdu9I2bPPPjsoU40rUe7vSo/XT2ODnjmqKNEVFcHi6tcU0cUPh4fAIYccUhwKVV4aby68uhDxZMjmQVLlQ83ZffIqyUuAZSlJQ/0T5HoRQTT5VhcQC/65ST6aSfx48GHLjXB5iBQ89HjIUtZvX9axmipHSMNi+km/G6qvkiBY8JgzZ04YxoK2w/cORIkvfi4qPgSyeUKQny3btSJPWC6JG8Oo7eW7B+LCvhzY5rueua5DLR4LE13ijReHdVIt4pXkMUUluiQRLs/ML774IslD1b4pAoqAIqAIKAJlQwCjUPl+QDksIvuU6JqLSEMQXUnx9OnVq1dwj8h9cfvtt8utkrZ8/PHH08qOHTs27XjSNr755pu0/hK5BIHUgVjp1KmTM9zN9W2NkXmPHj3S2sEzjG/QsBBxxU8BkFRdFX33wxZi6Fyq+FEUuH+IlpJJyKVFTnbm+EQLknstvIwjfFqm89fCvrjvr7jbE4wxdA9fV9k++eSTXTHCo4ajSEmZwYMHS1NVs6zW+3u//fYLrtWDDz4YGW/JpUcIQ/Xoigxn3gaU6MoLUfIL8CAkTxfygg25xoMwqZOHcqIZ9uJAUR9FcC+Xl4q/BG9IVV/wrOJDQMrhxk9ItrCELXuYFBci77//fgqvsWyTHyx+sllPFdJ+uEyp/aSdSvbVTxAK9tdcc014KAVthz9OwiHddtlll+DaZgvJQBixbJMS+nbmmWcW1BcKxY1hKe3luwfiwr4c2Oa7ngVfiBopGCa6brzxRnc/jxkzpkZGWD/DiEp0+WE4Pvvss/oBTkeqCCgCioAioAh4CFx66aXB3N73vpFvOSW65oIVJrqE2Pj11189NONZFeyTYIgD4bHeeusF94j07eKLL844WD8Sxuqrr54zlxcNQCgNGTIkxRy9e/fuzrCVsPh8y3744YcZzxHnTomEJOOC2EJIAyD7WIIBnkEY9eIFhq6Jb8TTTz89xTj9sqwTESeT8M3hl33vvfcyFWvwfZ9++mlaP/v3719yn3iu+GPOFHEJTxGfWPPLh9eJylBuwZgXT0bGzfUuVfj9lCvyUKY+xX1/xd0efQ57fYajN4njQliP4d8H1fZeStr9neneybbPj16kRFc2lJK7fwG6ZqpUrNW+scp/Yz0CjFX0G/vCNjaEn7FMubEvgiodVfHdtsp106hRI2MnIMaGXDM2JrQ59thjjX1BFd9YFdewuauMzaUVjMB6QhlroRdsF7tiJ53GhsJLq7bAAgsYa8ll7CQwbT8bdqJqbCzmYL99QRrrbRdss2JDSxpLoAX7rKWYsS+sYNu6pBv+Fl100WCfv2InvsYSeMaGZTR28uAfMmuvvbaxlj5Z66YVzrORr59UT0Jf+e1bN+C00XTt2tXd/5ZsTNufa8N6zhkbhzcoYj9WzBFHHBFsW+8l8/bbb7tt7gGbSNRYzy63bQlNYy00zEUXXWTsR19QZ4899jD2pRhsL7PMMua1114zCy20ULAvbgzjbC/fPRAX9uXANt/1DC5AnazwfrSGAGbcuHGmVatWxhJd7tloQ6wa7lOV6kHAhgxyzxF6/MQTT5g111yzqM5bLz5jlRCujk1ebdq0aVNUfS2sCGRCwH68G+vlblZdddW0d1ymsrpPEVAEFIEkIGCJLmPDgbmuHH/88caGHnfrNjKDW0b9jkzCGOPogyU6zOKLL26sh5JrzoZvNxMmTDBTp051++M4h7Qh2L/66qtm2WWXld0NsmSMjDUszMMsYRHebSxRZGzIRbc/ly7qo48+cror9Da5hPmdtSyn3cMAAEAASURBVPo3fNeWQ3hvW8V60DTX2YZOM6ussoqxJEWwv5gV6xXmdHCNGzeer5qNuGQsSeb221xSxkakma9MEnaILk36Yg1V03QEsr+Q5c4772ymTZsWFLXEl7FeIm4bjPv27eswDwrkWGnSpIl55ZVXzFJLLZWjVP5D3H+WyHLzfxuByCy55JJBJetVZuijXH90FuhUM+m9gkreCnoQS4q67xNLGJpFFlnE6UtsjnnD87ScEvf9FXd7jN3/BmP7/PPPd++gr7/+mk0n/C7Y/+KLL/5vT/qCZ5Il29N3lmELnZJNceDuOWsYaaxXllliiSVMs2bNTIsWLYw1VDbc39mkoe7vbP0pZb+vC7766qsjP4utsamxxgzmvPPOc+9QuIyG/haXdy76aPTStSQ1RXRZLxtj81W5icbNN99cS9cp51isFYhZbLHFnBLTWl4Y627uJkb8kOpJwhMT63ljrMt4SRDwcIY05aHuC2SWtWDydwXrkE98KIkwebHhD2XTLW34OsPLXiRMdNnEyMZacrkJBXWFTJHysmQibWPLO8JF9rG0VnaGD7eokq+ftJ+Evs6YMcPsuOOOGYe7wgorOCWwDaGA56qxseSNdUM3NgSD+/vzzz8dGWwTBzuS2HooBe1AckF2ifBC8u8lPvg4L5MAyFB/gkIdPhxGjRplbFxtA5Yi119/fdqkIG4M42wv3z0QF/blwJaPx1zXU65HvSzDRBcfMtaK1JHmEI0q1YNAVKLLf0+hcEChoaIIREGA+wgjI96zK664orE5Kd17DoXXP/7xjyhNa11FQBFQBMqGgI1+YlBeITZklOnTp49bF8WPEl0ODtMQRJcNBe8UqnN70DD/UfzZcM/znZzvRuvRlLbfeqCZjh07BvsyKQ3RLfAdyLca36CFig2dZy688EL3fi20TiHlbJ5Ws/nmmwdFbXQgYyOaGN8AMTiYZwVC5Oijj3Z6D9+gU6r9/PPPTq/CdzPSr18/Z6wux5O0hOyTZwH9wjgwm64hV7+//PJLw73iC4axcp/ceuutxuZh8g+79aWXXtoZITKHwhitefPmBuIQI+gFF1xwvvLF7uBZh2E0AoEl9zj7OBYWCGeMySE5conNXed0ZBComQTiyOaXMjYsn0Hhz30d1zdI3PdX3O0JHsyVwVIE3SX4810uApEFwRQ2aJfj6BGHDx8um2VZottCDwnBlUsee+yxrLrKhrq/c/W32GP+sxD9bJcuXYptIq08ukEcUdDBTJw40SSJ6EK/jZ67lkSJrhq4mv4EFGsrLEVsDGAzcODAGhhd4UPAygXLFJHWrVsH1meyr9AlBBcEoi+QTkx+Mk3gKMek1bogB6QHZAcvKl9++OGHNC8vm+zUTQylDN4Vb731ltvkPJBlKKkXXnhhKZK2DCv08eyzIfScBU1awSI38vWT5pLSVzzsmDjJ5LmYoXKN8br6/PPP3YRL6jK55GUkwscAyrs//vhDdmVd2hAf5rbbbjNMVOmbT5iJtZxUjhvDONsr5B6IA/tyYJvvegr+9bJUoqt2rrQNXWhef/11N6BSPLqow/wAwfOxffv2bl3/KQKlIiDEebg+Vp98FPJRjhFaHAqa8DnKuY0CgnccSiYMMpS0Kw5txa84vLR05RHAKl4UhhiH4j2DKNGVfi18PQNHKuHRZcP6pXmapPeo/FsomXlv8S0UluWWW84pKf39NvetOeecc4JdKDDXWWedYJuoQxi3yjd+cOB/K0T9gFDACwbDzLBwDHIgLmKA9vHs4dtWhPFCdkB2oYwtJOgT7/Vtt93WoM/ASyubYIDOtzpCZBT0VUSYSKKEv92JiFFMlBgZU7gd9DoYkYq3m+8xJHUgHsFKysj+QpeTJk1ypCgG8Hht4VEVlhNOOCGIOCOedXidoUPIpucgQlIujyyOQwjmEgyh0NUNHjzYeYnRN+7pcPSjXG1kOxb3/RV3e/SbqAfoBkVfxf1PpJUpU6aYXXfdNdvQHO42/J8z1qaQDReaFkEqa8USD9iwiY7kKoSMxxsQQovoYmEpx/0dPke5t7kuXB+E3xNebFFEia4o6BVft6aILnHB3mGHHQwTjnoRFOvizswDs2fPno4cIbRYPYmQfDJmJl82N1FWYkrKZVries0EVV5GEE2Eq+PlkksgtiT0BZNSQi/4wqRxq622csQK+wl9gIW+iG+tL/vwTGIiSkggyBOULVjDMEGlfSwCfOEFtdZaa/m7il7P108aTEpf6QvXHm86JhHFCB8lBx98sKuC1RXWVwj3DiQiHzMiuO4zSc818YfoxGUfjy/k999/N3gW8uEigvJHPqLjxjDO9gq5BxhTHNiXA9t811OuRz0sw0QX3okobgnZg9ehSvUgEJXo8sN6Emo33zutepDRnjYUAhgG8bzlfZdNmMdgycr8lPlqNQhhoyQcMZ4fNlZ/NXQ7MX1U/BJzKbQjWRDAS4Y5O+J74MgcXT265gLXEERXOcIizh1NYf+zhS2U2nz7YFAr4hsaovyF0PKNI0TBKeVlufLKK7v5uHj54PWFNxvzdDxk/G9OwoVhcBsXQQS54Yceg3Ag7QLCedBnoG8IC3Xor80b5CKntGzZMlwkbZsxEMoRvQUinmNphRK0Id9I0iWMy8C+WMH4GmJHJGzsmokcQn9AeHFIgmyG1dJepiVkqoSEhMjPFHqTVAt4pyAYJOGVT3hMX1cRbtv3/AofQzcCMRQWdClt27Z1qWVmzpzpUmxgXIx+TeZWmYzCw+3k2477/oq7Pek/RhV+yEHmlMwtEXRF06dPl6JpSwwUuWYSypD7wua3K+n+SGs4wwYkN0YfvjcZ58NojTnd8ssv7/4I5ykhObMRb+W4vzN0uay7/OvCc4HtKAK+eLOCDTpc9eiKgmYBde2PuWrFhuBxCR5JmIh88803btvmQKraMZXScZubKWXdf11Vq5x3GNgfUClNVXUdO4FK2Y+TIOmnnaBFGo/1ygnasnmxCmrLTlBT9iHo6lmrq4x1aNe6oru+hpPNWuuftDH4yScLWbcWRylrjZPxvMXuzNVP2kpSX+mPzZWVshPKlP1YTVkyMQX+lvBzWAt29mWcshPslJ1ApuzLhWqBkPxXyrG0OaqCY7JC+9baKq0c9xzX3Fp8SbG0pf3Ycf2hTTvhS9mPt+B43BjG3V6+e0AGEhV72okb20Kup/S/1pckuub+k+TevDPZ5h2qUl0IkLCca8eftTIruvP2gzao7z+Lim5IKygCHgLW+n6+BPZyn/pL5ijWwCR4FnlNJG6VvkrfbRijxPUv6R1S/JJ+hbR/Ng9K8Bu3VukBIPK753tCJZWyCnr37SNYWOW5w82Gg5ddsS0F+7i+ZUvtmA3jFNwbloxKWcv+YJs+WoPqoGmbwzntmA3/FhyTFUscpZWhDZtTPZULQ6vMTllSKa2eJTKkychLS+CktW3DdKW1aQ1p3bWXayJLvqPpW6Fic9CknceG7yu0aoOUk28kGa81gi26H9aDz+khpA2WfJf6Yj33UpbsSMNGyttQiSlLWPnFC1q3qReC9ni+ZRJrCB+UsZFtUpbQD7Y5v/XOSVliNoXORPqD/sKSU/M1J7pYKSdL5kzWGzIob8nblDWuS6ETkTIsw/dcUKGIlbjvr7jbYyjWcD5lowWljd3/Buc34eMi69wHCO8i2cfSGvK7/XH+49pwnf3z2AggKRt5Z77T2PQuaeVsNKn5ypTj/p7vJGXeYQn6YJzcv1GF3xX4ol879thj3frHH38ctdlI9eV627C6kdpJYuWa8uiyRJezEiGObj732QI4wKopQkg9LDLsg9kltsN6I5z7qWoGE7GjWOZhoYe1EF4i4llTarNYlGF1gpUTlimFCJZY5M8i3A3LTILn0KxZs5x1RPg4edbw9MIarBjB6wwvjUzWO8W045fN1U/KJamvfr9lHY88++B1YRKwrCNcQjbBim7YsGHOCxDrNCzZMlme0x4xiy1J6eJV4z1XyH2GtxnnJzyFL3FjGHd7+e4Bfyz+ejHYS704sS30esq5a3lJqDoswsQCFfd7kg1jXebnDKxlDGplbL5HVynhVMTrGzxyxVavFbx0HJVDgGc+1rrW4MIQPieXYCGKBTzhjkqxlM7VdlzHfI8kPPHvvPPOuJqui3YUv7q4zFU9SD9HrFUKB+HvrQGbG5d6dM29vH4ucPaQA5eoF4R0ype3Z24Lhf8X7PnGKsWjpfAzZS/JuwxPE4kS0rlzZ3dvSAQQavqeKBI1QVok5w4eML7wbUYOdRHyRzMvzxRaTsqwpA94ERD6EAET3q9x4E6EEUu2uXb5F/Y4Yh/Rkgh1x/X2hfPzDbGtDVuYT8h7jXcawnjJ/9O0adN81RrseNj7jjkNEVuKEd9bVOrh3UX4Pl/whOd7jHPwDRwWvJ/w8PJDTIbL+NvkSSOyD0LEDiJ3hEW+CcP72UZ3xfi5P8MeOVxDoguJ/PLLL+76y+9E9pPfLFOuL47jKejnP4sj31Tc91fc7TFuvtd4ToigX8JTkLxrCDoL8kH5ed3ZLylO8MDDq0uE7/ioYfSkLZY885jnkk5ChAgMvBfD+k90o+FzE1VJIlpJfZZx399+25VY53f/ySefuFMRLY6ocVFEPbqioFdCXftQrVoRKwIsL5Cvv/7aMaOHH3541Y6plI7bj8mU/SG6qljfwMxaN+JSmtI6CUIAixKr1EzzSBLW3V/iYWRdiNM8hSo9jGrqa6WxKfR8cWMYd3uFjkPLJQ8BO7l27wWbu8x1TrzdbDjW5HVWe5QTAd+jqxSPLJkj8A7BCllFESgHAlh725As7rnjz1fC68xfbY4v55Fdjn5EadP3SIrD6jhKX6qxruJXjVetvvpM9BN5JmFpLSL7bI5d2VXXy7BHlyW6HG5W0R07LoJ97A0X0aAN8RzcF/QHbyybryblP9OI5kGUBImkI/3Ga4PoLmGxJEFam0OHDg0XybptjV/T6vJ9F4cQiUT6zdIqcTM2y3joL2P2y+PphmdCLsGziXJSj4gqSZfnn38+6C/9tuHmiuoyc2uiysiYWebTTXIfocvz6/jreBRyvWxIuZx94Zkl9fBGySQ2zUFQRsqyJAqO7ylkw3emlSPyii/WsCntOG3ki6Z06aWXptWxpLDfZNHrcd9fcbcnAwp77uFVFxaidFiCMcDH5lBOiTchUYj8a2UNs8PVI21bIj6tfbx2Mz3HOAnX2O8L65aIzXn+uO7vnCcpw0EbojUYK8+FqGKJLtceHuTHHXecWyciWUOKXEv16CqBSCtnFXImWbc/M3DgQJdc3RJdxk4wDJY3JMeuF8FqknxQNiSRee2111zuJBu+0Zx11ln1AkFNj5NkkMS1xrqNexxrKDyOiJNL3ot8sbErCU419bWSuBRzrrgxjLu9YsaiZZOBgFjviUeXWIbhAZsrAW4yeq+98BGI6tGFpzCeNAjeN1hqqygC5UAAD2mrHHNNE3UAC2Fi0tsPuvlOh5Uw1sPM4ZMivkcSeVQkP0JS+pf0fih+Sb9C2r8hQ4YE+gKeV/JuFK8iPHjI5VvvEvbo2m+//VyEALwP4vbMEexz5Qsq9/XA4wTPEwRvBuZNSy21lDnmmGOcJ7ycn9yUeLOQL0ckm2dD2JOFe8/3ppL6mZZ9+/YNcmdx3CpcXe6jTGWL2YfeyBJPQRXygFuSJtgOr5DjFe+uOXPmpB3id0LOnkweeHhC2zCQQXm8PsAoLmE+QT4hPx9a1LaJ5MM9z/czQtQWMPfzdmc7hw1D5vJ5fvfdd0ER+kYunnz50xkH1wTvLktmZpwrWbLVeUsRvSqT4MFlySR3iCgyRBkKR5LBO0zypflthL8J8fIhapTkX2U+xzeICPpXG3JPNg19Qzeb6T6gEHjyzfnBBx8EdciFhz6rVIn7/oq7PcaFhx2edr6Ak0094+9y63yn41FmSS43f2bejJAL14YLdJ5fbONZhIdRXMJvVKIW8Ey36Tsy6hd5Fu65554Z7818UULiuL/jGm+h7VhngsDLzZL6BXmw5mp79OjRzvONeQUefdZpx31b8I3RUCLvXO4Bm+qiobpRlvMuAINYlpYr0KgSXXNB9okufjS8hEj6PXjw4ApcBT2FIqAIKAKKQJIRCBNdkhA37tAHScagVvoWleiycdRdUmHwuP/++92HU61go+NIFgKEXLnnnntcp1CW8BFMCBA+9EaOHGls/oa0DqOUoQ7PqySIT9QQGtrG5zc2H6UzOkKZhbKP/YsttpgLI9WpUyfTqlWrJHQ9EX1Q/BJxGbQTORBA2STKQgyAunTp4kqL4keJrrng1RvRRTg+nvGIzVdkHnjgAbcueie3keEf7zBCFIbD01GUd96AAQOCWhBD1ssn2M62QnvodHj3IJAIEGvZyIRs7WTaT+jJsLHbjBkzTKNGjTIVd/sgKUiPESZKCHt28803zxeKMRzCz3qypIVwy3qiPAdQX2IcQygwCBRIF4y84xI/fB1tEj5yxIgROZsHO8hLUqn4cuKJJxrIymIEnCHfuecgCMJC6DjrNT9fioXwfZbpOw/CLUxWZgvTCqkBWYZAitqIUUFXrPeYI+VkB2Go6W8mQtBGFDE2z1SawRBhGSEAo0jc91fc7RFylHvHD+8o8+Fs4yaMYSbilvcT33AI805CmOb6rWZrP9N+ngM8DxAIS0IthoXj3CfhubuUC98fsj/TstT7O1Nb5dy38cYbGyGtIQJ5zkWR++67zxHV/I4I4apEVxQ089etKaKLuKIwr4W8jPJDUz0lbLJI93EN+87LiJeSTs6r5/ppTxUBRUARKCcCYaLr6quvdh9I1k3d2ETX5Ty1th0zAlGJLhQkeL0jKAjIZ6miCJQDAT+/A0o5vNJFsJgmhym5VLEa9oX8L+TOiUOR57db6Ppff/1lbEgq9y3BeqGCV5rkISm0Ti2WU/xq8arW5phQNqGcR4gEI+9GJbrSr3eY6Np///0N+YYmT55sllxyyfTCEbcE+4by6EIhDbklAhmKTgWBUMGrgtxEmYS8XOTnyiRh7ykisuDpgRdVJpk5c6bLN0/OefGooVxcRBFtoYRnPL6g4EbRnUtmz57tiJvw+86G+TJ4PWAAIgK54WNCbjMImjZt2kiRjEuIPa4F3kiZ8phheOJ7H9jQcK7djI2VsDOTFw5KbvIkhQ1aIP3wbEIR7l8rTouX6BVXXJE1RzjzH/4kV1O4q8ybrrzySqcQDxNeeAShOPfrogv0CT9ISa6BCPdu2JOIa8G1zISzT2aFCZqwlyLnsGHQnOcjukmeDRDG5HfjvgjPp+K4l+O+v+Jsb9asWcaGm0/zYAMjcrLhFVus4MDAnFmEdRueUjYjLckPJt6cEPYQllxvhN8i9zf3PnN3Ee5tIoOI8Fslspg/d4/7/pZzVWrJu0BISgz38OKNIhiYknOPa4nOXomuKGjmr6tEV36MEl9itdVWc9ZDuJRLWKJslhmJH4x2UBFQBBQBRSBWBCQ5sSRCltAWWCdiGKJSPQjw0YQVGFKIQiI8Mj7IJak1lp8YB6koAuVAgI95rIkRFCg298N8p0GJQ5htrNZ92XLLLQ1EPAnvKyFYlxJSCeUqIWJKEZRFhBtqCEFhOW7cOIcxYyHMNeFnILJ5/meyDo6zn+XGD0t5xtC2bds4u61t1TkCPHtuvfVWh4IflkjIFjUanXuD1BPRxTMcHYoIynybo0w2jRiKBTu8Fd8r0NvtVvHSYL717bffBodsHidHCqBQ5p7DE+izzz4zhHMjfJ2vVKYS4cogvlBExyEQJ4RGo28iEDz5QuxRFo8qviUIZ+cHh4IEPf/886U55wEkZLLsJBwkZBrGIa1bt3aKdIg9FMp4i2C4zjuN/hEykncYHla+Ah0lP8pikXKk7OA+CL/T8aDBW5m+Mw48bAjhmUkgAsAn1/sXEoz7BpIUzy8hF8Lt8Y7FOAgCwpcePXoEoQrZT1922223oEiY6PK/AaRQLsIEg7h+/fq5oowDclvmZdw3eBlNmzZNmipqKeH0i6oUKuwbK8ihKPdXnO0xb8HzzhfmZYTwxiOrWCF8Jt6dIgcccIAzCpPtKEuMy3yPRcJ1Eh4ToopvTuaUvkBY27yWplu3bmn3f9iANu772+9DJdbXXXddw7MJYbxRw6sr0VWJqzbvHEp0zcOiatd42TJBwhoDNh5WHtdp4j+rKAKKgCKgCNQ3AmGiC+tAm9w6zYK5vhGqntFHJbrwVMHqFrnrrrsMhIKKIlAOBHyFQb7cH5C2EE1Yiotwb6J89pVbcizOJcoawpOI1WahbaNsJK4+lsuEqkLpgDVzpeTnn3924UfBDkVE2Npb+hHOqyH7cy1Rxk6dOtVgkYz1OkpJUW6F65UbP/pPCCdEv23C6Ot2FAQIH8czBsFiXd6NSnSloxomunjWYZxA6CyIiDhFsG8ojy7fQINxQXS0adMmGOIff/zh8rSEFb88IyEhcr2vwuRM0GgBK3vvvbfzqMjVfgHNzFfEz0HDwUKJLmlIDOdkGwX+9OnTZdN5LMSRk4swd/xGmzRp4tom5KifPw9FPfdlnPLll1860qhY4xcIoeOOO855veUjJSHDMFJHuLaEODzyyCPTvOL8MeEdhde7CMQbZJt4Y0EUbrjhhnLYhYPmG1CEMTG3kvkCzzxwzSaQWH7kD4gLIkeJQEpCMhZLdvE7f+mll6SZkpd4xMR5f+F5GVd7PEskHK4MEC9EP2ed7C9k+dtvvxl+BxLGlNxmkOJxCNcRI0ieb/kE8of3JvN6CHm8/kQwCpD8huyL+/6W81RqCfEs3yV4T/KtEEXGjBnjfuMY2aCzByvuOYweGkrknas5uhrqCmQ5LxOKY4891sXlJTRTvYYuJGEhH9tPP/20m3TCrsfJ8meBX3crAoqAIqAIVAECYaILpSHKQyxDsyU0roJh1WUXoxJdWAxLuEI+ULbZZpu6xFEHXX4E/OTWhDQRZU62M6OsYe4KgSNCDhOU0eUUFD+FhCPBwpUwTyh9+ZgnpEncYbsKHSfhYlDyFULOQTgeYnNrFCJY0fN+IEQLlrwiKOAItYMSLpzYvpz4EWYJrMXjgGsAAaeiCMSBgB+Wi9yBWKkjovhRj665KNcT0UWUA5+oIbxUs2bN5gLxv/+QfDxT5RkJuYPnC0rofEIuqVzEQrg+RBReHOWKvoBHEB4mCN4mECnZjBrCfZNtPH4YP0IYPUJki4ARuclQEkcVn2Tx8+vRbrlyzhJ6j+dAocQrxi700yebco0bApNwb74Q1hLSAUN2yASIM8L+4Y3FtZo4caJfPI2cxLuOEIvkxEIwauQcvvCs45rRLkRRPg8+DEyElIIEwijJFzwPjznmmLT8W/7xTOv0ib5Flbjvr65du8Z2v+KBh8cwBgEIIT2JrJIph1mhOIiRgZQnf6AfalX2l7KEiGe+6Htohtvhm/Haa681zMUQQnXybPJ/H9wr8g6N+/4O96fc236uWebdvAujCNcLz02+a7gvlOiKgmb+ujXl0SUfW1ge4DpZL4LbOeE8iFcsLst8kGJJoKIIKAKKgCJQ3wiEiS4+wpiAYxFJKBSV6kEgKtGFYlw+ivgAkzCG1YOA9rRaECAOPconpFCCAgUjijc/B8rw4cPTQvFkGz8KDxQ4KBII/4QVNgo7lJQkSSeEjG+ZLO3woY5SKhwmSo7LEovlxo0by2ZJy1L7KCeD8IFs8i1m5VimJdbv4FGI1wVJ4fv372+wGs4mKMS4pn7YnXLiR98JhSXCswtFgYoiEAcCPhnvK7FESQeZgeKv3iVMdIniG4v0bDmmSsVMsPcVp6W2VUo9Pw8q743XX389YzOMHa8GCAjC6hWjAIVMwtAIggPjgrCAKe8q7j88hssp5JUabEMAYswAeUSuq2IFxTgGEujeMLzGKywshOfDuK4Q44xwXbYhCTDoFs8H8PG9iNB/QdSVQ+bMmeOMPyAC0DWGhT5hNEiOP95RhM4rVMhfBuGei1zI1RZzK4yI8OwS4d7CY4Q2CXcnmMlxlngCNW/e3IWu9PdnWoc023XXXd24aBuPnrAwN+F6gA9/eDwyT+D3DPnHtfND45HD1Q8RGm6v2O2476+42uP5wPOS39eFF14Y2biQkPMQxyIQ4eyLSwgnCQnq3+d4JfIcYu6ZiXDnWdinTx9HdvE7ZS4pef7KcX/HNdZC2iE9kHi5QQpnuvcLaUfKKNElSFRmqURXZXAu61kgufDqInwJFrG4yfbs2dM9UMt6Ym1cEVAEFAFFIPEIYGn32GOPuVAzfHBAckF2ETe/U6dOie+/dnAeAlGJLkIwSA4AJTrn4apr8SMgzx1a5iOffFyFCGG4ySshih+UVyRYb9myZdbqhO7DShKCK5fwHJT73y+H1T4RIrBwxmKV0D6EQhKr6LCVul+30PWofeQ8kNMosMKCYpQQMeQPIMwWCixIOfpdiNINxSSW2hBx+QSFxsknn5xWrFz4PfHEE4aIHSJKPAgSuowDgdNOO82F8KUt7jWstxEhW/R+c3A4EgelNXkAkVomuniPCJlOhBxC85VTiEZEDhievTyr8ZglJFm+kHdx9olQaBAVvC+iCG3Q72zvHMLlQYDwXiWMNgpkFOOQNLyveI/hJU05CEBC6BKFgHUIJFJzIBix+MTisssuG3ilRel/vrqMDw8vjDuYn3DNODfhfaMIHoJ4N+Xzeg+fA+yYp+yzzz7hQ46oIPSwPNPmK1DkDggb5kf8lSLy3Sl14yANpC1ZxnV/las9aTfKEkMkonL4xmBxf8txbzOXZs6OsRgGTuLBlavvkNj8/sNe/+W4v3P1I85jOJNIqMhiw7pm6gcGNSeccIIjt8l3px5dmVCKb19NEV2SewKrTUmAHR9UyW0JSw0YZybpU6ZMcVYXxO+96KKLkttp7ZkioAgoAopARRAQhTOTTYguyXmSKwFxRTqmJykagahEF4oF5gsI1pWZrPOK7pRWUAQyIEDYwWeffTY4QmJu3+o4OJBhJRyWKNeclo9PlJN//vlnhpbSd6FEgywSr8b0o+lbWM2KpSxKON96PL1k/q24+ojinXj+vmDRi9FCqd5mWHxDLPokF0pEvLtQcBDGEGt98fTiGB/r+SQO/MAc5SbXlnsHS2F5fuU7vx5XBPIhcOqpp7r7m3I8qzAaRZTocjAE//jN+0QXnhjkrkIxH1ZqBpVKXBHsG8qji/PitYI3LLmSfO/VEoek1WJGIOzpS0hh8R6P+VQVbY6Qb+RQzpVzkw5BrOFBxrxIPGcq2tESToaBDnMvBIKOEMSSV8zt1H8FI0AELwyOxNPojDPOcHO4ghtooILVeH+jY4fgRsA9qoctxBbXjmuGF2qSiC4Mf3jn1ZIo0VUDVxM3cV50fEjzUYg7N67nl1xySQ2MToegCCgCioAiEAWBMNGF5SAfU3x0aOi6KMhWvm5UoosJu4QxwSAIwyAVRaAcCJCgHE8sEZQ3eBoVIliG4p2EFTGCNSkhpMJkDnlBIFQksTpl8R4jsgGWzFjG80c8fCGq+FDlgzWfhMm2TLla8rXB8Tj7SLgfwj/5AjaEiYQEY+zFCPjiwYZXgQg5FTCU89vi45eoEUjr1q0N4W3ySVz40Te8AFZcccWcXn35+qPHFYEwAj4Z6+cVEbKF35SGLjTzeXTVMtEVvkd0O3kIEG6RsKMieDNjjFErgmEH+bjwqOHdByGERztzGfJ35fJuTyoGKPcl5DK57DBaUSkdAe4PjFXx2oM0qaZ7oprubyIkSHQJvmfw8IoiSnRFQa+EuvbiVa08+uijKWudnrJxVN0YrJul27ZhLqp2TKV03E7IUzZ2rqtqLSQcBjZRZClNaR1FQBFQBBSBGkPAEl3uvfDJJ5+4kVkjCLdtPQNqbKS1P5w999zTXTvmPlZxX9KAqcuf/dAsqb5WUgQKQcB6dAX3Kvcb89NixIbHS6tvww6mVbfeBCkbujutDPN/S4yklWPDWnynlbNhvucrE95x8cUXp9WxOQvCRfJux91H61WVsoZsaf2S37O18E7ZPBh5++QXsJ5gaW0deuihKUuG+0VS1no+ZT/2g3KUKUTiwK+Q82gZRaBUBPhWlt+P//uWfZYgL7Xpmqq33nrrpaznaDAmS3Q53H744YdgX1wrgn1c7Wk7tYfA4MGDg98t94s12qq9QdbYiGw+6OCaWZKyxkanw6lFBJgLy/uIpSUXIw/TRkNwbdqIKikbLtytW0I7crtRGpAx1uJztKo9uoi1j6U6oQeOPvpoF/OXuPokTLz22mtLoP2qswqWZ2uvvbaxxJ957733XDJMLDKx2ldRBBQBRUARqG8EyD3D+0Esli+99FKXd4BE2ttuu219g1Nlo7dEl8GzBCk1jIJYq+PVJzkPqgwG7W4VIMC8nEgDIiRcP+KII2Qz71IsH6UgUQqIVoAQZm+rrbZK80QiN+35558/X34QQuSEPRfJR2WV3NJ0xqV4vspBwiXhVVSolKuP5Ae54IILXHgt+3E7X3ewlsbDK5+3LqEIwdAqq4M28OLq2rWr2WKLLVzILvKlYXnte8xZAitjTpCgkf+tRMUv3J5uKwJxI9CvXz/ncUm7vsemvCPVo2su4uHQhQcffLB58cUX0zCL69oI9g0VujCucWg75UOAnFQTJkwITnDHHXeYrbfeOtjWlWQhgOc4nvQSAs6fyyWrp9obRWAeAszhrTFdsKPYb4CgordCbjq+P/BItQZ3GrrQw6YcqzVFdJE4j482QpZYL69y4JW4NvnIxa1S3IDJgUDc3r322svlYUlch7VDioAioAgoAhVFIEx08ZFx9dVXO0UpYatUqgeBOIkukkMTClFFESgHAhdeeGGa0RmGaHfddVdBpyLRNgZbGG+J+MqRcI4O8lTdfffd85Fc1PWV2dIWH6/kpsolV1xxheE3IkJuLAn7KftY8jHM3Jsw4n4+l3L3EUUfhn4ff/yx351gvUOHDi4XQOfOnV2C8ODA/1auv/56RwyG9+faJpwkectIOJ5PouKXr309rghERcB6jZr77rvPNUO+jKZNm7p1IVuU6JqLsBJdUe80rR8nAqTokFDEtOuT1HGeR9sqDIFXX33V5QlFD0u+T75TfGGuAjkpYj3PNdemgKHLxCLw999/p4UqHD9+vAsdGqXDGI4dd9xxhnxYU6ZMUaIrCpgF1FWiqwCQklwEK0s+rtddd10DS/z+++8b6x7slFf+B3qSx6B9UwQUgYZFYNKkSS7xciYlXsP2TM8eBwJMqphckTwcwwjyr2AMQpx7jENUqgeBOIkuPPt69OhRPYPXnlYVAmPGjDF9+/YN+oy3kA3lFyiTgwOhFZQlPLN4L/lCFAfIGwRrSJ5fCMppYudnylHA+fjNZPJ88ttzDYX+3XDDDWbIkCHBXp6hGJX5QjJwlG6QTXjH4iUrUok+8g0AAXf77be753umcZLDF4U+RnC+7LfffkGuLfJ8tWjRwtjwtn6RtHXGd9VVV+W9flIpKn7Szrhx4xzh+MUXXxgS2oO3iiIQBwI8n3hOIZDqiy66qFtXosvBEPxToiuAQlcSgIBPdPFbJVqFSsMg8N1337k8n3iIIxjBEFXL96KXKCIcX2KJJQxGBQsuuCCbKopAYhEgl9iqq64a9I88wcyTowjRdTA+HjhwoCHaBJErshnRRTlPMXVlvgP5Rj7eWpKaIrpwc8d1ebfddjPDhw+vpeuUdSySWN7Gz3Y/FhJXbr/99qbWEnNmBUAPKAKKQCQESPSONTyTThuf1+y0006R2tPKyUMgTHSJpwXeFXhZqFQPAnESXYWGIKsedLSnSUIAwoo5uU++ZPugowweUCTXpowfKo8xdevWzZEsMj5ClGMNiUDkPPnkk3IoWHLc5pJJC80XHLQr+bw17r//fhcCUOpkel5imYwFs8jkyZPNkksu6TYr0Uc5L8sPPvjADBs2zIWpDePHcRRPeMU1adKETbPBBhuYH3/80a3zXBk6dKhTGOLhMn36dBcWcvnllzcouSHJ+CtGORUVPzqG8R6hFAnXiDRr1sygbCimH66i/lMEMiBw4oknmgceeMAdsfk3zD/+8Q+3LoqffM+IDE3W5C6eFY0aNTJYtCPgwnP6jTfeMM2bN491zIK9hi6MFdaaaox3Lu9ehHDGvNdUGgaB8ByIXmDUhMc4hvfMJQ488EADIYZgMOMbBLmd+k8RSCACzDsJuSny9ttvm6WXXlo2S1oq0VUSbCVXUqKrZOiSUVHih/IhahPcGSbqxOUn7wb5N1QUAUVAEciFAMqxTp06uSKrrbZa8PGQq44eqy4EiAeNxy85FfAAJr8LpCahvjp27Fhdg6nz3vpEV6nhP0SRxH2AV4eKIlAuBA4//HDz7LPPBs1DSEFMYaSFIhMiA08K5q8YamWStdZay+XRwRJYhDkuH50IFsR8PIq3F+FGeLbhufrrr79KFWcAxnlElllmGfPaa685pYzs85coclHoivihE2Uf5BDkErLwwgs7pQ5KHqRcfWTez594n7iTef/Akfk/z/ww4UU+X4gs6kJCijJ5hRVWcN5dcRJIUfFjSKNHj54vlxree+3atfNGrKuKQGkI9OnTxxmJUlt+C6zLO5Lf/9lnn82uuhYluur68idu8ITKO+CAA5wRDR4Ra665ZuL6WC8dYv6Gh114roHRAIaUGKb487BzzjnHkONPRRFIOgLct/6zhZxaYihWat+JJHHMMce4sOOEX1WPrlKRLKxeTRFdhNwg3wjWf+QfqQdRoqserrKOUREoHwJYvWN5joQVdeU7q7ZcSQTCRNf555/vrO3uueces8UWW1SyK3quiAjESXQRlg1LSxVFoFwI4DFEjqgffvjBnYKIA3gRQ8ZASOUT8s2ee+65htB6vpx33nlmxIgRwS6O43HEnBgvg6+//jo4xsomm2xiRo0a5TzDCJsjgtVxtlB4hD0kOoJI7969XchE2f7yyy+dB/Ts2bPdLpTB4h3CjnL1kdxXhJ6FqMIjRQg+6ZcsMWIhhDkkoC+EKyWU0P777++86OTYoEGDzBFHHCGbkZdR8aMDEHaXXXZZ0JdWrVo5rzMhE4MDuqIIlICAzI2omonoOvTQQ83gwYNLaLm2qoSJLnAhx2EcoZx8pFCWY4yF+NfDL6PrigAIfP/992aRRRYJPKgVlYZDgJDGzCnyCR7ihNDHO1RFEUg6AnPmzDEY2ongnejn4ZX9xSwff/xxc/TRR5sBAwYERn68S8kb3FAihj0aurChrkCW8/qsKDdNPRJdkihPPrCTgsHnn39uUKJiHdqzZ0/Dx6mKIqAIJA8BLFS6dOkSdAwrbM3VFcBREytitSzXVhSwI0eOdGEra2KQdTKIOIkuLNV9j5U6gVCHWQYECBdOQngILYgfPLbwGoJwmjVrVlFnZN4IaXXUUUe58HqZKkOWEb2AHFn5hBy2hMoh5Ai5rCB0RCTst2z7S5lPy77lllvO5Z7AopPk6njFkjdKBAKK36dIufoI+QaJhED4kGeIuPoYqmQSwo3tu+++wSGUTLz38W7r169fsB/POMKZEgoql/DdgYEM15Ycj76nnV8vKn60hWceuQxECLvLN4WKIhAHAhLWmbZ8YkUUP0p0zUW5UkSXGO+Gr8fcXuh/RUARSCoCEFgYUUIGZBMNl54NGd2fRAT4lvENyTDQi2pk9cQTT7hvm/79+5sZM2a4ebgSXeW7+lXt0eWzorgBSjLocCz/8sHX8C3/9ddfpn379mbDDTd0CXWZqDd0njI+7nFXRtGBoOxAmYbleOvWrRsetAT2gESqKGCIdY4SWuLEJ7Cr2qUaQwDrdvIaiqiXjyBRO8sw0YUnzw033OA8HDbbbLPaGWgdjMRXckcNXXjGGWek5ReqA/h0iGVAgNCEhCiMKoSjI49UocZR5POCrPVzgIX7QJQHEqOLRxgx98lD6Su1mX+JYtuvz/x60003NT/99JO/O+M64U0wvguH/itHH/fee28XctHvCKEHIf5InA2hxxyS/hPOnDBPEydO9Isbvp/oc/fu3R1B6R8khwbJsrFkBbdvv/3WEWOQa2PHjnXrtI3gDYdXXCaJAz+UZn7e0HHjxqnhXCawdV9JCKA74HeL+M8EeR4o0TUX1jDRddhhhxlCiBL6tWXLlnMLxfBfjHdpyr8eMTStTSgCikCZEeD3C5nF92V4Xkb0EPKchudIZe6SNq8IlIzAL7/8Ygj3jWAIhvFWVEky0YVRGQaGtSRKdFX51fzzzz/dh+1GG21kSPxM8m8sLPHQILRJQ8itt95qzjrrrIynJjcD/YOMI5SMui/PhQmFg8QwzpQHIiOYulMRiAGBMNFFqCByi6jUDgJKdNXOtYyT6DrllFMMoZtUFIEoCBCujxB6xQjKUUJ1QMxAJkG4N2vWrJgmXFmIF7ySCCMowgcpCaTxdPJJEjlObi+eiShS8YJ65JFHXN4wOe4vw6Hz/GOyjgc0815Rjst+WcbdxzvuuMN5pYUVSXK+fEvIK0gr5t/kSCPXyTfffJOxGoZqubzmuG6EhMwmceAnYdJQto8ZM8YpHLKdT/crAsUggFIHxRPiEyvyW1aiay6alSK6RKcRvh5ze6H/FQFFoBoQYM6DERL5uxDmSPfee69p0aJFNXRf+6gIOARmzpxpiAiB8K1AOPCoQp5iIjDw3cL8m8gKSfHoUqIr6tWNuX7YowvLRSwaUdLycVUPwgfoaqutZjbeeGOXYJowKh07dnRWsYRVaQjBI+TUU0/Ne2o+slFwQHzxBwlWr+ITXSgyJbl5veKh464cArhikzdFBJIaa02V2kEgTHSR8+bGG290Hx48g1WqBwGf6HrmmWccUVBs70WJh9cG4RNUFIEoCGDFSySFqVOnBs00bdrUtGnTxv2ttNJKzgsHryO8+gllHTXOfXAiuwLhg5EX7zLC6Iknkl8m0zr5wyDFlllmmUyH3T4MkPAKIx9IWJZcckmzzz77ONIsX4LquPv48ssvu9xVEsIw3Lds23ysEzWAfouAA54thGMsRvjuoC2+QbJJHPgRHQJycp111skanjHb+XW/IpALARROKJ74HiWMkIi8I5XomotImOjCgxdPXrxFl112WYEt8hKPW4wUEJ94jNywNqAIKAIVRYB8e3yj/Pbbby5Pq3jVV7QTejJFIAICP//8syG8OcL963/jlNrsU089Zcj3i6EpxJkSXaUiWVi9mvLoqkeiSyaFeEeNHj3aWbXiHpwrnEhht0bppXgwdOrUyfDxXIxg8cHkmbAsWJHWk/hEF6TfnXfeWZXDJ+k51r3EtUW57hMocQ+okueKu+9Jao9Qo5tvvnnQJfXyCKComZUTTjghbTJ1zjnnmJtuusm9M3h3qFQPAnESXRDa2byvqwcR7WkSEICMIG8TYWkgs5ZaaqkkdCuWPvAxSpJmvJ8hxvBi2muvvVwesUUWWSSWc5TaCGEXMex74403DIqlbAK5SN4zcnVlMiojN85DDz3kQg5NmzYtYzOEQ4RExJgOkov5HXjkkyTjl6/very2EUDhhOIJ0nry5MnBYJXoCqBwK5UiuiDG+R5GlOhyMOg/RUARUATyIoD3EYZeUXNI5T1RHRXwia7wHKFUGJToKhW50uop0VUabomphaUEH61Y5eMWLEprwrWMGDGiwfqJ9StKNP/DodDOYF1LPq+DDz64pFA2hZ4nSeV8omv99dd3Sukk9a+QvmBxS74Hyc2GhSSWCvLRUkgbhZap5LkK7VO1lvNdsxkDybn9BPXVOi7t9zwEwkTX4MGDDbljCHdL2FuV6kEgDqKrjfW0wcOEXEgXXnhh9Qxee6oINCACEEkQO4WQO5XuJiG/MPbDq+3rr782EHCEh1x++eUNnnTF5NEhnAo5jz///HMDAUbOL8hLQrhEscpOMn6Vvl56vmQgIGEx8UrCO0lEiS5BYu4yTHQdccQRzluD3H/LLbdceuEIW0p0RQBPqyoCikBdIoDnHEYbRBa47bbbDHpElegIkJ9XsGzevLkzKIvaqhJdUREsrn5NEV0SgqueQr/JpFDi5POBy3rnzp2dZWZxt0O8pU8++WQXTlFaZTJMkkoeHOPHjzcvvPCC+e677+TwfMvGjRu7JNfk86p18YmulVde2bz44otVN+RMISvx0iOnAoqSOKWS54qz30lsy0/+TP/4gB00aFASu6p9KhEB8ueQR4fk4e3atXNePOSU4be54YYbltiqVmsIBOIgujCOwUimnuZKDXGt9JyKgCKgCCgCyUUAY49x48a5/Hp4R4oo0SVIzF1WiugiGkiHDh3cSdWjK/0a6JYiUG4EMGwR4ze+D+S3WO7z1lr7lcbx8ssvN1dccYWDkdCvkCkq0REgMhnvPgSDMXTXUeXpp582vXr1MujIMU7zdTNR2y61vsx3NEdXqQiWqV44R5cSXaNcQmm8uwhRQg6WhhTJCyN9GDJkiPPUkm0syvHMIc43f9OnT5dDwRIXXB7eXbt2DfbV4opPdJFDgZcUBAT3NJa1c+bMcbkJyGuBazKhIQlFkyThIxFPvLCQ3+L2228P7460XclzRepolVRu27ats9ymu1xDfqsqtYNAmOg688wzndUXEyyZxNXOaGt7JD7RxXuzffv2RQ+Ya84EvqE9v4vuuFZQBBQBRUARUARiQmDPPfc0b775pssz9//snQn8V1P6x8/YGWSJGMNgLLOg7DNCQrbCIEsoWyjZslTKEiVb9lCUJVlrGGlEmGxj37OMLCHrDKIslfH//s/7/Oa5zvd2v+u997s+z+v1+93v3c4993O3c87neT4PA1BiMvCjObpaEAkTXQzUgRd5/YgaTcpmz55tNtxwQ1ecEl1JoarlKALFIYDzY9++fd3GpBBhrCXJHHzF1aL+t6o0jshXX3zxxQ44FAcgUJARV4uHgE900SbwnWHKLZnoOxzKTzrpJDe+q0RXuUgWt19dR3RNnjzZ9OrVyyVTJ6k6OvAQADRchdkuDob63QoCBM18cuzcfvvt5vPPPzfkXNlxxx1dDpZqnhnJrv3k1oUaxLxQ2Iaor/fffz+oOi9rcspEkSjBRnX6Y/78+eajjz5yA478LtbWW289JxtR7PaV2u66665zH1tyx4mtuOKKriMp80lNK3mspOpcq+WQ5P2bb75x1VOiq1avUvn1ouNCw1uIESL2IJ+RFpWw/PJL1z0riUASRBd5PD/++GOThhNCJbHQYykCioAioAgoAuUisOuuu7oE8yScJ0edmBJdgkTLtFJEly+lrkRX9jXQOUUgbQT69evn8qzLcYYPH2723XdfmdVpkQhUGkef6KKK5MvFKV4tHgI+0YVTKWMocY0yjjjiCEcoM9atRFdcRPPvr0RXfnxqfq2E+TNwhZwbubHIuUKSaHKwVNMYQEWmEFt99dXNE088UVR1yDUwbNgwg7SWb3RC6IzUu0HInnLKKS7RruBT6jmRY+XRRx8tdbeKbI8cJfnhuN54BO2yyy6OkE7j4JU8Vhr1r5UyIcrJ74f16NHDDBkypFaqlrcevO+QnSGnCM8V0q3LLrusy1nYu3dvs/DCC+fdv1lW4jlEPi48iSDJleiq3yufBNGFQxDPy+abb54lL1y/qGjNFQFFQBFQBBSB0hDo2LGj834X+X/ZW4kuQaJlGia6yAeD8ghSTkg6JWWzZs0K+vlKdCWFqpajCBSHwJ577umUlmRrzdktSJQ2rTSOBAhcddVVQSULBRYEG+qPvAj4RBfKWwTYxLVaJroGDBhgGDtrJGsooovBTiKZ9t57b4NeaTOYhPm3b9/e3HrrreaLL75wOVdovIeJokriIfWQY+IRgmdIsfbGG2+YQw891EWoyT4HHXSQI8DISwYRBvF1wAEHmNNPP102cfJrJBRm/59++skN6qIxvNJKKwXbRP0gEo59iGpBEpAcJml4Q1AnBhd5eZZihCKTuwvtXUjDgw8+2KyxxhpBEWlgEhSuPxoeAensc6KHHHKIi6Cs1ZOmIwxpc//997vEoCS4j7JLLrnE7LPPPlGrci6r1HsgZwVSWhEmunhn3nzzze4d2gjOAynBVpPFJkF0IQX86quvOv39v//97zV5nlopRUARUAQUAUUgTQTEyWu77bZzcs5yLCW6BImWaaWILpw/RWVAia7sa6BzikCaCJBOBIUoxpPEGGO74IILZFanRSBQDRwHDx6cFdzwyCOPuDHDIqqrm+RBwCe6+C6hghPXyJV++OGHG1JK8I2rpYguJbriXt2E9w9LFzYj0QUxg+zY1ltvbW655RZHoNAgDTfaE4a+YHHhHEoktyTpb9ggfpDuIw8Vf2+++aaBqOJ32Pr372+OOeYYFzpK2CdGDq9XXnnFkVLTpk1zkVJRub5yDXoTEXL55Ze7aDiSR4pR7oEHHuhCS1dYYQVZHHuKXBTRd4Xsl7/8pYvM48XKQDTXtFWrVjl3Ew8BNoiLSc6DVGgFUVq8+NEYZkCWeztNS+p4EC4QkvxV2sDq6quvNm+99ZZZaqmlnHwpz1uxnpZEgJIPDqtlootGBjKmxRDFZ599tiPLi7kWlX4PFFOnJLch6emECRNcToX111/fDBo0yIwbN85MnDjRtG3bNslDaVkpI+ATXTSY11lnnZKPuN9++5lnnnnGkJvvH//4R8n76w6KgCKgCCgCikC9IyDKIyhPjBo1KjgdJboCKNyPShFd/sAisk7V6E9ln7nOKQLNgQCKKES2+sY4AuN3asUjUA0cGR8lfY0Y/btVVllFZnVaJgL+94i0QOPHjy+zpJ93o89N7s8TTjjBfPjhh0p0/QxNKr8aKqJr+vTpplOnTs6LH2KjGUz0rLfZZhs3cCneUNXOvXHNNddkfRxXXnlll9By+eWXd4TN3LlzXR4uGrI//vhjwUtFFBTSjIsuumgW0cWOSJdBVnTt2tVFdEUVFjV4f++997r8bt9//33ULm4Z3i1Ejyy55JI5tyllBbmrNt100yyPmaj9IfwgLIo1n+hin3IxgezjRY7sIC9g7ici28izRVQcevZ0COMYpMzIkSPNmlZ+kSg9n8Aj79Z5553novE4BqQdEpzbbrtt2YdM83h4PnGvQ7rjmbHYYou5KIkuXbo4CcCyK13kjjxHI0aMcHiGnyNk+5Ao44NaiFwlEhZHASwND6649xWEOHmm/BwK+SBaZpll3D283HLL5dvMravGe6BgpRLeAKlUnmukZogKHThwoHOM4NxxlFCrHwSSILr4HuLxBxGO9JCaIqAIKAKKgCLQbAig3kEfkO8qTo9iSnQJEi3TahBdyCvT51dTBBSB9BFAJeXoo4/OOhDqQeeee27WMp3Jj0A1cDzuuOOc46rUDIUqHObV4iHgE10SUBKvRGOmTp3qnLCPP/54F+jh50+PW3a5+0t7RyO6ykUwpf3CEV1EM+y0006O8Lj44otTOmptFSt61hABSFGF56tV2z59+phJkyYlcni8z88666xASlDCPqVwBmvREc4lc0BDGfLET6h53333GT4MfhSXlBee8jIiIiIpe/HFFw34QERASPLypCExc+ZMdwjyWnEvl2JJYPLCCy+4UFoIrnyG1BVykOWaRJewv9y3/CbiJArnNm3auKiDcqUk0zoe+Y6IjEHuLsoOtdKbRBXNnz/fedpwnddee+2oTctaBvlD5xwJskIGsRFuwPr77Lbbbi55KcvCHX6W8Zyg//zPf/7TDQpw3xJ2XUwnNIn7ChlW3gFhgzinvnihQZy2bt3aEcQ8QwsttFB48wXmq/keWKAyKS4IE100ZnAciPssp1hlLToHAtzvL730kltbbkRXr169HDnP8/Pyyy/nOJIuVgQUAUVAEVAEGhcB2o1ITYUjF2TgB0exwVYWqtmtGkRXqQ6fzX6N9PwVgTgIIFGIMoxvMo7hL9Pf+RGoBo5I4dEfxBhbRKFHo2HzX6di1vrsvvICAABAAElEQVREF8pHON7HNZxMcTZlDBqVLyW64iKaf/+GiuhqRqIrHMEVjvDKf/nTW+vn/Cn1KITbbrjhhk66b+edd15AZxZpQ5+0wiOPBrEYcnc9e/Y0JA6EhCDKBrJEjLDRI488MovkQr6iX79+Tp+YAWA8+yTSK5cuKy9AtuO+mzdvnotMWnXVVd2UCLNvv/3WEFkCQYP8IRFnv/71r6UaWVM/7JhILv98sjbMMRMXEwb8IS44j0JGBBbEAx2fKENKklB3ouCI3AJ/3wjXFZ1bZNSmTJnizpcBXCKUomzIkCGREVKFjkVZSR5P6kZ9Ro8eLbORU3KpERlHJ5mPIzgQWk5EXxI2duxYc8YZZxRdFB9VCI8o43niHsLCEi7k20MylFB43yRnnr8s/Dup+4rGNl4wvpFb4frrry8p8tHfP6n3gF9mrf4+9dRTzZ133unymvG+lPcN14eoVbX6QcBPclwu0SU52xZffHFDJLyaIqAIKAKKgCLQbAjkIrRyLW82fOR8w0QXjnNELqAeQl7rpMzP7006gmWXXTaporUcRUARyIMADuM4jvvGMvqPasUjUA0c999/f/P000+7SjLeKM6Qxddat4xCwCe6wmNjUdsXs0yJrmJQSm6buia6JDyUlzAvFnIzQYwwaDt8+PDkUKrhkuQhlJxcs2fPdiRR+/btza233lqVmiPPB8lEzqJcBgHEACv5RehQrLHGGgZiAO+6QuG2yB0SURJlNL6JXsllRNew7yeffBJsAgGFBwYyeWLSiGcecopIFt/YHxk/iMViTeQlo7Yn79CYMWOCVUR9IRdYrMXBhAFwBr796wUWnTt3dtcR8o6/M888MyDgkD9DBi3KIBEhr7ALL7zQ8AH2zfd24RwhMCAnc0Xksa8f+eWXVehYbJvk8SiPKC0IlrARQUTOG/I9cV9A1kLoIQ0nyV2T0viF4OaZJ0efGOTyUUcd5a4j70IkFek0+nbppZeavffe21/kfouUGTOUA5GJEe3Bs/DZZ5+5ef8f3kLkUoMIjrIk76soYpH3BAP2kGD+sxtVl/CypN4D4XJrdT5MdEHq33HHHS6qh3e1Wv0g4BNdkLW8c0o1ydHGfvneu6WWq9srAoqAIqAIKAL1goAQWjhz0Q8Sk+Ua0dWCSKWILvpPm222mTtoqf1guXY6VQQUgdIRIG1BWMq8kBpM6Udp/D2qgeNee+1leF9iKAeFHYMbH/V0zlCCSSidvvcVV1wR+0BKdMWGsKQClOgqCa7a2zhMdM2ZM8fJypGTh8ikathrr73mSBI5Nl7jEJA0XvH84iW81lprlR1WS6QVUQlhoyFOPq18kmVE1hBhI0YOIyJz/H0gtdAlFuKHbcLERqnRNByPPGXPPfecHDpretFFF7lcS7KQxgb5U4q1cjGByIDo8/M7IWMHqQW55Rt50ohUE8sVDeKTT0hknXbaabKLm/qDrBBdEEK8+MWQn6PDiVSdRNUhkYdEXzhvWaFjUWaSxxOZTKmrTIlGAzMhJ/GmocPGNefjKJYrOlDWFzvl2UZ+Tox79Nprr80ifCDXaKRK9BzbEtkI1mEcRcqMbSDQbrrpJidliGwokYm5DJIEiVJC5X1L+r6CPIfQEo8l/1hEBULkkJ+xWEvqPVDs8aq9XZjoCs9Xu356/OIRSILoGjp0qCEfIqZEV/HY65aKgCKgCCgCjYOAEFpInCNTLybLlehqQQQlCvph0gaXPgP95VxKJYJlKVOf6EJFAoUXNUVAEUgfAfrQYYUHVIsY31ArHoFq4Oj3C5MaZyr+jBt3S0kHxBkyHsZYbVx79NFHnUIVAToETdSSdCFjrzj9NJI1FNGF3BuhhUndjPVwoSXMX6IwGJQmUgpZL2TSqmFhMgAC4Igjjki0KpJAWAploJ18M1EEmGwDaUJUlR/lQiQI0UQQg0jtkXeJ+gvJxb5RUUkQjF26dMmKDJPjQBARscYLTEgCyBy0j4lcizJyyvmeAkjeEeFWipWKCXmXwMOPbkOnftiwYVnEH3UgsSURbL7lksLr3bu3gQTD9thjD3PllVf6uxnpIGUt/N8MJBeRJkT6haN4uDbrrbde1m6FjsXGSR2PaElIIK69b/lyuN1zzz1ZnWfuGXJdxTWfvKMsMCNPVdi4xlxTkSVkPVKOREL51rdvX/exZRmkGSQjkV/+swIZDLEFke1b+Nhp3VeQXeTag2Qmp0LYiJzjvHgX5rMk3wP5jlNL68IRXEp01dLVKa0ufoem3IiuSy65xMnucmQlukrDX7dWBBQBRUARaAwEhNCiTY0igpgsV6KrBZFqEF3l9IPl+ulUEVAESkOAPOKSK172DPfvZblOcyNQDRwZn2OcDmOcCmdltfgISDogSurevbvBSTSuPfbYY66sPn36mE8//VSJrriAFthfia4CANX66jDRRRQHg9EMevOBqoaRl4kBaTEiPiB6kjQImg8//DAocp999jEM3uWzUaNGORIn3zbhdeAIYRiV1JF8VuTnQiYOYovonXXXXTfQFGcwnpcYoa9EneANl8suu+wyg6ycGGHHRL6FDRIBjxsi4iDmfCsVEzoR5FkSgxxF7tKPbpN1MjAu80yRzGKgNWwQm/KRhbCSBJmynZ8PSpYxBUOij9gHw5sP0lqMuiHJ6VuhY7FtUscLk1aUXYhUDxOY5557rosWZN845oepcx/QwIm6bhzj9ddfdxGWQg4RWUnko294s06YMMEtateunbtn/eeLa809CpkEwTlx4sRg97AnbFr3lRwQj1Ki2WbMmCGLsqYbbLCBIxd32mmnyOc26fdA1sFrdAYvHd5jEoVJrrbx48c7+VFkSNXqB4EkiC5kTcmjiJVCdEE24+FWSrRx/SCrNVUEFAFFQBGodwRwVESlAjWRQiaEVjgPsCxXoqsFwTDRJU6GSZNRqIagHoLl6ge31Ej/KwKKQJIIkFqBvPa+MSgv70J/uf7OjUA1cCS9h/Tl6CP6jvO5a6prCiFAehDGvTAUpE4//fRCuxRcr0RXQYgS3UCJrkThrHxhEua//fbbG+S4RMJuyy23NOTIqYaFcxil0VgllNpPtliM18mBBx4Y5Noiv89KK61kyG2Vy/CKIBqpEslwkZHyPQWIKpOXq9Rv7ty5LmKRAf4oj41SMfGjgjhHCCnIurCBM8SKECX+eqLoIBZ8AzPJkQdBiG4wyTHFiLh57733ZDaYMviKbKIYpB5lM7iKQWRCaPpW6Fhsm9TxkGD0894RQQeJmys/FEQo5/POO+8EVYakCUtCBitL+EFoOgSqWNT9IuuY+hhE5VfzI7r8/fjNNbj55puDa8g5+HnXIFjHjRsX7JbWfRUcwP5gIIP3CtFdhIFH3ZtcH0i4sKRhLb8H/HNM8jfEIHKX8rwKsUkuPUh4tfpBwCe6yv224oiAkwAmnaN8CECS4oTw/PPPu2eN7xVtDjVFoFgE+OZL2yUsdVtsGbqdIqAIxEOg0Z/Dxx9/3MmVo6ZBXxTFjnwmg7j0WXCKE5PlSnS1IFINoos87PlUWuRa6bT2EcAJG7UYHEbJYeQPGNPXR3UEh82ffvrJKbfQ72SMJp9ByrAPg9GkxeBeWXrppfPtkug6yHScgN9++22Xq9ofw0nqQGnglqtubdu2zco7j0NbOGdXrn11+c8IxMWxnPua1C2iNtSjRw+niPRzjfRXuQig5CSBGrlUrEotmzYK6XGQCORa43j+0EMPuUCJUstKantp7zSidCGDFnVrthGUsVJwGctcu3OwkQtu3n546vacSq24fUjcOdvGuNvVEl1u3uZdKrWoxLa3nl6uDlwb/uzgWGJlS0E2EinrGJbwk1U5p5YcCPax8m0Z26DK2IHCjA0fzVi5toxtJGXs4F3GDgJnuLdYXymz0TRB3cDMvggXOPQDDzyQtY0Nqc3aplRMbKhzUJ7NoZZVlsxYmbqM/YAG28k1lakdLJVNg6kdUM/a3kaRBOv4YSMOs9ZTlm30Zm0jM5a8C7Yt51hJHo86ynkztR2/jI3Yk6pmTW00VMY2NrK2t7KFWduUO2M78FnlUhfubdvgz1mk7VgE+9goxQW2O/zww4P1/jly7a2HZdb2lmTK2IZcsD3PjW3wB9ukdV8FBwj9sJ2MjNU6zqy55ppBnfxzOProozO2sRLsVcvvgaCSCf+wRJfDxua5cyVbYtPN24jUhI+kxaWNgB24C+7zd999t6zDWceQoIx8BdicnxmbGy/YVp4rK22abzddpwhkIfDZZ59lbBS6u4+sI0TWOp1RBBSByiDQDM+hVVnI+l717NkzY50EcwIs3zTrLJa1jSzXb10LLPQFrANtgJGVhHc409dJ0mRMA/xtrt8ki9ayqoiATT0QPJdWrSZD2xKjT2LVN4J18twxZVwkyuiT0o6gHH975umn2wH/qN3cMusgmrE5cTLW6S9DXzaO2bQFWceXc4pTZnjfJHELlx2et6khss4naswlvE+tz3N/WQIyY2VpMzYdgxuXsYP5GZtKJFNu/6nQOZeLY5z72iohBdfO5pEqVEVdXyQCjB3JO0a4hiJ3zbkZ47uUaZXPMrUyFiPnaFOr5Kx3va6o64guO/DvNLWRYYJpxbMDnVKiDcir1AwGG0yY7I477mjGjBljiPrBQ5/Qf5EiqzQO4C8Jazk28m2WeEu0Gocccoh55JFHgjInT57sJBuDBRE//NBePFVIoptL7i1i91QXWcLN2AHF4BgkPPRl+1jh51VBBhHJRD+aqFRM/MgAIq+ITpLoLDyViF664IILDB5FYkSN4dkvRqTWc889l1UPIsMscSKbZIX7+t4RsoElKFxutMUWW0wWBdMzzjjDRe2wgLoRkeJbvmOxXZLHi5IutB8H55VBlFSrVq2cxzoeUERMzJ8/36+qGThwoLGkS9aycmbIqYbMZNi4FyifnGFLLLFEsBrpQu4lyRdH9N60adOC9fwgH9cLL7yQtYx7gogpnpuwkcuA968YyTTx+MTSuq/w+uPPPzc5PlPbaHXh+sgqEvHlGx45vA/Zt5bfA36dk/wt0YgiI3viiSeau+++20VxilRoksfTstJDgLyHr7zyijsA340oidtCR+c+QB8cyxXRRbQ4noG0q8JGDj//HR9er/OKgI+A/83iO0U+3ajvvb+P/lYEFIFkEWiG55BokXAUAhLtRJNEmXgy03+mHy0myzWiqwWRcEQX3uj0x/BOpx+UlPnShbTZRcYwqfKbuRz6T0iWIzeJND2qIERArbjiii56ivEz8tynYUQs+Lnan3zyScO1ZmyIekUZYxrnnHNO1irUS8g5jHpRLiNPPVES4fQOqH9Yp0g3LsC+cSTe6BszPuEbfVB/TIZ1cTFPCjfqgXQ9Cj1EoC211FKGyCPySdE/ZiyMsRg7mB2cUjFKScHGFfjBPcO1ZaylkBG5zJhL+FsQ3o9UL7zLCkX+yn5p4RjnvmasibQpYkRLIrOnFh8BSQdESUnhytgzykLWWcTQz+ZdZQltF8kav8bllSDtnUaM6GoooosBXaTCaOgyQN8MZj30DDKFyHONHj3aIJdmvQlMVB6eSuHBNeBaiNGwILw7SaPz4eeHuv76642Nysp7CDo7NPDEaKRYbz+ZreqUxgckkhhEAhJwYh9//LGxUVfGegy5RYQpM1DtW6mYkC/q2muvDYpAzpH7iA85pAf5xXyDUKXhw0CrT5SQ88hvHLPORi8Fu/q6tjQ+kNHzDcnNXDJYyG/KvYPckfXOyZImyHcsjpHk8ZBU6Ny5sxuk8+tf7G8+br/+9a+L3TzndhCc3Au5bPXVV3cSj0g58H5AdpAOhRgD4wyQi3FevC98KUTWhe9B2Z4pZBLOBWJIH0KeYGndV+QIs15YjqjiWELKSh1kilQk+e4YzPcNWRrkaWr5PeDXN8nfNPhvueUWIxKXNqLVEda8Q8m/plY/CCRBdPmOFVFEFxIYkN9R0r5bbbWVc6qho6ymCBSDgD/AzvYQtcstt1wxu+o2ioAikBACzfAc+vknfdisp3JWv0TWyQAP8tvIcIvJciW6WhCpFNEl6Rg4alReZrk+Oi0NAfr09Jv83MtRJYi8edS6OMvCTqn0RRgbimp/chycecn17suJQtTQ72SMopDh8IlEu2++4yzLIUwYUyjVrJqO64cimSgWRZolgXkSuOFYBBb+uJzUmyltscGDBwd9eJYtv/zybhyoUjLT5GTHifqLL75wfXTSc/gG4YkzAsQs43aQU1E5GBnPYEyK8QLGQ4s1CD/yFjN+ksvSwjHufU1/jTFBMca/GQdXi4+AT3SF83iWWzqEbbdu3ZxjOve7El3lIlncfkp0FYdTzW4VJrqIxMFDP4oIqdRJdOjQIWuADALn8ssvT/TweAbh6SIW1aiRdTL1SROWEbFC5F84ckq2lymY0kCA+KEjlIYGNAOK4Ca2yiqrGDpsyyyzjIuOGzlypPnoo49ktfuIkzfLt1IxodML6UQUYCHD84coJRo/YU+mdu3aOd1tKYMXt0T3sIz8QCQuxiDsaFBIxE379u2z8l65jbx/NCx8Eo3Gi3/e+Y6VxvHAjEgG6lWK0WkmAWUSxiAhg91i4MOzUEzjH68trqMfpQXBRc4v3yCRiGALe6fJNjQguV+FDIUExVMQS+u+4j0iefmoF+QaEWx0iKIMTy6/sUej2Epxusa0kKfsV0vvgajzSGKZ5E2DoORZ5n3J9S03IiiJOmkZ5SGQBNHl59kLDzTwbBOVLc+a1BKvX3IQ+HkUZZ1OawMBvjF8n1u3bu0cDio1SFHo7MMD7LybiapXUwSKQaBW7+tcda/V+jbDc0g7GHUMIo18o9/GdeE75psQWrRfaceKyXIluloQwRmO7wkD0hgR4TiTgalg1bJlvP8+0XXjjTcu4BgZr/Tm3JuBdEiuYgb+IX/A3R84TwI1cnD5pBX5tPx+NBE1EBhE2KBURMR3mzZtgkPjlIfTrN/Ppd9KdBdRPuQgZpxJIr1Y56vPUBDtV/LLipVLdIXLQdkGQsrPRZ4U5nFxs/KfDvewwoxgkGuKagy5eZM2HGghW3G+lHEIyEY/oopIPMY0xDEYJ35IBt8gpSALfOPdwT0S7rvINlwf7in6PHKfyDqmrOOco1Qy0sIxifua8xEsOY/wOBnL1MpD4IcffjAoNmGMF/v56csr0ZhaJrp4n4raS7nnV2v7NRTRxSAmERe8/HgJNoMx0Gxz7hircew+4DQC8NCP+shXCg8aM3ycxfyIHlkWd8pANcSVGN4dhFzmM0Ky8VJ/8cUXszbDc4QHm8YSUU00sriX+FgShcNvaSRAKuAtkrRRPpF54aiaqOPQEMTrKiy7WA4mRFORsNkPVw8fE0ID0g1sMF78RBT5A6R+Z4eyIARnzpzptg9LV9KhpK50mhh4B/d81r1794AkCieDLHQsyk3yeJSHhwf3my+dyfJ8hjwDOCRh3L8+2UfDjA4MdfJlJsPHQrIQT5/wQDX7bLTRRkEHAuKIDqx83MPlyDy4IhuL0UD0n/k07iswRCbTNwZLIWuJYoWE5Z7iWSKSj/pIp1z2ofPB81Or7wGpZ9JTQu6J7IPcgphWoitphCtXXhJEl9+x9N/jnAVtJ973vkGcEM2rMpc+KrX3m3ebfAOi5I+rVWOR2JbjV1umQ+qh0/pAoFbv61zo1Wp9m+U5pB+M7Jmv4MG1ilIpEJJGot3lmspyJbpaEKkG0RVWC5Fro9PiEWCchLERcS5lTxwFGSvjPbXqqqu6P5uPKSCe6Pv50vTFHy33lmFnXn9LHBYhPnIZfTrGISDqxegP0p/1nTEpx+ZXd5tAkjB+41uYMIkiungP0E+U/rK/P7+nT5/uUqT4hBsEm6/IkyTmcXAj0gd1HR83zgGnTxQZUAjyz4N1Yig3QB4mabRNuecwsMdpF0dTnKHDx0J9hbFEnKJQYSFSy7eoVBb0URioD5vND+scv3CsxiiLcRQUjWiL+uNfK620kusno4gjlhaOSd3XomYm9c0VvSzrdVo8AoytMb6EhZ/z4kvJ3lKcsGmPcG/VUkRXIxJdPOB1a/aD5hK6SYI4O3jj5u1Ls27PqdSK2wgZd86WTHK72ugjN2/DqEstKrHt7cfD1YHkdpZ0y8yYMSOxsqUgOziX8ZMvFpu01jZSMtZrL6ifJOCTaTiJpCyXKYmO0zL7Es1ZLzm+JeUytuETWYVyMbGdwYz13sk6tu3kZSyZleEZizJLAmYsmeX24RrbPC5Zm9mooYzVe85QTlTCT/uiz1id6Kx9cs2Q7Ng2ajKWjIlMTlzoWJSb5PEozzYOM1Y20eFjw+ldslNLZLnkuZZgcfNyzZhSx6Ts+eefz7pWHA+zjZ2M1f3NStAL/twz1hsqYwc5claB+kl95X2ac+P/rbCNRXePsB9JgMOW9H1lIxXc/ST1LHVqPQiDpOS1/B4I45jEPAmawcs27l1xVjLEzVtCMInitYwKImA9H4NnNerdWkxVePfK8+Nvz3ucZ1nWMbVOM0W/q/2y9HflEeAdJ9fOktmVr0COI1pP26Be1M9K+uTYUhcrAgsiUKv39YI1bVlSq/VtpufQqp1krBNd1nvH5q/OWBWIrMsm70srCR653OajzFrerDNWpcP1neX8rWOdwzZXf1S2K3Xq36M2IqfU3XV7DwH66fTP5R5navPCZCzx4W3V8tMSmVnbWQffBbaJs8CSHFnlS50sQZShL5nPbGqKrH0t+bzAPvQ3GXOQctkmbLRvZT1Tm5sqaxNLEATraQdbtZus9cwwBuSXYQn1rG2SxjwObjZCLquunJN1ZMtYZ+WgzpbsyjB2FH5X0u5nPDFJs3nCs+rDs864hX/dBFtLFmZsyoUM7x1ZFp5akiCretaRc4FtraN0hnPMZW+99VbGOrBn7SfjqbJPWjgmdV9bhY6s+luSWqqu05gIWDIywNYGGMQsrWV3xiO5lxmXs8pE7jf3YTVNnq0RI0ZUsxqpHLuhIrokXw9J3tD2bQbDU4MQYyJs8E7AU8F+zJzXPt771TB7p7qkffaj5qJMbOcilWogv0TeGbw1TjrppKKPAYNO9Av7l2IkxSX/UFrng7cLXkv2479AtfB+IWSWSAzkDHNZuZhwzQgnJ5kqEh8S3ZbrOLIcLPHI8UP2ZR0yhWhYiwePLC9niucL0Tr8RVmSx6L8QseLqoO/jBxRhI+LiWSczMeZEmnoe48hz0AEp9js2bOdZx4RTnglSSSerM81tZ0AFw2A7GQ4WjDXPnhFca5EfDANW9L3FXI0RMaBQSlGlBrPrh92XqvvgVLOq9htRZte7hW08fFcJDmz7WQUW4xuVwMIIPEheQWIKuX7V6pJu4H9/IguP3qWdbzXiRhN65vHMdSSQ8CPJCGqmrwztWC0Bf3IbetYYYikV1MEikGgVu/rXHWv1fo223NIjqfTTjst6zKh3uF7/VtnMLfeV6VggSzXiK4W+MIRXWm1IWmXi2xeLUUlt6BQP/+J1KEN4EfzoHY0bNiwBfp39P123XXXrJMLq6dkrSxzxjoAZEnG0Z9HnYbluQyJOc6DNAViRHHRDibqCJk7onLoz/hRa1EyY6ynLUv/HvMjuug3o6rjS9qF85X5KiayP8cWicW0MC8HN/KI0ZeXiC2kIImQjMqHTuQrUVNhIzINTJIyP6KLMolsIV+0rwYjx0JZgjz0YVUWWc+Uvgnjn2KMDxx88MEy6xQoJk+e7GQwg4URP3jnMIYqY2/cX0SbMRaWFo5J3tf0A4lgFtP2tSARf8rzg0oaZolJs8MOO8QulHFaxqJQO0PFSyO6YkOat4CGIrpEjocXNh/zZjAG+PnYi6QeA8sMXCJFxodfLRoBXl4Qgeg1+zrR/tY0whicIdwZkosGAqROmvbOO++4EH5IW46FLOU+++xjOnXqVPBjnWa9tOzSELBeoE7nnL0gWehI0NBMwsI5usKN8SSOUetlMChhI89csly/cxOuN0Qfzw65uqI6U7X6HgifR9x5ZElo/NJxYBAhrfwKceup+xdGIAmiy8/LJ0RX+L3C9w8pEL59avWBgD/AXk356jBatEtxwJJ3dVISIOHj6HxjIlCr93UutGu1vs32HHK+yF/5ktfk6GLwVHK7CqHFMnIji8lyJbpaEKkG0UVenh49esgl0WkJCITJCwgBiN8oJ8Zw2gMOw+Au+YOSNAgrHGrFGNu45JJLZDZyCjlT6nge4yaQIFHjNQxUM86C+URXOPc46+nHk5MbgwxhDAjiQ4w+qFVPklknleoTRklhXg5uEyZMMCeffHJQN/I0I5UWNvrAyKEjfxe2QpKS4e0LzYeJLpydIGmiDJIJxwwxpBZx8OUeFiPtxqGHHiqzLq8XuerFyEtHLu9ijPuQdqkYUv/kvUoLxyTva2RG/WuLgxv3jFp8BOiziDNpUrjS1rCRoS4nIe8T7rEpU6ZU1aFU2juNKF2oRFf856CqJYSJLirDDWtDsl2enapWrk4ObmWcjJVXdDml+OgTCYO+c9u2bYuOhkn6VHm50kiLaqglfSwtL3kEJAcSJSdNOkvkqtQaTfIoEkfWN/IU/WTycRGJSL5CyMSVV17Zac6Tv4vfxVotvgeKrXuh7YR4veuuu5yXX+/evZ0OPZ3h1VdfvdDuur6GEEiC6PI7nEJ00VHy8zKQfw+vXrX6QcAfYKdzlmsQoRpnRHtKBonIGYg3o5oiUAwCtXxfR9W/luvbbM+hlQRyeWnp24ldffXVLkcR8zLAg6PHcsstJ5sEy5XoaoEEhxf6oxJ9QdsApQq+MTIQGIAX44cf0aXfifKBhNiQiG7yTT388MOR/SHUMcj5DCkctqSdKCEqfDUOHKkgpfIZCk2Sawt1EnIoWbnMnLtAnlx55ZUux1bURhAhDz30kFsF2U3OLZSQyHNPX9I3HJ3J1wU2kD5++1icy/3t08K8HNxExYP6LbHEEk4FgtxcYeNdSK6zKMM5aerUqVGrylrm9ztKKYDrDhHJt4t8SeIwRVQpJK0YzuuMvYgNHTrUoFJRjEGI0T8Wg+SF7E0LxyTva3Kq47wqhroXEWpqySAgbYSkIhyF6OJdhOqVEl3JXKdcpTQU0SUeyYSuIlPVDPbRRx+5iCPCzkeOHOlOeU0b0cUHmkaKmiKgCFQeAaKIaEBjNLRocCVlRCDSyBaTKB2Z16kiEEZg8ODB5oYbbnAh8njmWp1+g6QDHUhIfbX6QSAJootBP5FjgOiyWvhuwIEOP9auXTsX/Rfl/Vs/SDVfTf0BdgZxGJixeRacIwDOPHjIshy5Hzxm8W72k26niRjKAzhmYZBcDGKqKQLFIFDL93VU/Wu5vs34HBIZNHr06OBSMRhOhDsmg1gQYgwIi8lyJbpaEKkU0eVHm6uzjdyNpU932223IEoHR0gcIsNGFA8Rc74soL8N0TJEzSRljM0hLydmc3U62XuZj5qiQAH5iUHIEXmDogeDwzavnpNmXHXVVZ18P/1u/vK1W8PvAuTzGMCOkt6H2GVQmugeyDMx2k4QQGFHyrQwLwe3gQMHutQe1Jl3GZiFjWVErNFGzGVJOtLmI7r69+8fSbghI0iKEiFEiZITOU6idYcPHx5UnSg+yhFDycSP8JLl4Sn3JO95wYFj8j1gmhaOSd7X9OXp04uBCdioJYOAtAUk9UPcUnEW4frUItEFcQyB3EjWUETXyy+/7MKIkx5YruULPnPmTLP11ls7j7VrrrnGVRXvKho2eKKoKQKKQGURQP/7d7/7nfMS48hJ68x//vnnZosttghOig48jXs1RSAXAnRW0Zemc8iABd6JdGCefPLJig1056qbLi8NAZ/oipNjTRrvEF20HdDEF4vKbyDrdFp7CPDNwekJL07JP1FMLfGOJcdEJYx2Ku1VDA9lXyamEsfXY9QfAvVwX/uo1kN9m/E5nDVrlsHBR6K6GMBkvIB8x/IdJErEV9CQ5Up0tdzhlSK6uFY42mDhiI2Wmuj/YhBAUo97HOO+Jupjgw02cPMM6CMBRyQP5IMY32UGc8XI0YrsJ89LEkYeIT/KnAF6nALyGfJxojqASgfOefmIrHxlsS4sUUh+d0gsITnC+6+zzjqB1KGsO+ecc7JyIsnytDAvB7cBAwaY2267zVVtjTXWcMScfx0huegH+jnJuD+Q++vZs6eckiNCIQeTsFxEF/cdhBsSimELR3X6WJBvDck3MchHX8qQ+4VxUFSaogyFAcZP+Pvhhx+CTSC3wAZLC8ck72siFH1Cjyg0/xoGJ6Y/ykJA2gLcS36u4bIKszvxTu3atau758kNWEsRXUp0lXtVU9qPFxyeoejQEq6qRFcL0UW4MR8AGhFqioAikCwCeGNAGqA1zvsHLzPfJNGkLEtae5fOOo1vkZrQQWlBWqe5EKBjNmbMGEMyZUhSkanDm5HOgFr9IJAG0UXuAeQ/MSJ+kJdhELAZjcFq8r0S6ejnbKk1LMgzgcc7g0B4wZdjRP9DllbC/AF2P6KiEsfWY9QPAvV2X9dbfZv1OST5O21zMQa3GViVQSwZTJf1slyJrhZEwkSXyLMzuMyYQ1LG4DMSZRiDt0RlqJWOAKpGSJiJIf+GQyT9RyKpkHr3jX4BUoI8E8jji5FLyFcQkeXlTHmW/Lxf9KOJKs9n5LxCYl0s7iB+WBFFypUpuJG7PZc8Iu9PIryiyLa0MC8HN1RkOA+xLbfc0g2uE8HPgD1RUjKGwDa095EiRcqeaCMG4DHuGwbmmca1KKILWU3ITxy1wkSXr1Qlx8ZBSvK6kUf4tddeM+TvwlCkIOILZ2Ax3k3HHHOMI3l5p3/22Wdu7IZvAaSnT/Syz4477uiIL3F6SAvHJO9r+vHkIReD5OI5UUsGAWkL4BSIc2Bce/755w35CXmu58yZo0RXXEAL7F/XEV1hoovBGTwDCMVOygOhAH5VX81gO0kHO3fubNDaxZAkWnfddSND1ateYa2AIlDHCCDx1aFDh8ALisYQ0RA0yMQIGxeZAyQO6DRENYpl+3KmeKf+5z//cbuqvEc5CDbXPiLXIRrTSnTV7/Xv0qVLMBCRREQXEh04xogRjernIpDllZjS6STxOFr7dNx8eTsGaHAyeOONN1yHlg4HHqjkbMhndHrZBy10OvlEu/NejjJxXkASh3x/dPyLzX/IwBEetJwDXqVp5r6jQ8/Ao0j6RJ1L1DK+V0T8c42pH5I4ePtWwvwBdn4z0JLLiDTlHuB6QDjyjWvTpk2uzYPlpVzrYCf9kYVANTGst/u63urLhW7W53DEiBFOXUFudgZVaafLIJYSXYJM9LRSRBcD7OQYxxgMpj2gVjoCyLt17NjRzJ07t+DOEItIeRL5Eo54IrqOb3ESBnEp+bEoD7IUR/V8Rp/Fz8NEGwbnzv322y/fbi5CC2lG2mWMkfltPl++1S+EexxnQI7Zr18/f5X7TVuEyLhcEUJpYV4ObpBHRD8VY61bt3bS9uQTx/woJuYHW+l7BuXjWhTRxfPNc06b288rRbuU9CsQYb5JQIMsC8vJIdFPfcsxomyIcvQj39LCMcn7WpS95JyReYS0VksGAWkjcC/Qf4prOBrsvfferp+InLxGdMVFNP/+SnTlx6fm19I4JwSWwa+rrrrK1ZdoD8iuag1W1TxoWkFFoEwEhFz3d6dRhNcbnkA01pBOhRDD0vJcZxAYLx4M6QeN3nRQ6L8cCIhXmiR/JhKRexmvNvTt1eoHAZ/oQn5EGuGlnoHsB6lAx18syotS1hUzJaE3TjcQaHha4incrVu3oiIHfQkO3qvkXRVnAcgO3q9hw7sT77iw4QiA9yfkk0hWsQ3lkgia5NNI8/gmEp+yrBQsfEmVtCUByXXlXzOpb3iKFy5OERtvvLGTg8JTt1WrVuHN8s7jqAHhB+lELg+uB+8M7h8GJor15vcH2PG6JZ9C2MiVwCAWEXW+hXMx+Ov4Xc61DpeRa55vOXkwua+JpuQ8atXi1DUJDPF4RVqKgSuc7YoxjouHK30ZBhFwwihkSdzXhY5RzHp9DrNRSuIeyi7x57k49zal8E7h+RXj3Y9zrHwHcxFdOC0kmadIjl9vU77jRIAQ3YGlFdGFh7tI7DEYGJU7qd6wq1Z9GfTn3vUjd8J1wXETZ02J2EHCje+6/zzEaWf6x4OwYoBfjEgbP6eSLPen1J374MUXX/QXu751nz59nJQYdcdBg+genmm+QfwWGWci0uiji9EmhMzxjbyl9957r/tu4cBA3fy8ZhyDAelCUotpYF4ObvPmzXPtvnDEkn/O/GasEHLTz9WMAxXRf+JIxT3CNnGNdjhkmtSJdiltK8hLrjPjGvRJl1tuOXef+A54/rH9XGi08Qlw8O20005z0pz+sny/aY9C5PlEm2yfFo5J39c+eYtjNeNDtaxIIfjWw1TaCEmleuBdhhIUfUaeBSW60r0LlOhKF9/US48iuuhg0mFkIFNNEVAEkkOAwVsazf/3f/+XVSgh9AyAMWAjjTg2yKXlnbVzGTNnnXWWufHGG4M9w15NwQr9oQhYBMJEF9IGDEqSaFkbw/V1iyRBdNHJWtPK1mF465JbQAxPWfIKlmp4DuM1P3LkyAXyHfB+RKKGzmQ+gsYnujg+HQsGOPG09Mkqv250FnjP+saABR65fv4Bfz2/0Vr/61//ahjgEDvuuOMcqSPzOA09/PDDMptzKmoCsgFkmiSzlmVJThmM2nTTTbO+NVHlI9Mjsi5R6/Mtg9ghV4E4VOTaloEfBoX8QeSobX2iCxkdf8ALuSokqnJ5jue7DuVea6kj58k9y/MAQeMTgUj/nHfeeUG+Ta4rA1k4l1XD0qprXAzBggFwBqp4TvF4xzM+H9nFPYw3N7li5NnmnobM9ttQUTjHua+jyit3mT6HPyMX9x5K696WGtJmJzrXj3DBQxtnNMwf2GdeBreU6AIN4xxWaDekTXTx7AuZUIqjSUst9X8YAUgfiBJIeTGIBaK6cfaJGtwnagYik2cCKWue7WIj2+UYUVOcZWgHCgGFA43IVEZtL8vefvttF32O7FyULbHEElnPdXibcIQL3xvajSKJSPsUmUecVcXYhhxx1JnvEm2cYp0Ck8a8XNxwHCLXVNT3dPHFF3fqV1zncNQUGCBvSHsYHJKUEJW+KMQh7W//viJPGlLA4AzZlcsgMXkv41hB281X1JF9aLdCzvG+Yruw0UZhLIdyeBbyWVo4Jnlfh/Ms005Fkl4tPgLSFkBRpBhliUJHVKKrEELJrm8oosu/ecIDH8nCVjuloSOMtwWDDAwyYXgT82BWKsl47aChNVEE0kcAuRPkCQsZjTWkxWhQJm2E9NPwFlPPR0FCp1EIiHY8URR4r5H4lwF8OgErr7xy1C66rEYRSILo8vNgkLuNjqxY2PtVlueb4gGLV2U4EidqHz/Rc3g99yT3phgDLAw2hAchZT2DMBARRPyI+R10WZZrGpbOQUYH7zoxSLCoKDJZL1OJkJR5Bo/8/BiyPMkp7V08mhmkoQ0IkcRzjowJxuAPZFupxrXE+/myyy4zeLMWaxz//PPPzynZ6BNdRJkxyIHxLcNxI2owgn34g4iNyiUY51rLefnXHAKL/BsY90GUrBIdXfKM+FJIUlba0zTqmgSGnHd4oAXikLIlUsDHhnuUATikpXyDdDjhhBNSua/94yT5W5/D7EHRQtiG37myfRr3tpQtU75tkKRiF198cfCMT58+PautLoNbDIRqRFd1iC7eB0jqqcVDAIISsoQ8rHy3cPKJei+Hj0JED6RYOPI9vF0p80TsIFuMM/ZJJ51U9K7UhT4v+5diyBHSLgpHB9G2IUcYkWC0n5B5TNKSxrxc3IjCJ4INRwKIJKS+id4i3UkhJ0f6CZAxEEFJ5uxFrg2nIdqo5RoEHE4LxbTDkJTkXNiHaCfuZ8ZnuLeLtbRwTOq+pt1OdBvXiz49ChhJXrNicWrE7aQtgENjEu9CcYwkzRLOUjiFocBWiHBNE1s5x0ZMhVLXRBdEDp7pfCzpHDUj0TVjxgxDY1D0xnkQ+KCTf8HXQk7zAdGyFYFmQwACC2/kfIOgSDCRADsNo9GGlxkNN4x8MnTUS2m4pVEvLbM2EeBeZfCaDg8RNUTWMFhLBGKhHEe1eUbNWyuf6MLTsJwcSwx4iLffFVdc4bx3BdH27duXJPvBfuG8DlJWrimeojSow4bHnE9a4e3pD0zi0EObD49vBih47/kedtzTkE7yXqR85FGI7mJwh/ufzqBEerGOaFgx3ufIotBpFCsU9cg+DKAysIHxDqZMcltU2pABEklAIrl87IqpC2QT+NERizI6eeAN8SgY+tuxjuNHyRn6RBe4Q4yQgy2qnUoEF8m0advmsrjXWsql7yD3AG1nlBDADeLWj/6Q7ZmS85BOaqUt6bomhSE4EP2Gt7ZvvKtEUl2WE8GFIyIdfDEGn4gG452w4ooryuJgGve+Dgqq0I+49dXnMJ3nEMcAcuyIMXAuua2RyfWjCGTgR4muFrTC0oXyLuIdgvxZUsZ7QQb8wpG/SR1Dy6lPBGjXEfXNtyZX2wbHH9p6tGMhuWjnar+4Pq93s9Ra7+vavtLSFiCSMAnyUImuyl7vhiK6/ARvzeKBFUV0MTiEtwINUDVFQBFIBwG8oyCzaHTLIKccCTIBrzUGcNKycKcdjy0a+WqKQBgBol6QeGCQkQ4ggzdTp041fDNJRKxWPwjgiUmDGyuX6JKGNmXw/oLcEENDn0iqYu2rr75yhMQ333wT7IJ3LLl2kIuCCILUwCPSN3JvEInqm0So+8vkNxEgRIPlMuRw8MzFe1MsKrk05UjuBTxbkZnxLZwPgcisKHkf2Sf8Hi5X+lHKizOFQCBCTwznryjiQNaHp+Twi0rCjvc1XtG8OzCIQMoGGxzO/O8fxDmDUauttlpW8T7RRZQzHr1RkjrIB3IerM9lSV1ryif5uAx2gxXvRQjVXFGE7ONHfjFfKUuyrkliyPnjfMNzEpaXGjRokHsX4EFP7gyJ5BPM6KugRkGUXy6Le1/nKjet5XHrq89hOs8h+RxxdBDj+yARvGGnHxncoq3ULOMJgkvUtFJEF+8JVGmwUtsiUfXWZY2JAJErjH8RHQxRgBQd7TmkEIuJVmtMVPSs6h0Bva9r7wpKW4C+rC91X25NkYZFpaJ79+7OmU4juspFssj9bAe1bs16XmasN3PGSqy4c7AyTG7eyqDU7TmVWnHrme3O2XpIB7taoitjPWGDef2hCCgC6SFgdb4zNnGrew55H/Hs2bwy6R3wfyXz7G+44YbuuHaAKWMHlVM/ph6gPhGwRJe7Tywx4k7ARiO4eUs+1OcJNXGtbcRR8K6xg/FlIWFzXwVlcE/w3pI/G02TsdIiRZdrydNgX8qw0YIZ6wSQtT/lWcmqrO2st23GEh1Z2zEv9fCnNromY8mVrG3DM1aGJmtf6hHeh3e1lVQLtmObsL3xxhvBeupgnRnCmwTzlijO2E5QsP0GG2yQqeYzRV193GxejqCuxfywBFXW/pRlO2OZOXPm5NzdyiNmbERb1n6WOF1ge0uSZW3j15PflgjLWJJpgf2iFiR1rSnbkqdBvWykWUbejVK/TTbZJGOJh4yNMgi2sxEMC9y7UfVMelmSdU0SQzlPK0WYsdGWAU5gyPNhc/5lbB6NrOWsA2tLlMvuOadx7+ucBae0Im599TlM5zm0kZtZ96Al1YN5S9Bm3Q3y/NvcgVnLm3XGEl0ZqyIRnL58z21OnWBZEj8sAR9cExuNk0SRWoYioAgoAoqAIlAWAtIWCPdryyrM7mSJLveNoz1vJZvdbxuhWm5xiewn52gVXhIpr5YKaaiILjyy9tlnHyfLNHjw4CKpvvrejCgOvKdhh5EgwpD1QUIGz1Q1RUARSB8BIhfwbEfOaaeddqqYRxnPP+89pEvj6F2nj5AeoZoISCTAuHHjzDbbbOMSMZOIvdSIj2qegx67BQE/ootk2sgUl2pEMR144IFuNyIsaDf5Rh5C3inFGBEb3FdiRCOQ/DtseN1269bNIE8ohvxROE8DEem+LB5RquRxYnkuY3vuaz9qjIggInOIrsULj/czkWq8q8XsgHSkvCySSRKZQhQTkZBhIyIGmUM8MMWI5CDJebWMnDPSDqQOpd4fRAgefPDBQfWREJw8ebKTiAwWRvwgzwDRPJJnC+yRAvPzJxAFlStK6sQTT3T5N4rJZ5n0te7Vq5c7x4jTctGu3M/ggFzh6NGjg824nyTyIFiY8o+k6po0hv5pI/XJM+BLE/rr5Te5mnj2i5GVintfyzErNY1bX30Os68UUedJPIdIjvuSo+Qrfeqpp9zBwvlKLUHrlmtEV8u14JtIJC/9DYx39t133+1yvfJ+TMpoJ4gUYlTEdVLH0XIUAUVAEVAEFIFCCEhbAMWRYtqrhcojlzV9U9Qr6EdqRFchxOKtr2uiC21/kqj37dvXNbpoqCJFQDJzkls3g0URXegTIx/DQKaaIqAIKAKKQHMjwIA+uVJuvvlmJ7vFYA+DPkjYJZFctbnRrezZJ0F0kdha8gcicSz5uuRMIHCQGyzG9tprL0eYsi2Eko2IyinZaiM+XBJs6+3likauLCxlBmFF4nQxSDgkp/IZ+efIQ1eKQcaRTyqq42K97AJJK0gbyLmwBCAyisjTipF3inOppnysVTcwSEKK4ewUlS+LwURyOiJJ6EtxSJta9mcwk/Z1MRaWBZN3jeyLpCMkSJQhaQeJU4wlfa3JCeeTr1IHtPjJ3SWDuNSdcxATGViZr8Q0qbomjWH43CFYIbu4z6KM/Gvk2ivW4t7XxR4nqe3i1lefw5+vRJLPIQnfkdQVg3x/7LHH3CxyQsificnglhJdLYhUiujCEYXvEsY3F2csNUVAEVAEFAFFoBoISFsgl6NeqXVSoqtUxOJt31BElyQyh/yycgPxkKmTvSWpPImzRXvcyue4BiIDmWqKgCKgCCgCzY2AlY5yeVDGjh3r8hgRtYHXeDgBe3OjVB9nnwTRxXWXiC0rPefyGsydOzcAYKmllnIkaDFRohA85OkSI2qK3Bq5jAh0HHQwks4z+OgbbRkIWLFcEWKyninRaZJri/wMOPrgfZfLrLysIWpt2WWXjdyEKCafeOnfv7+LOJKNb7vtNjNgwACZdZFL5P0qJ7ouKCSBH+RbGzp0aFBS1LXgOlupQZffAhxuuummYHtyaxFpI0ZZ6MgXYxBid911V7ApBKp45rPw2GOPzZv7DULz/PPPLxg9lvS19u/HoPL2B0QvhK8YpA1ta4lUgtgLR0LKthC5DNgmTXomVdekMZTzlikRfpAIVrJUFgVTIuP8qJpgRZ4fce/rPEWnsipuffU5/PmyxHkOfy6l5RfENVHEYj7RFc6/IYNbSnS1oFUpooujCfZ8y3GcUVMEFAFFQBFQBKqBgHyPkiK6pk2bZrp06eL6rVYOUSO60r6otaSjWGpdrHSI07a0HqxuV+tx6eZt4thSi6rb7a1sjjtn23gPzoE8EdYrOpjXH4qAIqAIKALNiwA5UtBglhw4dqDTzX/99dfNC0qdnrmf68Ym4i7rLNADF01uCrAkRTAvyy1xU7Bscm/J9jIlzxF5rnLZAQccEOxjo6oW2MzPm0KZVg5vgW3CCzimHJ+2ELm5uNf79OmT2WGHHTLkLSXfB3ronFc4d1e4PM7LRvIEZVriLvP555+7zWhnkqNJjseU3C+1YBMmTMiqF/nXwmaJxaxt/HeAJfCy1lmpvvDukfM2KiILExtFtkCeNuuAFpTNevJ4+Rjy20pwZ+yAc+QxZGHS1zqcU4p6nH766XK4rCm54qTOUbl7LLmVof9hVRXc/TNmzJis/ePOJFXXpDH0z4tcRzxzglN4Coaffvqpv0vB33Hv64IHSHiDuPXV57AlZ2S5z2GuyxnOJ2kdfoL7lGfXN7lvo55zf7tm+W2Jrgz5CsVstK/DzkYGy6LEppJHk++EmiKgCCgCioAiUC0EpC2Q1PEt0eW+ndaBUnN0JQVqnnIaKqJLpEWQxEAaoxnMJoI1tlNpkA9CLgNr27atQe4B+RA1RUARUAQUgeZGQHKG3HjjjS6no3j041mUK6qluRGr3bMnygQJQIwoJvJYlGpEO3Xo0MHthpca8kC0IXxD2o/IpYUWWshfnPX7k08+MeQ5CRtyf0cffbSLDvKjwqg38m8S6cG9xz3oG5Jnvuwy0VXkHc1neOaLt92vfvUrh0u+eucrS9aRP8iXVaRc6k4E1KxZs2Qzg5zc8OHDg/lq/rDkniECQYxITl9uj+W+xOCiiy5qiGTgemHh/Tnn++67L0vSy234v3+WJHN5q8hdJZFOrELWkevvG/cJ9wvGdUdqnPfQCy+84G/moqAsGeruHfKfUS7SmlLHJK/17NmzzYYbbph1fDvI6vK5LbbYYlnLmaFfQVQsRnQXueN8C0ujgT3XIAlLsq5JYuifG9Gh3H9ynf11/m8kyZDSjXp3+NvJ7/B9Wep9LeVUahq3vuH99TnMvnKFnsPsrX+eu/76640looMFvFeIPMXk+yErxYub7xG5F5vdaA/gfS7va4ngRWZz3XXXTRQeIoFF9hTVGnn3J3oQLUwRUAQUAUVAESiAgLQFUCJJQqWBfjD9ePo55L3UHF0FLkDM1Q1FdEneCespaqwnWExo6mN3BgJ23HFHs/feewe5Gdq1a2cI+Rcpn/o4E62lIqAIKAKKQBoIyOD2DTfc4AaNu3XrZp588knz2muvOaeINI6pZaaDQBJEl42SMuTHwmSAD8lnBq18Q56vd+/e/qKs35AkO++8c9YyfwYpP+TdVlttNWMjPVyOuH//+9/BJuSPYlDXt8MOOywYfGQ5g5M48+Qzkvr6jj2l5gCKKvvjjz82SPuRLDiXMcCHPKCf5yrXtpVYjuQj0o9i5KMZNGiQzBrOies1Z84ct8x66Ju77747WE+nC/LBRq8Fy7hGxxxzjCN26PBxHcmhRnsb0ue7774LtuUH7VGILz/3GRj6g6Grrrqq25/l/fr1y6pDVmH/m/EHm5O81pLj1j+mvCP9ZfL7zjvvNKeeeqqbpcOL1v7SSy8tqw37Dh48OJhPMl9wknVNEkNOdt68eebaa6915JVPeIINhCd9Ee6XsLVv394wgM4zj3NeLot7X+cqN63lceurz6Fxz1I4d6Rcr0LPoWwXnkJY2SjLYHExRBcym8htNrtVkuhab7313DsFzJEuZDxDTRFQBBQBRUARqDQCQnSR13jxxRePfXi+aVaZxeXJtoFIhvYM0vdWeSR22eUWIOd4yimnmOOOO67cYmpyv7omuh5++GFDR1ISZivRdam7yawsiRt4YSBTTRFQBBQBRaC5EbDyvi7iV0gDPImeeuopFxnkD9Q2N0r1cfY+0cU3HhKpVGNgmsEkTMhOPKd32mmnwJOadUT8TJw4MWdElZ/ri+3J/QRZJt7YLMtlRFwRHUV0iW9hwo2cUVZy0N9kgd/+wCcrIVkuvPDCBaKZwjvioY53nZVSM1buOYu0YFtyVJFvJ8rIY0bOl/XXXz9qdeLLIKmI6llrrbWMHyXnH8iP1GP5Kqus4nJNQSLQPh45cqT56KOPgl1QAQhH8oXJmmDjIn507drVXHDBBQt44IfrBWZTpkwJSrz66qvd9aLTF2V4+EvkRZLXGky33nprl0+L40K8WHmzqCq4ZVby093jskEYPwbR/eiPc88915APMQlLsq5JYsh9RR+MZ8g3yMxbbrnF5WmDuAGrESNGBFj725I3iQjKXBa+f8q5r3OVXepyfQ5bIqCSvIeSvLfzXU8/vyXfH6IyIautTK1hPME3GfhRoqsFlTDRJRHPNoVE0Jbw8Yvzm9ydQpgTbU4EqJoioAgoAoqAIlBpBKQtkJTThfQjRG2DtlStEF30tf08zZXGOo3jKdGVBqoVLBOGuVOnTs5rGq99DC9d3OPyvgAAQABJREFUWGcGMtUUAUVAEVAEmhuByy+/3EmWEWnB92L//fd3A99JNdyaG93Knn0SRBc1lsY7A3wM9GHIOkGG+gYpMWnSJBMl5RaWPLz99tudJzYRQOFIH79MpOsgRDiXsBExQ8NfjLKslrnMRk4hSIhqpz6+EZFl83QZmzPJeYUTqQSxR8QFUSb8logtSLpRo0b5u7tzQV7v+eefz1oOFkSwdOzYMWt53BkIQiKmqCdRd0S/8Sf15Ty5bkglbrHFFgscjnOxuVTMV199tcC68ALkIJHei5J4PO200/ISPuGyiAIjKidXdN8XX3zh6gvhgfkKBFIWA6YoMXD+YeNckffAkr7WlMs9R4QWpC73Sj7r3r27sTnJ3CZ4PuIBKRaOGEH6UiInZZs406TqmhSGXHOiw8LENuQ7z3BYVhVSDMmzsLQhUYh8o3JZUvd1rvLDy/U5rO/nMHw9mUdmFSdQm4vLreY5FwlgX/pf9pXvI887Dg/NbrzjcZCRb2yaRBffJmk/MI6BdKeaIqAIKAKKgCJQaQSkLYBj53LLLRf78Ep0xYawpAIaiuiiQYSneliupSRE6mxjJbrq7IJpdRUBRUARqDACV1xxhSFPF9EpRO3gSUROSxpcRKao1Q8CSB5AUGLlRnSxrzTex40b56KZWPb999+7+2PmzJnMBsaAti/JJivI1wFpITZhwgSz+eabu/oRzcLAtgyCE2VFNBIyhLTRVl55Zdkta4osHtsIAQX5QN7RQoaMM9EzUUQJ+xIFNXfu3JzF4LF+xx13LLAe0ohIpRkzZrhBUgbdyC+EQ1EhI9cYRCIRKETHgQHnRWQW8oH8ke8LIghi68svv3RETqFyo3KbyT7yrMt81BQ5whttvj65B6K2oT2NNCG5tKhb2JZffnkX3UROJjzwCxlkJUQoTlhc06h9wAaC5JprrsmKPAN/3l9iSV9r7tPWrVsHhK8cJ2rKswFBC0EIPv69CVnKO1UsjRyISdU1CQyJkAnnQwZH5DBtAm+BIWvKPQ8hiAcrzyPRhkTCQULkszj3tT6HPyPbDM/hz2f78y+iCf18eUjy8p7BoqKG5d3IN4VvWbNbJYku8ibyjcR4dmk3qCkCioAioAgoApVGQNoC9Hdp38Y1JbriIlja/kp0lYZXzW1N8mcGLv2BgE033dQNqtAhVlMEFAFFQBFobgSuvPJKFwVCFApRF/vuu6959tlnDTmWaiW/UHNfoeLP3ie64ng7S+P9zDPPNMgFihHpRBRT2KJk2MK5aJDy8wesGayiUQ8pQpRHsbk2aLsge8YAVz5Js3AdIYqIACu17QM5x/nlkiFERgnv/2+//dYRXBBNhYzni2gXIewKbV/K+qjcZrI/nvAdOnSIJKdatWrlojkZ2M2XE0nKkikROEREQFpC8KywwgoGaTqIu1KMCDoIv1w4S1kcB7KESDoiL8gpyH6+pXWt/WPk+s01JQLMT0wNIerf+23atHHv2FxlVGp5VF3l2HExJPKQiBcx7inI4kJRcbJ9KdNy72t9DhdEuZGfwwXP1rgIwi5dujhHAllPWwiHCww1FHJJ+ibfR97hw4YN81c15e8w0YXEEY4tSNAWep+XChh5xnEAwR544IFIp4hSy9TtFQFFQBFQBBSBUhGQtgD9Svo9cU1yWzMOQx9KpQvjIpp//7omutDsx9NY9N3xbqZDTPLjgQMH5j/zBlkbRXQhlUIHHI99NUVAEVAEFIHmRiBMdOEYQaQG349c+X6aG7HaPfukiC7xmsZRJpyHasCAAea2225bAASiASCSxMI5upDCI+9JNQ2S5J577nHn5EfX+HWifcRgPDmZILm23377kkkbv7yo3+FcY1HblLsMiclDbSRVLnvnnXdcG5iIIjpSRKsxkItsaZQEZa5yan15rVxrcHriiSccsSmY0Q5HurDWLQ6GyMAh+/byyy87Mpv8bj7Zl/S5l3Nf63OY9FVYsLw499CCpSW75L333nPPpS+XiVQvEprI2mJhBw2WyeCWEl2gYUwliS6ipSHhsXvvvddstNFG7rf+UwQUAUVAEVAEKomAtAUef/zxnEoFpdTHH7fHcVCJrlLQK33bhiK6xBO5V69ehhwDzWA+M0zeBoyBGwY38GRUUwQUAUVAEWhuBJBau/DCC83IkSMNRAmD3kRLIH2LlJha/SCQFNHFIJ/k3kLGzDeiJ3bffXfz7rvv+otdNA+SY+LBDZGCp7xYtRPqSj1kynkhOYjcHIOxRJaRNwi5uWKjy6SsUqdCJof3wyNw9dVXNyuuuKLTeyfKSv6EhCJ6ac0113RRVwz4QTAyYIuRv4Rop2IIaogI2oL8NbpV81qDLRKggwYNCmAulHcq2LCGfpSDIfm+iCyF4C4m0jGJ0y3lvtbnMAnEiy+jnHuo+NJL25JoIyKPRAZP9r766qtdpDEOQFhUrlIZ3CK6+bzzzpNdm3ZaSaKLMQxyU2JJ5zls2guoJ64IKAKKgCJQMgLSFpg6dapBTSOu+SmHcLqsJaILBRWChxrJlOiq86sZRXSRjJyk3+EE6nV+qlp9RUARUAQUgTIQYGDnggsucDkpyC9DXiX0phmUksH1MorVXaqAQFJE16233ho4BH3wwQcLnAnECmQXcn2++TLJojUu6yFgisldJds38pTBf/IXoelOdA+Dd2BTimSg4EMuo5tvvtkRCUiPJpEQWcrWaTIIEGV3/fXXB4WhKoG6hFp1EdDnsLr4V+PokK/k48LBJ2wdO3Y0N9r8hEhuPvbYY04SlUjBsOFoQDmoxJx//vnh1U03Hya6TjnlFDN+/PhUpAU5lkTgkdeReTVFQBFQBBQBRaDSCAjRlZSMLuMuO+64oxuHWWSRRZToSvmCNhTRJdIhJJlFeqcZTAaa9ttvvyDRLjI1P/74oxvIbAYM9BwVAUVAEVAEciNA0nUGayC8Onfu7OSmXnzxRcMATzj3Te5SdE0tILDLLrs4b3TqEidHFxHfaIRjtCOWWmop99v/9+CDD7rBehxnxLbbbjtz0003uVly9GyxxRayyowePdrJ4wUL9Ici0CQI7L///lm54SAmt9122yY5ez1NRaB2EEBCc/DgwQtUiNxPSPLyrZPBK5w5RowYscC25IckcvCAAw5wTkILbNBkCypJdCEp/NFHHzmEx44d63JONhncerqKgCKgCCgCNYCAtBWSkuZn3GWHHXZw4zCMv2hEV7oXua6JLsIIyVNAYm3kCdDPPPjgg10OCaRemsGiiK5wg7QZcNBzVAQUAUVAEYhGYNSoUS6hOgM6DOwgq/XSSy85aTo8itTqB4GkiK6vvvoqyKeTLxILsou8XPPnz3cg+U41yAGS7wTPdwx5TAb81RSBZkPAfy45dxwJkKdUUwQUgcoiQCQtBIlv22yzjXP0QV4TEgUyBWPbnj17+pu630gU4eDB94zvWrPbVlttZX744QfXbgSLNCO6OnToYN5//30HuTrPOBj0nyKgCCgCikAVEBCiKyqXZznVUaKrHNTK30eJrvKxq4k9leiqicuglVAEFAFFoGYRuPbaa825555ryEmxxx57mD333NO8/PLLLu8PGtFq9YOAP6D+9NNPG3I+lWvSgMf7/bDDDstZDGTXscce6yLFIU07deoUbIss33/+8x83z+DXcccdF6zTH4pAsyDgP5c8V8iiqSkCikDlESBfN9KEEFUrrLCCQeXliCOOMNLWueeee5yDLDXjN5FeYfvtb3/r8jr6jh3hbZppPkx0nXrqqal5oiMvKTkpJa9sM2Gt56oIKAKKgCJQGwhIP/mOO+4wKKbFNXJfb7/99s7hmNQRtRTR1bdvX3PiiSfGPcWa2r+hiC46ljRuSbLer1+/mgI6rcpEEV3hBmlax9ZyFQFFQBFQBGofgeuuu84MHTrUXHHFFY7kgux65ZVXzIwZM8xCCy1U+yegNQwQ8AfU4xJdkvQdsoqk7/ls9uzZLnKrVatWWZsh7YSEIvaHP/zBTJ48OWu9zigCzYDAkUceaaZMmeJOVQfHm+GK6znWMgLI6kJ0rbLKKgu0cfyILwadoqLalejKvrrhcYU0iS4caaZPn+4qIG3W7NronCKgCCgCioAikD4CQnSNGzfOEBke13DiwJkDh+PFF19cia64gBbYv6GIrkcffdT06NHDeR7TCGsGe+ONNwzJ6X15BSQZvvvuO+ex3wwY6DkqAoqAIqAI5EYA+ZchQ4aYyy+/3HkRIV/46quvOnmYX/ziF7l31DU1h4BPdD3zzDNuIK/cSg4fPtxF+bH/Bx98UFYxZ511lrnxxhuDfZOSdwgK1B+KQB0gQM47pNOR8SRKBNJXTRFQBGoPAZElROb/9ttvj6wgkrzkuiaPJd/JZrdKEl1+G+eSSy4x++yzT7PDr+evCCgCioAiUAUEhOgi9yeRWHFNia64CJa2f10TXY888og55JBDnFQOkjnh+dKgqM+to4iurbfe2syZM8d57NfnWWmtFQFFQBFQBJJCYMyYMeacc84xl112mUuA2qVLFzNt2rSyyY2k6qXllI6APwgUl+iSNhO1ePLJJ81qq61WcoVI0EsOL7G9997bXHrppTKrU0WgaRBAwhMpknDUY9MAoCeqCNQ4Al988YXZdNNNXS3zSfauu+66Li9l165dzcUXX1zjZ5V+9cIOtGlGdEn7lLPSvJ/pX1s9giKgCCgCikA0AkJ0IdtP/zuuoaSz3XbbuTQSSyyxhEZ0xQW0wP5KdBUAqNZXRxFdhFZ+8803zmO/1uuv9VMEFAFFQBFIFwE8kRjUEe/Y3XbbzSB7S4NLrb4QSJLoop2w0UYbOQDwWsd7vVT7+uuv3cDhf//7X7crA/3IDmmkYKlI6vaKgCKgCCgCaSIwceLEII8kjh5rrbVW5OHWW289M2/ePBdNRLup2a2SRNdf/vIX89JLLznIyS1LpKyaIqAIKAKKgCJQaQSE6BoxYoRBDSeuvf/++6ZDhw6urCWXXLKmiC7yc5Gnq5FMia46v5qvv/66YdCSPBkXXHCBO5ttt93WzJo1y3ns1/npafUVAUVAEVAEYiKAtBwSc3gm46GM3O1bb70VJPyOWbzuXkEEfKILubQ2bdrEOro04ikXj7VyjLyokyZNCnZFmmHhhRcO5vWHIqAIKAKKgCJQbQQOP/xw8/DDD7tq5JPrXX/99c3cuXONRii3XLFKEl1IFT7//PPuwCgRoNyjpggoAoqAIqAIVBoB6SNL6oe4x6fdwTg9kctLLbWUEl1xAS2wf0MRXVOnTjWHHnqoOf74483JJ59c4NQbY3UU0QVT/OWXX5rXXnutMU5Sz0IRUAQUAUWgbATGjh1rSMB+0UUXmf3228+F37/99tuGROxq9YVA0kQX9wX3B1YuQcV+eGETIfb73//eTJ48WSO66uu20toqAoqAItDQCPz000+G/FzYcccdZ0h5kMt+97vfmR9++MFJPSP53OwWTomQpnQhOceffvppBzntk549ezY7/Hr+ioAioAgoAlVAQIgucRSOW4UPP/zQoLymRFdcJIvbX4mu4nCq2a0gszp37my6detmzj//fFdPtD/JFQAJpqYIKAKKgCLQ3Ago0dU4198nup577jmz8sorxzo5P0/XbbfdZkg6X45BduGFvcceexh0x9UUAUVAEVAEFIFaQYA8lPSVsUI5KXHY+P77750DB57czW5hoqtfv37mjjvucE4tf/jDHxKF56CDDjJPPPGEK3PQoEHmqKOOSrR8LUwRUAQUAUVAESgGASG6ksoXKUQXY/e//OUvNaKrmIsQY5uGIrr+8Y9/mMMOO8yccMIJ5qSTTooBS/3sGkV0dezY0Xz++eeG/F1qioAioAgoAs2NwLhx4wwDBsjbInO78847u2iud955p7mBqcOz59r961//cjVPguj68ccfzTrrrOPKw8PsqquuqkNUtMqKgCKgCCgCikBuBDbZZBOndrLIIosUjGaHvPnuu+/Mnnvuaa644orchTbJmkoSXUgV4oCD9e/f3xxzzDHut/5TBBQBRUARUAQqiYAQXcOGDTM4YcS1mTNnGr6npB1aeumlleiKC2iB/RuK6EJ3G/3tRkymlus6RhFd22+/vfn000/Nm2++mWs3Xa4IKAKKgCLQJAjccsstZuDAgS7qF4/mTp06GXSip0+f3iQINM5pJk10gQz3BvcI9vLLL5vll1/e/dZ/ioAioAgoAopAvSMwZ84cs8EGG7jTIBLpT3/6U95TUqIrGx6klpAmfvXVV92KNCO6jjjiCPPQQw+54yAvicykmiKgCCgCioAiUGkEhOgaMmSI6dGjR+zDf/TRR4acl+RKX2aZZWqK6GrEQKGGIrpoGNFA6tu3ryO7Yt+NdVBAFNG1ww47mI8//jjw+q6D09AqKgKKgCKgCKSEAJJ0AwYMMOKRtOOOOxq8it56662UjqjFpoWAT3QhFbjSSivFPhSEJ+QnRn5T8pyqKQKKgCKgCCgCjYAAuUmfeeYZdyo4+RSyP/7xj+bbb791UrxXXnlloc0bfn0lia6jjz7a3H///Q7TZhrPafibSE9QEVAEFIE6Q0CIrrPOOssF08StPuPzpAggDcGyyy6rRFdcQAvsX9dE16OPPurY1WOPPdaQGFWJrpYcXTqIWeCu19WKgCKgCDQRAngw44E7dOhQ0717d6POEPV78dMgukBj9913D7y1kT1GO1xNEVAEFAFFQBGoZwSQIJQ8Utddd53ZaaedCp4O0V9EgfFdHDFiRMHtG32DMNGFpODtt99u7rvvPgMpmKT16dPHTJo0yRWJ0w3ON2qKgCKgCCgCikClERCi6/TTTzdHHnlk7MN/8skn5s9//rNLIbHccsulluuylIrKOWpEVymoVWDbMNH14IMPmp49e7r8XFysZrCoiC6VpWqGK6/nqAgoAopAcQjceeedzhlEQu9V3rY43GpxKwbpJBLvhRdeMK1bt06kmi+++KLZa6+9XFlIBSEZpKYIKAKKgCKgCNQzAsgEIReEFRPNxXYbbrihmT17ttG8laBhzLbbbmtmzZplpk2b5ubTJLogt+655x53HG2LOBj0nyKgCCgCikAVEBAS6LTTTjO9evWKXQMlumJDWFIBDRXRNWXKFMe2NpP0ThTRxUDYjBkzzNtvv13SzaAbKwKKgCKgCDQeAuPHj3fExTnnnGNI9N2xY0fz+eefGyJ31OoLgbSILlDo2rWree655xwgTz31lPnVr35VX+BobRUBRUARUAQUgf8hQE4porKwCRMmmM033/x/a/JPNtpoI5eTqnPnzubqq6/Ov3ETrK0k0XXSSSeZv/71rw5VortQI1BTBBQBRUARUAQqjYAQXSjHoSAX1z799FOXI5S+PPmwUdyZPHlyEHUet/xy9pdzbMQI6romuh577DEnwyQNoQceeMAcddRRbkCvWZKXRhFdSBu9++675p133innftd9FAFFQBFQBBoIAQZ4cAA5++yzzaGHHmq2224785///Me8/vrrDXSWzXEqaRJdOMhwb2AMCHLfqCkCioAioAgoAvWGwLx588x6663nqr3YYouV5PzZtm1b8/XXX5vddtvNXHPNNfV26onXt5JEFwOKqBBgeNDjSa+mCCgCioAioAhUGgEhgXDASEIt7rPPPjNbbrmly4u9wgorKNGV8gVVoitlgNMuPoroIsEd0VyQXWqKgCKgCCgCzY3AXXfdZUjqLclUO3ToYL788kvD90OtvhDwiS7kBldcccVET+Ciiy4KcpJcddVVTrop0QNoYYqAIqAIKAKKQMoI4H197733uqM8+eSTZrXVViv6iO3atXNSfbvuuqsZOXJk0fs16obhNuOAAQPMbbfdZv7+978b8pklaRBbt956qyvy6KOPNgMHDkyyeC1LEVAEFAFFQBEoCgEhupLKX6VEV1GwJ7aREl2JQVmdgpToqg7uelRFQBFQBOoFgb/97W/OE+mMM85weSzD3rn1ch5aT+O8wKZPn+6gSIPomj9/vll33XUDqJ999lnTpk2bYF5/KAKKgCKgCCgCtYwA0nd4YGNEsRPNXoptvPHG5quvvjI4jo4aNaqUXRty20oSXbRTx44d63A88sgjzemnn96QmOpJKQKKgCKgCNQ2AkJ04ThDtHFcI23EFltsYXbccUfnqFpL0oWNmBOzoYiu+++/3+D9k5SOZtybuRL7Iz2FtMIBBxxgLrjgAndIPNBIVv/ee+9Vogp6DEVAEVAEFIEaRoDE3mgvM2DAwME222zj8k+Qv0KtvhDo1KmTSZPoAg1yt9GOwPCCf/zxx83CCy/s5vWfIqAIKAKKgCJQqwi89NJL5i9/+UtQvX/9619mySWXDOaL+bHJJpu4qHdSAVx77bXF7NLQ21SS6Bo8eLC54YYbHJ5KdDX0baUnpwgoAopATSMgRFfv3r0Nkcxx7d///rdLDbDDDjuY1q1b15R0oRJdca9uwvsz+HLwwQebY445xvTv398o0dVCdEF8vfnmm4Z8G2qKgCKgCCgCzY3AxIkTDQ2YQYMGuTyWW2+9tZkzZ4555ZVXmhuYOjz7ShBdwDJ69GgzZMgQh9Dhhx/uZC/rEC6tsiKgCCgCikCTIDBz5kznpEH7BrvpppuCvJOlQLDpppuaL774wiAVfN1115Wya0NuG87rmqZ04dChQwPMe/bsaYjwUlMEFAFFQBFQBCqNgBBdSTldkB99s802M9tvv71ZaaWVlOhK+YLWdURXmOiaPHmyS1zar18/06dPn5Shq43ioyK6lOiqjWujtVAEFAFFoBYQmDRpkvsmkvuA5N5bbbWV+eGHHwyez2r1hYBPdHH9SGablhEp/tRTT7niR4wYYXbfffe0DqXlKgKKgCKgCCgCZSNA3tGuXbsGaib77ruvGT58eFnlMRDFgBTfW5w+mt3CRJfk0aJtueGGGyYKz3nnnRfkRTviiCPMmWeemWj5WpgioAgoAoqAIlAMAkJ0JfUtwoEGR5qOHTualVdeWYmuYi5CjG0aiui67777DKGFRHcR5dUMFkV0de7c2bD8/fffbwYI9BwVAUVAEVAE8iBAwnC+iXjh8o3885//bObNm2fI8aRWXwhUkuj6/vvvze9///sAIHK9kbtETRFQBBQBRUARqBUEvv32W7P//vsb8lZjSO4+8MADZplllimriptvvrlBYog8GmPGjCmrjEbaqZJE10UXXWRwrMGSGlxspGuh56IIKAKKgCJQGQSE6Con12dUDXHIQRqZbyr5rzVHVxRKyS2ra6LriSeeMAcddJAbuGMALzyYlxxMtVtSFNHVpUsXM23aNPPBBx/UbsW1ZoqAIqAIKAIVQSAc7axEV0VgT+UgDLy9/fbbruy0I7o4yGeffWa23HLL4FymTp1q1l577WBefygCioAioAgoAtVC4LvvvjOHHHKIee6551wVfvGLX5jx48e7PBjl1olk8SSNJ4/G9ddfX24xDbMf3ufgQf5OLM2IrksuucRcfvnl7jgqm+xg0H+KgCKgCCgCVUBAiK4ePXoEcv5xqqFEVxz0St+3oYiusDxT6XDU3x6SNB5PtgsvvNCdAPJCr776qovoosGvpggoAoqAItC8CODZfNRRR5lTTjnF5er605/+ZH788UfzwgsvNC8odXrmPtH18ssvm+WXXz71M5k+fbqTcJIDPfLII2attdaSWZ0qAoqAIqAIKAIVRwBHDMgQnD7FkkhfgHMHZZNH44YbbpCim3ZaSaLriiuuMBdffLHDWomupr3l9MQVAUVAEag6AkJ0HXjggQZZ3bj21VdfOWWUDh06mFVWWUUjuuICWmB/JboKAFTrq5XoqvUrpPVTBBQBRaC6CEyZMsWQSPXkk082xx9/vIvQ+emnn8zzzz9f3Yrp0UtGoBpEF5WU6HGp8IQJE2J5zEs5OlUEFAFFQBFQBEpFgPyRxx13nMulJfvusssuLr9TXCdPnIE+/fRTl0fjxhtvlOKbdlpJouuqq64KHHdVurBpbzk9cUVAEVAEqo6AEF1+QEmcSs2aNcu0a9fObLvttmbVVVdVoisOmEXsW9dE1z//+U8Dw9qrVy8XRn/vvfeaY4891gwcONAcffTRRZx+/W8SRXTtscce5pVXXjEzZswwCy20UP2fpJ6BIqAIKAKKQNkIPPjgg6Znz56mb9++5sQTT3QEBQNBzz77bNll6o7VQcAnuvjOL7fcchWrCHk/8UITE+JU5nWqCCgCioAioAikiQD5RYn4GT16tMFhR4y8WjfffLNZcsklZVHZU+SdP/nkE5dH46abbiq7nEbZMUx0Mc5yyy23GMZdNtpoo0RPc9SoUWbYsGGuTCW6EoVWC1MEFAFFQBEoAQEhuvbdd18zfPjwEvaM3vTrr782bdu2Ndtss43LJXr77beb++67z/zxj3+M3qECS+Uc4VBOPfXUChyxcodoKKJr4sSJzrtr0KBBTqapcjBW70hvvvmmwYNtv/32MyRwxfbcc0+DpNF7771nFl544epVTo+sCCgCioAiUHUEHn74YSfvA8kF2bXZZpu5b8MzzzxT9bppBUpDgJwh77zzjtup0kQXB509e7bZcMMNg0ovssgiTir5l7/8ZbBMfygCioAioAgoAkkjQG7uM844w/Vv+eaQnwvbeOONHcm1zDLLJHJIIbpw7Bg7dmwiZdZzIZUkuiAwhwwZ4uDCQYvrraYIKAKKgCKgCFQaAWT6/+///s/svffe5tJLL419+G+++cY5h2y99dbm17/+tVGiKzakeQtoKKLrnnvucbJMp59+upNpynvmDbJSia4GuZB6GoqAIqAIpITA1KlTzaGHHuq+j0ThbLrppmbRRRc1Tz/9dEpH1GLTQsAnusjF2apVq7QOlbPcTCZjBgwY4BroshEe9l27dpVZnSoCioAioAgoAokggEIJ+THIN0o0evv27R3ZRdQVpBTkyNJLL53IsSiE8j/66CMnL0SUWLMbucqQcmTMAUszogupyLPOOssdB8ltxnTUFAFFQBFQBBSBSiOw/vrrm7lz57ogEvJHxjUluuIiWNr+dU10Pfnkk6Zbt25OppBGlxJdLRFdf/nLX8xLL71k3n33XYO3tZoioAgoAopA8yLwyCOPmEMOOcRFPJ9yyilmk002MYsvvrghx4VafSFQC0SXIAbRtvvuu8usm0KeojuupggoAoqAIqAIxEEAImvEiBEuj8V///tfs8EGGxjke4myIqk7/V3UTBZbbLE4h1lgX7ytZ86c6eSFxo0bt8D6ZltQSaILYlHIraOOOsqg0qOmCCgCioAioAhUGgEUTFAy6dKliyF/ZFwTVRScaVZfffWaiujq06eP6devX9xTrKn9leiqqctRemWiIrqU6CodR91DEVAEFIFGReCxxx4z3bt3N9KIUaKrfq+0T3RNmzbNLLvsslU9GSQdjjvuODNp0qSgHmuvvbabVznDABL9oQgoAoqAIlAkAh988IEZOXKkmTBhgpk/f77LZYH0MnkiWY6RS4Ic3UR4JW3kz/jwww8NhBe5qJrdKkl03XbbbS5iHMzJt44js5oioAgoAoqAIlBpBFDA+eKLL0ynTp1c5Hjc48+ZM8c57Gy11VZmjTXWUKIrLqAF9m8ooutvf/ubOeGEE5yeM7rOzWBKdDXDVdZzVAQUAUWgfATIa3HQQQeZ3r17uwGEdu3aGUiIf/7zn+UXqntWBQEGnIjWxmqB6BIQkDX605/+JLNu2rp1a5es/le/+lXWcp1RBBQBRUARUATCCLz44ovmuuuucxKFP/30k+Hbccwxxxjkg5Cze+ONNwzfFSSE8IhOy7bddlsD2cYxbr311rQOUzfl4mDz8ccfm3/961+uzmlKF44fP96gPIBJm9XN6D9FQBFQBBQBRaCCCEBI8e1LKl/nt99+a/74xz86yeXf/OY3SnSlfC0biui6++67DR5fZ555pjniiCNShq42iqfRufPOO5t9993XDB8+3FVKI7pq49poLRQBRUARqAUEwjK/bdu2NSRthwBTqy8EfKLrtddec9exls7ghRdecEl7w3UiufzBBx9sFlpoofAqnVcEFAFFQBFoUgTIfzFx4kSDZB1yuNg666zjonk233xzc+WVVxr690QP77LLLmbYsGFmxRVXTBUtBrWIHmOQiwijZrdKEl0ylgPmxx57rIvca3b89fwVAUVAEVAEKo9Ax44dXT5QHDnvuOOO2BX47rvvzB/+8AfnGLrmmmsq0RUb0fwF1DXRRX6RAw44wIiGszSOmp3o2muvvQxece+8845ZdNFF898BulYRUAQUAUWgoREgb9L+++9vJLH3RhttZFq1amUef/zxhj7vRjy5Wie6BHM873fddVeZDaZEEo4aNcrlPgkW6g9FQBFQBBSBpkEA0urZZ591BNff//538/XXXzsJQiQDDz/8cLPWWmu574RIFzIgdMYZZ7j8XJUAKenBrUrUOc1jkBeNnGVvvfWWO0yaEV2QnsghY0wlusst0H+KgCKgCCgCikCFEMC5BvW0jTfe2KAcF9dqmegier5///5xT7Gm9m8oouuuu+4yffv2dfIGNJSbwWh07rTTTqZr167m4osvdqesRFczXHk9R0VAEVAEikMgTHSRXHX55Zc35O5Sqy8E6oXoElRp1DMoFtVBWHjhhc3ZZ59t9txzz6rnGpP66lQRUAQUAUUgeQS+/PJL1+Z45JFHnJMN8xhON/vss4+L+J01a5YZM2aMmTJlivnvf/9r2rRp46J6unXrVlHHTSW6sq9/JYmu++67z0kWUgNUehjXUVMEFAFFQBFQBCqNgKik/f73vzf3339/7MN///33hrK23HJL59Bz++23G755yBlWy5BQxJToqtYVyHHccETXX//6V3PSSSeZwYMHm8MOOyzHXo21ePr06S5BHp2ESy65xJ2cEl2NdY31bBQBRUARiIMAntPI2yLpS8QzDaqVVlrJMOCkVl8IyAActX799dfN0ksvXTcngNQiHtrvvfdeZJ2XWGIJF3XYpUsXs+666xqIMDVFQBFQBBSB+kOAHFfPP/+8ee6559wUlZFMJuNOBHILJ02ifsnD9cADD7h8jmyDEdFFBDpOnIsvvrhbVsl/4lDCYNSdd95ZyUPX5LE6derkcpYx5oANGjTIjBs3zkXkIYWdpEFycu2xk08+2Rx//PFJFq9lKQKKgCKgCCgCRSGAGg7OwmuvvbaZOnVqUfvk2+iHH34wv/vd78wWW2zhylSiKx9a8dfVdURX2EsdiQMaRXgIH3roofHRqYMSooiuvffe25An4+233zaLLbZYHZyFVlERUAQUAUUgLQQYbMIZAgcQHEHQh8ZTOolGW1p11nKjEahnoss/I3KxXHTRRQWjCiG78KjbfffdDZKbaedm8evYaL+RC+Pvp59+WuAvajnLiKrw18kyyvCXyzwD2f4f2zAv06h1UctqYXu/Dv5vqW94mT/v/467PffhL37xC5ffjqn/R867qHWFlss+lF1oW1kvx/Xn+R1VRq7lucqQ5VIvmRZTtmybqwyW8x5ZZJFF3JTfMk89/eX8LmaZlEHZzW48+zNmzDDkjOYPB4xXXnnFSMQW+CCjv8kmm5j27dubNa0M4bx58xwBRj/+ww8/dBCCO9KFPXr0MBBNcg9VA19yUkG6MRg1fvz4alShpo5ZSaLrH//4R+CsfOqpp7qIvpoCQyujCCgCioAi0BQI0B559NFHzWqrrWbIdx7XyEm6/vrrG/KP/va3v62pHF29e/c2AwYMiHuKNbV/QxFdNEbRcj7nnHPMIYccUlNAp1UZyCwkBSC3Lr30UneYeiW6kDhiQJYkxLxQ1BQBRUARUATiI0DORiJ9+S7yfVSiKz6m1SrBJ7rIg0XOq3o3vv0MeOIhziBXqYYMJx0H/vCUY0pE2LLLLhtZFMQDg7OQODLld3g+1zpZLtPwvrKc6Y8//hgcw18ux8q3Plyu7CPTUvbl2JAvaoqAIpAcAhBj8geZw2+ZynJ/mb9OfjOFOJP5XNtLebKdTP3tw9v462R7pkL0+cvYNkzc8d7497//bT777DPz6aefBn/+/Oeff+7enT6qOCRssMEGZoUVVnDShEsttZR59913HQHGvmJEa/35z3920V30ZXHAqQWD2MGRdLPNNjOoxTS7VZLoYlCRwUWMQTcG39QUAUVAEVAEFIFKI3DUUUe5iHPaNIylxDWcfNZbbz3XtmC8u5YiupToint1E94/HNGlRFf9El3kGiM8FH12vPgg7fDiVlMEFAFFQBGIh8BLL73k3qcMHgwZMsTpQ6+66qplkQrxaqJ7x0WgEYmuKEwYPOW+veeee5x+edQ2zbpMokmY+tEn8pupDGTLb3+fqN+yr1+m7MsAuPyO2leWsY0fVcNvWSZTf32+ZfnWRZVRj9v7dfZ/y/nJMu5zyNl8UWLhdTIv06ioMtZhso1Mw9vmWi51iiqj2LKlDDmmP5+rDFke3jZXGSwXcjhMNlOWrJOpvw2//fm421BWMxjEFhI9YO8bzgdEduHNDInUrl07g2RtrRmyivRLN910U0P+72Y38CBqD+daLE3pQrzmycmGnX766YGMoVug/xQBRUARUAQUgQohgNz+xIkTnVMpzqVxbf78+c4Rk7YFDplKdMVFNP/+DRXRhY42Ye4M5Ik3UP7Tr/+1SCsgsYC3/mWXXeZOqB4jurhuvg46shU33HBDRS/QY489ZsaOHWtat25tzj33XDdQVNEK6MEUAUVgAQS++uorNxDHc6lWHgLICO2xxx4u2TvvNqJeiJp9+OGHyytQ96oaAs1CdEUBzKD07NmznUMM+V/I9cXgG5ECTD/55JOo3RpmGVLUREBAPEEuCQHFNGpZKdsIWZWvnDS28Y/nn4cfdSLbNMyF1BOpKAKQS0Q/8scgg/z5yyCwmGfKH9v4y2RbWS/z/j75lklZlAsBREJyJGyYMo+XbyMYEcZEZa2yyioGZxqm/LEM72Vyb0Hg1rrtvPPOToYRUu7uu++u9eqmXr9KEl3PPPOM2W+//dw5nXXWWebwww9P/fz0AIqAIqAIKAKKQBgBGZ+mH0JfM67RTqQtRNuCyK5aIrp69eplTjvttLinWFP7K9FVU5ej9Mrw0EEKEf10+eWXuwLIxYIEILIL1UjiW/pZGOMP3rH/brvtZq655ppyiip7H+S8kFDCyB0iDe2yC9QdFQFFoGwEGBgijPqhhx5y77GRI0ea7bbbruzyZEcGvW677TY3CIOTQDPYtGnTTJcuXcyBBx5ozjvvPNe4+s1vfmMefPDBZjj9hjpH/1vZKNKFlb5AEuHhD1rLYLg/lcFpf5k/sC37Fztl36iywstkvthyZTspXyJeKo1r2seTCCcinjB/Xn6znPUy7//OtU6W+9vK71zrWO//+cfzl0s54WUyX8x+1CG8ncxHraNs7gGJcJL7QZbJVNYz9ZfV8/ZyHuAivzm/WjUIXSGwmfIXtUzW0afzt+G3LJNt8k3D23Ks8DLuHzHeRZBw/EHMyW+mbEfk1pJLLum8nflNeY1gu+yyi3nzzTfNxhtvbP72t781winFOgeIP8YbcK7F0ozoIsc4DrtYMzkuuxPWf4qAIqAIKAI1g8AZZ5zhgiCoEA6WcY3+Grm5aFsgs69EV1xE8+/fUETXHXfcYfr162eGDh1qunfvnv/MG2QtHs0MfO25557miiuucGdVb0QXXthotPt20EEHmWHDhvmLUv/tE10+cZj6gfUAioAisAACkyZNMn369AmW837jPRfXhg8fbq688kpXzFZbbeUiR6Okc7799lt3fAaBttxyS5ccm8HFejSSw+M8cMABB5gLLrjAhcvjWT1lypR6PJ2mrrNPdDEQx+CimiLgI8AAPwPUdKj4LUSY/Gad/LEu6rfs769LY39ICI5B2f4fy4SAkfVpbBs+hl8H/7ePr/6OjwDfUvkjUpDfEjEov/314W0gWcLbyzb+/v42uZZLJCEkDX/Mh6dRy2SbqHXFLvNJpfioaglJIbDrrrsaHEmQVkQ+t9mtkkSXKBCAOY5ZOGipKQKKgCKgCCgClUYATuG6665zh1Wiq9Loxz9eXRNdEt7es2dPA+MKK9q/f38nO3fwwQfHR6cOSmgEouv66683Z599dhbaxx57rJOhzFqY8oxPdG2zzTZm3LhxKR9Ri1cEohGA5IG4nzNnjjn++ONd1Gb0lo271G9ccJZTp041a6+9duwTFk9dKQinCI4VtksuuSSIkmVd586dzdVXXx3erC7mIUQ4b6JUiVYlbB6PogceeKAu6q+V/BkBJbp+xkJ/KQKVQgBCzP/juP68/IYcy7VOtvl/9s4E/o7p/P+ntQax71uprS2h9i2UkFQQbSp2Yg0RNEKQKBJZGhoJmkWRkIj4pyJpiEaKSOx7KFGkildssQdpFH31+z/v0z7zO3e+c/e5987MfZ7X6/ud/cw5nzl35pzn8ywsi51T7Hi4DO4r5XMtBIr8QfAIoSL7wkvOCV8XPqfYNtfLvcLn+mXLvdinoggkEQEMgzAQ2mmnnVx+jiTWsZ51YvxIfi4J3VRLjy4xzKJ9Gl2lnk9Z77VkyRKz2mqrOWMHRUMRUAQUgREjRgSOJEp0pa8/ZIroIhxVv379nCcQHkHNIGknurDUPcCGI1u0aFHO42pEAlqf6NJwFTmPQzfqiMCLL77ownbw20DwKCJ0Cv2zmWT8+PFm0KBBrskkMH/ppZcCZV2lOBDai/xUeDGIoHSbNWuW+fGPfyy73PLMM89sRQRBQLZr1y7nvDRskFSdHAvdunUzDNoguUiCOnv27DRUX+voIcD3knxUyGuvvebCRnmHdVURUAQUAUVAEVAEqkAAw6YFCxaYHXfc0cycObOKkrJxaT2JLhmvghy5x8lBrqII1BoBQrkz72vbtq2ZOHGiCy1W63tq+YqAIpBsBMaMGWN+97vfuUrGQXSh28NoG29x9FFJCl141llnmUsvvTTZD6TM2qWa6HrmmWfMUUcdZU4//XRzxRVXuLwrzUZ0ofBC8XXEEUcE4bjSFLoQBX7v3r1bddtGWHH5RBdhvebNm9eqXrpDEag1AkLY+/fhozh9+nSz1lpr+bszvX7ccceZJ554wrXx4IMPNhBf1QrEACFYwhLlQdqxY0eX59A/l3CqaTSiwBIXDMl7cO2117pBFrGh77vvPr95up4CBJToSsFD0ioqAoqAIqAIpBYBcpqS2xTDJgycml3qSXRJ7nEwR8nIs1BRBGqNAHMjiFUEBbRGvKg14lq+IpB8BHyj6ziILqIvoGPGWxy9Mzq/P//5z2aHHXZoGBjkbEeU6GrYI4i+cZjouuOOO0z//v2bKqbz22+/bX72s5+ZLl26mNGjRzug0kJ0kdiYMEzk6ArLH/7wB0OM9HqKT3QRe59BDh4gDLohFMnZw34SL+PaftBBB5lNNtmknlXUezUBAo888khkjkF+57fddlsTIGDMZ599ZnbbbTeXu4UGDxw40OXIqrbxDCZ69erVqpiwMoOBCBMdEq77cvbZZzuvYX9fGtZFcSC5Bxlk4cGGJ5tKuhDwiS4sn6Pyy6WrRVpbRUARUAQUAUUgOQhgPEquqO23317HSfax1JPoQpm4//77u85w0003RRqnJaenaE2yggB5oIl4gRB6l4hJGmY3K09X26EIVIYAaWwI1YvEQXQRYnyLLbZw3uKML5Toquy5lHpVpjy6Jk+e7FzurrrqKoM3QDOIDAixeMLyCUkL0XXNNdcEXmjhZwVpue+++4Z312T722+/Ne+++64bTLNeqmy77bYGV3cVRSBuBEh8yYD766+/DopeZ511zPz584PtLK+Qn+ziiy8Omgj5JxYnwc4KVjAGwFs0LExqwHbttdd2h8SIInye5IMM70/6djjELYMsBlgQfyrpQkCJrnQ9L62tIqAIKAKKQLoQ+MUvfmEII44BpHq+15foeu+998w+++zjOsytt97alDmK0/VryUZtfaKLFpErDqNmFUVAEWheBKZOnWr69u3rAIiD6KIg9FkYWOPFlSSii9CtQupl5Ymnmuh69tlnXc6R0047zQwYMMAI63r11VebY489NivPqGA7yG213377GeKJjx071p2bBqJr4cKFzmPLz5XjN7TWuXDeeOMN9+LipYX3SCWCsvjhhx+u5FK9JsEIfPzxxy5kHuHe6CcffPCBIUfUnnvuafDoWW655UqufTVlffTRRwZrxscee8x5bWBR2bNnz+DekLLkrdp0003NhhtuGOzPwsopp5xi5s6d65pC2EZZr7Ztffr0cSEgo8oZNWqUCwHLMTzImGCHRcLkhvcnfTvs+SuDLA3Jk/Qn17p+eHbyPBG+o+TwU1EEFAFFQBFQBBSBeBDA+/2FF15wnu+ay9S4+Toe5BhNISjD0Lncc889LgRTPKj/t5QPP/zQ7LHHHm6De6DjUFEEao0AeXjEYJx7PfXUU2ajjTaq9W21fEVAEUgwAnzjzjvvPFfDuIguMTaG7FKiq7YPP1NE16RJk8xll13mksYdc8wxtUUuIaWnkegiER+5YrCWEyEpn78d1+D5iy++cC7oEBUi3H/33Xc3n376qewqaYnXByG/CGm22WabmRNPPNFsvvnmJV1b6Un//Oc/DXmB7r77bkfe0r9FIAnxPPnb3/7mQrzhYYZ1wHrrrSenRC6ZRHAN2BB6kRBm9bRaqkWbaGg17fr888/NtGnTDBPa559/3hC6LkpGjhzpPCajjsm+OMuSMsNLfvc9evQw5JxaccUV3WST51iKQNzxYeU5QCjRlwtJNbgWKjffMUKE8j4gbCjCAEOsafJdU+p+wo1CXkYJ+R7xMuW+e+21l/nkk09anSZGFa0OJHyH/53Aq03iQ/OeVUkXAkp0pet5aW0VAUVAEVAE0oVA165dnZe/5ur573MjlUC9iC7m5rvssou78Z133umMDNPVe7S2aUQgbOBInnbmSlkSDLvRb6y77rpVNyvOsqquTJMVQFhdjKBJq8L8HqNqwmyi/8P4eeuttzbk4UaXUs/c7hjP4mxCXYjKgxNG2oU0Nng6IXERXbxX0NntuOOOSnTVuIMo0VVjgGtd/DvvvGPat29vDj30UHPDDTe42yXdo4t6El5SBKUy1nP9+vWTXQWtxMjthRU7xFMhee6558wJJ5zgTuGeHTp0cOt+WIRC16+66qouT9DOO+/sPhYMvNdYY41Cl+QcI5EximQ+QijNIZOwDsKb4uc//7nBU6WYPPjggwYvEmT55Zd3MeMph7JR/kN0hCUfGcOH8Prrr3cvVd+TjnKPP/54g7eLhG4Ll1lsm4ETz6PYM6GcONtEedW2a8aMGWbQoEElEZ9XXnmlI4e4b5TEWVZU+bKPetxyyy2y6awtyWtXipx88smGATxSKPxmtbi6G1Tw709/+pM5//zzgysJD0o9qxU85CC4RRhoMEgUwSvu6aefdmFqfM85Oc6ye/fuZvDgwf6uVKwTmpVQsCgrsFjk3cMAGAJdJV0I+EQXXqcQ3SqKgCKgCCgCioAiEA8CGGNi9Iay8P7774+n0BSXgo7h1VdfDcbMtfTowggTBSDCnIo5eJaF+TjzE4wkyQOOASr6B5X6InDJJZeYKVOmBDdlPpiVaCn0MSLSoH9Bf4a+gDDolUicZVVy/2a+hrzhEEi8F0sRIhAx9//1r3+do/8o5dpyzyEKDmSxSKdOnQxpONIuRO5C94PERXShg2FssdNOOyWK6MKA3neoSPuzo/6pJrogMiB1Tj31VPfjuu2228zll1/ucrAcffTRWXg+RdvgKzBF0S0D9CQqwZ588knnCSVES5s2bQxsOQOKiy66KGgvuWPwTgoLilkIGZR7eFf4eXzC5+IJIh4LfmhH8h7tuuuuzqMlfI2/zaB+lVVW8XeVtE5oh0svvdTQ1kJC7PdevXqZLl265D3NJ4U46YknnnAD4m7duhnBMHwxRAbEjS8zZ850WC1btszfnbNOzh68mngmpQgeQRCIxK/n5c8z4ZmRL04+ClHlxNUmyq6mXXj20ZdKVfa3bdvWWdCsueaarZoVZ1mtCo/Y4fdtDmO9M2fOnIgzc3cRigVSWQSSEytNlr5Ug6tfTiXreJlJqMI4lQz07QsuuCCoEp6ShCvEw00EhQb75/2PCJT9ssRTmPAWaZP333/f7L333o5gJ8TtVltt5ZQHpQ6W09beLNeXJO0y2E7iNz7L2GvbFAFFQBFQBLKPgBiMFjIGyz4K/9fCehJdzC2ZHyPML2X9/2qT7jUMQ4nGgkcGS0LQ+/mYaR1eGegHxFg33S1OR+3D82oi32SFcMTT5pxzzgkeBPnIyENYicRZViX3b+ZrICGIXlaJ1Cr1AlFy0Iugy/WFCDq+QbZ/LE3r6KeFU5C5d7X1RwezzTbbOIPjJIUuVKKr2icb8/VKdBkj3knk77nxxhsdwkklulC2Qjj5ObFg/yEq77rrLnPhhRcGPSSfF8eBBx4YxAiHhIKMyidgIsexkIIkEpk/f7776GPtgIU8XnFDhw41eMghK6+8siMA5PxSlpAdPIPrrrvOYHVRqnBvPNyiQshBXkDoiUBAnHvuuYGiU/bLEmuwYcOGGcKwicyaNcuFf8tHjMl5LLH68J+Df8xf5/lg0UdYuyiBrMDriDxSWEjRRvFgi6NN3LPadk2YMMHl9gvXHzdvyCA8Dbewedhw8aev0Sdwx46SOMuKKj+8j2fEb0YEcjLKu0+Oy5KPmG+dimchecB8qRZXv6xy17Fo3G233QISF/Kb/h6H8J556KGHgqIeeeQRN2D0LY4gskg8mi90JSSuH8M9KCzhK4sXL3bhXzp27Ogs+ZToSvgDK1A9n+higsE7X0URUAQUAUVAEVAE4kGAORQkRKlGZPHcNbmlMHd/5ZVXzNv/yw9aS48uorZg5IYwX+QZpF3QD0BoQdwxj0cfUorki9BSyrV6TnkIoGsRg1F0Q//4xz9KilJT3l0ac/aQIUNyvGswJhWdTLk1irOscu/d7Of37t27ZG+uKKxE5xp1rNx9zD8hTHmfRelMskJ0ESbyiCOOcPBkneg644wznMNQuX0hyednyqNr4sSJ5oorrnB5VnxFf5IfQLV18y31RWGdRKILkgUlMuSkCO60kydPdgOJ6dOnO+8aOYarKCSDLyjBCbfly4IFCwyeNlGCwpzwayLFPLR8t/ViJJqUKUvuA4mAx0yUEBJwgw02cARVlFcVxyCEwgMPJlp+Xyamq5B33AdvMF5MWLxBOuFVRVkiKPapl09yEQYCTzg8uLAkIJyh1Iljxbw8CN02btw4uUXkEtIOazU+qrgzUy/ahyddtW3ihnG0y/cckkbg9YIFSrmefHGWJXXh4woBComFtyYYikBqYWHJ5EmkWJgFroH8bWlpcZcQZpJn7f+m4sBV6lPJEuwhSBHq9/jjj7swHpWU5V9DzH+SW8vvQIhvJu7gmE/wTCSU4ldffeVOSWu+BgnbyMCTvoQlEb9F3rsq6ULAJ7qYiIe9MdPVGq2tIqAIKAKKgCKQLASw4GZMjVGQbyCVrFrWrzb1JLoYp4M78uijj9Y8F3bcKBJdiD9CMOKZBXGHghRPtXKFXOAY4arUHgF0VE899ZS7ETqbfPqc2tck/juMHz8+iPRDznpI11JSTUTVJM6yosrXffkRwNAW7ykMAfA6JsQr4TXRg6KnQA9IlBr0bETG4h3kC84CGGZXI6R8uPbaa/MSXFJ2Voguoh4RhhGJi+jCeEMMjpPk0VUrrz/pE41YpproIn42pA5KZpSj/HgHDBhgRowYYQjt1gwiRJcfCzWJRBcKe8khxnOBjMGyaZ111nGPKZyXh7B/G2+8cc4j9F82HCg0AfFdTaWQhQsXutjEsh1eEu6PD7gIXl9SP9mXb/nHP/4xMowieYAYpELqIRATlAspiVeUkA4cI4kkYfRQwjP2rXkAAEAASURBVItgPYfHWZScddZZLkRi1DH24U3Ftb7lGL8LEkX6ylHKmT17tiuGQTnkQj4J54aS8/B04nlA+C1ZssS0a9fOkSh8hGVwD9GAt0w1beJ+cbUrirAjTAHh7Xin+BhJO/Mt4yxL7uF7XzGwYRDuC95OJGoWoU/hoZVPCFtAyAERJvLDhw+XzdhwDQosc4XfAnn0CP2J7LnnnjntK7O4nNNlcCg7/baDWT5vON5R/F7mzZvnLqVPRIV6lHKTuiRHIMQWg1y8TgnHgyEA4RxV0oWAEl3pel5aW0VAEVAEFIF0ISBKb4wPJZR2uloQb22JZkBuaFH01dKji7mAGLqisPWNN+NtVW1KI4S/GMcVuwN6DvJ2Qz6grMYzgqgbS5cudZcq0VUMwfiOd+3a1elnKDFrv/vjjjsuiGp08MEH5+i6ykUwzrLKvbee/99IXr6eMB8m6NrQDfsRpjCKR69RqaALOfPMM3PKzFdWVoguvnnMuxH5/uVrc6n7MTZGP7zLLrskKkdXFokuFO2pFesd1LL55pu3WC8u1wbrDeC2bUiv1Lap3Ipb5t612XbO4FIbds3ts4RAsK+RK9YarsUO5FydeF52ANFiB685VbLWT8FxzrGESc5xNqz3Qc451gOr1Tmyw36Ic861xIscyru0ZELONTYsZN5zwwcsQZVzLW046aSTWuxgN3xqsG0V5i3WwybnOktuBMdZsSRRznHK5Y9nbEmznHPDG/J7kGts6LZW11ivqxY7oQjuwTn5xOY7C86TMlnacIctVpEeXGaJvBYbq7fFWkPlnG/jQbtzqmkTBcTVLuvF1mIJj5w6SrtsiLcWO9kI2lRsJc6y5F7WUy+om80bJbuDpY0fHhyn3vTffGKNAnJ+g3YilvPMuC4uXPPVodh+68WZ05477rij2CUlHbfWoS02DGVO2fRlEe4jz91f0gcQGxM757jNiySXpmZpPdpcG3gn2VwAbt1ag6Wm/lrR/0PAhoEN+uN33333fwd0TRFQBBQBRUARUASqRsASXe47a40Fqy4rCwVYjy6Hh7Slf//+bttGnpBdsS5lLG4jucRabj0Ks9FSgjGatEOWVrnZYsmrFmtk1oL+JkrYb8kIN2ezERiiTtF9NUDAhicLnpvoK2pwm7oXyfyPfid9kLl+pRJnWZXWQa8rDQEb/cnpW+W5s7QG0aVdHHGWTTvTYqPaBP3ILxfdgjW8zjlWSJ8YUXxid1kvuaBdcVXSEl3uHY8eGxytEUlcRVdUjjxLG4WrouuTfFGmPLrsy9t5duFSiVdTMwhuqnjK+BYaYpWShPwdeBMRGoywgyJ4BeExI0KYAkJOEsZQhBB6MOh4WxBiD8G9s1+/fnKK80bBMyMszz77bCuPPizCsAwrJHgCEm9WhNB7UXmz5Li/JLwCllciuKViNeGHm5Nj/pKQarRRQiziMULIutVWWy04jXCFElqQncSOxiWZ/fmE8/fbbz+DJ4cIZRPqcJ999nHh8PAoC8fWjfIc4vovv/zSHHDAAYb6+lIopxfeaRwX8fMbVdImyom7XSQAJqcZYSbsi1qqGizxSMPDC0+YYhJnWdzr7LPPdnnIWCc+8KhRo1jNEbyeyL+E4DVoSZuc42zgAcdv0BI0wTG8F08++eRgO25cg4LLWCEEJ30S4XeDxy5WjtUK3op4LYpgNUkIVXKuIXhZkpQXa1VfeNfwDMaOHeu8uuQYof86d+4sm6lY4mW50047uXcCOckIwSgelqlogFYyQID3+qJFi9y2hi4MYNEVRUARUAQUAUUgFgTEawHPIkLpN7swdyTcGV4ChDy79NJL3ZydOSTzpLjFGse6Iom2QPj2NEmURxfRYcgTTCoCQo0VEzy7mJtoDtZiSMV3nHmdNSB1BaLvIB1KFiQccYj81PL7Krd9cZZV7r31/NIQwIOLKFnWQDondCFeYHiL+vrF0kr871noicJ6R3LYo79FhxKOpJUVjy68c3mnI3F5dBF6Ev0ykXWSFLqQb5Qlu1xbs/Iv1UQXIeAgdVDYorhtRqLLz71C+5GkEF3W2txARPGcRHDTx+2VcHaQJrw0UDqH48jK+QwO5XrIiMsvv1wOObJHXj6yE9IMQsXPY8WxUoiu6667zsWdlbLyJevkHoRBxO1UBuAPPvigweVT5Pzzz8/JOSb7o5YkmyVPlsikSZMCN1n2+YpNtonLyzWFhPBkfOTKEev14vJoRcVtDpNWlOuHf4u6T5g4JISjkIGVtIl7xN0uqTdxuSE2iD0cJfQzSDvcwKPw8a+JqywGDzLQzpcQ+8ILLzTWg9XdHiITMjccblMmpFJHSGRC1kGYitQKVym/2BJCFuKFiR1CCENyu8UhEoJGyooKBcLkhoEapCCy0koruXCFvK8I90jYRxEw9wlc2Z/kJUQ14UQhQyG6CF/A751Ji0q6EPDfnYT59H/H6WqJ1lYRUAQUAUVAEUgeAieccILLM2wtnV2eqOTVsL41ahTRxZyM0PhpkmOPPdaQfkGEeSNGpGuttZbs0mUCEfDDgjMf9A2fa1ld9EmM4yUvXdz3wrBcwq9WG5IxzrLibmczl4dekncOujqM7CX0qWCCXgidCgav1QgkCDpKSBobWcqcdtppgUFyVokusJXfZlxEF8bGEI+77757ooguft84o2RJMkV0SYJECAvInmYQPIFghH3FMC8fkmg22tr74osvrkqRusoqq5hzzz03UDKHiS5e6D/96U9zHjPefDz/sEAC4OFWiKRAATxkyJDg0ihLNZLK2nCDjhDxLX7CRBDlWFfeoKxCK3369DE2LGNwComP5aXKTnmecgLKaZTUheT4448Pcm2Rd4r8X1ji5RPagsdQPg8aG6Yix1sIqw4IAHCNEixK8CICcxEIoI022shtVtImLoy7XVI3lljQMRikn2HBGeXhRbshOmxYO//SVutxlMXzuOaaa1zZ9FsIXxLk+sKApmfPnsEu6wZtevXqFWyHvSCx5MHDKeypWEtcg8oUWLn99tsNMf9F+vbta8477zzZrHg5a9Ys55XlF0C/hfQJC7np8CojdjJEMuQiYt313TtWSDjfezZcRlK3GfTiGbv33nu72OxKdCX1SRWvlxJdxTHSMxQBRUARUAQUgUoRwCCKSB2MlYnu0exCVAmijQjxJAZ0UfPkOLASj5O4FItx1KnUMmzofmfQK+ejYEZHo5JsBMiXI1Frunfvbsi9XYoQWQljSQy2UV6jJyjVa8Y3dEZn5OugSrl3sXOY+6Enw/AcYV7N/LoSibOsSu6v17RGAJKUqESQTDgQhAUjAYwUMJzG+yoOoS9FeZriKejrPdGTjRs3Lo5bNryMuL9HvCPQh2LgnSSPLnEcajjgMVYg1UQXZA4Kc/kg8YPiw4R3DPubQfCE2HXXXV1otQkTJrgmC4nQSKJLSMdKnwGh4lDy+y9mBtQQXyIMtP2QZHhx4c0F+x4lhELzywufg5cLYepECKVo86HIplvi9mvzaAX7COWwxhprOE8oSAYRPiq+h5fsDy+ZSOEqKoMQiCObuyuHQJIJl1xbrB2c5w/YIH0ZTPERwvuHUBCElOQli3cPHyP+ClnN4UkHASQCcQZhEBWC4Z133jE2r5HziJHzCW3B8xOppE1cG3e7pD7hJQQd7xHaCGkVFkIcDB8+3CUPDh8Lb1da1pQpU4zfp6JC5jGwYRArnkhrrrmmC/+3/vrrO+8uCCzpW9QLCzUs1cJSL1zD95Xtq666ytxwww2y6cKi+L/t4EAZKxgBEBZUJi5cimceYT/zCWRWlIeMzU9gFixY4C7Di5MJP15faREJOUCoSzx/hfSij6mkCwG+SbxjEVE6pasFWltFQBFQBBQBRSC5CKBXwOANxfUTTzyR3IrWqWZKdJUONJ4VeHWJ2Nw1hrF3IWEuhzGqzQ3u5mzM2zC2ZE7H/DkcqcMvi5DvGOrhhYihXinC/IhoOhCJKFuZA2ZBiHJAuHn0KBhL0zbCkBKdo5iAncylSyGEwBA9AYpqX++EHoe5N0bMYeNUvw5E2mD+LkaUGCVL6ET/vGrWCWFHhCER+sq2224rm2Ut4yyrrBvryXkRgJiYN29eq+PogNAF8x7yDedbnRjjDnQrvqF1sahPMd665kXFTXRhbEykMb4LSSK6hE+pOaB1vEGmiC7xyMmnzK0jrnW7FUpcBii+d1GjiS4UqYSSjPKIEWD4oOO6SZxSmG1yjvD8RHCHHTBggGy6JQMYP1cSISUgTxgIcgxiiSXCCwQXzKuvvtpt84/BDwrrfII3D9eIQGSEc4D51jdYNEAaMagJX8ugCm+SfKEKyJkDMcsfuZ1EwuQd+8MfMrx4eEkWEt8Fn7owCC5EZBUqi2NhjzX2gT8fNZ4jZB9KVwb4hNuTwSLnIeF2VdImyom7XQxO+ZN8TdzDF8hi3if33HNPK8ILryCIQ7k2zrKow5w5c5xbuNQHghUCMSyQs5C0Ijxv+i3Pwc+NR2x48RCTc2UZN65SbqlL2oU7vAiTE35/5EcoJEwGeQcymfDz4WFZR55G36OQcrB8YgJSrgwcODAnlGLaLDTxROVdi5s8dYfwI1cfAyyVdCGgRFe6npfWVhFQBBQBRSBdCMgchfG0H4YuXa2Ir7YYyL344otujo0xmHp05cc2THTNmDHDGZX6VxD1hPMwdoVQ9XMo++exTl5h9CrMi8JCTnKU2cw/0TdMnTq1INmFvoG0BuRz5hqEeYGEwPfL5zjl4dGIjoboFngqQbph7IrBJxFuaiUQzBjloV8oJsxxRo8ebTAI9Y07uY7+Sr4gjIqZ90QJOgufJGRO6hs1h69B90TUIowI8wl1Z24uKS7C54Er5KQIujzIpDgFnZaELWQOiLF2pRJnWeE6NLKvldPPpN6NrK/UgSURvSBcw4KBBseIAIIhO3rSWks4f1spZHGt6xRX+Up0xYVk/ctRoqv+mMd6RwYeeOX87Gc/CzxuGkl0hfMy0ViILF6yWBgwUGOggQLbJ16wZvLJG7zU/HB+AhpEl5BZ7INkwDoFwknIFQY1DOII9+YTVbjvMhDKJ+IhKMfJJeaHU8PSCg8REhMi/qAEixzCguHCLkIsZIgglMq8JBcvXuwGi4Twwzsq7GZMSDSIr3B4RQZnhDMUYcDLoK2QSHx5OQePLMKyVSq0D5IwnPus1PIg2jbddNPg9EraxMVxt4swlxCgED1YPfGsogTChLCYeHj54pNHcZbFPV5++WXnoSj3y0d00S8huqX/y/n+kgE8A/N8A+64cfXvXco6MYHp177wfuDdwe+bvsPkBYIYYgtPVrwSGeDhccf75eyzz3Z9HOIZqzgmYb4QlpMcZvkw8M8Nr/P7o8+KROX5kmNJXIIdoRh5Z+H5i4UohAleqyrpQsAnurAADn8v0tUara0ioAgoAoqAIpAsBJToyn0eSnTl4lFoCw8L+o8I0SmIfoLhIQbAr7zyiiO5fCNXOTffMh9JQSQMImKIoFvByBZj4rAQCYC6cH9ffENp2U/kGObEEFyFBC+OfPPmQtcRag0CkLkc80/q4AvG0kQGglhDd4EuJV8UDfQT6L2IsFNMwka3cr4Yjcs2RtK+V57sZwm+KPGFKPSPhdfJ50y6gygJpx6ASIozPw79DbJD6nnRRRflREWKqlO+fXGWFb5HLftanP1M6l3L+so9Sl2i46SNhQTdBwbRhBVEP1IrQYfj919+w/57sFb3rUe5cRNdkOAYC5CGRj26avsEM0V03XTTTWbo0KEu1xBu9s0gfHxwfUZRLx4R4QFpPXBA2YwHlh/ejvtC3jAQ870touoj7ZBjEFiQKj4ZxjE8axg4FPIWk4EMRBIKXfnIM/CDPIgKTUbZKA0hDEUYmFJ3rKkgp7AUevfdd+WwywXm54LDUwLPj0qkW7duzvss6iOEp9qDDz4YFFto4CQnESqBQY0IylCS4frEnxzzlyjEGQR/8MEHzhLEjzMNsYCnXblkFx8Iwib6UkmbuD7udgkpTNlgT6gBJgJR8Yc5J2ypx8CbkHb07zjL4l4SlpR1pF+/fq3yTf33iHFxvX2PSNnPkvANTCiYKOWTuHHNd598+/ldM3GoVvi9Q3KDXXjiFCauy7kXVnuULZaChP3knZAW4R1I+AKMIiC6SEiLpRe50VTShcC+++4bfIeU6ErXs9PaKgKKgCKgCCQfATHGYx5YTJGY/NZUX0OZ30hKhFp6dEmobWqdxhxdEl2oGtSZj4rugnIYszNPCkvUvUjhMGbMmJxTmRehePbJNfQrkDnkbPJDI0LkQHLhdVZM8LZiToERXZQw74Iso7+gp0IgpDA8FsH4EB2HGMNKGhI5zhIyjxCEUYLeCWPeUiXK04R+JvWjHAxXff2OlI3RI0an/rNhXoV3F8prlNaEMxRPL44x/44SdCno68AZXQLGqIXm6VFlFNrnEw/ogDA4xtOnEomzLP/+cfW1evQz6h1XfX0Mqlmnv/HbikqxES6XOT/PsZg+Nnxdqdt+XnmuyVJ0NSG6MKKOMiIoFSM5D+MA3rk4SCSJ6KpFnkBpc6OWmSK6brzxRueSjdeO/xFtFLj1uC8eDmGlZSOILgY64VCDeADxoosib8LYYCFBqDFfcCeO+ijjHovSP/xiJ/8WHmW+gpsBjT84JEksofaiBI8Y4qXiJVdM8D7DkilMxPXv398p2otdL8d5yTGhwlMsn0BYQUSIYNnk526S/f4SIhA858+f7+922JxzzjluQMbLGg80iBq82RgEsS6eQYQk4DflC+Qh94+KCeyf569D4vFcfKmkTVwfd7uoG6EffCFUCZ6DeBIRCgJiFEzwJMQjKDzpZeDDADfOsqStDEwkHw8Yco8oYaBMSD5irvvCgAYDAD/kp39c1uPGVcotdcmkgT4dFT6j1DLkPCYovAOZmJNLC4G4JExEVE45ua7YMpxXjhAT+SZ3xcqq93HelVtuuaX7VhDSMmwcUe/66P0qR8AnutKoBKq85XqlIqAIKAKKgCJQewQw6iN8OGHwGfc3u9ST6PKN/NI4xkEXgk6kVCENAHM0/oi8QPQbiA/m28xPCRmJjoAIF2FBB8QxIsb4QjQalP/MDdFL+OHtOQ9jPXRlePz4gq6BuZivX0GHgz4HvQfX8UcecjF6RaeCbiUs1F8i9UCIMR+DcEF/g3LXF8LqEyEFY1I8vCRvlZyDYjgqvzL6GnQ+hKsXAUfaThuI9oPBMn3KFyK0+DonDHwPPfTQ4BSIQghDX9ADYAyN0a8Ic3K8v3w9F8ays2fPdqdA3qFbySeUhWHxZptt5p57vvPK3c+cvkOHDkEEJHRbvh6pnPLiLMu/b1x9rR79jHrHVV8fgzjW6dvopSCQMebnj/xvUYLzAXo9v79GnVfJvnCu9bSleCjUZiG6eD+hI6xWSH2CflFSSFTqGVttPeR6aV/aohVJ/QstU0108fFHoSkMZDMSXXzc8TRA+YXFDhJOGluoA8R1DPdLPtYiJLTDhTVMBMnx8DIcq5jjEFqUGyUQOHhYMdCC4MJTiXaHmXbc0RmIQFIwwGLCwiAyn0DMhUmZ8LmEJGQQKy+G8HFehFgYMUCNip3Lyw0SCTf1fKSbXybWUIQqFAIK4g5ys5gQ85uXVngALNfhNUdc63wC9jyDsDAABXdC5vHHc8ciCzwYsBMDGnJFZPDgwYb+4EulbaKMONuFFySWYAzkKhH6GyQhk5I4y5K60I+YNFE/LMnoe/mEAT99nVxpDPD5GDNYL5WMiRPXfHUstp8wkljz8butRCC06H/gxARHXPUZgPnempWUPWXKlByCGZKafWmRLWxIEwhZ+mk43G1a2qD1NO5bj2cx37O3335bIVEEFAFFQBFQBBSBGBEgXNoDDzzgwguFDchivE1qigoTXWLUSTh3lHZxCvNKyaWURqKLMOoYQBYS5tedOnVy5FaheV2hMuQYXgaQREuXLpVdbnx47rnnunljVKhCDALRRfiCTo05pESu4BjkD6QW5JYv5PX66KOPgl1i8BnssCs+AcF+DJq5BtLMJ9I4BtEFYUXI+Si9Cecw1yYfsy8QZhBnIuhK0D/4inzqgdeL71kFgY3BLhFPEIgCP+INnnI8H1/CUXu4F/NVX88FqYXeRdrHOXjR1FuIosP8V6SQR5yck28ZZ1lyjzj7Wj36WZz1FQxqtURfhB6IPOdR7yHeC37Ep7jqgS7Nj+qF4TLviSyI6HsxfsEYoVpBbw/5j+4+SR5dGBmQwzFLkimiC+Jj2LBhTrkbtsTI0kPz20K+KCxdhBXmWCOILsJi4ZWBKybPoJCHkl9/f11ioss+XNn95KCyv9wl9SIWMorBYv2CDyYK8aiBFi+lY445xoVOJJxhKYK1DhZX1IHBEIM0BozUpRwhTBr5dPDKINZuqQJhgAdWuWHW+DgRBrQSN3ospRhEi+Qj5iptE+XG2S6SAUNuMoguRyBVwIg+IRJnWVImkz4IbbGMk/1RS8JSMKlhwgPBRWzmciROXMu5r38uEwTIUzzZUOhDxoI1ZCKTEiZn/BY5j98pXomQuazTZowfaiGEosAqzreUIoY8FlJpECbT/J4JVwhOTCrx7lJJFwLi0aVEV7qem9ZWEVAEFAFFIB0IEJ4MoykMKVHQN7vUk+jCgEcM0zDAq1WorVo9U8iicKQQ7sX8hVCBEBDVklvhukPUoEPxQxOGz2Gb1AfoEMI6CHQURBDxvZUIFYjS0ydyKCMqB3JUOMAwAYERcO/evSM9JCFiiJIRjpjC/UQwLMTA0Bc81/wQ7PkMpGkf7fG9M6mL6FMgvfx8QsyNmCOJMP8DH98zDDKN6FHo3zD2hRgn/KCQXFxLyghfRyDl1XopRD334ffDO6xcfYDUMc6yKDPuvlbrfhZ3fQXXeizpjxBQpIcRod+ifyNHVJxCCNSpU6cGRTbaSymoSAwrQnQVigpWzm1wVkCPTM7tJBFdRIZCh58lyRTRJUk58QrAYqQZBIU2Vvq+dwEfXlxYGSyGBzO1wgTmfuHChc5dnIlBJYIyHysDFPtYwcgApJKyqrnmjTfecNY/uP+CH5ZXRx55pOnYsWPqBtzgwEf67rvvNlgoSaiBMD6E56MfoUSF5MLlvdK+44dtgKBgUFyLiUrc7cJqCY8+BoT+QDWMFeE06QtMWKJCSXB+nGWF71/r7bhxrXV961k+gxwmiuIJedlll7l47fWsQ6X3wgoJgwQI81133dVZkk4oI7xKpffV6+JFgEk130iUD1jtqSgCioAioAgoAopAfAgQ+ozxHsab4RDw8d0lPSWRrwgcmB8zr6ulRxcRWCTcOt50cStka406+hghjIieQIg8iBI8hsIeSXHWhcg4kDXM4aIEhTekRZSEo+rQBqIEhUkurg2nHmAfcwuijvgSJiAgjiCUooR84L5HGqQg5KpEKuIaogQRCccX6Zfsg2xC3xBVZ45jBIpuUCK4ELZRQjryW+c3LwJ5BrElIhGjZLuUJbojyLlKdSml3CPqHMi4PfbYIwj/iD4Hb7RKJM6y5P5x97Va97O46ys41GsZrj/3HThwoEubEmcdMKr3w4tiKFKJsXycdYqrLCG64nLAIH0EEaF4xySB6NrCRvzhvYgxAEYHWZJUE13E+8V7SWJKQnARKxfCy4+1m6UHFm6LvOD9MHN4LUHSpNHlP9y+Rm5DdjBAqfcgpZZtxjoO5SjeMgyG8Y4hhjTWBeGwj5XWAyIAYg3BPReLklpLnO0ipjkTLZIu41kESUe4SzzxCAdYKPRluJ1xlhUuux7bceJaj/rW4x70DSYNEPMQXeX0h3rUL989yDnHYI2JIxO8aiY/+e6h+2uPgBJdtcdY76AIKAKKgCLQvAhInh2IiXKjPWQRNSEU6kF0+R5deMkwdk2LEPaP+oqx5Pnnn2/69OlTl+oTkWP//ffPIYzkxlEpBOQYS98zCs8fQnRFzW34LdAXhCzyywh7cIh+yj+nlHV0EYRAQy/hYxkVcg0i0c+rjr4BvUM+gUBlDof4ucUIwUn+chHCH/qRifB0kFxb1A/ylX6aTyD1Ro0aVdSLilz0RMEheglGwqS1qFYg6XieInja4HFXicRZltw/7r5W634Wd30Fh3oucR7g3S3Ss2dPZ6wg23EsTz311Byye+7cubF7rsZRz0rKEKIL0pB8etUK7y2Ied7XSSC6iBbGNwsDfniULEmmiC7y0eAmTAhD4vw2g2AlhFeJn2gSixUsVwp9hJsBG21jYxDA2wnvPkTy5zWmJnpXRUAREAT4TkDWYmGI12ajYsdLfXRZGQJCdOGFKxP2ykrSqxQBRUARUAQUAUUgjIDkWVpzzTUNRrXNLnglEe1CQgnW0qMLbygJUYcSkDFPWgQDY5SXIoMGDcoJiSf7ZYmSHqM5vJnQ55ADG6IJkokQ7aUKIdzJr8LziRLClWMEvuGGG0YddsbhksuLucLs2bNbncdx8m374fv8k/C2wutKpBABcckll0QqVAmrRtQJjLcR3zuOPGTk8hKJKh8PTK7PF20FjwXIJQTDVcIpIqS3QPkvwn24nwj4QSQiEH0jR450kVuIZkQ+aPos8ysU2OhA+MvnWSZl8qyIwCThJqk7HozFrpPr8y3xyOBZi5CfDOK+EomzLLk/jghx9rWofiD3iqOfxV1fqVslS6KwYIQNkUoEppVXXrloMRi10x/9+eJpp53miNWiF5dxgv/b4jJSeWy++eZllJDcU4XoisvDmPcJ6TgI0atEV22fe6qJLsLz8ZGQ5GmjR492yfdwMY7DKqK20MdTOh9IrFJwU5bYqEp0xYOtllI+At9++63rjwzWEZJh+gleyy9Rr1AEFIE4ECDHGwmYGVRhGMHAl0TKKulCQCb+SnSl67lpbRUBRUARUATSgYCEYYJsQNfQ7EL4fpR8GDGioKsl0QWhgCIQId8zxEJaBDIQUlAEjyQMy1DGE/KcOTJ/ePBAjrCeT8AZzyF0PBhxQ4REyeuvv+5C+km4xKhz2Mf1GIQLieifR27jF1980e0iig0eTuR/R/BSIxIElv60Q4TQgjNmzJBNF5aR3GSQVUg+AoLrULQTkSks4XDwfu52wqARDk3EJ0RlH0vuD7FDdBmfCIBcQR8hIRIhFIl+hBCS7PTTT3fr/AuHeYS8lChJEGR4d1VLSKGzw9vKFzzpCDNfjYDhpEmTgiLQD6KLITxZIeE589vDi1XSTcRZltw77r5W634Wd30Fh3KX5CHnXSLelPRtvA55PxIKjwhNYcFLh1x099xzT84hvAj995QcxDuSvHxEfSIcKdeiNyhFxBhCzoVE5reSBRGii9CocUS/ShrRRc5I9LbkE+RbkyXJFNGFmzBWGGGX4yw9sHBbCI3GQMqPNYz1AbmYNH9HGC3drhYBErnecsstZtGiRS43UXgCQoJLP/FqlmL0VoudXq8INBKBdu3auYGwJGvu1KmTy9vXyDrpvctHQIguJvNY9qkoAopAshBgwoiCgWW+9fBxtvkTEWUG27KOAhLlGn8SVtvfzrffvy58jhzzl6yrKALNjABh0giDRsL4BQsWNDMUru1hoqtfv341s0SHEJLcLhdffHFOSLmkP4hwrqe46htlNIr+B30X5JV4BXE/8l1B9EDGMCcPC54geEwRaoz+jQwdOtSVJeeizMUYDm8QyDvC+PsCecJcArJKyCKO+4bmUQQE5BJ5uiD6wkQXkZiIyOTL9ddf77yn2IdxF79F8ncheFL54QXdTu8fIcbot+TVXrx4sSN/Pvroo+AMlLuEV0NQyhO2S4RcZpBdIhjUE7ZMJEyEyf5yluQEHzFiRHAJ9SS/txCFwYEyV/CqQ0/jC999vNzQF5KuAlJryZIljtjCQw/SECKFMQherHi0ggH9Iq6ypF1x97Va97O46+s/l3LW8UTEayqf8FvGgwpShj/eCYR+JaezL7xb8WDk9+QLhDkem/xWRMjnPX36dNksuOT3CxEkEpf3k5TXyKUQXURKi2N8DK7kujzAeuYlwaMLUpN3PYYAfGuyJEp0pfxpYg20zTbbGP9lxMuGF5bvppryZmr1E4AAA0TcbAmvgPCyxz3eDxMK0QzhjDDYZgDMAEtFEVAEGosA8e4ZCN95553OopMJIpNklXQhoERXup5Xs9RWiBomS5A7LGVdCB/ZlqWcF7Us9xruL+Wy9NfDx/z7+etxXZP2Z86YDSUIiql8y/Axzst3ruyP4xrKQEGAtwNW5/z567Ivan8cCoq0P1utf2kIkNMGK3jmMRJmq7Qrs3lWt27dDN466BbwJKgl0QWColhEsUv4tLQISkuwiVMghwjH5+eegsAi/1eYgCJ8HueiuOTbhkcc0Y74BoYFb40LLrjA7YboIH8VJGMxYS4xceJEZzhHLi2fEMKzRHJ0RxEQeItAGoVJKhT05Piirb7gZYZHjQgeZIQHRAgp6pNlRHLCM4vveDHhG0cbJMwkHizt27cPLvPz3rOTedNFF10UHOdbgudDsYg1EEq8P3hO++23n3ufSCF4yeEZKUI/L0RkyHnFlry3Ks3J5ZdNfyP9hN9u/3g565RFe5mDxt3Xat3P4q5vObj556LTJeVA1G/ZP6/QOt8z3g/8TsMi7/Tw/lI9s4gaw7MQ4bcb5WUmx9Oy9A0vxKuz2rrjnMK4mHeuEl3Voln4+lQTXSjRDz/8cEOSyGHDhhmxjrj55psN1urNIHzQGdDw4RcXcj72xP5Va+9m6AH1ayPeWT169Mi5IUoHLLgOPvhgN3BlUCQWU1gqMJBUUQQUgcYjIK7yxJQn5wHfCX67KulCQImudD2vetWWyS8W3uX8MYEr5/yoc6WMUpRL9cKimvugwEIJJmSPEDgs/X2lrMu1pZzLOfyJ+KSMrPOM5Q8vL1lnWWy7lHNqXYa0rRFLMBTyC2KMPxT2si5Lf5+syzLqnHz7wtfIM2xE2/We5SNA2DMU9ni2+Fbq5ZeUjSvqTXQRvg2SgPEOeWXTIk8//XRR8kPawjuB0F4YK+N9tO6667owYeTR4o9Qg4TO5B3jCyQXZFH4m4tHEIQMHju+cH6fPn0cweDvJ4QgHlMit956q8uxJR7Est9fYuyKgauE78JrBKM5XwGMVxJEJfWD4BDlN3qqP/3pT85IlnvgQUXd8CCi3uLF59+PdT9HEvWl3sj8+fNzwlrSTxijEHZU7ulODP2DTCMMI+X6Ivlv2ce3GAW/5DSjvoRm456+HGD1HOecc47ZfvvtHSbkSsPr7IUXXnAedaxLeMrwnCtM9uGxwzOsVsCd3FTM9aoVPM7AIY6y/DCkcfY1MKtlPwPDOOsrJH4lzwbvuttvv91F7GJMV45AOhHSkuguUYKH50MPPdTqEGFM813jn8w5X375ZbALIprfdtrFJ8H991w17SIEJe//Dh06JILoku9tOA9iNW1MyrWZIrrExbmZiC4sdnC/9q1olOhKys8rW/XAko++Ff64oszBEgo3ZX9wWSwJb7bQ0dYoAslGQFzlmbAQuiQqTEiyW6C1AwEhuvBqeOONNxSUKhBAKUK4Fv4w0CA+PWFxmBCSp4A/UTRh1OELig8UcSgxKIelrKP84Q8SiD/ZlmW5+7kurNTy69LM60wWfRJKCCMhmeR4qedwPuITQzxrGfeE93NMjvtL2c+SMv0/6si2LOWYbLNEWPr75Dz/Wv/cUvZLGaWUK+dKuXKN7JdtWRbb73vP8duRbfo2f2zn2y/nsOQclvzeWA//UU5SBax4x2BZzRKFMX/hfeHtfOdwHqQa2KvEhwDeLhiPgi+pAJpdUIARuh7lfJs2bWru0SVhsMhRxdwyLcJ7CQIH7zd+k7z/RfidEvKP8TcW/YSSE8JIzillGfai4hpIMkgkPKOi5KuvvjLMyWfPnu3GJHjWjB8/PvCOkmsId4gHjx/ujHaQJwyyLCpUIJ4bEMMogRmXEvKTtiFDhgxxIdJp57Rp04L9HOO9zRgWL7RCCnHIolNOOcWN0whtKFFkwvnQmNugQIaYJtwcJBrPA6ENW265pfOIOfPMM83666/v9vv/IPB870HIDRTRIhiQn3jiiTmh3eQYS54vY7t8EvYS4zwhFzBEJEQc9YxLxo4d6/Iwk3erEuFZYuCMjjHOsqQucfa1WvazWtRXyqx0+cUXX7iwmxCveHpBxjCP8XVwlM3vjt/iAZaQhSCGUM8nhDvl/eALcyAIWN75xYRwl7NmzXKnQdLz+4yzPxe7f62O+/n74iK6+A7wbcBDLwkeXRhbMJ7GoMUPp1orTOtZbqqJLj5+hx12mHP15eMkRNe4ceNcbOF6AtmoezHp5uONK7kkG2QggjeXKsEa9VSye1/Jg1eshQxcH3744VaWaMWu0+OKgCJQGwRkYMVkCmIaa0YmdirpQoDJMmFQlOgq/NyYRDBGZOKGogwLWwgpleZFQCbdLOUPNKL2Fzsu18l5shR0ZZslfVH+OC7rUUs5Lsuoc9gXddzt1H+KgIcAXmx4SpCbhSVjc8h7vBpYyl+YyPeKaMpVlPqMlVBeY+TX7FJvogtiQ/InEb0nHNIu6c8DchTPDXJ28b7G4wRdDQYX1QoeU0RPEYG0Il8WXkVxCPUlDzd6JAh58VYqVjaECt87lOO+LF261IXB5bdUqUBYQSJRHxHGdOLdxT4/rCHbeJfwHDBcwuunGKmIgQR6RAgtiLC+ffsGOcwoD6GNeIxBopUjEHCQb2GvNe4JUUj/YEwft6AjZL4AEUJeNDDkPngJQuKDDd8AzoMowSONHE2sQ775YSPjLEvaGWdfq1U/k7qyjLO+frlxrTPHod/ze4E8LoWgknvzriI3JYQHwvvr2muvdalx5JxCS0I84plJ7jeiquEhmQUh3KpEv4mL6Npzzz2dYRfRsJJAdDE+pO+Q03DkyJFZeGxBGzJFdOEWy48SKxU6T7MILyNcRnEvRXjBvPXWW+5j3SwYaDvrhwAEFi9+LPvyCbGrjznmmHyHdb8ioAjUGQEIEiwosfokVjxGIljpqaQLASG6UGAyIVf5LwL0bb5N5KNAAZIWQeHAZJQ/FEH8yba/ZD/nivcMS1lHuSTb+faBR6FzpAxZRpUjx8JLOddfyrqcG7Wdb1+5dQ3fQ8oNLzkvy4ISBmUUS1lnmz9E1mUZ3hd1XdS+8HVR5UddF7WvlmVF3a+UfaWcQ5vD57Et+wXj8DlynP0oHVHOYYUtS443QrDoRaFNng0swFniJdKsQu4iPFB45y5cuLBZYQjaTS4iwvJBHKAgJzQaoeKw4I+LYAluZlcuvfRSl0uGfShPUQyq/BcB3hFdu3Z1BAlEBZ5HkreqmTAK5+gix9cOO+xQcwggEQhrSvSofN6eEJr8LvDeg+TCMyzr44+aA683qDkCy5YtM4899pgL80yYUu2zxulKMJqEpMbDMQ4RfUzHjh0TQXTRNsajhGeFR8mSZIro4uFAdhHDFHfAZpEtttjCfVD5yCP8cGCddXDeLD2g/u1EqQiZxUCPCbsvWHGQ7BIlk4oioAgkAwF+l4RAg+hiANulSxdHCiSjdlqLUhFA4YPFpSrgjPnkk0/ceG/MmDEF4UPRgKc7YyPGSyqKgCKgCGQRAZSwhGHFupqQRq+88ooL5cUyHNaoWPvJH4QnOO9PlpBhzaL4wptj6tSp6jn9v06C4SJeLISFwzOm1kSXH0Zu4MCBLsRbsf7aTMeZd5M7CWInbd5ucT0nPP0OP/zwoDi89yVkYrCzxisYm2FYjscU716IR3KkEWWpmAdZjaumxSsCikAMCEhONUI7YoARh5CCAA8qHFOS4NFFaFr0QxhQwKNkSVJNdDFwJ/wS8ZBJLIm7HW7H4bi6WXpgUW0hfi5s7H333ecO483GR1fDLUShpfviRIAYy1deeWXQ1+iLWN8RV11FEVAEkoMAXlzE9cYSkXjdRxxxhCEUqUq6EGh2ogtrZmKm9+jRI/LBofS58MILDaGWVNEQCZHuVAQUgSZGAAULJBhKWvnDYpl5YyFhXE9+HP74DsURhq3Q/Rp5jDxFzGUI6UgIt2aXehNd6DN69uzpYM+i8q3Z+1Mc7cebirzhIhjxEW5PRRFQBBSBuBAQoktyAMZRbtKILgwE8OYjFCw8SpYkU0QXCdR+//vfmwkTJpgDDzwwS8+pYFu22morZ2knSQTxZiORaKHQcgUL1IOKQBkIoHh84IEH3EsS6wRVLpYBnp6qCNQJAby4iC9PLke+j8Re53upki4EsKwnjj6h7JrJmIVcBiQ57927d6sHBqmFYnKDDTZodUx3KAKKgCKgCBRHgNwehAMjZwx/JLr/7LPPIi8kr8txxx3nDAq23nrryHPSvPPiiy92eY8g8yAFm13qTXQRkQYPbITcVvPmzXPr+k8REAQYBzMeFhk3blzQZ2SfLhUBRUARqBQB5p0Y8CMStrfSsvzrJMIOkUaS4NFFqGo8/rOoF0o10YULPZZlDMAIo3bNNdc4C/WJEyc6i3W/U2V5nUkGZBeJBBFiAZN8Ml/s4CxjoW1TBBQBRUARaI0A5BYTQ3I5KtHVGp+07Gk2oosQPYxtCBvhC2G1CFNd71A1fh10XRFQBBSBLCOANxORG/h79NFHI8Mf8k066aST3Hx8hRVWyAQc/fr1cwooQjW+/fbbmWhTNY0IE11CBOJ5hZIsbiE8Pt92ljyD559/3qyzzjpx30bLSzEChApE/yXpEzQ3eIofplZdEUggAr7XKCmB4hJy90Es4ZGqRFdcqEaXo0RXNC6p2rvtttsaXCvxqkFEoQkRqKIIKAKKgCKgCEhIW3I54vWr4WDS2SfIl0IOljZt2mTeaxvlFgpUP7cM1nU33nijYdyjoggoAoqAIlAfBLBufvbZZ53hAWH9li5dmnPjtm3bmvPPP995eqU9skP//v3NHXfc4doXp4IrB7AUbZAigpxQpIxYbbXVTK2JLqBBCSgGu3/4wx8ckZoiyLSqdUBgt912Mx9//LG7E3n1zjvvvDrcVW+hCCgCzYDAkCFDzM033+yaGuc4oH379uarr75y37QkEF3bb7+9G89lMaVFqokuYVqPPvpoM3z4cPc3evRoc9tttxnCNDWLkERuk002MXPmzHFNVqKrWZ68tlMRUAQUgdIQIKwoSZNnzZplIL1+9atfmWuvvba0i/WsxCAgRNcqq6wSKIESU7mYKgKRd9lllwVe6hRLe1E87rzzzjHdRYtRBBQBRUARqAQBvCkIJ4eShpyJYSF37wknnGDS6uH1m9/8xtx+++2uWXEquMI4pWW7EUSX5EkDo+7du5vBgwenBS6tZ50QkH7J7fAslFz1dbq93kYRUAQyjACGlRj4EEaX0KhxieRMP/TQQxPh0bXDDjs44k2JrriecEzlhIku3JbHjBljJk2aZPbff/+Y7pL8Yvi4k5ti7ty5rrKSi4XkwiqKgCKgCCgCigDWsSSeZyLIoO3II480I0eOVGBShkCWiS5C0EyZMsUQNsoXcskxACeEkYoioAgoAopAchB4//33HSnE/DssGCcQpidtgqEFugREiS7jvPSeeOIJg14Bz716eHSBP88BQeEoOg63Q/8pAhaBAQMGmAkTJgRYzJgxQ42hAjR0RRFQBKpBgGhpCPPSvffeu5qicq6Fo/j888/NYYcdlgiiq127doYcrV26dDE4DGVJMuXRdfXVV5uxY8e6ATdsabMILofrrbdekKxVfkAvv/xys0Cg7VQEFAFFQBEogAADKsLOzJ4925AA9aijjnJ5LQtcoocSiICEaiE0VJbCE+PF1bt3b4MyTYS8IFdccYULlST7dKkIKAKKgCKQPAT+9a9/mbvuussQ7ufrr78OKkjidULPrbHGGsG+pK9cfvnlLjoM9VSiy5jjjz/e5WlDr7D66qsb8bZiPFmrPJmSh136CjniNt98c9nUpSJgCMXeq1evAAmNVBFAoSuKgCJQBQJffPGF2XHHHV0J5Cpdfvnlqygt91JxSDn88MMTRXRRnyiDpdzap2srU0TXVVddZW644QYzefJkQ/zLZhFcDknS+vDDD7smi0vkSy+91CwQaDsVAUVAEVAECiCAR8xf//pX59HVuXNnIyF/C1yihxKIQBaJLsit4447LgftZhvH5TReNxQBRUARSCkChPq55557XL4uvwk33XSTM7Lx9yV13fcUUaKrMUQX/WinnXZyIZXoJ4MGDTInn3xyUruM1qsBCCxZssTsuuuuhlCqyIorrmgWLlyo3v8NeBZ6S0UgSwgwXhk6dKhrUtxjgAMOOMDlFsSDKgk5uiD0IPYwiMZhKEuSKaJr2LBhzmosraESKu1YdFAs5bB2QggTQfL2F198sdIi9TpFQBFQBBSBDCHwy1/+0rzwwgtm5syZzj1dia50Plwm9Z988onJikcXOVWxnhfBUGfUqFFmrbXWkl26VAQUAUVAEUgZAiifCT83cODAoOZEIIEEi9M6Oig8xhXqfOutt7oS41ZyxVjNuhVFvrXHHnvMYECLvqEeHl007rTTTgvyj2MFz3hBRRHwETjnnHPMvffeG+x68803zXLLLRds64oioAgoAuUisMUWWxjC6RMlTcIYl1tGvvMPPPBA8+GHH7qQ/EkgujAowWiAnGE4DGVJUk10vfbaazkhmH7729+aG2+80bGjhEpoFvnpT3/qlF6PP/64azJtJ2wESk0VRUARUAQUAUWAkB7PP/+8IYY9pBdh4chrqZIuBIToWm211VwoynTVPre25Ii7/vrrg509evQwl156qfn+978f7NMVRUARUAQUgfQisHTpUtOtWzdDXm2Rp59+2my44Yaymbgl3kPjx4939VKiy5hGEV0333yzC4XJg1hhhRXcGDZNITAT17EzWCGILeY0eCQQRpM8xJrPNYMPWpukCNQRAcnPRXhUIqfFKUkjuuARyBlGtB/CTGdJlOjKwNPcZZddzEorrWSefPJJ1xoS5n3zzTdm/vz5GWidNkERUAQUAUWgWgTIyfXMM8+4HBoonQgVR7hflXQhkBWiC6+ta665JgCfpPMQXSqKgCKgCCgC2UPggQceMGeccUbQsGnTphlC8SZRyDMGyYIo0WXMiSee6KLGEP56zTXXrJtHF2HoOnbsGHQRDJoh3VQUAR8ByK7nnnvOeUisvPLK/iFdVwQUAUWgLASIkMY3D6nF979Dhw7mgw8+ML/4xS8SEbpw5513Np999pk55JBDnMNQWWAl/ORUE12vv/666dSpk7MUGzFihIulSUzNKVOmGMieZhEUX1g6PfXUU67Je+21l/nuu++c5VOzYKDtVAQUAUVAEciPAB5cfCP++Mc/Om8ukosT7lclXQhg2PLpp5+atm3bmgULFqSr8v+rLaGrzjvvvKDu/fv3Nz179gy2dUURUAQUAUUgewj4Cd5p3cSJEw35KpImSnTlPpGTTjrJPPLIIy4lAmGF6xW6kFpg/Q6RgZCqgfDbKoqAIqAIKAKKQC0QEG+uH/7wh2bu3Lmx3+Kggw4y7733nvNETULoQtEr/PznPzfwKFmSTBFdMjBFkQfZ0yyy++67OzdtrPWRPffc05DEFesWFUVAEVAEFAFFAGKL8LaTJ092FrFYxWIdq5IuBGRAuvrqq5uXX345XZW3tf373//urG6XLVvm6q6Ea+oeoVZYEVAEFIGKEfjPf/5jttxyy+D6u+++2xA6J0kiqRCoUy0supPU1lLq0kii67rrrjPXXnttUM3p06cbDHxVFAFFQBFQBBSBOBEg9c+PfvQjV+TDDz9syNUVtxx88MHmnXfeMV27dk2ER5foFZToivtJV1meuLQfeeSRhlwPzUp0hYmtMPFVJcx6uSKgCCgCikDKERBFBRbUJ598smGbb6ZKuhCQAWkaiS5ytXTp0iWwzm7Xrp1BabXiiium6yFobRUBRUARUASqQkCspimE0Psbb7xxVeXFeTFhnSUpuxJdxnTv3t2g9CP399prr2369u1rpk6dav7yl78ESsE48ffLev/990379u2dAS/7ieQjYSX983RdEVAEFAFFQBGoBgExCqaMWn37CcdL2eROT4JHl6REyOK3NdUeXWGia/DgwWbcuHHmzjvvdF5N1XT0NF0bzslFzPPlllvOkOxXRRFQBBQBRUARgNyaN2+eueWWW8xpp53mFBd8M1XShYAQXSRkf+mll1JV+XPPPTcIO0Sej1mzZplNNtkkVW3QyioCioAioAhUjwCRRwgNJEI6gqTk17n66qvN2LFjXdVqpeySdqdhKeNHcn+vs846dSW6wOfss8924wXWv/e975l7773X7LDDDmyqKAKKgCKgCCgCVSPwr3/9y2y33XauHAxdDj300KrLjCoAQumtt94yOOokgeiCN/j4449dPkx4lCxJpoiuQYMGmfHjxzsroz322CNLz6lgW/bZZx+DqyWWVgiKsJVWWslZyBW8UA8qAoqAIqAINAUCp556qnnooYdc/OUzzzxTia6UPnUhuiCKSAyfFiGk9MUXXxxUF8KVOOUqioAioAgoAs2JwD//+U/zk5/8JGh8Ukil4cOHm9GjR7t6JaVOAUgNWGk00YVRD97gIvvtt5+5/fbbZVOXioAioAgoAopAVQgQShBjDqSW331CBP7jH/8w3bp1SwTRRSS4jz76yBBSER4lS5JqootcDzwUXP+I33zllVc6a/W77rrL8NCaRXDp/+qrrwKllxJdzfLktZ2KgCKgCJSGwBlnnGEeeOABZ6Xcq1cvc8opp7hvZmlX61lJQWDnnXc2n332mUkT0bVo0SJzyCGHGJSaCKTrwIED3br+qw8CjzzyiLntttvMuuuua4YOHeq8/utz53TcRfFJx3PSWmYPgTfffNMceOCBrmH777+/mTRpUsMbec0115hRo0a5etRS4dXwhpZYgTDRdeGFFxp0Lffff39gAV9iURWfdvrpp5sHH3wwuB6FHDogFUVAEVAEFAFFoBoEmKdiQIHg1UR4wVoJ82E4jKOOOioRRBfOQR9++KEzPsUINUuSKaILxcmtt95qpk2bZnDDaxZhYvD5558HielJ6rvqqquaxx9/vFkg0HYqAoqAIqAIFEAALy7yKfz+9783v/71r5VsKIBVkg8J0bXWWmuZF198MclVdXVraWkxxx57rHnqqafc9tZbb23+/Oc/JyZEVRhAJjvPPvusU6ARHhJybsGCBe60VVZZxWy//fbm+9//fviyxG/jNSFEI94KRx99dOLrXM8KKj71RFvvpQjkIkCuxj59+ridN910k8HiuZEyYsQIN1aiDkp0GWcYNXfuXPP88887Y4lGEF0oBlEQ/vvf/3ZdY7PNNnPGW23atGlkV9F7KwKKgCKgCKQYAeapW2yxRdCCWn/zk0Z07bXXXuaDDz4wHTp0cDxKAEQGVlJNdL3xxhuOfcTV8LrrrjMDBgwwEyZMcMnNSazWLIIlHEzs3/72N9fkHXfc0aCgefTRR5sFAm2nIqAIKAKKQAEEJMcB3s8olMjTxTdTJV0IYMiCYQsJ4SVccZJbMGXKFHPJJZe4KkIQodCErGukoCi76qqrzOLFi53ibMMNN3TVYUxJCGwIoRVXXNGsttpqZsmSJeY///lPUN1f/OIXZuTIkWb55ZcP9qVhxSdyfvnLX5rrr78+DdWuWx0Vn7pBXdKNvvnmG/Pll1+6aBWEZufdQf4E8jqRI2jzzTdXr8SSkEzPSbyX5Jv26quvGgwLGiWMk9ArILVWejWqjeXclwgAPtF1wQUXOKNiogRsu+225RRV1bli0CyFEKng8ssvl01dKgKKgCKgCCgCZSGAATDGLcjDDz+cQ3qVVVCJJ3fu3NmQkxSDwyTk6Np7773N+++/bw444AAzceLEEluRjtMyRXRdccUV7gH96U9/cnmq0vEIqq8lDCxMLBMDpF27dgZrb0KxqCgCioAioAgoAueee66ZOXOmwZvjoosuMoSB4Zubj9TZAABAAElEQVSpki4E0kR0QchhiMMSSUqfg+SdM2dOxQ8ekgilbJrEJ3I0v0nrJ1ctPvfee68hDx1hxPGYZVyuEo3Ap59+al555RVnjIdXKjmFEd4TJMRm+e2330Zf/L+9kOWQEVtuuWXB8xpxUPtC5aj/4Ac/CC5uJMHEOx6DBqSR9QjAaPCK5Hh97rnnzHrrrWcaRXQtXbrUeVuj80AgwFEUYpGuoggoAoqAIqAIlIPAwoULgzCFRx55ZPDdL6eMcs899NBDnc7+mGOOUaKrXPDKPD/VRBeJ3JhMinUqVj3kIJgxY0bDLYbLfA5VnU6M6nfeecexwxREaB0GovPmzauqXL1YEVAEFAFFIBsIoHy9++67zbBhw0z//v1Njx49zGWXXZaNxjVRK4TowqtBkuYmtfkyJqN+G2ywgbMIJ6xyIwXMiAJQjfTu3dsp+qopo97X+kQOJAHjZJX/Q6AafCBryBWMtxECcQO+lNnMgmckBnhYrqJM4I91iK44hMgdeIgmSbQvVPc0fKXTjTfe6DxuqyuxsqvJz0WeLkSJrv/m1XzooYdMo4kungeeZXiYiWy88cbmvvvuc3lLZZ8uFQFFQBFQBBSBQggwRvXH6UT1WGGFFQpdEsuxww47zBl7EdY/CR5d++yzj3nvvffMz372M8ejxNLIhBSiRFdCHkQ11ejUqZN56623XGI7yuFHK0qlasrVaxUBRUARUASygQDhClEKDh482IV6UaIrnc91p512cuH0kk50vfnmm85KTvJp4H0BGdBo+eyzzwwKcj8cYb46Eb4Qo6G2bdu6UIV4j5A7hjGXeKHkuzZp+30ih3aoIVTuE6oGHyaq/fr1yynwhz/8oXvfEl2hWYTf1JNPPumiSTz99NMub7D8/muBARij9E6SaF+o/mkcf/zxQY7pt99+23zve9+rvtAyS1CiKxcw8YImf+X666/vwl8znnzwwQfNNttsk3tyHbZ+85vfmNtvvz2400EHHWTGjx/fkL4SVEJXFAFFQBFQBFKBAONVCCdJ+4OxhE961bIRXbp0MS+99JI57rjjEkF07bvvvubdd981+++/v5k0aVItm173slNNdKFIISwOOROIr4l1Og8Iq3WsnptFJKkdHm7Ij370I7PJJptUFZqnWbDTdioCioAi0AwI9O3b10ydOtWQ44C/M88806AsUEkXAmkhusSDEHR32GEHFzaTMENJEELMEeKaHFxb2ATE5DT9y1/+4hTzUj+IYMiLtOXikvqHlz6Rg8Ui7f3uu+8M40YMpQgJxf42bdo4XFAcMo5sFqkGH8KEn3TSSa2gyqJ1ZKtG2h1YgkLwTJs2zcX5jzqnlH3LLbecU6KTmwkiH5KZ/sh+n+xAQYH3HNErCIeaJGn2vhDHs+D5SkjK7t27O+OcOMotp4wxY8aY3/3ud+4S9ej6b9hhSK1nnnnGGdKK4VSjiC7y9RHNR1I28KAIp4i3tYoioAgoAoqAIlAIAfQgt956qzvl4osvNuecc06h02M9dsQRR5i//vWvBo8u8lj/+c9/dvPkWG9SRmHt27d3keGyGNY+U0SXWPjcc889BmVQs4jE+kRZgZAYljjnJIlVUQQUAUVAEVAEGMih4McgZMiQIaZnz54uhKEiky4EhOhad911zfPPP5/IymOEREhlCeVGcluS3CZZSESMwZRIGuosdS20JNcRlnp4ohXLe+SXwziyGcaQceFz8803u2TWX3/9dQBj0r0ug4pWuYJV6hNPPFG0FLwgN910U+chiWflokWLgmv23HNPc8cdd2SCWG7mvhA80CpXwJBxCsL3BLKznnLDDTeYq666yt1Sia7WRNf555/vjEXIdbn11lvX89EE90LngcLwyy+/dPswpBk7dqzp3LlzcI6uKAKKgCKgCCgCPgIQXBBdCKHcMXz0jancgRr+w0GHMNfk6EIv02iiC4KL8TiE1+TJk2vY8voXnSmi69JLL3UPaObMmWbHHXesP5oNuuPhhx/uLJFlME4YAazh7r///gbVSG+rCCgCioAikCQEyMuFIhEvFRQ4Z599dqtwW0mqr9YlGgHGNl988YXzdiBfRhJF+hp1S0s+KPKxEK5KRCzXZbtRy48//tiRCH//+98N8eM/+OADs/rqqxuIAX7DUQpgzsODkzEhhEIlgqfbww8/XMmlib+mVvh89NFH5qabbjKPPfaYWXnllV1+IQwKsiyQ2ZCiUSEK8YYkugbhUJhA8+6S/AePPvqoOfHEEwNo8J5h0p8Vaca+EPezw2ATwVtSSK+475GvPPKD/fa3v3WHZW6d79xm2H/GGWc4wwdCkm644YYmCUQXuBOCl7CKYlSDByjepYw7VBQBRUARUAQUAR8BnGHOO++8YNeCBQuc8VWwow4reCO/8MIL5uijjzZ33nlnw4kuxuiMcwhhiJ4oS5IpokuUK/fee69p165dlp5TwbaICyTWTVg0bbXVVi5m9uzZswtepwcVAUVAEVAEmgMBCe2LAhylfq9evcwll1zSHI3PUCuTTnQtWbLE7LXXXkY8W1D8402UdJGIANRz1VVXDeK2N6Len3/+uQsDxxgOrz1CeUXJyJEjzZFHHplzCIXf7rvvbj799NOc/cU2sGbEQIrQ15tttpkjITbffPPgMpI2o/glNDjhNnifiEByQAwS616ID8JVEnquEoHIpT4QeuUIlv1MWgnJSBvI4RSWWuETvk8zbdMHfdIdT7YBAwYYwl8SHjRKXn/9dZfrTo4xuWaSXUuptF/Vsk5adn4EGulVxXdr6NChrnJKdBlDKF+MZ5966imz0UYbJYbo4gFNmDDBvW+kJ6299trOSh4CXkURUAQUAUVAEQABPKfQfYiQ4zVqniDHa7UUouuoo45yKSUa7dFFmHXyoe6zzz7OUKRW7W5EuakmuiB2CIcD0YMlLpbqWPI0usPU+0HKD4ZcC1hQ8qPdbrvtDIn1VBQBRUARUAQUgSuuuMIQjg1L3Ouuu86ce+655qKLLlJgUoaAEF0khCcxfNLEDwkBUYJXUFJycxXCilw/5BtBMJTCYCoOwbODsBiE3yIBMZ4thWTGjBlm0KBBJRFVV155pTnllFNyiiNfEpOVYgKZt9tuuznLd7xudtllF5erLN91YCP5kBhnEl8eEuPll1923mOvvfZaq0t9Io6cKoSuKxYeBMLkhBNOcGWh6O7QoUOrcsM7sIzE0I06tLS0BIfJMQaZT5gQkVrhI+WXuwQ/LEwJG/LJJ584TFEk480CQRzXJLzcflhOO8AUjw+82Ji4MyfLR3BJuYRt8Z8L+b3oj+VKLftVuC61xDB8L7bjuh9EOb+7Yr+9qDo0ch+/5S2sZykybtw407FjR7dej39+6EQluozL6UpexyeffNJsvPHGLhcW36qHHnrIGdfW45kUugdGGHjhiUC233bbbQ3NeyJ10aUioAgoAopAYxHwv+nUhJCBGGU2Qrp27Wrmz59vunXrZu66666G8xZwKXAqe++9t8sZ1ghManXPTBFdTGhJ6jZr1iyXpLhWoCWt3F/96lfO6pfQNiuuuKKbGJCkGcJPRRFQBBQBRUARQCl+yy23OJd9DENw3ce7SyVdCEDC4LmywQYbOC+apNX+sMMOc1411AvyIS2h28h1+sorrzg4UcD7+boKYQyB9Yc//MGNuyBo1lhjjeB0JlbDhg0LwipBEEEEEiYiLHga9enTx3lMhY9Fbbdt29aFyFtzzTVzDuNJt+uuuxo8sArJq6++alZZZZVCp+Qc84kuDpCTCUU8E7WosHWcc/LJJzvSDi8w2sb4lDBT5AvMJ7yXIH4Q+hI5V/IJCvwxY8Y44j5fHbgWQh9iH6kVPq7wMv7Rbwi3juK4kPzkJz9xFqiQpIUkrn5Y6B5xHnvkkUdcSDopE6V5ueHG4u5X9cawlvfj9w9RjMEjRA2/PbwsCXXfvXt3gT3xS/+9XE/Cafz48e7dBUD1vG9SH8iZZ55pkkx0QYoOHjzY8NxEINv5PqDEU1EEFAFFQBFoPgS++uorZ/Dm68QbHWlE9PZEQ8DIq9EOOgceeKAzxoT4gwDMkqSa6MLNDnc7JoCjR492k2ceEAN7JofNIigasOwmFAgWs1jAYfVNrjIVRUARUAQUAUWAHBco3iEeUMwr0ZXOPpFkoku87EEWUocwR5WGr6v308GriZCBCKQMno+lyIUXXugs8jgXAmvSpEnuMqz0OBYWCEqs4MMeL+HwS3LdWmutZfDaZwLC2G7dddd1BBXeM/k85bAUPOecc1z+LsbIeJERhuudd95xxXIt48VyZM6cOY6kkmsYX0Ie5VMCk4sJkg8PH5lEcS3kGiRbPjnkkEOC43hkQahFybfffus8zCBMShESLIs3XS3wKaUOnAOhiecBXrXffPNNqZe5upNbkZCMURJXP4wquxb7pP9I2ZUQXXH3q3pjWKv7PfDAA4ZQrB9++KHAm7PECxTDF35DGIfyu4jLczDnRjFskE+PEJiIRC2JodiiRfieyfnecUULydAJYaLr17/+tTPKaFTop3zQogsiNLd49pLDEsOKs846K3UejfnaqPsVAUVAEVAEiiNADkcMLt9///3gZIwhDj744GC7ESsS7hvCa/r06Up01fAhZIrowmqTpG7kNfjxj39cQ9iSVTQJnFEokR8BBQYTFpQ2WDuqKAKKgCKgCCgCKJ0huMi1AOHVu3dvc8EFFygwKUMAq3ws1EgIT2L4JImf1wSChdBBaRBy92AcJII3lx9WTfZHLfkdoaRHCBlNHhOIHMgpwqpFCZbnYa8KlM8oDX0hjARemOV4XvnX++sS8YB9xcgm/zpZJwcXpJUIY2yfsMLgjPB1GJmhYMeDBFIP8pDxqC+Fkj8Tvu7jjz8OTo/yPIMsOvvss52HQXCiXYFchWxcunSpi3LAeSJMLAmlmE+qxYdyCecIGdWmTRv3rgUDX2gX719CLUYJuWXADMX6smXLWp3CMYiJKFIirn7Y6qY12oFRou/ZR3hPwmeWKrXoV3FiWKwv0M447ye48W4hzF8hgSx97LHHzMCBA52HKf2UfoUnaBKFMJ4IoZfr5Z3DvQj3jCjRZRxRhG4FwwMMEJJKdPG8MHaGRPa9mlFsDh8+3PCOVVEEFAFFQBHILgKLFy92xn0SHYKWEgWDOWk548xaISQOKoQwZOzbaI8uQsRjSLTnnns6HqVW7W5Euakmuhh8MqklFAPu6c1KdJEYnPAnhN2B6Npqq61cCBBRvjSiY+k9FQFFQBFQBJKDwO9+9zv3nUShjvcIHit4rqikCwEhusjjg4FLkuS4444LPHBQ+LOdBsFIqHPnzkFVyc+F51wpcvXVVwfh9cgLAlkF6VNIOep7fsk9ohTU5NGCjOY3C4lTjZD3yw/rhFcT9S1VJIJC1PlYyxOGL0rwHOvUqVNwiPEpHm1RAnF79NFH5xxauHChi1Tg78Rb5fbbb/d3Oa8UFPfbbLON2w+ZRq4oIbuKEV3V4sNNIbEgOhHetxih+RImd+TYlltu6Sbl++67r9tFnXk+EMd454h3AgfxkMSIDWWzL3H1Q7/MWq7fcccdztJW7lFujq5a9Ks4MSzWF2h3nPejPAlPzLoveH7yu4NoXbJkiXu3MT+E3BcyYI899nBJ0f3rkrKOYurTTz81O+20UxDWtNZ1QyF2+eWXu9sUepfXuh5JKZ93fFqILjBDaYdXs2+MQV5TDL4abc2flGeq9VAEFAFFIEsIMJ4hYgLGvL6xGMZ2hHImv2QSBKNBjAcxiGQs1miiC695vOeTPA6s+LnZCVRqxU68W2yy85ZevXq5NlgLHrdtBzapbVMlFT/++ONdu+0EpsVaELt16w5ZSVF6jSKgCCgCikAGEbDWrO7bYJXEbnnttddmsJXZb5LNv+men7W8SlRj7aSiZeutt3Z1syH2Wmz+pkTVr1BlbFg+V2/Gk9Z7oMV6BBU6PeeYJXiCa22OoRbrqRVsU55V0rZYgqPlRz/6UbDfKp1b7IQspxzwsyRPcA7Xyl/Hjh1bLIGSc365G5Z4Ccqj3Pfee6+sIqiv1Mdf2olaiyVm8pZlw3LkXGc9p/Kea4nRnHMt2djqXOst1kL/8utgw2q1Oo8d1vjNnQfeVkkbeY7srBYfyrEebUG9fvvb30rRwdISVMFxqf9JJ53UYj00g3PCK5bQabHhHHOusyRK+LSWuPphq4JrtIPfhGDA0k76y7pT3P2Km8eJYbG+EPf9rOVyDp6CrfW8afnkk08CbC2B2mJzLbVYr8Kc860Ha3BO0lZs2NGgrvWqmyW66n7PerWtkvtYosvhYcPfustt6Gu3bQmlSoqryzU2NGwL72H5Lcgy/JuoS2X0JoqAIqAIKAI1QYD5iY1Y08IcTN7zsrRGhC02THNN7ltpoZbocvWU7+jLL79caVGxXGeNP1x9rEFgLOUlqRAsBVMr1srKPRgbwsS1wVq+uu3XXnsttW2qpOInnniia/dnn33WgrKEH7d1i6ykKL1GEVAEFAFFIIMI2LBd7ttgw0W5pc0Rk8FWZr9JNjSce342Z1OiGvvwww+7ejH+SLLSNAo06x0U1H2//faLOiXvPlEAyqTKX0Jy/f3vf3fXWo+h4B6cA4ERFsZv1ovAkW1+ObJuoxe0WG+o8GUlbdu8JTn3X7RoUUnX+Sf5ZB11sp5ILdYbzj+l1br13Mm5LwRHlEB0SDtlufvuu7c61Xql5ZxnveMKEkU2LGXLd99916qc8I448LH5D4O62fxl4Vu02HxiwXHaaMOFtKCMLSYQFTasXHCtDV3Yqs1x9sNi9Ynj+NSpU4P2gAXYlCNx9yvuHSeGxfpCnPejj0cpeOjT+cRaEefgLwaj+c5v5H76v7wTaGs9xP8m1ON+Sb+H9Gf5bvB+45m8+eabSa96C+Tuz3/+86APUW/eodbyv6T3b+IbqBVUBBQBRaAJEbAhrFuuv/76yPGPDf3eYkM0JxIVMWpMCtGFMSXfRRtKMZF4VVOpTBFdNgyTe1BRCoRqQEr6tWJBzGQAS2Q6Kz8iFUVAEVAEFAFFAAQYDPJtEM9nm4dIgUkhAkklumyoQte/6GNpI1H9up922mll9QqMimhz+A/POyG5KNCGmcw5p9AEzIaibrE5znLO98s/9NBDnYfSf/7zn5LrigenX0Y+S3xIIRsG2xlNhQtv3759ThmMuYuJzXWTc02U5SL3DCsiqWsU0SUTRGnL888/X6wKJR2PAx9ISqkXJFZYbBjC4DjnYXxQqowYMSLnWohlX2rRD/3y4163eQly2oNHUjkSd7/i3nFiWKwvxHm/MGlF3+rbt29BOMPE7qRJkwqe3+iD8rsq5pkZVz19IjWuMtNcTpqJLnDnG2PDWbXYPJo57x22b7311pavv/46zY9H664IKAKKQNMgYMPstRCdJmx8xzgBA7wBAwaUFZmj3sDJPEYMRqLmRfWskw0v776LROjImqSa6MKyiE7NAAyxOUfcto3pn7XnVLA9Nn+DazehggiBAiY2N0DBa/SgIqAIKAKKQPMgMHr0aPdtIGwL3wglutL57IXowlotSUK4ZPoVf4TFSpPIZIO6E76sHDnggAOCdkv7WdqY6znFoGjzlWx33XVXzvHwBuEAH3zwQRcKkXCKftmyDjlUakhDm+8pp4y//vWv4Vs6ZZ8QbBhQhQVPPbk3Swi5YhImJKL6hnib+mWzjtV9mMwL16GcMJOF6hoHPrxTpQ08M5tXKOeWYUKC8GilisxvpHwm+r7Uqh/694hzfebMmQFWtKlcoiXufkXb4sSwWF+I8379+vXLwZL3Au+bfEKIe4hY6Uss33///XynJ2K/KLQI9VkPmTJlSoBPPe6X9HsQOYd+QiQdRL6ZafDo8rEl8o3NjRc8W/83QPjapP8O/LbouiKgCCgCzYIAY5pZs2a1kK4n35zohBNOKBplIgl4oaPn22PzSLplo4kuMTRMWzSWUp5lpoiu3r17uw7jW9GWAkLazzn99NNduz/44IMWwjrw4yHXgYoioAgoAoqAIgACNhGr+zbIwGrUqFEKTAoR+PGPf+yeY5KILuKfS34u8ir9+9//ThWyMshn7FQo3FdUo4R49BVml112WdSpLVjLyXlXXHFF5DlROxnTolgM56aSsgi59uWXX0ZdGuyDWJPzWT766KPBMVkhd49/DnlffWES6R//+OOP/cOR6+HcQcTR94XQhxBafrn+evgexx57bM65Y8eO9YureD0OfP7f//t/OXVjUu5L+Pi4ceP8w3nXCetHnjHBBbzCREY9+mHeClZwAM8caQ/Lcg0v4u5XNCFODMPPOtwX4rwf7xsfS8JcMh+MEgxEJQqIXENI1KTLsGHDgjbWo65+Drl63C/p9yC0Jf2F3OiIjCPfeustt522f4S8GjNmTNCn5LfA8rDDDnMe0+F3bNraqPVVBBQBRSDNCPAOnjdvXgspF376059Gvq95ZzM3KcXwLilYSD5iMSBRoqt2T+Z7FG1SKu+++67Zd999TefOnY2dPBtLdBlrMWlsDgNjJ4UpbVX51baJuI1VUBj7Izdt2rQx9mVgbN4CYy0kyy9Mr1AEFAFFQBHIHAI2bIsZMmSIOeSQQ4xVMppLLrnEWOVF5tqZ9QZZZayxiXfNpptuah5//PFENNd6B5kjjjjC1cWSRsZ6xySiXqVUwhIpZo899jDWc8idbkNKGBve0yxevNhYZbGxZI+xXkNmhRVWMJZoMpZgNCuttJI715JLxhJ7ObfhHBuizqy44oo5+9mw4cyM9eJx+3fYYQdjvb5yzrEEoeFv5ZVXztkvGzbcoLGEgLFK/qC+cox6WLIm77Vz58411vtfTjfDhw83tNUX61llbIhTt4v22ny3Zvnllw9OOfnkk42ddAbb9913n6E/FhJr8W8OPPDA4BQ7KTXWm8esueaahmPWUMstOWGDDTZwdbQW98H5lsgyVvEYbFuPOzN58uRgm5UuXboYq3g1lgTO2V/ORhz4zJkzx9jQl8Fte/ToYSwJEWyH77HxxhsbS4CYtdZaKzjHX6HvWTLM/dnQWsEhMLDkZrAddz8MCq7hCvO0U089NbiDJV+MTRoebBdbibtfxY1hsb4Q5/3uvvtuYz21cyDjd8b33XpCmTXWWMNYQsLNEa0nnLGGCTnnhvtTzsGEbNgcfsYmcHe1sWSL+d73vlfTmvEu5TuAWC+mmt4rDYVbQwv33rYhUw3fON639957r5HtNLQhqo58b/mtMmZ57rnnWp2yzz77GBs1yOma/G9hqxN1hyKgCCgCikDVCDC2s6HdjTXGc2MWG6ksskzmSdYDyc0Zis1DIgto4E5LzLk22jD0bg7AXJA5YaMEHsUaHTr+gPFkliRTRBcDfR4Qk0lr8Zil51SwLQzCUDig9ILosgnQjQ3BYZjQqCgCioAioAgoAuPHjzeDBg0yNumoU8TbcEfGWhMpMClDQIiuzTbbzA2Uk1B9jGpEoW89lRx5kYR65asD9l2QODZvloEAfu+99/Kd2mr/Tjvt5IgmDoSV7eyz+T6MDQvGaiu58847zUUXXeT2L7fccuall14yq622WnCezW1mIHYwVLKh6vJOfGzYOmNzSjlFY3CxXUERbD3S/F3Bug0ZaKxHWbCNgZSNcR9sgwEkpUwqGUfaPErBcVYgJiAoRG655RZz0EEHyWbeJUQXWIkwQd12223dMxClO3jYvDhOge0TcJBYNuyqXGpsaHL3Dgt2eCsQR/w+rHch0SrMsmXLXHsgKvn75ptvjLUMNSgvwxIHPtYq01jvmKDoMNFlw1E6ovTDDz8MzmGuAiHBJNeGY3EEq/W6cX0TUhRS25eDDz7YEV++oj/ufujfr1br1kvN2DB0QfGVEORx9qu4MSzWF+K8H/0KMvjVV18N8CxnhbkjhhNJFp8YfOKJJ8wmm2xS0+pOmzbNXHDBBe4eSnQZk4/o4nfMeysLgnELRiRDhw7N2xwUq7y3MCjGGERFEVAEFAFFoDIErMeWWbBggTMysPl2DX82DU/BwpiDMdfBuBIjnjTKiSee6Ig8CCb0940muiDcbG5m489v04hrVJ1TTXQxMWfCioX6jTfe6CzampHoEssqBpyrrrqqsWErnAXthAkTop657lMEFAFFQBFoMgQwfICEwAgCr4z+/fs7S9UmgyH1zU0i0UVfgqRAsPIOezklCXS8qvAosqGLKqrWhhtuaJ5++ml3LWPQ9u3bB95VRBgQHKIKRxHNeFUEYqtr166y6YgoCBcE6/E+ffo4z518CjW8+G0ov+B6PM2YNEZ5k+EFYfNvBefSDhvO1LRt29aRKkRFIEqCSLhu7Mf7yuYNk1PcmFu8HoKdESsoDzFEKxRAQrxKIHZ23HFH59lGUYxpIQ0gwkQggK688srgHNlfynLnnXd2kR/C58aBzyeffOLG31J2lDEBROjAgQPllLKW3bp1M3i7hT0L4u6HZVWqwpOx2MWqVaQSD9U4+1XcGBbrC3Hfz+YWct6E5ZJdkBTMHdMgQqgwt/W9RGtRd0h+jA0QJbqMOe+88xwJxNhxyy23dOQ8yjms7vEezJpgbECkHEivQt8t2o3SlXfzbrvt1urdnDVctD2KgCKgCFSCAGMiDAxff/31nCUGaMWEaA2QQhj0YMiWdsFYgnGXRNhpNNEFrswdmXsxP86SZIroCg/EsvSgCrXF92RDKUAYHqw+seBXUQQUAUVAEVAExOsGxTxKRrw58OpQSRcCQnShXELJlASBrJk/f76rCuH1wor4JNSROhCmiAmTeBGVUy88r1BkQSwx4RKZOnWq89KCiEHxvv3228uhyKVMcDjImLVv377BeSjLnn322WCbFbyUUOriAUWIO+5D/fEIIZyXkG5yEaHwourANXvuuaf57LPP5NS8S/oYE6/vf//7OefgjYZXmgieSIRALUVszhsD8SMhIuWadddd14wYMcIR8LJPxvKyjcKREGy+4IXCeZ9++qm/u+g6Xq2EYAxLHPigEN1vv/3MO++844qnXTzTsPjEcPhY1DbhMvGmw+spn8TZD/PdI879PD+bVDwokr5mc9GV/e6Is1/FiWEpfSHO+wEkJDG/SciIUoX+ST9NgwjRVc57p9J2+eEglegyrQyJeQZZJrr8foPXAdbukJ+VGBDzDd9uu+1y/lDWSghk/166Hg8CvH+FoAyvcwfZ5y9lf7gGUo5/vJp9fvlSTnhZzr2kPCmjnGvlGln610q5/r6o80rdJ+WVen74PPFiZ+mvU254O2qff46/7p/rr+c7h/35jnE9UuicqGP/vSq3Hfnu4e+X9Uqvj7qOfVKuLOW8fEvmVoR6x+AGIx4ILd6Z/JVrVMhYkPfl7rvv7v7QaWOYlyUhVDdhfxnTM79pNNFF5AwijESF1E877qkmuvhBMQGUkBdh1/q0P5xS6+/nJltllVXMXnvtZTp16uRC8pRahp6nCCgCioAikF0E8DRBwcr3gZBthJojtJZKuhAQoitJlviigGRiQm6TpAqkCJMmJmWFZJtttnFW67QLvPFQI+9rmPiRMvg9QdiUYmkICUKYCMrCM4lQESKQ0Xic+RN8OVbKEkMnPMLyKdDI71VMqU0oPZR58kz9+2LlTqhCIQoh9vz6++dGrUOG4jmG1wl4EaKQ8CPU2xeeEwp4yDwm2hB666+/vn+KW+c5QvSRc5BJIxNswnej8BdCjTEx4U0gOI888sic0ILhAqvFh/J4pgMGDHDPkDCP+cKo443HuRCb5IkLC6Qm1p6nnHJKK5IvfK5sx9UPpbxaLskZBYErfZ2+QN64SiTOfhUnhqX0hTjvB3aEMeT3xW+BP5RP/Cb4PWMccf/99+fkUCQvGkqXNAi/B9rGO5lwP7UU3m0Q6YgSXa2JLsJeY1SB0RRhlJtNvvjiC/ddmj59usOh2dqv7VUEFAFFoFoEGJ9jxMb4nD++7WyH5wTV3idp10u+46QQXczDyLWNkSTf9SxJpoguP4Rf1CQ9Sw/ObwtxxIknTgJ0Xg5+OEf/PF1XBBQBRUARaE4EJD8QXikk3VaiK539QIguEsKj3G+0+CG6CG1HeMwkC14UhH9DIYyXFJaD5KWCXFlvvfWC/Bu1bANEEZ5Zfjg+uR9eepBREsJQ9hdbEt6QMEvHHHNM3lMhgAhfGEWsQAZxLRECCGeYT1DMT5482RGBksMm37nV7IfEQpkN0eXnvSpWJtdBnnAd+JZqkUq5ceBDORAMKEL5rZYiGO0tWbLEEbAQoGuvvbbZaKONyqp7KfcJn1OoH4bPrcU2oTOvuuoq52lISMd6KDcq7Vf52l8Mw3L7Qr77yP5i95Pz8i3J7UdYUpFyyWq5rhFLvDElUkmtySdC8KJTQGp9r0ZgWe49/cgxkPfNTnRF4cd3B+8F+guhcPmD0GebJd8EFUVAEVAEso6AeGVBWmE4iGEbcwz+Vl999WBJpIx8BoRZxkiILpxSMD5qtEcXuSdffPHFuhgR1fu5ZoroaiZXer+jSDgZrFp5aRCaCothJpEqioAioAgoAooAnjbk0yGJNgMaCAmICZV0IYDV27Jly0xSiC5IUzxlkJEjRwbr6UI1ebUlfjseRiRnFu+kqFpusskmpmPHji6kIn2jmLzxxhuGfFjkvYIEwsOT50cZUbm9ipWXteOKT9aeqLbHRwBvQzw2Ecjxv/3tb6n53dcznCBWzZA5iBJdxviRY/Bu7tmzpzNEIAQp+fVUFIFaIcD4hz+IRP78bdlf7b44ypUyWCL+NuuyLcdkW46xRKRNsl+25TrZluPhZbHjnM85Up5sh8vxt/0yuc7flvPiLjNcXjn1ZGwLgSLGTqzn+/PP5RzZznc9xylXypPzZZ9sy/Hw0r/ePzeqrv65lCPnV3Kv8PVSVrh+si3Hi92L81TKQ4BIDXPnznVphsh73Gii65e//KUzrmQOCZeQJckU0dWsFkbkSJgyZYpzN8QiEotd4m2OHj06S31V26IIKAKKgCJQIQKSXJ0YzCQdReF12mmnVViaXtYoBITo2tImhC8nF0ut6jtjxgynBKP8fPmhanXvZiiXRM2E8CP3GWHIIKMI44fHD7k/okL6lYILSgQmqDpJjUZL8YnGRfemGwHxzKEVaUs87htV1Jp8Qtlz1llnuYdd63uloUedf/75LkfVnDlzXIheJbrS8NS0joqAIqAIKAJJQ4Ccu4Q2JxQ831Qlumr3hFJNdDHp9/NRNevAC+tcQsnMnDnTeXQR9x43RKyBVRQBRUARUAQUAck5QSgBEsUOHDjQMNhSSRcCQnQRPgiLsEbL2LFjXShA6rFw4cK8+aEaXU+9vyKgCCgCzY4Anpu8p5GTTjrJDBkyJDWQQDjtv//+rr6EgsPyvFZCgvgzzzzTFa9ElzFhogsSEDLwiSeeMHgVqygCioAioAgoAopAcQQwMobg6tChgyO8Gk10de3a1ZDrFv0QY58sSaaILgalPKBmG3iRa4Uk5oR1IHQhDDGd1o/DnqVOq21RBBQBRUARKA8BBlKE9yXsDN4h5LsgTrRKuhBgIPr111+bpBBdhMCcOHGiA1EVgunqS1pbRUARaB4EyO/F94P8hMjw4cPN0UcfnRoAli5d6pKlU2FCr5Lro1ZCzuszzjjDFa/fNWP69Oljpk+fbgizRM4VJbpq1fO0XEVAEVAEFIEsI8DYgjEGjikYrDaa6CJ8PR7z5K2mXlmSVBNdixcvdkmMsVAbN26cs76C6HryySddSJcsPahCbRFFE6GpILrAg05LvgwVRUARUAQUAUVALJR/8IMfuJwTgwcPNt27d1dgUoZA0oiuo446yjzzzDOGfkVeKRVFQBFQBBSB+iPAe/iWW24xixYtMj169HAGj34tnnrqKXPMMccEu0iCvt122wXbSV8hR8sWW2zhqlnreT7W1hLaWYkuYy644AIzbdo0pwRDGSaGxbV+Dknvk1o/RUARUAQUAUWgHAQYnzH+OuCAA1wKgkaH/e/WrZt59tlnnRELxixZkkwRXdJxGMyTv6BZ5Morr3STm7vuussRXYcccoiz0sNaT0URUAQUAUVAERALZcLMvPfee0aJrnT2CSG68MwjxnejBaUXeaQ0XHKjn4TeXxFQBJoVgY8++sjlZ162bJmDgNx7N9xwg+ncuXMAyTXXXGNGjRrltjGKxCuqluH/ghvHuIJBxf9n70zgrhq7978MicyRmbeXTEWhUYmEpCQ0KEOpTBUZU5GhkQyRocwZKgkhmZIhiVBJJfPwMc8kMy//93u/v/v893M65xnPPvvsfa71+TzP3mcP93Dtfc6+932tdS0ML2iimsMynq1e2llEl9nZZ59tzDF4clREV1h3nsoVAkJACAiBJCPgn5+FQnR5h9U6deo4ScUkYR9rouvLL7+0Jk2a2IEHHmi33nqrkxlgMu+ll16yLbbYIknXqdS+oLF+88032z333GPrr7++tWvXzrp165bKm1HqydopBISAEBACiUfAT9xsvvnmxrNz1KhRduyxxya+30nroCe6CmVA6iceBw8ebH379k0a3OqPEBACQqDgEYCAwNkzaGuuuabdeOON7h2ZvJzk5IIQw5hg8ZKzwXMKfd0/bzzhElZ7IdKOP/54V7yILhFdYd1nKlcICAEhIASKCwFPdO233342Z84cizqiCwlruJNCcaDN5d2QKKKrT58+Tj8a+QYm84rFRo8e7V5m7r77bhfR1aFDBzvmmGOM7TIhIASEgBAQAgymkCrcZJNN7Ntvv3XPB54TsnghgNTUb7/9VjASA37ikUiBww47LF5gqrVCQAgIgQQg8NZbbxlqHn///XeJ3qyxxhq2zz77uPwLP//8c2pfXHN0+ufN448/brvuumuqP7leefbZZ1M5TEV0mZ1zzjl27733ujzoONsUq4JOru8zlScEhIAQEALFhYDPcdmyZUubO3du5EQXktao4RVK7u9c3g2xJrrwTGvcuLEdcMABTroPPW10tdGZ3GyzzXKJU0GXNWbMGBs/frxNmjTJRXQhIYTnHpFeMiEgBISAEBACzz//vHOAIIH7jz/+aJdccokdffTRAiZmCBQq0TVt2jSXMzVmcKq5QkAICIFEIICzAfKEZRnS/ji+VK9evaxDC26/J7rCjugS0VXy0g8cONB4xnuCUURXSXz0SQgIASEgBIRAeRA45ZRT7LHHHnNOSMzNRB3RhQoc+TZFdJXn6uXxmHSiCz1t5JkWLFhgtWrVymNLoq3K664jQ8Ek5hFHHOE80fDYkwkBISAEhIAQ8Inoa9SoYeTxwEGCwY0sXgh4oovcWEg1R21+4jHsnClR91P1CwEhIAQKHQEILNQ8kCrMZpdddpnhwRtHy9fz5rnnnnMOo2CkiC6zdKLrhBNOcOOPYksVEcfvjNosBISAEBAChYMAMv+QWy1atLB58+ZFTnR1797dXnjhBatdu7ZzgiocpKreklhHdH399dfWqFEja926tU2cONHpaTPZsnDhQtt0002rjk5MShg7dqyNGzfOYUCOrs6dOxvRbRdddFFMeqBmCgEhIASEQJgIIOlLwtFq1arZn3/+aXGe7AoTp0IvG4Lr999/NwgvvNqjNj/xuHjxYtt4442jbo7qFwJCQAgUNQL++U7u5n/++acEFs2bN7fJkyfb6quvXmJ7XD745w3ex1tttVVozUZOyOcwFdFldu6557o84Hih161b14o1VURoN5wKFgJCQAgIgaJAoF+/fvbII48Y4zEIpqgjulD3gXBjfIWTT5IsUURXz549DbmBRYsWuTwkSbpQpfUFkguy65ZbbnHShXjqISswdOjQ0k7TPiEgBISAECgSBHguEu3LBBd5PC6//HIjAaksXgh4oos8GU888UTkjfcTj++//76RD0YmBISAEBAC0SPAxMWwYcOM/F0YsjTIz8VZ8cQ/b5YtW+bed8NC2Us9U76ILhFdYd1nKlcICAEhIASKC4H+/fvbzJkzbe+993aSgVETXeRrZ8yz3XbbuZxhSboasSa6vvnmG2vYsKHtv//+dvvttzu5vmIkurwu+0033eQG/oQgkujuvPPOS9K9qr4IASEgBIRAJREg4ob8jd6QvCXCSxYvBAqV6NJkYLzuI7VWCAiB5COAUwsSt8gVt2nTxtZdd91Yd9oTXR988EGoUWmQhD6HqZ5tZoMGDbKpU6emPM+LNSd6rL88arwQEAJCQAhEjsBpp51mM2bMsGbNmhlpJaImuoheJ4p92223dYRX5ADlsAGJIrp69OjhtCVfffVVq1mzZg5hKuyixo8f7/KtTJgwwRFd3LCERTIwlQkBISAEhIAQwAO6ffv2KSCuvPJKJ3Ob2qCVWCDgia5dd93VJYaPutF+4lGTgVFfCdUvBISAEEg2Avl63iCN6HOY6tlmNnjwYLv77rud3NJuu+1mxZoTPdnfLvVOCAgBISAEwkZgwIAB9tBDD1nTpk2NPJdRE12eP9l6662dlGLY/c9n+bEmur799lvba6+9rFWrVnbHHXe4xLFoSxZbrggiuUaNGmVEdm2wwQYusg22+JxzzsnnvaS6hIAQEAJCoEAReOONN6xt27ap1l111VV25JFHpj5rJR4I7LjjjvbHH3+YiK54XC+1UggIASEgBKqOwF9//WU77LCDKyhs8gkva9IAYGHX5Sop8H9DhgyxKVOmOLml3XffXURXgV8vNU8ICAEhIAQKEwFPdDVp0sTInx410eVTP5H3FCefJFmiiC4fevfaa6/ZRhttlKTrVGpfyM01YsQII1cXRBeeVqeffrqdddZZpZ6nnUJACAgBIVAcCLz99tt20EEHpTp79dVXu5xdqQ1aiQUCnugiITyJ4aO0f/75x2rXru2aoMnAKK+E6hYCQkAIJBuBzz//3En90MuwnzciukreS6RCmDx5sj388MNWv359O/744+2ZZ56xhQsX2qabblryYH0SAkJACAgBISAEMiLAHP2DDz5ojRs3tldeeUVEV0aUcrMxUUSXT6a2ZMkS23DDDXODUAxKmThxol188cU2duxYR3SdcMIJjuTiiyQTAkJACAgBIfD++++7fJYeCRwjDj/8cP9Ry5gg4ImuevXqucFxlM3+9ddfbZdddnFNCHviMcp+qm4hIASEgBCIFgHSEvgxS9jPG+SEunbt6jocdl3Rolq+2kV0lQ8nHSUEhIAQEAJCoDQEzjjjDHvggQesUaNGtmDBgsiJLu+4suWWW7qcYaW1PW77Yk10fffdd7bnnnvafvvtZ3feead1797daUuSi2T99deP27WodHvp+wUXXGCXX365I/hOOukkJ1uIfKFMCAgBISAEhACTNfvuu28KiGuuucY6duyY+qyVeCBQSESXl48GuWKZDPz555/di0mdOnUMPXOZEBACQkAIhI/AE088YbzfYmE/b/Cy7ty5c17qcpUU+L/zzz/fJk2aZDNmzLAGDRq4FAnPPvusLVq0yDbZZJMCb72aJwSEgBAQAkKgMBA488wzbfr06dawYUMXFR21dGHv3r3tqaeess0339xJKRYGSrlpRaKILhLHoi35+uuv23rrrZcbhGJQCoNPBqFjxoxxEV19+/a1QYMGWb9+/WLQejVRCAgBISAEwkbgk08+sRYtWqSqIafjYYcdlvqslXggAMHy559/GgnhH3nkkUgb/dFHH1nLli1dG8KeeIy0o/9X+VtvveXytnz//fe2+uqrG3nufIRBIbRPbRACQkAIJBUB79RJ/8J+3uBl3alTJwdl2HXF4XoNHTrU7rrrLnvooYdsjz32ENEVh4umNgoBISAEhEDBIUBqofvvv98F6xCpHjXR1adPH5s9e7ZtttlmTkqx4ACrQoNiTXQx2cCACy91BmAkjkVXe/ny5bbuuutWAZZ4nTp16lRHbI0aNcpFdJ166qmGzMDJJ58cr46otUJACAgBIRAKAsH8FlRw3XXXWYcOHUKpS4WGh4AnukgIP3PmzPAqKkfJb7zxhrVt29Yd+cEHHzjypxynxfaQgQMH2rRp01Ltb926tSEdnU977rnnnIIBeVEY862xxhr5rF51CQEhkAEBFEb+/vtv5SvKgE2uNl1xxRWGgw4WNvlE7qkjjzwyL3W5Sgr8H6oxEI3kFUFJp0ePHjZnzhxjkq5mzZoF3no1TwgIASEgBIRAYSBw9tln23333VcwRBcpj5588kmrVauWUywpDJRy0woRXbnBMdJSmHhhAmbEiBGO6BowYIDhfXXiiSdG2i5VLgSEgBAQAoWBwNdff+30oH1rxo8fb+3bt/cftYwJAjvssIP99ddfLiE8ieGjtOBk4LvvvmvVqlWLsjmh173//vsbue68tWvXziZMmOA/5mVZt25dQz4RQ67a55HJS+WqRAgIgRII8FuMigbesNWrV7cbbrjBWrVqVeKYynz4z3/+Y3fffbeRM+GAAw6oTBGJOyfoaBA20YUk3xFHHOEwDLuuOFwoEV1xuEpqoxAQAkJACBQ6An4sQ7DO4sWLI4/ogi+YNWuWc9TivT5JFmui64cffnBa0UjnIN/HCz8JZPEyrlGjRpKuU6l9IfyRMMiLL77YEV1of1500UWG5qZMCAgBISAEhEAwnxJoMEHPRL0sXgh4oos8GeTLiNKILjruuONcE958801bZ511omxOqHV/9tlntvfee5eo45hjjrHRo0eX2Bb2hyDRhWziuHHjwq5S5QsBIZAFAaJq+/fvn9qbq9yXweil5s2bu8jRtddeO1WPX/npp59c/ZBsTZs2tV69eiU2srZnz55GXigsbPKJSCUvSxt2Xa5DBf4vnejiuc/zn0m6jTfeuMBbr+YJASEgBISAECgMBDzRxXv8a6+9FjnRRe5TcqCSbxMnnyRZrImuFStWOK/mffbZxyZPnmxdunRxSdSSPuGSfgOime2juDbccMNUdBfSAjIhIASEgBAQAv556ZHA8/yQQw7xH7WMCQLbb7+94e1fCEQXA2MGyNiyZcts/fXXjwmKFW/mbbfdZsOGDStxIjLRvLDk04JEl3fyymf9qksIeAQgee655x5buXKlewdByrPYbOTIkXbzzTenuv3MM88Yv9FVNSRhcdr0BrFAXek2duzYEmQ3UdpEayfRcMwhBzdSeRBRYRoETseOHV0VIrrMLrzwQrvjjjvsgQcesL322suOPfZYmzt3rpuk22ijjcK8FCpbCAgBISAEhEBiEDj33HPd2Ll+/fq2ZMkSe+yxx4x3u6iMVEePP/54XsZW+e5jooiuzp07uyRqJAzP5PmWb3DzVR/yRT4vF0TXoEGDXO4GBqIyISAEhIAQEALInQUHUjfddJMdfPDBAiZmCPz73/92uWCQPMDJJUqbPn26EUGOJdmzG2IRObKPPvqoBNxRSEQHiS5ypZAzRSYE8o0A33dyGPHdwIgo4l4MPmPy3aYo6rv11ltt+PDhruoNNtjATVqsttpqVWrKn3/+abvssouTqPUFrb766s7rd9ddd/Wb3NJ74gY3QkCSwzFp1qRJE/vyyy/zIq+Dl/Vhhx3mIBTRZU4l5vbbbzee+Q0bNhTRlbQvl/ojBISAEBACeUGAefqpU6fabrvt5pxEoya6TjnlFEe2EZ3N2D5JFmui68cff3SD+RYtWtiUKVOsU6dOLona22+/7V66knShSuvLo48+6jTiYYjxrDrvvPPs0ksvte7du5d2mvYJASEgBIRAkSDw66+/uskz310RXR6JeC1r165t//zzj0tiGzXJgWT0+eef7wBE13vTTTeNF5jlbC04n3766ascHUWOrCDRBenppbxWaZw2CIEQESB/1ODBg0vUQCQTE+HFJGXGe9YLL7zgcDjwwAMN4quqhipJJieUTBGkBx10kPHOGzTkVJFVTZL9/ffftuOOOzryLx/yOkuXLrVDDz3UQSiiy1xqhIkTJxqpEho1auTur+eff94RuzjYyoSAEBACQkAICIGyEWDszBi6Xr16Lko9aqKrX79+9sgjj7j0R0SYJckSRXThXchkyzvvvGNrrbVWkq5TqX3x8kHnnHOOu0nR0o5iAqbURmqnEBACQkAIRIYAXuJ16tRJ1X/LLbcYk2SyeCHwr3/9yzW4EKJ5IEtHjRrl2kN+1C222CJeYJajtb/99pvtv//+Ro6udItC/jNIdFWrVs3pqvPdfu+99+yDDz4wcvawnXxp6623nh1wwAG29dZbpzddn4VAlRAI5ucLFrTffvvZnXfeGdyU2PXvvvvOTfr7qDbyJJMjq6rGhAMTD+lGlBbRWt4gf4j8+v333/0mt+zbt+8qJGSJA2L4Aax55mH5ILqQ4kUGEhPRZU62F/ne++67zxo3bmxHH320zZs3zyAEiWSUCQEhIASEgBAQAmUjMGTIEBegw/vc8uXLI5cuJM8sY0ue5TzTk2SxJrrQhSfsj0S9MKMkjkW3mxf+NddcM0nXqdS+zJ492/r06eMkhPCs4mUL3XYi3GRCQAgIASEgBJgUIwLEG57neKDL4oWAJ7rIk0G+jCjt6quvtquuuso1gaiGJBIqV1xxhV177bUZYUZJAEWBfNgff/xhn3zyiYv0YL28ttNOO9mTTz5Z3sN1nBAoNwLkprryyiuNaGFv+SAhfF1RL8lPhpKGN8g///vst1Vmed111zlnxfRzkUQkUTg5qrCXX37Z5aZOP+6EE04wHB6TZDiw+vFKPu4xcoGREwwT0WVOnpMx47333mtISPpIxqTn5kzSd0h9EQJCQAgIgegRQHlt8uTJhhQ1uVijjuhCLYA0SOTZ5pmeJBPRlYCriXRNz5497bTTTnPShSNGjHDJiSH+ZEJACAgBISAEQMDnd2Id71yiPWTxQsBPpBYC0YVE1o033ugAzNUkbyFdDSTBDjnkkBK5coLtCzsXzrvvvmtE6jPRSkRDZQypyzlz5lTmVJ1TwAh8/fXXTjIPAoD75PPPP3femE2bNnVS5mussUa5W1+Vsr766isjshMZM3Ijt23b1tD79wYpixTKNttsk7iIz+OPP96eeeYZ11VkG/2673tll+Q9RAIyk0G6+9xRODUiJ5duOD5eeOGF6Ztj/Xn+/Pl21FFHuT5A9OHUGqbhZc1vPyaiS0RXmPeayhYCQkAICIHiQYD8znfddZeLyEeqOmqiC/5gxowZTgUEJ58kWayJLiRa0Lfce++9XVK3jh07uiRq77//vlXkJS/uF9RLiBB6SEQXk094BHbo0CHuXVP7hYAQEAJCIEcIIF2IzBlGYnEk2WTxQsATXSSEzzYZmq8eETXgZcqY5GWyNymGHBly2MHEvHvssUeJz7wYNGjQoMpdXrFihRGtEZSAon4kor799tsKlU85ENpImm277bZ27LHH2nbbbVehMip68M8//+zGnQ899JB169bNeInz9tdff7nIEyaO6RMRZigx1KpVyx+Scfnll186SQ+wIVIQz0ekGPNlYfSJtlelX99//73LkfP44487mXaidDNZeRQdcllWpjaw7aOPPrITTzzReJFHTp7vC9exPAZxh1IH1wFCiXu5NKsKrqWVm20f75/8HvjnKRMFkNK5MBxQIC8zWZcuXYwoU+pt1qyZffPNN6sc1rt3b7voootW2R7nDUE5x3wkTMfLGtIWE9FlhgMtctfTpk0zyHR+51988UWXXySfv8txvofVdiEgBISAEBAC/t155513trfeeityomvAgAHG+9u6667r3ruSdIViTXTxAoS+JYN9JCTwcnvttddcnoLVV189Sdep1L4gGYSMwMknn+wiusaMGWMTJkxIyS6UerJ2CgEhIASEQFEgwKCKnEPYHXfcYa1atXLr+hcfBDzRRUJ4EsNHaWeffbbL2UEbkMeDxEiKMYa69NJLU91hnEmUPEmEvZVGdPE9q169uiOw/PGZlgsWLLBjjjnG7aLO1q1bu/VPP/3UyXJnOie4jRcT7gXy1zDxTqQfDk/lNfTY6QekHv/6DgAAQABJREFUBJPmTFpuueWWToLt4IMPLhd56eWzqRPZcMbhlEPZTP5DdKRbNjKG6KJx48Y5kgOSzBvlkheGaBcv3eb3lXcJMQQRyF9Zlss+UVdV+/Xggw86+bDyEJ/Dhg1z5FC2PuayrGx1sJ12EDnsjQgZ8tqVx1CpQK0CK01+s6q4ugoq8Q/Z2DPOOCN1Zq5+/4iQg+D2BmlN7j1v5EEkHyIewMHIOb+fZY8ePRwxEdwW93UcKrwcYz6ILn6z+P3DRHSZjRw50pAqZa6FZyHRdUTZ4cDAM0gmBISAEBACQkAIlI2AJ7oY26IcEnVE1+mnn268F9SoUcNJKZbdg/gckSiiiwgmJDI+/PDDcr3Ixucyld5SXnq6du1q6LJvtNFGztsPKRE/SC/9bO0VAkJACAiBYkAAxxAcRDARXfG84p7oYjKUxPBRWt++fe3RRx91TSDKpLzRGlG2uTx146lOJJQnWtZZZx174okn3ATzwIEDU0UQZUB0UrrhGQchQxQL0RXBPD7px3rJCLa3b9/exo8f7w4h7xFRe/77mn6e/0zkAS8nFTWUD9CJp6+lGb8Z/fr1K1UhIEgKURbOV0zYd+7cOYVheh0QGcOHDy+xGY14sPrll19KbA9+QMUBgpdrUh4DPwhEXiSZsOaacM0OPfRQRwhkKyNXfaL8qvSLKDjuJe6p8hga+8gI8i6QbrksK73sTJ+D9zb7iSh+6qmnMh1aYhuydEHpdUhOvF7Tcy9XBdcSFVbiQ1C2EAeSWbNmVaKUVU/h3j7rrLNSO1DoQK6QCDdv1MX2Z/+PCPTb/RIS4rLLLvMfE7GE/IYcx7i3IdPDNO63Nm3auCpEdInoCvNeU9lCQAgIASFQPAggLc0czI477mjIj0dNdOG0hfMW71WZHBPjfGUSRXTx4ooHabENSvEI7tSpk/Xq1cu9AJAcnqSxPnFvnG9QtV0ICAEhIARyg0D9+vUNKTAMfeh99903NwWrlLwh4IkuEsKTGD5KC072ZiN9omxfZer+7LPPHOEUzIlFLhzGVxCLRLF5yxbFgSQoRBJWlocc8liQVRgSfZBE3hYtWmRIUiPFvd9++9k+++xjo0aNso8//tgdQk4kJmQrYpAd5FW7+uqr7ffffy/3qdRNhFsmCTnICwg9bxAQJDfONhavVq2aXXLJJYYMmzcIU4gRTy767ZmWyGwEr0OmY9jG9Tn//POdXGCmY7h/iToij9TUqVMdvl5+Mxd9os6q9guJ2UwydES1QAYRXVH7v3nYNt10U3evcU9kU7TIZVmZ8EzfFoz4ZF95X6KROwwSRzjt4bwXtKriGiyrouvIPhJF6e9VyG/u91wYvzNPP/10qiik6XlWE03jDSKL3/5s0pW8C19//fX+8EQs+Q5w/2JErOLUGqYx+eTfobP9joVZf6GVzXOH7yC/k6SLUERXoV0htUcICAEhIATigIAfz+D8hUx11EQXzlU4WaFCQoRZkixRRBfesCRRI6KrmMx7PyJXwQsA3n/y1i+mO0B9FQJCQAiUjQDyZn4Cf9KkSdayZcuyT9IRBYWAJ7rIk0G+jCjNT3bRBiJOkM6LszFxTZ9wHvLWokULmzx5slMJICca0TXe5syZ40gG/5klk+DpOCxbtsyItMlkTJgjv+atrAitQYMGuclGji+LRPNl+iX1QCIwZsxkSAJuvvnmjqDKFFXFPiY6PRnky3j55ZdLkFZE9nnyjmNQW0BxgOgwcikRVUVZ3pjYp12eOGA7v1VEdxHBRa4mIjp8m9iHzEZp5nPKlHYMpB3RTxCZEydOdO2if0TSVbVP1JuLfgXJZN8XJpqRBKxoJF8uy/JtIbIGAhQSC1lCrq03PEPbtWvncrP5bShQIL+XzTgH8veff/5xhyAzybUOfqdygWu2+suzHewhSDHaN2/ePEdSl+fc0o5BlhIHBv898MQ377XgmM1498Mbd+XKle4Q8vMRgZok8zkk6BO5DHFqDdOYfCJXGiaiy1wEIQ4S/BY3b97cqcjwXS7reRXmNVLZQkAICAEhIATihoB/5+BdCqfIqIku75TG+B0nnyRZrIkuXnp5ofYTPrwIMOgK6pkn6WJl6wuebUwkkOcBogvpG01iZkNL24WAEBACxYlAcFKdyXuiNGTxQqCQiC6fFxUEIYEgCOJsTNgjc+cNMoYXkE022cRtSs/Lg+zfVltt5Q93y6DkFRt22GGHEhEawYO97HRwG950eNVlM+T+iNj3RtSXb5/flm1JfpVMMorkAcJjH1IPI+qLcvHgJyrKkw7sq1WrliM1mYT3hnMZEWeZjNyxSCRmM6KpOJdIOm9IHpJrNihVRznIY2LbbLONIxf88enL9NxQfj+RTlwPCL8ffvjBdt99d0eiEOnqJSJ9pGRV+kR9uepXJsKOnDh4YEJcBTHy/cy2zGVZvo5g9BVyeRDFQSPaKUjIlyWrTgTjzJkzU0Ugy3755ZenPucK11SBFVzhu0AePR+x6d8/K1hMxsOJwgpKDgb7TlRbNkkZfqP4vjz77LOu3GxSjxkrjcnG4447zohu8w4DOA+Eae+9914qX6KILnMRuBDZU6ZMcc8JonFxBuCeLK+MbJjXS2ULASEgBISAEIgDAv49rlCILnIpoxKA2gZOPkmyRBFdeAHCRDJALSYjGSxJnnnBRLs86HVVTDior0JACAgBIZAdASblvvjiC3eA98zNfrT2FCICnuhCsgziIkpD2sl7fzFIhiSIqz3zzDNOntCTOkwWE91DLjRvSIgNHTrUf7SFCxc6ybjUhv+upJNh3bt3dxEvwWP8+tFHH12CsCmPJBeT/tddd50vwuXYSifbUjvTVmbMmOHkAYObIZlwjlpvvfWCm1PrEG8kKmac6S1dSs47nfn9frnXXns5OYxsUnocRyQV3o3eiKK45ZZbSsjvETFDzjQv1cYxRNVkMi+bmL4PmT908T0pSFQbhNdmm21mHTt2TB3uo8Wq0icKy1W/yNUGoTV//vxUG/0KuaEgkg466CC/qdRlLsvyFQWJrlNOOcWGDBnid7klzoe8m3lD4i+Y585vZwm5euSRR6aIVSJ3IG/8NeOYXOFKWZUxyBZIF2+Q43zHq2qQyzieBAlfvuc4MWI8rwcPHrxKNT4/mE9u7g9AehNZnKQYOBDFBclN1CxRbmEaRCYStJiILnPPMJxAvIMUzgivvPKKk85FLlUmBISAEBACQkAIlI2AdzrDyZDgnKgjurxDGu+9SeNQYk108dKGRIP3wCxWost7EDPwhOhikgAPSiY1ZUJACAgBISAEQADJmU8//dSB4XMtCJl4IVBIRBcRQJ988kns7ycml1EEYALVG1FBEAzekBODKGGizxukCHnuIH6Q2MPSJ6QhpojMSDcmCRmzBY0IMrzkS7Mrr7zSrrnmmtQhSO9lypuVOiCwMnfuXEcY+U1MhPOCFZSb8/uCSyTV6KOXWORlCMm6IDmGuoKXFuRc8oqRt43t2YzjkU/95ptvUodQNpPa/FYRKUBEGeSVJ7k4MFPkENt//PFHa9WqldHeoJWW0wvJTfZ7C+Y3qkyfKCfX/eJdh5xmd955Z4oE8u1lSUQaEV5+Yj64L309l2VRdt++fV0eMtaJ8EQ6Pd2CDhb8ZhAVkm5EavEd9MQ5+/F67dmzZ+rQXOOaKrgCK0hwck9ifG8guyHkqmpEKxK16I3IJSRUPYkAEQYhmy7ZB/nFNYCsJqrLG9E3OEAmxfidIAqTXHTInwaJ9zD6yOQTvyWYiK5ViS7ygnN/lhWB7ADUPyEgBISAEBACQsAhMHLkSJd3tfZ/8+uiHsH4r7R3pbBhQ+kDx1ne27xaQdh15qv8WBNdv/32m+HNhsctScJ5EYeJTFrYXVk3g5dYwGMVoouEvUmQESqr39ovBISAEBAC5UeASXk/acOghqggWbwQ8EQXeXogK6M0InY8qeA9vaNsT2Xq/vPPPx0RRTSJNyKkTjrpJCdnR//4zjCpt2LFCn9IiSURJ/58yAiiK7xB9uy2227+o1tCmkGoBPNYsaM8RNfVV19tV111Vao8ItHSc2axkzqYhMRj0EtLzZ492/r06ZM694wzziiRcyy1I8PK2LFjXZ4sv4voNn5PvDER/dFHH/mPxkQo55RmqA+MHj26tENW2cdvFvc9uZHSLZ20Yn9Q/i39eD6nE4dIOBI9hlWmT5yX635RJkZUF8RGNnl27jNIuzZt2mTE53+l/O9/rsqC/CUnMAZxSiRRunn9f7ZDZELmBqO02I68ZTqJTHJsXry9hYWrL7+sJYQsjpWQThgShkSY5cKC+Q4pj3uQezFokDuQXZCCGBKnRLzxe4XcI7KP3sA8SOD67XFdIjPK+y33Tz6IrqB0qR8zxRW7XLQbEjWYFkFEVy5QVRlCQAgIASFQbAh4omu77bZz701RE10+9zPqG9neL+J6jRJFdPFyxwUKegTG9cJUpN3e8wxvSl4EmGgheTPexjIhIASEgBAQAiCAx7/31lHUbzzvCU90EfFC9FCUVrdu3VRuI8Yd2fI0RdnGsur2nmxlHZdtf40aNQw5Nj/JnE50Qb7sscceJU6HqIKwSjcmcXHUykTi+GNvvvlm4yXJG9FORPQEDScwFA782NATEelEEOUEZdiCZaSvn3nmmc6Bym9/+umnXb4r/xlHK+QAvZWHSA9KN5J3ivxfTDBnMyIsiBjKFkGDbF4wWggPSQgAcM1kv//+u4siCjrHQQBtueWW7vDK9IkTc92vYNuJbIPc5D6bM2dOxggv+g3RUZakYS7K4npcccUVronctxC+NWvWDDbZRQ0ia+iNl+p+/fr5j6tEQRIpyIt/eqRimLimGlPKCrmPzz///NQR5DU47bTTUp8ru/Loo4+6qKzg+dy3kDvphownUWU77rijI5K9POF3331n5OD0JByyssFcfunlxOkzfaKfRM0S1ff555+v4iSQ6/5A2kN0YyK6/hdFSw457+CAxCjRjMy3lBURnOtro/KEgBAQAkJACMQVAZyYyFfLGPfjjz+OPKIr+O6UtPFOrIkuXlJ32mknN7jH84+XOi4QXqzFZHxJ0HZH9gOiixf9bC9JxYSL+ioEhIAQEAL/H4Ek5VT6/70qrjVPdGWTAMsXGuSyIpLIS8oR2UCEQ5yMiWDk0SprEMdM8iOn5S09RxSRKkFJMqK4iOYi4iqTZcr7FTyOsS4ydd4yRdLNmjXLyJ3kbcmSJUb+LyKhIBm8EY0TjPDy29OXSB726tXLiH7DII6QzA4SSESgcJy3svrBccGIwCOOOMJN3JMDCYWGN9980+UrgnTCaYvxPX+l5ftKz1MEccZYeIsttvDNSi0ZN5NvjYgYbxCGXD9vlekT5+a6X7496UsIunHjxrk++u9h8Bik65DORAavLKtsWen3VCbJvJ9//tmRvT4SifcU5P/Ij0Z0FwSWv7doJ9Kcwbxpvu35wtXXl74kHxd5irylf7f99ooskQNFjcRHxnIukXlEgmYziJ9gpJs/rn379rZs2TL3kShO5EWJ+oq7IVnYoEED955LjlHkl/l9CNP8ezV1JG3ipzK4+dyQ3qGF32tIbX43SGAvEwJCQAgIASEgBMpGACULFArIOYr8f9QRXUFFhaSNdxJFdDGJx+CUF/BiMvJLIGPEyxKTGXjqR/2lKSb81VchIASEQBwQ4BnhJ4iYMMcDXBYvBAqF6PKORh49coOWFUHijy2E5W233eZILgi7bEaUEXlgkcgmSgYvfyKqvPXu3dsuuugi/9EtiZgM5kpCmgLyhMl99kEs+ahKpAqP/28esGBuHeShmLDOZkTzcI63TDnAgjKDTELynYeUSj8XyTOiSTbeeGNfXIklE8xcV/7I7eQt0wQ/uZSCpFF5kisHpVRpC9EqpRFZvv5sy/SINY4Df6KHuI6Mj4lye/HFF53cnidefHnp/apMnygr1/2CFOXP52vy7fVL5Mshh2bMmJEinv0+ooIgDv25uSyLOpAq5HvgDYIVAjHdIGd55njjeiMrSbRhMDdely5dUhFi/li/zDWuvtzyLukXES3ekDHk+0eehdIMEg8ii0i3YPQLUqhExgQjCimHfGyQfxW1iy++uISUYhydDzL12UdX+Rxu+XjPZ/IJZxIsaRM/mTAuaxsOHURv8n0lstZHu/LbE3R4KKsc7RcCQkAICAEhUMwIeKcpxsHM4Uc9Zx8c2yZtvBNroouXVOQbGjZs6CRV8CbOh6RBoX05v/rqK5en7IADDnCTKbxM4i1JtJtMCAgBISAEhAAIMFH0+uuvOzCUxzGe94QnuojiDua0yXdvvJe9rxcZBojUOFh6XibaDJEFGUWUCRPYSEMygR0kXohMQa7Rmx97+s9+GZQIZRskA+MxCCdPrhCRQfQ9cm9M+Hvr0KGDXXfddf7jKkvkAZlk9EYusaCcGtEOXIeVK1e6Q4iCeeCBB9w6kSA4RZHjxhtReRBBRJFwbxExwcQyEn5479PnoOFQBvGVLq9IxBdyht4gEhmTlmbHHHOMPf/886lDiMhClq2yRv8gCdNzn5W3PIg2PCy9VaZPnJvrfiFzCQEK0UNetfScb769ECbIYhLFFrQgeZTLsqhj6dKlLkLR15eN6OK+ZILc3//++OCS9zlIYZ9TLriP9Vzjml5+WZ+HDRtm3NdB4/eB3w6+39w7kFr8NkJskdOLSQyitoi44/elb9++7h6HHCDnFlF3QUOWkyi3bBgEj01f5/vHPestU54vvy9OS8YsjF26devm5FHzkaLAO5CCU9Imfipz7UV0VQY1nSMEhIAQEAJCoCQCPudloRBdQTWMpI13Yk108UKBbrd/kWdyIR9JakvertF/4oUKDHiJxGMVr9ZsCcqjb61aIASEgBAQAlEgQB5H5Iww5XGM4gpUvU5PdJE/hJwxURlORc2aNUtVj6QXk5GFbEw2E4EFgRM0yBvaH4y2CO7360SeBPNtQWBBqgTJMI4lsmbAgAEZ8yf5snz0EEQSknleypAoMsiDTNJknEsOq2AuNGT5aDvydJBTSMcRjeANYgOZKW9EeRD5URnr3Lmziz7L5MFPpNrs2bNTxdJ/8kSVZqgPDBw4MHUI5Nlll11WgvhL7QysMPZn8pt7kO8BOZ28MUFNhFFFyS6+V8gmBq0yfeL8XPfLR09QNtiTLw05zGySYUSsQQp4Q74OSTvu71yWRfmQORC+3gYPHrxKvim/j5xwwYhIv50lue54JhE9mc1yjWu2erJt53udi5xcfN8hucGO97agpRPXwX1lrZO/irL5fmDIfvKbEHfz9zMkKvKoRBGlR8Hluo8iukoi6p1Dbr/9dhexjLTo4sWLXXRytmdVyRL0SQgIASEgBISAEOA9h5yXjNF4j4k6oktEV4HekyK6/ndhvGc1Ht54DOLNyQu7nxAr0MunZgkBISAEhEAeEQhOcoroyiPwOazKP9eJ7gjKaOWwinIVhVd9cJKWKCSikQrZmKRLlxokAgjZt0zkTXpfyDuF1FjQXnjhBdt6662Dm9z6PffcY0z6p+dOIp8Xk4ZB7Jg8ZxLd2xNPPOGk9vzn4JKImKZNm9p3330X3Jxxnegzcv2kE3HBxMMZT0zbSBQYkSKlRexBWEFEeCNKLJgPzG8PLpGNBE9yvQQNbPr372/16tUziD8c2CBqiGYj6op1HxnUtm1bp3UfPB/ykPqDUorB/ZnWIfG4LkGrTJ84P9f9om2vvPJKsGmGJyjOfUQSIT3JZDOYIItJRNBLL71U4ngkKsEzl2X5vkI2IieHgSF1ZDLkTpHkW7BgQYndEHBEhAYlP0sc8H8fco1rpjpK2wYZzT2NFGRVDQIasoBnsnc+gbgkwjFTTrny1peeV45oThwh42z8HkIAQpxzH7/zzjuO7AqzT0FHjqR5OFcGNy+H6+UwvdMU44D050tlytc5QkAICAEhIASKAQGf85KxHioaURNdvBfzfowlbbwT64guXjp22GEHl6iaSTtejpGI8NJM7ooVwb+ffvrJvcAyGUFEF1+YbJMvRQCHuigEhIAQEAIZEAhOchL5G4xOyXC4NhUgAp7oIqonPTIpn80lYgaSwRtkERO3hWxEoDGB6a1Hjx6GHFl5J+qYhEY+LWgQWsHItuA+CBwirMAKgguJQiYIIW+CRlQ+301ICqKaICqQUMxmYJ1OyqQfiyQhLy7+fknfT5QE9w8ECuPmdIM84fqSD4z8VmUZcodIFXoCCuKuQYMGZZ3mJq2ZnOdlL5MRNffbb79l2uW2gT3XIN2QMQR3JPP447ojBwce5O2aNWuWI1f8eSNGjDDuh6BVtk+UwWR8rvoFoY3HZWn55ILtTl/nfoMkJLIrl2X5eriPeFGmfcjnce9lMwha7nUmyCGBIezwbC0vGZNLXLO1saztyEgi38n3tjIGocX9B07ImR533HGOaCdvQzBaszJlT506tQTBzHsh2+JsyPGT44177N5773V5uH2ew7D6BbmOhC2WtImfymCGJCrkrJekFdFVGRR1jhAQAkJACBQ7Al4KmPc80g9FTXSh8oETC5a08U6iiC5eEHjxwNuzmIwk4UxEMCiH6CI/F96cVfEKLCb81FchIASEQDEgcNRRR6WkjMiFgsyRLF4IeOICxx4Sw0dl6bmimAhLj3aKqm3Z6sUxCgepTTbZxC655JJSI5SyldGzZ88SkULI9ZFbqKpGux577DFHdB166KGlFkfEEuPdTAQVY0C+50gHImdYHkOmC2UA2gDpV7NmTSepkZ6Hq6yykEkjb9y///1vNzFd1vF+P+N2IrAqKrPWuHFjGzVqVKlyd76O9KWfuPXbsxFzle0T5eayX0i2QW7yvauIQaqAEfeEt1yW5cuETFyxYkWJHHZ+X/qSdxYcEnHSg+AiL1VFLJe4VqTe4LGQdJCnRLIhFQoZC9aQicgwQhTzXeQ4vqcQJ5C5rNPnsJwCkC8k4vPHH39MNffWW2815FnjajznLrzwQsML+vb/kvcQ2BClYZrPfU0dSZv4qQxukFz8Zvp7iejtJUuW2If/ldKt6HOiMvXrHCEgBISAEBACSUCAsTwOi7Vq1XJjwqiJruHDh7tnO9gmbbyTKKILKR9yKJDfoJgsKOHIixX5uZDYwYNYJgSEgBAQAkIABJCNQvoLQ+J29913d+v6Fx8ECoXoImq8e/fubmIXSTI81Lp06VLQQCI59vbbbzsZrMqOj5jMR9KOiX0imIg0iMLIUUOeL8a7TDQS2dSpUyc76KCDysw1FkV7y6oTko0oU3I4MZGdyZDnQ36vRYsWBsnVunXrSk+yBqU6ICiWL18eCm657hey5LwgM8ZPl8UMYoacJvcCubp23XXX4K7Uei7LShWap5Vc45qnZuelGqT+ILp9JOTQoUON/FZxNSL+yGlBdCwSuZCkECxhGoRko0aNXBVJm/ipDG7pRBfOGDx7hE1l0NQ5QkAICAEhUKwIeClg3kPJ1Ro10YWiBSoFWNKe6bEmupAmQfoB+SVekMlRtXLlypTeebF8gXjZxYMWmRiILl5eSRKLR6FMCAgBISAEhAAIIM01Z84cB4bP2SJk4oWAJ7rIZ4N3e1SGRBl5m4j+QY6Michg1EhU7Sq2ehn/QXQlyaseeToiNoiWgdBgLLvNNtu4MW667GNlrzdEAO8NGJGtRLiGbbnsF+Qy8m3vvfeeiywizxUyKCS3Rg6wNOnL9H7msqz0svPxOZe45qO9+aiDewMpGoh5iK6K3A/5aF9F6vCJ25HdJKorH5FERA16Oc2kTfxUBHt/7Lhx44zJOSbDINDJbZkPwtHXH+clzzCiWHlWI8XLb3WSntdxvjZquxAQArlDAPlqxpP84UCGXLh+61bF1ytKoC7CWCNqomvkyJHOyZCWJm28kyiiCy9PJF0geYrNILrw2oTowtMa+cbyytYUG1bqrxAQAkKgGBEg3w4RvxgyaXXr1i1GGGLd50IhuiBK+/bt6wgIpLvIL0OEl0wIxAEBJmuJ7sPIkcSLnkwICIHCQwDZQuQLp0+fbkjs8I4PkUeEZ1gmoqsksj4vJBG3bdq0sXbt2uVFQrJkKwrnE9GSRP3hjY8sqXc6wPGAv6B0aJitZhIZ54/11lvPLVkPfvbbWTLpvOaaa7rvDZPQfH/47P/4HNye/jl4nF9nmX4cn/mTCYGkIUCABYQ1y+Af2yC0/X7WMx2Xfg6f049FpYvfF8ii9GWmbenHpH/2eXOjvhY429SpU8dJvfMei2xf8I/562IxHyHtHUWjJrqQN7/pppsc/CK6Cugu5EfERzKhr9+8eXPnNVNRDfsC6lKlm8KPB/kn+KEgPxfSL+jEy4SAEBACQkAIgMAJJ5zgcjiyHvXAijbIKo6AJ7qQbfPJYyteStXPYNLxzDPPdPmR3nrrLZcH6Nhjj616wSpBCISMAC/+5LVlkgEjSqRr164h16rihYAQqAwC55xzjt17771uzDJkyBCXpw4ygUn2sIwo5T333NMVn7SJn8pgdu211zp5YibDDj74YDvkkEOM5z4ET9KNuSbuN+aWmF9BAlmWGwQg1iDmmK+CiOMz5B1/5Av16/4ztfpt6fv9dr8sbb/f58vzn4Pn+n1sS9/vj/PL4H7OC3725+eiPMrgfiRyJrjut7Hd//ltfhnX4xmnMWbzfxBBED4sC4XEcRdD/6qEANGuKJU0bNjQ/e22226hyIlXqZE5OtlHSKNWQcqlqOdjRo8ebTfeeKPrXdLGO7GO6OLHvHbt2inZkb333tv9+C1atChHt2J8iuGlHU1+iC60+5HyIDxeJgSEgBAQAkIABE4++WQ3oGKdPB48N2TxQsATXeSHuu222yJr/JQpU4xJRyYDmQBC4xtpTJkQiBqBl19+2X03PvroI5eb6IgjjijRpPnz55eQ2Zw1a5YjbEscpA9CQAgUBAL9+vWzRx55xObOnWunn3668Y5PjkImxcOyH374wUmlUn7SJn4qg1k60dW2bVs3zwABlET76quvXBoIlA9mz55dri4yB0PeW+al8NTP9EdkFcRHJiOygwl8ZA5RJ/rll1/cknW/Lbjd7/fLbMdBCMiEgBCIPwI4dzC3W7169axLL49a2jHsK8/+TMfw3IXI5S9o/H7x3CTKlYholjiMBNe/+OILpzjmncyC52dab9mypR144IHWqlUr97ua6Zg4bvPP04022shhFjXRhSLLhAkTHJRJG++I6IrjNyRDm2G+0frkS5MPWYcMTdAmISAEhIAQKGAE/IQRTdTkbgFfqFKa5okuBv+33nprKUeGuwuSbdiwYYZk9Lx589z68f+VxpQJgSgRYIJyv/32c5OEtINJRV7giEDwdsUVVxgvmhgTj0uXLl3lpd0fq6UQEALRIsBzBcllnDhx1lmwYIGTHWUSLiwjtxm5+7CkTfxUBrPrrrvORb7i9Q3JlUSiC6IIQpVx1ZtvvpkVJiLayN/GvAt/zLskwZiohhTL9EfkjN/PerZj2M5x2Y5hvy+L44g2YsnEd/CP4/jsy+OY9L9s+5JwLZLUBy9vWdklxApSmP58CBYvj+nXWbLfH+OX6ef67RVZVuTYYDv9eWzLRm4n6TpXtC+QYvzOEhnMEiWy0hTZyD97yimnWMeOHV3e3orWV0jHe6Jrgw02cDK3URNdY8aMsfHjxzuIkjbeiTXRxRVh0gcPmpkzZ1rTpk3dg5FBcLHZHnvs4cK/iejix4JE3jIhIASEgBAQAh6BAQMG2EMPPeQ+Pvnkk7bTTjv5XVrGBAFPdJFjiMTwURnkAV5gtIN7iTwqffr0iao5qlcIOAQg8E888cQSaDDhwAQt5DAv1OTkghDD8BQl/49MCAiBwkTgqKOOMqIwly9fbj179rRXXnnFTY7huR6WrVy50pEYlJ+0iZ/KYHb99dfbZZddZjfccINzGoDsIZqLyLq4G88CJBnJP5bJjj76aNtnn32sWbNmzqE40zHaVtgIBOX8aCmfvaSf3xdchr2PNqTXARlS1h+EjidNgsf67X4b5bOevt2fm2m7PzfTkuN9mcH9bqP+CYEcIcB3gty5qDIwl+/nK9KL79Kli51xxhkuR3T6vjh89o4j66+/vjHWiJro4tnOMx5L2ngn9kRX7f+GiNerV8954TRp0sQ9vBgEF5uhaYrnAkRXUgafxXYN1V8hIASEQJgIMDB84IEHXBVPPfWUSwwbZn0qO/cIeKKLhPDZJmZyX+uqJV511VVGQl2863gZGTp06CoEw6pnaYsQCBcBvEOJNuCFOWh41TJZycsznvvehg8f7ibP/WcthYAQKCwEDjvsMHvttdecA2e3bt3ykof6p59+cnMLIJG0iZ/KXF28vfH6xsGlXbt2xvgDh1rSJMTVPv/8cyM3CTne0438o9x322+/ffoufRYCQkAICIE8IcCYHiKISFsirYNGZC3RUdtss01wc8Gve8cRFCUYa0RNdAVVLpI23kkU0dW4cWPnwQATXGzmo9kguj799NNSw+6LDRv1VwgIASEgBMx8UnewePrpp22HHXYQLDFDwBNdeFTjhRyVXXLJJc67m4nHqVOn2vnnn28nnXRSVM1RvUIghYCXBUltyLKCFMqcOXNcroIsh2izEBACESNA1DCTL3h6B6O71l133dBaBhlet25dV37SJn4qA5qP4Ibwat++fayJLvLGnHfeeUb+raAxpurdu7dTB/KRL8H9WhcCQkAICIHoECCqe/LkyTZp0qQSjeBZzTZS+MTBvOMIYxjGGiK6wrtqsSe6/v3vf9uuu+5qjz76qDVq1Mjptr700kvhIVagJTdv3twlK0XvkwSAr7/+eoG2VM0SAkJACAiBKBA499xz7Z577nFVk/NC3qpRXIWq1VkoRNfFF19sEydOtF69ernl4MGDrW/fvlXrnM4WAjlCAAILb/3Scq0g18HEuUwICIHCRYCE9HhyL1myxLp3724vvPCCS2iP7E9Y9ssvv7i5BcoX0WXOqQXnFjzRDz30UCdZ7MnHsK5BrsslNxSe68jYBu20005zBFfNmjWDm7UuBISAEBACBYgA+flQpxk4cGCJ1nXu3NlJ6qNwVsiGBDDP0xo1arh8wlETXWPHjrVx48Y5yJI23kkU0eXl+9DyLjbbd999DS8lIrpghxcvXlxsEKi/QkAICAEhUAoCeLHiDYU9++yzhqOILF4IeKILebb0CZt89mTIkCE2ZcoU69+/v5v8gkRlXSYECgUBXoYhs5D4JP9G0HAO47fQ554I7tO6EBAChYNAUK2FfEnz5s2zpUuXGo6dYdmvv/5qu+yyiys+aRM/lcGMsQaOA+QW6dChg8t3+PHHH7tcaZUpL9/nPPfccy43Y7BeotCPP/54W2uttYKbtS4EhIAQEAIxQWD27Nmr5IfGCbN169YF2wP/PF1nnXVckErURJdPRQBgSRvvxJ7owiN95513diHoaHVWr17dXnzxxYK9ucNqGF9o9KYhuni5X7hwYVhVqVwhIASEgBCIIQIXXHCB3Xnnna7lvPh70iSGXSnaJvtrFjXRRQ6L6dOnOzlMvKSRxcQzWiYECg0BJsaHDRuWmpTlvWHatGlWq1atQmuq2iMEhEAaArvvvrtttNFGNnfuXDv22GPdkpxdbAvLfvvtNze3QPlJm/ipDGbIJI8aNcrlQyF31QEHHBCLNAk//vijI7OCcyKQWzh9MV8kEwJCQAgIgfgjcMcdd9iFF16Y6gjj/JkzZ1qYEsepyiq44p+nPIN+//13e+KJJ1KONRUsKieHE81FVBeWtPFO7IkucozsuOOOTt9yzz33NNhRZA2KzXxiWDzcCNksxqi2Yrvm6q8QEAJCoCIIeLk5zmHSaLvttqvI6To2YgSISqldu7ZrxSGHHOLkhKJqUr9+/eyRRx4xyNMRI0bY2WefbQMGDIiqOapXCJSKwN9//21PPvmkkwlhvFyIL7+ldkA7hUCRIoAz67bbbmt4bh933HGGkw6qJRtvvHFoiCBzx9wClrSJn8qARlTsyJEj7ZprrrGOHTs6b3mca994443KFJeXc5gHCUrTrrfeeu4ZsNVWW+WlflUiBISAEBAC+UMARTMcMd59991UpThkovhWSOafp0QTM9aImujiuX7llVc6iJI23kkU0bXHHnu4l1e8N4vNmPR66623nJQDL/DFiEGxXXP1VwgIASFQEQSYqGCAhT3//PNu8qgi5+vYaBEIEl3t2rUzEsRHZX369HETj8gZ4R1NhNcZZ5wRVXNUrxAQAkJACCQQASSWSTaPY0XPnj2d7PKiRYtCTTyPMkqdOnUcmkmb+KnMLeIn5jzRtf/++9uXX35py5cvr0xxoZ7DOIlJu2uvvTZVD2NfSFKZEBACQkAIJBuBdDnDQnPE9M9TAlMYa0RNdPGsRJkFS9p4J1FEV4MGDYzktEzgFZvBYCPlAMm12WabuReBYsNA/RUCQkAICIHsCEBK+LxORD5vvfXW2Q/WnoJDIEh0tW/f3saPHx9ZG72EFNrekFynn366nXXWWZG1RxULASEgBIRAshDwhBOpCUg+ny+i66+//jIUY7CkTfxU5g655ZZbXOQ2EkeHH364FSrRxXXr2rVrifQNUi+ozBXXOUJACAiB+CLw3XffGUpv3nhm3XbbbQWRl/fWW2+14cOH25prrmk8s6Imusi9efnllzuokjbeiT3RhccVg1Fukvr167scVQxqis2OOOIIw8ONLw3SRk899VSxQaD+CgEhIASEQCkIXHbZZXb99de7I8hlKQmXUsAqwF1BouvQQw9NXcsomspk0ksvveSiyvr27evyc5GnSyYEhIAQEAJCIBcIIEVENFezZs3snnvusV69etnTTz9tCxYsCDXH3n/+8x8jxweWtImfylwXPzF39dVXG/MNrVq1sq+//tpef/31yhQXyjmQok2aNDEmOLF9993XTWziNS8TAkJACAiB4kKA53iPHj1SATDwBA8++KCtscYakQIB4UbeYNpBG6MmunCaHTNmjMMkaeOdRBFdu+22m5MymDNnTqQ3cBSVd+nSxV5++WVX9a677upylkXRDtUpBISAEBAChYkAci5Iz2DkL9hyyy0Ls6FqVUYEgkRXhw4dDC+sqIw8HeRJuf32212y91NPPdUGDhwYVXNUrxAQAkJACCQMgR9++MFQa2nZsqVNmjTJevfu7Rw5X3nlFadeElZ3g8/apE38VAYzPzFHBPeRRx5p++23n3377be2bNmyyhSX83O4XkT9eZKL6HKizGVCQAgIASFQ3AhceOGFdscddzgQDjjgAOcAESUiEydONHKmr7766kb+4KiJLtIgXHrppQ6SpI13Yk90kSwW/e5Zs2ZZvXr1nIfXs88+G+X9G0nd3bt3N6SoMAg/tMxlQkAICAEhIAQ8AnjjMlGBEY2zxRZb+F1axgCB4OQbcsXBHBT5bn7btm3tnXfecUQXMob9+vWzQYMG5bsZqk8ICAEhIAQSigBRQ40aNbLWrVsbk0M+NySOnZtvvnmovf7Xv/7lyk/axE9lQPMTc2PHjrVOnTq5aKnvv//eli5dWpnicn4OXvveyZkJO+ZEZEJACAgBISAEQOD88893zjKs867KO2tUhoPoRRddlKo+aqKLlBaktsCSNt6JPdG10047GYPRJ5980skbMPB95plnUjdPsayQZPW5555z3UWTlNBMmRAQAkJACAgBj0Aw4Wg+Jop8vVrmBoEg0UVElY/Oy03pFSvF5+i46aab7JhjjjHkCwcPHlyxQnS0EBACQkAICIEsCHz22We2995728EHH2w8a0488UTn2JqPiHRPdH344Ye22mqrZWlhcWz2E3OoAnTu3NlF2K1YscKWLFkSOQA333yzjRw50rWDyUOi/mRCQAgIASEgBDwCvD8ju/vqq6+6TVOnTnVjC78/n8s777zTLrjgglSVURNdjK1GjRrl2iOiK3VZCmNFRNf/roPXLedT48aN7b777iuMC6RWCAEhIASEQEEgENRhDjvHRUF0OGGNKCSiq3nz5vbrr7+6PGF4T5988sl23nnnJQxxdUcICAEhIASiQuCjjz5ypEr79u2N8ctJJ53kZH7ykWPUE10ffPBBQSSwj+oaUC+yT8g/XXHFFUaqhH322cdWrlxpr732WpTNcvLJOP1gUectjRQIVS4EhIAQEAKlIvDHH38YSnDe8jGO8HUFl4VGdAWdRUR0Ba9UAazvvPPOtu2229rs2bNtl112sa233trpdxdA0/LaBO/lRqU+aW9eG6DKhIAQEAJCoKARCHrtLFy40DbddNOCbq8aVxKBINF1+OGH27hx40oekMdPyEmRSJc2HHXUUc7TfujQoXlsgaoSAkJACAiBJCPw/vvvG9HDPoI5CqLrvffeszXXXDPJMJfZNz8xd/nll1vXrl2tRYsW9vPPPzuiqcyTQzrgl19+MXKSY0TcEXknEwJCQAgIASGQDYEvv/zSmjRpktodxfP9rrvusuD7MumX4DOisltuucVGjBjhqhfRFdVVyFJvkNwKkl5ZDk/sZmSDHn30Udc/n7Q3sZ1Vx4SAEBACQqDCCAQHM4sWLbJNNtmkwmXohOgQIGktOUkxJBjIuRaV1a9f3zbccENj4ktEV1RXQfUKASEgBJKLAHkgDzzwQDvyyCNdflEihx9//HGXkxrH1jDNR3RFMREWZr8qU3Y60eUjur0MVGXKrOo5/vpQjq5RVdHU+UJACAiB4kDg+eefd5L79LZbt242ZsyYvHZ80qRJLmeYrzRqouvWW2+14cOHu+aI6PJXpUCWQaIrKGNYIM3LWzNOO+00mzFjhqsP7zf0tGVCQAgIASEgBDwCPs8Cn5mgqFmzpt+lZQwQCBJdfuIvqmb7sdcll1zipIz69OnjpI2iao/qFQJCQAgIgWQh8Oabb7r8XMjlIZt3yimn2GOPPWbz5s2zbbbZJtTOeiLl3XfftWrVqoVaV6EX7j3QL7vsMufYQt6033//3XCYisJGjx5tN954o6t6zpw5Vrt27SiaoTqFgBAQAkIghggMGTLEpkyZ4lqe73xdkydPLiH1HzXRddttt9mwYcMcFiK6CuxmJmx9yy23tKefftrpbuLtzA1TbHbmmWfa9OnTXbfbtGlj6G3KhIAQEAJCQAh4BPxkBZ/JrbDRRhv5XVrGAIEg0dWpUycbO3ZsZK3efvvtndQCXmAkpycBPIngZUJACAgBISAEcoHA8uXL7ZBDDnHkCiRLv3797JFHHrG5c+fadtttl4sqspbhiS6iytZaa62sxxXDDu+Bjuc7HvCkSPjzzz8NCex826effmpElGHnnHOO4egrEwJCQAgIASFQXgR4ftWpUyd1OGONddddN/U5zJW7777bBg8enKoiaqJr4sSJdvHFF7v2iOhKXZbCWKlbt65tvvnm9swzz9gOO+zgyC5kDYrNBg4caNOmTXPdbteunU2YMKHYIFB/hYAQEAJCoBQE8F7CiwlbsmSJk54r5XDtKjAEgkQX5NKVV14ZSQv/+usvN97ac889nc44pFuvXr1SA+VIGqVKhYAQEAJCIFEILFu2zNq3b2/du3e3Sy+91Pr3728zZ8605557zjwRFVaHfflvv/22Va9ePaxqYlGu90DnGnAtmjZtav/5z39swYIFeW+/vy5UnLRJubyDqQqFgBAQAkWKAPMgHTp0cL1Hgh9nmnwYEWSDBg1KVSWiKwVFzldW+29y839yXmoeCxTR9T+wgyGYPmlvHi+DqhICQkAICIECRwBnCJwisKVLl9oGG2xQ4C1W84IIBIkuL+UU3J+vdZ8EnskuvNLIF9azZ8+Uxne+2qF6hIAQEAJCILkI+ImoY445xpCrO/XUU+3hhx+2fMjVeULlrbfesrXXXju5IJejZ95JCqnio48+2po0aWJMH73yyivlODt3h9x00002atQoV+DixYtt4403zl3hKkkICAEhIASKCoFgoAhONLvvvnvo/b/nnnvs3HPPTdUTNdEVTGuRNOeRRBFdXkoH/e5iswsuuMBIFotFnbuj2LBXf4WAEBACcUDgvvvus7PPPts1FU/p9ddfPw7NVhv/D4FCIbp++OEHa9CggbVs2dLdT4cffrj16NHDRowYoWslBISAEBACQiAnCEBm4Lx53HHH2ciRI51MHfmon332WSNVQZjmiS7yhK2zzjphVlXwZXupJchGSMfGjRvbaqutZi+//HLe2h6UmpJUct5gV0VCQAgIgcQisGLFCqtfv77rH3LIRIvzbAvTgk7H1BM10XXHHXekcmyL6Arzylei7Hr16lmtWrVSg15ydj366KOVKCnep5BEjmRyWNeuXe3yyy+Pd4fUeiEgBISAEMgpAg8++KCdfvrprsx86lHntBNFXFiQ6IryOf/VV1+5ia7WrVvbgAEDTERXEd+U6roQEAJCICQEXn311RLPF543Dz30kEtXgHNrmOaJrjfeeMNq1KgRZlUFX7aXWiKa6thjj7VGjRrZGmusYS+99FLe2n788ce7606FSZuMyxuIqkgICAEhIARKIHDzzTc7Rxo2jh8/3skllzggxx/uvfdel1/SFxs10UWgDAEzWNKerbGP6AoSXQxKCTkk9LDYjMEnIf2Yl3goNgzUXyEgBISAEMiOAJ7QPnG3iK7sOBXqnkIhunwy+LZt21rfvn1LeNwXKnZqlxAQAkJACMQLgUIgujRWMvNSS0TVEV3XsGFDq1atms2fPz8vN9TPP/9spKrArr32WjvssMPyUq8qEQJCQAgIgWQj8Ntvv9nOO+/sOokc7sKFC50jR1i9DqrrUMeTTz5pO+20U1jVlVmuiK4yIYrugN1228022WQTF9FVu3ZtF36IfnexGQn0rr/+etdt5cootquv/goBISAEykaAaGeICUxeymXjVWhHBImufCbOTcfh/ffft/33399NNp1wwgluiZe3z52Rfrw+CwEhIASEgBCoKALpRBcR6USmP/3007bDDjtUtLgKHe8jukR0mXmpJeSJkSnea6+9rHr16vbiiy9WCNPKHqxorsoip/OEgBAQAkKgLASYQ2cuHbvmmmucA2dZ51R2//33329nnXVW6vSoia677rrLhg4d6tqjiK7UZSmMFSK4YF+9Xjd5I/BaLzYbO3asjRs3znWbiScfglhsOKi/QkAICAEhkBmBJ554wk466SS3U3knMmNUyFuDRFe3bt1szJgxkTT3rbfesjZt2ljnzp0Nx5oOHTookjySK6FKhYAQEALJRSCd6DrjjDPsgQcesKeeesrq1KkTasc90fX666/beuutF2pdhV54lETXX3/9lSI1r7rqKpeHvNDxUvuEgBAQAkIgPgh8//33tscee7gG77LLLvb444+Hlqtr+vTpduaZZ6bAiZromjRpkp1//vmuPSK6UpelMFY80fXMM88Yet3cpOh3F5sRyn/FFVe4buOxP3jw4GKDQP0VAkJACAiBUhCYPXu29enTxx0BWbH22muXcrR2FRoCQaKre/fudumll0bSxGXLljkNc9qAVPKhhx5qRx99tF1yySWRtEeVCgEhIASEQPIQWLx4cQlpXCaHmCRiLLPjjjuG2mFPdPG8W3/99UOtq9AL9zlFhg8f7pxb9txzT1tnnXXshRdeCL3pwfwpSZuECx08VSAEhIAQEALlQsA70nAwcr3NmjUr13kVPSiYL51zoya6Jk+ebOedd57rRtKesbHP0VW/fn3bcMMNXYJSZAwYfHEDFZuRPM97d5OD5Zxzzik2CNRfISAEhIAQKAUBIp+JwMHeeecdW2uttUo5WrsKDYEg0RUlsRT0skdCsX379hYl8VZo10ntEQJCQAgIgaojsGTJkhIRw1EQXUuXLrUNNtig6p2JcQk+p8iwYcMMGUGcitddd12bN29e6L3yhGPHjh2dpFToFaoCISAEhIAQKDoE5syZ46R56Th5IAkiCcMIyBkwYECq6KiJrilTptiQIUNce0R0pS5LYawgVYinFRFdyBigG42sQbFZ0OMJ3U90zGVCQAgIASEgBDwCzz33nEskzud3333XJRP3+7QsfASCRBeRVKNHj46k0S+99JJ17drVkEk+8sgjrV27dhallGIkIKhSISAEhIAQCBUBZAODzxfeb8lvkY+JIU+wQLbhUFvM5nOKXHzxxdarVy+XDx1M5s6dGyosK1ascHVRCdF9pKqQCQEhIASEgBDINQLI5OLEsXLlSucIvGjRolCiuQuN6Lr77rtTSnAiunJ9V1WxPO9VBNGFjEHDhg2drEEVi43d6RMnTjQGoNi5555r/fv3d+v6JwSEgBAQAkIABJCZIfIGe++992zNNdd06/oXDwSCRNexxx5ro0aNiqThzz//vJMsRCYZr7dDDjnEiOzyiXwjaZQqFQJCQAgIgUQh8MYbb1jbtm2dY8Xll19uZ599thFdNGvWLNt5551D7asnul577TXbaKONQq2r0Av3OUUuuugi6927t/m0EThPhWmMKa6//npXRdIm4MLETWULASEgBIRAxRFAFW3GjBnuxLFjx1qnTp0qXkgZZ1A+9XjLh+OOryvTcurUqTZo0CC3K2nP2dhLF3qii8S0DHobN27sBsGZLmSSt9111102dOhQ10USyp100klJ7q76JgSEgBAQAhVEYP78+Y6Q4DQRXRUErwAODxJdxx13nI0cOTKSVuFYhHwR0guQXCK6IrkMqlQICAEhkGgEyCXapk0b69y5s1155ZVOlp98UU888YSRMD5M80QXUr01a9YMs6qCLxulHPKXXHjhhS7P62677WabbLKJIfUUpvlrwGQjk44yISAEhIAQEAJhIeCfdZR/8MEH20033ZTzqmbOnFkiIEVEV84hThUYe6LLJ0SF6GLQ26RJE2MQXGwWZGO9tECxYaD+CgEhIASEQHYEFixYkPJOev/9922NNdbIfrD2FBwCQaKrR48eNmLEiEjayCQjzjTkAj3wwANLeNxH0iBVKgSEgBAQAolDAInlAw44wI444gi7+uqrIyG6kC+C1ClmI/c5KREuuOACJ1lcr149q1WrlpH3NUzzRBfONdtvv32YValsISAEhIAQKHIEvvvuO6cOx/s2eSiJ6K5WrVpOUXnkkUesX79+qTJnz57tVOlSG/K8cs899zg1OKpVRFeewS+rOnJyVa9e3SC6dt11V2vatKlNmzatrNMSt98niqVjeHnj7S0TAkJACAgBIeARwDP58MMPdx8/+OADW3311f0uLWOAQKEQXX6QPnjwYGvVqpWIrhjcO2qiEBACQiBuCOCQs//++1vHjh3tmmuusYEDB7p3/Mcff9y984fZH0+yiOgy8zlFUI458cQTrW7durb55pu7/OhhXQMfzUf5SZt8CwszlSsEhIAQEAJVQwBJfgguDBKoWbNmVSsw7exHH33UkP73FjXRBW/C2ApL2rM29hFdnujiJmHgxc3ITVls5geh9HvMmDEuMXyxYaD+CgEhIASEQHYESKreoUMHd0DSBjPZe52cPf/5z39SXs09e/a04cOHR9K5oHd3ixYtRHRFchVUqRAQAkIg2QgwTtl3333t0EMPdbmaoiC6Fi5caJtuummygS6jd36OIZ9EF/nG/XyOxqtlXCDtFgJCQAgIgZwgQD7Q6667zpVFLi3US3JpOOqcfPLJqSJFdKWgyPlKYogu9C0Jpd97770NGb9iM+9hTb/DSp5XbJiqv0JACAiBJCGwfPlyl0+JPmniIH5XNkh0kSNr2LBhkXQCeWgG/hBtyEW3bdvWunbtarwcyISAEBACQkAI5AKBTz/91Jo3b+7GLTfccEMkEV1IPiPTV8w2Y8YMY8LP5wBHQWfLLbe0p59+OjRYfESdxhahQayCCxiBn3/+2dZcc02nWlXAzVTThEDiEHjhhRese/furl8NGza06dOn57SPXv7fFxo10eXf6WlP0uaGYk90cQOinQnRRXJUBsR33323v+S2GWIAAEAASURBVHeKZhn80iDvgMyDTAgIASEgBISAR+DNN990yVX5nLTBjO9jkpdBoqtXr15GPs4obMqUKTZkyBC75JJLjKh6EvZ26dLFrrjiiiiaozqFgBAQAkIggQh8/vnnTqmlTZs2dvPNN7s8EkT5PPbYY07FJcwue6LllVdesc022yzMqgq+7IcffthOPfVUO++885wn+s4772zbbrutMUEXlnn8IdkaNGgQVjUqVwgUFAIobxC5inRnnTp17KqrrnLzm6uttlpO2/nxxx+7+VIk7JnU33rrrXNavgoTAnFF4LfffrPdd9/d/vjjD8cxLFu2zNZee+2cdSc4Z0+hURNdwfRHSZsbSgzRNWvWLHdTIqPDJEyxGV5VTHxhEyZMsHbt2hUbBOqvEBACQkAIlIKAT+zOIUkbzJTS7cTsChJdvXv3tosuuiiSvt15550uKT0RXPXr1xfRFclVUKVCQAgIgWQj8PXXX1ujRo3sgAMOsNtuu80GDRrkVFvIcYGKS5jmiZaXX37Z5aMKs65CL3vmzJnWv39/5+Byyimn2E477WTgg5NxGMZEI2QaRp62NdZYI4xqVKYQKDgEOnXqZESRBq1GjRpOPQEZ16222sp9/3bYYYfgIRVa/+yzz2yfffYx3ikwJvFRiTjuuONsm222qVBZOlgIJBGBzp07G04uGBFPqJfkyuAsyHXpLWqi6/7777ezzjrLNSdpc0OxJ7oYADMAgh3F46dly5Y2adIkf+8UzfK5555zDyg6fMstt9hBBx1UNH1XR4WAEBACQqBsBHxid45M2mCm7N7H/4gg0dWnTx+78MILI+nUrbfe6mQLr776akPCSBFdkVwGVSoEhIAQSDQC3377rYsabtWqld1xxx2REF0vvfSSbbHFFonGuazOQSz27dvX4d+vXz/bcccd7d///rcxYReGzZ8/34466ihXtMaqYSCsMsNE4L333jNy2fL7RTTIV199Zb///ru1b9/ekcXrrrtu1ur32GMP+/7777Pu9zu23357J+mKdDgOZxWx22+/PaujHGN65lIh1Zjcr169ekWKLvexf//9t4HTokWL7J133jEcMX/99VeXgoa6wYFoM5kQiAKBMWPG2Pjx413VXrI3V+2A2OId3lvURBfSjGeeeaZrTtKet7Enuho3bmyE80J08aPIj+Ndd93l752iWb744ovWrVs3119eBngpkAkBISAEhIAQ8Ah89NFH7gWGz0kbzPg+JnkZJLpOOOEEF1UVRX9vvPFGGz16tEvWy4SXiK4oroLqFAJCQAgkG4EVK1a4SVyiDyZPnmyDBw92clvkpSZdQZjmI7p4vyaKopgNqUgiuc4991wX2YWkGhElzL2EYRdccIEROY5prBoGwioz1whAZPE9QVUKcjybnXTSSS7XXab9//zzj4tUJT9XRYwoLKKxmAfcaKONyjyVFC/8lpZlkFxNmzZ1742QX5BgVTEidIkcef31140+ErmZzTbddFPr2bOn+91Za621sh2m7UIgFASIVuY9GyMdEGmBcmVPPfWUocrijc88U6OyBx54wM444wxXfdKet7EnuvA24MHAYGvPPfe0/fbbLzU4iuqGiaJewisJs8R4yCLhKBMCQkAICAEh4BHwid35nLTBjO9jkpdBogvZg6FDh0bS3euuu86QLYTwql27toiuSK6CKhUCQkAIJBsBJkPr1q3r8nSRm0tEVzTX+/HHH3e5ucgdRK4uSC6cXNgehjVr1szIz7b33ns7qcow6lCZQiAXCBCtxViYPDc//PBDmUVuvvnmhhxqJvvrr79s//33N5wSg0ZkE079XmowuC+4vs4669gRRxxhp512WqnkPBFjyMEScVYRI4qMSBTmGyuas2jhwoUGyffNN99UpErbZZddzKtHVOhEHSwEqoAA92nDhg1dCTzriLrKlQXTDVFm1EQX0aenn366617S5oYSQ3Qx2CIpOpFMRDQVm7366qt2+OGHu25PmzbNeWAUGwbqrxAQAkJACGRH4Isvvkg9G5I2mMne6+TsKRSii5dOEmQjYYgnqSK6knOPqSdCQAgIgUJBwOdqQr2FieQoiK4XXnjBtt5660KBJJJ24EzMJPU555zjJtGZ8CaHFhEsYZiPphsyZIiL6AijDpUpBKqCwMqVK+2GG25w42Ak98pr2WTH//zzTxflQSoSjDm9Aw880EV68H0jTQsE2IcffmhEmRKFQYRUJqtZs6aNGzfOqVxl2s82ziWqZMmSJdkOybqd8okgI+Jqk002yXqc30Ed3bt3t59++slvqtCyWrVqLpqU3yCZEMgXAjhakM+O795bb71l3Ie5sGeeecaO/29OPG9RE10PPfSQDRgwwDUnaXNDsSe6CKll8geiC+YVTwi0Z4vNCANu166d6zbMLNFtMiEgBISAEBACHgGf2J3PSRvM+D4meRkkukqTPwkbgyuuuMKuvfZa51RE7hIRXWEjrvKFgBAQAsWHABEORA/xTsu7LcQHqiUzZ8603XffPVRAPNkyb94859ARamUFXng60UV+LmTMyN0VhnnsmYAjLYVMCBQKAvwmTZw40Ul3Z4rgWnPNNV3+OnIiByOw2E60Fbl1N9hgg1W6c9ttt9mwYcNS23v06GEjRoxIfU5foR2QYji3I7PG56AxOY/yQqdOnYKbS6yfffbZzoHAb2Q8f9lll9l3333nyDQm5IlYy2Y1atRw0WykjclmH3/8sXXo0CFr3jF+28n/R9QM5CF5u5BWzBT1JuI7G8raHgYCvGd7ed5c5tF69tlnHUns2yyiyyOR+2XsiS7C2/GCgOhq1KiRtW7d2j2Acg9VYZcI09ymTRvXyHxolxc2GmqdEBACQkAIpCPAy4t3ghDRlY5O4X8OEl0nn3yynXfeeZE0+tJLL7UJEya4nCno6IvoiuQyqFIhIASEQKIRIDUB8riQWpBbURBdzz//vG277baJxrmszs2aNcuQS2ZiHM9vrkm9evWM+YYwzBNdy5Yts/XXXz+MKlSmEKgwAsi/E5H1xhtvrHIu849HHXWUi6KCACLK680337Qvv/zSRYRCDq+33nqrnOc33HzzzTZy5Ej/0ZHrkOzlMd7nkBSfPn16CcILucMrr7wyK9nFdxky2Rv1E6nljd/fxYsXO9k2JvrpT7pB4KHyAJmVycArm+wbEWGQe7Qz3fi9JydgMF8ZxyETyTuHTAiEjQDKJdzbGN9PP89e1XrnzJljENneoia6ZsyY4SK1aU/S5oZiT3QRVugTQJKvizBf5HSKzfAcIZoNg31G01YmBISAEBACQsAj4BO78zlpgxnfxyQvg0QXieGZ9IvCeBlm0E/OFBJfi+iK4iqoTiEgBIRA8hEI5oPCuWPy5Mn28MMPW/369UPtvCdb5s6da9ttt12odRV64USMnHDCCXbWWWe5XB5g48nHMNrusdc4NQx0VWZlEHjttdccyZUuF4jz4PDhw6v8e0TaFaK9vK211lr2zjvv+I/lWpIHC6IqSA4ReZktlx7E3Pz581Nls77lllumPqevkNOLY4j6QkLRGznEwCBIkrEvPReRPx65Q0gDzqGf2Yy5zWOOOcbJx/ljIL4h2P1vhN+upRDINQJ8b3AqxfhuQtrmwojEDH5Xoia6GE+RexNL2jM3MUQX4fPIGB500EF2yy235OI+jFUZ6Pa2bNnStZlQY/R8ZUJACAgBISAEPAI+sTufkzaY8X1M8jJIdCH1Qb6SKOziiy92kfP333+/81AV0RXFVVCdQkAICIHkI0AuKCKqiAqIgujC+7r2fyOYitnAnkm+M88800V0EZ3SoEEDwxM816Zxaq4RVXlVRQAH8tNPP91FafmyiC7q37+/I3+RCayqETkKqeMNecOlS5f6j+VeEtXF9zRo2SIjIelQ+sD4jaUN5TECDEaPHr1Kqpig1Ogff/zhgg+C75pEul1wwQXWtWtXIxKsPAbZhfyibyfnoOaFo51MCISJQDCIhIjmoUOH5qS69O961EQX0ZP8lmHB72tOOhtxIYkhumD3+eHDQwBP42Kzzz//3PWffktmodiuvvorBISAECgbAZ/YnSOTNpgpu/fxPyJIdPXr188GDRoUSacY7N91111O8mTttddWRFckV0GVCgEhIASSjwASebVq1TLyWkRBdFEvxE4xGxNxvXv3tjPOOMMRXTjTkjsrKHuWK3yQh2vevLkrTuPUXKGqciqLAJFWOHf9/fffqSIY9yJpdsghh6S2VXUFiUOUqbxttdVWLk8WZBcRVMzzHXbYYY5wXnfddf1hJZbffPON8W7w0ksvpbYTMUV6E6KugsaxDRs2TG3q0qWLkX+3vLZ8+XI7/vjjnTSjPweiDgIMI49vsDxILvIrevl8f055lkFpNX+8HBA8ElqGhYDPEUr5fPe4p3NhSJIeffTRqaKIfCRyPSqDQ+F3A0vaMzf2RBeDIXRwuUjIGOJZfNNNN0V1r0RWb/CBxQOOhJIyISAEhIAQEAIeAfJZ1qlTx31M2mDG9zHJyyDRhfcV+vVRGJFkJItm3IUna9u2bZ2HJomvZUJACAgBISAEcoUAhAoTu0wORUF0SSXFDAyY1CanD5EtTMoxYf3ggw/m6jKnynn11Vft8MMPd581Tk3BopUIEEC6DJlwclV5Q3Zv4sSJLqLRb8vFMjiPR3k77riji2Ldb7/9SsgE1qxZ08mp8bvIRDx/X3zxhRG1hcrCL7/8UqI5nTt3dnm6Smz874d0+TRy73bv3j39MOO945NPPrEPPvjA/ZGf7OWXX3br6QfjfMeEOfOy/D6w9Ea+oyOPPNJ/rPASUhFyzdu4ceNSvxN+m5ZCINcINGrUyJArzWUU4QsvvFDiuxY10YUqHioxWNKeuYkhugi7g/RiwoVEhcVmP/zwQ+qhu2jRIuNBLBMCQkAICAEh4BHAI9F7JidtMOP7mORlkOhCT3vgwIGRdJd6p02bltL9F9EVyWVQpUJACAiBxCPARBMOFThxnn/++TZp0iQnmYd0Xpjmc8BEPQkVZh/LWzZRbT179nQJ64nqCpPo8qQabdM4tbxXSMflGoG3337bRXEEyZrNNtvM7r333lWkTJHyY1xMGhHes8gfiHxgRebi0iO6fMQk0ZOM/StjTM5DyhFNlW4TJkwwyC1v9G3zzTe3jTfe2DbccENDAYQ8XPzhJFmWNW7c2DnAVatWzUWidevWLXXKPvvs43IrpjZUYgXpuFmzZqXOhIQk/5hMCISJQK9evVyuOfJRk6cvF/biiy9a8PsR9Rjjsccec4Q+fUvaMzf2RFeLFi1c0kWILtZh/G+44YZc3IexKiOoaU2YM9q+MiEgBISAEBACQQT85E3SBjPBPiZ1PUh0nXbaaXbOOedE0lVe4MkDQN4OvElFdEVyGVSpEBACQiDxCKDWwkQyTpxREF1PPvmk7bTTTonHubQOBokuorqINkH2jHFAri3JMkq5xkrlhYcA0U1EXnhjohuSK9NvQXrOHc5ZZ511bJtttnHEFxFh/H322WcGIYTyVLr8IPv4rfPWtGlT51DWsWNHW7x4sd9criX5r4jQgJTOlgsLVQjmTnNh5Ny66KKLXM5eyrvmmmtKRJHxmX5UxYI4gC2RZeRJkwmBMBHgvr799ttdFbmaN5k/f74dddRRqWZHTXRBGp988sk57WOqcxGvxJ7owktg5cqV9vDDD1vLli2tffv2Nn78+IhhzX/1JH1k4Im9+eab7gGb/1aoRiEgBISAEChkBER0FfLVKb1thUJ0MdFFbg48r5mAFNFV+nXTXiEgBISAEKgcArzbr1ixwpYsWRIJ0aXIATPy4fTo0cOIJOf5z2Q/kXZIpeXaGFtQB5aricVct1HlJRsBf78He3nrrbfagQceGNyUWifKFBK+vJYpwun999+3/fffP1UEhNh9993nyC5kyoPyiamD0lbIw9WqVStDXnznnXdO21vyI3VRZ2WM9Ci77767+w0gZYxXCvFl8VsBht6IhIEorKyhWoUUos+TRiQXv8syIRA2AjfffLONHDnSVZOr5xHR6ZDD3qImup544gk76aSTctpH37eol7EnuvwAGKJr3333tUMPPdSuv/76qHHNe/1BSar33nsvqwdH3humCoWAEBACQqBgEBDRVTCXosINCRJd5Mk466yzKlxGLk5Agx+v67lz59pPP/3kIunxTiNhtkwICAEhIASEQK4QaN26tX3++efOgz+KiC5kferWrZur7sSyHJ/PhygQSCgm0f1EfK47pIiuXCOq8iqKwAknnGBEcnojmoiopGwWJGezHRPcTiTSggULbNNNN01tJkIJpzFvwYhJykfBAaf2dOMcFK2222479zuFBGFZhhwjv2meOMp0/Prrr2/16tVzeZ15b6T8bbfd1sk2pkejpZ/fu3dve+qpp9xmpAyRgYSEq6yRExjyzlufPn3swgsv9B+1FAKhIUDUI889LFdEFznuunTpkmqziK4UFDlfSQzRNWPGDCNhY4cOHey6667LOVBxKFATmHG4SmqjEBACQiA6BPSciA77qtYcJLqQJEFCMArD8wsPMHTG8bREMlpEVxRXQnUKASEgBJKNABEDOHC+++67kUR0MdFF9EIxG04txx57rOHkgmwyERVeWi3XuChHV64RVXkVQQA5bohclt7K+g0gfUinTp0cGe/PKWt5xx13uOgrf9zChQvtyCOP9B9dBNODDz6Y+szkOPJi3333XWobK1tuuaXdeeedGSUVSxwY+LBs2TKngOU3Va9e3fidJUpz6623NvKCEaVVWWlAImCIhPFWlYl8SDnmd8lh5m3KlCmO3POftRQCYSEAIc13G8sV0RUsk3J55vGdi8rIfUcOPCxXfYyqL+n1xp7oIorr+++/dzI6hOGW5XWRDkCSPmsCM0lXU30RAkJACOQeAT0nco9pvkoMEl2QXJBdUZj3duXF+5tvvrF27dq5xLpjxoyJojmqUwgIASEgBBKKAEotTMx+8MEHNnToUEMmDOfWBg0ahNpjP1YimmKPPfYIta5CL9znICLvD0QX0SDNmjWze+65J+dNf/XVV+3www935SZt0i3nYKnAnCPAPcfcore11lrL3nnnHf+x1CWOX/yRUgW1A5b8cf6ECRNKnEv+L0glbz5q0n/mN4ffnqBB9qDmgJNZ0NZbbz2nZoVsYXkMFSxkSL0RHUWUVK5s6tSpNmjQoFRxV111VQkSL7WjHCu0DVLQG2lakC3MlnvMH6elEMgFAsHfg1w9j9JJ7aiJLqJXea/HctXHXGCfizJiT3TB8n/77bdu0Cui61/unkjaTZqLG11lCAEhIASEgJmfvNFzIn53Q5DoQraQF94o7Pjjj3ceaAzWv/jiC+cZSuLuSy+9NIrmqE4hIASEgBBIKAJHHHGELVq0yEV0XXzxxXknuh544AHba6+9Eopu+bo1b948O/roo+2UU05x0oVhEl2fffaZ7b333q5hGqeW7/roqNwhAJnUpEmTEgW+8sorVh5JwBIn/d+HP//80+W/IarJ21ZbbbUKWRXMk8Nx5MELyif6c5EbHDdunPsL5u1aY401jN9H8mOVZTfccINdcsklqcPKilhLHVjOFfDq3Llz6mgixcg3VtEIsSuvvHIVycjJkycbOc5kQiAfCBCt6aWLc/U8YjzDuMZb1ETX7NmzU0R3rvro+xb1MvZEF94LX3/9tSO60PHGC4gHQDGaJjCL8aqrz0JACAiB8iOg50T5sSq0I4O5OM8+++xUwvZ8t/O4444zvE8XL15sn376qYiufF8A1ScEhIAQKBIEkMWdP3++LV++3EaPHp13ouv+++93kl5FAnfGbhJB0q1bNzdhT46u3XbbzZo3b27kzsm1BR16kjbplmusVF7uEWCcTTTVihUrUoWTH4tIxora66+/7nLpvvnmmyVOzaQ+FZTs5OCNN97YjbFLnBj4wOQ0zm5EjgWtZ8+eLn9VaRFPw4YNs9tuuy11Wq4n2jORhcgZ8u5QHqNP5GMMSjdyXjHP8ZYHNx0TDgK5njcJRi3T4lx//yqKAvn0yKuHJe2Zmxiiix/DAw880IXGEiJbjJbrL2IxYqg+CwEhIASSjICeE/G9ukGiq7Iv3rnoPZ7deHgvXbrUDYqRlmJb0EM0F/WoDCEgBISAEChuBMgNRY6o1157zS6//PK8E13Tpk1z+aiK+SpANEI4kscDooucZS1atDBy5YRhGqeGgarKLC8C6XJ5REvddNNNbp6xPGUwWTx27FjnhM+4Pd2uvvrqEhEd7IcUQwY8aG+//baRPyubkbeQ7+T7779f4pCWLVs6IgvZxUxGrr1HHnkktWv69OnWsGHD1OdcrHgHBV8W0VyQV0iklRbZRWQbRBxOdEEjyo5ormx9Ch6rdSGQSwRy/TzCSRSy21vURBfRpr169XLNEdHlr0qBLJErxHMAouuggw5yCeN4uBSbEb5cu3Zt1+2k3aTFdi3VXyEgBIRAWAj4AduHH35Y6stGWPWr3MojUChEl3+BxcP+vffesw4dOtgxxxzjvO0r3zudKQSEgBAQAkKgJAJMwDARQwJ3JojznaOLfDNeSq9ky4rnU5DoIrKlfv36Tj6MiecwzI9TNZ8RBroqsywE5syZs4oE4Oqrr+6iGpHv9PenL+fHH390RBVkPJPWSPcRmZjJiNQiv206YYM6FRJ/QSMX1a677hrctMo6OcDI2ZsucwgRTW6ratWqrXKOH8P7HUgEBqUG/faqLIN5f4LlIAPbv39/FxFao0YNtwsJ9FmzZjliEOzSbc8993R92XDDDdN36bMQ+H/snQfUFdXV/k/yTxQ1WEABCy78FDUIlihqENAIalQiAQQ7KnbFElAULGADRLAAoiIqKiq2oCiixBpLosGOxq5LUCwRxC7Gj//9nXz75tx55/Yzd+7M3Xut9517586cOfNMO7OfvZ8dOQJyvft6HnGf2GeffbL9jpvoYvuUJMB87aNtrA7+JT6jS4guNLR33313e6Pmht1oRprvFltsYXc7bSdpox1L3V9FQBFQBKJCQAZs//znP428ZES1LW3XLwIu0XXaaaflFJP2u6XCrfXv39++qCPHQsQpA3ai7i+88MLCK+qvioAioAgoAopAGQgcc8wxBofv008/baZMmVJzoktrwhjzzDPPmAEDBthsjMGDB1tpt+7du5ubbrqpjCNZ+qIyTlV/RumY6ZJ+ETj77LPNjTfeGNpoixYtzPrrr2/+/e9/22D7JUuWhC4XNpP72YgRI5r8xPh+k002ySHI7r///qxvr8kKzgyC3SdNmmSzyNy6XfkC0MgcI4NMjGuadwqfxv4grTh79uzQZiH6NtpoI/Pdd9+ZDz74IHQZZkLK8W4RRtjlXUl/UAQ8IuD7eYQaCkooYnETXY899phB8hRL2zM38UQXdbkWL15sSLv9/e9/bwdiSBs0mhENscMOO9jdTttJ2mjHUvdXEVAEFIEoEHAzf5977jmz9tprR7EZbTMiBFyia9iwYTYqMqJNFWy2b9++hvPnrbfesnVTkGBAex8NfjVFQBFQBBQBRcAXAmQQ4SzFGTNt2rSaE104u3feeWdfu5PIdshAIcDliCOOsAE2ZFiAST4ioJqddMep6s+oBkldt1oEILmRMYTQqsS4TqjH41ohpzaZox999FF28VKJLlkBsmv8+PHy1ayyyiomWB+MH7l2UfUQi6r2Fe8sEIZk4ZZrkImjRo3KkXgrtw1dXhHwgYBvomvBggW2trX0rdA9QZaJcqpEV5ToVtm2El3/AZAHlgzEdWBY5UmlqysCioAikEIEvvnmG9OhQwe7ZxQXX2+99VK4l+ndJZfoOv300w06+3EYL8W8vCNbSGQa3wcOHGjOP//8OLqj21QEFAFFQBFIKQJDhw41d955p5W2QooL5/O9995r5fOi3GVxbk2fPt2gHtPIhpwY0mYUrCf7A/mxXXbZxcqJ+cbl+++/N5tttpltVv0ZvtHV9spFAMlU5AqRFizFfvGLX9j6dWRToTRF1pJkWaG8BHmVz0Qtgd9XX311w3var371q3yLh84nM4u6glizZs3MG2+80WQ5dzv8SJ2vs846q8lyvmbcc8895sorrzQoiRQzMr3IdqE/LVu2LLa4/q4IRIrAjz/+aDMt2QjBnUHJ0Uo2HqzHFzfR5Uq1pu2Zm/iMrh49etiChWR07bnnnjbFddy4cZWcd4leh4KUYIHxWVN8E304tfOKgCKgCHhHgOznHXfc0bb75JNPmrZt23rfhjYYHQIu0XXGGWeY4447LrqNFWiZmlwvv/yyjQiF8OrTp4+VPTjvvPMKrKU/KQKKgCKgCCgC5SEwfPhwc8stt5j77rvP3HrrrTUnuq677rrs+3V5PU/P0mRwk8lNHQ8y7LbddltL/kEC+rZly5ZlScy0Od18Y6Xt1QYBggS5/+AQ/vDDDw3Ob6TfIWLWWWcdq47BtHXr1lZdqXnz5rZjy5cvN+3bt892EvIGUimfkflEFhNkGeNp5ELLNUi1yy+/3Fx99dWWZAsj1q655pqsAgP+woceesi0a9eu3E2VvfwTTzxh6y1yXfMHqU3WGbixfQL2u3btqrL6ZSOrK0SFgFsaiEwsubar2R6ELyp0YnETXX/961+tKgv9SdszN/FEV8+ePc3ChQvNXXfdZdMADzjgADN27Fg5dxpmSp2M3Xbbze6vSlI1zGHXHVUEFAFFoGQE3MHVU089ZTbYYIOS19UF40fAJbpw/hFlGoeh78+59N5771kJQ3GAnXvuuXF0R7epCCgCioAikFIERo4caSBUCGjlXb/WGV04hcnMaGR7/vnnswEtEF3bbbedQVHn+uuv9w7LJ598Yrbffnvbbtqcbt7B0gbrGgGILkjhL7/80hJi8+bNM0jyFTJItJ9++slmYxVarthvtPGzn/3M/PznP2+yKGQYpBtOfJQhJIOyyYI6QxFocAQ+//xzm8EMDL78664vhnbjJrogoKmzjaXtmZt4ogtyh4PC4JdU1wMPPNCMGTPGHqxG+udmdPEg1YdWIx193VdFQBFQBIoj4A5mKC7epk2b4ivpEnWDgEt0UcyaotZxGJFoSDggXYisS79+/czhhx9uI1Hj6I9us34QwEnJi+Gmm25qo5Lrp2faE0VAEUgiAhdeeKGZOnWqmTlzppUsrDXRRWaEG32dRAyr7TOZ2yJRDNHVuXNnm+VGtptv++CDD0y3bt1ss2lzuvnGSturfwRwapMNRoAY0oVqioAikBwEqJlH7Tzs6aefNuuvv37Vnadu3h577JFtJ26iC4UfpFaxtD1zE090EWVFVDH63fvss49lJBkUN5pxYnbv3t3uNqnPMkhsNBx0fxUBRUARUATCESAgZMiQIfbHF1980ay11lrhC+rcukTAJbrOPPNMc/TRR8fSTxl3QXa5Reop2q3WuAjwsgbhSbQwsqjUtcFBjFzq//t//69xgdE9VwQUgYoRGD9+vJk0aZKtB/Xggw9mZQw7depUcZulrCg1uqZMmZJTOL6UddO2jEt0nXDCCVaejUDjadOmed9VV6EmbU4372Bpg4qAIqAIKAKRIfDuu+9ma3Q+9thjVg602o1RN8/NEvfVbqX9QuGHRCEsbc/c1BBdd9xxh+ndu7fVmLzgggsqPdaJXc9N9b/44osr0vVN7M5rxxUBRUARUASKIjB58mTD8wHTWo5F4aq7BVyiq5jWf5Sdl9qoRKWRGUgdgSOPPNKcffbZUW5W265zBNy6D25XqWOx9957W9UFMgHCpHTc5evtM/r1N954o63DQSCdknblHSHFrzy8dOlcBCC5ILvI6sIhJPW6akV0sX0CaRvZCIwSHwtEF8ELOOq45/u2V155xT4raDdtTjffWGl7ioAioAgoAtEh4MoM/uUvf7FqFdVujSBRSi+JxU10kalG6Scsbc/cxBNdpP4hnwPRJWn1559/vpw7DTOlUGaHDh3s/p500klm6NChDbPvuqOKgCKgCCgCxRFA7g7ZHyxtg5nie5/8JVyiC1IJcikOI1OH4JrXXnvN/P3vfzf77befLbAN+abWuAgsWbLEdOnSxXz33Xd5QVhvvfVs1hcvVT6KOufdkMcfGFszxsY0kKx8YBW/8jHTNf6LANKBo0ePNgTqEHl86623mjlz5piOHTv+d6EIPklG1+WXX279CxFsIjFNvvzyy+YPf/iDlTcaPHiwlXLC/wL56NtEDpl2dZzqG11tTxFQBBQBRaBUBCSbmeXvv/9+L/Kjbrkh2o2b6Prb3/5m9t9/f7qSumdu4okuqRUB0dWnTx9z6KGHmvPOO88erEb6h1RMu3bt7C4TdTVx4sRG2n3dV0VAEVAEFIEiCBxyyCGG6PpmzZoZUufVkoWAS3QhE3jEEUfEsgO77LKL+eyzz8yrr75qZICMjCJyimqNjQDR+DhC33///YJArLbaajaCcNCgQV407wturMofXaKGgDoc32qlI6D4lY6VLtkUgenTp5uRI0eaCRMm2JqQtSa6LrnkEluHsmnPGmeOZFkhb8T9nYAG/C+QkL4tzTJKvrHS9hQBRUARUASiQ0CCOdnC3XffbbbZZpuqN0aCzq677pptJ26iy93HtAWXpIbouv32203fvn3NYYcdZs4999zsydNIH7bcckuzbNkyyzbDOqspAoqAIqAIKAKCALJhn376qR2oMWBTSxYCLtGF4w+SIA7beeedzeeff24WLFhgI+xxfh177LFm+PDhcXRHt1lnCPz73/+2L4TI/b300ksFe/eLX/zCZkucccYZZp111im4bFw/ukQN9W+pg6tWOgKKX+lY6ZJNEYDY4v5AVheES62JLs3iNPZZj/wsmbhIF3bt2tXstdde5sorr2x6wKqc8/DDD2fHNmlzulUJja6uCCgCioAiUEMEHn/8cTNw4EC7RZJqtt9++6q37tb9ojEluqqGNG8DqSG6Zs6cafbdd187OMIB1IjGoJMIaxwHFHPVOgKNeBboPisCioAi0BSBH374IastjcOCAutqyULAJbpGjRplJeDi2IPu3bubpUuXWqfjE088YQ4++GBz/PHHm9NPPz2O7ug26xgBxqKzZ8821LkpZL/61a/Mn/70Jxusxhi2nswlaojm1CCB8o6O4lceXrp0LgJ33XWXGTJkiM3qIhOd931fEkK5W8r9JtKF48aNs/K8ub821jd8C/gYkDeC6ILwj2ocybE97rjjLMBKdDXWeaZ7qwgoAopAPSEwb948K81Pn6gPutNOO1Xdvffee8+gjCIGmSaqbDKvllOptc020/bMTTzRteeee1oJJga+/fv3t1I+SPo0oiFj9NBDD9ldZ9q+fftGhEH3WRFQBBQBRSCAgFtQVbNvAuAk5KtLdJG5TgZ7HOYSXUhhIomJ82vYsGFxdEe3WecIIPWH/BfWsmVLs8kmm5hnn33WILkdtE033dRQZ3fHHXcM/hTbd5eo2WijjWz0ZWydSeCGFb8EHrQ66vJ9991nny9kdSGJWmuia8yYMYas5UY26nHib6EeJ896xgC9evUyV1xxhXdYZs2aZU455RTbbtqcbt7B0gYVAUVAEVAEIkPg3nvvtXK9bOCGG27IIagq3SjPNZ6hYnETXbyPwaFgaXvmJp7oIsIIBx4D3wEDBtji7BRpb0Qjkw0tc+zSSy+1Uo72i/5TBBQBRUARaGgEyEI4+eSTLQYXXXRRtvBoQ4OSsJ13iS5qkVKTNA5ziS4kF+jHiSeeaE499dQ4uqPbrHMEcFAjN4Z17NjRzJkzxzqskQFh7P6vf/0rZw9+9rOfWakyCPl6MJeo+eUvf2kefPBB8+OPPxp09onM/Prrrw3zV1llFUNmWo8ePeq+7lgtcVX8aol2+rZF4CaBnGR8fvTRR+a2224zc+fONZxXUZpkdF1wwQU2mCPKbdV72xIohZ+F7G2i0ffZZ5+imbqV7BfPBMkOT5vTrRI8dB1FQBFQBBSBeBC48847zdChQ+3Gp02bZnbbbbeqO/LBBx/YrGhpKG6i6x//+IdVxaM/aXvmJp7oInWelHoGRkQaHXXUUeass86Sc6ehptddd122Phl6okTFqikCioAioAgoAhdeeKGZOnWqBYKBG/W61JKFABkwIm/A8110w2u9F26NrkcffdRmlp100knZl4Fa90e3V98IcK7ygoghSwhBJPbNN9/YwKzrr7/eUNvLNWSyuG/FJWW4fPlys2jRIrPHHnsYPpdqZKX95S9/KXXx1C6n+KX20NZ0x1x5XEhxanI/8MAD5te//nWk/RCiK86gkkh3sIzGX3/9dXsfJOobout3v/ud6d27t5k4cWIZrZS2KFHzosyTNqdbaQjoUoqAIqAIKAL1gMDNN99sRowYYbty1VVX2czmavu1cOFCW+dS2omb6Jo/f77p16+f7U7anrmJJ7pInac4LUQXL8VHH320OfPMM+XcaaipRFaz00S6EfGmpggoAoqAIqAIUET86aeftkDwzFx99dUVlIQhUC9EF9Hcn332mQ0yksLxSA0Rca+mCAQRQPqLF0RspZVWMm+99VZwEUt+oUqAU9u1rl27mquvvtpmSrnzo/r89ttv28xEXvaWLFlS0WYgo3lxjcO4LrnPgzH7snjxYnuv32GHHWzdm6hr90aNn9Qf3njjjeOAV7cZAwIiqzNo0CCbPVlroov7EttuZKM22u67726jviG6dt11V/PHP/7RIEvr2wjIIsABS5vTzTdW2p4ioAgoAopAdAgQhEdNbIzADgI8qrUPP/zQdOnSJdtM3ETXc889l1WBS9szNzVEFwXi0NBu5NojSDr89re/tRcOL7MvvPCCWWONNbIXkn5QBBQBRUARaDwEkLxDMozsiQ033LCJM7nxEEnmHrtEV5xySkRzf/LJJ4a6HWSuHHnkkWbIkCFZacxkoqu9jgoB6smhOICttdZa5sUXX8y7KTI1kMD86quvsstAdhHlH3Vm108//WQzXT///PPstkv5gNQitbs233xz07ZtW3PwwQfb+2wp6/pYZunSpeauu+6yWS68sHK/DzPqpEnUZtjvYfPkOl+2bJmVYySLBnnGMIsaP/ovjnXqAnIPVEs/Ai+//LL5wx/+YA466CArGVproguVGNRiGtkgmJFs4v4B0YU8a58+fcxll13mHZZJkyaZ8ePH23bT5nTzDpY2qAgoAoqAIhAZAgTpEayHVTKGDuuY66/n97iJrueff94+z+lL2p65iSe6GPwyCJ4xY4Z9uTzuuOOstj8HqxFtq622Ml988YXddaKikFxRUwQUAUVAEWhcBIju79mzpwUgqgLijYtu7fbcJbpGjx5tHX+12/p/t8S5hPQCUd7UKyKTHnKCOl1qikAQAVQWGKNjLVq0sEFYwWXc7wsWLLDjeQgcMWr0iJyVzPM9DUZZ5mt/tdVWM9ttt53ZZpttzNZbb21+85vfxBZURu1FpNVKIecgHA877LB8u5Uzn8wwSCVqq7mSkpCNBBWSvcmxdC1K/L788kuLNWQaxjGAaFdLPwIuyfLzn//cUNuvltKFyBYdc8wx6Qe6wB7KGLJv3742M1RILxx/vg2SC7ILS5vTzTdW2p4ioAgoAopAdAiQxTVhwgS7gXHjxtkySdVuLUh0/fWvfzUilVxt25WsT2IMGdpY2p65iSe6KIb60ksvmRtvvNHWqyDSSIqYVnKwk74OEW9PPvmk3Q2NeEz60dT+KwKKgCJQPQI4K8844wzbEM5inMZqyUPAJbqIMMPhHIcRQEOdJWTKcDjiBDzttNPM4MGD4+iObrPOESDbj4wjrFSCgpow1IOB4BC74oorDER9MYOYwRnOWJiiz0gQkoXUsmVLs84661iN/d///vdNmvnuu+/MtttuazNfm/zozPjnP/9pVl11VWdO+R8r7aNsCcIHsumee+6RWQWnzZs3t3isueaaBZfjx3vvvdcMGzbMfPvtt3mX3WKLLewxXWWVVbLLRIkfx5L3GzHIxVmzZslXnaYYASncTk1urjuubQIsyKCM0sTxhE8B30IjG897kSsEC5ExFAegT2zcerJpc7r5xEnbUgQUAUVAEYgWATfwgmcTig3V2scff2yQExdTokuQ8D9NPNGFViYyKNOnT7eRijhacLg0ql188cVm8uTJdvc32GAD89RTTzUqFLrfioAioAgoAhkEcIj++c9/tljcd999plOnTopLAhFwia6xY8ca6q7FYXvuuafN5nr33XfN/fffbyO81RkYx5FIxjZxjM6ZM8d2lowgnKalGLKYSIZx3mPUFaQmXKtWrfKujnQf9eJwjhcy+oOca9CQ8DjhhBMM8t8777yzLRjNyy0ZjFizZs3suR9cr5zv1faRbfHOQ+2goCENSWTmjjvuaKgVtvbaa1tygH6TDVPMuJ7JzHSzuPKtc9JJJ5mhQ4fm/BwVftQcRppejMw0MtTU0o/Ap59+aiVFkcvj/L7zzjvNvHnzzGabbRbpzgvRpdnKxvCsR7IYnwvKOQQKDBgwwOBz8G0EYyFViynR5RtdbU8RUAQUAUWgVATcwItyVBEKtY8k+Pbbb59dJG6iCx5Fao+l7ZmbeKKLFzpS7tD/p1gsL2gMShvVHnnkEXP44Ydnd78W8g7ZjekHRUARUAQUgbpDgMghIojIpnjllVesE7fuOqkdKoqAS3RddNFFZv/99y+6ThQLiGT0+++/byBOCTBSeacokE5Hm2SQPvTQQ9mdQYps5ZVXzn4v9AFZvmuvvTa7COc8536YQdJAcv3www9hP+fMo34tZBGZQcUMEnfmzJl2MTJKyOiq1Hz1EaLn0UcfzekGNXp5F6o024z3B4hFl+RCnpHsLjK4yAxGzlAyvfgN6cRi5gM/MOdFnGPLuUPWWdRER7H90t9rgwBZnQTn7LTTTqZNmzY2kxASfNNNN420A0J0af3J2hJdqA9wr8HS5nSL9IStsnEy9AlUIEiEupNk6/LOwHW3ySabVNm6rq4IKAKKQPIQIKCMdwXMV71OCd6xjWb+xU10SR1U+pO2Z25qiK5p06bZguhhEYZyIjXCNKhjTyQ/L/5qioAioAgoAo2HgETisudE4V599dWNB0JK9tglunxphVcCDUXocYjgGMFxz7jL1wtAJf3RdeobAYLQyMQSI6OJTKNSjNpTZCctX77cLo7jbf78+U3InNtvv93Klv/v//5vtlmyx5A769Chg1l33XXtH9kCQlQhfYYEWjELkm2c+8gglms++3j++ecb3ntcAxuc8pBg7Hs5Br5ksFE7QGzfffe1pKLbFjKlBNBhpapG+MKPvi1evNi0bdu2YFaf9F+n6UCAc7N9+/ZWVhTyiex0iHPmRWlCdJ188sn2uopyW/Xe9nvvvWd22WUXQ7kIMiv32msvG2iTL+igmv0RBQKyahm/qkWLAE5XshYKBS107tzZqgVBNKspAoqAItAoCAwfPtzccsstdncJwiCjuVr717/+Zccz0k7cRBcB0CILr0SXHJU6mUpG19SpU21BdB2QGnuyctJiRDwi8aCmCCgCioAi0HgIIAGDcxeLU+6u8ZD3v8cu0YVkENJBcRjbfeaZZyxhwPiCcdfZZ59tg43i6I9us74ROPLIIw0ZGGLlKg2g0kBdHrErr7zSOlrlO7IbkDI//vijzLK/c9+D4HINhx2OPTGIWrKVCpkrCc5yf/vb38x6661XaJUmv/nuI/WwILT+/ve/N9kW434k3Hfbbbcmv+Wbcf3115tRo0Zlf0YmDiLNlTtECp36BEImsgwZZMXMB37FtqG/pxuB//mf/7Hvs5DTtSa6Gl0phjML51f37t2tfwFHHwEESCczpvRtSMeSKV5t9iz9+uabbyzpX2oGse99qff2IBLxoy1btqxoVwk4ue2224oupwsoAoqAIpAWBJDnRi4Z8yVjTACfqybxxBNPmA033DA2yBYsWGCf6XRAia7YDkP4hiWy+KqrrrJRRprBZAxF6sFDrBYSD7ItnSoCioAioAjUDwJI2SJJhUFOaERm/RybSnoiUeZxEl0HHnigrf+J3AGR9WSR4CR3ZZMr2TddJ50I4BiFUBIrlxS95557bNagrO+e+8jsdevWLScTCQfs6NGjc0ga1n3ttdcM9eVcK8WJPWHCBDNx4sTsak8++aTNKsrOKPIhqj5CdjHev/HGG7N1zNyubLnllvbapLZOIUOKEAyJMhUjiwuJ0i5dulgJK94jkAsUkovlSs0qrRY/6ZNOGxcBsjJbt25tttpqKzNr1iybIRq1nJo8a6kxiPxmIxtydtwjILjI6OLecNBBB9n7rG9cJDCCemwECFRijE0g+9944w0ru3fppZfamoxI8qn9BwFkYJGDlQznUnAhiJpamWqKgCKgCDQCArwjzJ492+4qCmnwDNVavRFdr776ajZ4UImuao+u5/X79u1rkEGZMmWKYTCqWtrGRnjut99+WaQZlJJ6qaYIKAKKgCLQOAh8//332TomRA/hIFJLNgLifBs/frzp379/LDtDJgn1gRh7MSXKDXmyQw89NJb+6EbrGwGi/snCEuvatau5+eab5WvBKXLcZGvhsBRziS5IJxyuYtSpQmbEzUSS33B8Ih/o2sYbb5wNBHDnu58vu+wyg6NUjHOeDJOgQWhRf2yjjTay5JD8HnUfyepCUgV5sTDr2LGjJQp33313W3sluAxythCD5RjR/dQtK8VxXC1+5fRLl00nAoxfyMqhgDsSawTvcO1GafKsRa6TGpSNbAsXLjTct5EsxKeAhCHZnUje+baBAweaxx9/3AZlEZxVifXr189K3LrrkiHG+UNmGhm51HiL+hxyt19vn4P3ZaRvwY3n169//WtLaCE5TF1Gnm08UzkerVq1qrdd0f7UOQJIsxGQg2Q19wxkSeO0JUuW2KCdUiW04+yrbjteBFy57lIC40rp7dKlS83WW2+dXTTujC43CFCJruxhqY8PMpiZPHmyLYhOiiH1IhrZGJAwmONCYmBC0W1ehFdaaaVGhkX3XRFQBBSBhkIAWbmjjjrK7jM1XXAgqCUbAXG+XXLJJdYpEcfeHH300ba2ERJuDNCHDRtmLrjgAnPIIYfE0R3dZp0jgNSYGwVJttALL7xQNDKcLILBgwebl156KWcP58yZY6PzmXnmmWeaGTNm2N+JNMcxF+aIY3soQCD/GTS3veBvfL/mmmvs+S2/kdlEtpRrBBVQA1Fq2SAZK1aLPpJpBQGHMwkncdh+4rzkHSkoaSgZmvQXZ+c666xj3n//fel+kym1eiZNmlT0+MmK1eIn7Tz99NOWcFy0aJGhQDh4qzUGAjvttJOVoYOkIMMzH9nsEw151jKGogZlIxvXHMeAjFgcf8jdMZ5kXOnbCNTFZwH+OMgrMZyI+ECKGQEL7BP3kuA9vdi6Sf4dPxHBCp999ll2N8haJsMraJCcPFO22WabojK/wXX1uyIAAmTkIiOKuYFKdkYN/3HeozCAEgWBE6hfMZ5RUwTyIeCq4vhKHPniiy9sdrpsM26ii6xeGU8r0SVHpU6mQnTxgIbg8qWfWSe7V3E3kIbhhXfNNdc0XFBxPlgq3gldURFQBBQBRaBiBAYNGmQdvzSgkiMVw1hXK4rzjQwTMtrjMJFyeOyxx2y9IjLGkVDDYa6mCAQRgLDCQe2SL/kc1SxDBhQ1o1jGlcqjXTIJIFnEyDBAdgODyKH+V9D4HaesK83nLkOG4rnnnuvOyvl81113WbUImUk2GtkNrrlBBcxHOosgM6wWfbQb+r9/b7/9to3Cp85NED8WwbHLO0Hz5s3tGmTLIKWCQQZCouNgpi7B66+/bmUhqXWGoxOSjL+wjDnbQMi/avGjybfeesvKpSHXiLVs2dJmbJTTD7ui/kskAj179jQ43PfYY4+aE12MoyBWG9k++ugjQ7Ys+OMojpLoktrrZFy5tR1LxZ9nCHUXxbFe6nobbLCBDdbZf//9re+k1PWSuBxBSuynWL5np/yuU0WgGgRcoovrmyzBOIwxETUAxfKRu/K7ThUBMpchojBfQS/URHQDK5Toiu48+1lmQNA0vDG67XlvGUmTf/zjH4YUbLQzkSYhArTRDadmr169bOo/hbfbtWtnIxjiThdu9OOi+68IKAKKQC0QcDWgo4q8rcV+6DZyERCiizEPTuk4TIrzPvjgg9bZTMbKRRddlOM4iaNfus36ReCII46wY1DpIYQUzrWffvrJFj+GyECeEFmyd955RxbLmeK8RHrwV7/6VXY+EehSxwUZPRwZSPVhP/74o5Ux5Nx0nZ44WtiOWIsWLex7BJlmYQbhBhkmFhY4Bjkkzptf/vKXliCS9qLqI9HJ/DVr1ky6ljMFRxw51BcIEl6dOnWyRBbrQkJKFCeSXk899VRZRFbORkO+VIsfTd5xxx02kNFtnuy9qOs0udvTz/EhQE0o3mupEcU1TpAFEmtRmjxrkeRFmreRzSW6yOgiyKZYgECleElgAPd7t7Zjqe1xT6QuIQEWrkGK84zgmVPIVlllFTu2IqCH+2GUxrl82223ma+++soGa++6665Rbi7bNs8wlJDECBRnXKemCESBgEt0UetPsvCj2FahNlGeIMNcLF/Alfyu08oQiOu+VllvC68lGcYsRXbXqEw96mqN+728p9BWuXV/q91+cH0C2ghiweRdILhMUr8nnuiiRsWzzz5rIxCpz0XBWGp1qRmbgo7kCxrURHjGKXWkx0MRUAQUAUWgdgi4L7JxD6Jqt9fp35I433Cq47CPw0SKDQc6YwwyyMOc/3H0TbdZnwhAvFMjSrKqcOjhPIWMgZAqZqg3IJOFtJ5r1HuYOnVqdha/k3GEs5MacosXL87+xgdkvXEskhmG41yMOlUi3SHzZIrsoXutId3JNSD24Ycf2pdEXl6xYD3EqPoI2U19YogqAv3cF2fpG1PG/2SA4nxwjfcnav1R44xnhBjX85FHHilfq55Wix8dgLCbMGFCti/rr7++zToTMjH7g35IJQIDBgyw9YG4b1CfCym1dpkAzihNnrVI8uIgbWTjPorUHfdwiC7ux76cfkFcyd4j8IH7GbKy5RjPEjLwRPKQ+zbtQYgjU0iwLwQY0qxkNVG31pXvc7dFAATjLO6vURgBGhCGQrwhpUYABqRA1CZqSLIdxnJbbbWVfNWpIuAVAZfoIjPcDTTyuqEijV177bXZoAWkrsm8L6XOaJFm9WcHgTjva043vH3kGcIYFvMVNPz111/nyMDG7aMhyJBnO6ZEl4Whfv7J4JeXNWQLKchMWr2asVGcRCQRuYn+ZuvWre0LQr7oT8VMEVAEFAFFIPkIfPvttzZbgj0hOvbKK69M/k7pHlgExPkWp+QGhMO0adNsdg1FbIlw00AaPUFB4IorrjDPP/+8JbQgfnDiMebEUYpcRzlGBD6kFbr4kEdhBllG9D41sooZjjxqZ6211lpW2htCR4yaLtT+CTOcojvvvHP2pzZt2th7KtJ/1JKhzgM1bMSC2ZZR9dF9AYfwoQ4aTmgyysIsKFeFY3XBggXW6YQahhiOn3HjxhnerwoZTmVkITm2RGm7mXbuetXiR1u33HKLQSJVbOzYseaAAw6QrzpNOQJkVZHFBdnCNQeRIc/CqHZd2keSF2neRraPP/7Y7LDDDvZ+DNEPSU6W7jnnnOMdFskwxXcRJOeLbey6667LkaEt5pgkIIJziUxhZBL57hrEGEE8EEO+7dZbb7U+K7ddyDhqWvKMitK4jiQIhJqMKCOpwz9KxBu7bZfoIhOXe3kcxpiBWp8YBDjEl5pfBOK8r/ndk/+0RhY542TM11gAhQk3oCFuouvNN9+0z3b2UYkuUKgjk5RCXsooiD5ixAj7oldHXYytKwzYevToYXXNiWLlJZest5NPPjm2PumGFQFFQBFQBKJFgHozvPBjvMC2atUq2g1q6zVDQJxvcRJdki0IaUC1muDZAABAAElEQVS2CMRXnBlmNQNfN1QQAQp84/ys1oi+p44UTgkyd4oZ9by45xVSYoeogvCXjDBqPSHV4b7U5XOeL1++3Dp5lyxZUqwr9uWVLIRg7ago+ijS7W6nkNqC+KO+Dc5SHLX0/91337XqF88884y7uJUG44WbzAIIStco0k49CyTEwO2TTz6xL/xEtyJvyMs/bWNkw5EVF2Y+8HOlVdgGzqpSzo2w/ui85CEA2T137lxb14Io/FrUtIB0gKjHz4CPoZGNEgidO3e2PgWILjDxVa8kiKuQMJUQXciSudl31N3iXlWK8SxAzg+iySW8IIDIJvVNdvG8IVswaDyrqLEepW222WbZ4BBqdSHvq6YIRIWAS3QRiIPsOYEyZPS/9957hgwX5iMbSsAMvkvfz3fGb9ttt102g5IAPbJS1fwiEOd9ze+e/Kc13hMYf2IEf/H+W625wci0FTfRxXs81xzmvhPZGQn/l3jpQiG6iO4jmws5EQZhav9BQIpAM3DkQiXqldoIUWubK/6KgCKgCCgCtUdg6dKlhuwELCpHRO33SrcoCAjRhUOGuiVx2KRJk6zkGY5tZICQZmMecnBqjYsAMlBI6JVjkPDIa0PMkDHAWLVly5blNGGXxZlJVhIygmI4KDfffHOb6ST68/IbUyRWqE3Cix1OlnvvvTebCesux+egdF7wd77jGJ8+fXreTBPffbzpppusbGghgi+snzIP8grSiswupMIouk3mRpiRlVcoa47jhiRkPvOBH04pZOvI7sMZrRkI+dBO33yCNHmfhQTHKcO1BIkRpbEtnLEi8Rnltuq9beT9cBIjHUnWaJREF9JmOKW33HJLe08uBxuCb9wss5VWWsne28ppA8lbCCi3riP1JPGd+DaIOUg0Ai/EeP4Fgw7kN19T9gdnK6bZsb5Q1XaCCBDkQrY74y8JigkuE/ad8SAZlj6N8QkJEWL5Apvkd51WjkBc97XKe5x/TQLHCBTDCHZAvaRa437Pu4lY3EQXhLPUh0SBIU1j69QQXaNHj7bZXGeddZZ17snJ0+hTotGQrkJ/k+hPCjrjTJg5c2aTiNNGx0r3XxFQBBSBpCOw7bbbZuvgMHjRGiZJP6K5/ReiC4m4Xr165f5Yo2+ic49EG45xHCXUCkLiQa1xEcApDNmJnKUYdRDaZWrp8LfhhhvaKF2yjnBSE7FLBK8vg/CBeOW+R1SwZCIVa5/6YbzYUZMln+H0JNI+rJ7LGmusYR2/kGbIGRYy330kswVHqdQQKLRt9zeIPQhqHNZi4ECNY6ThyjEyPWiLLIF85gM/3mcgJ3GA03+1xkFA6kJy70AKtBYZfTiicEj16dPH8KxrZKO2ImNLnH4EE5NtC+GFio5vk+yPSoguHIbUHBTj+ePWYpT5xaYQ6UjBukYGa7H7u7t8qZ/JlqPOJH0noIDsWDIYozSy5b788ku7iTjVAaLcR207HgQIRKCUDAFEpWTBh/WS8SJ1GH3aYYcdZh599FHbJEFJ8tnnNrSt/yIQx33tv1v396lr165WGY0WkQtHvaRa++GHH2xwn7RTi8Ad2VbYFCKPZztGhmVQkSJsnaTMSzzRRco1knykqkNy+S6inJQDWaifMvAjgmfNNde0eCkhWAgx/U0RUAQUgeQhgByEZDQT1IBkrVq6EBCiK05iSTTYCTAigxApB7K7cNCoNTYCkBHUbeJFCTKLMWdaDAcOjl0cpxBjZDER4UkdMTIH4jSik3FYko3wv//7v3m7ArlIf3l34p0gaEh2UauMiFxq+4YZcoiQiDvttJOVMyMStJQI0HrGL2w/dV79IMA7PuckxAUOet77Ib2iNCFcevfuba+tKLdV721DgpNJiZwpY0xqlUDGuHXzfO0DGb7ch6ipOHv27LKaRV7VHfdyjnCucM9GfpK6VARjILErMrbBDUDqQfi7Mq/c3wkYLuYAZPsEelCPknst99h8tQuD263Fd4JRCBLgWHJMMcZvxeox1qJvbIOACMaVPIN4RuGrEuOcePbZZy2+jDPI+unYsaOhxlgh434BScm+t23b1mZeF1q+0G/1fnzdvsfRV44LgS9ybrn9KfSZ8QNKUwQXcIzILicwypchjYjSCecAduKJJ1oyzlf7tBMH3sH+R3H9BLfRaN8Z50s9Q1RUUFOp1shubN++fbaZeiK6IL0Y46fFEk90SWHB8847z6arjxw50gwaNCgtx8fbfhx33HFWix9skH8gSg2ZGQYJaoqAIqAIKALJRsDVfCbylohUtfQhIEQX9YbI1o7DcEKQvYITgrEEGSU4IXffffc4uqPbVARqigBEEo6ZUsidmnYsszEiRXlRJauNl3MctMhDrrvuupYYKKdeI3KGRHcuXLjQOp6p+QV5iQM6n5O4lP2tZ/xK6b8uU3sEkAsikpoMdRzetSC6JOuFzGkyqBvZyMxAUpCsViSxcURDBp1++uleYSHjtV0mmwPDMc1YoxyTzDNZB2citSPpN5JMYmTvkpHGNjif+CM7HUIEH4nI+snyKOIwzslnZPpyfhIERFtinK+QgmSHFcoYluUrnZI9gU+Hez/OWLIQXANXyCxq9nIPJysSUgKjDqMr6eauV85nyESISbKqOQ4QfDx3GLMiXUcWTTFz63yC3UsvvWTboW2yhKRWjtsO94aw+mlkOUPEsg77LwYByXkLgV2qxX18S+0ny0XZ12LnGdLRXbp0Kdpdxg9IoXJP4RqEeCUzPioLymojiwhR6sOixLvc/vm8fsK2Xez4h61T6Txf26p2vOkGBfDOzbt3tcYzgoAOsbiJLsb5BLFgSnRZGOrnHwMITpBRmaKC8qfFBZseHwZwPXv2tAMwIhmIbGLwcd9999kIuaZr6BxFQBFQBBSBpCAgBAj9TdtAJSnHoBb9lON81VVXmT333LMWm2yyDV4SjzzySOu8wYGArNN1112XLWbbZAWdoQgoAoqAIqAIVIgAz7sxY8Zk10ZeEyd6lIYDloxlnrNsv5FNar92797dPvsHDhxoBg8ebOsi+sSFjAtqo2GVEF1kVbgZXdIGJIsQO+X2l4j+66+/3qy66qqhq1LbEaIoSI65C5MBC4FWqVQvY3rOQUhApBldUoAgI64N2T8IIvrLsRKD2Prtb38rX3Om1ASDBCNAjn6WmylJ38h0hnwuZGRIQo4Wqi3rOuppC4lSHN4QjS6B6G7n0EMPNQS7i+HYhphmXJpvHZalpifncDGrxfHN1wf2n2PiHu98yzK/2r5We54R+MZ5RGZRISNbPN/1VGi9Sn9zZQuRWJ43b16lTeWsVy3eOY1lvnC+osaCEheEMQEGEMZco2Qu8iwqpJxR7fVT7fEP7k+h71Fui/MPQmru3LlWQpOALxI7CFrh2VWOIaFLexwbCHtkZqs12qonoosgEIJBsLSVvEh8RhcPfG4IFB/lQccfDz21pghIIUYiKLjgKWSNJicOqmLp+E1b0zmKgCKgCCgC9YDAySefbO6++27bFXTHS4mcrId+ax/KR0CIrjilAnFoICtDZDc1JSZNmmQoAi8RYeXvla6hCCgCioAioAiEI3DjjTfa0gTyKxJmrVu3lq+RTCWS25dzK5JO1qhRpPhw+JEpxHMfP0sU8l84FCFEMHwVMq4tdTeDhA41yW+//XabvUN9v3IMwgg1nFNOOSVvrdv777/f4lCIUJFtkgU/dOhQ+VrWlPXuvPNOuw4EFv4bjHlhbXJtPPLII1nZRDdi365Y4B/yoEjI8YeviO2FkcoQa4xDIZTIJC7VOIeo64pEXdAefvjhHFUmiATIKOo9hRkyjJB8/fv3tz8jCYYsJVK+pdjNN9/cJPvNXS/K44s0Juc32W/4MoPjZ/yZ1MOF6CCwDJJw5ZVXdruX89lHX6s9z+jQ888/b7MEkT/Dec7xpoYnmeEY7wzIgNbKIOnJHpNrtFSCs1j/fODtbgPZae41EFyFbM6cOXnVuKq9fnwc/0J9d3+LalsEYlLTk6CHMIP0PPfccw33ipkzZ9rzs5DPRJ5HPJtIGOGarNa4d7rbjDuji/urBEYo0VXt0fW8PunzFGNGQgcN7/PPP79sttZzl+q6OQYAMP5oa3NTJY0dvW1uCmqKgCKgCCgCyUKAFyWILoysZs1oTtbxK7e3QnQRVYYDLg57+eWXbVQuGfXUYKJe2IwZM0y3bt3i6I5uUxFQBBQBRSDFCAQd+ry7liPDWQk01Johm8SXc6uSPtTLOtQ5QsqRunwQXTgLqyFu8u2XSCTyeyVEF1kCBPCKcQw5dyC7yLpyJexkmeCUwF9IhzPOOMOQ/ZHPIJLAQhzoLEef2Q5ZOMgYImcomV759gd5Pogfsr3I2gqr9+gGs0lGClkxf/zjH833338f2kXXH0aWE74enMDlGnj06NHD+omoo4Qh18a+Iw8YZsg0QrbhQJX9d5fjN5zMrrOX3yGwhbTiOzXO3FqRZINB+uB8xpENVkJ44zyGmKRWsWsQljhxqdOE30sy31gGyUOkD8PM1/EFd8gLst7EmSxjaNkuxx7fHLKS2LRp06w/U35nyjlCuZYw89XXas+zsL4xD6lIjjdGJpd7TO3MCP8RzA+xgSE3DamAfGU15gtv6QOkGSRXKYQx2X3Tp0+3co+yvkyruX5ow+fxL3Zf87kt2X/ueVw7hQyCnQQZ/CVkvnIP4dwkEzHMyDCG/KfuHM8WsK/WeA6RnStG5ma156S0VcmU+5O8v1NLlwCCtFjiM7qE6OIBQgFLyK5DDjkkLcfH+35woZL6yiAFvWn+Fi1aZKMtwFJNEVAEFAFFIBkIMJCksDamdbmSccyq7aUQXXHWxBJnEucekb5E9eLUKUWbv9r91/UVAUVAEVAEGgsBJIgI0BSbP3++lXKS71FMpQi9L+dWFH2sVZtfffWVzSLgGQ/BQUAVjsohQ4Z47YIrPZiPGCq0QRzorrSXOy6m3hd1nojkDxrrQOJtuOGGlkQpRqLSBtkqZJCJIa930UUX5WR/UQfsgQcesItAYuBkDxp4ipQaZSX222+/4CK2XQKKMGTMUG6A9MmX6cRykCqS+cV3DDKF+r1khZRrOD9xyFPbSBSCgm1AhJG9A5YYpBIZPgRmQbK5RCNSbBwT18HrSmgF2wZLfH35jIBtAq5cI5sIhza12jBqsDFuFbIrH9Hl6/i6GYoQFLyzQbZAojJmdm38+PGW5EMxgQwv6aMsQ3Zd2HHz1Ve2w/nr4zyTPstUstPkO+cE53HUxvm26667Wjl/tiUZntVs1yfe9AMSHiIQMloMcnbvvfe29yLesfhDuUwIQrItg4Qu61Zz/bC+z+Nf7L7mc1v0HTITUjNoEPXIBOL3/uKLL2zABgHCIknI8sjdIhkZZtzT2rRpY+/13PPJLvdh8i5PW3ETXWRbcq/EqM0bFmxhf0zgv8QTXZBapCjz0CDagQesEjaFz0TSpYnEbt68uY1kYbDKwxg907gixAv3WH9VBBQBRUARcBEIFv0t9MLrrqefk42ADI6JWtttt91i2RleGJACwQFItBukG44PHINqioAioAgoAoqATwQef/zxHLWWWjhKIXUYZ/l0bvnEpJZtkQ1DlhJ1nsioQR3mT3/6k81C8NkP1+FWCdFFxk7fvn2zXQq2QcYDhAmZY67hSMaBCYlTipEJAIEiRsYTYzK3DASkFv4ocWCzTJgj1nUIQ+YOHz5cms1OXRIHgoDsusceeyz7+9prr22d5SNHjsxmUEFMkTkUVgsJ+TYc7GKQaziDITR5l8BPFJT+wvlJbTy2P3v2bCvZKOsz5TqBJEFqL8zefPNNS46+9tpr2Z+DsqBkf5HFFTRkRKlx5uLrLkPmJSSGYM1vkJcEYQWNjDvGq+BDLa8wv5ev4+sSXfSD85O+QmK4feU3iC4yCSUYnXlBI4OObDnXfPWVNn2fZ9LPiy++2EyePFm+2npu5daCy65cxgf8w27yQ6GsuFKb9Yk3cqoQ5NQmFNtrr70sqcU9yTXJMJZ5kM7ck12r9PqRNnwe/2L3NZ/bEolT2Q+ZkvEKQSikKtcP768EMvTu3VsWy5s9DNlM1ilkF/KvkEHInfowMrqE+I+b6HL9SUp0+Ti6HtugqBwDYB7a3EjJ6iISQq0wAjimyH5jsAR23JAwBnrqrCqMnf6qCCgCikCcCLhRr/QjbQOTOLGt920L0YVOOJJKcRhSOcjnQHYxhuDFDycE39UUAUVAEVAEFAGfCCBViENQrBZEF1I+SPqQnXLLLbfIphtyKg57/AOQXPgMqLGCfKFPk2xx2gySVKVsJ+jY3nrrrW3WkLsu42cCfMmccQ2CBuIDsqGQ4Uzm3KC2khgZGGRYQY4iQ0f2Es5Xl8zIl62F3B5Oa4xsI2qeBg0CjKzGMIPkgrgh6Cgo3UU/wsi7iRMnWkUfaY9MJ4KfXePcJ4ME4otsJBztIjVIyRA3qJxt079imQCoCkEs4WzGwI0sJ5ccg+hy5Q6p9UQmUxgBJv115emYhxOZddx2ZVmmSHFCALL9oPk8vnLdyDY45zj3IFyDBgkza9YsSzIGf5PvSKxBNov57Ctt+j7PpJ+oR3HOiSEdF1ajTX73NYWUF7lOzk2IRmToKjWfeCN5yn3EzQpFmhI/dpDQhRyGAHUtX43ESq4fadfn8S92X/O1La5l7tncW1wrJK1LJqn77OrVq5e997vr8xkpSe6fZNC9/vrr9toTCc7gsuV+514qWZtxE11ubUsCEgrVAix3P+NePvEZXRREJaqFdHSiIXyw9XEflFpt/4QTTjD33Xef4QJngEahSx78pLozwFRTBBQBRUARqC8E0E8mMlQsLMJPftNp+hAQoosXe/c8qPWeIgWDMwHHFwEySEHouKHWR0G3pwgoAopA+hEIOvqIhF9rrbUi3XEyliFeeMZBJDSy4eDFgUrWDEQXdYfwu+Bs9Wmu9CBZPDj+yzHkvOibGE5KcXTLPKYQUNTP4k+i6pkPqTIqk6lFEHU+I0sIZ3Q5xjmEgxTZuqCRcXDDDTfY2RBGDz/8cHARK2kXRo5ATjH2Yj2MTKwBAwZk14egFRnB7MzMBwl2lnlhRJf8FjZFApHzQIz6QmT4lWLUxAJ3MXxOUruKeUIwy+/55AXld6ZkpJFtJsZ5w/lTifk8vkGiC4c8Psswg5Qjc1IMfxwZKS7Jjjwb9fHEfPaVNqmP5vM8k35edtll5tJLL5WvVnpTSNPszMwHyB8c7WTQQBhXYxDRSNIJmYCEIUF51ZhPvCH73MQMCEyOdZDkor/BDEzmkYFJrbCgVXL9SBs+j3+x+5qvbQVJK/aFeyDJL/ksSLzmU4OT6xeZQ7JjfY4FOH5S37GeiK433njDNGvWLB90iZufGqILnWgenmh+7r///ok7EHF0mAuYwcErr7xiI+UYFJBKysOV9HMeyGqKgCKgCCgC9YFAUC6E6MBayD/Ux95rL0BAiK7p06fnFF2vNTqMF5B+4eWRlzOil3kZUFMEFAFFQBFQBHwiQFaJ6wwnC2TNNdf0uYkmbRFIQmBRofodTVZK6YzvvvvORrWDBQQH8n84XwcPHux1j3EmEniLVUJ0UbvKJQIgQyFF8xmEDRk2LsHAsgRR46gNy/ih9IPU2lpttdVsrThq4+QzfClkaeXLJOE3ArUxiDCyFYPydEK6BrdByQmkzsRwnFLLieOF4ReDKAoatazw94iV+y4RdC6jEORKxEm7YVMIMeqEieGsx+krBrlDAJ9YKbLYwXUgxjk2lZjP4yuO8nL7Qd8JINtqq61sRolkBnK9cd2J+ewrbfo+z6SfQWI17H0BpQjkJpGI45oR8lfaKHcaPMd9EPM+8Xal+7g3QHCH1QbkWujTp08OIS9YkLXI9e5a8Foo5fqR9X0e/2L3NV/bQurVJYMJyCCJI+zezX6SpcU9k2e7GCR5UCqS35YtW2bfa1EroS4oWa133nmnrFbVlOAEkaws9/5b1YZDVl68eHFWzY3MtWpJ5pBNxDcrE8mSaMsMRlZkioeuyLCzdpq5oBO9P7XufCbiYUVG/shil0nxXZF5sKzIRFnYv8wAakXm4VrrLun2FAFFQBFQBBwEMtG0KzIRpvY+zfOOv4z0h7OEfmwUBOT4Zxw6se5y5kV0RUbOYUXmpduej6+++mqs/dGNKwKKgCKgCKQTAcY78uxjmnFARb6jmRqYdpsZJ2Pk26r3DWSc0BaLTP2rFRnnqv2ckfnz3u2MMzF7nCvBPZOZlF1fzhf6Xsgy0t8rGM/I8jLNZFusyDhFm6yayVzPLpshyVZkMkZWMB7LqOSsyJCjKzKO1hWZAKAVGWnHFQ888ID9vUkjzoxbb7012x7bzsgYOr/+52OHDh1ylmG5s846q8lyzMg4urPLZsi60GUyWWDZZWgrk2UUuly+mcE+Z+qT5Vs0Z35GWnJFhtTKbht/U8bZm7MMuMsxYFrKu04mwD1nnUywdk6b5XzxeXwzBGpOv9z94vpxv8tnMMk4vrNdzmSRZJfjnHLNZ19p1/d5Jn3NkAPZfWA/M9KX8lN2msnGzFnmiy++yP5WyYcxY8bktHfVVVdV0kzOOj7xzkgRZvuXkfPM2Y584X6WIfyzy8k5ItOw67uS60e25/P4B+8Rwfuar21xHxQ8mG677bYrMsSN7FLONCPH2sSXklE1y1nG/YKPnDbl/sK91ZdliK5svzM1snw1W1E74CUYZsj5itqo15USn9F1+OGH29RN0udhj0lVdNO246MQk7NlirIOGjTIRtBkbjw2ZZ/MuKVLl9qoCjANizJIzh5qTxUBRUARSCYCwZoD6JojxZKqiJtkHppYei0ZXUQ7ZpwzsfSBjUrUIAV9ie6dN2+erdsVW4d0w4qAIqAIKAKpRECk82TnypVak/XKmZJdgJRexrlp5eHKWTdtyy5fvtwgV5xxItqMLkodnHHGGYY6LD6NyHqUZjC25Wb+lLIdaj8Fa4VmyKaC9Z1o96uvvrLSe0GZQ2T/GGuRvS5GZiEZhhiKCmR3hcmNyfLFpmRy4IMRo/5ZxnkrX209KWqhuoZsNH0Nq4l19tln22wglifbg6yPoGUCk3IywcgucSUfg8sHv2eIvZzMOXCgzlg+OdEMaWEyZJj9k2wz2hwxYoTNDnTbl5IkMo/aX/imChnt3HzzzTmLkBlIiQ4yPMoxn8c3X0YX42eOOTXZgsax5xwQc/GgNi5jbTGffaXWke/zTPoZPF/CfLWupCXXG5kl+bJypN1CU3BEFlOMbFS2y7VTyMiyod4TWZXB68sn3rw7SbYpmZxkIUl2Fn0gSwlfLOeQGOcNUqVi9JH6lS5O7vnCcqVcPyzn+/gXuq/53FYwu5R9yZA2thwPtbWoL0iWIFlT3Mt5lrkWdg+S36UeOu/aSI76HAtwLZPFiMWd0SX7SV8Y86DslhZLDdFFOu/kyZNtcU23YG1aDlTU+8HAg3Ro0olJoWVwQEo/N1BuEtwIGHyG6UtH3TdtXxFQBBSBRkNg4cKFttg3mvtiw4YNs4M3vQ8LIo03FaILWZOdd945NgDkZapr164Grfmg/ExsHdMNKwKKgCKgCKQKgUy0sJU3k3or1UiTlQrM3nvvbSDUkOTl3biRDccrUkvICeKgx+dSyEFYKVaPP/54tj5WJUQXEm/0U84T+gEBs8UWWxTtEucYAdM43PksRh0dtyYX3xnziEEsZRRx5GvZU8pHUCtdLEh0UScOmS/XqDWEbHSY3X777Vl5O2qOIQdJ/SfXkO+CABKcIFzY91KN9agphINUjJpLEKA46xmnfvzxxyaTQWFrZzFedR32rJNRE7LEV/B9RgLYpd1S6tFS1ymTgSmr5Ewh4SDKOC84rpDmEJvIVfIHFrxbdenSxa7n8/iGEV342HCaL1q0qAnRlcnyMZnMo5z+U8+McxLjeHJPEke0z75GcZ7JjiC/B0kjBqnqSmdmMlpMJqvJHheWqUS2VNqWKfXMOHdcg5DmvKd23wYbbGCl4yBhIbao6fXRRx8ZyHLuI0jjQuRzbQuR5BNv6kJNnTo12z3kKjmHkR997rnnDHJyrkHUIUPItco9Q4y6YQRliFVy/bCu7+Nf6L7mc1vci3hWQ9BUYgQqcC6EGecD9znOTeo/IiVKCQkfBgknpH/cRNenn35qZRnZr1qMrXzgV2obiSe6GHDBGnMzQqs4nx5xqYA08nIMAKZPn24HdDDeaJiSPQADDuvMg4cirVzoaoqAIqAIKAL+EWDATdBGcIDOIIuBkVpjIyBEV7CAd61Roa4FkYW8NPKCwYs7BaTVFAFFQBFQBBQB3wjgQMdBjdUi6lgi7nGSExXfyIbzlTpKRLTjSD3ppJNs1pGbeeIDHwJsqQGGkZl11113ld0sjkkclGKlEl2yvFtbhnmoJ5BdIuYSScyDqBk3blxRNSHIQjKpcGB369YtSz7hYIfUEwtmykECEFAkdZrIMnNr0sh6MuXacB3fl112ma3xI7/LFKc6BBHGsSVYqRyDbMMnVIkRkE62ihAIbhscf84DMc61jGSffM07hUyD3OBcLdfcTA2fxzeM6II0hTDhnMKBLkYWCtl3wVpuZP1wLxJj3E1/MZ99jeo8o5/UsHMD89q0aWN9ts2bN7dEKOQexJ9YvnNWfi9lGqxpXco6YcsQ6MD1Rl994s09CgJbsnrCti3z8LviiyVjkvMccl1s6623tqoa8r3S68f38S90X/O9LbCEDyiX7OJ9GtWcfAZRz70aIk2eI2EZsvnWLzSfd2dIdyxuoss9Vkp0FTpqMfwmFzSFUWG1fdwcY9iNutokNwqKhTIlLTajTWoZXhxZREMQecSgo1j6b13tlHZGEVAEFIE6RgCCi+iuYDTfkCFDbIZt2AthHe+Odi0iBIToQqYF50dchoMDR8faa69tIyGJcCYwppGMaDwknokYVlMEFAFFoF4QwCmOY33llVeuly5V3Y8ddtjBZonQUC0KpmdqRJnnn3/eBhgRaNTIRtQ8GTs4VXEoRkV0QSgee+yxFupKia7+/fubZ5991rYBaYATMZjRVOxYonCDUxtr1qyZeeONN7KrEBScqVVmz43szMwH5K1QwyF7jOwMsp3IviGbhawBPotsFkQUPiuM9nCmouKAZWrOm6Ay0R133GGztMjowYFfLEPtkEMOyTpwKe1x6qmn2rbdfxAu0ocgmecuV+jz8OHDC5JuwXUhISFKXYInuIyLPb+RJXb66acHFwv9Ds7sL+9T5dh5551nUCnAfB5fSDeIEslmg6CaNWuWJUfZDv415DrJHuJ8Q84szAg8hyTFyPCS7CiffaXtKM4z2uW85/5NqZRiRmABZEI1cqBsA+w5bzL1wYptsujv4lv2jTfvUJCztJvPIAhJ5OCegvHewfUj8qnMg6yRd8Nqrh+fx599KnRf87ktMOAa416Br7pU4z7L/TafSeYZRDPSklyfvoJeOM/lvhA30cX9kmQWjPtMuc/LfPjVw/zEZ3SRUopOMVFF11xzTc4DoB4ATmofeEHC4UpkE2ndRBMQRQTWmcKtNgqHgR7yBXJzTeq+ar8VAUVAEYgLASKGILhcLXH6ghb4BRdcoPfXuA5MnW5XnrdEGPJMjstcORX6EPdAvZY4zJw502azzZ8/376gMvbMJyNUy37pthQBRUAReOKJJ6wsFLJcONGoVZMG4x77zjvv2F0hEyVqEg8nGPL91KZyM0zSgGW5+wBxSsY2vgCIilNOOcWcc8452eyrctvLt7xbb6VSomvGjBk204jgMAiMSuq246RljAMRxH4Tze8afpCDDz44S7y6v/EZcqxQpsaOO+5oZchkPbI0Ro4caccTZFZBKgYNQoTAIiT4ihmkGeQIZAFthynxULcGwo1+klmCok8lxtiPbXCtIPsWNLJQ2M5hhx1WkioF70Q9evTIkoIQe2H9D25HvkNwIPlObTakMMkegcjDqSxZcUj/UZaDrIp+/frlSEfSjs/jy3scY0SICjIU2aYYvra3337brLvuupbskvnBKSQp+IEvvjkkDsV89pU2fZ9n0s+JEycWJBVYjvOe81Dec2TdaqZTpkyxEpnlkp+yTeqFURdNrknfeEPOQk5xnoqRJYqCC0kHYaQwWX4EG0B20T+kdeW8qvb68Xn8i93XfG4L7AjIIEkDLPkje5Zrn/OJjEmOoysXef7552elcgV7d8qxRmIVfzf3IcYC3Fd8GMEKjNGwuN+fXaKLew3Zi2mxxBNdEFycuGR2XXvttYYbqZvim5YDFdd+cBNloMggnxsvLxrc7LnQGUgxkCSlk4y6YhFGce2DblcRUAQUgXpDgAEecidocbtGVA1FdF0pE/d3/dzYCMgL4K233pqtKRAHIrzAuPIZODlatWoVR1dqtk1eSogWDkr84PgbVaGET806rxtSBBSBhkCAesqML8R23313K4ccNTEk24tqSm2Sl156yTaPcxgHX5QmOPLO++ijj0a5qUS0zdijU6dOluhCaYBnHs8+n0b2hcjUde7cueJsDAgEnJ4QTtUYbeD7CMsuwTlIBoF7rZWyLfaL+jzB7B0cs8uWLbP1pEppp9gyZNGQAcZfPkMuDtKYrJFCy+VbPzgfCTFqHkE2gRmqQJA4YFiOgSmqBZCMnGvVGv2BvKQf7Gcp/fF5fBk74i+r5nxkHyAlw7ItfPa1XKxLOc9oE6KR8yyMDIV05H4LeROFkx2CE9IDvyXnPDjy/OCZCOkJGUsfWI7+kY1JjTk+804e9Cv7xptzE4KKQA6Or2SFFjsW9INzmevMNd/Xj9t28HOx4+/zvlZsW8G+Bb9feumlVvlN5hcj0SHNIOkJlkAylPsRnIMP41n65Zdf2qbiJrrItBQ5VGqrBeVTfexvXG0knuiioCGSAgy2SAGltklaotfiOinCtossEWnupDQyeCHCgOJ91EcjtRMjQglJA9hvHwOmsH7oPEVAEVAEkooAOsjIU6BNHzQCBqg1yeBHTRHIh4AQXWQVIQMTlyHjgEyPGBJPLVu2lK+pm/LCO3DgQCvjHNw5IrEZ+6gpAoqAIhA3Ashh4ThxjZowvMMl2Q488EArAcc+4BCMWs5Ztsczt1AdjyRjWk7f27VrZx2wZJYghefKvZXTTqFlCeChRhVWDdFVaBs+f4N8IAuNjB2comGGPwTHNRn47BMBw6UQLWFt6bzaIpCk45uEvhKgMGLECIMznWsAvyEZddSLW2mllWp7cKvcWhLwrnIXU7c672rT/y9zFaKTelSFzjuym/DNHHDAAVZyFHl+X9ndSJoS2IDFTXQhwY8sMaZEl4Whfv4J0YUDggjjK664okkKcv30Ntk9IdIB3dxLLrnEklsQXqSXE63DhYEONbb++uvbNE80hEtJsU82Ktp7RUARUATyI0AtCV7eZXAVXJJBPxI5aSYJgvus3ytHQIiu2267zb4kVt5SdWsyMMehKkakPXUG0mhETSJdQUHtoHXp0sWqCRAVqqYIKAKKQNwIUM9j7NixTbqR9Pdjed9nxwiwjDqgUuocEdSJvFSjG5ltZCERWIzUVjHZp0rwcjPFk0B0ufuIzBVygGSN4AQnS4RzB9k9qa/jLq+fk4VAko5vvfcVfyJEV1oI33rHO1lXWnS9JWOQwAQMognJx0LGey2Z5MjUIjuKf5sEDx/Gc4HsV4wMPHzpcRn9EHnYl19+2WY3xtUX39tNfEYXknnI6DEgpcYJA3x0idWiQ4BUfqK5yZ4j5R1jMIdsEam+n376qR3kMZ80T6KYunbtaqPP0+oIY1/VFAFFoLERYPBOhBDEFnUC8hmp8GRvSQRNvuV0viIQRECILjIDKe4cl1GcHUkssbQVsJX9okYpkioSyCPzIaapvaDjTUHE35TsCRye1CNB4ilqh7a/nmtLikD8COBkJ+uGWl2uIYnEtZXUoBokzHA2YQQdRO0kPfTQQ21h+/XWW69JhpyLa6N83njjjW2NEoiuYcOG2ecfvhefRgkKMsWwpBFdPnHQthQBRUARUAT8IkDmoPiteXbxDlfIUCrp06ePYSyArG7r1q29yRgjFYhkIBY30YWEoqgJpS1oNTVEFxIDFGcPFmksdALrb9UhgKbs008/bZBQgmxEO7WQkQFGRBisMX+w6R06dIi8oHChPulvioAvBLge3D/adb/LZ8iQfL/JMkwxlnXnyeew9d1lg79L5FRwyjUZnOd+l99pj/nyXZbhu/wW9rssJ1O7cEr+cSzI1po1a5a54447sgOWfLvHoAqHORImglu+ZXW+IpAPASG6OOe23377fItFPp8sJ7TrxZDtSWNWE5kRBFC5BgFDRp1mrLuo+PvMuJB6DtjFF19s9fH9ta4tKQLpRwCyC+cMsvOukRV15plnurMS85makBDgGPWjozbkaInexrn17LPPRr25um9fiC7OK+QFkcJEEtOn4cMZM2aMbZLxDeMcNUVAEVAEFAFFoBoE8FFvvvnmtnYj7ZTybkHtaRR3GAsQXLrOOuvY4Jdq+iHr8v7MezQWN9H11VdfmY4dO9q+vPjiizYb2X5Jwb/EE13HHnusmTt3rpXQgXCZOnWqrR+VgmOTqF3gIiF6kCLt/MnFW2wn0Fhv06aNvXngPCLSkBsJn4N/FIrEYV6tCYkQJA1ol3lkrEEaBP+C68n67lT6JqSDtCHLFPrursPysixtymdZRn6XaXB+vu9h85nnbkPaDE6Dy0lb7jT4Wb5LW3yXee40+Fm+V7Keuy+0I22FTeV3psH13G3LZ5nKenyXeUzV8iMAuYMmMtc8U/njOxrJ/FEYlvnyvdA8fnOXZd1889z5spw7z80Y4DjiRCFDBX1m+ZPIm/x7mPsLgyOk3SD02aaaIuADASG6iC4j4jku4znZvn377EsD0h1cU2kyyLtevXplM9TZN8YovPAoyRXdkXaJLiSwL7/88ug2pi0rAilF4JNPPrHy8ryfia2yyipWhi+JWV3jxo2z5QnYl1oQXSKVCFZEdje68bxHpQWiC8ltgkCoXeLTJk2aZMaPH2+bVKLLJ7LaliKgCCgC6UWAYJTrrrvOfPDBB+aoo46ymVju3kImEWwsNm/ePCvFK9/DprIO7cExMBZ4/PHHwxYte962225rqNuOxU10ff311zYIm76gXtKiRQs+psIST3Qh/3T//ffbiE+cD0p0xX9eQgJQcBImXP4WLVoUf8e0B4qAIqAIRIAA0qwDBgww3bt3T1UkTARQaZNVIiBEFxJO2223XZWtVbe6O1B/5513LIldXYv1tTZZmEh9iTH452WHOiVq0SHgEl3dunUrKAMb1guktcm4w8GPJv+uu+4atpjOUwRSjwBKJ8OHD8/ZzxNOOMFKz+XMTMCXKVOmmIsuusj2tBZElwTSUmuJKOdGt0033dQw/oDoIiuQY+HW6fSBDzXAJbBBiS4fiGobioAioAikGwFK5uy8887m22+/tTtKUgRKHHvuuWd2xwmgIJACQ8b5lVdeKaqug2oZwRyUSaIkBWMB950w23gFH3h//+yzz+yazzzzjE36qKAZL6ugoMF7F0ZQTxIDofIBkXii6/jjjzdz5syxqYVEOE+bNs2gwalWXwjAWlOglQjDxYsX21pe1PPij+KtzFdTBBQBRaDeECDDlHR3/nBwMyWbg8hoNUWg1ggI0YVkpisdWOt+sD1qzZH1hL1fg5opdkM1+idFiGVzZH1CnsSZRSd9SfvUJbrQsb/77rtL3mUc0n379s1mGpJNy/ryEldyQ7qgIpACBMhQ79+/vw06lN3BiYFjhYz4JBmyhcgXYrUguiAEIc1XX3116xRLElZR9JXxb9u2bc3AgQPtcShF+qncfkCeQWhiSnSVi54urwgoAopA4yFAdhZZV66hFnT11Vebnj172jITBC5CiGG77LKLueGGG9zFQz+jVHbwwQcbuAaChpo3b95EDjp0xRJm8nwT37cSXSUAVuEiiSe6ZCDKi+2f//xnQyFTTmq15CFA0XdYZRh5pjiWqPmBQ5mpyn/Fc0xdaT757Er38dmdL5+Zun/03v3O51Lnueu567if3WXyte0uYzee+efOC/tcaBuynWLLyHLF2q+kHdYhekXqPkk9LL67n93lZH5wmm8dlnN/c9fLN7/QOoV+q7Y91ufewV/wM9/VFIEkIyBEF857SIA4DYeXyDjUwvFYy30V2SrZ5qmnnmpOPPFE+arTCBFwiS6ksh577LGSt0bUJfVjXKM2LO8HRGOqKQKNhsAbb7xh9tprrxwJVsiEvffeO1FQENxxyimn2D7X4nlDNug999xjVlttNfPaa68lCqsoOvvrX//arLvuujaj65xzzrESg5CoPu2CCy4w11xzjW1yhx12sDLBPtvXthQBRUARUATShQBjHAIv8Ue6hh8IxZ358+dn6/7y+3nnnWefY+6yYZ959yCDmXe/GTNm2LHAU089FbZo2fN4vpHsgcVNdH333Xc2iJu+aEYXKNSRDR482Nx7772md+/edkB6/fXXq0xJHR0f7YoioAgoAoqAIqAI+EGgnoiuoUOHGjLpsVo4Hv0gWLwVov523HHHbFbQ1ltvbXCyKlFeHDsfS7hEF1knDz74oPnxxx8N8pgoAKAnz3yCoJAg6dGjh1l//fXtppEVIXIzaMiakBGipgg0IgLnn3++VTyRfS81olmWr4fpQw89ZI444gjblVo8b/70pz9ZgrxZs2YGR1qjG/fl1q1b24yuUaNGGWQG+/Xr5xWWkSNHmunTp9s2lejyCq02pggoAopAahFw6zsW2kmCNQjQLCV54pFHHjGHH364Ofnkk81NN91k3zmQM/RhvGOicIbFTXR9//33WUn+5557zqy99to+drEu2kh8Rhcs6+zZs80+++xjpwyQfve739UFuNoJRUARUAQUAUVAEVAEfCEgRBeR5hAwcZorM1QLx2Ot9hVt97Fjx2Y3N27cuJwixtkf9INXBJYvX26o57rHHnsYPpdq1I75y1/+kl2cjIAJEyYYohTFkGsjUlFNEWhEBJYuXWprOv773/+2u4+sDzKfSPEkxaQwPP2txfOGLN477rjDkurUnW5022KLLQxS3mRyn3vuuebSSy+1MrE+caH2F5HzmBJdPpHVthQBRUARSDcCEFijR4+2UoX59rSc9zkJriHohUA5yLG//e1v+Zoua/5vf/tb89FHH9l1nn32WRtEUlYDHhdGUY33KIzsN57zabHEE10iLdCrVy+rpY3mJpFqaoqAIqAIKAKKgCKgCKQJASG6yGTfcsstY901AouIwMZq4Xis1c7uuuuuNnuI7ZE59MILLyTKIVwrnMK2Q3FlIh7feustg3OYiEVq3OC0PO6446ykrLsey+BQ5vxZsmSJ+1PJn9u1a5eV0JSVyMqbOnWq1dMnIwNZk2OPPVZ+1mlCESj3/ErobkbS7f32289AFokRAU2QaFIM+UApLl+L582wYcNsXUbkj959992kwBRZPzt27GiL1JMxS4bg5Zdfbv74xz963Z5gTqNKdHmFVhtTBBQBRSD1CKD+AJlFwJuUDZGd7tKli7n55ptLVudATQIZe95RUIzzSXTRlw8//NB2LW6ii8DC9u3b27784x//MK1atRLIEj9NDdHF4Hfu3LmWcUWiRE0RUAQUAUVAEVAEFIE0ISBE13333Wc6deoU664x5hLyoBaOx1rsrCvhwPY233xzK51Xi2372MayZctsbUbIpXKMosg4klkfGUDqsSALWIqRLXLXXXeZBx54wCB7EdTJlzaCUlc//fST6dy5s/n8889lkZKm1HikdhfHpm3btrZY9IYbbljSurpQ8hCo9PyKak9xpJx22mmWzKVOInWFClkl1xZ1iolMJnN3//33N2eddVZ2E2Rl4RjheuUaIhIXEqJYFO7kyZPNxRdfnG0HkguyKyn2wQcfmG7dutnu1uJ5M2LECOsUY4O12F69HwfGG9Q5hOjinJ84caItG+Gz3yIXSZtKdPlEVttSBBQBRaBxEKCWFpnHIjtMrd7bb7+96DjJRYh3mmOOOcaO96677jqvRBe1wxYuXGg3FzfRxZh2k002qYu+uPj7+JwaogupE5hXUt5lIOwDIG1DEVAEFAFFQBFQBBSBekBAiK45c+ZY52acfSLTSSK60+IIJMKOSDsxgqiuuuoq+eplSo0pIg1LlQ2DfCOSEIKnkCE5cdBBB9lFkF8kM62YkSFDZP6tt95qRNaMdZA2O/DAAw2OxxYtWuRt5u6777aFnUshq3jpPOyww7JtBbHO/hD4sNpqq1nZNUgF5Dp/85vfmDXWWCOwVPVfX3nlFSuBjkP9X//6lyX60PPnmuMdgxdlH0a2GTXfyBL5wx/+YItl+2g3CW2Uu+/VnF8uHpBlFBbnOuKaLnYtuesGP1OvgX6Jvfrqq6GkcDXXlkjmsA2uxZdeeslug3OU6OLXX39dNp+dBonk7A//9+Hll1+255vM57rmHp4U4xiKXG8tnjdnn312tq5fLbZX78dhq622ss8siC5IWIhT7l8+TcpR0KYSXT6R1bYUAUVAEWgsBAi6Q9b822+/NbvvvrvhXaIc4z37+OOPN6effrq59tprrcKHmxVfTlvBZeEqeNfA4ia6ePfbeOONbV/irhdmO+HxX+KJLnnh2G233ezJTEoiLKmaIqAIKAKKgCKgCCgCaUJAiK7777/fUDMjTkNfHJ1xLC2OQOrW9O7dOwvrgAEDcrIgsj+U+IHMjFtuucXqnlN/igg+sqYwMjBwuvft29dA4oQZGR2QTSuttJIZNGiQQdopn7lOwr333ttMmTIl36J2PvKXtMdLYD7jHCNba5VVVslZhEwS+kX/SjFIvSeffNKsueaa2cWpobXtttsaMCpk//znP82qq65aaJGqfoNwInujmPZ+hw4d7EtvMecu7UGOIqkI8eiScsipjBkzxmbi0GlIDCRRunfvXtU++FiZl11qEnGceAFHSpKsPuqbybmKBGQh87XvPs4v6Sd1GwYPHmy+/PJLO4vrm2yUSow6DRAgrr3zzjv2OLrzqrm2aMcluviOHCgk4b777ptDSPOb2KGHHmpJZ/kenOL0IVMT4lwM8o/syCSY64ypxfMGWV7kebFabM9uqI7/QTLiKDz44INtDUueLzxnfBoZ4mSKY0p0+URW21IEFAFFQBEoBwHGcYwdeT9ACh0pe19EF+pz77//vu1O3HKBjLclkE+JrnLOkBose8opp9jIyB49epiHH37YRqW60bg16IJuQhFQBBQBRUARUAQUgcgREKILSQWclnFarR2PtdjXoIMZx/7VV19d9qbJCELq4qabbso62As1wssUcmhB+93vfpetDwPZA+mTz+ir/I78IM7xfAZRCjHGMSxm1MIdOnRozmI4gKU+m/sD0lZk+e24446W6Fl77bUtSUWdrJ///Ofuovbz888/b0444QRbu4sXPwLVLrzwwqykB+uJ9EiTlaucwcsdx/ayyy4zFGMu1ejj2LFjrWxi2Dpgdeedd9qfILA4BzDmBXFkfuvWrc0jjzwSmhXE77UwJCd5n5II03zbLJZJ6mvffZ1f7IebmcN3iEeym8q1L774whKSQlSzfhhpVu21Rbu8z0Jsi4nDJR/hggMGArV///6ySujUvUewwIQJEyx5FrpwHc6U518+HHx2mTpU06ZNs03WYns++x5FW2TSkhFJRtdFF11kyBrea6+9vG7qyCOPtEHLNKpEl1dotTFFQBFQBBSBMhAgkI/3H6SjeVegXidEkA/bZZddzHvvvWebipvoIghKAp4g8lCySIslPqNL9Jw5YYhMu+222+wLdloOkO6HIqAIKAKKgCKgCCgCICCOvnogutz+pMURKC82crbttNNONiNLvpcynTdvniU0JIOklHUggZAjw5Eo5kp1ybwFCxbklTzcbrvtDHJpYvkyoSBVjjrqqBySi4wysrvI4ELGEDlDyfTiN1eqjfaRIHz00UdlU3ZKdh/kXrXZV8iEzJw507ZZjNzL6YDzBak3yCgy0ciuIiPONXACg3zSbci6QUBxXgsO7vr8Rh8lCtL9TZQmmLfZZpsZzgeOBQSgm03jroNTfeDAge6smn2GmIHkKoXsgySChMLpHWa+9t3n+UU9ITLpxColuoLtcI5ASLnSnj6uLfqJlI1LWhHUICQ2v5NVCClAliE1wDi/OSeLGaQy9R3FRJZHvtf7VJ5/tXjeQLgTxY3VYnv1jr0QXWSpUusNx1+xDM9y94msRHw5GMES+HTUFAFFQBFQBBSBWiPAew9jWoKleI/wSXS5QYxxE11I6aNAgaFssd5669nPafiXeKJryJAhVlaFSFDkKZToSsNpqfugCCgCioAioAgoAkEExNFHTdLNN988+HNNv6cxowtSAgJEbMsttzRkU5RqZO8Q/RdmyD7hvMNpjRTceeedl5WwY/m33norh5AhkwldeTE01HGkhxlRhsgsuvbmm2/mEGf8tnz5csN4GdlJMeTQiNBHRk+MAsyQqdgGG2xgKOzsmpvtIPPZP8bkkBRuW/J7qVNwQQ9fjKwv5PPKMY4hxxIbN26c2W+//XJW510hTAaSqEYc3BCcGFlfbB+HN1r/vBCKcQwhRsmecw0sRTaSfkMIQkwUcpa7mV9uW1F/pjg3xCIRnWIcOyTJIFGI7OTvnHPOyRIt3He4/4SZr333eX6RlUN7YmFEF9c4hN/qq69urwVZVqZcS8iMuhmQkMFSo5DlfF1btIWkDddpmHFtIqVTiVHHi36LQaaNHz9evtb9VJ5/SGTidIrSIMrJWsIKXbtR9qGe2kZmlsxBiC7OGe6J1C70abSNdCqmRJdPZLUtRUARUAQUgXIQ+POf/2wl2lGvYEzvk+iihjKy11jcRBd9kLGVEl2gUUcmMhlIiTA4Ql9+++23r6MealcUAUVAEVAEFAFFQBGoHgEZjOJ033TTTatvsIoWPv/882xmx6uvvhqr9FoVu5GzKuNInG1iZEpQt6uUIsbIvkFMUXtKjIyknj17ml69ehmUB9yMLSSg/vrXv9pFwzKXZs2aZTNtpK0DDjjAZinJd3d64IEH5pBRYc58lqce1KhRo7KrIvsNEeDKCkJqUYdFyA+WIVPLNfYRQitMr54sJmQYqZ1biZEtMHny5Oyqlbx4uUQXdV+GDx+ebY8Ps2fPttKN7kyIBV5mqUsVZpAdRHe+9tpr2Z9x9ErWh8w888wzzYwZM+xXiK5OnTplsxSYiZwj5BIvz5IthgMZOb1qs+GkD6VMOa8hOX/88cfs4kiRQWoFpUs6d+5sa0TJgpBCYTUCfe27z/OLTCg38yR4bXDMIegwSD6Or3udMh+i1D3XicYls801X9cWbXJehEnTklVDzTz3enX7UOxzMGOVe9INN9xQbLW6+V2ef/Pnz7fBAlF2DDJn0qRJdhNKdBnDPeBnP/uZfT5CmPLcqPQen++4udeZEl35UNL5ioAioAgoAlEjwFiL4D3emRgn8vwj296H8V719ttv26ZqMZ4p1mcZWyF5HwzeK7ZuPf+e+IyuU0891ZJb1OXi4KCBz2BMTRFQBBQBRUARUAQUgTQhIINRakm1b98+1l0jqh6HL4bckGh8x9qpKjfOC0e/fv1yWsHZuc8+++TMC/uC49utWwUeyNu1adOmyeJE8rEd5AkxyA/qJLmGhOAZZ5yRnQUBFMza4keiASEsXEPGLPhChvO8W7duhvphYjj2yTZiDI3MHwQq2S1CcrFcWEYU8yEjqAt044035mQ68RtGNhwviXKO/Gdu8f/UDZo4cWJ2QcjHtm3bZr+X8uG4446zGTosy7ETh7Ws+8QTT1gyT75vsskmZu7cuTkZdfKbO4XchdwSiUjwQybRJccg1mgrzDjOZJOxvWDWUi3JazKTOBfczD6I1NGjRzchUSB+yGZyjfpuvH8Fzee++zq/OJchX8m4wlyiC3lRagEJ4cjvwTpkBFC6xr0KZgAAQABJREFU+8r6HCtXKtD3tUU/ILrcfhFNTN/CCDCWL8VQPnElMpNKdNVCutfNflOiy9ggYjJaCaqgriHBDzjrfFrfvn2zz0Elunwiq20pAoqAIqAIlIOAjP1QmSD4zifRRZAIwXNYPRFdBDqi4pEWSzzRRdQo0hsMiIi2I82Q9Ho1RUARUAQUAUVAEVAE0oSAEF3UhsFZHqeRgQJJgjEOw2GcdIOAQlLCNbJcRMLKnR/8HMxEuvnmmw1qA0FbtGiRJbk+/vjj7E8bbrihgXxxDQIJbXixoAOe+RAWZIu59XuYH0Z0UVMFIqMcY2wNWccLXj5j7A0hJ4WVg8t17NjRFnQm261QO7IeTtRLL71Uvlrpv7BaWOw7L4oQipB0rpGVJJkqXCdcL65BFB9xxBHZWdSoouZvKeY6wFkeuUqkB8WQgwuSjPzWvHlzW+tMrtug3OQtt9ySlUyUtqKaBjMXqa/G9sMyheQ9y+1LPhnNKPbdx/nlRs+6RFfwGmMfIasHDRpkdxdik/vBF198kd19SNjevXtnv/MhimsLIpIsUTGIcc69agzJyaOPPjrbBPeOK664Ivu93j/I868WZQo4zpDumBJd/5ESJPsTogtsCOwoN4ih2PlFUAKBA5gSXcXQ0t/ThAC1E8ks5hmMrDLywWqKgCIQHwK81zL+JSiNYDmfRBfvQ8jTY/VEdFUSWBjfESq+5dQQXcgV8mKJ1Eu+IsnF4dAlFAFFQBFQBBQBRUARqE8ExNFHrSaczXGa66gPc/7G2bdKt/3999+brbbayjAVQ07uhRdeMM2aNZNZoVOXXGEBZMK23nrrnGU/+eQTm33lOrBZABlKskRcCzrhw9qDEIIYChqZRshiuMSSK2+IFCM1pqgFlM/I9uDljrpFxYysGWpR0WeyRtxaVrIumSjIjReTu7rmmmvMBRdcIKvZDDOyw1zj+CBHB7kWlpVCv6X2EBhQZ6tFixbZJoISbmwPKclSDEKMoDqx4LWI85dsx6BBlkKaikHUQQKSuYRBYgSzCWVZ8ARjX3WJXIlBji9EYKtWrWRz2SnnfZ8+fUKPZxjxGsW+05lqzy9ITchNDJlICFLqr+FsCB4rJBmRZgRz6mG59cg45yC1ghbFtUX9L/AX80HuSHF1aZMMUQj6pJg8/7jP5Kth5mtfiOAWbJToMgYy/IcffrBEF/dXAgm49/o07o/IIGNKdPlEVtuqZwSCsrc8lxgHqSkCikB8CEgtX94PqG3qs0YXY0kJUFSiK7pjnHiii6gHTkSyuJB9YRC/zTbbRIeYtqwIKAKKgCKgCCgCikAMCIijD1IhLMulll1y5d/I6EEuLg2G3B7a7K5RhwnJukIWJKaoN4LsH4ZTnTb5LrJ3blviXHfnISE4ePDg7KwRI0ZYx7vM4CWJjAwIkzBjTIxUnhhBYGSoYJAXECvUCEPy+/XXX7cydtRmYgwNGcVfWIaPtJdvCsHGSyERyhAUQUMGDwcyGU5hJrr48ltYZty8efMMdbjEyC4kU0eMLDTqYIldddVVOfJ7wd8hKd0ML1kvOOWcP/zww7N1rSAUicpkKsax/Prrr+WrnSIXR1Ro0DgOkHAYNc/OPffcnEUgW1iPyFKczNQak2yjnAXL/OI6lCEgkYILGg5n+u1KXbrLhPXX576723I/V3J+BWUiqfsGpm7moGwDYhQSn0w9HPpiyFNy3w0jBKO4tqiT52Z5Bq9n6Vc506AcKueSK7daTltxLCvPv1oQXRDTY8eOtbupRJex8raQ8pC6kIBRHAM3yl2JrjiuMN1mLRHgWcaY0A2mYPthdVFr2S/dliKgCBirZsF7xIUXXmgDCqMiunyM7ao9XjK2YsyJwkhaLPFEFycgL6y8mBP5RoFponHVFAFFQBFQBBQBRUARSBMCMhith5pY9OHQQw+18B500EFly+LV63GBeICAcA2nG07iQsTPiy++2ETSjEwkZPUWLFhgvvnmG7fJnM+oEqAH75pbA435vHxAfq255po2CwViRrJRkCqEeED6Roziya78DfJ64rBdb731DFrshfZH2sk3hWDjL1+mGzKQZPoxLg8SXp06dbIEW9i6kAnsixikWLA2mSsfSIYORJ1LNpGh5BJCkGJnnXWWNGkJC3cb4EEWz1prrZVdxv2AdN20adPsn2Rg8XuQfKTmE/vmWrt27Wy23korreTOtp+RpsRhjJHdRZaUa0GpOV8ZOEjvcb5iEDuQkmwfQ54MGUPOJfecJcOIYEIxMuSoDye4+953n+dXkISGzIbEYl/DDHlJnJCuUadB7nfufD77vrZok21xjxWj7luHDh3ka0VT6iq5ZGqpBG9FG4tgJXn++chuK9Y9N7NU7pvF1knz7zvttJO9H1DLj2fLjBkzbJ0/n/vsZoQq0eUT2XS2xXOLe8FXX31l5ZGDstP1utc8WxgbBeuhSn+V6BIkdKoIxIeABAYh+U5QlE+iyw02qyeii+BHGWfFh7y/LaeG6ILcQteZh0ZQ4sQfXNqSIqAIKAKKgCKgCCgC8SAgA1Dk4XCgx2ku0UUtKjJv0mKu1JnsU7GsteXLl9saS59++qmskncKAUVGlhBVPXv2NNdee22T5V3HHz9CDCFzCLHD9jBeviAmICxcQoj6aUTei0FGor8uBsly5JFHyteyp0gm4vDEyU+NKyFKgg3h1OElEaeUa9RzEnlBdz5Ba5AqYtQUQmpP7MMPP7TZdTi3MLJpkC137ZVXXrHZbjIvSHSRYYcUF1KSYmRIHn/88XY/uM6ooYbEJDWiIEpc0od1OGaQX+AuFiQnmY8sUT4HnNQAYDmOI5lpZA6JBSWNfGXgEKFKlqIYUpZk8EEu8dK9ePFi+clOIWJxKFJDB2zFkPFDggXzve8+zy+uNemn9N2dggfERj4pT+5vZHjlI4Z9X1v0jcxBZDHFIKlwgFZjkHXufSYK+blq+ldsXXn+hcm4Flu33N/BCbwwJbqMrTfJPXf//fc3ZMhGUVOQZwn3d+5DSnSVe8Y21vIEavTt29dmy7PnK6+8sg3EqDYYIEoUkVpmLJSP4JJtK9ElSOhUEYgPAZ5xqCiMGTPG1uskqI73AR/GOyABkFg9EV314Fvwga+0kXiiC8cDjCsRlLx8hWnGy87qVBFQBBQBRUARUAQUgaQiII6+epAXoA/Ia2FkxCAHlhYjGwkZJRxuYrzkkJ1UyJGCsx/JwnxkF+TkySefbB00bg0eMsjCam2xvZNOOim0RpL0S7KKIGII9JI+Q14wLoZAwVxShe8QNMjmuOQY84NG1gsydpAf3bp1yxIxbv/J6qF2FTWNwCnMOD9wkorhmOJFL5jpBNng1t9p06aNQUYMqUNeMnGyLlq0SJqxuAUz8JDbQ9JcLIykDJJIsmwp03333ddmPEk2k6yDkxZSRDLYyILgZTmfBQkYzgF3X1xnO21AyMg1l6/NUuZ/9NFHBhLVrUWXbz0CCSFEyHYLZkZRgw7SAfO9777Pry5dutg+Bvezc+fONpuS6wM5/KBtsMEGlqTNl+3H8r6vLdoMku3cB6hxV425zhVIO4jVfBKi1WwnqnXl+YfUJpKbURrnPBlvmBJd/8laXLp0qb2HQ5KjpkOwgE+jvSVLltj7khJdPpFNX1uSbeHuGcEq1M8sdK92l6/lZwLDCNpBgriYKdFVDCH9XRGIHgGCN3m/QsKYoDyfRBeBiIy/sHoiurhPbbTRRtGDW6MtJJ7ogmnlJRLHw2uvvWalR9CIV1MEFAFFQBFQBBQBRSBNCIijj8yctm3bxrpr1LERkgTSBDIEciUthsQXWRSubbbZZtbpHSRn3GUghIjYRT4PQoE6WRwroo8hcCQDyJWPy1fDiXbJpIGoEfJEtkW7EyZMMLvssovMMieeeKIl42QG0nebb765/Uq9J/ogNaFkGdY/4YQTDGNnjh9ZThBQZFYhb8hnyR4jK4YsHgyyB+k61yA8IVDIOsPZBMnGuhCAzz77rK195C6PXGBwzM7yO+ywg3V4usuGfWbsT4BbMNOGfYWUW7hwoV0NnOhv0OQdIjg/33ccsWTaFKrXhgTlaaedZvcdojK4f8G2DznkEFsrjfkcv1NPPTW7SDADh/pl2223Xfb3aj5A9HGOg1U+43yFZJTrGtlG9t11/LtSJz733ff5FeYYRVaUa7V9+/Y2M4CMPrdeGftNDbtC5DbY+b62aJNzCAJNjL65dedkfqlT5DeR+Zf7COcl11+STJ5/tYg6JoNP5E7d8z1JePnsK/cCajwSrED2YxTykWSOErBBjUOeAe7573NftK3kI8Bzh2dn0DhPRQ44+Ftc3yGICbT49ttvm3SB/uL0dp/7SnQ1gUlnKAI1RwB5XtQkkPEmKJDgPF8BnagjoESH8U7WsmXLmu+fu0EZW9VD/W+3X9V+TjzRBdMK40pkF5GRtYjyqhZ0XV8RUAQUAUVAEVAEFIFyEZDBKAQEmQZxGtFovKCL4dRPU41UnBJkdQlZIvsJ0TFq1Cj5WvEUOTsyx7DjjjvOkln5GuNFiEwmxrkQXBCMvCgJASHr4YiEIIBYglCDXGrVqpX8bN566y2bEYQsX5ghjVgoy8eNsscRjPxhIaIkbBsyj75DpvHyGDTqV0BOFTKit6dPn55XTx5n18iRI23/kIBj+TDjxZVlIe0+++yzJotA2EHwHZapGyakYZOFAjPIPOM4UeupmHF+odcPWUc/3GuI7XLMxcjQW3311eVr1VPuIxAqZGOJcd6wn2TohRF6SEaRXYTznwhXiCI3u8bXvvs+v8h0pO6VyHdCwpKZggSlGMsMHjzYSlaSEQi5tO6668rPBac+ry02hGwmDk8hmau9vyJjSr07McjtsAw2+b3eppAfQhrXwjHkEqNKdBkbwEAQBEQXmaaQ2hBTPg0ZWmRlIWWV6PKJbDrbgnBlnODWzcRhHAzmiXvvGUu6z0j6w/iAjFECntygMX5TogsU1BSBeBGQYBdILsgun0SXq1hQi/FMMSTFt6BEVzGkavw7TCuMK9Gjb775pnGjV2vcFd2cIqAIKAKKgCKgCCgCkSEgg9Gnn37arL/++pFtp5SGgzV5eBlAti9NBhFw4IEHNtklHxJyOPUgpjCiecnm8WE46+fOnWuJrl69ejVpkm3iwC9Xax6JN/abrDYx5CtxNEFYlWMQJLSV73whqp9I5zDiaY011rDrQbYUk12DwFm2bFnRjBzpOxl4OFnBEOKpRYsWluiQLDxZzvcUMgPiRWQmaR8JLzJwxFq3bm2JS/nuawpRCakC6Up9MMiEIIEati3OI3ABo2osbN+lPd/nF7JRZGnisOf8IvvQp/m8tugX1yjBnEjJDBkypOKucl5zL5D7DQ0lLTCUWn84gDHO1aBsqP3B4z9XjlKJrv8SXQRZkA3qM7tUDhvSuzwbkJ5VoktQ0WkhBJCJJmCBAAYCdQgOOfbYYwutEstvBEfhOCe7Hyc39TYlaEWJrtxDwriPdxyCR7jvo5IAVtwTCApzx0m5a4Z/891e+FZ0btoQcIku5AtRAOC89GH1SnQRFLjxxhv72MW6aCPxGV3ICnAiEjXJzXDevHk5L+F1gbJ2QhFQBBQBRUARUAQUgSoREKKLLBRk4uI0nKaQNcj44awmWwKptbSZ1IIN7hcyYhBGlRjkAuNWCBWMyF5q8tTK2C61lYiIdjOG3O3jTID0oM4UJBcZaPkIH2SEyMJCa16k0dy25DPk7G677WazAoIRzrKMTBnTo9pAFhPbJZusX79+dv1C0pGyftKnOO4OOuig7G4gWYhzuREtivMrKhx9X1vV9pOABM4jyC4x7j1IqybJqB3BMwarBfHEtSbkYi22V+/HApKRwAGILuqXzZo1yz7/ffYbiVCCF8g4VqLLJ7LaVj0gQL1TiNygBWUYGSNNmzYtuFiqvyPvyD2XAIxC48hLLrnEjgOLgeG7vWLb09/ThwAKC6hWkAk/evRoGwBG8KMPQ0ae8xyrp4wuxoWlKFH4wKAWbSSe6OIE5EREkoTB/EMPPWS11msBnm5DEVAEFAFFQBFQBBSBWiEgRBeR/qVKakXVNySGGBAToUpGCNknOL/SZmQXIdEoMoOyf2T88FLuZjjJb8Wm4siT5ZDFQBIqDiNq9r333rMSjTjpkepDFhMJvVIye9w+kzHDWBysiMKFkEI6kXMVYtaVUXTXK/QZ4gyiKx/JVmjdJP8m9QFkH4gAvfzyy+VrQ06jOL+iBNLntVVJPwn+HDp0qPnyyy9zVp8yZYrZe++9c+bV+xcy8agph9WCeLr77rvNySefXLPt2Q3V8T8kPpFZhejC7wI+bsapj66jzoOkG4SaEl0+ENU2SkGArDDGroxdGOt17dq1lNW8LUOdUTdoimvMlZn1tqFMQ+wj9/833njDrLrqqlZ+9IADDog1cI57CUFybsZxvn3mGXBYRka6kPlur9C29Lf0IuASXShQEIQh0tfV7jVBe/Pnz7fNKNFVLZr5108N0dWuXTvz/vvv2wi1NDGR+Q+d/qIIKAKKgCKgCCgCjYSAEF1InbRp0yb2XaeODZk/ECJkDLz66quRS0rFsdPiAKFOjGvUwypWS8pdXj5TD4p1xciGolaDmiIgCODQwbkvRnbbMcccI191qgjkRYCMURylV1xxRZNlkGucnqltlzQ76qijrGoL8po8Z6I2as9Rrw2rBbEW9f5U2z71KgmIwAkPCV9tzbj/z955gElRdG27DKiYE4qJDxEDGDCBCKKISDCAoogBEUGSiAFEUBFREBBQUAQkqaAISEZQgoCgGDBhThhezIo55/+96/trvt5hZndmtma3u/c517XbPd3V1VV398z01FPnnFTtIWQSkywYz5HQlYqQtuVCgOc3cpwyVoh3K+GPneHVPmjQIJsbjm2ERCU05/HHH++K5H05ffr0AvkSCWNNOGufRu5V8jTCAc+yoPEMj8cm+Wfr1KkT3FXkOpOjyNeHAMCEN0Iu8xlNrrQKFSqYpk2b2nCSqSpishy5QIkukIk5oWHHHXdMWdx3fSlPoo1lhkBQ6BowYID93CCctg/j9x+/A7EwCV1xcxiKvNBFuBdc6JlRzEyjuCVR8/FmUh0iIAIiIAIiIALRJ+CELh6Qc/GO8U0ArwBC37Fk4GvBggXm0EMP9X2aUNS3dOlSKzTwY9pZ/fr17TOoe53pcvbs2fYHvis/cuRI06xZM/dSSxGweciCedQI016Sg2+6BNElwEAtOWGS7fDDDzdTp061M/mT94X9NYPUCHhMCGBiQL7tkUcesflgOI+ELmMaN25sPXVbtmxpHnzwwbx813ONidCDR7CErnzf4WWnfrxaZ86caTvMdyjfpRjb2Jds5MMkVw2CTUlY0FuV8+Hd5MK0+jg/z6x4hL/yyitFVpfNhBpCr1155ZVW4CqsYjzWDjnkkI2KMOHixhtv3Gg7UQVoL+Gq+UzAyxPvM3KwEUkhnfmuL915tL1sEAgKXf3797fRLggz6sOYMMKEVSxMQhe/c/GsjotFXujiA5IPNkKiMJuYGN4k7ZWJgAiIgAiIgAiIQJwIOKGLkAfMlixt69ixo1m8eLEVgMaOHWtDSxUVVqS021yc8/MjgBAz5CTDcg0xg7A1bNiwRFOYaUvIHJkIOAJNmjQpkD8tDD+GXdu0DDcBF9Y/2Mp69erZkFXbb799cHMk1hG4GPDEfA8C20pT/ON7je83TEKXsV4ZhOJkJvq0adMMQiA5HH0ZniF4dBEKmLBqErp8kY13PS+//LIZPHiwKV++vPVWSpW/kxCkhLPDuL8I6coELcQUPJ1SGQPbbdq0SbXL+7bk50HfHv5uwD7ThmfiUcb7H5GLcMJFGR50jNWS0zdo/FbAQSFoxx57rPVkR9jK1nzXl+35VT5eBNz7Bu94njvwUly5cqWXTrZq1cq4iWxheLZ3Ywt8NuYSjt8LlDxUEnmhixlrzFwj/j/5ALgB3cNwHnipShEQAREQAREQAREoFQLuYZSZlMxyLG0jnAOhX/Cu54cAnl3E/4+zIXYR0orwL4h7JA7P1mA1ceLExGESuhIotPL/CQSFLt73vmaSCnD8CZAw/cILL7ThuHbeeWfrmdS+fXsbZjaKvUdoct6MeBPVrVs3790ghA/MMAldxoYgQ4Ait8hDDz1k81NWq1bN23VgwJyZ5IhnhKasVauWDYnm7QSqKJYEXEhTOjdkyBDrCZ3cUXKguudSBqsRV5hYVNj7Ouj5lVyf79cIdWPGjElUy7hmgwYNEq+Ls0IoQSIPfP/994lqCF+LiE/+07feesuee8OGDYn9rAwfPty0aNGiwDb3gvd/r1697PFuGyEfef6vXr26HZNlXJbfBQiK2EEHHWQnxbnyLBETJ0yYENxkw6B3797dIFpRZzbmu75szq2y8SMQFLrQG/D0TBZmc+01OZmffvppe/hLL71keE4rTXNjC0zw4b0aF4u80OVi2BPCh2SSxM6sVKlSXK6P+iECIiACIiACIiACloB7GA3DDDAaNGXKFEOoE35g3n777TasCCLcJptsEusr9sMPP9gwWsFcD9l0mLwEhC90JqHLkdDSEQgO4OXqOejq0rLsEfjiiy+s0EUux8LCPUWBDDlcLr/8ctvUkvruI0KMCx9W2IB4FPj5aCOD2AhQeHSRk8f3gNjPP/9sB8lr1Khh8NKR0OXjqsW/juD3ZOfOnc211167Uaevv/56m1eOHQhdhNfm/e2MSWMIN0SJ+uWXX+zmcuXK2VB/uXgWuXozXSZ74BJSsWbNmpkeXmg5QtX27t07UYZcXOPGjSsgIvHe4zneeb1RmEF9GCX3f+3atfYzIJjn65RTTrGiFuJW0OgDY7POkr1Af/31VytoOc8WV44lXiU9e/bMaiKZ7/qC7dF62SOQT6HrvPPOM0899ZSFGiaha9GiRcbnBJbSvmsiL3S5WbF8STEbgWSI5OuSiYAIiIAIiIAIiECcCDihKwwPxnAlxjiD8AwIMrDKQ3LcQh/k4/5p166dWbZsWaLqUaNGmdNOOy3xWisisGbNGtO6dWsrqDLQz0xpmQiURQJ9+vRJ5NUpKdEJD0q84rCSOmeYry3fT6+++qr16Jo1a5b373kmjyBAEN4MMVNCV5jvhvC0rUuXLjaMJi0izylhAJMNAezRRx9N3mxfM344ffp0U7Vq1Y08jEoqX83VV19dwHsxXU6rlB0oYmNQ5KMofSX3VbIROpTBd547nBHyEe8qZ5QhBC6pYpxxzMCBAzeaTPHGG29YL1BXjmWqkIiIU4MGDTKICoSoTbbDDjvMtgEvtEzMd32ZnFNl4kkgKHThnbjXXnsV+N1WnF5fcMEFVrOgjjD8nndjCxK6inNV83Csc1PF5Q/3XNRRbkSZCIiACIiACIiACMSJgHsYZVYlCZtL27777jvDDGx+ODMQxoAks1MvueSS0m5aqM/vcpu5RqYLueP2a1k2CXz11VeGnCO5eg6WTWrqddwIVKlSxXqnMcj6wAMPlEj3GE9gEBeT0PW/IgKeVuQ1wvOD0I7777+/t2vBGM4RRxxhBS4G2yV0eUMb64oYgJ40aZLtI2JVcAKR63jLli0LCDhu+3bbbWfvZY7D3MQtt7+kwqSS9xVxy5nPyWJnnnmmFY6pmzxmCFDpPHzx2MRz0wlORx99tEHUdoYzAQP0zsinBaNU9eGNRYjDoJGDb/ny5cFNiXW8uvA8++CDDxLbgiuHHHKI9ept1KhRRhEjfNcXbIvWywaBoNDFb1t+fyN++zAmsRGFDguT0MWEgDhNqou8R5fLD7HjjjsaBlyId7nnnnv6uAdVhwiIgAiIgAiIgAiEhoATul555ZXQDH7zY/fHH380CxYsMCeccIL94weCLD2B5FA1hM1hsEMmAiIgAiLwfwTwFEb0wBgIxYOjJIyBUhLGYxK6jGnevLlhgg25jR5++GE7YM3AtS8jKs9RRx1leJ5gLIewZ4Rwk4lAYQTw4Bo2bJgtQshsvAGT893gDfT+++9vVA15sQi75wyPJQQVvIIwwnGTky7fdvHFFxcQgMgDhLjvwxCPEZGd8d7FSyqdBVkl59UKeodtv/32VlQkdUyyMXCPwOYEs+D+wrzVyBlG3/n9sHLlypTHE1atR48eGYU09F1fsB9ajz+B+++/307eZCIi9z7fd4Ts9WFt2rSx9zh1hWHiqhtbSA4v6qOvpVlHbIQuZmUw0MKDaXKM2NIErHOLgAiIgAiIgAiIgA8C7mGUEEL80AyDOe8kfqC2b9/efPLJJ/bBPTm2fxjaGpY2BAdRaROhX4IzZcPSTrVDBERABEqTAGIHA5sY3gV4GZSEPf/884lBbgldxnpyMYCNMMBgmM/BeK7n559/bo455hgbGo2Z7hK6SuIuj/45pk2bZvNruZ7cfffdG4XMO/jgg81PP/3kitglA81EhUq2oAdU27ZtzU033ZRcxPvrYL4eKuf+r1SpUrHP4/LeBSsiRxm5ddPl4Qm2BccBRGdnvPfx+sI4njBnycZ+2CJcp7JMma5bt87ccccddgIdglWyNW3a1AwdOtQw/puJ+a4vk3OqTLQJBIUuctjhwZzqns+ll4T7JwceFiahqzAh2jY2Yv8iL3TdcsstNqniNttsY/hAx92dBIoyERABERABERABEYgTASd0vfbaaxn/wMt3/0ePHm1uvfVWM3z4cPsjeMKECYa/k08+Od+njnT9DMgQAopwMghd6QYeIt1JNV4EREAEikGga9eudrCTKhisLFeuXDFqy/xQRB3C9GESuoz10MBbpnHjxnZWOznM3PNI5lTTl2SCTJ06dUz9+vXtAKCErvSstOf/CBCqkJynzjp06GC9MNxrl/vNvWZZuXJlG4KMsMDJFvS2x7srGFIwuayv1y1atDAvvPBCojpf0anIpYWHZLJtvvnmplOnTjYU4FZbbZXYjUhFzl0nCjKZjkl1zpxXJ6/xniOKA4ywP//804Yx5LcA47HOXKhT9xpvu+eee87QBgwvOv6C7XBlWb733nvmzjvvNPPnzzfJghc5/ZgIETzWd33Btmi9bBEgTDKeXNzT1157rf2NxiQPH4bgy2QRLExCF+9p3ldxscgLXQwOjB071g4U4GrMDKwKFSrE5fqoHyIgAiIgAiIgAiJgCbiBJeLsM8EnDOa8ky688EIb3//cc8+1IZ8I9yATAREQAREQgVwI/P777+aAAw6wh5Zkfi5OSHhgwvRhErqM9W5jjKVhw4Y2Pxf5evbZZx/Lx8e/9evXW28uV7+ELh9U418HQgz5YZ0lC12ELCQcX9Duvfde06BBg+CmxDp5pcgvhW222Wb2c2DbbbdN7M/HCt5JPNM78zWW+dZbb1lh2tWbvOT9S2jGvfbay3pU4sHy5ZdfJooRPtENxrPRORe4AvwGYUIb4hJC3WeffeZ22SUhZ6dPn26aNWtWQDBj3LZJkya2zIgRIwyT5Y4//nhz5ZVXJoSzAhX99wWTHJhMx0B80Mi/5kJXst13fcFzab1sEcDzEU+uwYMH27DJCEDJ91+uRILhSsl9SQqm0jQ3tiChqzSvQopzDxo0yDArllkZf/zxh/2g3XXXXVOU1CYREAEREAEREAERiC4B9zAaJqGLSUb8ANh3330NiWzJs8FsTTzsGSiQiYAIiIAIiEC2BAgThOcBRjJ4BrFLyvBucPl7JHQZc/bZZ1tPDOdx9dRTT9kBcl/XwwkSzmOMEJWEqpSJQGEEXG43VyY5jx+egscdd1zCG6hu3brW88iVT16++eabCRGGfQgnhDPMp1WvXr2AF5QvDw8G0BGZnCEuPfbYY1aYctvSLTfddFMzadIkK0C5MniIIRr+9ttvblPaZY0aNezxO+20k825haecs8MPP9zMmzfPvsTjC+9ZjN8NV111lf3MT+e5i7cbk+mcbbnlloYIF847z3d97jxalj0CDz74oPXkQuDFs4t7Gs9CH0aYf96LWJiErqJy+Pnoe0nWEXmPLid08eHIjALc6ok/KxMBERABERABERCBOBFwQhc/xsOUA6tVq1bm2WefNQx+kcB7xowZNg8AAwwyERABERABEciWQHAwiHwWTKYoKQt6Q0joMjakGd/xeF4QttBXeDV3PfHYOOmkkxI5wCR0OTJaFkbg33//tZ6AH330kS122223WVE2eAzPo3hpMfGKgWpydhVmRCfgHse6detmrr766sKKF3sfE8UIsejM18A3Y6JBkY58ZnjJXnrppQWENXdetyRkIeHanNDvtrPEG468ZXBPZyeccIIZM2ZMIuoEk+EQsIOfoy70qRPQg3WRGwxBDW9ehDKuG84MiOFMoONzKGiEk3PX1Hd9wfNovWwRmDp1qvXkuvnmm03fvn3NEUccYcPN+6BwySWX2PCp1OXr/V6cdrmxBT4fEfTiYpEXunAn5MOUmQfEbvU1CyIuF1j9EAEREAEREAERiAcB9zD69ttvF4hLX9q9w7OeiUck92YwsnXr1oZ4/sTWl4mACIiACIhANgSC+WVKKldOsH1OeGFbcIA2WKYsrTOZhTDF5NFiQguDzRUrVvSGwAmLeKAw2Cahyxva2Fc0efJkc+ONN1rxZfny5YaQe8nGvUvEp6pVqybv2ug1ohkiD2OL1J3vgd8uXboYl/uHyfqEASQHVnGNesj/5Yx8VoQEJSIEXiowwUkA43w8uyM2d+zY0ey2227usI2Wq1evtsIh3nLOOP6ggw6yHlmIWsnG+Ozll19uP0vx1sJzhLy0hEvE26sw4Sy5ruBrwifiEYZnF+a7vuC5tF62CCAM9+rVy362IO4SrWT27NleIPAeW7x4sa0rTEIXnpZ4XMbFIi90MeOA2K7OwnCzuLZoKQIiIAIiIAIiIAK+CDih65133kn8sPNVd3Hq+fDDDw2zOPkRTY4D1onXz4BYYT+Yi3NOHSsCIiACIhBPAsF8MEygaNOmTYl21IXS46QSuowNF4YXV+3ate0A+XPPPef1u53Bd3IV4YEyZ84cr4OKJXrj6GSlQgDR5fvvvzeEAfRheBDhSVQS4bcR9Xlu/u6770yjRo2smOyjDwhAhPJzNnfuXOuV4l7jRUZ0CLymyNOVTd5fhCny6r333nuGHGZ4VGVy/Ndff21FtZ133tk1wzzxxBMGTzwXwjCxo4gVBDO+JxDhg+a7vmDdWi87BMgvd80119iwyQMGDDDknMM71IcFhS7yge6www4+qs25Dje2kPwZkXOFITkw8kIXyc5HjRqVwElSSlxuZSIgAiIgAiIgAiIQJwLuYfTdd99NxKQPS//4Qc2sTUJMLV261PDDgJmq5EyQiYAIiIAIiEAmBBiwPuyww2xRBpr5bZ/JIGomdWdahkHcevXq2eISuow577zz7MQVPK2ef/557znRGew7/fTTTcuWLe1gos/Z85lec5UTgTgRYPJ/MEfXwoULDd6xYTXCGRIFAk80onSlM0S5k08+2YrveIWlM9/1pTuPtseTAOIzIU/5DUsEOSZ5IH75sM6dO9uc1tQlocsH0dR1RF7oGjp0qLnrrrsSvSN5LDMLZCIgAiIgAiIgAiIQJwJO6GIWJblJw2QucS8z1a688ko7K/XPP/+0szWVOzVMV0ptEQEREIHwEhg2bJgZOXKkbWBpTZYIhk6U0GXMBRdcYJ588knrEYLnhe+c6M77BO8MBhMldIX3/amWRYMAEwROO+20RGMXLVpkwwUmNoR0hTxieNTyO4fIEFtssYX1Ht1jjz0M+buyjRLhu76QYlOzPBPAe4v8fPzxTELYXvJ2+bBguNIwCV14Ux955JE+uhiKOiIvdAUfhiGK63tJz/oKxZVUI0RABERABERABGJNIMxC188//2xnvHEBiP1/3333GbzuL774YtOvX79YXxd1TgREQAREoPgEvvrqK5ufydXkW1Bx9Ra1/Pzzz80xxxxji0noMjbvJiHB8LRjYM53TnSXTwhBbcqUKXawjUE3mQiIQG4ECEvYpEmTxMFxG8ROdEwrIpAHArNmzTLdu3e3EzdHjBhhPbwfeOABL2fq2rWrWbBgga0rTEIXOciYZBIXi53QxYf61ltvHZfro36IgAiIgAiIgAiIgCXghK4PPvjAJsoOGxbCO4wZM8Zcd911NqdK/fr1zYYNG2zS3UySgIetP2qPCIiACIhAyREgJ4YLD3TVVVfZQaaSO/v/nYnvLTfgI6HL2O/zlStX2hxITCr2PTi3Zs0aG7aQXGyTJ0+W0PV/t6LWRCAnAl988YXNK+QOnjBhgg35515rKQIikJ4AwjDRSS677DIbPY7fs5MmTUp/QBZ7qPPhhx+2R4Qh7ZIbW0DcIzxxXCzyQhfJC4nn6uztt982W221lXuppQiIgAiIgAiIgAjEgoB7GP3www9tQuewdYrBweOOO85OOGL2N7m6rrjiCuvpNW3atFC2OWwM1R4REAERKIsE8BJq3ry57XqFChVs2Nvy5cuXCopvvvnGhunj5BK6jLnooots/s0DDzzQMNby2muvme22287btcELnLCFeIDfe++9lv3cuXO91a+KRKCsEfjrr78ME8z+/fdf23UiLPAek4mACBRNYN68eebyyy83nTp1MmPHjjUNGjSw301FH1l0CeqlfixMQtfMmTNNzZo1i+5AREpEXui6/fbbzR133JHA/c4775gtt9wy8VorIiACIiACIiACIhAHAk7oCvPA28CBA+2PAmbC8Xf++efbJPZsJyyRTAREQAREQASCBBiUbdy4sVm3bp3dPHHiRNOwYcNgkRJd/+GHH8yhhx5qzxnm79uSgtK2bVuzYsUKO3DONfKdKmL16tX2WeGSSy4xeJ4cccQRRkJXSV1dnSeuBPDOIBwsRq6hbt26xbWr6pcIeCUwf/58+35p37694Xnk5JNPtt9NPk7CBFD3/RYmoYu8ZLVq1fLRxVDUEXmha/jw4Ya4mc54+CpXrpx7qaUIiIAIiIAIiIAIxIJAFISu7777zpxwwgmGBNDLly83f/75p80TsMkmm5hHHnnEVK5cORbXQp0QAREQARHwQ2DkyJE24Tu14dUVjNbi5wzZ1ULOyerVq9uDJHQZ065dO7Ns2TKz7777GkIn+04VsWrVKnPhhRcmZs9L6MruflVpEUhF4NxzzzVPP/203cXn2aOPPpqqmLaJgAgkESCHFrm0XDhd8t3h2eXDmATqclD69o7OpX1ubOGhhx5K5CbNpZ6wHRN5oQuRC7HL2XvvvWc233xz91JLERABERABERABEYgFAfcwGvaBN+KY9+3b1wpc/DAguTx5u0hkT7JbTUiKxe2oToiACIhAsQkw0HPqqafaevhueOGFF8wOO+xQ7HqLU8Fvv/1mCNOHhf37tjj9zPRYZrU/9thjplKlSmb9+vU2fKHPVBGPP/64DY946aWXmtGjR8ujK9MLo3IiUAiBG2+80dx3332JEniRICLLREAECifAxMwuXbqY8847z0ydOtU+o/Dd5MO6d+9uyIeFhUnoIj9q7dq1fXQxFHVEXugibCHhC529//77ZrPNNnMvtRQBERABERABERCBWBCIitD1999/m2bNmtkH+HHjxtmQVMQ5X7RokZ0d179//1hcD3VCBERABEQgdwJ4TjEBgtCFWFhC59Ce/fbbz7ZJQpcxHTp0MEuWLDF77rmn+fTTT827775rtthiC8vHxz+8xfAaI7Qa3n3y6PJBVXWUdQILFy40iMfOWrRoUcBBwG3XUgREoCABfq/yu/Xss8825K7iNy3fTT6sR48etk7qktDlg2jqOiIvdBHa4Lbbbkv0LqwJ2hMN1IoIiIAIiIAIiIAI5EAgKkIXXePhnRBUO+20kx0gY6b+6aefbsMeKSl2Dhdfh4iACIhAzAiQk2np0qW2V3369LGCShi6+M8//9gwfbRFQpcxHTt2NIsXLza77767+eKLL4zvCDqIaIhphHQiWs/hhx9u5s2bF4ZbQW0QgcgSIJT4UUcdlZhIgDj9zjvvGEKJy0RABNITcN9J/I7lu+jMM88skC4p/ZFF7+nZs6chTCAWJqFr2rRp5thjjy26AxEpEXmhKxjTmw9thC6ZCIiACIiACIiACMSNQJSELtgzEYkJSY0bNzZ4dvED+4wzzjB//PGHuf/++2P1QB23e039EQEREIF8EiDB+80332xP0bRpU3P33Xfn83RZ1x2179usO5jFAc4je5dddjFff/21nbCy6aabZlFD4UXd7HlmuvPcUKNGDTN//vzCD9JeERCBIgmQZ4h8Q84U/cqR0FIE0hMgVC8he3k2Ibddy5YtE3lE0x+V2Z6g0PX666+bbbfdNrMD81TKPesQorFOnTp5OkvJVxsroYsHLhKkykRABERABERABEQgbgTcw2hUZpgT/umss84ya9euNYQrJKnv8uXLDbP4t9lmGxu6weVBidu1Un9EQAREQARSE3jmmWdMq1at7M7ddtvNrF692msovNRnzW5r1L5vs+tddqU7d+5sB/vw0P7222+9e7m5fCgMAA4dOlRCV3aXR6VFIC0BhC0mmH3//femWrVq9n0sj660uLRDBCyBFStWmLZt25qGDRva/JQ8rxCNxIf16tXL4D2FhUnoevDBB03dunV9dDEUdURe6Bo1alTiptt8882tK30oyKoRIiACIiACIiACIuCRQBQH3hDlTj31VPP7779bYYuZ2nhzEaaqYsWKZs6cOTbvh0dMqkoEREAERCCkBD755JMCs4Zffvlls+OOO4autVH8vs0XRPL8kO9nu+22M+RV8z2x+OGHHzaXXXaZufbaa82gQYNs3ja2yURABIpPALHr+eeft3mGttpqq+JXqBpEIOYEVq5caSdnHn/88WbVqlXmggsuMAMHDvTS6969exu8p7AwCV0PPPCAqVevnpc+hqGSyAtdo0ePNrfeeqtlSf6HdevWhYGr2iACIiACIiACIiACXglEdeCN3B6EPtp7771tCBUGNYcNG2YT+1aqVMnwcO365hWYKhMBERABEQgNAcLeHXnkkYn2PPvss3bCQ2JDiFbcd1JUPKjziQ4RCuFp6623tqGHydHl08iBcvnll9sJMAMGDJDQ5ROu6hIBERABEciKwJNPPmnFrdq1axs80IlIQmQSH3bdddeZKVOm2KreeOMNG+HER7251uGedSZNmmTq16+fazWhOy7yQteYMWPM4MGDLVgSLL777ruhg6wGiYAIiIAIiIAIiEBxCbiH0SgOvLmcqvxomDx5sg1TxY8G8rSQ94OJS+yTiYAIiIAIxI/ARx99ZI477rhEx9asWWN23333xOuwrUT5+9Y3y27dutmcWYy1/Pvvv94nFuPZfeWVV5q+ffvavG2HHnpogbxCvvuj+kRABERABEQgHYGnn37anHvuueaII44wL730kmnXrp258cYb0xXPavv1119vJ3hyUJiErvvuu8+ceOKJWfUlzIUjL3SRuBYXdwxX3LfffjvMvNU2ERABERABERABEciJQNQH3viRwIM0oSDGjRtnypcvb3iOwzOfPKvMGmdAjVDUMhEQAREQgXgQwKu3Y8eOic688sorZocddki8DuNK1L9vfTLF2wqvK76bN9tsM/POO+/4rN7MmjXLdO/e3dx00012MFFCl1e8qkwEREAERCALAnibn3POOebggw+24QU7dOhgPY6zqCJt0RtuuMFO+KRAmISue+65x5x00klp2x21HZEXusaOHZuIl4k7/Ztvvhm1a6D2ioAIiIAIiIAIiECRBKI+8MZM8H79+lmxi1xdEyZMMLvttpuNf37VVVeZDRs22B8VTGBiv0wEREAERCC6BP755x9z1llnmRdffDHRCcLeRWEyQ9S/bxPAPaxcccUVZu7cubamfIy3zJgxw1x99dU2NBReXQwukhNMJgIiIAIiIAIlTYCcdjy7VK1a1Xowk6eyV69eXpoRVqFr/PjxplGjRl76GIZKIi90MSP4lltusSy32WYbq4qGAazaIAIiIAIiIAIiIAI+CcRl4O2OO+4ww4cPtyLXnXfeaUMWkruFAa4FCxbYGeNnn3226dmzp6lQoYJPhKpLBERABESgBAi4HBfuVAwa3X777e5l6Jdx+b71AZqJKLNnz7ZV5WO85aGHHrLf94QzltDl44qpDhEQAREQgVwJEK7wjDPOMOSRXr9+vY02wmQMH+aim1BXmDy60FUaN27so4uhqCPyQhfKI0lLsW233da6FoaCrBohAiIgAiIgAiIgAh4JxGngjZwczI7766+/TKdOnWzYonLlypkVK1ZYr68PP/zQJuht27atDXm14447eiSpqkRABERABPJB4IMPPjDNmzc333//faL66dOnRy4HY5y+bxMXIseVHj16mJkzZ9qjt9tuO/Paa6/lWFPqw7g/rrnmGjumg9BVrVo188gjj6QurK0iIAIiIAIikEcChFc+/fTTbR7RL774wv5GxbPZhxHZ5N5777VVhUnoIpVA06ZNfXQxFHXESujafvvtzauvvhoKsGqECIiACIiACIiACPgkELeBN35IdOnSxXz88cdm//33t6Goa9WqZf744w+bqHfkyJHmm2++sROZWrdubdq3b2+9wHwyVV0iIAIiIALFJ/D+++/b/EqrVq1KVHbAAQeY+fPn23yMiY0RWYnb921xsDOTnfCCGLnV+O72adOmTbMTX4jSg9B14IEHmkcffdTnKVSXCIiACIiACGRE4PXXXzennHKKYZLld999Zz2OySPtw26++WYzceJEW1WYhK5Ro0aZ0047zUcXQ1FH5IUu8jvg5o5xI7788suhAKtGiIAIiIAIiIAIiIBPAnEceOMHBDO5Fy9ebDbZZBMbKqJ3796mYsWK5ueff7az3njW+/bbb80WW2xhPQXatWtnqlev7hOt6hIBERABEciBALks7rrrLuuNGzx86tSppk6dOsFNkVqP4/dtrheAMMKEF8R22mkns3bt2lyrSnmchK6UWLRRBERABESgFAi89dZbNozfVlttZX777Tdz3XXX2egjPppCNDqi0mFvvvmmIe9laZp71mFyabNmzUqzKV7PHXmhCzUUVRTLx4OXV9qqTAREQAREQAREQARyJOAeRv/zn//kWEN4DyP/B89zCFrly5c3iFmdO3c2eOsjeBHaCMHrk08+sZ04+uijDV5ezLjbcsstw9sxtUwEREAEYkaAgZ+HH37YTkRg5nPQunXrZgjxQyjaKFucv2+zvS5MRuE7GNtll13Miy++mG0VhZYPhi4krBMe3osWLSr0GO0UAREQAREQgXwQWLdunTnppJPsBMx///3XehoTVcSHhVXoImc2YafjYpEXuu655x5z00032euRjwevuFxo9UMEREAEREAERCDaBOI+8EaYwuHDh5sHH3zQ5u4iRBI/LBC9yAtCPq8lS5aY++67zzz77LP2YuLNzwy0li1bmsMOOyzaF1itFwEREIEQE2CWM943s2bNMj/88EOBlrZo0cJcf/31Ztdddy2wPaov4v59m811wcsaDz2sQoUKBi8+n4a3GF5jROlhXEdCl0+6qksEREAERCAbAoRiPvHEExOH8N3Upk2bxOvirAwcONCMHTvWVhEmjy5+f/McFxeLvNBFIjdm/mA8WL/wwgt2Xf9EQAREQAREQAREIE4EysrA2wcffGAIoTB37lzz999/W5HrwgsvNBdffHEiR9fbb79t83gx4IrHF7bXXnuZ4447ztStW9cumQAlEwEREAERyI0Akwv4bb1s2TLz2GOPmffee2+jisjp0KNHD1OlSpWN9kV5Q1n5vs3kGhG2acqUKbbo7rvvbtasWZPJYRmXkdCVMSoVFAEREAERyDOB9evXm3r16iXOgjh1wQUXJF4XZ2XQoEHm7rvvtlUweYgoJqVp7lnntttuM2effXZpNsXruSMvdDGr98Ybb7RQ8jHDyCttVSYCIiACIiACIiACORAgdELlypXtkXEMXZgKCT80CFc4Y8YM88svv5jNN9/cClinnnqqjZ2OxxciF4OwCxcuNI8//riNpU5d5Pvi4R0vL/4OPfRQ+7fNNtukOpW2iYAIiECZJ8Dn6UsvvWTFLbx2CFH3008/peSCwEWYwoMOOijl/ihv/Oeff8y+++5ru4C4x3dPWTY89R544AGLYI899jDPPPOMVxwzZ860YineXIR12m+//WzeTq8nUWUiIAIiIAIikAGBTz/91Bx77LGJkkOHDjXnnHNO4nVxVm699VYzevRoW0WYhC6ffSwOH1/HRl7omjRpko2ZCZB8zDDyBVr1iIAIiIAIiIAIiECuBBiArF69uj28rAhdjtX3339vmPFNSEPCSWAMPCJe8UOkdu3ahpxdm222mR2kJawhfwzSkkvG2aabbmr23ntvGxaJ0EgHHHCAXa9atWqpJwN2bYzrEqHW/dFH1p0lb0/1OliWdVfG1eNeu3IInRjLdOtuv1umK+e2F1aOfTIRiBIBPldfffVV88Ybb5jXXnvNkGsLb1q8aNPZnnvuaQd7CBXLZ2lc7euvvzZHHnmk7R6CH5Npy7LdcMMNZvLkyRYBntNPPfWUVxxz5swxV155pR3TGTx4sBUZCVMsEwEREAEREIGSJvDll1+amjVrJk7rM6zfkCFDzKhRo2zdYRK6EODOPffcRJ+jvhJ5oYuHLh6+sHzMMIr6BVb7RUAEREAEREAEok/g448/tiH56ElZE7rc1UPMYDB26dKl9o8BWid0IHwhXtWoUcN6cCEKImDBzQ3isuQYF+rQ1YuQUbFiResBhhdY5f96zgWX2267rStql5yTkF7u788//9xo3W1zS8q6dbfMdFtyeQai3Ta3zLQuytF+6sBrIfjHNrevQIf1IpQEuG8Rb90yuO62uaXPfcG6WA/+ITZzTpbJ25NfB8ulO45j0u1LPkdy/bwOniN5f3BfcN2dr7BzB+ty5VhSD3/B/dm8Lu6N9uuvv5oNGzbYv6+++mqjdQQctz05x1aqc9P2gw8+2DRo0MAmZsc7lr7F3fieaNq0qe3m8uXLrYdR3PtcWP/69u1rmFyM7bPPPubJJ58srHjW++bNm2cuv/xy06dPH8Oscr5/+Z6XiYAIiIAIiEBJEwhOduHcd955p2nevLmXZgwbNsyG56cywvBvtdVWXurNtRK+bzFCKp5//vm5VhO642IldDHL7Omnnw4dZDVIBERABERABERABIpDgFlfjRs3tlWUVaErmR8Dusy2f+655+wfIhhCjjMGabfeemuDUMXfdtttZ18zwPv555/bQWBXVksREAERKOsEEPmqVatmatWqZY455hg7o7ks5jokH1n79u3t7TB//nw7gaIs3xukiSBdBMag2KpVq+y6r38LFiwwXbt2Nddee625/fbbJXT5Aqt6REAEREAEsibA70Sihjgj1CBh831YWIWuW265xbRu3dpHF0NRR+SFLuJFEzcay4crfSiukhohAiIgAiIgAiJQpgm8/PLLplmzZpaBhK7UtwLeDMzEX7dunfXkwpvrk08+setffPFFAREsdQ3R24onW7ly5RJ/wdfBdcrwmj8EwOCf63VwG+tYcJt77ZbBfcnlg2WC68Fj2I4Ft7n15O3utVu6cm7ptrNMZc7zL92SYwrbF9wfXE93jNueqizbsMLKuH3Jy+Tjgq8LK5u8z70OHo9I7Dz9WAbX8fxL3ub2u33pvAOTtwdfc35ZyRIgZGvl/3qt4sXq/oiKwjrL0k6MXrI0Up8NUcflACdHJMJfWTZyZ91zzz0WAbnLyIfp0xYtWmQ6depkevbsaWe64zWG2CgTAREQAREQgZImEEwXwLnHjRuXmGxa3LYwmeOOO+6w1YTJo6t///6mTZs2xe1eaI6PvNA1ZcoUc91111mg+XClD82VUkNEQAREQAREQATKLAEJXcW79AyuI4T98ssvNnShW/JjhgF7Bnf5I4SEW3dLRAqdetwAAEAASURBVCKZCIiACESBwO+//24/5/i8Y53PMTxaWeKxJSuaQFDYmTp1qqlTp07RB8W4xM0332wmTpxoe7jffvsZwjn6NMIUXnLJJeaqq64yY8aMseERJXT5JKy6REAEREAEMiXwxx9/2HD4rjzffw0bNnQvi7UcMWKEIecX9s4775gtt9yyWPUV92AXupDnnrZt2xa3utAcH3mhi8TkuLlj+XClD82VUkNEQAREQAREQATKLIFgzhB5dJXZ20AdFwEREAERyDOBiy66KOG1JKHLmAEDBpjx48db6uTC9C1C4SEG827dupkJEybYKD3Lli3L81VW9SIgAiIgAiKwMQEmR+K97IwclfXr13cvi7XEmwuvLixMQhe5OF3I5mJ1MCQHR17o4uGzd+/eFmc+XOlDcp3UDBEQAREQAREQgTJMgPAGjRo1sgQkdJXhG0FdFwEREAERyCuBunXr2pC3nOShhx6y+cryesKQV07uDkI3YQceeKBZsmSJ1xavXr3anH/++aZz586GAUXSUUjo8opYlYmACIiACGRBoEqVKjbiB4eQLqlevXpZHJ2+6MiRIw15urAwCV19+vQxHTp0SN/wiO2JvNA1bdo006tXL4udm3HFihURuwRqrgiIgAiIgAiIgAgUTuD99983J554oi0koatwVtorAiIgAiIgArkQIJztwQcfnMihN2/ePHP44YfnUlVsjhk4cKAZO3as7U+1atUMObV82po1a0zLli3tbHImMZMrznd4RJ/tVV0iIAIiIALxJkA+U8I/Y2gOxx57rJcOB4Wud99912yxxRZe6s21Ehe68PrrrzcdO3bMtZrQHRd5oWv69OnmmmuusWDzETM6dFdMDRIBERABERABEShzBD799NPEQ7aErjJ3+dVhERABERCBEiDwwgsvmBYtWiTORJg+wvWVZRs8eLDNnQUDRMBHHnnEK46XXnrJnHHGGaZNmzZm5syZErq80lVlIiACIiAC2RKoXr26zenMcTNmzDC1atXKtoqU5UeNGmWGDBli94VJ6CJKXpcuXVK2OYobIy90EU6gZ8+eln0+YkZH8aKqzSIgAiIgAiIgAvEi8O233yZmlb/11lumfPny8eqgeiMCIiACIiACpUyA0HnkqnCGt9Huu+/uXpbJJYNyDM5hhx56qFmwYIFXDi4HaatWrWzd8FaUHq+IVZkIiIAIiEAWBGrUqGG+++47e8ScOXPMkUcemcXR6YuOHj3a3HrrrbZAmIQunIe6du2avuER2xMroSsfMaMjdj3VXBEQAREQAREQgRgS+Ouvvwye69gTTzxhKlWqFMNeqksiIAIiIAIiUHoEevToYb2KNtlkE9sIcmiUdmih0qPxv2ceOnSoueuuu+wLBv/mz5/vtUnvvfeeadCggfXqWrp0qRUWJXR5RazKREAEREAEsiBw1FFHmQ0bNtgjfIYwvvvuu82gQYNsvWESuq6++mrTrVu3LAiFu2jkhS7cCLko2EEHHWQWL14cbuJqnQiIgAiIgAiIgAjkQMDF0fYZQiGHZugQERABERABEYglAQSXjz76yGy//faGCSYvv/xyLPuZTaeGDRtmyCuCHXHEEWbu3LnZHF5k2Y8//tjUrVvXNG3a1KxatUpCV5HEVEAEREAERCCfBMjJRdoAbOHCheaQQw7xcrpx48aZW265xda1bt06U65cOS/15lqJG1vo3r27ueKKK3KtJnTHRV7oIo4zM6+wfCRHDd0VU4NEQAREQAREQATKJAH3MDpixAhz5plnlkkG6rQIiIAIiIAI5IMAIYIRcvBaeu2112xurkWLFuXjVJGq8/bbbzd33HGHbTOz3GfPnu21/V999ZU5+uijrVfXs88+K6HLK11VJgIiIAIikC2BevXqmfXr19vDeA5Aa/Bh48ePNwMGDLBVhUnoQuRC7IqLRV7omjVrVuKC5CM5alwutPohAiIgAiIgAiIQbQJO6CJZLEljZSIgAiIgAiIgAn4ILFmyxHTo0MGceuqpdgZ3o0aNDINSZd2GDx9umGCD1axZ04Z29Mnkxx9/tLPl69SpY1555RVToUIF8/jjj/s8heoSAREQAREQgYwJ4N1NWF2MkLoHHHBAxscWVnDChAmmf//+tkiYhC7CFrpIeYW1Pyr7Ii90MaPoqquusrzzkRw1KhdS7RQBERABERABEYg3gZNOOsnwUJyP0EHxJqfeiYAIiIAIiEDhBG6++WYzceJEc/HFF5t7773XdOzY0Vx//fWFH1QG9uLNhVcXVrt2bTN9+nSvvXY5SHm2IWeJhC6veFWZCIiACIhAlgSaNGli3nzzTXvU8uXLE3mys6xmo+I8Y/CsgSGkbb755huVKckNbhLtZZddZnr27FmSp87ruSIvdM2ZM8dceeWVFtJhhx1mHn744bwCU+UiIAIiIAIiIAIiUBoE+vbtayZNmmRP/Z///Kc0mqBzioAIiIAIiEAsCTRu3NhOJrn88sutsDN06FBzzjnnxLKv2XSK/Fzk6cLIWzJt2rRsDs+o7H777WdDRZKva5dddjErV67M6DgVEgEREAEREAHfBE4//XTrYUy9eBjvu+++Xk7BJJp+/frZusIkdMUtWkzkhS6SobqkaYcffriZN2+elxtQlYiACIiACIiACIhAmAhMnjzZ3HDDDbZJ77//vtlss83C1Dy1RQREQAREQAQiSeDLL780tWrVsrmiKleubGbMmGHHFRhfKOt21113GUQ/7LjjjjNTpkzxjuSQQw4xO++8s/nmm28kdHmnqwpFQAREQASyIdCiRQvzwgsv2EOeeOIJU6lSpWwOT1uWCatMXMXCJHR16tTJXHfddWnbHbUdkRe6ELaYdYUplE/Ubj+1VwREQAREQAREIFMCq1atMhdeeKEt7jNeeKbnVzkREAEREAERiCOBhx56yIbtIUfFwoULbQi9119/3Wy11VZx7G5WfRo1apQZMmSIPeb44483999/f1bHZ1IYkfGff/4xv//+u9lpp50MzzsyERABERABESgNAq1atTLPPPOMPfXTTz9t9txzTy/NCE5aDZPQRX7SPn36eOljGCqJvNA1f/58Q+I07KijjjLk7JKJgAiIgAiIgAiIQNwIfPrppzZsEP0iX8ZZZ50Vty6qPyIgAiIgAiJQ4gQ6d+5sHn30UYPgdd5555kDDzzQvi7xhoTwhGPGjDGDBw+2Latfv34ihLLPplIvXnV4qkvo8klWdYmACIiACGRLgImlbsLFs88+aypWrJhtFSnLM1HECUphErrat2+f8DRL2fCIbYy80EVOLhKnYTVr1jQzZ86M2CVQc0VABERABERABESgaAL//vuvIaQS1qZNG9O/f3+7rn8iIAIiIAIiIAK5EcCLiMgw22+/vQ3R17p1a+s9PWDAgNwqjNlRY8eONQMHDrS9atCggSHHiG875ZRTzJtvvmm23XZbs+OOOxpCRclEQAREQAREoDQItGvXzixbtsye+rnnnjO77babl2Y88MAD5vrrr7d1hUnoatu2rbnpppu89DEMlURe6FqwYIHp2rWrZYnLO/G0ZSIgAiIgAiIgAiIQRwJNmjSxg0H/8z//k5hpFsd+qk8iIAIiIAIiUBIEHnvsMcNsZiaQ7LDDDmbkyJHmzjvvNM2bNy+J04f+HOPGjTO33HKLbWfDhg3NxIkTvbf5nHPOMcyaL1eunNljjz0kdHknrApFQAREQAQyJeC8vCn/4osv2tyRmR5bWLkHH3zQXHvttbZIGPJtM56AxW0CbeSFLmJoX3rppfbi1K5d20yfPt2u658IiIAIiIAIiIAIxI3ADTfcYIjvjb366qt2Bnrc+qj+iIAIiIAIiEBJEejevbuZNWuWmTp1qvXoeumllwwzuCtUqFBSTQj1ecaPH2+cd1ujRo0Mr33bxRdfbJYvX26r3WeffcyTTz7p+xSqTwREQAREQAQyInD55ZebefPm2bJr1661IXUzOrCIQtOmTTO9evWypcIkdOHJ7ia0FNGFSOyOvND1yCOPmC5duljYxx57rOHGkYmACIiACIiACIhAHAmQP6Rnz562aww2MegkEwEREAEREAERyJ4AYQvJ873llluapUuX2lQIVatWNYsXL86+spgegQfXzTffbHuHVzmhDH0bOdfJvY5J6PJNV/WJgAiIgAhkQ+Dqq69ORIvzObEUx5xrrrnGNiVMQtf5559vBg0alA2iUJeNvNBF0ljcCrG6desaXAFlIiACIiACIiACIhBHAu+++64hdBAWt3jacbxe6pMIiIAIiEB4CSBodezY0Vx00UVW8GIWd6dOncx1110X3kaXcMvuueeeRO4OcmmNGTPGewsI5eTGcSR0ecerCkVABERABLIgwDPAlClT7BGvv/66zR+ZxeFpiwYnrH7wwQdm0003TVu2JHZUqVLF/P3336ZVq1ZmyJAhJXHKEjlH5IWuRYsW2YdRaNWrV8+Q3E0mAiIgAiIgAiIgAnEk8M8//5j999/f/PXXX4aH0xUrVsSxm+qTCIiACIiACOSdgMvDMXv2bCvg4NU1Z84cc+SRR+b93FE5wX333WduvPFG29zTTz/d3HXXXd6bPnDgwISn2N57721Wr17t/RyqUAREQAREQAQyIdCvXz9z77332qJvvvmm2XrrrTM5rMgyM2bMMHiLYWEQuvbbbz87pkCezKFDhxbZ/qgUiLzQ5WZhAfz44483999/f1TYq50iIAIiIAIiIAIikDWBYC6LZcuWGcIsyURABERABERABDInsGHDBkOOb4QVZlmTBmGvvfYyK1euNJtssknmFcW8JHlByQ+KNW/e3Nx5553eezxy5EgzbNgwW6+ELu94VaEIiIAIiEAWBIKTL9555x0b3jiLw9MWJR8oeUGxMAhdBxxwgCGE81lnnWVuv/32tO2O2o5YCV3169c3kyZNito1UHtFQAREQAREQAREIGMCwTBChFnq0aNHxseqoAiIgAiIgAiIgLGCzW233WbDFP76669m+PDhNkn8pZdeKjwBAkwk7tOnj91y5plnmhEjRgT2+lllDKdv3762MsTGp556yk/FqkUEREAEREAEsiTAxAsmYGDr1q0z5cqVy7KG1MXxGL/yyivtzg8//LDUJ9UcdNBBhueffH23p6aQ/62RF7qWLFliOnToYEmdeOKJBtd6mQiIgAiIgAiIgAjElcD69ettuGb6t+eee5onn3zSbLbZZnHtrvolAiIgAiIgAl4JMIO5Tp065pdffjF4Rp922ml2HYFl55139nquqFdGaojrr7/ediNfs76Dg38SuqJ+x6j9IiACIhBtAkEv4/fee89svvnmXjo0d+5cc8UVV9i6wiB0Va9e3fz8889589b2Ai2HSiIvdBFH+5JLLrFdP+mkkwyznGUiIAIiIAIiIAIiEGcC5Ml45ZVXbBfHjh1rmjRpEufuqm8iIAIiIAIi4I2AyzvVtm1bU7FiRTN48GDTrl27RC4qbyeKQUUPPvigufbaa21PWrZsmQgx6LNry5cvN4RlxiR0+SSrukRABERABLIlMG7cOHPLLbfYw3wKUvPmzTNEY8F81msrzOHfIYccYn788UeTr/ybOTTJyyGRF7oee+wx0759ewvj5JNPNhMmTPACRpWIgAiIgAiIgAiIQFgJuEE62nfEEUcYZojJREAEREAEREAECidAmB5ye3/33XeGQadzzz3X/Pnnn2bVqlWmQoUKhR9cBvdOmzbNhnSk661atTJDhgzxTuGFF14wLVq0sPXiqf700097P4cqFAEREAEREIFMCAR/Z//nP//J5JCMysyfP99069bNlvVZb0YnT1GoRo0a9lnolFNOMWPGjElRIpqbIi90EWqA2VdYo0aNzPjx46N5JdRqERABERABERABEciQAAN0xxxzjPntt9/sETyQE8JZJgIiIAIiIAIikJ6AC0nEZFm+Q6dMmWJzZlx11VXpDyrDex566CHTs2dPS+C8886z3m++cZADheg8mIQu33RVnwiIgAiIQDYEpk6danr37m0P8SlILViwwHTt2tV7vdn0LViWybLffPONjQxDhJi4WOSFrqCbe+PGjQ0uhjIREAEREAEREAERiDsBHsB5EMeqVatmFi5cqFxdcb/o6p8IiIAIiEDOBD777DMrqJDX8rbbbjOdOnWywgpRYsqXL59zvXE+MCh0tW7dOhHOyWefN2zYYI466ihbpYQun2RVlwiIgAiIQLYEZs+ebdzkF59C1yOPPGK6dOlim+Oz3mz758rzvcv3b9ychiIvdK1YscIQWxtr2rSpufvuu+26/omACIiACIiACIhAnAm8//77dsDun3/+sd0kljiDUDIREAEREAEREIGNCXTu3Nk8+uijNhTfjBkzDN+jkyZNMvXr19+4sLZYAjNnzjQ9evSw623atDH9+/f3Tuavv/4yVatWNf/++688urzTVYUiIAIiIALZEMiX5xXPHzyHYGEQumrWrGm+/PJL07BhQzNx4sRsEIW6bOSFrscff9xcdNFFFvKpp55qRo8eHWrgapwIiIAIiIAIiIAI+CJAQltyjGA77LCDwdN911139VW96hEBERABERCBWBBYvHix6dixozn44IMNCdinT59uzjnnHDN06NBY9C9fnQjObGeC8U033ZSXU3FNfvzxRwldeaGrSrMhQHjwbbfd1my++ebZHKayIiACMSGwdOlSc8kll9je+BSk3HMIFfusN1fstWvXNni6k/6ANAhxsVgJXaeffrq566674nJt1A8REAEREAEREAERKJTABx98YGdhMRsaa9KkiYlTjO1CO6+dIiACIiACIpABAXJQEJrn22+/tfm9SXdQuXJlQxihbbbZJoMaym6RuXPnmiuuuMICIDf6jTfemBcY9erVM+vXr5fQlRe6qjRTAgxwI4hvt9121tuTHDYyERCBskVg1apV5sILL7Sd9ilILVmyxHTo0MF7vblenTp16phPPvnEerXj3R4Xi7zQFbwBmzdvbu688864XBv1QwREQAREQAREQASKJMCgU3AW1u23327OOuusIo9TAREQAREQAREoCwQYuGYmNWLXk08+af7++2+DpxJeRLLCCeA1jvc4xgBdnz59Cj8gx72M5axdu9Z6pb/wwgs51qLDRKB4BIYPH25GjBhhKznooIPs50bxatTRIhAPAoT6ZYIloX7JcxlnW7NmjWnZsqXtok+hK1+eYrlei+OOO8589NFHhokmDzzwQK7VhO64yAtdTzzxRCIfhYSu0N1fapAIiIAIiIAIiECeCRBipUGDBubrr7+2Z2J2OrHFq1Spkuczq3oREAEREAERCDeByZMnmxtuuMHstddeVuD6/PPPbbhCwhbKiiYwf/58061bN1sQwfD6668v+qAcSlx88cU2/DIDqAyoykSgNAgwcf62226zp95kk03svbjpppuWRlN0ThEIDYEvvvjCHHvssfY7FE+nAQMGhKZt+WjIyy+/bJo1a2ar9il0LVu2zHqVU7HPenNlcMIJJ5gPP/zQ4Nk1derUXKsJ3XGRF7qYkXXBBRdYsGeeeWZi9kXoSKtBIiACIiACIiACIpAnAsFk8ZyCWahz5swxW2+9dZ7OqGpFQAREQAREINwEGKw6++yz7eAcociYGELeDYQvWWYEmDjTtWtXW7hLly6md+/emR2YZamrr77azJgxwx4VhgHALJuv4jEhEBS66NLrr79u83VFrXsIE0yAO+CAA5RrLGoXL4Tt/fTTT63QRdPIXffmm2+aLbbYIoQt9dOkt956yzRu3NhW5vP7aMWKFYZcl5jPem2FOfwjNxcTS8jVRd7SuFjkha7Vq1eb888/314PwvQQrkcmAiIgAiIgAiIgAmWJwL///msuuugis3LlykS3TznlFDN69GjDjFSZCIiACIiACJQlAhs2bDDk8GaAzhkDV2PGjIl92CXXXx9L8pghcGEIXtdcc42PajeqY+DAgYkco2EYANyogdpQJggMGTLEjBo1KtHXZ555xuyxxx6J11FYYTAdD0l+G+yzzz6GwWxy+DKYHfeQc1G4PlFsY1Doov1MItlxxx2j2JWM2oyXE95OmM/vo8cff9z+Xvddr21oDv9OOukks27dOlOrVq3ERJMcqgndIZEXup566ilz3nnnWbDE0Bw2bFjoIKtBIiACIiACIiACIpBvAp999pmdffb999/b2XZ//fWXueyyy0zPnj3zfWrVLwIiIAIiIAKhIfD777/bMYJgrqdjjjnGEMZwq622Ck07o9CQRYsWmU6dOtmmEsIQz6t82Lhx48wtt9xiq/Y5sJiPtqrO+BLo16+fuffeexMdZGB63333TbyOwsr48eNThpbbZZddzKmnnmpOO+00U7NmTaOQjCV3NX/66SezatUq6yGItx3sESOrVatWco0oxpmSha6nn37a7LnnnsWoMdyH8psaYRjz+X3EhNQ2bdp4r9dWmMO/k08+2bzzzjvm6KOPNrNmzcqhhnAeEnmhizfYueeea+kSZ3vo0KHhJK1WiYAIiIAIiIAIiECeCSxcuNBceumlhjxd/Ij68ccfDbOkXZjnPJ9e1YuACIiACIhAqRLAi+GKK64w8+bNS7SjevXq5qGHHjKEL5RlR2Dx4sWG3FwYXLt3755dBRmWnj17trnqqqtsaZ8DixmevtSLMTnpyy+/NN9++60pV66czSnHs5ysZAn06tXLTJs2LXHSZ5991lSsWDHxOgor33zzjc258+uvv6ZtLiIFQgtOA/pcTIup2DvwCCT30aOPPmqYgBE0fqfxu43vp7Ab4hxeP86WLl1qw2K613Fb8jl8+OGH2275/D5C7CTHGeazXlthDv/w9CQM5RFHHGHmzp2bQw3hPCTyQhcfHK1atbJ0EbxuvfXWcJJWq0RABERABERABESgBAiQKP6BBx6wgyTkI+GH7uDBgxPPSyXQBJ1CBERABERABEqFwPDhwwvk7WYQke9EvBlk2RNYsmSJ6dChgz0QkQuxKx8WtgHAfPQxWOc///xj1qxZY8g5z/KVV16xz2vBMnvvvbedvKTJSkEq+V3Ha3H+/PmJk7zxxht28lhiQ0RWXn31VRvVgRBshRliKmJXu3bt7O+GwspqX2YEPvroIzvRAvH+vffeK/QgcsI1b9680DJh2Eko4KOOOirRFPJAH3nkkYnXcVvhtzP5rjGfghSf9+7z3Ge9ufJv2rSp4TMOUS84OSjX+sJyXKyELj6gGciRiYAIiIAIiIAIiEBZJfDHH39Yb3dCNu23337m888/N7/88ovNq4G3l0wEREAEREAE4kjgnnvuMTfddFOia/Xq1bO5KrfffvvENq1kR+Cxxx4z7du3twcRthAhIB/GrHJml2NhGADMRx///vtvK2jh3fHwww8XyB9X2PnIQ08+eln+CSD4LFu2zJ6IfFYIFVHNdYuXIF4ahGwlp1Jhtvnmm5szzjjD9O7d21SoUKGwotqXgsCff/5pFixYYKZMmWKee+65FCU23gTzmTNnWm+ajfeGawuhFw8++OBEoyZNmmTq16+feB23FSYiuJClPr+PgqmXfNabK3/CmCKKH3roofb+zbWesB0XeaELV2JCFmIoo4TnkYmACIiACIiACIhAWSZAyAVyl7777rs2JAaxxtl29tln2xwYylFSlu8O9V0EREAE4kWAcIWMA5DnyVmXLl1sPikGE2W5E1i+fLkNcUYN11xzjenatWvulRVyZNBjIAwDgIU0NaNdiAv8kTcVz6zffvvNCng///xzRscHC7Vu3TqRvyy4Xev+CRAtiqhR2M4772xeeukl/ycphRrJw4On2siRIws9+7bbbmtDiLZt29bm+y20sHYaxETe56NHjzZfffVVWiJbb721Ha/GOWOLLbYwhP4jb2RQPEp7cAh28B1bpUoVgwCE3XHHHVYYDUHT8taE//mf/7F1+/w+CqZe8llvrhDwJly7dq0dK2ACRlws8kIXbt4M5GDEuhwwYEBcro36IQIiIAIiIAIiIAI5EyDXAz+o1q1bZw455BDDbDxCmJD4eNSoUdbbK+fKdaAIiIAIiIAIhIAA323kl8CbGdtyyy3NxIkTDd5csuITePzxx81FF11kK7r22mtN586di19pihryNYM+xalKZBPPXeRJzcTIl8SgKp6H5EuCBSEjubcxCV2ZUPRT5swzzzQvvviirYyB/RUrVvipOAS1IE7gHYgRyrVq1ao2bCYiRrIdcMABpn///qZ27drJu/T6vwQQKRYtWmRmzZpl3n777bRMdtttN4NoyHt4hx12SFsuCjtq1KhhCImP9enTJxHSNgptz6WN+RC6gqmXwiB04cWJmM/YAPdzXCzyQhduocxOxtq0aWM/jONycdQPERABERABERABESgOga+//trOxCZkCT9amZ3KQ3b58uVteBKenUiGLBMBERABERCBqBEg9xZ5KZ0R6aVv375WLHDbtCwegaDQBeuOHTsWr8JCjs7HwGIhp8vrrsKELkLi1a1b1yCq1KlTx1SsWHGjthB2monceOYjMHbq1GmjMtrgn4DzcKBmBHRC/8XFCEs4depU2x3uz4ULF9oJcDNmzDDTpk0zeFUGjZCNHJMvcTt4riitjx8/3qbMwZsrnZHziDCYp556amw84/is+uSTT2yXyduI2BVny8f3UdBRJwxCFyFxn3/+eTtGgJdhXCzyQhcXxcUrRikPxuSOy0VSP0RABERABERABEQgVwLk57ryyivN4sWLbdz9448/3q4zU7hmzZpm0KBBZv/998+1eh0nAiIgAiIgAiVKgJwS5JYIGjmPDjvssOAmrXsgsGrVKiu4UNUNN9xgLrnkEg+1blwFXiWVK1e2O8IwALhxC7Pbkkrowovm4osvthGJUolbyWfAs4u8XuXKlUvepdd5ItC0aVPzxhtv2NrJQUQuorgYHloTJkyw3SGkK/nHnBFSc/jw4ebee++14fjcdpbnnnuuDZ2pMLD/S+XII480TCRMtm222cY0a9bM8kLoipsdd9xx5qOPPrLdwhMID8E4mxO6mGxAuEkfFnTUCcP3HJODSAdFTm/CFMfFIi90kWi9RYsW9nqgmN94441xuTbqhwiIgAiIgAiIgAh4IcBgCXH5R4wYYZNq80Psiy++MCTFZQCFyUKXX365DZvj5YSqRAREQAREQAQ8E3jzzTdNkyZNCtSKpwseL3gfyPwTePLJJ21uGWpmrIUxl3wYuaycUBmGAcDi9hFxgHwszho1amSGDBlidtppJ7dJyxASYDKYu//w7rrzzjtLpJXk0MLTjwHnfBkT2+6++25bPQP3DOAnG+IX7/MnnniiwC5EjrFjxxpyeJV14xole3MhXBP6Lc7v76DQFTcRONU97YQuwpcSxtSHBfUL9znjo95c63A5CeMWpjXyQhfxc3H5xphdxCwjmQiIgAiIgAiIgAiIwMYEGLDCu4uEyQceeKA56qijbEJkXu+44452AIvZxuSJkImACIiACIhAaRPA02flypX2t/6ff/6ZaA65uJgdHfW8J4kOhXSFCTHk+8RuvvnmRL4u3819//33zYknnmirDcMAYHH7hxd9MMwjnjINGjQobrU6Ps8Egt462aRGYfIYnmAItnvttZfNeZOpKETeLOcdQ7jKAQMG5KWXRL+65557bN0IMmvXrk17HkSbq6++ukCeOYQOPNyy9ewqDptUDfRdX6pzFLaNzyk+r5KN9zeMK1WqlLyr2K999jnXuoJCF+tTpkxJ2y++N+bNm2fWr19v9t57b3sv7b777mnLh3GHE7omT55sTjjhBC9NJB8W3nBYGL7nzj//fLN69WqbIxLv7bhY5IWu4I1SFuKExuXGUz9EQAREQAREQARKh8A333xj+vXrZ3+AMAOePBEMFJKHg9AlhN4gLDReXvmcWVo6vddZRUAEREAEokDgxx9/NDNnzrTfV8ntZYCNgTZZ/gmQ15NZ3xgD8AzE58NeeeUVc/rpp9uqwzAAWNw+4s2FV5ezhx56yBxzzDHuZcolz2AffvihzYODqMsfQi8TkfB2I/RhOiO/CgOWF1xwQcbhqJnkRCoQeNeqVcsg8sTBECFGjx5t3n77bbP11lvbviHW7rnnnkV2j1Def/zxhy3XrVs3O0Bf2EEwRKQi91XQywcxiEHkq666yubHTVfHDz/8YAhzR4hKjGdwFzox3TG5bifHHnkNMXL2MpZamL322mumdevW5ttvv00Ua9++vc2DmNhQyEpx2SRX7bO+4twjXB/e24iaycZ1P/vssw1j01WrVk3enfVrn30ubl1BoevYY4+1ed2SO4QnIJ6rfJ4HrWXLlmbYsGHBTaFfd0IX7ab9PiyoX4The473N9dsn332MUyGjYvFSuhixkwwGW1cLpL6IQIiIAIiIAIiIAK+CTDbjtnZhILadNNN7QAMP7B5CCf2PCIYAx/8YCOZMvtkIiACIiACIpAvAr///rshTBAzwR955JGNTkPoLXJKZOtRsFFF2pAxgaDQNXDgwEQYw4wryLBg2EI6ZdjstMWSha65c+eaI444okB57nfKMdCI12KqUHLugO2228564/Bclmx4NjLwjtCCp86MGTMKFbt+/fVXw7V88MEHE+IMOVsRlpONOqmPQVC8M5gshacSoluFChUMOa2Sw4km11Gc1zyrHnzwwRl5bv7222/mrrvusuH5gt6fnJ+wgCeddJLNkVanTp2UTULgCuas7dOnjxUsUhb+70byAl5zzTWGXLjpjLbPmjXLlC9fPmWRYGhQCiA2zpkzJ2XZ4m7s3r27bQv1ZCqovfXWW3aQH0HO2ahRozbKkej2uaUPNq4ulr7qK+494tqE2HXFFVcYQk6mM7yALr30UlO7du10RQrd7qvPnMRHXUGhC9Ee8d7Zd999ZwVQvrtTGaLfsmXLUu0K7TYndPnMTfnyyy/bPG50OgxC10UXXWQnujIJIBhqN7QXJcOGRV7oCt4onTt3tvG5M+y7iomACIiACIiACIhAmSZA7q4FCxbYHARugOXQQw+1AxgMZrgZecyIbdiwoRW8+OGW7gd7mYapzouACIiACGRN4IMPPrCD/Az0p0qGTh5JwkEx6YJwhbKSJbBmzZrEbPZbb721gJeSz5YEU1KEYQCwuH3DS55BRGfkkiOPD94xeGm9/vrrdmAR0SlTI+T0kiVLNio+ZswYM3jw4MT2ypUrW6E41QSljz76yNAWzh+0VDl3EB8Jd43AVZgtXLjQHHLIIYUVSbnv2WefNQiAGzZssAIqbQgak7EmTpxohTXSlCAapPsMwCOKkGDuuTVYT/L6ddddZxkkb2eSV9CrrbD7HSEej6+gF1dyfe41OXB79OjhXhZYPvroo4ZxTGdEU+DzLh8GP64VxmQB8nFlYngL4qHEfYsR3hzRYrfddkt5uC82rnJf9fm4R1ybWHLtZ8+ebQVoJg2mM0QhRDEiaGRqvvrM+XzVFRS6jj766IRoyj1FXjc8xpKNY/gj310mHpXJx5fmayd0EcKT97oPe/XVVxMicRi+50hXwHMX3018HsfFIi90BV3c+eDu1atXXK6N+iECIiACIiACIiACJUIAwYsfrRMmTDDM3sYIa7LvvvsaZj9++eWXiR8wDDIwK5kfbvwxKCDhq0Quk04iAiIgApEmwEAj4cTwQCFkGsvPPvssZZ8YHGPQl7wneGPISocA14lwxtjQoUOtR10+WoLwcsopp9iqwzAAWNw+jh8/vti5lhAjgkJKjRo1zPz58zdqWqpznXbaaQbPm6DhwYV4FBTX8OjHG4zB3GBoRAbHEbnwOivKCH993333FRCJgscQeQmxDIHp+OOPt7uC43hs4Dnyscces/l8eM3zaP/+/VlNGGKeyxeX2Pj/V8ijg+dFppYqLCH3nWsf9YwYMcKceeaZG1XJwDDCT/Da8FyMdxceXIQxJJyh8/RiH4JeKkMgQQSAM8/XeN4gaObDCDsIY2d4I6UTDl0Zt3Sio3vNPYMQmGw+2VC3z/p83CPJ/XWv+e1E/jP4ujCUbp9bkhcZZkGvQbcvuPTZZ591BYUu7mkEdrweg/eU6wceXLwfk8Vrtz8KSyd08TlICFIfRjhQoqRgYfiec58JiNY8j8XFIi90BRXRyy67zPTs2TMu10b9EAEREAEREAEREIESJ8CPbmL486P8p59+sufHo4tQhuSPSDYGYsjlVa1aNVO9evXEctddd00uqtciUIAAs4MRWVm6v+TXwTLJ+9xrt3R1JB/DSV0Zt3Rl3Wu3dNszqYNjCqs7uY5s6k5XNpPtwfO68q5/blnU9mAdRfXT1emWHIvxmcEgKn9uvailK+vKueOpz62nKuPKJy/TlXXlXJ28Dm5L9drVFVy6dXcsggx/eCHx2Rj8Y1u6fZSLmzFwi6cwIZ4If4WQgWgSHBxO7jN5Ilq0aGH/8EqRlT6BoKfVbbfdZj3r8tEqPI0YSMXCMABY3D7i4YD4k6lVqlTJnHjiifaPQWIGHhEheO5iAHLt2rWmcePG9hkruU7ChrHv888/L7CLtB6ITLwXr7322oQHhiu0xx572FB/eGcEjZBkTCB3n/3s4zOKAVqe8ziOv759+9rw1+w/6KCDzOLFi1ktYLSfYzAEMSIy8XnZu3dvKwgFC7tcOITQItdYsmCA15jzSAoeRwQCBtSDOZNgSd/pA58/DMrjORa04cOH288aty0otrItVYg+whsS2eDTTz91h9n3BAJG8HMcr7lFixbZMnvvvbfNn5Y4IGmFuhD8+fxL5yWVdEhOL9u1a1cgfBwee5k+q+PtRgg+l78Mb0E+z/l94Mw3G5/1+bpHXF/TLT/++GP7vp8+fboJhnt05fGGGzdunCHHVSrz2WefddHWoNDFZxP3e6rfhbx3EUaD74dUfQ37Nid0EfITjzwfxvMQ4V6xMHzP8RnJ5zaTHPiuj4tFXugKKqKpZmXE5UKpHyIgAiIgAiIgAiJQkgTw5GKwgdmAzNYL/qjPpB14hJG/gXwRrPNX2Hrwx3Im9RdVhsGN5D83eM/gCfvca9bZFnzt9ruy7rUrG3zNeqo/V1+qupPLB8sm153qeMqnahvHpipf2PncuZPLuNduvzufOzcD1pRhyb7g6+A6+9yfK8tr6pGJgAj8ryiIEMYfA0hufYsttjD88Tq4TLfuyqXaX9i+dOWDbWFw2hnvYzx9GZzl75NPPrFCFpNQ33//fVesyCX1ky+HATT+8GQInqfIClQg7wTI20lIOCydh4uPRgQFkTAMABa3T126dEmZZy5YL8JBo0aNrLhVpUqV4K6s1xlAbdmyZWKCEhXwXmIyOM9xqUIVcj15LgsaghphQoM5rvC0Q9RC3Aoaeb34HHCGFxgeTUELXle2I65wDKIZzw9BQ+hCsGIgOFUYNMpyP/I8GTQ8qBDOnJGLCzEhONBOO/AoC3pW7b777jY/jXv+JHQXOQCd4SnH9Qnavffea/r165fYxLnwPmPSg7PVq1eb1q1bJ/pHGbx9StsI/0gYQmcIcUxSy9Tw+iNfmzPEQ+eFyTbfbHzW5+secX0vaok3H7nZ7vuv2L1u3boCxfkuHjJkSAGR1RXw2WefddG+oNDl2htcItbjhcl7OA7mhC43YcBHn5hM6nIahuF7jrCphE/le4DP/rhY5IWu4KwLVFbUVpkIiIAIiIAIiIAIiIBfAjyQM9uLP2ZxEn4KsUJWtgkwkJbs1ZJqG2UyLZfueLa7fa4ut0ze7l67ZTbluKKUd8ekWrItXbmizunqS1cuuD14juTj0pVz21m6dY7Npc3B45PrC75OLke7nUDKYKZbL2rpyrpyvHaDoW7diaXJSwZm+UxK3u5eF2c/dbh6ktfdOd12vCeYSc2frCABPDsIv3bYYYfZJcJWcDC6YGm9CgOBYE70O++804ZZy0e7eM9X/v9efGEYACxuHxGLUoWCQlQh7NuFF15oiituJbcRoYa8YMHQhMlleE3OKMbN+NwOGp9h9erVKzCxiVCBAwcOTHx/uPJBzwS3LdXE82ShiwlUjNuR+y3ZCE04Z86cQnPFTJs2bSNvGAaiiUTgDG8aRMRko3/0J3ju4Bhicl61SZMmmfqBQXvEC/gEPcP4/Dr99NOtYE/4RYQkwg+67y3agKjRqlWr5OaU+Otk8ZXQcohfmdq8efPsvePKB0OZ+mbjuz5f94jre6ZL7oO77rrLThJI/s301FNPmb322itRlc8++6zLNZCwnuk+mwnvV1gOPVdHlJZO6PL5/sW7FO9bLB3LkmTk8vbhbZtJfsOSbFtxzhV5oSv4BUvcTN5gMhEQAREQAREQAREQgfwS4EcUD+w8qBMux/198cUXdp1l8Id+fluj2kuaAANkeIEQis0NlrEs7I82ptof3B5cT1WWbUWVKWp/PutIPrd7zSAuxjLdX1H7w1KHa6dblnR/OK8sfARINI93AH+E4GKGsPvDA4OBFIla4btuRbUomEuJAVsG9fNlbmAxDAOAxe0jocmcJzz5bAjJyXMTHkPJHknFPVfw+CeffNKKXYg6qawwcYNjCTvmjD6Q18tNknDbWZIyhBCHQSOMNd5jQUsWuhCOEJRS2bbbblvAIw1REG9C2uDspptuMm3/m7svaOTRcmG3EJsYI0zVZo5hojzeZO77lLCNeN5ghPAilJczxDOELWdjx461op97nckSwQ1xzj13ZHJMvsogJOKF5QwPnSlTpriXhS4Jw4d4yyQ3Z0Ghyzcb3/X5ukdc37NdPvHEEwah8ccff0wcSn4rcr0589lnn3W59vHZhZieygiNindQnMx9H+Ed6sSp4vaPvHgnn3yyrSYM33NMTiDvI5+9yV6/xe1raR4feaEr6PrXo0ePAjMMShOszi0CIiACIiACIiACZZkAgwjMKuaPwR33h1cF4arc31ZbbVVgHeEEc94bbhA93Wu2F1WG/a5ccOnW3X5e8xc8f7oyZeGcjotbpmLh9iUvU5XNhG1yPcmvXb2plm6bO8ZeSP0rQIDBPycgsu5ep1q6bZQPlg2+Lk4Zd2xw6daD50hub3HKuGODS7ee7Tk5DmPp/pLb6upMXkb5nAVuKL2IPYFgqojkUGW+O+8GFhEqyAEUVeM554ADDkg8TzAZm0nZJWHkUsLzwuVYDZ6TsGJt2rQJbiqwHvR6IZfQsmXLUuaMInwgwgHftclGDi1yaTlLFrrc9qKWXP/Jkydbz88gS0IxIrIFDSGRHEzO8KjCazSdkb/LhVgN5hZbsGCB6dq1a+Kw5AHu888/P5Fri/YRnvvDDz9MlE9eqf9fUW/kyJEGloUZnj3kCyO/E7ndXGizwo7JZd/s2bML3IdMPOBaFtW+9evX2xCYeHcGLXitfbPxXZ+Pe4T3FKEbEWBPO+20rD+jOJbwj84QjhALnfnss8+6XPt47/HeSmdnnXWWQUxlElwczH0fJQvexekbYSwJZYqFQejCo5VwrtzTaCtxsVgJXXxooEjKREAEREAEREAEREAEREAEyjYBBuGCf45GcFvyeiZlOMZZ8vHB18EyCB2YE0KSl26fWybvd6/dfrd024NLt88tk/exXSYCIiACmRAIRtBJHvjP5PhsyriBRTyFjjnmmGwODVVZBjARm5zdfPPN1svKvU5eIgZ9//33VpxiUhAhzhAfdtttN+sJmVw+3Ws86fHIevfdd1MWOfLII61HT8WKFVPuJ9+Sm9WPZyY5nJKN/YhlwfB9wTJ4W+F15awwoatXr17m1ltvdUUTSwQYPI1c+MGgdxx5yMjl5SxV/bvssos9Pl3+KcIXIi5heKISThEjV03QK4XzcD5n8ENIxBD6br/9drNq1Sozc+ZMG+EADz7ymCGq4LXBn5sQ4epIXnKt8JJ04SZpO+HBizouuZ5MXiNYcV8Gn2FWrFiRMoQmZfDwI88TZdxEJXeeZs2aWRHPvfbNxmd9vu4Rcrw5DziEzttuu83mk3MMiloSAhRPK2fNmzc3hIN15rPPPuty7QvmeOM9imCDF2TQuPd5TxOWOMrG/V+5cmXbBTyeCLnsw9577z3ToEEDW1UYhC4mYCCAM+k06K3po6+lWUfkha5gjEtmdqAyy0RABERABERABERABERABERABERABERABHInEIygM378eNOoUaPcKyviSCd0RX0C8wsvvGBDFbru4pFUs2ZNw4D7b7/9lsjhhwcP4khh+fzwfsdzCM8jcsUghKQyBikRmVy4xFRl2Mbxo0aN2ijPFfsYeF+7di2rdlIGHk7OOwsvNUIIMohNP5wRWhCPAGeEZSQ3mQtTmkpkoCzHtWvXziCYJFtySDfyjrlwhwygL1myJHEI/UUISzbO36lTJxvxiUFcZwh1eNI4jzcExVdffdXufuyxx0z79u1dUZMc5jGYowiBbPXq1cUWpJK9fDg5nnRVq1ZNtMPnCv2jn84QMxEEEVcZeEd4417imjIon8oOPvhgG7aScGfOfLPxWZ+ve4R7Ndmrjc+shg0bWtEHcd7d93BBHOTcCJcrV660goLjxRKhFC8oZz777LMu176g4Mz7hvc5nmN83gWNyBzkISQXIPcTIi7iTpBNsHwY1xG0EQsxwk5WqlTJSzPxJMWjFAuD0MV3LZ9B5cqVM3ibxcUiL3TxIewetpgRQjI1mQiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIQO4EguMt99xzTyLsUu41pj/SDaTiyTN9+vT0BUO+JznXk6/mBnMiuTp///13g6cd4pXzCmIfIgRCD2LMM88844onlnXr1rUeUxdffLHZbrvt7PZbbrnF1uUK4bWCVxL5vhjM/uyzz9wuu6xVq5a9TggATixiB14rLvxeKqGLQXKEK4S+ZKGradOm5u677y5wnjvuuMOKAmxkEJ1wmoTawoIT3+2GpH/kC0RM2GuvvWz+2Pvvv998+eWXiVJVqlSxHktswLOLAXpneLAgdjnDWw4vJ2fJQpjbns0Sjx48g5zRTrzE8iUKMIDP+KnzyEOAQIxB1ELMLMpgSQhM7o2g+Wbjsz5f94gTBYL9Dq4Tsg9RlXsU4ZB8XEHvuWBZvPjIeRg0n332WRdtRIzff//9E83Fc5HPFbZfc801Zs6cOYl9qVYQq/FsjYohiOPhijHZw33eFLf9hDo94YQTbDVhELq4dnzXcs+6cK7F7WMYjo+80BVM5hbHBHhhuEnUBhEQAREQAREQAREQAREQAREQAREQgbJFgBn5eCxgkyZNMuQdypcFc0SFYRAw135OnTrV9O7dO9fDUx6HOETYtGDuKQaayf+VLEAxCE3Z/fbbzw64jxgxwg6qJ4ef40TkaOnevbs9J4IH3gZ4nRVlhPLifthpp51sLq2gIHT44YebefPm2SpSCV2EcGMgPlmAwGuCvE/0NWh4meFt5gxvI0KkYXjYBMUyBDY8lhDnijLCA9IHvF+wjz76yBx33HGJw5IFV0JqBvODERYYLzs8xAozBCQGzrlO9erVsyKkK4+XHOOYzshxRGjF4hrC54svvmgFLQQXhBdEGNpAmMxsDE4InoR1dF4uycf7ZuOzPl/3yOeff249EZPfb8ksinrNe5j3Z/J97rPPPuuiP0GBhtfJnpWjR4+274V0wh6fRcuXL+fQSFhwsoLP7yLqcp83PuvNFSrfU3xf8VnGNY6LRV7oCj548WDUsWPHuFwb9UMEREAEREAEREAEREAEREAEREAEREAESoVAMKfI5MmTE7PR89EYQkS1bt3aVh2GQcBc+/jss88WKX64uhlgJAwe3hJ4H+26665m9913N+TR4o9QgzvssIMhhGHQELkQi5IFHTyCGOTee++9g8Wt9wX5WBCzgkYIQTymnJGTiRxb6QasKYdHwpgxYxJePXiSNW7cuEAoLrySCOtG+xjYd+EOEajw/qDfnAMPKvqy44472nany+0TzB9Ge2k3hphDvixn06ZNM3i5EenJndPtCy4RGQjD6Lw23L46deqYTz75xL5E4MHLy+U0o70tWrSw53TlWdb/r/jbtWtXQ0g/PJ3IlYbX2UsvvWQ96lh34SkR4oJ5mpLFPnKHcQ2LY8khGHOti/CJeNghvBXVJt9sfNbn8x7BI477D0HWecVlypd7A6GUHHd40CSbzz77rIt20lc8OBFMMd4Hw4cPt+vu39KlSw1hRxEEk41jCZEXFUO4c/kDfX4XBcV0n/XmyjUuk0uS+x95oYs4kiTBw5Jj+SZ3Vq9FQAREQAREQAREQAREQAREQAREQAREQASKJhDMKYIXQtDjpeijsyuBKMLMfywMg4DZtf7/StMPBBxy2DhBx+3Fq4ZBX0IHHn300TY/UnIYOFe2sCWiY9CLirKIZIhI6fLJ4NlD+DDyMuG1RcjCiRMnJryj3PkId8iAvBN82E4/yBOGWIaolWx4XZGTh+tGvpeHH37Y9o1yAwYMMOR3o5+zZs1KbGcf3k6M6eGFhtiVzhCL2rZta7766isb2hABBkvOhzZz5kybD+2NN94whGJERHNiIH3Yd9997fghE+R32223jU6HgIdXlTOEP8L7OWOiPWJsqsF8ynB9C/OIS/YS4xjCR+LtgrfU7NmzLWu252rcA3j6ZWOw4L1HPjlyTdHOdPng0tXrm42v+nzfI/QfIQlPMfKpMRkAAYy/H374wfzyyy/2Xub9haCK4AtTBNGimPrqM230WRf1kSoIIRnRff78+fbzgO1BQ9BFaOd9RGhSZ2effXaBEJ1ue1iX5B7jc5BJB2vWrPHWTD5TEdOxMHzH8R3Cd0lY2mMb4uFf5IWu4Ayjvn37Fkge6YGPqhABERABERABERABERABERABERABERCBMkfggw8+sAO0dJxBTvJo5dMYFMZWrlxpKleubNej+o/cLvSHMFgMjOPZhNCSypsj2z7iMXXhhRcmDmNQnVwreBX5MNq7fv16O4hPvi/nrVRU3Qz2IyjtvPPOBYr+9NNPNu8UQlCuhmCFiER7nOE15by72BYMa8hrhAeuAyEW8UoqSlTEYwWPHUQCxB/yMrkcZtSH0Uc8xhDRsrGaNWta8S3Za41zIhRyfyASFtcQDwnniNjnDMGF9xN/CKGwwJMQzz/Wy5cv74oWa+mbjY/6fN8jxQKUwcE++uxO47Mu6kRw5h5Nvofd+dyS9yqC6/PPP28/O/AK9HFvu/rzvXTfQ4jaCOa+DI9a9x0aBqGrX79+BjEfC0N7fHGOvNAVnGHERWI2hEwEREAEREAEREAEREAEREAEREAEREAERCB3Agx+uZwiCCl4euTT3ABjhw4dbMSefJ4rynWTb4uQfQgkiDgMVrq8VVHuV7ZtT86/REi5Qw45JNtqsi7PQD55yPBUQ0hLZQiaCIR47yFy4RmGCFgShnhGXjDCLyJmFeYt57s9vtkUt77SukeKw7W4fQ6e22ddwXrjus5nKxMSsKFDh2YchjYTHuR3c9+hYRCW8PDFqxcLQ3syYZhJmVgJXVykiy66KJN+q4wIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiEAaAsGcIi4sXJqiXjZfcsklhlwvWJwG3rzASaoErytySCHs4LFTFu3VV181p512WqLrhGWsVq1a4nVJrOD9hecj7xVEBYRHxKUaNWoU6UFWEu0rzXP4ZpNLfWG4R4pzDXLpc7rz+awr3Tmivj3oxUyIRt7Hvoz8fYSuxcLw/ebCyoalPRaMh3+RF7qCN2H//v1tYj8PXFSFCIiACIiACIiACIiACIiACIiACIiACJRZAsGcIoSiIo9QPo1QV2eddZY9RRgGAvPZV9VdfAJ4UzVp0iRRUUnco4mTaSUSBHSPROIyhaaReGqSbxB7++23bd49X40jxyC5GbEwfL8NGjTI5jwMS3ssGA//Ii90ffjhh+aEE06wKIidSQxNmQiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIQO4EgjlFGAA8/PDDc68sgyP4mVL6AABAAElEQVTxUiKPEEbIsZIMuWZPqn+RIhD0kKDhEyZMMCeffHKk+qDG5peA7pH88o1b7b179zZTp0613fItRm3YsMEcddRReak7l+tw6623mtGjR4emPbn0IdUxkRe6uPFczGjUyPPPPz9VP7VNBERABERABERABERABERABERABERABEQgQwKff/65OeaYY2zphx9+2Bx22GEZHpl7MZenq1u3bubqq6/OvSIdGXsChAqsWrWqQSDFhgwZYlq1ahX7fquDmRPQPZI5K5U0xn3/NGvWzIwcOdIrkq+//jrhFe1bRMulocOGDUv0MQztyaUPqY6JvNC1fv16U69ePds31Mhzzz03VT+1TQREQAREQAREQAREQAREQAREQAREQAT+X3t3Am9TuT9+/Hscx9AxpkEqmadMp2Q6FMlQGuRGxatJhogMUf3DVWlECeUqTRpUKokSiSTXVNdQhsicWyRjnAwH/77P/T27dba1z7jP2Wuv/Vmv1z7rWc+83mvX9trfvZ6FQCYFfvvtN7nssstM7ZkzZ8rFF1+cyZbZr9arVy/57LPPTAd++vIt+yK0TE9AlwLTJcF008CoBkjZEHAK8B5xapAOJXDo0KHAZ5wGgTp06BCqarby9+3bF7gr2gufbc8995yMGTPGnIsX5pMtVJdGUR/o2rFjhyQnJ5tTGzlypHTs2NHlNMlCAAEEEEAAAQQQQAABBBBAAAEEEMisgHOppVmzZkn16tUz2zTb9TZv3izNmzc37cP9jJRsT4qGnhXQH7svXrzYzK9GjRry+eefe3auTCwyArxHIuMebaPOmzdP7rrrLjPtr7/+OrCMbrjOY//+/VKnTh3TnRcCSxrk0mCXbl6Yj5lIGP5EfaDL+XBUAl1heEfQBQIIIIAAAggggAACCCCAAAIIxLyAc6mlOXPmSJUqVfLExC4fNXjwYOnevXuejMkg0SkwbNgweeONNwKTnzZtmiQlJQWOSSDAe4T3QGYEBg0aJFOmTDFVcyPwc/DgQalVq1au9Z+Zc3TW0aUZ9c413XLjfJ1j5WU66gNdzoejPvvss3LTTTflpR9jIYAAAggggAACCCCAAAIIIIAAAr4TcC61pL92r1ixYp6c47333iuffvqpGctPX8DlCV6MDaLLXOpyl3Zr3769jB492h6yR8Ashcp7hDdCegInT56U8uXLmyp6B6A+Gincm3NpRC98rr344ovmuYZ6nl6YT7i8fRXo0g8z/VBjQwABBBBAAAEEEEAAAQQQQAABBBDIvoBzqaWvvvpKKlSokP3OstBy165dUr9+fdPinXfekSZNmmShNVVjSUDfo5deeqmkpqaa0y5QoIBs2LBB4uLiYomBc01HgPdIOjgUGYEFCxbIbbfdZtIffPBB4PMnnDyHDx8WXV5VNy8EliZMmCBPPfWUZ+ZjJhKGP1Ef6Pr111+lYcOGhkLXl2zXrl0YWOgCAQQQQAABBBBAAAEEEEAAAQQQiF0B51JL+kWgXVIwL0T0WSb6BbVuXvhSMC/OmTGyJ+C8A1B70Oe8xcfHZ68zWvlSgPeILy9r2E7qxhtvlOXLl5v+tm7dmiuB8pSUlMBzLr3wmTZx4kR5/PHHzTl7YT7huphRH+jauXOnNGjQwHiMHTtWbrjhhnDZ0A8CCCCAAAIIIIAAAggggAACCCAQkwLOpZb+/e9/ywUXXJBnDqtXr5a2bdua8f71r3/JNddck2djM1B0CWhgS3/0fuDAAfNF8ueff54rX1RHlwqzdQrwHnFqkHYKaGDriiuuMFkPPfSQ9OzZ01kctvSRI0ekatWqpj8vBJZeeeUVGT58uGfmEy7oqA90OW9pf+GFF+S6664Llw39IIAAAggggAACCCCAAAIIIIAAAjEp4FxqafHixVKmTJk8dWjUqJHoc9l1+/HHH6Vw4cJ5Oj6DRY+ABjK+++47uf7666VQoULRM3FmmmcCvEfyjDqqBurdu7fMmDHDzHnVqlVSokSJXJn/sWPHpHLlyqZvLwS6Xn/9dXnkkUc8M59woUd9oOu3336Tyy67zHiMHz8+8IufcAHRDwIIIIAAAggggAACCCCAAAIIIBBrAn/++adUq1bNnPayZcvk3HPPzVOCTZs2yZVXXmnGvPXWW+Xpp5/O0/EZDAEEEEDAvwLOz5g777xTHn300Vw72ePHj0ulSpVM/14IdL355psydOhQz8wnXPBRH+javXu31KtXz3jog9SuvvrqcNnQDwIIIIAAAggggAACCCCAAAIIIBCTAkePHpUqVaqYc9e7Zc4+++w8dxg0aJBMmTLFjPvRRx8Fvv/J84kwIAIIIICArwR0ydMVK1aYc9JndJUqVSrXzi81NVUqVqxo+vdCoOvtt9+WwYMHe2Y+4YKP+kDX77//LpdeeqnxePnll6V169bhsqEfBBBAAAEEEEAAAQQQQAABBBBAICYFnL9Az+0vAUMBO5dP1Do//PCDFCtWLFR18hFAAAEEEMhQ4IsvvpBu3bqZev369ZP+/ftn2CYnFU6ePCnly5c3XXgh0PXuu++KPpNMNy/Mx0wkDH+iPtC1Z88eueSSSwzFxIkTpVWrVmFgoQsEEEAAAQQQQAABBBBAAAEEEEAgdgWcv0DPzWeXZCS8aNEi0aULddNHV3zwwQcSFxeXUTPKEUAAAQQQOE3g4MGDUqtWrUB+XjwD8tSpU1KuXDkzphcCS++//7488MADnplP4GLkMOGrQNerr74qV111VQ5JaI4AAggggAACCCCAAAIIIIAAAgjEtoDzF+irV6+WokWLRgzkn//8p0yaNMmMnxe/vo/YiTIwAggggECuCvTq1Us+++wzM0ZexhIuuugiM6YXAl36g5GBAwd6Zj7huuBRH+jau3evJCUlGY/XX3898KDScAHRDwIIIIAAAggggAACCCCAAAIIIBCLAvaLubVr10piYmLECHQZxSZNmsjOnTvNHF544QW57rrrIjYfBkYAAQQQiD4BfdbjgAEDzMT18Uf6GKS82uznqRcCXVOnTg0s1+iF+YTrGkR9oGvfvn1St25d46G/7mnWrFm4bOgHAQQQQAABBBBAAAEEEEAAAQQQiFkB+8Xc+vXrpVChQhF1+PXXX6Vhw4aBOejSS87jQAEJBBBAAAEEggR0iUINbtlt5cqVUrJkSXuY63v7eeqFwNInn3wi9913nzlnL8wnXPhRH+jav3+/1KlTx3i8+eabcsUVV4TLhn4QQAABBBBAAAEEEEAAAQQQQACBmBWwX8xt3LhREhISIu6wYsUKadeuXWAeuvxUzZo1A8ckEEAAAQQQCBbQG2UaN24sKSkppmjy5MmSnJwcXC1Xj+3nqRcCSzNmzJDevXub8/XCfMIFH/WBrgMHDkjt2rWNx9tvvy1NmzYNlw39IIAAAggggAACCCCAAAIIIIAAAjErYL+Y27x5s8THx3vCYebMmdKzZ8/AXObMmSNVqlQJHJNAAAEEEEDAChw7dkxuvvlmWb58ucmK1HMe7eepFwJLzs9RL8zHXquc7qM+0HXw4EGpVauWcYhENDanF4D2CCCAAAIIIIAAAggggAACCCCAgBcF7BdzW7dulbi4OM9MUVf0GTp0aGA+H3/8sVxyySWBYxIIIIAAAgicPHnSLNGndzDppivBvfHGG5IvX748x7Gfp14ILM2aNUt69OhhDLwwn3BdjKgPdP3xxx+B29Tfe+89adSoUbhs6AcBBBBAAAEEEEAAAQQQQAABBBCIWQEvfTEXfBHGjBkjzz33XCB75MiR0rFjx8AxCQQQQACB2BVITU2V+++/X6ZNm2YQypQpI1988YUULVo0Iihe+jxVh27duhkHAl0ReTu4D3ro0CG5+OKLTSEPInU3IhcBBBBAAAEEEEAAAQQQQAABBBDIqoCXvphzm/sLL7wgGuCy24033ijDhw+P2BeZdh7sEUAAAQQiJ6Dxgl69esnXX39tJnHGGWfI3LlzRYNdkdq89HmqFl26dDEUBLoi9Y5wGffw4cNSo0YNU/LBBx9I/fr1XWqRhQACCCCAAAIIIIAAAggggAACCCCQFQEvfTEXat66JFXv3r0DxQkJCTJ+/Hhp1apVII8EAggggEBsCGzcuFHuvPNO+fnnn80JFy9eXD777DO58MILIwrgpc/T+fPnyx133GE8CHRF9G2RdnBnoOujjz6SevXqpa3AEQIIIIAAAggggAACCCCAAAIIIIBAlgW89MVcepPftGmTed7ITz/9FKjWvHlzGTZsmJQvXz6QRwIBBBBAwL8CutrbAw88EDjBqlWryttvvy3nnHNOIC9SCS99ni5YsEBuu+02Q0GgK1LvCJdxU1JSpHr16qaEh4+6AJGFAAIIIIAAAggggAACCCCAAAIIZEPAS1/MZTR9fR7LSy+9JCNGjEhTVX+13rdvXylVqlSafA4QQAABBPwhsHPnTnn44YfN8oT2jNq2bSujRo0SXbbQC5uXPk///e9/S6dOnQwLgS4vvDv+bw5//vmnVKtWzRzpw+WSkpI8NDumggACCCCAAAIIIIAAAggggAACCESngJe+mMusoC5Xpc/pmj17dpomPXr0MHd9EfBKw8IBAgggELUCJ06ckLfeekseeeQROXXqVOA8hgwZIl27dpW4uLhAXqQTXvo8Xbx4sdxyyy2GhEBXpN8ZjvGdga7p06dLnTp1HKUkEUAAAQQQQAABBBBAAAEEEEAAAQSyI+ClL+ayOv/vvvtOHnvsMVm1alWaprfffrt079494s9rSTMpDhBAAAEEsiQwd+5ceeaZZ2T9+vWBduXKlZNx48ZJ7dq1A3leSXjp83Tp0qXSsWNHQ0OgyyvvkL/mceTIEdH1NnX79NNPpVatWibNHwQQQAABBBBAAAEEEEAAAQQQQACB7At46Yu57J6FLtH09NNPy/fff5+mi2bNmkmvXr2kQYMGafI5QAABBBDwpoDewaV3606YMOG0HzF069ZN7r//filcuLAnJ++lz1P9Icg//vEP40Sgy0Nvl6NHj0qVKlXMjGbOnCkXX3yxh2bHVBBAAAEEEEAAAQQQQAABBBBAAIHoFPDSF3M5FVyxYoX5pb/eBeDc8uXLZ+78uv7666V48eLOItIIIIAAAh4Q2L17t7z//vvy7rvvyo4dO9LMqGHDhjJs2DCpUaNGmnyvHXjp81Q/D9u1a2eICHR56J1y7NgxqVy5spnRrFmzpHr16h6aHVNBAAEEEEAAAQQQQAABBBBAAAEEolPAS1/MhUtQvyR988035aWXXjqtywoVKsg999wjLVu2lDPPPPO0cjIQQAABBPJGQB9XNGfOHPn4449l3rx5pw2alJQk/fr1E7071+ub3ommny+6eSGwpEv66o87vDIfM5Ew/In760Ftfz+pLQwd5nUXx48fl0qVKplh9dbFatWq5fUUGA8BBBBAAAEEEEAAAQQQQAABBBDwnYAfA132IukKQboy0IgRI+SXX36x2Wn2d955p1xzzTVy6aWXSv78+dOUcYAAAgggEF6B/fv3y1dffWUCXLpPSUk5bYCrrrpKunbtKo0aNTqtzKsZu3btkvr165vpbdq0KeKfJ6tXr5a2bdua+Xgh8Bau6xb1ga7U1FSpWLGi8dAor13GMFxA9IMAAggggAACCCCAAAIIIIAAAgjEooANdP3444+efe5JOK7Lzp07zRerY8eOld9++y1kl/oL+A4dOpjAV2JiYsh6FCCQ1wJ6H8PJkydF93r3iKbtse5tnq1ny9Pb27qZbRuOsbUPfelm98Hp+Ph40SVHnS/Ni4uLk6yU2bpu7XKjTMdhSyuwfft2+c9//mNe+tyodevWpa3wf0dnnXWWdOzYUW699VYpW7asax0vZzqXClyzZo0UKVIkotNV5zZt2pg5EOiK6KVIO7gz0KXrLNu7u9LW4ggBBBBAAAEEEEAAAQQQQAABBBBAICsCNtC1cOFCufDCC7PSNGrr6h0E3377rXz66acyZcqUDM9D7y644YYbzK/1S5cunWF9KuSOgAZj9KXfE2Z2n5W6ofp09qFBI+dxenPKaV0dR1+60pXutT827wpokEufAVioUCEpWLCgedm03Wu+Tdt9RnkZlWsw0AvbkSNHRH8wsX79ehPM0kCLBn/0ztpQ2xlnnCGtW7c2S+xdfvnlEb8LKtQ8M5M/ffp06dOnj6m6cuVKKVmyZGaa5VodvQ6tWrUy/RPoyjXmrHesHxp2jUu9pdGms94TLRBAAAEEEEAAAQQQQAABBBBAAAEErIANdE2ePFmSk5NtdkztDx8+LD/88INZ5nDSpElZOndd8rBBgwbmVa9evUz/it95Z4wNYthAiwY0bAAleO8Mnti0re/sx9nO1tM8m86ojVv7zLaxY7iN5+zXmU6vjZ6X1nXe/ZOli+TByvYOI72ryL506UwNWuje5jnvaApOp3dHktbVcjuOW1sts/WCy53H4ejHOVftW8fWze6D0/a9oe8L+74LTmsdZ559j2TUNqN6wf1mZQwNSh47dizw0iCPvn9za1M/DZjp3ad6B5Hu7cseO/caWNLjokWLmn2xYsUCac13Lt+q89ZlBvfs2RN47d27N5DW5fk2bNhgjrNyfrocYePGjaVhw4ZSt25dKVCgQFaae7buuHHjZNSoUWZ+y5cvl1KlSkV0rhs3bpQWLVqYORDoiuilSDu4/g+lfPnyJnP+/PmBdNpaHCGAAAIIIIAAAggggAACCCCAAAIIZEXABrqGDx8ut99+e1aa+rqufrmry0/ps+L1OV/6BS+bPwX0y337SkhIMGm7t/m61zwN2GSmLDN1NUhhXypr07p3bjbAp/uM0touVB1b5lZuy+zerY4zT+vppnnO/IzStk3wPlQ7radbeuO4lZtGGbRzjums7+zPjqt7/X46uEzzbB0tcx7bNho4+/PPP82zqHSvdz7pXl9+35KSkqRWrVpSs2ZN89LHEel/G37c+vfvL1OnTjWn5oU7ujZv3izNmzc38yHQ5aF3nP6PoVy5cmZGCxYsEPuPMA9NkakggAACCCCAAAIIIIAAAggggAACUSdgv2Pp3LmzPPnkk1E3/7yesH5JbZ85o8+b0dfWrVvzehqMhwACPhVwBjxt0NO5t+V6+jZtyzVPg225HUTTu5X0u3r7uuCCC+TMM880SzeWKFHCLNund4vp3Xuxsl177bXmzmA9Xy88o0s/l6644grDT6DLY+9C+w+vWFoz2mOXgOkggAACCCCAAAIIIIAAAggggIDPBPT5KPpclTp16og+Y4Qt7wTsnSC6183ubdqWhzrWfN1sPdveHruV2Ty7d6try4L3wf0HH2t93dLr01lm69q9syxU2lnXmdb6zmNz8NefUP3YfGe74DbOMrd08HhufTrb2fp27yyzbW2Z7u1mgxg2qKH5odK2zO6dbd3ybLkts3ubHzyOLde9bsHlodrZfNsmeG/Lg/vTeroF5zvru5WbRhm0C+7D9mP3dky7t0Ebe6x7uwyjpnVzHjvLnX0G1wlup8ds0SWgd+3VqFHD3K2nM9dlHfUu0EhuP//8szRp0sRMgUBXJK+Ey9g20LVo0SI5//zzXWqQhQACCCCAAAIIIIAAAggggAACCCCQFYEHH3xQ3nvvPdPET1+GZcWAuggggAACCGRX4KeffpKrrrrKNC9YsKB5dll2+wpXu19++UX0eWi6+emzPe6vXwX872cN4ZKKQD820LV48WIpU6ZMBGbAkAgggAACCCCAAAIIIIAAAggggIC/BD766CMZMGCAOSk/fRnmr6vE2SCAAAIIeFVAn82lz+jS7eyzzzZL2kZ6rjt37pQGDRqYafjps91Xga6lS5dK6dKlI/1eYXwEEEAAAQQQQAABBBBAAAEEEEAg6gXWrVsnbdq0Mefhpy/Dov7CcAIIIIAAAlEhMHToUHnzzTfNXKtUqSJz5syJ+Lx3794t9erVM/Pw02e7rwJd+pBPjYyyIYAAAggggAACCCCAAAIIIIAAAgjkTODQoUNy8cUXm07Wrl0riYmJOeuQ1ggggAACCMSQwDXXXCNr1qwxZ5ycnCyTJ0+O+Nnv2bNHLrnkEjMPAl0RvxxpJ2CXLly+fLmUKlUqbSFHCCCAAAIIIIAAAggggAACCCCAAALZErDfuXzyySdSt27dbPVBIwQQQAABBGJN4I8//pA6depIXFycpKamSvv27WX06NERZ9i/f7+Zl06EQFfEL0faCdh/dK1YsULOPPPMtIUcIYAAAggggAACCCCAAAIIIIAAAghkS8B+56LLL3Xt2jVbfdAIAQQQQACBWBOYO3eudOnSRcqVKydbt26VPn36yMCBAyPOoAG4mjVrmnkQ6Ir45Ug7AfuPrlWrVkmJEiXSFnKEAAIIIIAAAggggAACCCCAAAIIIJAtgSuuuMJ8Qad3c+ldXWwIIIAAAgggkLHAY489Jq+++qo0adJEFi5cKCNHjpSOHTtm3DCXaxw+fFhq1KhhRiHQlcvYWe3eBrp++OEHKVasWFabUx8BBBBAAAEEEEAAAQQQQAABBBBAwEXg+eefDyy15KcvxFxOlSwEEEAAAQTCJtCiRQuzNOB1110nU6dOlQ8//FAuu+yysPWf3Y7+/PNPqVatmmnup8/1uFN/bdlF8Uo7G+jSB7sVKVLEK9NiHggggAACCCCAAAIIIIAAAggggEBUCyxatEhuvfVWcw4bN26UhISEqD4fJo8AAggggEBuC/z888/mTq5GjRqJhl+WLFkiK1eulJIlS+b20Bn2f/ToUalSpYqpR6ArQ668rWADXWvXrpXExMS8HZzREEAAAQQQQAABBBBAAAEEEEAAAZ8K7Nu3T3TZQt106UKb9unpcloIIIAAAgjkWOD111+XRx55RIYMGSIvvvii+ZHIt99+m+N+w9HB8ePHpVKlSqYrAl3hEA1jHzbQ9eOPP0rhwoXD2DNdIYAAAggggAACCCCAAAIIIIAAArEtYL93GTx4sHTv3j22MTh7BBBAAAEEMhC45ZZbZPHixfLuu++au6KbNWsmkyZNyqBV3hSnpqZKxYoVzWAEuvLGPNOj2H9wbdiwQQoWLJjpdlREAAEEEEAAAQQQQAABBBBAAAEEEEhfoE2bNrJu3TrR718WLFiQfmVKEUAAAQQQiGGBPXv2mGdx6fKAffv2lXvuuUfuu+8+uf/++z2hcuLECalQoYKZC4EuT1ySvydhA12sFf23CSkEEEAAAQQQQAABBBBAAAEEEEAgHAKvvPKKDB8+3HS1efNmiY+PD0e39IEAAggggIDvBN566y2zZOHAgQPlwIEDMnHiRNGlDK+88kpPnKs+M6xcuXJmLgS6PHFJ/p6EDXRt2rRJ8ufP/3cBKQQQQAABBBBAAAEEEEAAAQQQQACBHAmsXLlSbrjhBtPHtGnTJCkpKUf90RgBBBBAAAG/CnTo0EGWLVsmX3/9tfTr109WrVolK1askBIlSnjmlG08hUCXZy7J/yZiL8yWLVskX758Hpsd00EAAQQQQAABBBBAAAEEEEAAAQSiV8D5PI8BAwaYpZii92yYOQIIIIAAArkjsH37drn88sulbt268s4770jt2rWlcuXKMmvWrNwZMJu92ngKga5sAuZWMz9emNyyol8EEEAAAQQQQAABBBBAAAEEEEAgqwJt27aV1atXy1lnnSX/+c9/stqc+ggggAACCPheYPTo0fL888+b5X7PP/986dKli9x9993yz3/+01Pn7sd4StxfazKe8pRyNibjxwuTDQaaIIAAAggggAACCCCAAAIIIIAAArki8PLLL8sTTzxh+l6+fLmUKlUqV8ahUwQQQAABBKJR4OTJk9K0aVPZvXu3fPvtt6JBL302l5eez2Vd/RhPIdBlry57BBBAAAEEEEAAAQQQQAABBBBAAAFXgXXr1kmbNm1M2ciRI6Vjx46u9chEAAEEEEAgFgXmzZsnd911l3mm5dixY80Shjt37hR9zuUZZ5zhKRICXZ66HH9Pxo8X5u+zI4UAAggggAACCCCAAAIIIIAAAghEVkAXBCpXrpyZRHJyskyePDmyE2J0BBBAAAEEPCTQuXNnWbhwoXz00UdSsGBBufbaa6VFixby2muveWiW/5uKH+Mp3NHlubcZE0IAAQQQQAABBBBAAAEEEEAAAQS8JzBo0CCZMmWKmdiSJUvkvPPO894kmRECCCCAAAJ5LLBq1Sq5/vrrJSkpSaZNm2aeyTVp0iTRO7tuuOGGPJ5NxsMR6MrYKCI1/HhhIgLJoAgggAACCCCAAAIIIIAAAggggEAIgfnz58sdd9xhSvv06SMDBw4MUZNsBBBAAAEEYkdAlyzUpQtfeeUVady4sTRo0EDi4+Nl6dKlUqhQIc9B+DGewh1dnnubMSEEEEAAAQQQQAABBBBAAAEEEEDAewKpqalSo0YNOXr0qFmWyYvPHfGeGjNCAAEEEPCzwLJly6RDhw5Su3ZtmT59ugl2Pf7449KjRw95+OGHPXnqBLo8eVlE/HhhPErNtBBAAAEEEEAAAQQQQAABBBBAIIYFnnrqKZkwYYIRGDJkiHTr1i2GNTh1BBBAAIFYFjh58qRZmvD77783z6685JJLpGnTpnLgwAH55ptvpHTp0p7k8WM8hTu6PPlWY1IIIIAAAggggAACCCCAAAIIIICA9wR27NghycnJZmIlSpSQhQsXStGiRb03UWaEAAIIIIBALgtMnjxZ/t//+3/SsmVLcyfXCy+8ICNHjpQ777xTHn300VwePfvdE+jKvl2utvTjhclVMDpHAAEEEEAAAQQQQAABBBBAAAEEsinQu3dvmTFjhmndvXt3GTx4cDZ7ohkCCCCAAALRKbB7925p0aKFWc53zpw5UqBAAbnyyislLi5OFixYIKVKlfLsifkxnsIdXZ59uzExBBBAAAEEEEAAAQQQQAABBBBAwHsC69atkzZt2piJxcfHy6xZs6RKlSremygzQgABBBBAIJcE9Ices2fPlgcffFB69eolPXv2lJkzZ0o0LOtLoCuX3hQ57daPFyanJrRHAAEEEEAAAQQQQAABBBBAAAEEckugT58+Mn36dNO9PpPkww8/FA16sSGAAAIIIOB3gY8++kgGDBggtWvXlo8//lj0jq577rlHqlevLp9++qnkz5/f0wR+jKdwR5en33JMDgEEEEAAAQQQQAABBBBAAAEEEPCewPbt282STceOHTOT02eU6Jd8bAgggAACCPhZYOvWrdK2bVtJTU01Qa1ixYqZu5wPHjwon3zyidSsWdPzp0+gy6OXyI8XxqPUTAsBBBBAAAEEEEAAAQQQQAABBBAwAiNGjJAXX3zRpBMSEmTq1Knm1+3wIIAAAggg4EeBo0ePSvv27WX16tXy+OOPS6dOnaRz586yePFiGThwoOjdztGw2XjKli1bJF++fNEw5QznGPV3dJ04cUIqVKhgTnTbtm0ZnjAVEEAAAQQQQAABBBBAAAEEEEAAAQRyLpCSkiItW7aUHTt2mM7Kli1rft1evHjxnHdODwgggAACCHhMYNCgQTJlyhS59tprzQ89nn76afnXv/4lycnJ8tZbb0XNEr420LVq1SopUaKEx5SzN52oD3TpP6p07UvdCHRl701AKwQQQAABBBBAAAEEEEAAAQQQQCA7AgsWLJDbb79dTp06ZZo3b95cXnvtNd/8Qjw7JrRBAAEEEPCfwBtvvCHDhg2TypUrmyUKv/zyS+nbt6+ULl1aPvvsMylVqlRUnLTzxqGFCxfKhRdeGBXzzmiSUR/o+uOPPwLrXhLoyuhyU44AAggggAACCCCAAAIIIIAAAgiEV0CfzzV58uRAp926dZMhQ4YEjkkggAACCCAQzQLz58+Xu+++WxITE02Qa8+ePWbZwri4OPnggw+iatneAwcOBOb7xRdfSNWqVaP50gTmHvWBLn3IW61atcwJ/fTTT1KgQIHAyZFAAAEEEEAAAQQQQAABBBBAAAEEEMhdAV1tp23btrJ58+bAQMOHDzd3egUySCCAAAIIIBCFAmvWrJEOHTqIPp/rzTfflLPPPtsca1xi/PjxcvXVV0fVWenNQpdffrmZ84wZMwJBr6g6CZfJRn2g6/Dhw1KjRg1zasuXL4+aWwRdrgVZCCCAAAIIIIAAAggggAACCCCAQFQKrF27Vtq1a2e+CNQTiI+PlwkTJkirVq2i8nyYNAIIIIAAAr/88otcf/318vvvv8vIkSPNs7jat28vv/76q1nGsEuXLlGHtGLFCvN5rROfNm2aJCUlRd05uE046gNdx44dM+ti6snNmzdPKlas6Hae5CGAAAIIIIAAAggggAACCCCAAAII5KLAlClTZNCgQYERChUqJK+++qo0adIkkEcCAQQQQACBaBDQ5Qn1Tq5NmzbJwIEDRQNcnTp1kq1bt0qvXr3kwQcfjIbTOG2Os2fPlu7du5t8Al2n8UQ246KLLjIT0PUw69evH9nJMDoCCCCAAAIIIIAAAggggAACCCAQowL6bK633norcPYFCxaUZ599Vq677rpAHgkEEEAAAQS8LKB3ct12222yceNG6dy5swl49ejRQ3bt2mWW5X3sscdEn88VjZsuvzh06FAzdZYu9NgVtIEuXRNT14RmQwABBBBAAAEEEEAAAQQQQAABBBDIe4HU1FS55557ZM6cOYHB9cvArl27ykMPPST58+cP5JNAAAEEEEDAawK6tJ8Nat18881mNbkRI0bI8ePHpW/fvtKvX7+oDXKp9VNPPWWWFta03t1VrVo1TUb9FvVLF+oVsIGuYcOGSTSuixn17yJOAAEEEEAAAQQQQAABBBBAAAEEEPg/AX3MhAa75s6da3I00HXq1Cm5+OKLzd1d1atXxwoBBBBAAAFPCejn1KRJk+SJJ54wQS19NpfewbVkyRIpVqyYjBo1Slq3bu2pOWdnMrrs4meffWaafvPNN1K2bNnsdOO5Nr4KdN11113yyCOPeA6ZCSGAAAIIIIAAAggggAACCCCAAAKxJKB3dunzuqZOnSoJCQlSsmRJ+e2338wdXfr9jf4ivkiRIrFEwrkigAACCHhU4NdffzV3Hc+fP1/i4+PNjTX//e9/5ejRo+Y5kyNHjpQyZcp4dPZZm9Y111wja9asMY1WrlxpPp+z1oM3a/si0NWiRQuzXmZSUpLoA9TYEEAAAQQQQAABBBBAAAEEEEAAAQQiK6C/jh83bpyMHj1a8uXLJzVr1hT9MlF/IV+qVCm57777zLNPNBDGhgACCCCAQF4LnDhxwjxXUgNZhw4dSjO8fk49/PDD8o9//COqlyp0npR+LteoUUNSUlLM57I+g0wDe37YfBHo0l8ITZkyxVyPbdu2+eG6cA4IIIAAAggggAACCCCAAAIIIICALwS++uor6d+/v+zbt0/q1q0rFSpUkJkzZ8qRI0fk/PPPF11GqWPHjlKgQAFfnC8ngQACCCDgfYHFixfLo48+KuvWrUsz2YIFC4reeXzvvfeaJQvTFEb5wY4dOyQ5OdmchQbyli9fHuVn9Pf0fRHoevHFF0UfCKfb1q1bfRNh/fsykUIAAQQQQAABBBBAAAEEEEAAAQSiV0Dv5BowYIAsWrRIEhMT5eabb5bDhw+bpQ2PHz8u5557rtx5553mDq/ixYtH74kycwQQQAABTwtoYEtjCfPmzUszz/z585vPpt69e/tmmcI0J/jXwZdffil33323ydY7uz7//PPgKlF77ItA14wZM0TfgLrpP5j010BsCCCAAAIIIIAAAggggAACCCCAAALeETh58qRZIuqZZ54xQa6LLrrILAmlz+768MMPzR1eGgRr166d3H777VKtWjXvTJ6ZIIAAAghEtYAGuMaOHWvuKHaeSOHChU2Aq0ePHr4NcNnzHTNmjDz33HPmsGXLlvLKK6/Yoqjf+yLQpQ9P04eo6fbGG29I8+bNo/7CcAIIIIAAAggggAACCCCAAAIIIICAHwX0GV3PPvusCW7p81EuvPBCueGGG+TYsWPy8ccfy+7du81p16tXz3z5ePXVV0vRokX9SME5IYAAAgjkssB3331n7uBaunRpmpHOOeccueOOO6RTp05y5plnpinz60HXrl1lzpw55vS6dOkiw4YN882p+iLQ9eeffwZ+5fPggw+atZ19c4U4EQQQQAABBBBAAAEEEEAAAQQQQMCHAps3b5bx48eb4FZqaqpZ0lCDWiVKlJDvv/9eli1bZs46ISFB6tevb37Y3KxZM6lcubIPNTglBBBAAIFwCejSuC+88IL5jAnus2HDhuau4datW4suVxhLm/6AxP6YZPjw4cbBL+fvi0CXXgy93V03/QfRhAkTTJo/CCCAAAIIIIAAAggggAACCCCAAALeFtDnd73zzjsyefJk2bNnj5lshQoVpFy5cmY5w507d4oGxex29tlny6WXXir6hZ3ua9asKQUKFLDF7BFAAAEEYkxAfywxe/ZsGTVqVJrPCydDnz59pH379qKfL7G4/fzzz9KkSZPAqb/77rvSuHHjwHG0J3wT6NI1NGfNmmWux7Zt26L9ujB/BBBAAAEEEEAAAQQQQAABBBBAIKYEjh8/Ll988YVMmTJFvvnmG9FlDXUrVqyYFC9eXFJSUuTQoUNy9OjRNC4a5KpatarUqlVLqlevLlWqVDHHJUuWTFOPAwTyWkCfS3fq1Cnz0rE17cyzZc59ZstD9aftbZnt19mnljmPnXOy7YLLbT92H1xu2+leN63n3DvTtq3Ns33afXrl2iYuLk53IfemMKg8X758Yl/a3qZ1n9Xj4DbaPrgPZx1b7ra39YLLND8+Pj4wT3tO7P8noKu7rV271ix/qz+QSG/T5z3eddddMRvcctpMnTpV+vfvH8havny5lCpVKnAc7QnfBLr0Lq6nnnrKXA+/XaRof5MxfwQQQAABBBBAAAEEEEAAAQQQQCArAnv37pWFCxeagNeCBQtE7+rK6qbP9SpdunSa17nnniv6svlnnXWW+TI5q33b+vrlvP1i3qb12ObZtAbt7EvzNK13INi0LdO95jnLnGm3em5tnPWcadu3beMsc6btvEKNHVzXWc+ZdqunebZ/W2492SOAQOQEChUqJMGvwoULS8GCBU/LD65nj7W+Tevetj3jjDPEvrSOBvOCt4MHD4o+w3H9+vUmkKXBLH1pXmY3vRNY79xq165dzC1LmJHRoEGDzA9JtJ5+DtrlgTNqFy3lvgl0LVmyxDygVOEnTpworVq1ipZrwDwRQAABBBBAAAEEEEAAAQQQQAABBNIR2LFjh3lulz6764cffjCvAwcOpNOCIgQQQAABvwtce+210qlTJ/McR32eI1togeTkZNHPUt1atmwpr7zySujKUVjim0CX3rJYrVo1cwm6d+8ugwcPjsLLwZQRQAABBBBAAAEEEEAAAQQQQAABBDIS0Lun9Nle+kv/ffv2yf79+83LpjUIpundu3fLTz/9ZO6QyqjPWC63S6Xpcml2ybT8+fObuy6C82y5zbf74D6c9YL7yqiN1rd1nHu3fmyec+9so/Oy/WnaLjNnl4sLztNj3Zz5bnnp9ePW3o7nbOfs16bN4PxBIJMC9i5NvZNSX7oErN4pqekjR46Ifmeur+C0PbZ7Zz2bZ/duZTpubm9lypSRypUrS6VKlQIvzdNlaRMTE3N7eF/1v2XLFmnWrFngnB544AG59957A8d+SPgm0KUXQyORGzZskPPPP18WLVrkh+vDOSCAAAIIIIAAAggggAACCCCAAAIIhEHALpenQQ8NNrAhgAACCCAQCwKvv/66PPLII4FT1WdhNmjQIHDsh4SvAl2jRo2ScePGmeuit7Lrg0rZEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIFYFLjttttEn3epP/LQ56Zp7ET3ftp8FehyPqdrwoQJcvXVV/vpWnEuCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggECmBA4fPix16tQRfYZZSkqKNG7cWN59991MtY2mSr4KdOkapLpmp2633HKLPPPMM9F0LZgrAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIBAWgRkzZkjv3r2lSJEicujQIXnooYekZ8+eYenbS534KtClsD169JBZs2YZ461bt7LmspfebcwFAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEE8kSga9euMmfOnECga+7cuYGbhfJkAnk0iO8CXXrR9OLpNn36dHNbXh5ZMgwCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggEHGB3377TRo1amSex3XkyBGpUqVK4CahiE8uzBPwXaArNTVVKlasaJhuvPFGef7558NMRncIIIAAAggggAACCCCAAAIIIIAAAggggAACCCCAgHcFRo8ebeIjxYoVk4MHD8qQIUOkW7du3p1wDmbmu0CXWuizucaPH29Y1q9fL4UKFcoBEU0RQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgegQSElJkSZNmsgff/wh8fHxcvLkSVmyZImceeaZ0XECWZylLwNde/fulaSkJEPh5yhlFq811RFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQMDnAi+//LI88cQTUqJECdm/f7/cfPPNMmLECN+etS8DXXq1evbsKTNnzjQXbvPmzSZq6duryIkhgAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAzAvoXVyXX365HDp0SBISEkSfz/Xll19KhQoVfGvj20CXRinr1KljLtyAAQOkb9++vr2InBgCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggg8Pjjj8vEiROlVKlSsmfPHmnXrp2MGTPG1zC+DXTpVRs2bJi88cYb5gL++OOPUrhwYZPmDwIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgJ4ENGzbI1VdfLQULFjSndezYMZk3b56ULVvWT6d52rn4OtCVmpoqFStWNCddqVIlmTt37mkAZCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAAC0Sxw4sQJuemmm2T58uVy7rnnyq5du6R79+4yePDgaD6tTM3d14EuFVi0aJHceuutBuO9996TRo0aZQqGSggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBANAi89NJL8uSTT8o555wje/fulbPOOsvczZWYmBgN08/RHH0f6FKd5s2by+bNmw3Upk2bJH/+/DlCozECCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggg4AWBNWvWmGdxJSQkmGULNdD18ssvS+vWrb0wvVyfQ0wEuvSWvQoVKhjM+Pj4QNAr13UZAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBDIJYFDhw7JtddeK1u2bJGLLrpItm3bJtdff72MGzcul0b0XrcxEehSdo1oXnPNNeYKdOvWTYYMGeK9q8GMEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAIFMCJw6dUp69Oghs2fPlnLlysn27dvN87lmzZolJUqUyEQP/qgSM4EuvVzPPvusjB071ly5SZMmSbNmzUyaPwgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBANAk899xzMmbMGCldurQcPnxYUlJSZPLkydKwYcNoOo0czzWmAl2q1bhxY/nvf/9r4L766qvAkoY5lqQDBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQCAPBD7++GPp37+/FC9eXAoVKiQ7d+6UBx54QO699948GN1bQ8RcoOvkyZNSvnz5wFVYtWpVTN3CFzhxEggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIBB1At98843cddddkpCQIGXLlpUff/xR2rRpIxMmTJC4uLioO5+cTjjmAl0Kprfw1ahRI2D3/fffm6hnIIMEAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIOAxgfnz55vncqWmpkq9evVkyZIlUrVqVdE7vBITEz0227yZTkwGupR2165dUr9+/YCyRkA18smGAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCHhN4MMPP5SHHnpITp06ZYJcS5culZIlS5ogV7ly5bw23TybT8wGulR4+/bt0rRp0wD2+PHjpW3btoFjEggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAJAX07q2nn35aJk6cKGeccYZUrFhRfvjhB7NS3TvvvCO1atWK5PQiPnZMB7pUXx/Q1qBBg8CFaNKkiVnHsmjRooE8EggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAXgv88ssv0rdvX1m2bJlo3KJ48eKyY8cOOffcc2XSpElSvXr1vJ6S58aL+UCXXhF9Zlfnzp1lxYoVgQv0/PPPS7t27WLywW0BBBIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCAQEQF97tawYcPkwIED5k6uuLg4E8+oW7euuWHnvPPOi8i8vDYoga7/uyK6puVrr70mjz32WOAalSlTRkaPHi0NGzYM5JFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBHJLQO/iGjp0qHz55ZeBITTIpVuXLl3Mc7oKFCgQKIv1BIGuoHfA+vXr5aabbpKDBw8GSho1aiT333+/XHbZZYE8EggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAuARSUlLk5Zdflpdeekk07dzOP/98GTFihOjjl9jSChDoSuthjvTBbq+//ro8/vjjaUo10NWzZ0+58sorWdIwjQwHCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggkB0BfbzSW2+9JRMnTpTff/89TRf58+c3d3H169dPEhMT05Rx8D8BAl3pvBN+/fVXefLJJ2X69OlpaulD3u69915z5xdvrDQ0HCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggEAmBLZt22YCXO+//36aVeZs02bNmpklDCtVqmSz2LsIEOhyQQnO2rBhg4wdO1ZmzJgRXCSdOnUyr1q1ap1WRgYCCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAgggYAWOHj0qs2bNkilTpsiiRYvk5MmTtiiwr1u3rjzwwAOSnJwcyCMRWoBAV2ib00r0AXCTJ0+WcePGnVamGV27dpWWLVtKvXr1RG8nZEMAAQQQQAABBBA4XeDUqVMm0+71wKbt3rayx1nd2/ZufUeiLzuf4LGzM79Qfdm+M9NnRn3Yvuw+vT7D0VdW+7Dzsnvn/MLRV077cM4reG62LLP7jObi7D+jPjPqy7ZPr8/M9mH7snu3PrPbl7PPnPYRzr6C5+J2zna8jPbBfdn6WenT9qF7++Byt71bnm0bqkzz0yvLSfuM5mvLQ41vy0Pts9vO9pfd9um1y6hvbZte+1BlGbXLzXFD9a35uqU3t/TKbNuM9sEmWl+39PpOr+x/rbPePrvt7Pyz2z6z7bSe23lntr2dp90722XUt63LHgEEEIgVgSNHjsjXX38tn3/+uXz55Zfyxx9/uJ56nTp1pG/fvjw+yVUndCaBrtA2IUv0GV76ptSgl74p3bbzzjtPbrnlFtHnemn0lSUO3ZTIQwABBPwvoF9M6S9z7BdUzmNNp/cKbpfZtplpp/K2np2DPday4Dx7HM529nyyOp5bO5uX3jxtHed4Ns/ZLjjPHudlOzsf595eH83TzR4H7+187T5U3eB87Sc4L70+tMyW232oPoLrmoH4gwACCCCAAAIIIBBTAvny5RN9xcfHm5cz7ZbnLNe0/qhc69l8uw/O03wNvunevjI6zmobHTOjPoPLszqGnbtzH9xn8HF2xrB9WEd7bMd1HsfUG5aTRSCHAikpKbJ8+XJZunSpLFu2TFauXCka7Aq16Z1bPXv2lKZNm4aqQn46AgS60sHJTNGhQ4dk7ty58uGHH8qCBQvSbVK2bFlp3769NGrUSGrWrClFihRJtz6FCPhRwPllp56f/XI0M/laRze3L3Vt++D+Msq3fTnbOcfITH5GYzj7sGkdw6ad+1Bjax3nyzlvm6959qV5J06cSGNly2xb3WsdressC2d5cL/22G1MW+Yc35nnTIdqr35sCCCAAAIIIBBbAvoFnPNlz96ZF5zOqI6W2zbOtOYFHwfnuZU7+8qoPLg/29YtP7gvt2PN03872c2m7T4z5bats25W2rvVdeblRv9ufTrn70w75+KWdsvLrf7d+g01vs23e+c5OdPO8tzo363PUOOHmouzD9IIIOBdARv80r0NjNk8Z/AvVJlbvm1v+9TPu+B6bmV2vOC6bsfap+0jM+OF6iM43/bpNufgunrsrGeP3fqwZW59uM1f87RvtsgJHD58WFavXi1r1qwJ7Ddu3Ch6w0x629lnny3t2rWTDh06SNWqVdOrSlkGAgS6MgDKSrG+cdeuXWsitdOmTZMVK1Zkpbn5n3jlypUl+HXBBRdI4cKFs9SXW2X75bH+w1K/3LZfcNsvw+1e6znLnGn7RbOt6yxzpoPrOY8zW8/Zxi2teXYe6aXTK3O2z2y9jNo4fbVP+3K2c7s+5CGAAAIIIIAAAggggAACCCCAAAIIIIAAAnktoEE1femdk/alxwkJCaflO8tt2u4z20dm+nYbO1Q7Z76m3V42qKhztQHD9JyPHTsmv//+e5rX7t27Zc+ePSZP01qu+3379qXXVaBM51W7dm254oorzEuXKdQ8tpwLEOjKuWG6Pezdu1c2bNhgIrmffvpploNf6XZOIQIIIBBmAfsrJ7u3H/zBe+evkLTM1tcPZ+dxcDt77Gxv22qZtnce2/rOvS23YymB5tm9pu0rOM9U+uuPLbf7nNTTPpztnWlbZvNMxb/+OPNtnt07y8KV1r6dfdmxgvOddbKaDu4rXGME9xtqXjkZL7fGyGy/OTmn3Bojp/1m5pyifQznOeq52M2Zn5O09udsb/sPznfWyUw6s+1zMl5ujZHZfkM5ZOaccmsMt36ddzWESjvnrOlQ9ULlZ7aNcxxnX5ltn5024RwzvfFDjZNeG2dZZtLBTpkZ09lvcHtnWai0c4zstg/Vd6j8nI7p7De9OTvHcbZxptNr76znTKfXJrfGDB4/M+M42zjT6c3fWc+Zdo6X3fbO/kKlneM460TLmOnNOdS5Ods40/acNc++bJ7d2/q23O5tud1nVM9Z7mwT3F9W6tm6GfWXlXqh6oYaIzg/+Nj259wHp/XYmefsw5kOrheqTU7q2T4zGjcr9ULVDTVGcL491j0bAgjkrkDJkiXNY40uvfRSSUpKMmlWecsdcwJdueOabq/6gaS3Mx48eFB27dolW7dulS1btpj9tm3bTPrAgQPp9kFh+gL6BYf9Ytx+GW6/RLdfpOs+uCy4jS0P3ofqS8cN1a/tw7Z1jpXdslB9Oedh07rPq5deHZ1bqPG0XMvc6tiy7JQ729qxNY8NAQQQQAABBBBAAAEEEEAAAQQQQOBvAV2BSL+jtIEzm9Z9ZsuC2zrbZVRmy4PbaH5GZbZOXu3tHFUveMzMlNnzcba17TIqCy53tsuozJYHt9F8tzKtpytSHT9+3Cy5p6uXhXppHVvX7kPV1XI/bgUKFJAqVapIhQoVRJcg1NdZZ52VJn3OOeeE/AGjH00ieU4EuiKpz9gIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgOQEN/h09elSOHDliAnv6eKFChQqx3KDnrtRfN1X8Fb39+6m0HpwgU0IAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIInTzxtgAABYRJREFUIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeQECXZ6/REwQAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEDATYBAl5sKeQgggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAp4XINDl+UvEBBFAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBNwECHS5qZCHAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCDgeYH/D8O0MR1ChKw+AAAAAElFTkSuQmCC)"
      ],
      "metadata": {
        "id": "doyAVWtX4rBB"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### But how have things changed in 2025?\n",
        "\n",
        "Right now the three-step pipeline idea is a little outdated, and we have just 2 phases:\n",
        "\n",
        "1. **Pre-training**. Includes all self-supervised learning approaches with Casual LM and Masked LM.\n",
        "\n",
        "2. **Post-training**. Includes both supervised (and sometimes self-supervised) approaches and RL training.\n",
        "\n",
        "Distinguishing between just two stages is more convenient, because in 2025 we have seen how many different techniques and goals actually exist in post-training, not just Alignment, but also long-reasoner training, tuning for agentic scenarios and more.\n",
        "\n",
        "Moreover, the pipeline composition might be more complex than just SFT + RL. For example, DeepSeek-R1 was obtained from DeepSeek-V3 through a combination of cold-start SFT, RL with GRPO to establish long reasoning capabilities, and then another turn of RL for alignment purposes.\n",
        "\n",
        "At the same time, some teams actually skip the Human Alignment, relying on the high-quality pre-training and Instruction Tuning data. Mistral and Microsoft's Phi models are famous for not doing any RLHF/DPO, and just doing pre-train and SFT."
      ],
      "metadata": {
        "id": "U52W6CAiIvTd"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Fine tuning techniques\n",
        "\n",
        "From the algorithmic point of view, fine tuning can be divided into\n",
        "\n",
        "* **Supervised Finetuning** (**SFT**), which requires data in the form `(prompt, desired_comletion)`.\n",
        "\n",
        "* **RL training**. It requires a **reward** , which can be either a deterministic one, such as answer accuracy, or a trained **reward model**. An LLM is trained through trial and error to maximize the reward it gets for its completions. We'll discuss it in more details in the notebook 6.3.\n",
        "\n",
        "\n",
        "A very special case of Supervised Funetuning is **DPO** (**Direct Preference Optimization**). It's so special that it's often grouped with RL (despite not being RL), because:\n",
        "\n",
        "* It's used for Alignment Training, which was traditionally an arena of RL methods\n",
        "* It trains LLMs on triplets `(prompt, accepted_completion, rejected_completion)`, unlike ordinary SFT"
      ],
      "metadata": {
        "id": "kUc5mK5YCwRZ"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "The three colab notebooks of this topic cover three important fine tuning tactics:\n",
        "\n",
        "* **Supervised Finetuning** - it's this notebook\n",
        "* [**DPO** (Direct Preference Optimization)](https://colab.research.google.com/github/Nebius-Academy/LLM-Engineering-Essentials/blob/main/topic6/6.2_dpo.ipynb)\n",
        "* [**RLHF** (Reinforcement Learning with Human Feedback) with PPO (Proximal Policy Optimization) under the hood](https://colab.research.google.com/github/Nebius-Academy/LLM-Engineering-Essentials/blob/main/topic6/6.3_rlhf.ipynb)\n",
        "\n",
        "And if you want to know more about fine tuning and particular approaches, don't hesitate to check the long reads of Topic 6."
      ],
      "metadata": {
        "id": "GXpVR0R5C7pg"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Important comment\n",
        "\n",
        "In this notebook we are talking about LLMs, or more accurately, about decoder-only transformers.\n",
        "\n",
        "We'll talk about fine-tuning of encoder-only transformers (embedding models) in the fourth notebook of Topic 6"
      ],
      "metadata": {
        "id": "Z-yTkMBn4wZt"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Human Alignment\n",
        "In Chapter 6 we will talk about several steps of Post-Training - including Human Alignment.\n",
        "\n",
        "Human Alignment is what allowed GPT 3.5 to jump in the quality to the levels of ChatGPT. Human Alignment can be done through several different methods (RLHF, DPO, GRPO). Specifically in ChatGPT Human Alignment phase was done through RLHF process, which itself consists of Reward Modeling and RL.\n",
        "\n",
        "There are several techniques for doing Human Alignment, most famours are 3 of them, which we will study in next notebooks:\n",
        "\n",
        "1) Human Alignment through RLHF (this is what Open AI did with ChatGPT)\n",
        "It was introduced in the paper `InstructGPT` - https://arxiv.org/pdf/2203.02155\n",
        "\n",
        "2) Human Alignment through DPO (this is what Meta did with Llama 3.1) - `DPO` was introduced in the paper - https://arxiv.org/pdf/2305.18290\n",
        "\n",
        "3) Human Alignment through GRPO (This is what DeepSeek did with DeepSeekv3) - This is a new approach which has a lot of discussion around it right now - https://arxiv.org/pdf/2402.03300\n",
        "\n",
        "All these 3 techniques for Human Alignment are covered in the following notebooks.\n",
        "\n",
        "For this notebook we are focusing on Post-Training phase, specifically on Finetuning of some GPT-like LLM, that was pre-trained before."
      ],
      "metadata": {
        "id": "50jYWZnI4pc4"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# SFT (Supervised Finetuning)"
      ],
      "metadata": {
        "id": "xpMSOQUkCmGM"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### What is actually SFT?\n",
        "\n",
        "SFT very often happens as the first step during post-training. There are usually 2 goals of SFT:\n",
        "\n",
        "#### Goal # 1 (Domain Adaptation)\n",
        "- Introduce some in-domain specifics into the model, or how people say \"make the model more domain-oriented\". This is done through simple autoregressive supervised finetuning on a standalone corpus of topic-relevant data.\n",
        "\n",
        "  The data might contain just domain-oriented texts, making SFT just a continuation of the pre-training process. It can be of the form `(prompt, completion)` as well. However, SFT isn't supposed to bring new knowledge to the LLM (you need too much data for that). Instead, you might help the model to cope with relevant terminology or style.\n",
        "\n",
        "  If you worked in classical NLP before, this was called **Domain Adaptation** (Sebastian Ruder, Phd Thesis: https://www.ruder.io/thesis/ )\n",
        "\n",
        "#### Goal #2 (Instruction Tuning)\n",
        "- Introduce some sort of instruction-following, or how people say \"make the model ready for chat/instruction following\". This is done through the same autoregressive supervised finetuning, but the data is always represented as tuples `(question, answer)`. It was popularized in the `T5` paper - https://arxiv.org/pdf/1910.10683\n",
        "\n",
        "  Instruction tuning often teaches an LLM to produce completions of specific format or style - or to understand specific prompt formats.\n",
        "\n",
        "\n",
        "Example of SFT Type I: https://huggingface.co/mistralai/Mistral-7B-v0.3\n",
        "\n",
        "Example of SFT Type II: https://huggingface.co/mistralai/Mistral-7B-Instruct-v0.3\n",
        "\n",
        "\n",
        "### Ok, but how is it different from Prompt Engineering?\n",
        "\n",
        "After reading about the purpose of SFT and how it changes the behaviour of the model, attentive reader might ask \"Ok, but how is it different from Prompt Engineering? Why do I need SFT if I can just make the promp and ask for behavioural change?\"\n",
        "\n",
        "**Similarities between SFT and Prompt Engineering**\n",
        "\n",
        "From the point of outcome results, SFT and Prompt Engineerng influence the behaviour of the model: both approaches change how the model responds to the prompts.\n",
        "\n",
        "**Differences between SFT and Prompt Engineering**\n",
        "\n",
        "Prompt Engineering does not update the weights of the model and can be done in real-time to modify the behaviour. SFT requires the update step where the actual weights of the model will be changed. In some sense SFT is more profound change.\n",
        "\n",
        "On one side, fine tuning is more costly. On the other side, it decreases inference costs (no need for long prompts) and is more efficient in format establishing."
      ],
      "metadata": {
        "id": "11tGY4rlcBgD"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Ok, what is PEFT and Lora and all other terms?\n",
        "\n",
        "There are several machine learning methods related to fine tuning, including:\n",
        "\n",
        "- **Linear Probing**. Plugging a linear head into any place of a frozen transformer and training it for a certain goal, you can try to learn something about how information is represented inside an LLM. For example, you can probe an LLM for its \"understanding\" of geography by training a linear probe on geography-related data to classify countries or directions.\n",
        "\n",
        " Researchers usually freeze the LLM weights, only training a linear model as a probe, but several other modifications exist as well.\n",
        "\n",
        "- **Sparse autoencoders** are another, more powerful way of getting into the inside of LLMs. They allow to disentangle meaningful features from LLMs' internal representations. See, for example, [this paper from Anthropic](https://transformer-circuits.pub/2024/scaling-monosemanticity/)\n",
        "- **Full Finetuning**. This method unfreezes all weights of the model and updates all parameters. It can potentially lead to better results, but [often suffers from \"catastrophic forgetting\"](https://arxiv.org/pdf/1612.00796). It's also quite costly - you need around 4 times more memory that the LLM's weights required\n",
        "- **PEFT (Parameter Efficient Finetuning)**. This is a broad set of techniques all of which somehow update only the fraction of the model's parameters. Sometimes Linear Probing is considered as part of PEFT (though their goals are different). Most notable PEFT methods:\n",
        "  - [**LoRA**](https://medium.com/nebius/fundamentals-of-lora-and-low-rank-fine-tuning-e748f2f1255d) - Low Rank Adaptation\n",
        "  - **QLoRA** - Quantized Low Rank Adaptation\n",
        "  - **Prompt Tuning**\n",
        "\n",
        "In this notebook we will do **Full Finetuning** to get first familiarity with the basic process. In the notebooks 6.2 and 6.3 we'll do PEFT with QLora."
      ],
      "metadata": {
        "id": "hZXB6KOKgQ6S"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Ok, what is API-based SFT and self-hosted SFT?\n",
        "\n",
        "Depending on whether you use API-based or self-hosted LLMs, your fine tuning journey might be different.\n",
        "\n",
        "This notebook demonstrates SFT for self-hosting LLM, which is quite straightforward, because you can do anything with the model as long as you have enough compute and data.\n",
        "\n",
        "With some API providers, [including Nebius AI Studio](https://docs.nebius.com/studio/fine-tuning), you can also order API-hosted SFT. In this case you just submit the `SupervisedTuningJob` into the platform and wait for the results."
      ],
      "metadata": {
        "id": "u4RuPd8fAIjN"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# The task at hand: making LLM's generation grounded in citation"
      ],
      "metadata": {
        "id": "vRvOWy56LCvm"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Problem Definition\n",
        "\n",
        "Today, LLMs are known for generating hallucinations, which limits their adoption in the broader fields. We will take the pre-trained LLM and we will try to reduce halucinations by forcing LLM to always output the \"citations\" component."
      ],
      "metadata": {
        "id": "bI1SGs458dx_"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Formal definition\n",
        "We will finetune the model such that it will generate the response + it will output the citations of the context it was using. This model behaviour is called **grounding**."
      ],
      "metadata": {
        "id": "DwIXJ35_LCJ8"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Our Objective\n",
        "\n",
        "We will fine-tune the model such that it always generates the list of citations in the end in the specific format.\n",
        "\n",
        "#### Example\n",
        "Before fine-tuning:\n",
        "```\n",
        "Q: What is the purpose of Norepinephrine?\n",
        "A: Norepinephrine is a neurotransmitter that is released from the sympathetic nervous system, and it is involved in the regulation of the body's response to stress.\n",
        "```\n",
        "\n",
        "After fine-tuning:\n",
        "```\n",
        "Q: What is the purpose of Norepinephrine?\n",
        "A: Norepinephrine is a neurotransmitter [260104] that is released from the sympathetic nervous system, and it is involved in the regulation of the body's response to stress [283012].\n",
        "\n",
        "References:\n",
        "[260104] The role of noradrenaline and adrenaline in the nervous circuitry ...\n",
        "[283012] Stress-induced reactions of the body provoke increase in levels of ...\n",
        "```\n",
        "\n"
      ],
      "metadata": {
        "id": "YcFKbkjXwHxL"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Why is it so cool?\n",
        "\n",
        "Several empirical experiments suggest that *grounding* an LLM and forcing it to always cite \"references\" actually leads to slight increases in the **factuality score**. If you put the finetuned model into Evidently.AI and examine its factuality score, there's a big chance the model will score higher compared to a non-grounded model.\n",
        "\n",
        "There's a long-lasting big debate whether \"finetuning can decrease hallucinations or not\", but grounding actually helps more often than not."
      ],
      "metadata": {
        "id": "FmTH7RdkM5SO"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Dataset preparation\n",
        "\n",
        "In order to finetune the model, we will use the dataset in the `(question, answer)` format. The `answer` will always contain some citations that were used in order to generate truthful answer."
      ],
      "metadata": {
        "id": "VZKtbcxP97ct"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install datasets==2.14.4"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-g6Y-sreEm3l",
        "outputId": "b7545d32-a32f-4873-b84e-f55ba353fc60"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting datasets==2.14.4\n",
            "  Downloading datasets-2.14.4-py3-none-any.whl.metadata (19 kB)\n",
            "Collecting wldhx.yadisk-direct\n",
            "  Downloading wldhx.yadisk_direct-0.0.6-py3-none-any.whl.metadata (1.3 kB)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (2.0.2)\n",
            "Requirement already satisfied: pyarrow>=8.0.0 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (18.1.0)\n",
            "Collecting dill<0.3.8,>=0.3.0 (from datasets==2.14.4)\n",
            "  Downloading dill-0.3.7-py3-none-any.whl.metadata (9.9 kB)\n",
            "Requirement already satisfied: pandas in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (2.2.2)\n",
            "Requirement already satisfied: requests>=2.19.0 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (2.32.3)\n",
            "Requirement already satisfied: tqdm>=4.62.1 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (4.67.1)\n",
            "Requirement already satisfied: xxhash in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (3.5.0)\n",
            "Requirement already satisfied: multiprocess in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (0.70.16)\n",
            "Requirement already satisfied: fsspec>=2021.11.1 in /usr/local/lib/python3.11/dist-packages (from fsspec[http]>=2021.11.1->datasets==2.14.4) (2025.3.0)\n",
            "Requirement already satisfied: aiohttp in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (3.12.15)\n",
            "Requirement already satisfied: huggingface-hub<1.0.0,>=0.14.0 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (0.34.3)\n",
            "Requirement already satisfied: packaging in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (25.0)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.11/dist-packages (from datasets==2.14.4) (6.0.2)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (2.6.1)\n",
            "Requirement already satisfied: aiosignal>=1.4.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (1.4.0)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (25.3.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (1.7.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (6.6.3)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (0.3.2)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp->datasets==2.14.4) (1.20.1)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0.0,>=0.14.0->datasets==2.14.4) (3.18.0)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0.0,>=0.14.0->datasets==2.14.4) (4.14.1)\n",
            "Requirement already satisfied: hf-xet<2.0.0,>=1.1.3 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0.0,>=0.14.0->datasets==2.14.4) (1.1.7)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests>=2.19.0->datasets==2.14.4) (3.4.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests>=2.19.0->datasets==2.14.4) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests>=2.19.0->datasets==2.14.4) (2.5.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests>=2.19.0->datasets==2.14.4) (2025.8.3)\n",
            "INFO: pip is looking at multiple versions of multiprocess to determine which version is compatible with other requirements. This could take a while.\n",
            "Collecting multiprocess (from datasets==2.14.4)\n",
            "  Downloading multiprocess-0.70.18-py311-none-any.whl.metadata (7.5 kB)\n",
            "  Downloading multiprocess-0.70.17-py311-none-any.whl.metadata (7.2 kB)\n",
            "  Downloading multiprocess-0.70.15-py311-none-any.whl.metadata (7.2 kB)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets==2.14.4) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets==2.14.4) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.11/dist-packages (from pandas->datasets==2.14.4) (2025.2)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.11/dist-packages (from python-dateutil>=2.8.2->pandas->datasets==2.14.4) (1.17.0)\n",
            "Downloading datasets-2.14.4-py3-none-any.whl (519 kB)\n",
            "\u001b[2K   \u001b[90m\u001b[0m \u001b[32m519.3/519.3 kB\u001b[0m \u001b[31m32.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading wldhx.yadisk_direct-0.0.6-py3-none-any.whl (4.5 kB)\n",
            "Downloading dill-0.3.7-py3-none-any.whl (115 kB)\n",
            "\u001b[2K   \u001b[90m\u001b[0m \u001b[32m115.3/115.3 kB\u001b[0m \u001b[31m11.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading multiprocess-0.70.15-py311-none-any.whl (135 kB)\n",
            "\u001b[2K   \u001b[90m\u001b[0m \u001b[32m135.4/135.4 kB\u001b[0m \u001b[31m13.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: dill, wldhx.yadisk-direct, multiprocess, datasets\n",
            "  Attempting uninstall: dill\n",
            "    Found existing installation: dill 0.3.8\n",
            "    Uninstalling dill-0.3.8:\n",
            "      Successfully uninstalled dill-0.3.8\n",
            "  Attempting uninstall: multiprocess\n",
            "    Found existing installation: multiprocess 0.70.16\n",
            "    Uninstalling multiprocess-0.70.16:\n",
            "      Successfully uninstalled multiprocess-0.70.16\n",
            "  Attempting uninstall: datasets\n",
            "    Found existing installation: datasets 4.0.0\n",
            "    Uninstalling datasets-4.0.0:\n",
            "      Successfully uninstalled datasets-4.0.0\n",
            "Successfully installed datasets-2.14.4 dill-0.3.7 multiprocess-0.70.15 wldhx.yadisk-direct-0.0.6\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "\n",
        "df = pd.read_csv('with_sft.csv')\n",
        "df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 640
        },
        "id": "TSF28bvq978d",
        "outputId": "c107cfaf-5f2b-483a-ed20-37ed8e3fe2db"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "      Unnamed: 0.1  Unnamed: 0    id  \\\n",
              "0                0           3     3   \n",
              "1                1           7     7   \n",
              "2                2          11    11   \n",
              "3                3          13    13   \n",
              "4                4          19    19   \n",
              "...            ...         ...   ...   \n",
              "2100          2100        4707  4707   \n",
              "2101          2101        4711  4711   \n",
              "2102          2102        4712  4712   \n",
              "2103          2103        4715  4715   \n",
              "2104          2104        4718  4718   \n",
              "\n",
              "                                               question  \\\n",
              "0                     Are long non coding RNAs spliced?   \n",
              "1     Which acetylcholinesterase inhibitors are used...   \n",
              "2     Which are the classes of anti-arrhythmic drugs...   \n",
              "3     Which are the major characteristics of cellula...   \n",
              "4     Which currently known mitochondrial diseases h...   \n",
              "...                                                 ...   \n",
              "2100        What is the role of PCAT6 in human cancers?   \n",
              "2101          Can METTL3 methylate long noncoding RNAs?   \n",
              "2102  Which disease is caused by repeat expansion in...   \n",
              "2103                              What is EpiMethylTag?   \n",
              "2104  Describe Multilocus Inherited Neoplasia Allele...   \n",
              "\n",
              "                                                 answer  \\\n",
              "0     Long non coding RNAs appear to be spliced thro...   \n",
              "1     Pyridostigmine and neostygmine are acetylcholi...   \n",
              "2     Antiarrhythmic drugs can be divided into four ...   \n",
              "3     The defining characteristics of cellular senes...   \n",
              "4     Mutations in the POLG gene have emerged as one...   \n",
              "...                                                 ...   \n",
              "2100  PCAT6, is a carcinogenic lncRNA. It is abnorma...   \n",
              "2101  Yes, METTL3 can modulate methylation and expre...   \n",
              "2102  An ancestral 10-bp repeat expansion in VWA1 ca...   \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...   \n",
              "2104  Genetic testing of hereditary cancer using com...   \n",
              "\n",
              "                                   relevant_passage_ids  n_docs  \\\n",
              "0     [22955974, 21622663, 22707570, 22955988, 24285...       6   \n",
              "1     [21328290, 21133188, 15610702, 20663605, 21815...       6   \n",
              "2       [10810787, 9803978, 1290288, 7875632, 11564050]       5   \n",
              "3                          [18976161, 9624027, 8824885]       3   \n",
              "4     [20927567, 12825077, 22647225, 15351195, 18546...       5   \n",
              "...                                                 ...     ...   \n",
              "2100                               [34885209, 31676070]       2   \n",
              "2101                                         [34505967]       1   \n",
              "2102                                         [33559681]       1   \n",
              "2103                                         [31752933]       1   \n",
              "2104                                         [30580288]       1   \n",
              "\n",
              "                                                 prompt  \\\n",
              "0     Question: Are long non coding RNAs spliced?\\nC...   \n",
              "1     Question: Which acetylcholinesterase inhibitor...   \n",
              "2     Question: Which are the classes of anti-arrhyt...   \n",
              "3     Question: Which are the major characteristics ...   \n",
              "4     Question: Which currently known mitochondrial ...   \n",
              "...                                                 ...   \n",
              "2100  Question: What is the role of PCAT6 in human c...   \n",
              "2101  Question: Can METTL3 methylate long noncoding ...   \n",
              "2102  Question: Which disease is caused by repeat ex...   \n",
              "2103  Question: What is EpiMethylTag?\\nContext: Docu...   \n",
              "2104  Question: Describe Multilocus Inherited Neopla...   \n",
              "\n",
              "                                                    sft  \n",
              "0     Long non coding RNAs appear to be spliced thro...  \n",
              "1     Acetylcholinesterase inhibitors are used for t...  \n",
              "2     Antiarrhythmic drugs can be divided into four ...  \n",
              "3     The defining characteristics of cellular senes...  \n",
              "4     Mutations in the POLG gene have emerged as one...  \n",
              "...                                                 ...  \n",
              "2100  PCAT6, is a carcinogenic lncRNA [34885209]. It...  \n",
              "2101  Yes, METTL3 can modulate methylation and expre...  \n",
              "2102  I cannot enhance the answer with a citation fr...  \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...  \n",
              "2104  Genetic testing of hereditary cancer using com...  \n",
              "\n",
              "[2105 rows x 9 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-00792b0b-58c0-430f-8924-8be7d32142ef\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Unnamed: 0.1</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>id</th>\n",
              "      <th>question</th>\n",
              "      <th>answer</th>\n",
              "      <th>relevant_passage_ids</th>\n",
              "      <th>n_docs</th>\n",
              "      <th>prompt</th>\n",
              "      <th>sft</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>Are long non coding RNAs spliced?</td>\n",
              "      <td>Long non coding RNAs appear to be spliced thro...</td>\n",
              "      <td>[22955974, 21622663, 22707570, 22955988, 24285...</td>\n",
              "      <td>6</td>\n",
              "      <td>Question: Are long non coding RNAs spliced?\\nC...</td>\n",
              "      <td>Long non coding RNAs appear to be spliced thro...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>1</td>\n",
              "      <td>7</td>\n",
              "      <td>7</td>\n",
              "      <td>Which acetylcholinesterase inhibitors are used...</td>\n",
              "      <td>Pyridostigmine and neostygmine are acetylcholi...</td>\n",
              "      <td>[21328290, 21133188, 15610702, 20663605, 21815...</td>\n",
              "      <td>6</td>\n",
              "      <td>Question: Which acetylcholinesterase inhibitor...</td>\n",
              "      <td>Acetylcholinesterase inhibitors are used for t...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2</td>\n",
              "      <td>11</td>\n",
              "      <td>11</td>\n",
              "      <td>Which are the classes of anti-arrhythmic drugs...</td>\n",
              "      <td>Antiarrhythmic drugs can be divided into four ...</td>\n",
              "      <td>[10810787, 9803978, 1290288, 7875632, 11564050]</td>\n",
              "      <td>5</td>\n",
              "      <td>Question: Which are the classes of anti-arrhyt...</td>\n",
              "      <td>Antiarrhythmic drugs can be divided into four ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>3</td>\n",
              "      <td>13</td>\n",
              "      <td>13</td>\n",
              "      <td>Which are the major characteristics of cellula...</td>\n",
              "      <td>The defining characteristics of cellular senes...</td>\n",
              "      <td>[18976161, 9624027, 8824885]</td>\n",
              "      <td>3</td>\n",
              "      <td>Question: Which are the major characteristics ...</td>\n",
              "      <td>The defining characteristics of cellular senes...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>4</td>\n",
              "      <td>19</td>\n",
              "      <td>19</td>\n",
              "      <td>Which currently known mitochondrial diseases h...</td>\n",
              "      <td>Mutations in the POLG gene have emerged as one...</td>\n",
              "      <td>[20927567, 12825077, 22647225, 15351195, 18546...</td>\n",
              "      <td>5</td>\n",
              "      <td>Question: Which currently known mitochondrial ...</td>\n",
              "      <td>Mutations in the POLG gene have emerged as one...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2100</th>\n",
              "      <td>2100</td>\n",
              "      <td>4707</td>\n",
              "      <td>4707</td>\n",
              "      <td>What is the role of PCAT6 in human cancers?</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA. It is abnorma...</td>\n",
              "      <td>[34885209, 31676070]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: What is the role of PCAT6 in human c...</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA [34885209]. It...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2101</th>\n",
              "      <td>2101</td>\n",
              "      <td>4711</td>\n",
              "      <td>4711</td>\n",
              "      <td>Can METTL3 methylate long noncoding RNAs?</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "      <td>[34505967]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Can METTL3 methylate long noncoding ...</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2102</th>\n",
              "      <td>2102</td>\n",
              "      <td>4712</td>\n",
              "      <td>4712</td>\n",
              "      <td>Which disease is caused by repeat expansion in...</td>\n",
              "      <td>An ancestral 10-bp repeat expansion in VWA1 ca...</td>\n",
              "      <td>[33559681]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Which disease is caused by repeat ex...</td>\n",
              "      <td>I cannot enhance the answer with a citation fr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2103</th>\n",
              "      <td>2103</td>\n",
              "      <td>4715</td>\n",
              "      <td>4715</td>\n",
              "      <td>What is EpiMethylTag?</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "      <td>[31752933]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: What is EpiMethylTag?\\nContext: Docu...</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2104</th>\n",
              "      <td>2104</td>\n",
              "      <td>4718</td>\n",
              "      <td>4718</td>\n",
              "      <td>Describe Multilocus Inherited Neoplasia Allele...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "      <td>[30580288]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Describe Multilocus Inherited Neopla...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>2105 rows  9 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-00792b0b-58c0-430f-8924-8be7d32142ef')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-00792b0b-58c0-430f-8924-8be7d32142ef button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-00792b0b-58c0-430f-8924-8be7d32142ef');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-6237665a-7e03-41bb-bce6-75933c053d90\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-6237665a-7e03-41bb-bce6-75933c053d90')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-6237665a-7e03-41bb-bce6-75933c053d90 button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "  <div id=\"id_c5f7d9fc-7886-403b-873d-6a38293f3470\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_c5f7d9fc-7886-403b-873d-6a38293f3470 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 2105,\n  \"fields\": [\n    {\n      \"column\": \"Unnamed: 0.1\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 607,\n        \"min\": 0,\n        \"max\": 2104,\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          1432,\n          342,\n          984\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Unnamed: 0\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1271,\n        \"min\": 3,\n        \"max\": 4718,\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          3472,\n          1160,\n          2719\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1271,\n        \"min\": 3,\n        \"max\": 4718,\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          3472,\n          1160,\n          2719\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"question\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          \"What does the boxed warning of pimavanserin say?\",\n          \"Selexipag is used for which disease?\",\n          \"What is the clathrin triskelia structure?\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2093,\n        \"samples\": [\n          \"Interstitial deletions of the long arm of chromosome 6 are rare. Clinically, these deletions are considered to be part of a unique microdeletion syndrome associated with intellectual disability and speech impairment, typical dysmorphic features, structural anomalies of the brain, microcephaly, and non-specific multiple organ anomalies. ARID1B is the key gene behind 6q microdeletion syndrome.\",\n          \"During infectious processes, the production of inflammatory cytokines including tumor necrosis factor (TNF), interleukin-1b (IL-1b), gamma interferon (IFNg) and chemokines orchestrates the anti-infectious innate immune response. However, an overzealous production, leading up to a cytokine storm, can be deleterious and contributes to mortality consecutive to sepsis or toxic shock syndrome.\",\n          \"The human bombesin receptors, GRPR and NMBR, are two of the most frequently overexpressed G-protein-coupled-receptors by lung-cancers\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"relevant_passage_ids\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2019,\n        \"samples\": [\n          \"[23030360, 23555858, 305444, 1083874]\",\n          \"[22511941, 17400358, 24262797, 17612411, 25415612, 24688893]\",\n          \"[24972834]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"n_docs\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 1,\n        \"max\": 6,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          6,\n          5,\n          1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"prompt\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          \"Question: What does the boxed warning of pimavanserin say?\\nContext: Document # 28493654:\\nOBJECTIVE: To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance. We also describe a new labeling feature that presents additional efficacy data to clinicians.DATA SOURCES: Data sets for all relevant clinical trials of pimavanserin and the Applicant's and FDA's analyses of these data were considered in this review. Data were available from 616 patients with Parkinson's disease with hallucinations and delusions who received at least 1 dose of pimavanserin, with a total exposure of 825 patient-years in the Parkinson's disease psychosis population.RESULTS: Pimavanserin 34 mg/d was effective in treating hallucinations and delusions associated with Parkinson's disease. In the Applicant's single pivotal trial, 80.5% of pimavanserin patients experienced at least some improvement in symptoms compared to 58.1% of patients taking placebo. Pimavanserin did not worsen motor function, an adverse effect commonly observed with other antipsychotics, probably because of a lack of consequential dopamine binding.CONCLUSIONS: Pimavanserin is the only FDA-approved treatment for the hallucinations and delusions seen in patients with psychosis of Parkinson's disease. Although pimavanserin appears to have a pharmacologic mechanism that is different from other atypical antipsychotics, concern remained that the increased risk of death seen with antipsychotic use in elderly demented patients, and described in all approved antipsychotic labels, would also occur with pimavanserin. Pimavanserin bears the same boxed warning about the risk of death associated with antipsychotic use in elderly patients with dementia.\\n\\nAnswer: Pimavanserin bears a boxed warning about the risk of death associated with antipsychotic use in elderly patients with dementia.\",\n          \"Question: Selexipag is used for which disease?\\nContext: Document # 26152132:\\nOBJECTIVE: Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension. Film-coated tablets with strength between 200 and 1,600 \\u03bcg were used. Bioequivalence between 8 x 200 \\u03bcg and a new 1,600 \\u03bcg tablet was evaluated at steady state in healthy male subjects.MATERIALS AND METHODS: This was an open-label, 2-treatment, 2-period, crossover, up-titration, phase 1 study. The treatments were selexipag at 1,600 \\u03bcg b.i.d. for 4.5 days either as 8 x 200 \\u03bcg tablets (reference: A) or 1 x 1,600 \\u03bcg tablet (test: B), both preceded by an up-titration phase starting from 400 \\u03bcg b.i.d. doses, in 200-\\u03bcg steps every 4th day. Subjects were randomized 1 : 1 to the A-B or B-A sequence. The pharmacokinetics and tolerability of selexipag and its active metabolite, ACT-333679, were investigated.RESULTS: 80 subjects were enrolled in the study: 65 subjects completed the study according to protocol, and 15 subjects withdrew from the study. The most frequent adverse events (AEs) were headache (86%), myalgia (73%), and jaw pain (73%). There was no difference in nature and overall frequency of AEs between the two treatments. Steady state was attained within 3 days of the selexipag 1,600 \\u00ce\\u00bcg b.i.d.TREATMENTS: The 90% confidence intervals (CIs) of the geometric mean ratio (B/A) at steady state for AUC\\u00cf\\u0084 and Cmax,ss were within (0.80, 1.25) bioequivalence interval: (0.92, 1.06) and (0.95, 1.14), respectively, for selexipag and (0.95, 1.06) and (0.94, 1.07), respectively, for the active metabolite, ACT-333679.CONCLUSIONS: Bioequivalence was demonstrated between 8 x 200 \\u03bcg and 1 x 1,600 \\u03bcg selexipag at steady state.\\n Document # 24392948:\\nINTRODUCTION: Selexipag is a first-in-class orally available selective non-prostanoid IP receptor agonist. This review was based on a PubMed search and focuses on the potential role of selexipag in the treatment of pulmonary arterial hypertension (PAH).AREAS COVERED: Selexipag is rapidly hydrolyzed to an active metabolite, ACT-333679. Both selexipag and its metabolite are highly selective for the IP receptor compared with other prostanoid receptors. This selectivity for the IP receptor offers the potential for improved tolerability with selexipag, as side effects (e.g., nausea and vomiting) that might result from activation of the other prostanoid receptors may be minimized. In addition, the selexipag metabolite has a half-life of 7.9 h, thus permitting oral dosing twice daily. Selexipag showed effects on pharmacodynamic end points obtained with right heart catheterization in a Phase II trial in patients with PAH, and is being evaluated in the ongoing Phase III trial (GRIPHON trial, Clinicaltrials.gov NCT01106014).EXPERT OPINION: The signal of a beneficial effect of selexipag on disease progression may become more robust for long term under prolonged exposure. Pending the GRIPHON trial results, selexipag could provide a convenient first-line prostacyclin treatment option for patients with PAH.\\n Document # 22362844:\\nIn this phase 2 proof-of-concept study we examined the safety and efficacy of selexipag, an orally available, selective prostacyclin receptor (IP receptor) agonist, as a treatment for pulmonary arterial hypertension (PAH). 43 adult patients with symptomatic PAH (receiving stable endothelin receptor antagonist and/or a phosphodiesterase type-5 inhibitor therapy) were randomised three to one to receive either selexipag or placebo. Dosage was up-titrated in 200-\\u03bcg increments from 200 \\u03bcg twice daily on day 1 to the maximum tolerated dose by day 35 (maximum allowed dose of 800 \\u03bcg twice daily). Change in pulmonary vascular resistance at week 17 expressed as a percentage of the baseline value was the primary efficacy end-point, and was analysed in the per protocol set first and then in the all-treated set to assess robustness of results. A statistically significant 30.3% reduction in geometric mean pulmonary vascular resistance was observed after 17 weeks' treatment with selexipag compared with placebo (95% confidence limits -44.7- -12.2; p=0.0045, Wilcoxon rank sum test). This was supported by a similar result from the all-treated set. Selexipag was well tolerated with a safety profile in line with the expected pharmacological effect. Our results encourage the further investigation of selexipag for the treatment of PAH.\\n\\nAnswer: Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension.\",\n          \"Question: What is the clathrin triskelia structure?\\nContext: Document # 18502808:\\nThe clathrin triskelion, which is a three-legged pinwheel-shaped heteropolymer, is a major component in the protein coats of certain post-Golgi and endocytic vesicles. At low pH, or at physiological pH in the presence of assembly proteins, triskelia will self-assemble to form a closed clathrin cage, or \\\"basket\\\". Recent static light scattering and dynamic light scattering studies of triskelia in solution showed that an individual triskelion has an intrinsic pucker similar to, but differing from, that inferred from a high resolution cryoEM structure of a triskelion in a clathrin basket. We extend the earlier solution studies by performing small-angle neutron scattering (SANS) experiments on isolated triskelia, allowing us to examine a higher q range than that probed by static light scattering. Results of the SANS measurements are consistent with the light scattering measurements, but show a shoulder in the scattering function at intermediate q values (0.016 A(-1)), just beyond the Guinier regime. This feature can be accounted for by Brownian dynamics simulations based on flexible bead-spring models of a triskelion, which generate time-averaged scattering functions. Calculated scattering profiles are in good agreement with the experimental SANS profiles when the persistence length of the assumed semiflexible triskelion is close to that previously estimated from the analysis of electron micrographs.\\n Document # 16669634:\\nA principal component in the protein coats of certain post-golgi and endocytic vesicles is clathrin, which appears as a three-legged heteropolymer (known as a triskelion) that assembles into polyhedral cages principally made up of pentagonal and hexagonal faces. In vitro, this assembly depends upon the pH, with cages forming more readily at low pH and less readily at high pH. We have developed procedures, on the basis of static and dynamic light scattering, to determine the radius of gyration, R(g), and hydrodynamic radius, R(H), of isolated triskelia, under conditions where cage assembly occurs. Calculations based on rigid molecular bead models of a triskelion show that the measured values can be accounted for by bending the legs and a puckering at the vertex. We also show that the values of R(g) and R(H) measured for clathrin triskelia in solution are qualitatively consistent with the conformation of a triskelion in a \\\"D6 barrel\\\" cage assembly measured by cryoelectron microscopy.\\n Document # 22704991:\\nBACKGROUND: Signaling by transmembrane receptors such as G protein-coupled receptors (GPCRs) occurs at the cell surface and throughout the endocytic pathway, and signaling from the cell surface may differ in magnitude and downstream output from intracellular signaling. As a result, the rate at which signaling molecules traverse the endocytic pathway makes a significant contribution to downstream output. Modulation of the core endocytic machinery facilitates differential uptake of individual cargoes. Clathrin-coated pits are a major entry portal where assembled clathrin forms a lattice around invaginating buds that have captured endocytic cargo. Clathrin assembles into triskelia composed of three clathrin heavy chains and associated clathrin light chains (CLCs). Despite the identification of clathrin-coated pits at the cell surface over 30 years ago, the functions of CLCs in endocytosis have been elusive.RESULTS: In this work, we identify a novel role for CLCs in the regulated endocytosis of specific cargoes. Small interfering RNA-mediated knockdown of either CLCa or CLCb inhibits the uptake of GPCRs. Moreover, we demonstrate that phosphorylation of Ser204 in CLCb is required for efficient endocytosis of a subset of GPCRs and identify G protein-coupled receptor kinase 2 (GRK2) as a kinase that can phosphorylate CLCb on Ser204. Overexpression of CLCb(S204A) specifically inhibits the endocytosis of those GPCRs whose endocytosis is GRK2-dependent.CONCLUSIONS: Together, these results indicate that CLCb phosphorylation acts as a discriminator for the endocytosis of specific GPCRs.\\n\\nAnswer: The clathrin triskelion, which is a three-legged pinwheel-shaped heteropolymer, is a major component in the protein coats of certain post-Golgi and endocytic vesicles.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"sft\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2105,\n        \"samples\": [\n          \"Pimavanserin bears a boxed warning about the risk of death associated with antipsychotic use in elderly patients with dementia [28493654].\\n\\nReferences:\\n[28493654] Pimavanserin bears the same boxed warning about the risk...\",\n          \"Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension [26152132, 24392948, 22362844].\\n\\nReferences:\\n[26152132] OBJECTIVE: Selexipag is a novel, oral...\\n[24392948] INTRODUCTION: Selexipag is a first-in-class orally...\\n[22362844] In this phase 2 proof-of-concept...\",\n          \"The clathrin triskelion, which is a three-legged pinwheel-shaped heteropolymer, is a major component in the protein coats of certain post-Golgi and endocytic vesicles [18502808, 16669634, 22704991].\\n\\nReferences:\\n[18502808] The clathrin triskelion, which is a...\\n[16669634] A principal component in the protein coats...\\n[22704991] BACKGROUND: Signaling by transmembrane receptors such as...\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(df['prompt'].values[0])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bsH9b8iQ-Bft",
        "outputId": "a8e003d6-cfdb-4911-d2fd-3e0d063eb013"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Question: Are long non coding RNAs spliced?\n",
            "Context: Document # 22955974:\n",
            "Splicing remains an incompletely understood process. Recent findings suggest that chromatin structure participates in its regulation. Here, we analyze the RNA from subcellular fractions obtained through RNA-seq in the cell line K562. We show that in the human genome, splicing occurs predominantly during transcription. We introduce the coSI measure, based on RNA-seq reads mapping to exon junctions and borders, to assess the degree of splicing completion around internal exons. We show that, as expected, splicing is almost fully completed in cytosolic polyA+ RNA. In chromatin-associated RNA (which includes the RNA that is being transcribed), for 5.6% of exons, the removal of the surrounding introns is fully completed, compared with 0.3% of exons for which no intron-removal has occurred. The remaining exons exist as a mixture of spliced and fewer unspliced molecules, with a median coSI of 0.75. Thus, most RNAs undergo splicing while being transcribed: \"co-transcriptional splicing.\" Consistent with co-transcriptional spliceosome assembly and splicing, we have found significant enrichment of spliceosomal snRNAs in chromatin-associated RNA compared with other cellular RNA fractions and other nonspliceosomal snRNAs. CoSI scores decrease along the gene, pointing to a \"first transcribed, first spliced\" rule, yet more downstream exons carry other characteristics, favoring rapid, co-transcriptional intron removal. Exons with low coSI values, that is, in the process of being spliced, are enriched with chromatin marks, consistent with a role for chromatin in splicing during transcription. For alternative exons and long noncoding RNAs, splicing tends to occur later, and the latter might remain unspliced in some cases.\n",
            " Document # 22707570:\n",
            "Thousands of long noncoding RNAs (lncRNAs) have been found in vertebrate animals, a few of which have known biological roles. To better understand the genomics and features of lncRNAs in invertebrates, we used available RNA-seq, poly(A)-site, and ribosome-mapping data to identify lncRNAs of Caenorhabditis elegans. We found 170 long intervening ncRNAs (lincRNAs), which had single- or multiexonic structures that did not overlap protein-coding transcripts, and about sixty antisense lncRNAs (ancRNAs), which were complementary to protein-coding transcripts. Compared to protein-coding genes, the lncRNA genes tended to be expressed in a stage-dependent manner. Approximately 25% of the newly identified lincRNAs showed little signal for sequence conservation and mapped antisense to clusters of endogenous siRNAs, as would be expected if they serve as templates and targets for these siRNAs. The other 75% tended to be more conserved and included lincRNAs with intriguing expression and sequence features associating them with processes such as dauer formation, male identity, sperm formation, and interaction with sperm-specific mRNAs. Our study provides a glimpse into the lncRNA content of a nonvertebrate animal and a resource for future studies of lncRNA function.\n",
            " Document # 22955988:\n",
            "The human genome contains many thousands of long noncoding RNAs (lncRNAs). While several studies have demonstrated compelling biological and disease roles for individual examples, analytical and experimental approaches to investigate these genes have been hampered by the lack of comprehensive lncRNA annotation. Here, we present and analyze the most complete human lncRNA annotation to date, produced by the GENCODE consortium within the framework of the ENCODE project and comprising 9277 manually annotated genes producing 14,880 transcripts. Our analyses indicate that lncRNAs are generated through pathways similar to that of protein-coding genes, with similar histone-modification profiles, splicing signals, and exon/intron lengths. In contrast to protein-coding genes, however, lncRNAs display a striking bias toward two-exon transcripts, they are predominantly localized in the chromatin and nucleus, and a fraction appear to be preferentially processed into small RNAs. They are under stronger selective pressure than neutrally evolving sequences-particularly in their promoter regions, which display levels of selection comparable to protein-coding genes. Importantly, about one-third seem to have arisen within the primate lineage. Comprehensive analysis of their expression in multiple human organs and brain regions shows that lncRNAs are generally lower expressed than protein-coding genes, and display more tissue-specific expression patterns, with a large fraction of tissue-specific lncRNAs expressed in the brain. Expression correlation analysis indicates that lncRNAs show particularly striking positive correlation with the expression of antisense coding genes. This GENCODE annotation represents a valuable resource for future studies of lncRNAs.\n",
            " Document # 24285305:\n",
            "NONCODE (http://www.bioinfo.org/noncode/) is an integrated knowledge database dedicated to non-coding RNAs (excluding tRNAs and rRNAs). Non-coding RNAs (ncRNAs) have been implied in diseases and identified to play important roles in various biological processes. Since NONCODE version 3.0 was released 2 years ago, discovery of novel ncRNAs has been promoted by high-throughput RNA sequencing (RNA-Seq). In this update of NONCODE, we expand the ncRNA data set by collection of newly identified ncRNAs from literature published in the last 2 years and integration of the latest version of RefSeq and Ensembl. Particularly, the number of long non-coding RNA (lncRNA) has increased sharply from 73 327 to 210 831. Owing to similar alternative splicing pattern to mRNAs, the concept of lncRNA genes was put forward to help systematic understanding of lncRNAs. The 56 018 and 46 475 lncRNA genes were generated from 95 135 and 67 628 lncRNAs for human and mouse, respectively. Additionally, we present expression profile of lncRNA genes by graphs based on public RNA-seq data for human and mouse, as well as predict functions of these lncRNA genes. The improvements brought to the database also include an incorporation of an ID conversion tool from RefSeq or Ensembl ID to NONCODE ID and a service of lncRNA identification. NONCODE is also accessible through http://www.noncode.org/.\n",
            "\n",
            "Answer: Long non coding RNAs appear to be spliced through the same pathway as the mRNAs\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(df['sft'].values[0])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "m_UckNbz-GdJ",
        "outputId": "f2b1a3d6-1daf-4ec3-a481-fb7a9819613d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Long non coding RNAs appear to be spliced through the same pathway as the mRNAs [22955988, 24285305].\n",
            "\n",
            "References:\n",
            "[22955988] The human genome contains many thousands...\n",
            "[24285305] NONCODE (http://www.bioinfo.org/noncode/) is an...\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Dataset format explanation\n",
        "\n",
        "- `df['prompt']` contain text in the format:\n",
        "\n",
        "  ```Question: {some_question}\\n Context: {some_context}\\nAnswer:```\n",
        "\n",
        "  Yes, not only prompts, but also context and answers. Before training, we'll get rid of the answers :)\n",
        "\n",
        "\n",
        "- `df['sft']` contains the text with the format:\n",
        "\n",
        "  ```{Some_answer}\\n References: {some_references}```\n",
        "  \n",
        "  This is our actual target."
      ],
      "metadata": {
        "id": "zD49VXOE-o0I"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Loading the model\n",
        "\n",
        "Let's load the model an try it on a prompt."
      ],
      "metadata": {
        "id": "gIZBCpL6RWUe"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
        "import torch\n",
        "model_name = \"Qwen/Qwen3-0.6B\"\n",
        "\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_name)\n",
        "model = AutoModelForCausalLM.from_pretrained(\n",
        "    model_name,\n",
        "    device_map=\"auto\",\n",
        "    torch_dtype=torch.float32,\n",
        ")\n",
        "\n",
        "print(tokenizer.eos_token, tokenizer.pad_token)\n",
        "# Very important: unlike other GPT-like models EOS_TOKEN and PAD_TOKEN should not be the same\n",
        "# Very often in SFT code, you could see something like: tokenizer.eos_token = tokenizer.pad_token\n",
        "# For Qwen Family of models, this would produce wrong results"
      ],
      "metadata": {
        "id": "FwxB9-ifYSGR",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 380,
          "referenced_widgets": [
            "9117cd7b0c474ebca88c66bc6aeb2289",
            "99f37751a8cb409bb8c4e64b6743736d",
            "ce6af90a1f3b4f0384c71a9d2152b387",
            "c0f4ef17de3a451dadaa0f90fb59ca6b",
            "16240a2116b94bf498e108c232642d5e",
            "813d838dd01649768fc2854dac28c35c",
            "f5b1c69f285d43328a1754028da7e35e",
            "d10a2ee026444804a5a5838a05c92e8c",
            "f92448a164374c86922e78401129bc8b",
            "f32ffa09263645b6a19b65f1a3ce8ca9",
            "25130400df094dc1a5c0b02739b25608",
            "12c6c5820fa642cd8dc15652b52b881d",
            "b7bb73a53dee4d49a23cb4866b9bff9b",
            "f702bfbe38d14657a854a670f95574c4",
            "436cb9f26bdc40898fe8bcb21075c902",
            "5f2ec72eef5f4c4aab87f15485a46661",
            "25541806db404389be1035217a6c21d3",
            "eba9f9bd6bd24788b3dd42503d71be32",
            "f542f2ee954c49af9da5a6ad16787cc2",
            "a8d8738eca3246f786adbb68ec97499d",
            "08d7332d480a4fa7aea6c44215a8db8b",
            "30c41a599d954eaa993a982e00d2f737",
            "c33749b9c8e74faca62ce5f40fd0baff",
            "b811339df03045eaaae113d05704331e",
            "ebd781160611445e879c5d533379696a",
            "578eb4ba506c4fa1a8f0ba93604fce9a",
            "a7f714d582e3455eabe578477388e6ed",
            "758e046d11514e5d9ea764d5d0814b40",
            "98c3af53e59743fb92a847d8e168c1a3",
            "4c3572656fc54ab297ebed4351f5e4a7",
            "2f7809473d734d79822a1be6d89c9074",
            "49b8510d8bb5482d80f34ba4d58a378c",
            "a9216737b5134e4f8dab888d2b103fec",
            "cde36aa5ead94a9684c107ef2ea0002e",
            "8c1728f7e1c344219c6645a0520ef49b",
            "4ceedf6c6e484c83814cdd648d6b67f7",
            "c09f44bfc45e4a58b142d73007ae52be",
            "2c86280a2a1344a08b36e4f2c78bef8d",
            "a0fd1723adbc47aeb8ed79fb89669830",
            "99fa755903e543e0b37ed02897ea7602",
            "6f13aea764fd4ec29cb6a70b46e7d39c",
            "264ee980bdc64cad84c3687dee232d39",
            "e33e1d9cc3b14e14b7b9631da2752118",
            "e81101b8ca5a45ad8e992f6a46e7de62",
            "1d0c301c2d4b46ae99a7a1b690db46d7",
            "d9ba01833afe465aabd17c2e6222009a",
            "2cd46d010dc845fcba32aa362e371fbf",
            "2e51735ff51a415b9e7d3bd6089f1afd",
            "06368724bb7d4cb6b697eb6dcf7b0026",
            "2a470f8b8c004816969930414695d6be",
            "99798f74b2cd4f5688c3da428b7b16e6",
            "00c070bb3ca74016a92cee57e5d67545",
            "aa44047b3d964e98a6895f781a9effba",
            "8d855921b40a4f48963a573395b88075",
            "a281ed649fcd4dc48fafd46f3d2f48cb",
            "4b78ace971724b94a3885e88600388ca",
            "3a8d5256998346dc9472ed5d9aebffc8",
            "7a6997e6d55349dc9daff38cde79661e",
            "e5147ee49bc24abbb53068912f6e69a6",
            "6fd9c2b4dc974c34accde186189d4f59",
            "b1d4075246cf4d678d6f89a53c60ae29",
            "cd5068f91188428bbc1c38deb409f6eb",
            "e3f6a657f69845c7ba9de1fb789e41b3",
            "0570d1370ddc4b0589ac8f758e870216",
            "4177f15b71d545fd805543fed5cb39d2",
            "8c86f5d0e425451ca8238bc95b67ae13",
            "5cae5a5f636e4adfa2a6c94bd8c94ffd",
            "c1ee7469c90541e9b53f70718e3608d7",
            "1b3bcc66a9294f6bbab3939e82c73dd2",
            "588b58bdd873465e8ed76273db865257",
            "aa35e97b7fbe410988b3dc5b6d587ffb",
            "8530c3172c61468aa73834b3053b21bc",
            "b3569b4ce463441d80a70d8eb9efdfed",
            "bea1e0a3a49d4458a62b85ffd9688227",
            "8105a56db2b54df685bdac348566178d",
            "f41b4f7829bb4c7baedd14f78c5fa9e8",
            "c810daa976b84a4e8c3d7c2f9f7072cc"
          ]
        },
        "outputId": "7806bbce-ea57-435d-f945-df1e2230d66a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "9117cd7b0c474ebca88c66bc6aeb2289"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "vocab.json: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "12c6c5820fa642cd8dc15652b52b881d"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "merges.txt: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "c33749b9c8e74faca62ce5f40fd0baff"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/11.4M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "cde36aa5ead94a9684c107ef2ea0002e"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/726 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "1d0c301c2d4b46ae99a7a1b690db46d7"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/1.50G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4b78ace971724b94a3885e88600388ca"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "generation_config.json:   0%|          | 0.00/239 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "5cae5a5f636e4adfa2a6c94bd8c94ffd"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<|im_end|> <|endoftext|>\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "prompts = [\"Give me a short introduction to large language model.\"]\n",
        "messages = [{\"role\": \"user\", \"content\": prompt} for prompt in prompts]"
      ],
      "metadata": {
        "id": "OkMN3dKsZ8sk"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "text = tokenizer.apply_chat_template(\n",
        "    messages,\n",
        "    tokenize=False,\n",
        "    add_generation_prompt=True,\n",
        "    enable_thinking=False\n",
        ")"
      ],
      "metadata": {
        "id": "haHpgpIMRFsl"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(text)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KK8cmg1IRTlS",
        "outputId": "239572ca-b2e5-45f8-e456-a5d7643c80f7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<|im_start|>user\n",
            "Give me a short introduction to large language model.<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Z8kQJVbuXRpj"
      },
      "outputs": [],
      "source": [
        "model_inputs = tokenizer([text], return_tensors='pt').to(model.device)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "generated_ids = model.generate(**model_inputs, max_new_tokens=512)"
      ],
      "metadata": {
        "id": "_9n0esYsbMGc"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "generated_ids[0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AXDd2EhBbbwB",
        "outputId": "2ef9617a-cfb5-4d88-9051-223ae19d99e3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "tensor([151644,    872,    198,  35127,    752,    264,   2805,  16800,    311,\n",
              "          3460,   4128,   1614,     13, 151645,    198, 151644,  77091,    198,\n",
              "        151667,    271, 151668,    271,     32,   3460,   4128,   1614,    320,\n",
              "          4086,     44,      8,    374,    264,    943,    315,  20443,  11229,\n",
              "           429,    646,   3535,    323,   6923,   3738,   4128,     13,   1084,\n",
              "           374,  16176,    389,  12767,  14713,    315,   1467,    311,   3960,\n",
              "         12624,    323,   7269,   1181,   5726,    311,   3535,    323,   5889,\n",
              "           311,   3738,  20959,     13,    444,  10994,     82,    525,   1483,\n",
              "           304,   5257,   8357,   1741,    438,   4378,     11,  14468,     11,\n",
              "           323,   6002,   2473,     13, 151645], device='cuda:0')"
            ]
          },
          "metadata": {},
          "execution_count": 23
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(tokenizer.decode(generated_ids[0]))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aJaraIxwbVqn",
        "outputId": "62cb1610-3d1d-47e0-8e23-bda680610524"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<|im_start|>user\n",
            "Give me a short introduction to large language model.<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "A large language model (LLM) is a type of artificial intelligence that can understand and generate human language. It is trained on vast amounts of text to learn patterns and improve its ability to understand and respond to human conversations. LLMs are used in various applications such as writing, translation, and customer service.<|im_end|>\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "The model seems to work, so let's fine tune it!"
      ],
      "metadata": {
        "id": "-0KNXWveRanD"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Preparing data\n",
        "\n",
        "First of all, for the sake of resource preservation (we don't want to get out of memory error + too different lengths in batches reduce efficiency + with too long sequences), we'll restrict sequence lengths by 512 words. In average, it's around 512 * 1.3 tokens."
      ],
      "metadata": {
        "id": "Tn9aGdW8Roqr"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "MAX_LEN = 512\n",
        "BPE_FACTOR = 1.3"
      ],
      "metadata": {
        "id": "FMtCjLqK66Qo"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's remove answers from `df['prompt']`, leaving only prompts and contexts:"
      ],
      "metadata": {
        "id": "2nHUPanZVDMz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "df['prompt_no_answer'] = df['prompt'].apply(lambda x: x.split('Answer:')[0])"
      ],
      "metadata": {
        "id": "F4eeb8oRkZ25"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Applying chat templates:"
      ],
      "metadata": {
        "id": "n14RwsTbVPIw"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "df['formatted_prompt_no_answer'] = df['prompt_no_answer'].apply(lambda x: tokenizer.apply_chat_template(\n",
        "    [{\"role\": \"user\", \"content\": x}],\n",
        "    tokenize=False,\n",
        "    add_generation_prompt=True,\n",
        "    enable_thinking=False\n",
        "))"
      ],
      "metadata": {
        "id": "4aUxiGE-PnjX"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(df['formatted_prompt_no_answer'].values[1])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "p3RXK-hkP6CU",
        "outputId": "d5657bf1-4153-4261-fbf2-f3d0f837596e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<|im_start|>user\n",
            "Question: Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?\n",
            "Context: Document # 21133188:\n",
            "Myasthenia gravis (MG) is caused by failure of chemical transmission at the neuromuscular junction. It is an autoimmune disorder in which antibodies interfere with neuromuscular transmission. It has a prevalence of around 20 per 100,000. The incidence is bimodal with a 2:1 female to male ratio in the younger population and a reversed sex ratio over the age of 60. Around 15% of cases are associated with a thymoma. MG presents with fatiguable painless muscle weakness. Diplopia and ptosis are the most common presenting features. Around 80% of patients presenting with ocular MG will subsequently develop more generalised weakness. Respiratory muscle weakness is the most serious manifestation of MG and can be fatal. A detailed history is the most valuable tool in the diagnosis of MG. This should elicit the pattern of weakness, severity and diurnal variation. Exacerbating factors including extremes of weather, emotional stress, menstruation and intercurrent illness should be enquired about. No one diagnostic test is 100% sensitive and patients who have negative antibodies and normal neurophysiology may still have MG. Treatment should be directed at ameliorating weakness with acetylcholinesterase blockers and modulating the immune system. Pyridostigmine is the most widely used acetylcholinesterase inhibitor. Most patients with generalised MG require immunomodulatory therapy and prednisolone is generally used as the first-line agent. Despite the availability of symptomatic and immunomodulatory treatment, up to 20% of patients will experience a myasthenic crisis requiring admission for ventilatory support at some stage.\n",
            " Document # 15610702:\n",
            "Treatment for myasthenia gravis should be individualized to each patient based on the clinical characteristics of myasthenia including the distribution, duration, and severity of weakness and resulting functional impairment; the risks for treatment complications related to age, gender, and medical comorbidities; and the presence of thymoma. Acetylcholinesterase inhibitors provide temporary, symptomatic treatment for all forms of myasthenia gravis. Immune modulators address the underlying autoimmune process in myasthenia gravis, but are associated with potential complications and side effects. Most patients with generalized myasthenia who have significant weakness beyond the ocular muscles and who remain symptomatic, despite treatment with cholinesterase inhibitors, are candidates for immune modulation. Although corticosteroids are effective for long-term immune modulation in myasthenia gravis, several more contemporary immunomodulators including azathioprine, cyclosporine, and mycophenolate mofetil have shown efficacy in myasthenia gravis and are used increasingly as first-line treatments and as steroid-sparing agents. Plasma exchange is used to achieve rapid improvement in patients with myasthenic crisis or exacerbation, to improve strength before a surgical procedure or thymectomy, and to minimize steroid-induced exacerbation in patients with oropharyngeal or respiratory muscle weakness. Intravenous immunoglobulin represents an alternative to plasma exchange in patients requiring relatively rapid short-term improvement in the setting of poor venous access. Because of a lack of controlled trials, the role of thymectomy in nonthymomatous myasthenia gravis is unclear, although evidence suggests that thymectomy increases the probability for myasthenic remission or improvement.\n",
            " Document # 20663605:\n",
            "INTRODUCTION: For more than 50 years the acetylcholinesterase inhibitor pyridostigmine bromide has been the drug of choice in the symptomatic therapy for myasthenia gravis. The sustained-release dosage form of pyridostigmine (SR-Pyr) is only available in a limited number of countries (e.g. in the United States and Germany). Astonishingly, the therapeutic usefulness of SR-Pyr has not yet been evaluated.METHODS: In this non-interventional prospective open-label trial, 72 patients with stable myasthenia gravis were switched from instant-release dosage forms of pyridostigmine bromide to SR-Pyr. The results from the 37 patients younger than 60 years were separately analyzed.RESULTS: The initial daily dose of SR-Pyr was 288.1  171.0mg. The drug switch was unproblematic in all patients. The number of daily doses was significantly reduced from 4.3 to 3.6 (p=0.011). The switch to SR-Pyr ameliorated the total quantified myasthenia gravis (QMG) score from 0.9  0.5 to 0.6  0.4 (p<0.001) in all patients and in the younger subgroup. This was accompanied by a significant improvement in the quality of life parameters. The health status valued by EuroQoL questionnaire improved from 0.626  0.286 to 0.782  0.186 (p<0.001). After switching to SR-Pyr, 28 adverse reactions disappeared and 24 adverse reactions occurred less frequent or weaker, however, 17 new adverse reactions were documented.CONCLUSIONS: Our results support the usefulness of SR-Pyr in an individualized therapeutic regimen to improve quality of life regardless of the patient's age in myasthenia gravis.\n",
            " Document # 21815707:\n",
            "Acquired myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular junction, characterized clinically by muscle weakness and abnormal fatigability on exertion. Current guidelines and recommendations for MG treatment are based largely on clinical experience, retrospective analyses and expert consensus. Available therapies include oral acetylcholinesterase (AChE) inhibitors for symptomatic treatment, and short- and long-term disease-modifying treatments. This review focuses on treatment of MG, mainly on the use of the AChE inhibitor pyridostigmine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors, of which pyridostigmine is the most commonly used, are recommended as first-line therapy for MG. Pyridostigmine has been used as a treatment for MG for over 50 years and is generally considered safe. It is suitable as a long-term treatment in patients with generalized non-progressive milder disease, and as an adjunctive therapy in patients with severe disease who are also receiving immunotherapy. Novel AChE inhibitors with oral antisense oligonucleotides have been developed and preliminary results appear to be promising. In general, however, AChE inhibitors provide only partial benefit and most patients eventually switch to long-term immunosuppressive therapies, most frequently corticosteroids and/or azathioprine. Although AChE inhibitors are known to be well tolerated and effective in relieving the symptoms of MG, further efforts are required to improve treatment options for the management of this disorder.\n",
            " Document # 21845054:\n",
            "Myasthenia gravis is an autoimmune neuromuscular disorder. There are several treatment options, including symptomatic treatment (acetylcholinesterase inhibitors), short-term immunosuppression (corticosteroids), long-term immunosuppression (azathioprine, cyclosporine, cyclophosphamide, methotrexate, mycophenolate mofetil, rituximab, tacrolimus), rapid acting short-term immunomodulation (intravenous immunoglobulin, plasma exchange), and long-term immunomodulation (thymectomy). This review explores in detail these different treatment options. Potential future treatments are also discussed.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df['formatted_prompt_with_answer'] = df.apply(lambda x: tokenizer.apply_chat_template(\n",
        "    [{\"role\": \"user\", \"content\": x['prompt_no_answer']}, {\"role\": \"assistant\", \"content\": x['sft']}],\n",
        "    tokenize=False,\n",
        "    add_generation_prompt=False, # VERY IMPORTANT: do not add generation flag for GT (this is QWEN peculiarity)\n",
        "    enable_thinking=False\n",
        "), axis=1)"
      ],
      "metadata": {
        "id": "f9F9r3BAU8Jk"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's look at formatted prompt with answer, which should have both `user` and `assistant` persona"
      ],
      "metadata": {
        "id": "ZdTS-aKMMbZn"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "print(df['formatted_prompt_with_answer'].values[1])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VYZoRaFZMYUS",
        "outputId": "7e3cbf10-6a70-4a06-d4e7-559d16cff8d8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<|im_start|>user\n",
            "Question: Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?\n",
            "Context: Document # 21133188:\n",
            "Myasthenia gravis (MG) is caused by failure of chemical transmission at the neuromuscular junction. It is an autoimmune disorder in which antibodies interfere with neuromuscular transmission. It has a prevalence of around 20 per 100,000. The incidence is bimodal with a 2:1 female to male ratio in the younger population and a reversed sex ratio over the age of 60. Around 15% of cases are associated with a thymoma. MG presents with fatiguable painless muscle weakness. Diplopia and ptosis are the most common presenting features. Around 80% of patients presenting with ocular MG will subsequently develop more generalised weakness. Respiratory muscle weakness is the most serious manifestation of MG and can be fatal. A detailed history is the most valuable tool in the diagnosis of MG. This should elicit the pattern of weakness, severity and diurnal variation. Exacerbating factors including extremes of weather, emotional stress, menstruation and intercurrent illness should be enquired about. No one diagnostic test is 100% sensitive and patients who have negative antibodies and normal neurophysiology may still have MG. Treatment should be directed at ameliorating weakness with acetylcholinesterase blockers and modulating the immune system. Pyridostigmine is the most widely used acetylcholinesterase inhibitor. Most patients with generalised MG require immunomodulatory therapy and prednisolone is generally used as the first-line agent. Despite the availability of symptomatic and immunomodulatory treatment, up to 20% of patients will experience a myasthenic crisis requiring admission for ventilatory support at some stage.\n",
            " Document # 15610702:\n",
            "Treatment for myasthenia gravis should be individualized to each patient based on the clinical characteristics of myasthenia including the distribution, duration, and severity of weakness and resulting functional impairment; the risks for treatment complications related to age, gender, and medical comorbidities; and the presence of thymoma. Acetylcholinesterase inhibitors provide temporary, symptomatic treatment for all forms of myasthenia gravis. Immune modulators address the underlying autoimmune process in myasthenia gravis, but are associated with potential complications and side effects. Most patients with generalized myasthenia who have significant weakness beyond the ocular muscles and who remain symptomatic, despite treatment with cholinesterase inhibitors, are candidates for immune modulation. Although corticosteroids are effective for long-term immune modulation in myasthenia gravis, several more contemporary immunomodulators including azathioprine, cyclosporine, and mycophenolate mofetil have shown efficacy in myasthenia gravis and are used increasingly as first-line treatments and as steroid-sparing agents. Plasma exchange is used to achieve rapid improvement in patients with myasthenic crisis or exacerbation, to improve strength before a surgical procedure or thymectomy, and to minimize steroid-induced exacerbation in patients with oropharyngeal or respiratory muscle weakness. Intravenous immunoglobulin represents an alternative to plasma exchange in patients requiring relatively rapid short-term improvement in the setting of poor venous access. Because of a lack of controlled trials, the role of thymectomy in nonthymomatous myasthenia gravis is unclear, although evidence suggests that thymectomy increases the probability for myasthenic remission or improvement.\n",
            " Document # 20663605:\n",
            "INTRODUCTION: For more than 50 years the acetylcholinesterase inhibitor pyridostigmine bromide has been the drug of choice in the symptomatic therapy for myasthenia gravis. The sustained-release dosage form of pyridostigmine (SR-Pyr) is only available in a limited number of countries (e.g. in the United States and Germany). Astonishingly, the therapeutic usefulness of SR-Pyr has not yet been evaluated.METHODS: In this non-interventional prospective open-label trial, 72 patients with stable myasthenia gravis were switched from instant-release dosage forms of pyridostigmine bromide to SR-Pyr. The results from the 37 patients younger than 60 years were separately analyzed.RESULTS: The initial daily dose of SR-Pyr was 288.1  171.0mg. The drug switch was unproblematic in all patients. The number of daily doses was significantly reduced from 4.3 to 3.6 (p=0.011). The switch to SR-Pyr ameliorated the total quantified myasthenia gravis (QMG) score from 0.9  0.5 to 0.6  0.4 (p<0.001) in all patients and in the younger subgroup. This was accompanied by a significant improvement in the quality of life parameters. The health status valued by EuroQoL questionnaire improved from 0.626  0.286 to 0.782  0.186 (p<0.001). After switching to SR-Pyr, 28 adverse reactions disappeared and 24 adverse reactions occurred less frequent or weaker, however, 17 new adverse reactions were documented.CONCLUSIONS: Our results support the usefulness of SR-Pyr in an individualized therapeutic regimen to improve quality of life regardless of the patient's age in myasthenia gravis.\n",
            " Document # 21815707:\n",
            "Acquired myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular junction, characterized clinically by muscle weakness and abnormal fatigability on exertion. Current guidelines and recommendations for MG treatment are based largely on clinical experience, retrospective analyses and expert consensus. Available therapies include oral acetylcholinesterase (AChE) inhibitors for symptomatic treatment, and short- and long-term disease-modifying treatments. This review focuses on treatment of MG, mainly on the use of the AChE inhibitor pyridostigmine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors, of which pyridostigmine is the most commonly used, are recommended as first-line therapy for MG. Pyridostigmine has been used as a treatment for MG for over 50 years and is generally considered safe. It is suitable as a long-term treatment in patients with generalized non-progressive milder disease, and as an adjunctive therapy in patients with severe disease who are also receiving immunotherapy. Novel AChE inhibitors with oral antisense oligonucleotides have been developed and preliminary results appear to be promising. In general, however, AChE inhibitors provide only partial benefit and most patients eventually switch to long-term immunosuppressive therapies, most frequently corticosteroids and/or azathioprine. Although AChE inhibitors are known to be well tolerated and effective in relieving the symptoms of MG, further efforts are required to improve treatment options for the management of this disorder.\n",
            " Document # 21845054:\n",
            "Myasthenia gravis is an autoimmune neuromuscular disorder. There are several treatment options, including symptomatic treatment (acetylcholinesterase inhibitors), short-term immunosuppression (corticosteroids), long-term immunosuppression (azathioprine, cyclosporine, cyclophosphamide, methotrexate, mycophenolate mofetil, rituximab, tacrolimus), rapid acting short-term immunomodulation (intravenous immunoglobulin, plasma exchange), and long-term immunomodulation (thymectomy). This review explores in detail these different treatment options. Potential future treatments are also discussed.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Acetylcholinesterase inhibitors are used for the symptomatic treatment of myasthenia gravis [15610702, 21845054, 21815707]. Pyridostigmine is the most widely used acetylcholinesterase inhibitor [21133188, 21815707, 20663605] and is recommended as first-line therapy or considered the drug of choice for symptomatic treatment [21815707, 20663605]. The therapeutic usefulness of extended-release pyridostigmine is being evaluated [20663605], and novel acetylcholinesterase inhibitors with oral antisense oligonucleotides are being developed and studied [21815707].\n",
            "\n",
            "References:\n",
            "[21133188] Myasthenia gravis (MG) is caused...\n",
            "[15610702] Treatment for myasthenia gravis should...\n",
            "[20663605] INTRODUCTION: For more than 50...\n",
            "[21815707] Acquired myasthenia gravis (MG) is...\n",
            "[21845054] Myasthenia gravis is an autoimmune neuromuscular...<|im_end|>\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Now let's look at the answer only part of the same prompt + answer"
      ],
      "metadata": {
        "id": "9N0QAOckMjqx"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "print(df['formatted_prompt_with_answer'].values[1][len(df['formatted_prompt_no_answer'].values[1]):])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KHv8nGbbVYnY",
        "outputId": "c0445fb4-0865-4767-a07c-b2bee4ee462d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Acetylcholinesterase inhibitors are used for the symptomatic treatment of myasthenia gravis [15610702, 21845054, 21815707]. Pyridostigmine is the most widely used acetylcholinesterase inhibitor [21133188, 21815707, 20663605] and is recommended as first-line therapy or considered the drug of choice for symptomatic treatment [21815707, 20663605]. The therapeutic usefulness of extended-release pyridostigmine is being evaluated [20663605], and novel acetylcholinesterase inhibitors with oral antisense oligonucleotides are being developed and studied [21815707].\n",
            "\n",
            "References:\n",
            "[21133188] Myasthenia gravis (MG) is caused...\n",
            "[15610702] Treatment for myasthenia gravis should...\n",
            "[20663605] INTRODUCTION: For more than 50...\n",
            "[21815707] Acquired myasthenia gravis (MG) is...\n",
            "[21845054] Myasthenia gravis is an autoimmune neuromuscular...<|im_end|>\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df = df[df['formatted_prompt_with_answer'].apply(lambda x: len(x.split())) < MAX_LEN] # first we filter everything larger than 512 words\n",
        "df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "9F3EvzxMxwnt",
        "outputId": "c0d120ca-5dc7-4a33-dfff-f971e4772403"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "      Unnamed: 0.1  Unnamed: 0    id  \\\n",
              "3                3          13    13   \n",
              "5                5          24    24   \n",
              "12              12          41    41   \n",
              "17              17          67    67   \n",
              "18              18          68    68   \n",
              "...            ...         ...   ...   \n",
              "2099          2099        4704  4704   \n",
              "2100          2100        4707  4707   \n",
              "2101          2101        4711  4711   \n",
              "2103          2103        4715  4715   \n",
              "2104          2104        4718  4718   \n",
              "\n",
              "                                               question  \\\n",
              "3     Which are the major characteristics of cellula...   \n",
              "5     Is Alu hypomethylation associated with breast ...   \n",
              "12    Which factors activate zygotic gene expression...   \n",
              "17                   Is TENS machine effective in pain?   \n",
              "18    Is there any algorithm for enhancer identifica...   \n",
              "...                                                 ...   \n",
              "2099  Which is the literature-based database of phen...   \n",
              "2100        What is the role of PCAT6 in human cancers?   \n",
              "2101          Can METTL3 methylate long noncoding RNAs?   \n",
              "2103                              What is EpiMethylTag?   \n",
              "2104  Describe Multilocus Inherited Neoplasia Allele...   \n",
              "\n",
              "                                                 answer  \\\n",
              "3     The defining characteristics of cellular senes...   \n",
              "5     Yes, Alu elements were found to be hypomethyla...   \n",
              "12    Nanog, Pou5f1 and SoxB1 activate zygotic gene ...   \n",
              "17    Transcutaneous electrical nerve stimulation is...   \n",
              "18                                                  yes   \n",
              "...                                                 ...   \n",
              "2099  PheneBank is a Web-portal for retrieving human...   \n",
              "2100  PCAT6, is a carcinogenic lncRNA. It is abnorma...   \n",
              "2101  Yes, METTL3 can modulate methylation and expre...   \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...   \n",
              "2104  Genetic testing of hereditary cancer using com...   \n",
              "\n",
              "              relevant_passage_ids  n_docs  \\\n",
              "3     [18976161, 9624027, 8824885]       3   \n",
              "5             [20682973, 24971511]       2   \n",
              "12                      [24056933]       1   \n",
              "17             [17333874, 7644247]       2   \n",
              "18            [23526891, 22328731]       2   \n",
              "...                            ...     ...   \n",
              "2099                    [34788791]       1   \n",
              "2100          [34885209, 31676070]       2   \n",
              "2101                    [34505967]       1   \n",
              "2103                    [31752933]       1   \n",
              "2104                    [30580288]       1   \n",
              "\n",
              "                                                 prompt  \\\n",
              "3     Question: Which are the major characteristics ...   \n",
              "5     Question: Is Alu hypomethylation associated wi...   \n",
              "12    Question: Which factors activate zygotic gene ...   \n",
              "17    Question: Is TENS machine effective in pain?\\n...   \n",
              "18    Question: Is there any algorithm for enhancer ...   \n",
              "...                                                 ...   \n",
              "2099  Question: Which is the literature-based databa...   \n",
              "2100  Question: What is the role of PCAT6 in human c...   \n",
              "2101  Question: Can METTL3 methylate long noncoding ...   \n",
              "2103  Question: What is EpiMethylTag?\\nContext: Docu...   \n",
              "2104  Question: Describe Multilocus Inherited Neopla...   \n",
              "\n",
              "                                                    sft  \\\n",
              "3     The defining characteristics of cellular senes...   \n",
              "5     Yes, Alu elements were found to be hypomethyla...   \n",
              "12    Nanog, Pou5f1 and SoxB1 activate zygotic gene ...   \n",
              "17    Transcutaneous electrical nerve stimulation is...   \n",
              "18    yes [23526891, 22328731]\\n\\nReferences:\\n[2352...   \n",
              "...                                                 ...   \n",
              "2099  PheneBank is a Web-portal for retrieving human...   \n",
              "2100  PCAT6, is a carcinogenic lncRNA [34885209]. It...   \n",
              "2101  Yes, METTL3 can modulate methylation and expre...   \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...   \n",
              "2104  Genetic testing of hereditary cancer using com...   \n",
              "\n",
              "                                       prompt_no_answer  \\\n",
              "3     Question: Which are the major characteristics ...   \n",
              "5     Question: Is Alu hypomethylation associated wi...   \n",
              "12    Question: Which factors activate zygotic gene ...   \n",
              "17    Question: Is TENS machine effective in pain?\\n...   \n",
              "18    Question: Is there any algorithm for enhancer ...   \n",
              "...                                                 ...   \n",
              "2099  Question: Which is the literature-based databa...   \n",
              "2100  Question: What is the role of PCAT6 in human c...   \n",
              "2101  Question: Can METTL3 methylate long noncoding ...   \n",
              "2103  Question: What is EpiMethylTag?\\nContext: Docu...   \n",
              "2104  Question: Describe Multilocus Inherited Neopla...   \n",
              "\n",
              "                             formatted_prompt_no_answer  \\\n",
              "3     <|im_start|>user\\nQuestion: Which are the majo...   \n",
              "5     <|im_start|>user\\nQuestion: Is Alu hypomethyla...   \n",
              "12    <|im_start|>user\\nQuestion: Which factors acti...   \n",
              "17    <|im_start|>user\\nQuestion: Is TENS machine ef...   \n",
              "18    <|im_start|>user\\nQuestion: Is there any algor...   \n",
              "...                                                 ...   \n",
              "2099  <|im_start|>user\\nQuestion: Which is the liter...   \n",
              "2100  <|im_start|>user\\nQuestion: What is the role o...   \n",
              "2101  <|im_start|>user\\nQuestion: Can METTL3 methyla...   \n",
              "2103  <|im_start|>user\\nQuestion: What is EpiMethylT...   \n",
              "2104  <|im_start|>user\\nQuestion: Describe Multilocu...   \n",
              "\n",
              "                           formatted_prompt_with_answer  \n",
              "3     <|im_start|>user\\nQuestion: Which are the majo...  \n",
              "5     <|im_start|>user\\nQuestion: Is Alu hypomethyla...  \n",
              "12    <|im_start|>user\\nQuestion: Which factors acti...  \n",
              "17    <|im_start|>user\\nQuestion: Is TENS machine ef...  \n",
              "18    <|im_start|>user\\nQuestion: Is there any algor...  \n",
              "...                                                 ...  \n",
              "2099  <|im_start|>user\\nQuestion: Which is the liter...  \n",
              "2100  <|im_start|>user\\nQuestion: What is the role o...  \n",
              "2101  <|im_start|>user\\nQuestion: Can METTL3 methyla...  \n",
              "2103  <|im_start|>user\\nQuestion: What is EpiMethylT...  \n",
              "2104  <|im_start|>user\\nQuestion: Describe Multilocu...  \n",
              "\n",
              "[1238 rows x 12 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-baeb83b7-4976-447a-bb46-73d6b1cc4e77\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Unnamed: 0.1</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>id</th>\n",
              "      <th>question</th>\n",
              "      <th>answer</th>\n",
              "      <th>relevant_passage_ids</th>\n",
              "      <th>n_docs</th>\n",
              "      <th>prompt</th>\n",
              "      <th>sft</th>\n",
              "      <th>prompt_no_answer</th>\n",
              "      <th>formatted_prompt_no_answer</th>\n",
              "      <th>formatted_prompt_with_answer</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>3</td>\n",
              "      <td>13</td>\n",
              "      <td>13</td>\n",
              "      <td>Which are the major characteristics of cellula...</td>\n",
              "      <td>The defining characteristics of cellular senes...</td>\n",
              "      <td>[18976161, 9624027, 8824885]</td>\n",
              "      <td>3</td>\n",
              "      <td>Question: Which are the major characteristics ...</td>\n",
              "      <td>The defining characteristics of cellular senes...</td>\n",
              "      <td>Question: Which are the major characteristics ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which are the majo...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which are the majo...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>5</td>\n",
              "      <td>24</td>\n",
              "      <td>24</td>\n",
              "      <td>Is Alu hypomethylation associated with breast ...</td>\n",
              "      <td>Yes, Alu elements were found to be hypomethyla...</td>\n",
              "      <td>[20682973, 24971511]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is Alu hypomethylation associated wi...</td>\n",
              "      <td>Yes, Alu elements were found to be hypomethyla...</td>\n",
              "      <td>Question: Is Alu hypomethylation associated wi...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is Alu hypomethyla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is Alu hypomethyla...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>12</td>\n",
              "      <td>41</td>\n",
              "      <td>41</td>\n",
              "      <td>Which factors activate zygotic gene expression...</td>\n",
              "      <td>Nanog, Pou5f1 and SoxB1 activate zygotic gene ...</td>\n",
              "      <td>[24056933]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Which factors activate zygotic gene ...</td>\n",
              "      <td>Nanog, Pou5f1 and SoxB1 activate zygotic gene ...</td>\n",
              "      <td>Question: Which factors activate zygotic gene ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which factors acti...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which factors acti...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>17</th>\n",
              "      <td>17</td>\n",
              "      <td>67</td>\n",
              "      <td>67</td>\n",
              "      <td>Is TENS machine effective in pain?</td>\n",
              "      <td>Transcutaneous electrical nerve stimulation is...</td>\n",
              "      <td>[17333874, 7644247]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is TENS machine effective in pain?\\n...</td>\n",
              "      <td>Transcutaneous electrical nerve stimulation is...</td>\n",
              "      <td>Question: Is TENS machine effective in pain?\\n...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is TENS machine ef...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is TENS machine ef...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>18</th>\n",
              "      <td>18</td>\n",
              "      <td>68</td>\n",
              "      <td>68</td>\n",
              "      <td>Is there any algorithm for enhancer identifica...</td>\n",
              "      <td>yes</td>\n",
              "      <td>[23526891, 22328731]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is there any algorithm for enhancer ...</td>\n",
              "      <td>yes [23526891, 22328731]\\n\\nReferences:\\n[2352...</td>\n",
              "      <td>Question: Is there any algorithm for enhancer ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is there any algor...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is there any algor...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2099</th>\n",
              "      <td>2099</td>\n",
              "      <td>4704</td>\n",
              "      <td>4704</td>\n",
              "      <td>Which is the literature-based database of phen...</td>\n",
              "      <td>PheneBank is a Web-portal for retrieving human...</td>\n",
              "      <td>[34788791]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Which is the literature-based databa...</td>\n",
              "      <td>PheneBank is a Web-portal for retrieving human...</td>\n",
              "      <td>Question: Which is the literature-based databa...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which is the liter...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which is the liter...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2100</th>\n",
              "      <td>2100</td>\n",
              "      <td>4707</td>\n",
              "      <td>4707</td>\n",
              "      <td>What is the role of PCAT6 in human cancers?</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA. It is abnorma...</td>\n",
              "      <td>[34885209, 31676070]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: What is the role of PCAT6 in human c...</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA [34885209]. It...</td>\n",
              "      <td>Question: What is the role of PCAT6 in human c...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is the role o...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is the role o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2101</th>\n",
              "      <td>2101</td>\n",
              "      <td>4711</td>\n",
              "      <td>4711</td>\n",
              "      <td>Can METTL3 methylate long noncoding RNAs?</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "      <td>[34505967]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Can METTL3 methylate long noncoding ...</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "      <td>Question: Can METTL3 methylate long noncoding ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Can METTL3 methyla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Can METTL3 methyla...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2103</th>\n",
              "      <td>2103</td>\n",
              "      <td>4715</td>\n",
              "      <td>4715</td>\n",
              "      <td>What is EpiMethylTag?</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "      <td>[31752933]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: What is EpiMethylTag?\\nContext: Docu...</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "      <td>Question: What is EpiMethylTag?\\nContext: Docu...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is EpiMethylT...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is EpiMethylT...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2104</th>\n",
              "      <td>2104</td>\n",
              "      <td>4718</td>\n",
              "      <td>4718</td>\n",
              "      <td>Describe Multilocus Inherited Neoplasia Allele...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "      <td>[30580288]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Describe Multilocus Inherited Neopla...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "      <td>Question: Describe Multilocus Inherited Neopla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Describe Multilocu...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Describe Multilocu...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1238 rows  12 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-baeb83b7-4976-447a-bb46-73d6b1cc4e77')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-baeb83b7-4976-447a-bb46-73d6b1cc4e77 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-baeb83b7-4976-447a-bb46-73d6b1cc4e77');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-68570120-1ec6-4b21-bd4e-1adac1f71dec\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-68570120-1ec6-4b21-bd4e-1adac1f71dec')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-68570120-1ec6-4b21-bd4e-1adac1f71dec button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "  <div id=\"id_d206c50d-92f9-47bb-baea-d752f1754182\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_d206c50d-92f9-47bb-baea-d752f1754182 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 1238,\n  \"fields\": [\n    {\n      \"column\": \"Unnamed: 0.1\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 581,\n        \"min\": 3,\n        \"max\": 2104,\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          1131,\n          401,\n          1521\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Unnamed: 0\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1195,\n        \"min\": 13,\n        \"max\": 4718,\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          2963,\n          1345,\n          3612\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1195,\n        \"min\": 13,\n        \"max\": 4718,\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          2963,\n          1345,\n          3612\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"question\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"What is CamurWeb?\",\n          \"Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?\",\n          \"What type of antagonist is istradefylline?\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1233,\n        \"samples\": [\n          \"Yes. 5hmC is enriched in the gene body of highly expressed genes at all different stages of T-cell development in the thymus and that its presence correlates positively with gene expression. Further emphasizing the connection with gene expression, 5hmC is enriched in active thymus-specific enhancers and genes encoding key transcriptional regulators display high intragenic 5hmC levels in precursor cells at those developmental stages where they exert a positive effect.\",\n          \"TissueEnrich is a tool that calculates tissue-specific gene enrichment in an input gene set. TissueEnrich can assign tissue identities to single cell clusters and differentiated embryonic stem cells.\",\n          \" Here, we report that the rate of sequence divergence of the 3' end of the Fxy gene is much higher (estimated at 170-fold higher for synonymous sites) when pseudoautosomal (present on both the X and Y chromosomes) than when X-unique.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"relevant_passage_ids\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1156,\n        \"samples\": [\n          \"[30091218]\",\n          \"[26819472, 27380722, 26058579, 25477242, 23153116]\",\n          \"[17417937, 7998766]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"n_docs\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 1,\n        \"max\": 6,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          3,\n          2,\n          6\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"prompt\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"Question: What is CamurWeb?\\nContext: Document # 30367574:\\nBACKGROUND: The high growth of Next Generation Sequencing data currently demands new knowledge extraction methods. In particular, the RNA sequencing gene expression experimental technique stands out for case-control studies on cancer, which can be addressed with supervised machine learning techniques able to extract human interpretable models composed of genes, and their relation to the investigated disease. State of the art rule-based classifiers are designed to extract a single classification model, possibly composed of few relevant genes. Conversely, we aim to create a large knowledge base composed of many rule-based models, and thus determine which genes could be potentially involved in the analyzed tumor. This comprehensive and open access knowledge base is required to disseminate novel insights about cancer.RESULTS: We propose CamurWeb, a new method and web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study. Additionally, CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments. The user can create her profile, upload her gene expression data, run the classification analyses, and interpret the results with predefined queries. In order to validate the software we apply it to all public available RNA sequencing datasets from The Cancer Genome Atlas database obtaining a large open access knowledge base about cancer. CamurWeb is available at http://bioinformatics.iasi.cnr.it/camurweb .CONCLUSIONS: The experiments prove the validity of CamurWeb, obtaining many classification models and thus several genes that are associated to 21 different cancer types. Finally, the comprehensive knowledge base about cancer and the software tool are released online; interested researchers have free access to them for further studies and to design biological experiments in cancer research.\\n\\nAnswer: CamurWeb is a classification software and a large knowledge base for gene expression data of cancer. It is a web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study. CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments.\",\n          \"Question: Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?\\nContext: Document # 22726460:\\nBACKGROUND: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heterogeneity and poor prognosis poses many challenges to diagnosis, prognosis and patient treatment. DNA methylation is an important mechanism of epigenetic regulation involved in normal development and cancer. It is a very stable and specific modification and therefore in principle a very suitable marker for epigenetic phenotyping of tumors. Here we present a genome-wide DNA methylation analysis of NSCLC samples and paired lung tissues, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the tumor and paired lung samples. The MethylCap-seq data were validated by bisulfite sequencing and methyl-specific polymerase chain reaction of selected regions.RESULTS: Analysis of the MethylCap-seq data revealed a strong positive correlation between replicate experiments and between paired tumor/lung samples. We identified 57 differentially methylated regions (DMRs) present in all NSCLC tumors analyzed by MethylCap-seq. While hypomethylated DMRs did not correlate to any particular functional category of genes, the hypermethylated DMRs were strongly associated with genes encoding transcriptional regulators. Furthermore, subtelomeric regions and satellite repeats were hypomethylated in the NSCLC samples. We also identified DMRs that were specific to two of the major subtypes of NSCLC, adenocarcinomas and squamous cell carcinomas.CONCLUSIONS: Collectively, we provide a resource containing genome-wide DNA methylation maps of NSCLC and their paired lung tissues, and comprehensive lists of known and novel DMRs and associated genes in NSCLC.\\n Document # 23524404:\\nINTRODUCTION: DNA methylation is part of the epigenetic regulatory mechanism present in all normal cells. It is tissue-specific and stably maintained throughout development, but often abnormally changed in cancer. Non-small-cell lung carcinoma (NSCLC) is the most deadly type of cancer, involving different tumor subtypes. This heterogeneity is a challenge for correct diagnosis and patient treatment. The stability and specificity make of DNA methylation a very suitable marker for epigenetic phenotyping of tumors.METHODS: To identify candidate markers for use in NSCLC diagnosis, we used genomewide DNA methylation maps that we had previously generated by MethylCap and next-generation sequencing and listed the most significant differentially methylated regions (DMRs). The 25 DMRs with highest significance in their methylation scores were selected. The methylation status of these DMRs was investigated in 61 tumors and matching control lung tissues by methylation-specific polymerase chain reaction.RESULTS: We found 12 novel DMRs that showed significant differences between tumor and control lung tissues. We also identified three novel DMRs for each of the two most common NSCLC subtypes, adenocarcinomas and squamous cell carcinomas. We propose a panel of five DMRs, composed of novel and known markers that exhibit high specificity and sensitivity to distinguish tumors from control lung tissues.CONCLUSION: Novel markers will aid the development of a highly specific epigenetic panel for accurate identification and subtyping of NSCLC tumors.\\n\\nAnswer: Yes.\",\n          \"Question: What type of antagonist is istradefylline?\\nContext: Document # 28870576:\\nBACKGROUND: Istradefylline, a selective adenosine A2A receptor antagonist, has been reported to improve daily \\\"off time\\\" and motor symptoms in patients with Parkinson's disease (PD). However, the effect of istradefylline on sleep problems has not been thoroughly investigated.METHODS: We evaluated the effect of istradefylline on daytime sleepiness, sleep disturbances, and motor symptoms in 22 PD patients who were affected by the wearing off phenomenon in an open-label, 3-month study. Participants received 20-40mg/day istradefylline once daily (morning) over a 3-month period. The Epworth Sleepiness Scale (ESS), PD sleep scale (PDSS)-2 and PD Questionnaire (PDQ-8) were administered at baseline, 2weeks, 1month, 2months and 3months. At baseline and 3months, patients were evaluated on the Movement Disorder Society Revision of the Unified PD Rating Scale (MDS-UPDRS) parts III and IV.RESULTS: Twenty-one patients (95.5%) completed the study. At 3months, MDS-UPDRS part III (-5.3, p=0.0002) and part IV (-2.5, p=0.001) scores improved and off time decreased significantly (-50.1min, p=0.0004). PDQ-8 scores were unchanged at 3months. ESS scores decreased significantly at 2months and 3months (-2.4 and -3.3, respectively, p<0.0001), but the total PDSS-2 scores did not change.CONCLUSION: Istradefylline improved daytime sleepiness in PD patients, possibly through its effect on enhancing alertness. In addition, the lack of significant changes in the total PDSS-2 scores over the study period suggests istradefylline had no negative impact on sleep.\\n\\nAnswer: Istradefylline is a selective adenosine A2A receptor antagonist.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"sft\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"CamurWeb is a classification software and a large knowledge base for gene expression data of cancer [30367574]. It is a web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed [30367574]. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study [30367574]. CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments [30367574].\\n\\nReferences:\\n[30367574] BACKGROUND: The high growth of Next Generation...\",\n          \"Yes [22726460, 23524404].\\n\\nReferences:\\n[22726460] BACKGROUND: Non-small cell lung carcinoma (NSCLC)...\\n[23524404] INTRODUCTION: DNA methylation is part...\",\n          \"Istradefylline is a selective adenosine A2A receptor antagonist [28870576].\\n\\nReferences:\\n[28870576] BACKGROUND: Istradefylline, a selective adenosine A2A receptor...\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"prompt_no_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"Question: What is CamurWeb?\\nContext: Document # 30367574:\\nBACKGROUND: The high growth of Next Generation Sequencing data currently demands new knowledge extraction methods. In particular, the RNA sequencing gene expression experimental technique stands out for case-control studies on cancer, which can be addressed with supervised machine learning techniques able to extract human interpretable models composed of genes, and their relation to the investigated disease. State of the art rule-based classifiers are designed to extract a single classification model, possibly composed of few relevant genes. Conversely, we aim to create a large knowledge base composed of many rule-based models, and thus determine which genes could be potentially involved in the analyzed tumor. This comprehensive and open access knowledge base is required to disseminate novel insights about cancer.RESULTS: We propose CamurWeb, a new method and web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study. Additionally, CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments. The user can create her profile, upload her gene expression data, run the classification analyses, and interpret the results with predefined queries. In order to validate the software we apply it to all public available RNA sequencing datasets from The Cancer Genome Atlas database obtaining a large open access knowledge base about cancer. CamurWeb is available at http://bioinformatics.iasi.cnr.it/camurweb .CONCLUSIONS: The experiments prove the validity of CamurWeb, obtaining many classification models and thus several genes that are associated to 21 different cancer types. Finally, the comprehensive knowledge base about cancer and the software tool are released online; interested researchers have free access to them for further studies and to design biological experiments in cancer research.\\n\\n\",\n          \"Question: Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?\\nContext: Document # 22726460:\\nBACKGROUND: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heterogeneity and poor prognosis poses many challenges to diagnosis, prognosis and patient treatment. DNA methylation is an important mechanism of epigenetic regulation involved in normal development and cancer. It is a very stable and specific modification and therefore in principle a very suitable marker for epigenetic phenotyping of tumors. Here we present a genome-wide DNA methylation analysis of NSCLC samples and paired lung tissues, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the tumor and paired lung samples. The MethylCap-seq data were validated by bisulfite sequencing and methyl-specific polymerase chain reaction of selected regions.RESULTS: Analysis of the MethylCap-seq data revealed a strong positive correlation between replicate experiments and between paired tumor/lung samples. We identified 57 differentially methylated regions (DMRs) present in all NSCLC tumors analyzed by MethylCap-seq. While hypomethylated DMRs did not correlate to any particular functional category of genes, the hypermethylated DMRs were strongly associated with genes encoding transcriptional regulators. Furthermore, subtelomeric regions and satellite repeats were hypomethylated in the NSCLC samples. We also identified DMRs that were specific to two of the major subtypes of NSCLC, adenocarcinomas and squamous cell carcinomas.CONCLUSIONS: Collectively, we provide a resource containing genome-wide DNA methylation maps of NSCLC and their paired lung tissues, and comprehensive lists of known and novel DMRs and associated genes in NSCLC.\\n Document # 23524404:\\nINTRODUCTION: DNA methylation is part of the epigenetic regulatory mechanism present in all normal cells. It is tissue-specific and stably maintained throughout development, but often abnormally changed in cancer. Non-small-cell lung carcinoma (NSCLC) is the most deadly type of cancer, involving different tumor subtypes. This heterogeneity is a challenge for correct diagnosis and patient treatment. The stability and specificity make of DNA methylation a very suitable marker for epigenetic phenotyping of tumors.METHODS: To identify candidate markers for use in NSCLC diagnosis, we used genomewide DNA methylation maps that we had previously generated by MethylCap and next-generation sequencing and listed the most significant differentially methylated regions (DMRs). The 25 DMRs with highest significance in their methylation scores were selected. The methylation status of these DMRs was investigated in 61 tumors and matching control lung tissues by methylation-specific polymerase chain reaction.RESULTS: We found 12 novel DMRs that showed significant differences between tumor and control lung tissues. We also identified three novel DMRs for each of the two most common NSCLC subtypes, adenocarcinomas and squamous cell carcinomas. We propose a panel of five DMRs, composed of novel and known markers that exhibit high specificity and sensitivity to distinguish tumors from control lung tissues.CONCLUSION: Novel markers will aid the development of a highly specific epigenetic panel for accurate identification and subtyping of NSCLC tumors.\\n\\n\",\n          \"Question: What type of antagonist is istradefylline?\\nContext: Document # 28870576:\\nBACKGROUND: Istradefylline, a selective adenosine A2A receptor antagonist, has been reported to improve daily \\\"off time\\\" and motor symptoms in patients with Parkinson's disease (PD). However, the effect of istradefylline on sleep problems has not been thoroughly investigated.METHODS: We evaluated the effect of istradefylline on daytime sleepiness, sleep disturbances, and motor symptoms in 22 PD patients who were affected by the wearing off phenomenon in an open-label, 3-month study. Participants received 20-40mg/day istradefylline once daily (morning) over a 3-month period. The Epworth Sleepiness Scale (ESS), PD sleep scale (PDSS)-2 and PD Questionnaire (PDQ-8) were administered at baseline, 2weeks, 1month, 2months and 3months. At baseline and 3months, patients were evaluated on the Movement Disorder Society Revision of the Unified PD Rating Scale (MDS-UPDRS) parts III and IV.RESULTS: Twenty-one patients (95.5%) completed the study. At 3months, MDS-UPDRS part III (-5.3, p=0.0002) and part IV (-2.5, p=0.001) scores improved and off time decreased significantly (-50.1min, p=0.0004). PDQ-8 scores were unchanged at 3months. ESS scores decreased significantly at 2months and 3months (-2.4 and -3.3, respectively, p<0.0001), but the total PDSS-2 scores did not change.CONCLUSION: Istradefylline improved daytime sleepiness in PD patients, possibly through its effect on enhancing alertness. In addition, the lack of significant changes in the total PDSS-2 scores over the study period suggests istradefylline had no negative impact on sleep.\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"formatted_prompt_no_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"<|im_start|>user\\nQuestion: What is CamurWeb?\\nContext: Document # 30367574:\\nBACKGROUND: The high growth of Next Generation Sequencing data currently demands new knowledge extraction methods. In particular, the RNA sequencing gene expression experimental technique stands out for case-control studies on cancer, which can be addressed with supervised machine learning techniques able to extract human interpretable models composed of genes, and their relation to the investigated disease. State of the art rule-based classifiers are designed to extract a single classification model, possibly composed of few relevant genes. Conversely, we aim to create a large knowledge base composed of many rule-based models, and thus determine which genes could be potentially involved in the analyzed tumor. This comprehensive and open access knowledge base is required to disseminate novel insights about cancer.RESULTS: We propose CamurWeb, a new method and web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study. Additionally, CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments. The user can create her profile, upload her gene expression data, run the classification analyses, and interpret the results with predefined queries. In order to validate the software we apply it to all public available RNA sequencing datasets from The Cancer Genome Atlas database obtaining a large open access knowledge base about cancer. CamurWeb is available at http://bioinformatics.iasi.cnr.it/camurweb .CONCLUSIONS: The experiments prove the validity of CamurWeb, obtaining many classification models and thus several genes that are associated to 21 different cancer types. Finally, the comprehensive knowledge base about cancer and the software tool are released online; interested researchers have free access to them for further studies and to design biological experiments in cancer research.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\",\n          \"<|im_start|>user\\nQuestion: Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?\\nContext: Document # 22726460:\\nBACKGROUND: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heterogeneity and poor prognosis poses many challenges to diagnosis, prognosis and patient treatment. DNA methylation is an important mechanism of epigenetic regulation involved in normal development and cancer. It is a very stable and specific modification and therefore in principle a very suitable marker for epigenetic phenotyping of tumors. Here we present a genome-wide DNA methylation analysis of NSCLC samples and paired lung tissues, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the tumor and paired lung samples. The MethylCap-seq data were validated by bisulfite sequencing and methyl-specific polymerase chain reaction of selected regions.RESULTS: Analysis of the MethylCap-seq data revealed a strong positive correlation between replicate experiments and between paired tumor/lung samples. We identified 57 differentially methylated regions (DMRs) present in all NSCLC tumors analyzed by MethylCap-seq. While hypomethylated DMRs did not correlate to any particular functional category of genes, the hypermethylated DMRs were strongly associated with genes encoding transcriptional regulators. Furthermore, subtelomeric regions and satellite repeats were hypomethylated in the NSCLC samples. We also identified DMRs that were specific to two of the major subtypes of NSCLC, adenocarcinomas and squamous cell carcinomas.CONCLUSIONS: Collectively, we provide a resource containing genome-wide DNA methylation maps of NSCLC and their paired lung tissues, and comprehensive lists of known and novel DMRs and associated genes in NSCLC.\\n Document # 23524404:\\nINTRODUCTION: DNA methylation is part of the epigenetic regulatory mechanism present in all normal cells. It is tissue-specific and stably maintained throughout development, but often abnormally changed in cancer. Non-small-cell lung carcinoma (NSCLC) is the most deadly type of cancer, involving different tumor subtypes. This heterogeneity is a challenge for correct diagnosis and patient treatment. The stability and specificity make of DNA methylation a very suitable marker for epigenetic phenotyping of tumors.METHODS: To identify candidate markers for use in NSCLC diagnosis, we used genomewide DNA methylation maps that we had previously generated by MethylCap and next-generation sequencing and listed the most significant differentially methylated regions (DMRs). The 25 DMRs with highest significance in their methylation scores were selected. The methylation status of these DMRs was investigated in 61 tumors and matching control lung tissues by methylation-specific polymerase chain reaction.RESULTS: We found 12 novel DMRs that showed significant differences between tumor and control lung tissues. We also identified three novel DMRs for each of the two most common NSCLC subtypes, adenocarcinomas and squamous cell carcinomas. We propose a panel of five DMRs, composed of novel and known markers that exhibit high specificity and sensitivity to distinguish tumors from control lung tissues.CONCLUSION: Novel markers will aid the development of a highly specific epigenetic panel for accurate identification and subtyping of NSCLC tumors.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\",\n          \"<|im_start|>user\\nQuestion: What type of antagonist is istradefylline?\\nContext: Document # 28870576:\\nBACKGROUND: Istradefylline, a selective adenosine A2A receptor antagonist, has been reported to improve daily \\\"off time\\\" and motor symptoms in patients with Parkinson's disease (PD). However, the effect of istradefylline on sleep problems has not been thoroughly investigated.METHODS: We evaluated the effect of istradefylline on daytime sleepiness, sleep disturbances, and motor symptoms in 22 PD patients who were affected by the wearing off phenomenon in an open-label, 3-month study. Participants received 20-40mg/day istradefylline once daily (morning) over a 3-month period. The Epworth Sleepiness Scale (ESS), PD sleep scale (PDSS)-2 and PD Questionnaire (PDQ-8) were administered at baseline, 2weeks, 1month, 2months and 3months. At baseline and 3months, patients were evaluated on the Movement Disorder Society Revision of the Unified PD Rating Scale (MDS-UPDRS) parts III and IV.RESULTS: Twenty-one patients (95.5%) completed the study. At 3months, MDS-UPDRS part III (-5.3, p=0.0002) and part IV (-2.5, p=0.001) scores improved and off time decreased significantly (-50.1min, p=0.0004). PDQ-8 scores were unchanged at 3months. ESS scores decreased significantly at 2months and 3months (-2.4 and -3.3, respectively, p<0.0001), but the total PDSS-2 scores did not change.CONCLUSION: Istradefylline improved daytime sleepiness in PD patients, possibly through its effect on enhancing alertness. In addition, the lack of significant changes in the total PDSS-2 scores over the study period suggests istradefylline had no negative impact on sleep.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"formatted_prompt_with_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1238,\n        \"samples\": [\n          \"<|im_start|>user\\nQuestion: What is CamurWeb?\\nContext: Document # 30367574:\\nBACKGROUND: The high growth of Next Generation Sequencing data currently demands new knowledge extraction methods. In particular, the RNA sequencing gene expression experimental technique stands out for case-control studies on cancer, which can be addressed with supervised machine learning techniques able to extract human interpretable models composed of genes, and their relation to the investigated disease. State of the art rule-based classifiers are designed to extract a single classification model, possibly composed of few relevant genes. Conversely, we aim to create a large knowledge base composed of many rule-based models, and thus determine which genes could be potentially involved in the analyzed tumor. This comprehensive and open access knowledge base is required to disseminate novel insights about cancer.RESULTS: We propose CamurWeb, a new method and web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study. Additionally, CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments. The user can create her profile, upload her gene expression data, run the classification analyses, and interpret the results with predefined queries. In order to validate the software we apply it to all public available RNA sequencing datasets from The Cancer Genome Atlas database obtaining a large open access knowledge base about cancer. CamurWeb is available at http://bioinformatics.iasi.cnr.it/camurweb .CONCLUSIONS: The experiments prove the validity of CamurWeb, obtaining many classification models and thus several genes that are associated to 21 different cancer types. Finally, the comprehensive knowledge base about cancer and the software tool are released online; interested researchers have free access to them for further studies and to design biological experiments in cancer research.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\nCamurWeb is a classification software and a large knowledge base for gene expression data of cancer [30367574]. It is a web-based software that is able to extract multiple and equivalent classification models in form of logic formulas (\\\"if then\\\" rules) and to create a knowledge base of these rules that can be queried and analyzed [30367574]. The method is based on an iterative classification procedure and an adaptive feature elimination technique that enables the computation of many rule-based models related to the cancer under study [30367574]. CamurWeb includes a user friendly interface for running the software, querying the results, and managing the performed experiments [30367574].\\n\\nReferences:\\n[30367574] BACKGROUND: The high growth of Next Generation...<|im_end|>\\n\",\n          \"<|im_start|>user\\nQuestion: Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?\\nContext: Document # 22726460:\\nBACKGROUND: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heterogeneity and poor prognosis poses many challenges to diagnosis, prognosis and patient treatment. DNA methylation is an important mechanism of epigenetic regulation involved in normal development and cancer. It is a very stable and specific modification and therefore in principle a very suitable marker for epigenetic phenotyping of tumors. Here we present a genome-wide DNA methylation analysis of NSCLC samples and paired lung tissues, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the tumor and paired lung samples. The MethylCap-seq data were validated by bisulfite sequencing and methyl-specific polymerase chain reaction of selected regions.RESULTS: Analysis of the MethylCap-seq data revealed a strong positive correlation between replicate experiments and between paired tumor/lung samples. We identified 57 differentially methylated regions (DMRs) present in all NSCLC tumors analyzed by MethylCap-seq. While hypomethylated DMRs did not correlate to any particular functional category of genes, the hypermethylated DMRs were strongly associated with genes encoding transcriptional regulators. Furthermore, subtelomeric regions and satellite repeats were hypomethylated in the NSCLC samples. We also identified DMRs that were specific to two of the major subtypes of NSCLC, adenocarcinomas and squamous cell carcinomas.CONCLUSIONS: Collectively, we provide a resource containing genome-wide DNA methylation maps of NSCLC and their paired lung tissues, and comprehensive lists of known and novel DMRs and associated genes in NSCLC.\\n Document # 23524404:\\nINTRODUCTION: DNA methylation is part of the epigenetic regulatory mechanism present in all normal cells. It is tissue-specific and stably maintained throughout development, but often abnormally changed in cancer. Non-small-cell lung carcinoma (NSCLC) is the most deadly type of cancer, involving different tumor subtypes. This heterogeneity is a challenge for correct diagnosis and patient treatment. The stability and specificity make of DNA methylation a very suitable marker for epigenetic phenotyping of tumors.METHODS: To identify candidate markers for use in NSCLC diagnosis, we used genomewide DNA methylation maps that we had previously generated by MethylCap and next-generation sequencing and listed the most significant differentially methylated regions (DMRs). The 25 DMRs with highest significance in their methylation scores were selected. The methylation status of these DMRs was investigated in 61 tumors and matching control lung tissues by methylation-specific polymerase chain reaction.RESULTS: We found 12 novel DMRs that showed significant differences between tumor and control lung tissues. We also identified three novel DMRs for each of the two most common NSCLC subtypes, adenocarcinomas and squamous cell carcinomas. We propose a panel of five DMRs, composed of novel and known markers that exhibit high specificity and sensitivity to distinguish tumors from control lung tissues.CONCLUSION: Novel markers will aid the development of a highly specific epigenetic panel for accurate identification and subtyping of NSCLC tumors.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\nYes [22726460, 23524404].\\n\\nReferences:\\n[22726460] BACKGROUND: Non-small cell lung carcinoma (NSCLC)...\\n[23524404] INTRODUCTION: DNA methylation is part...<|im_end|>\\n\",\n          \"<|im_start|>user\\nQuestion: What type of antagonist is istradefylline?\\nContext: Document # 28870576:\\nBACKGROUND: Istradefylline, a selective adenosine A2A receptor antagonist, has been reported to improve daily \\\"off time\\\" and motor symptoms in patients with Parkinson's disease (PD). However, the effect of istradefylline on sleep problems has not been thoroughly investigated.METHODS: We evaluated the effect of istradefylline on daytime sleepiness, sleep disturbances, and motor symptoms in 22 PD patients who were affected by the wearing off phenomenon in an open-label, 3-month study. Participants received 20-40mg/day istradefylline once daily (morning) over a 3-month period. The Epworth Sleepiness Scale (ESS), PD sleep scale (PDSS)-2 and PD Questionnaire (PDQ-8) were administered at baseline, 2weeks, 1month, 2months and 3months. At baseline and 3months, patients were evaluated on the Movement Disorder Society Revision of the Unified PD Rating Scale (MDS-UPDRS) parts III and IV.RESULTS: Twenty-one patients (95.5%) completed the study. At 3months, MDS-UPDRS part III (-5.3, p=0.0002) and part IV (-2.5, p=0.001) scores improved and off time decreased significantly (-50.1min, p=0.0004). PDQ-8 scores were unchanged at 3months. ESS scores decreased significantly at 2months and 3months (-2.4 and -3.3, respectively, p<0.0001), but the total PDSS-2 scores did not change.CONCLUSION: Istradefylline improved daytime sleepiness in PD patients, possibly through its effect on enhancing alertness. In addition, the lack of significant changes in the total PDSS-2 scores over the study period suggests istradefylline had no negative impact on sleep.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\nIstradefylline is a selective adenosine A2A receptor antagonist [28870576].\\n\\nReferences:\\n[28870576] BACKGROUND: Istradefylline, a selective adenosine A2A receptor...<|im_end|>\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 33
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's filter out everything longer than 512 words which is roughtly $512 \\cdot 1.3$ tokens.\n"
      ],
      "metadata": {
        "id": "aB-h7wlmZfxz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "usual_tokenization_length = [len(x) < MAX_LEN * BPE_FACTOR for x in tokenizer(df['formatted_prompt_with_answer'].values.tolist())['input_ids']]"
      ],
      "metadata": {
        "id": "17ZGaZmkisVQ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df['usual_tokenization_length'] = usual_tokenization_length"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RREVeqZwjEHb",
        "outputId": "79f0ca98-9905-4ff2-9089-357c5ee5d5e0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/tmp/ipython-input-35-3785683993.py:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df['usual_tokenization_length'] = usual_tokenization_length\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df = df[df['usual_tokenization_length']==True]\n",
        "df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "UOt_9kQBjL2M",
        "outputId": "1bddf298-c4fa-41e7-9e01-659927a5a8dd"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "      Unnamed: 0.1  Unnamed: 0    id  \\\n",
              "5                5          24    24   \n",
              "12              12          41    41   \n",
              "17              17          67    67   \n",
              "18              18          68    68   \n",
              "19              19          73    73   \n",
              "...            ...         ...   ...   \n",
              "2099          2099        4704  4704   \n",
              "2100          2100        4707  4707   \n",
              "2101          2101        4711  4711   \n",
              "2103          2103        4715  4715   \n",
              "2104          2104        4718  4718   \n",
              "\n",
              "                                               question  \\\n",
              "5     Is Alu hypomethylation associated with breast ...   \n",
              "12    Which factors activate zygotic gene expression...   \n",
              "17                   Is TENS machine effective in pain?   \n",
              "18    Is there any algorithm for enhancer identifica...   \n",
              "19    In which breast cancer patients can palbocicli...   \n",
              "...                                                 ...   \n",
              "2099  Which is the literature-based database of phen...   \n",
              "2100        What is the role of PCAT6 in human cancers?   \n",
              "2101          Can METTL3 methylate long noncoding RNAs?   \n",
              "2103                              What is EpiMethylTag?   \n",
              "2104  Describe Multilocus Inherited Neoplasia Allele...   \n",
              "\n",
              "                                                 answer  \\\n",
              "5     Yes, Alu elements were found to be hypomethyla...   \n",
              "12    Nanog, Pou5f1 and SoxB1 activate zygotic gene ...   \n",
              "17    Transcutaneous electrical nerve stimulation is...   \n",
              "18                                                  yes   \n",
              "19    Palbociclib is useful for women with hormone r...   \n",
              "...                                                 ...   \n",
              "2099  PheneBank is a Web-portal for retrieving human...   \n",
              "2100  PCAT6, is a carcinogenic lncRNA. It is abnorma...   \n",
              "2101  Yes, METTL3 can modulate methylation and expre...   \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...   \n",
              "2104  Genetic testing of hereditary cancer using com...   \n",
              "\n",
              "                relevant_passage_ids  n_docs  \\\n",
              "5               [20682973, 24971511]       2   \n",
              "12                        [24056933]       1   \n",
              "17               [17333874, 7644247]       2   \n",
              "18              [23526891, 22328731]       2   \n",
              "19    [26236140, 25792301, 25524798]       3   \n",
              "...                              ...     ...   \n",
              "2099                      [34788791]       1   \n",
              "2100            [34885209, 31676070]       2   \n",
              "2101                      [34505967]       1   \n",
              "2103                      [31752933]       1   \n",
              "2104                      [30580288]       1   \n",
              "\n",
              "                                                 prompt  \\\n",
              "5     Question: Is Alu hypomethylation associated wi...   \n",
              "12    Question: Which factors activate zygotic gene ...   \n",
              "17    Question: Is TENS machine effective in pain?\\n...   \n",
              "18    Question: Is there any algorithm for enhancer ...   \n",
              "19    Question: In which breast cancer patients can ...   \n",
              "...                                                 ...   \n",
              "2099  Question: Which is the literature-based databa...   \n",
              "2100  Question: What is the role of PCAT6 in human c...   \n",
              "2101  Question: Can METTL3 methylate long noncoding ...   \n",
              "2103  Question: What is EpiMethylTag?\\nContext: Docu...   \n",
              "2104  Question: Describe Multilocus Inherited Neopla...   \n",
              "\n",
              "                                                    sft  \\\n",
              "5     Yes, Alu elements were found to be hypomethyla...   \n",
              "12    Nanog, Pou5f1 and SoxB1 activate zygotic gene ...   \n",
              "17    Transcutaneous electrical nerve stimulation is...   \n",
              "18    yes [23526891, 22328731]\\n\\nReferences:\\n[2352...   \n",
              "19    Palbociclib is useful for women with hormone r...   \n",
              "...                                                 ...   \n",
              "2099  PheneBank is a Web-portal for retrieving human...   \n",
              "2100  PCAT6, is a carcinogenic lncRNA [34885209]. It...   \n",
              "2101  Yes, METTL3 can modulate methylation and expre...   \n",
              "2103  EpiMethylTag is a fast, low-input, low sequenc...   \n",
              "2104  Genetic testing of hereditary cancer using com...   \n",
              "\n",
              "                                       prompt_no_answer  \\\n",
              "5     Question: Is Alu hypomethylation associated wi...   \n",
              "12    Question: Which factors activate zygotic gene ...   \n",
              "17    Question: Is TENS machine effective in pain?\\n...   \n",
              "18    Question: Is there any algorithm for enhancer ...   \n",
              "19    Question: In which breast cancer patients can ...   \n",
              "...                                                 ...   \n",
              "2099  Question: Which is the literature-based databa...   \n",
              "2100  Question: What is the role of PCAT6 in human c...   \n",
              "2101  Question: Can METTL3 methylate long noncoding ...   \n",
              "2103  Question: What is EpiMethylTag?\\nContext: Docu...   \n",
              "2104  Question: Describe Multilocus Inherited Neopla...   \n",
              "\n",
              "                             formatted_prompt_no_answer  \\\n",
              "5     <|im_start|>user\\nQuestion: Is Alu hypomethyla...   \n",
              "12    <|im_start|>user\\nQuestion: Which factors acti...   \n",
              "17    <|im_start|>user\\nQuestion: Is TENS machine ef...   \n",
              "18    <|im_start|>user\\nQuestion: Is there any algor...   \n",
              "19    <|im_start|>user\\nQuestion: In which breast ca...   \n",
              "...                                                 ...   \n",
              "2099  <|im_start|>user\\nQuestion: Which is the liter...   \n",
              "2100  <|im_start|>user\\nQuestion: What is the role o...   \n",
              "2101  <|im_start|>user\\nQuestion: Can METTL3 methyla...   \n",
              "2103  <|im_start|>user\\nQuestion: What is EpiMethylT...   \n",
              "2104  <|im_start|>user\\nQuestion: Describe Multilocu...   \n",
              "\n",
              "                           formatted_prompt_with_answer  \\\n",
              "5     <|im_start|>user\\nQuestion: Is Alu hypomethyla...   \n",
              "12    <|im_start|>user\\nQuestion: Which factors acti...   \n",
              "17    <|im_start|>user\\nQuestion: Is TENS machine ef...   \n",
              "18    <|im_start|>user\\nQuestion: Is there any algor...   \n",
              "19    <|im_start|>user\\nQuestion: In which breast ca...   \n",
              "...                                                 ...   \n",
              "2099  <|im_start|>user\\nQuestion: Which is the liter...   \n",
              "2100  <|im_start|>user\\nQuestion: What is the role o...   \n",
              "2101  <|im_start|>user\\nQuestion: Can METTL3 methyla...   \n",
              "2103  <|im_start|>user\\nQuestion: What is EpiMethylT...   \n",
              "2104  <|im_start|>user\\nQuestion: Describe Multilocu...   \n",
              "\n",
              "      usual_tokenization_length  \n",
              "5                          True  \n",
              "12                         True  \n",
              "17                         True  \n",
              "18                         True  \n",
              "19                         True  \n",
              "...                         ...  \n",
              "2099                       True  \n",
              "2100                       True  \n",
              "2101                       True  \n",
              "2103                       True  \n",
              "2104                       True  \n",
              "\n",
              "[941 rows x 13 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ca2b65ab-a674-45f9-ad97-f35921afb824\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Unnamed: 0.1</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>id</th>\n",
              "      <th>question</th>\n",
              "      <th>answer</th>\n",
              "      <th>relevant_passage_ids</th>\n",
              "      <th>n_docs</th>\n",
              "      <th>prompt</th>\n",
              "      <th>sft</th>\n",
              "      <th>prompt_no_answer</th>\n",
              "      <th>formatted_prompt_no_answer</th>\n",
              "      <th>formatted_prompt_with_answer</th>\n",
              "      <th>usual_tokenization_length</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>5</td>\n",
              "      <td>24</td>\n",
              "      <td>24</td>\n",
              "      <td>Is Alu hypomethylation associated with breast ...</td>\n",
              "      <td>Yes, Alu elements were found to be hypomethyla...</td>\n",
              "      <td>[20682973, 24971511]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is Alu hypomethylation associated wi...</td>\n",
              "      <td>Yes, Alu elements were found to be hypomethyla...</td>\n",
              "      <td>Question: Is Alu hypomethylation associated wi...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is Alu hypomethyla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is Alu hypomethyla...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>12</td>\n",
              "      <td>41</td>\n",
              "      <td>41</td>\n",
              "      <td>Which factors activate zygotic gene expression...</td>\n",
              "      <td>Nanog, Pou5f1 and SoxB1 activate zygotic gene ...</td>\n",
              "      <td>[24056933]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Which factors activate zygotic gene ...</td>\n",
              "      <td>Nanog, Pou5f1 and SoxB1 activate zygotic gene ...</td>\n",
              "      <td>Question: Which factors activate zygotic gene ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which factors acti...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which factors acti...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>17</th>\n",
              "      <td>17</td>\n",
              "      <td>67</td>\n",
              "      <td>67</td>\n",
              "      <td>Is TENS machine effective in pain?</td>\n",
              "      <td>Transcutaneous electrical nerve stimulation is...</td>\n",
              "      <td>[17333874, 7644247]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is TENS machine effective in pain?\\n...</td>\n",
              "      <td>Transcutaneous electrical nerve stimulation is...</td>\n",
              "      <td>Question: Is TENS machine effective in pain?\\n...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is TENS machine ef...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is TENS machine ef...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>18</th>\n",
              "      <td>18</td>\n",
              "      <td>68</td>\n",
              "      <td>68</td>\n",
              "      <td>Is there any algorithm for enhancer identifica...</td>\n",
              "      <td>yes</td>\n",
              "      <td>[23526891, 22328731]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: Is there any algorithm for enhancer ...</td>\n",
              "      <td>yes [23526891, 22328731]\\n\\nReferences:\\n[2352...</td>\n",
              "      <td>Question: Is there any algorithm for enhancer ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is there any algor...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Is there any algor...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>19</th>\n",
              "      <td>19</td>\n",
              "      <td>73</td>\n",
              "      <td>73</td>\n",
              "      <td>In which breast cancer patients can palbocicli...</td>\n",
              "      <td>Palbociclib is useful for women with hormone r...</td>\n",
              "      <td>[26236140, 25792301, 25524798]</td>\n",
              "      <td>3</td>\n",
              "      <td>Question: In which breast cancer patients can ...</td>\n",
              "      <td>Palbociclib is useful for women with hormone r...</td>\n",
              "      <td>Question: In which breast cancer patients can ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: In which breast ca...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: In which breast ca...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2099</th>\n",
              "      <td>2099</td>\n",
              "      <td>4704</td>\n",
              "      <td>4704</td>\n",
              "      <td>Which is the literature-based database of phen...</td>\n",
              "      <td>PheneBank is a Web-portal for retrieving human...</td>\n",
              "      <td>[34788791]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Which is the literature-based databa...</td>\n",
              "      <td>PheneBank is a Web-portal for retrieving human...</td>\n",
              "      <td>Question: Which is the literature-based databa...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which is the liter...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Which is the liter...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2100</th>\n",
              "      <td>2100</td>\n",
              "      <td>4707</td>\n",
              "      <td>4707</td>\n",
              "      <td>What is the role of PCAT6 in human cancers?</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA. It is abnorma...</td>\n",
              "      <td>[34885209, 31676070]</td>\n",
              "      <td>2</td>\n",
              "      <td>Question: What is the role of PCAT6 in human c...</td>\n",
              "      <td>PCAT6, is a carcinogenic lncRNA [34885209]. It...</td>\n",
              "      <td>Question: What is the role of PCAT6 in human c...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is the role o...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is the role o...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2101</th>\n",
              "      <td>2101</td>\n",
              "      <td>4711</td>\n",
              "      <td>4711</td>\n",
              "      <td>Can METTL3 methylate long noncoding RNAs?</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "      <td>[34505967]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Can METTL3 methylate long noncoding ...</td>\n",
              "      <td>Yes, METTL3 can modulate methylation and expre...</td>\n",
              "      <td>Question: Can METTL3 methylate long noncoding ...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Can METTL3 methyla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Can METTL3 methyla...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2103</th>\n",
              "      <td>2103</td>\n",
              "      <td>4715</td>\n",
              "      <td>4715</td>\n",
              "      <td>What is EpiMethylTag?</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "      <td>[31752933]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: What is EpiMethylTag?\\nContext: Docu...</td>\n",
              "      <td>EpiMethylTag is a fast, low-input, low sequenc...</td>\n",
              "      <td>Question: What is EpiMethylTag?\\nContext: Docu...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is EpiMethylT...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: What is EpiMethylT...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2104</th>\n",
              "      <td>2104</td>\n",
              "      <td>4718</td>\n",
              "      <td>4718</td>\n",
              "      <td>Describe Multilocus Inherited Neoplasia Allele...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "      <td>[30580288]</td>\n",
              "      <td>1</td>\n",
              "      <td>Question: Describe Multilocus Inherited Neopla...</td>\n",
              "      <td>Genetic testing of hereditary cancer using com...</td>\n",
              "      <td>Question: Describe Multilocus Inherited Neopla...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Describe Multilocu...</td>\n",
              "      <td>&lt;|im_start|&gt;user\\nQuestion: Describe Multilocu...</td>\n",
              "      <td>True</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>941 rows  13 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ca2b65ab-a674-45f9-ad97-f35921afb824')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ca2b65ab-a674-45f9-ad97-f35921afb824 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ca2b65ab-a674-45f9-ad97-f35921afb824');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-f8c78d6e-1a71-4bd7-a6b9-bf2801eb5ebb\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f8c78d6e-1a71-4bd7-a6b9-bf2801eb5ebb')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-f8c78d6e-1a71-4bd7-a6b9-bf2801eb5ebb button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "  <div id=\"id_b16e1f40-f2d6-4367-9234-bee4385b9221\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_b16e1f40-f2d6-4367-9234-bee4385b9221 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 941,\n  \"fields\": [\n    {\n      \"column\": \"Unnamed: 0.1\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 577,\n        \"min\": 5,\n        \"max\": 2104,\n        \"num_unique_values\": 941,\n        \"samples\": [\n          857,\n          1327,\n          1018\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Unnamed: 0\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1196,\n        \"min\": 24,\n        \"max\": 4718,\n        \"num_unique_values\": 941,\n        \"samples\": [\n          2490,\n          3301,\n          2776\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1196,\n        \"min\": 24,\n        \"max\": 4718,\n        \"num_unique_values\": 941,\n        \"samples\": [\n          2490,\n          3301,\n          2776\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"question\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"What is libgapmis?\",\n          \"What are the effects of 14-3-3 dimers on Tau phosphorylation?\",\n          \"For which disease is sutezolid developed?\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 939,\n        \"samples\": [\n          \"Manta is a method to discover structural variants and indels from next generation sequencing data. Manta is optimized for rapid germline and somatic analysis, calling structural variants, medium-sized indels and large insertions on standard compute hardware in less than a tenth of the time that comparable methods require to identify only subsets of these variant types: for example NA12878 at 50\\u00d7 genomic coverage is analyzed in less than 20\\u2009min. Manta can discover and score variants based on supporting paired and split-read evidence, with scoring models optimized for germline analysis of diploid individuals and somatic analysis of tumor-normal sample pairs. Call quality is similar to or better than comparable methods, as determined by pedigree consistency of germline calls and comparison of somatic calls to COSMIC database variants. Manta consistently assembles a higher fraction of its calls to base-pair resolution, allowing for improved downstream annotation and analysis of clinical significance.\",\n          \"The Zika virus belongs to the family Flaviviridae.\",\n          \"Yes, poly (ADP- ribosylation) plays a role in the maintenance of transcriptional fidelity.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"relevant_passage_ids\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 871,\n        \"samples\": [\n          \"[27846416, 26282889]\",\n          \"[25526884, 22974263, 19426495]\",\n          \"[29540340]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"n_docs\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 1,\n        \"max\": 6,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          2,\n          1,\n          5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"prompt\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"Question: What is libgapmis?\\nContext: Document # 24564250:\\nBACKGROUND: A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable.RESULTS: In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment. Extensive experimental results demonstrate that the functions of the CPU version provided in this library accelerate the computations by a factor of 20 compared to other programmes. The analogous SSE- and GPU-based implementations accelerate the computations by a factor of 6 and 11, respectively, compared to the CPU version. The library also provides the user the flexibility to split the read into fragments, based on the observed gap occurrence frequency and the length of the read, thereby allowing for a variable, but bounded, number of gaps in the alignment.CONCLUSIONS: We present libgapmis, a library for extending pairwise short-read alignments. We show that libgapmis is better-suited and more efficient than existing algorithms for this task. The importance of our contribution is underlined by the fact that the provided functions may be seamlessly integrated into any short-read alignment pipeline. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis.\\n\\nAnswer: libgapmis is a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis.\",\n          \"Question: What are the effects of 14-3-3 dimers on Tau phosphorylation?\\nContext: Document # 29659825:\\nNeurodegenerative dementias collectively known as Tauopathies involve aberrant phosphorylation and aggregation of the neuronal protein Tau. The largely neuronal 14-3-3 proteins are also elevated in the central nervous system (CNS) and cerebrospinal fluid of Tauopathy patients, suggesting functional linkage. We use the simplicity and genetic facility of the Drosophila system to investigate in vivo whether 14-3-3s are causal or synergistic with Tau accumulation in precipitating pathogenesis. Proteomic, biochemical and genetic evidence demonstrate that both Drosophila 14-3-3 proteins interact with human wild-type and mutant Tau on multiple sites irrespective of their phosphorylation state. 14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant. Moreover, 14-3-3 elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner. In contrast, the R406W mutant, which lacks a putative 14-3-3 binding site, responds differentially to elevation of each 14-3-3 isoform. Although excess 14-3-3\\u03b6 stabilizes the mutant protein, elevated D14-3-3\\u025b has a destabilizing effect probably because of altered 14-3-3 dimer composition. Our collective data demonstrate the complexity of 14-3-3/Tau interactions in vivo and suggest that 14-3-3 attenuation is not appropriate ameliorative treatment of Tauopathies. Finally, we suggest that 'bystander' 14-3-3s are recruited by accumulating Tau with the consequences depending on the composition of available dimers within particular neurons and the Tau variant.\\n\\nAnswer: 14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant. Furthermore, recruitment of dimers on accumulating wild- type Tau increases its steady- state levels ostensibly by occluding access to proteases in a phosphorylated-dependent manner.\",\n          \"Question: For which disease is sutezolid developed?\\nContext: Document # 27280980:\\nTuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance. Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease. This review presents a general introduction to the current status of the disease, the biology of the pathogen as well as the state of drug development against tuberculosis (TB) with emphasis on the major problems and bottlenecks associated with the same. Starting from the first drug against TB, the review discusses the entire history and the course of development of the drugs which are available today in the market as well as those which are under various phases of clinical and pre-clinical trials along with their mechanism of action. It also talks about the possible role of nanosciences in combating TB.\\n\\nAnswer: Sutezolid is being developed as a treatment against tuberculosis.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"sft\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"libgapmis is a library for extending pairwise short-read alignments [24564250]. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations [24564250]. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment [24564250]. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis [24564250].\\n\\nReferences:\\n[24564250] BACKGROUND: A wide variety of short-read...\",\n          \"14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau [29659825], but they are not essential for toxicity of either variant [29659825]. Furthermore, recruitment of dimers on accumulating wild- type Tau increases its steady- state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner [29659825].\\n\\nReferences:\\n[29659825] Neurodegenerative dementias collectively known as Tauopathies...\",\n          \"Sutezolid is being developed as a treatment against tuberculosis [27280980].\\n\\nReferences:\\n[27280980] Tuberculosis is very much rampant in...\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"prompt_no_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"Question: What is libgapmis?\\nContext: Document # 24564250:\\nBACKGROUND: A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable.RESULTS: In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment. Extensive experimental results demonstrate that the functions of the CPU version provided in this library accelerate the computations by a factor of 20 compared to other programmes. The analogous SSE- and GPU-based implementations accelerate the computations by a factor of 6 and 11, respectively, compared to the CPU version. The library also provides the user the flexibility to split the read into fragments, based on the observed gap occurrence frequency and the length of the read, thereby allowing for a variable, but bounded, number of gaps in the alignment.CONCLUSIONS: We present libgapmis, a library for extending pairwise short-read alignments. We show that libgapmis is better-suited and more efficient than existing algorithms for this task. The importance of our contribution is underlined by the fact that the provided functions may be seamlessly integrated into any short-read alignment pipeline. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis.\\n\\n\",\n          \"Question: What are the effects of 14-3-3 dimers on Tau phosphorylation?\\nContext: Document # 29659825:\\nNeurodegenerative dementias collectively known as Tauopathies involve aberrant phosphorylation and aggregation of the neuronal protein Tau. The largely neuronal 14-3-3 proteins are also elevated in the central nervous system (CNS) and cerebrospinal fluid of Tauopathy patients, suggesting functional linkage. We use the simplicity and genetic facility of the Drosophila system to investigate in vivo whether 14-3-3s are causal or synergistic with Tau accumulation in precipitating pathogenesis. Proteomic, biochemical and genetic evidence demonstrate that both Drosophila 14-3-3 proteins interact with human wild-type and mutant Tau on multiple sites irrespective of their phosphorylation state. 14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant. Moreover, 14-3-3 elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner. In contrast, the R406W mutant, which lacks a putative 14-3-3 binding site, responds differentially to elevation of each 14-3-3 isoform. Although excess 14-3-3\\u03b6 stabilizes the mutant protein, elevated D14-3-3\\u025b has a destabilizing effect probably because of altered 14-3-3 dimer composition. Our collective data demonstrate the complexity of 14-3-3/Tau interactions in vivo and suggest that 14-3-3 attenuation is not appropriate ameliorative treatment of Tauopathies. Finally, we suggest that 'bystander' 14-3-3s are recruited by accumulating Tau with the consequences depending on the composition of available dimers within particular neurons and the Tau variant.\\n\\n\",\n          \"Question: For which disease is sutezolid developed?\\nContext: Document # 27280980:\\nTuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance. Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease. This review presents a general introduction to the current status of the disease, the biology of the pathogen as well as the state of drug development against tuberculosis (TB) with emphasis on the major problems and bottlenecks associated with the same. Starting from the first drug against TB, the review discusses the entire history and the course of development of the drugs which are available today in the market as well as those which are under various phases of clinical and pre-clinical trials along with their mechanism of action. It also talks about the possible role of nanosciences in combating TB.\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"formatted_prompt_no_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"<|im_start|>user\\nQuestion: What is libgapmis?\\nContext: Document # 24564250:\\nBACKGROUND: A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable.RESULTS: In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment. Extensive experimental results demonstrate that the functions of the CPU version provided in this library accelerate the computations by a factor of 20 compared to other programmes. The analogous SSE- and GPU-based implementations accelerate the computations by a factor of 6 and 11, respectively, compared to the CPU version. The library also provides the user the flexibility to split the read into fragments, based on the observed gap occurrence frequency and the length of the read, thereby allowing for a variable, but bounded, number of gaps in the alignment.CONCLUSIONS: We present libgapmis, a library for extending pairwise short-read alignments. We show that libgapmis is better-suited and more efficient than existing algorithms for this task. The importance of our contribution is underlined by the fact that the provided functions may be seamlessly integrated into any short-read alignment pipeline. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\",\n          \"<|im_start|>user\\nQuestion: What are the effects of 14-3-3 dimers on Tau phosphorylation?\\nContext: Document # 29659825:\\nNeurodegenerative dementias collectively known as Tauopathies involve aberrant phosphorylation and aggregation of the neuronal protein Tau. The largely neuronal 14-3-3 proteins are also elevated in the central nervous system (CNS) and cerebrospinal fluid of Tauopathy patients, suggesting functional linkage. We use the simplicity and genetic facility of the Drosophila system to investigate in vivo whether 14-3-3s are causal or synergistic with Tau accumulation in precipitating pathogenesis. Proteomic, biochemical and genetic evidence demonstrate that both Drosophila 14-3-3 proteins interact with human wild-type and mutant Tau on multiple sites irrespective of their phosphorylation state. 14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant. Moreover, 14-3-3 elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner. In contrast, the R406W mutant, which lacks a putative 14-3-3 binding site, responds differentially to elevation of each 14-3-3 isoform. Although excess 14-3-3\\u03b6 stabilizes the mutant protein, elevated D14-3-3\\u025b has a destabilizing effect probably because of altered 14-3-3 dimer composition. Our collective data demonstrate the complexity of 14-3-3/Tau interactions in vivo and suggest that 14-3-3 attenuation is not appropriate ameliorative treatment of Tauopathies. Finally, we suggest that 'bystander' 14-3-3s are recruited by accumulating Tau with the consequences depending on the composition of available dimers within particular neurons and the Tau variant.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\",\n          \"<|im_start|>user\\nQuestion: For which disease is sutezolid developed?\\nContext: Document # 27280980:\\nTuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance. Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease. This review presents a general introduction to the current status of the disease, the biology of the pathogen as well as the state of drug development against tuberculosis (TB) with emphasis on the major problems and bottlenecks associated with the same. Starting from the first drug against TB, the review discusses the entire history and the course of development of the drugs which are available today in the market as well as those which are under various phases of clinical and pre-clinical trials along with their mechanism of action. It also talks about the possible role of nanosciences in combating TB.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"formatted_prompt_with_answer\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 941,\n        \"samples\": [\n          \"<|im_start|>user\\nQuestion: What is libgapmis?\\nContext: Document # 24564250:\\nBACKGROUND: A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable.RESULTS: In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment. Extensive experimental results demonstrate that the functions of the CPU version provided in this library accelerate the computations by a factor of 20 compared to other programmes. The analogous SSE- and GPU-based implementations accelerate the computations by a factor of 6 and 11, respectively, compared to the CPU version. The library also provides the user the flexibility to split the read into fragments, based on the observed gap occurrence frequency and the length of the read, thereby allowing for a variable, but bounded, number of gaps in the alignment.CONCLUSIONS: We present libgapmis, a library for extending pairwise short-read alignments. We show that libgapmis is better-suited and more efficient than existing algorithms for this task. The importance of our contribution is underlined by the fact that the provided functions may be seamlessly integrated into any short-read alignment pipeline. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\nlibgapmis is a library for extending pairwise short-read alignments [24564250]. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations [24564250]. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment [24564250]. The open-source code of libgapmis is available at http://www.exelixis-lab.org/gapmis [24564250].\\n\\nReferences:\\n[24564250] BACKGROUND: A wide variety of short-read...<|im_end|>\\n\",\n          \"<|im_start|>user\\nQuestion: What are the effects of 14-3-3 dimers on Tau phosphorylation?\\nContext: Document # 29659825:\\nNeurodegenerative dementias collectively known as Tauopathies involve aberrant phosphorylation and aggregation of the neuronal protein Tau. The largely neuronal 14-3-3 proteins are also elevated in the central nervous system (CNS) and cerebrospinal fluid of Tauopathy patients, suggesting functional linkage. We use the simplicity and genetic facility of the Drosophila system to investigate in vivo whether 14-3-3s are causal or synergistic with Tau accumulation in precipitating pathogenesis. Proteomic, biochemical and genetic evidence demonstrate that both Drosophila 14-3-3 proteins interact with human wild-type and mutant Tau on multiple sites irrespective of their phosphorylation state. 14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant. Moreover, 14-3-3 elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner. In contrast, the R406W mutant, which lacks a putative 14-3-3 binding site, responds differentially to elevation of each 14-3-3 isoform. Although excess 14-3-3\\u03b6 stabilizes the mutant protein, elevated D14-3-3\\u025b has a destabilizing effect probably because of altered 14-3-3 dimer composition. Our collective data demonstrate the complexity of 14-3-3/Tau interactions in vivo and suggest that 14-3-3 attenuation is not appropriate ameliorative treatment of Tauopathies. Finally, we suggest that 'bystander' 14-3-3s are recruited by accumulating Tau with the consequences depending on the composition of available dimers within particular neurons and the Tau variant.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\n14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau [29659825], but they are not essential for toxicity of either variant [29659825]. Furthermore, recruitment of dimers on accumulating wild- type Tau increases its steady- state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner [29659825].\\n\\nReferences:\\n[29659825] Neurodegenerative dementias collectively known as Tauopathies...<|im_end|>\\n\",\n          \"<|im_start|>user\\nQuestion: For which disease is sutezolid developed?\\nContext: Document # 27280980:\\nTuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance. Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease. This review presents a general introduction to the current status of the disease, the biology of the pathogen as well as the state of drug development against tuberculosis (TB) with emphasis on the major problems and bottlenecks associated with the same. Starting from the first drug against TB, the review discusses the entire history and the course of development of the drugs which are available today in the market as well as those which are under various phases of clinical and pre-clinical trials along with their mechanism of action. It also talks about the possible role of nanosciences in combating TB.\\n\\n<|im_end|>\\n<|im_start|>assistant\\n<think>\\n\\n</think>\\n\\nSutezolid is being developed as a treatment against tuberculosis [27280980].\\n\\nReferences:\\n[27280980] Tuberculosis is very much rampant in...<|im_end|>\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"usual_tokenization_length\",\n      \"properties\": {\n        \"dtype\": \"boolean\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          true\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 36
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Final dataset assembly:"
      ],
      "metadata": {
        "id": "CcxPYpGcZqn2"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import torch\n",
        "from transformers import (\n",
        "    AutoTokenizer,\n",
        "    AutoModelForCausalLM,\n",
        "    Trainer,\n",
        "    TrainingArguments,\n",
        "    default_data_collator\n",
        ")\n",
        "from datasets import Dataset, DatasetDict\n",
        "from sklearn.model_selection import train_test_split\n",
        "\n",
        "train_df, val_df = train_test_split(df, test_size=0.1, random_state=42)\n",
        "datasets = DatasetDict({\n",
        "    \"train\": Dataset.from_pandas(train_df),\n",
        "    \"validation\": Dataset.from_pandas(val_df)\n",
        "})"
      ],
      "metadata": {
        "id": "KHngMA0klkFX"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "datasets['train']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Nlu8rCFUs3lu",
        "outputId": "bf5f216b-b232-4f50-b2ec-9dbeaff535ec"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Dataset({\n",
              "    features: ['Unnamed: 0.1', 'Unnamed: 0', 'id', 'question', 'answer', 'relevant_passage_ids', 'n_docs', 'prompt', 'sft', 'prompt_no_answer', 'formatted_prompt_no_answer', 'formatted_prompt_with_answer', 'usual_tokenization_length', '__index_level_0__'],\n",
              "    num_rows: 846\n",
              "})"
            ]
          },
          "metadata": {},
          "execution_count": 38
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's check the lengths (in words). As you see, everything is below 512:"
      ],
      "metadata": {
        "id": "b9Azxwt7Zs2Q"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "sns.set_theme()\n",
        "sns.histplot(df['formatted_prompt_with_answer'].apply(lambda x: len(x.split())))\n",
        "plt.xlabel('Length of Text (Words)')\n",
        "plt.ylabel('Count')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 475
        },
        "id": "BMv3tZp_2FG7",
        "outputId": "f12928da-b45b-454e-b6a1-aac7b54ed4b9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Text(0, 0.5, 'Count')"
            ]
          },
          "metadata": {},
          "execution_count": 39
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### What happens next\n",
        "\n",
        "Before we can proceed with actual training, we need to perform the tokenization.\n",
        "\n",
        "Below we implemented the function `tokenize_and_mask`, which takes the batch of prompts with and without answers and tokenizes them. The tokenization happens with a trick of applying `[-100]` - this is the standard huggingface method to ignore the tokens during objective function minimization. Why do we want to ignore some tokens if we are doing full finetuning? Because we dont care about gradients that flow through the prompt. We only care about gradients that flow through the desired answer, hence we just mask out all tokens that belong to prompt.\n",
        "\n",
        "This function is then applied to both datasets."
      ],
      "metadata": {
        "id": "bxjRTzTyD6a_"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "max_length = int(MAX_LEN * BPE_FACTOR) # because of BPE\n",
        "\n",
        "def tokenize_and_mask(batch):\n",
        "    full_texts = batch[\"formatted_prompt_with_answer\"]   # list of prompt + answer strings\n",
        "    prompts    = batch[\"formatted_prompt_no_answer\"]     # list of prompt-only strings\n",
        "\n",
        "    tok_full = tokenizer(\n",
        "        full_texts,\n",
        "        truncation=True,\n",
        "        max_length=max_length,\n",
        "        return_attention_mask=True,\n",
        "    )\n",
        "\n",
        "    input_ids      = tok_full[\"input_ids\"]\n",
        "    attention_mask = tok_full[\"attention_mask\"]\n",
        "\n",
        "    labels = []\n",
        "    for i, (seq_ids, prompt) in enumerate(zip(input_ids, prompts)):\n",
        "        p_ids     = tokenizer(\n",
        "            prompt,\n",
        "            truncation=True,\n",
        "            max_length=max_length\n",
        "        )[\"input_ids\"]\n",
        "        prompt_len = len(p_ids)\n",
        "\n",
        "        lab = seq_ids.copy()\n",
        "        lab[:prompt_len] = [-100] * prompt_len\n",
        "        labels.append(lab)\n",
        "        all_100 = True\n",
        "        for x in lab:\n",
        "            if x!=-100:\n",
        "                all_100 = False\n",
        "                break\n",
        "        if all_100:\n",
        "            print(f'All tokens will be ignored for sequence #{i}')\n",
        "            print(len(seq_ids))\n",
        "            print('------')\n",
        "\n",
        "    return {\n",
        "        \"input_ids\":      input_ids,\n",
        "        \"attention_mask\": attention_mask,\n",
        "        \"labels\":         labels\n",
        "    }\n",
        "\n",
        "tokenized_datasets = datasets.map(\n",
        "    tokenize_and_mask,\n",
        "    batched=True,\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 81,
          "referenced_widgets": [
            "b0baaea81df64ae1aa7aadf8e28084d0",
            "d349982ca02f4033966a2179e68d805f",
            "95c60fe19e5a4cfba5827321a503551e",
            "ef12b0e7a87d4642ab8e87922b6bec5c",
            "645eaf01b77245cd92a30916bf307800",
            "91734fc795da4b3ba1f149e3e97aa8d4",
            "043398962cc743ddac97603b8dfd8bac",
            "f0561815b5e1407f82469e8ae8c0b8b0",
            "9bb20c1fcd44402b92b14d4016d3d189",
            "cc4d2f98e4744e5b84e80376ddfac1bb",
            "9231faf666d54d3095fad2a4b445d85c",
            "3e43678c2b834dc0a4aa36da29e1dbe9",
            "9c333b2342dd4082b62c8a17e4c0d8d6",
            "e65386a294284392b262782aa9e068ba",
            "9120ec92b1ee4eeea0b731bdad6191ef",
            "65bbaedc5c00451aba31d1105356910f",
            "369b3941e6ad40e6af2eb41a3be0d9f9",
            "0b4f769502a14aab860bad180452c73f",
            "5b02a9dcfce84eb1a83b2d9d0f6e0c11",
            "c467420c8ab4470189804ada45d457ad",
            "3a62590f897d4c81b87243073ed31831",
            "14f0dd02f5ce4ba8a2e05ee6ed96643f"
          ]
        },
        "id": "wjs6YEu-svbv",
        "outputId": "c434ffff-5be2-4a2f-922e-88a30bf10857"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/846 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b0baaea81df64ae1aa7aadf8e28084d0"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/95 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3e43678c2b834dc0a4aa36da29e1dbe9"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's check whether we have the same correspondence between `input_ids` and `labels`"
      ],
      "metadata": {
        "id": "WhVqAwfSFVL_"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "ex = tokenized_datasets[\"train\"][192]\n",
        "print(\"input_ids[:20]:\", ex[\"input_ids\"][-20:])\n",
        "print(\"labels   [:20]:\", ex[\"labels\"]   [-20:])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ZXCRJNLr1fnL",
        "outputId": "9ef25d22-894e-4805-f4a1-e42b28eb00a6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "input_ids[:20]: [23, 18, 60, 2350, 23609, 266, 519, 323, 22008, 258, 4998, 1609, 320, 2828, 953, 8, 374, 1112, 151645, 198]\n",
            "labels   [:20]: [23, 18, 60, 2350, 23609, 266, 519, 323, 22008, 258, 4998, 1609, 320, 2828, 953, 8, 374, 1112, 151645, 198]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "As we see they match, which is great. However, attentive reader might say, that in order for us to finetune the model in the supervised regime, we actually want to shift the labels by one index forward: to predict $t_1$ from $t_0$. This is absolutely correct, and some people do the shift during preparation of the dataset. However, we will do the shift during training.\n",
        "\n",
        "To summarize:\n",
        "- Shift forward by one index for labels can be done within dataset on data level (this is what some people do)\n",
        "- Shift forward by one index for labels can be done within training, the `labels` in this case mirror the `input_ids` (this is what we are doing)"
      ],
      "metadata": {
        "id": "1g-rbwv8FcEI"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "It's useful to check several predictions BEFORE fine-tuning:"
      ],
      "metadata": {
        "id": "FtME2U91Z5-Z"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "sample_prompts = df['formatted_prompt_no_answer'].iloc[:5].tolist()\n",
        "sample_gt = df['formatted_prompt_with_answer'].iloc[:5].tolist()\n",
        "pretrain_outputs = []\n",
        "print(\"=== Before fine-tuning ===\")\n",
        "for i, (p, gt) in enumerate(zip(sample_prompts, sample_gt)):\n",
        "    print(f'Reference answer #{i}:')\n",
        "    print(gt)\n",
        "    print('-----------------------------------')\n",
        "    print(f'Prediction #{i}:')\n",
        "    inputs = tokenizer(p, truncation=True, max_length=max_length, return_attention_mask=True, return_tensors=\"pt\").to(model.device)\n",
        "    out_ids = model.generate(\n",
        "        **inputs,\n",
        "        max_new_tokens=128,\n",
        "        do_sample=True\n",
        "    )[0]\n",
        "    prediction = tokenizer.decode(out_ids, skip_special_tokens=True)\n",
        "    pretrain_outputs.append(prediction)\n",
        "    print(prediction)\n",
        "    print(\"-----------------------------------\\n\\n\\n\")"
      ],
      "metadata": {
        "id": "_xqngyoEm89F",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "900979f5-6e43-4b9b-8c21-7ae002c85c91"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "=== Before fine-tuning ===\n",
            "Reference answer #0:\n",
            "<|im_start|>user\n",
            "Question: Is Alu hypomethylation associated with breast cancer?\n",
            "Context: Document # 24971511:\n",
            "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes, Alu elements were found to be hypomethylated in breast cancer [24971511], especially in the HER2-enriched subtype [24971511]. Furthermore, Alu hypomethylation was identified as a late event during breast cancer progression [24971511], and in invasive breast cancer, tended to be associated with negative estrogen receptor status [24971511] and poor disease-free survival of the patients [24971511].\n",
            "\n",
            "References:\n",
            "[24971511] The changes in DNA methylation status...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #0:\n",
            "user\n",
            "Question: Is Alu hypomethylation associated with breast cancer?\n",
            "Context: Document # 24971511:\n",
            "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes, **Alu hypomethylation is associated with breast cancer**, particularly in subtypes like **HER2-enriched breast cancer (IBC)**. Here's a summary of the findings:\n",
            "\n",
            "- **Alu hypomethylation** was **not significantly different** during the progression of breast cancer, but it **tended to decrease** during the transition from **DCIS to IBC**.\n",
            "- **LINE-1 hypomethylation** **significantly decreased** from normal to ADH/FEA, and was **similar** in ADH/FEA, DCIS, and IBC.\n",
            "- In **\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #1:\n",
            "<|im_start|>user\n",
            "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
            "Context: Document # 24056933:\n",
            "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition [24056933]. Maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression [24056933].\n",
            "\n",
            "References:\n",
            "[24056933] After fertilization, maternal factors direct development...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #1:\n",
            "user\n",
            "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
            "Context: Document # 24056933:\n",
            "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "The factors that activate zygotic gene expression during the maternal-to-zygotic transition (MZT) in zebrafish are **Nanog**, **Pou5f1 (also called Oct4)**, and **SoxB1**. These factors are conserved in vertebrates and are essential for initiating the zygotic developmental program and clearing the maternal program by activating the microRNA miR-430.\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #2:\n",
            "<|im_start|>user\n",
            "Question: Is TENS machine effective in pain?\n",
            "Context: Document # 17333874:\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
            " Document # 7644247:\n",
            "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management [17333874].\n",
            "\n",
            "References:\n",
            "[17333874] Transcutaneous electrical nerve stimulation is widely...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #2:\n",
            "user\n",
            "Question: Is TENS machine effective in pain?\n",
            "Context: Document # 17333874:\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
            " Document # 7644247:\n",
            "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes, TENS machines are considered effective in pain management. According to the context provided, TENS machines are effective when used appropriately, and their effectiveness depends on the correct targeting of the nerve. The study also confirms that TENS can produce a hypoalgesic effect (reduced pain perception) at specific frequencies, with lower frequencies (like 4 Hz) showing the most significant effect. This supports the claim that TENS machines can be effective in managing pain.\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #3:\n",
            "<|im_start|>user\n",
            "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
            "Context: Document # 23526891:\n",
            "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
            " Document # 22328731:\n",
            "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "yes [23526891, 22328731]\n",
            "\n",
            "References:\n",
            "[23526891] Transcriptional enhancers play critical roles in...\n",
            "[22328731] The chemical modification of histones at...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #3:\n",
            "user\n",
            "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
            "Context: Document # 23526891:\n",
            "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
            " Document # 22328731:\n",
            "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "The provided documents discuss two different approaches for identifying enhancers in eukaryotic genomes:\n",
            "\n",
            "1. **RFECS (Random Forest Based Enhancer Identification from Chromatin States)**:\n",
            "   - This algorithm integrates histone modification profiles to identify enhancers. It was tested across two human cell types (embryonic stem cells and lung fibroblasts) and showed improved accuracy and precision compared to previous methods. It also identified a more robust set of three chromatin marks for enhancer prediction.\n",
            "\n",
            "2. **ChromaGenSVM**:\n",
            "   - This method uses support vector machines (SVM) combined with genetic algorithm optimization\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #4:\n",
            "<|im_start|>user\n",
            "Question: In which breast cancer patients can palbociclib be used?\n",
            "Context: Document # 26236140:\n",
            "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Palbociclib is useful for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer [26236140].\n",
            "\n",
            "References:\n",
            "[26236140] Women with hormone receptor-positive, human epidermal...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #4:\n",
            "user\n",
            "Question: In which breast cancer patients can palbociclib be used?\n",
            "Context: Document # 26236140:\n",
            "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Palbociclib can be used in **breast cancer patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer**. This is the most common subtype of the disease.\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from IPython.display import HTML, display\n",
        "\n",
        "table_template = \"\"\"<table style=\"border:1px solid black; table-layout: fixed; width: 100%;\" >\n",
        "  <tr>\n",
        "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PREFIX</th>\n",
        "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PRETRAIN</th>\n",
        "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">SFT</th>\n",
        "  </tr>\n",
        "{}\n",
        "</table>\"\"\"\n",
        "\n",
        "# Modified row_template for text wrapping and better alignment\n",
        "row_template = '''  <tr>\n",
        "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`{}`</pre></td>\n",
        "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">{}</pre></td>\n",
        "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">{}</pre></td>\n",
        "  </tr>'''\n",
        "\n",
        "\n",
        "rows = []\n",
        "\n",
        "for i, prefix in enumerate(sample_prompts):\n",
        "    prefix = prefix[0:512] + '...'\n",
        "    rows.append(row_template.format(prefix, pretrain_outputs[i], None))\n",
        "\n",
        "display(HTML(table_template.format('\\n'.join(rows))))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "oNY4eTKVCAr7",
        "outputId": "4000d860-1a75-4df5-95d8-4ae3a05e7167"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "<table style=\"border:1px solid black; table-layout: fixed; width: 100%;\" >\n",
              "  <tr>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PREFIX</th>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PRETRAIN</th>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">SFT</th>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is Alu hypomethylation associated with breast cancer?\n",
              "Context: Document # 24971511:\n",
              "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the chan...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is Alu hypomethylation associated with breast cancer?\n",
              "Context: Document # 24971511:\n",
              "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes, **Alu hypomethylation is associated with breast cancer**, particularly in subtypes like **HER2-enriched breast cancer (IBC)**. Here's a summary of the findings:\n",
              "\n",
              "- **Alu hypomethylation** was **not significantly different** during the progression of breast cancer, but it **tended to decrease** during the transition from **DCIS to IBC**.\n",
              "- **LINE-1 hypomethylation** **significantly decreased** from normal to ADH/FEA, and was **similar** in ADH/FEA, DCIS, and IBC.\n",
              "- In **</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">None</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
              "Context: Document # 24056933:\n",
              "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program ...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
              "Context: Document # 24056933:\n",
              "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "The factors that activate zygotic gene expression during the maternal-to-zygotic transition (MZT) in zebrafish are **Nanog**, **Pou5f1 (also called Oct4)**, and **SoxB1**. These factors are conserved in vertebrates and are essential for initiating the zygotic developmental program and clearing the maternal program by activating the microRNA miR-430.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">None</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is TENS machine effective in pain?\n",
              "Context: Document # 17333874:\n",
              "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
              " Document # 7644247:\n",
              "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was as...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is TENS machine effective in pain?\n",
              "Context: Document # 17333874:\n",
              "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
              " Document # 7644247:\n",
              "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes, TENS machines are considered effective in pain management. According to the context provided, TENS machines are effective when used appropriately, and their effectiveness depends on the correct targeting of the nerve. The study also confirms that TENS can produce a hypoalgesic effect (reduced pain perception) at specific frequencies, with lower frequencies (like 4 Hz) showing the most significant effect. This supports the claim that TENS machines can be effective in managing pain.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">None</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
              "Context: Document # 23526891:\n",
              "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of ...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
              "Context: Document # 23526891:\n",
              "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
              " Document # 22328731:\n",
              "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "The provided documents discuss two different approaches for identifying enhancers in eukaryotic genomes:\n",
              "\n",
              "1. **RFECS (Random Forest Based Enhancer Identification from Chromatin States)**:\n",
              "   - This algorithm integrates histone modification profiles to identify enhancers. It was tested across two human cell types (embryonic stem cells and lung fibroblasts) and showed improved accuracy and precision compared to previous methods. It also identified a more robust set of three chromatin marks for enhancer prediction.\n",
              "\n",
              "2. **ChromaGenSVM**:\n",
              "   - This method uses support vector machines (SVM) combined with genetic algorithm optimization</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">None</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: In which breast cancer patients can palbociclib be used?\n",
              "Context: Document # 26236140:\n",
              "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
              "\n",
              "<|im_end|>\n",
              "<|im_start|>assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: In which breast cancer patients can palbociclib be used?\n",
              "Context: Document # 26236140:\n",
              "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Palbociclib can be used in **breast cancer patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer**. This is the most common subtype of the disease.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">None</pre></td>\n",
              "  </tr>\n",
              "</table>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Final preparations\n",
        "\n",
        "As we said above the shift forward between `input_ids` and `labels` will happen during training function and not inside of the collation function. Luckily for us HuggingFace implemented this shift within Trainer API. Some people like to do the shift during collation phase, in this case you can use `DataCollatorForLanguageModeling`, however we will use `DataCollatorWithPadding` which does just convenient padding.\n",
        "\n",
        "In case if you wonder why do we need padding within a batch of text: GPUs can only operate on perfect shaped tensors. If there is a batch with 32 rows, each row must have the same number of values. If some texts are longer than others we need to pad shorter texts or truncate the longer ones.\n",
        "\n",
        "Also during collation we mask out the pad tokens with `-100` the same way we masked out prompt tokens."
      ],
      "metadata": {
        "id": "5p2q66MgaAfW"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import torch\n",
        "from transformers import DataCollatorWithPadding, PreTrainedTokenizerBase\n",
        "from typing import List, Dict, Any\n",
        "\n",
        "class SFTDataCollator(DataCollatorWithPadding):\n",
        "    \"\"\"\n",
        "    Extends HF's DataCollatorWithPadding so that it ALSO pads 'labels'\n",
        "    (which by default would be ignored and left at their original lengths).\n",
        "    \"\"\"\n",
        "    def __call__(self, features: List[Dict[str, Any]]) -> Dict[str, torch.Tensor]:\n",
        "        labels = [f.pop(\"labels\") for f in features]\n",
        "\n",
        "        batch = super().__call__(features)\n",
        "\n",
        "        batch_size, seq_len = batch[\"input_ids\"].shape\n",
        "        padded_labels = torch.full(\n",
        "            (batch_size, seq_len),\n",
        "            fill_value=-100,\n",
        "            dtype=torch.long,\n",
        "            device=batch[\"input_ids\"].device\n",
        "        )\n",
        "        for i, lab in enumerate(labels):\n",
        "            length = len(lab)\n",
        "            if length > seq_len:\n",
        "                lab = lab[:seq_len]\n",
        "                length = seq_len\n",
        "            padded_labels[i, :length] = torch.tensor(lab, dtype=torch.long)\n",
        "\n",
        "        batch[\"labels\"] = padded_labels\n",
        "        return batch\n"
      ],
      "metadata": {
        "id": "zUWKWumW_FD-"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Let's launch it!\n",
        "\n",
        "Now we have everything ready and finally can launch the funetuning code.\n",
        "\n",
        "In case if you want to experiment later with parameters for finetuning main loop, here are some recommendations:\n",
        "- learning_rate: the most important parameter. Usually is setup to be `1e-5`, but is really dependent on the phase of training.\n",
        "- weight_decay: this is the regularization coefficient applied to the weights. If you are coming from classical Machine Learning, think about it as `l2` regularization coefficient.\n",
        "- fp16 - this is to say that we use float 16 with 5 bits for exponent and 10 for mantissa\n",
        "- bf16 - this is to say that we use 8 bits with exponent and 7 for mantissa. **This option is more preferrable in deep learning!** We are not using half-precision at all"
      ],
      "metadata": {
        "id": "1NKAFSOyI0ih"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import DataCollatorWithPadding\n",
        "\n",
        "training_args = TrainingArguments(\n",
        "    output_dir=\"./qwen3-sft\",\n",
        "    num_train_epochs=1,\n",
        "    per_device_train_batch_size=1,\n",
        "    per_device_eval_batch_size=1,\n",
        "    learning_rate=2e-5,\n",
        "    weight_decay=0.01,\n",
        "    eval_strategy=\"steps\",\n",
        "    eval_steps=100,\n",
        "    logging_steps=100,\n",
        "    save_steps=100,\n",
        "    save_total_limit=2,\n",
        "    fp16=False,\n",
        "    bf16=False,\n",
        "    push_to_hub=False\n",
        ")\n",
        "\n",
        "data_collator = SFTDataCollator(\n",
        "    tokenizer,\n",
        "    padding=\"longest\",\n",
        "    return_tensors=\"pt\"\n",
        ")\n",
        "\n",
        "trainer = Trainer(\n",
        "    model=model,\n",
        "    args=training_args,\n",
        "    train_dataset=tokenized_datasets[\"train\"],\n",
        "    eval_dataset=tokenized_datasets[\"validation\"],\n",
        "    data_collator=data_collator,\n",
        "    tokenizer=tokenizer\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wrBfyh8uuFVD",
        "outputId": "eee65b5b-8807-4558-c13b-33e57d5bf896"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/tmp/ipython-input-48-1171261345.py:26: FutureWarning: `tokenizer` is deprecated and will be removed in version 5.0.0 for `Trainer.__init__`. Use `processing_class` instead.\n",
            "  trainer = Trainer(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's confirm that our dataloader gives us indeed correct results, our `labels` and `input_ids` should match because we dont do any shift within data part."
      ],
      "metadata": {
        "id": "IHfTgbEJJ8yq"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# 1. Grab one batch\n",
        "batch = next(iter(trainer.get_eval_dataloader()))\n",
        "\n",
        "# 2. For the first example in that batch, find all positions not masked\n",
        "labels = batch[\"labels\"][0]\n",
        "valid_idxs = (labels != -100).nonzero(as_tuple=True)[0].tolist()\n",
        "\n",
        "print(\"Batch seq_len:\", labels.shape[0])\n",
        "print(\"Valid token count:\", len(valid_idxs))\n",
        "print(\"First valid index:\", valid_idxs[0])\n",
        "print(\"Last  valid index:\", valid_idxs[-1])\n",
        "\n",
        "# 3. Show a little window around the start and end of your answer\n",
        "start = valid_idxs[0]\n",
        "end   = valid_idxs[-1]\n",
        "print(\" input_ids around start:\",\n",
        "      batch[\"input_ids\"][0, start : start+10].tolist())\n",
        "print(\" labels    around start:\",\n",
        "      labels[start : start+10].tolist())\n",
        "print(\" input_ids around end:\",\n",
        "      batch[\"input_ids\"][0, end-9 : end+1].tolist())\n",
        "print(\" labels    around end:\",\n",
        "      labels[end-9 : end+1].tolist())\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "T0GnFl7FU5x7",
        "outputId": "af4cb2cd-67ea-418e-c760-7c87ff24ff5c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Batch seq_len: 619\n",
            "Valid token count: 137\n",
            "First valid index: 482\n",
            "Last  valid index: 618\n",
            " input_ids around start: [2740, 41410, 33865, 374, 264, 6733, 369, 32359, 92759, 2805]\n",
            " labels    around start: [2740, 41410, 33865, 374, 264, 6733, 369, 32359, 92759, 2805]\n",
            " input_ids around end: [25, 362, 6884, 8045, 315, 2805, 28806, 1112, 151645, 198]\n",
            " labels    around end: [25, 362, 6884, 8045, 315, 2805, 28806, 1112, 151645, 198]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer.decode([151643, 151645])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "6c9sbD8OHW4n",
        "outputId": "79315b63-5e05-4c16-cd06-e29aeca13445"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'<|endoftext|><|im_end|>'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 50
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sns.histplot([len(x['labels']) for x in tokenized_datasets['train']])\n",
        "plt.xlabel('Length of Text (BPE-Tokens)')\n",
        "plt.ylabel('Count')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 475
        },
        "id": "xHVxXAbKabX3",
        "outputId": "e4845d9e-8739-4f37-c8ef-b6f196b28cd9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Text(0, 0.5, 'Count')"
            ]
          },
          "metadata": {},
          "execution_count": 52
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's make a pre-SFT evaluation making sure that the loss is not NAN and everything is working end-to-end:"
      ],
      "metadata": {
        "id": "o1QYSkNDaQ5u"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "metrics = trainer.evaluate()\n",
        "print(metrics)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 329
        },
        "id": "DUPuYIJTvAO6",
        "outputId": "275efb4f-34dc-4d4d-edb1-2c070bba4f9a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='95' max='95' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [95/95 00:18]\n",
              "    </div>\n",
              "    "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[33mWARNING\u001b[0m The `run_name` is currently set to the same value as `TrainingArguments.output_dir`. If this was not intended, please specify a different run name by setting the `TrainingArguments.run_name` parameter.\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Javascript object>"
            ],
            "application/javascript": [
              "\n",
              "        window._wandbApiKey = new Promise((resolve, reject) => {\n",
              "            function loadScript(url) {\n",
              "            return new Promise(function(resolve, reject) {\n",
              "                let newScript = document.createElement(\"script\");\n",
              "                newScript.onerror = reject;\n",
              "                newScript.onload = resolve;\n",
              "                document.body.appendChild(newScript);\n",
              "                newScript.src = url;\n",
              "            });\n",
              "            }\n",
              "            loadScript(\"https://cdn.jsdelivr.net/npm/postmate/build/postmate.min.js\").then(() => {\n",
              "            const iframe = document.createElement('iframe')\n",
              "            iframe.style.cssText = \"width:0;height:0;border:none\"\n",
              "            document.body.appendChild(iframe)\n",
              "            const handshake = new Postmate({\n",
              "                container: iframe,\n",
              "                url: 'https://wandb.ai/authorize'\n",
              "            });\n",
              "            const timeout = setTimeout(() => reject(\"Couldn't auto authenticate\"), 5000)\n",
              "            handshake.then(function(child) {\n",
              "                child.on('authorize', data => {\n",
              "                    clearTimeout(timeout)\n",
              "                    resolve(data)\n",
              "                });\n",
              "            });\n",
              "            })\n",
              "        });\n",
              "    "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "\u001b[34m\u001b[1mwandb\u001b[0m: Logging into wandb.ai. (Learn how to deploy a W&B server locally: https://wandb.me/wandb-server)\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: You can find your API key in your browser here: https://wandb.ai/authorize?ref=models\n",
            "wandb: Paste an API key from your profile and hit enter:"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            " \n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[33mWARNING\u001b[0m If you're specifying your api key in code, ensure this code is not shared publicly.\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[33mWARNING\u001b[0m Consider setting the WANDB_API_KEY environment variable, or running `wandb login` from the command line.\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: No netrc file found, creating one.\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Appending key for api.wandb.ai to your netrc file: /root/.netrc\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Currently logged in as: \u001b[33mmishacamry\u001b[0m to \u001b[32mhttps://api.wandb.ai\u001b[0m. Use \u001b[1m`wandb login --relogin`\u001b[0m to force relogin\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "Tracking run with wandb version 0.21.0"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "Run data is saved locally in <code>/content/wandb/run-20250717_235823-nk7h1ckz</code>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "Syncing run <strong><a href='https://wandb.ai/mishacamry/huggingface/runs/nk7h1ckz' target=\"_blank\">./qwen3-sft</a></strong> to <a href='https://wandb.ai/mishacamry/huggingface' target=\"_blank\">Weights & Biases</a> (<a href='https://wandb.me/developer-guide' target=\"_blank\">docs</a>)<br>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              " View project at <a href='https://wandb.ai/mishacamry/huggingface' target=\"_blank\">https://wandb.ai/mishacamry/huggingface</a>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              " View run at <a href='https://wandb.ai/mishacamry/huggingface/runs/nk7h1ckz' target=\"_blank\">https://wandb.ai/mishacamry/huggingface/runs/nk7h1ckz</a>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'eval_loss': 1.5665117502212524, 'eval_model_preparation_time': 0.0081, 'eval_runtime': 19.0762, 'eval_samples_per_second': 4.98, 'eval_steps_per_second': 4.98}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Fine tuning and aftermath\n",
        "\n",
        "The training loop:"
      ],
      "metadata": {
        "id": "rPSwwy87aYjT"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "trainer.train()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 377
        },
        "id": "P2akIWePvEPw",
        "outputId": "11c7f3a5-76cd-4524-9390-958e11e73d71"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='846' max='846' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [846/846 40:39, Epoch 1/1]\n",
              "    </div>\n",
              "    <table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              " <tr style=\"text-align: left;\">\n",
              "      <th>Step</th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Validation Loss</th>\n",
              "      <th>Model Preparation Time</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <td>100</td>\n",
              "      <td>0.676500</td>\n",
              "      <td>0.523372</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>200</td>\n",
              "      <td>0.538000</td>\n",
              "      <td>0.516137</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>300</td>\n",
              "      <td>0.543300</td>\n",
              "      <td>0.492658</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>400</td>\n",
              "      <td>0.779400</td>\n",
              "      <td>0.474537</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>500</td>\n",
              "      <td>0.487500</td>\n",
              "      <td>0.473438</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>600</td>\n",
              "      <td>0.483800</td>\n",
              "      <td>0.455958</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>700</td>\n",
              "      <td>0.525600</td>\n",
              "      <td>0.444625</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>800</td>\n",
              "      <td>0.553700</td>\n",
              "      <td>0.435374</td>\n",
              "      <td>0.008100</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table><p>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='190' max='95' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [95/95 02:47]\n",
              "    </div>\n",
              "    "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "TrainOutput(global_step=846, training_loss=0.569864933654208, metrics={'train_runtime': 2440.8672, 'train_samples_per_second': 0.347, 'train_steps_per_second': 0.347, 'total_flos': 1009865902915584.0, 'train_loss': 0.569864933654208, 'epoch': 1.0})"
            ]
          },
          "metadata": {},
          "execution_count": 54
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Let's check the metrics after SFT to make sure that loss has decreased.\n",
        "\n",
        "However, actual evaluation should happen manually when we look at the outputs and confirm that model indeed generates the citations."
      ],
      "metadata": {
        "id": "-sKvV19_aaYt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "metrics = trainer.evaluate()\n",
        "print(metrics)"
      ],
      "metadata": {
        "id": "YvLtGhRH6gNL",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 74
        },
        "outputId": "d382eeb1-9cde-4edb-b621-fd58a3993981"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='95' max='95' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [95/95 00:19]\n",
              "    </div>\n",
              "    "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'eval_loss': 0.43468138575553894, 'eval_model_preparation_time': 0.0081, 'eval_runtime': 20.1315, 'eval_samples_per_second': 4.719, 'eval_steps_per_second': 4.719, 'epoch': 1.0}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Eyeball metric here:"
      ],
      "metadata": {
        "id": "9eiqfuf0alZo"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Show a few predictions AFTER fine-tuning\n",
        "posttrain_outputs = []\n",
        "print(\"=== After fine-tuning ===\")\n",
        "for i, (p, gt) in enumerate(zip(sample_prompts, sample_gt)):\n",
        "    print(f'Reference answer #{i}:')\n",
        "    print(gt)\n",
        "    print('-----------------------------------')\n",
        "    print(f'Prediction #{i}:')\n",
        "    inputs = tokenizer(p, truncation=True, max_length=max_length, return_attention_mask=True, return_tensors=\"pt\").to(model.device)\n",
        "    out_ids = model.generate(\n",
        "        **inputs,\n",
        "        max_new_tokens=128,\n",
        "        do_sample=True\n",
        "    )[0]\n",
        "    prediction = tokenizer.decode(out_ids, skip_special_tokens=True)\n",
        "    posttrain_outputs.append(prediction)\n",
        "    print(prediction)\n",
        "    print(\"-----------------------------------\\n\\n\\n\")"
      ],
      "metadata": {
        "id": "47H5WVejvI2-",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "879ef67e-82b2-4fe8-c32b-27ee8607e59b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "=== After fine-tuning ===\n",
            "Reference answer #0:\n",
            "<|im_start|>user\n",
            "Question: Is Alu hypomethylation associated with breast cancer?\n",
            "Context: Document # 24971511:\n",
            "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes, Alu elements were found to be hypomethylated in breast cancer [24971511], especially in the HER2-enriched subtype [24971511]. Furthermore, Alu hypomethylation was identified as a late event during breast cancer progression [24971511], and in invasive breast cancer, tended to be associated with negative estrogen receptor status [24971511] and poor disease-free survival of the patients [24971511].\n",
            "\n",
            "References:\n",
            "[24971511] The changes in DNA methylation status...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #0:\n",
            "user\n",
            "Question: Is Alu hypomethylation associated with breast cancer?\n",
            "Context: Document # 24971511:\n",
            "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes, Alu hypomethylation is an early event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype [24971511].\n",
            "\n",
            "References:\n",
            "[24971511] The changes in DNA methylation status...\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #1:\n",
            "<|im_start|>user\n",
            "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
            "Context: Document # 24056933:\n",
            "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition [24056933]. Maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression [24056933].\n",
            "\n",
            "References:\n",
            "[24056933] After fertilization, maternal factors direct development...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #1:\n",
            "user\n",
            "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
            "Context: Document # 24056933:\n",
            "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Maternal Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish [24056933].\n",
            "\n",
            "References:\n",
            "[24056933] After fertilization, maternal factors direct development and...\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #2:\n",
            "<|im_start|>user\n",
            "Question: Is TENS machine effective in pain?\n",
            "Context: Document # 17333874:\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
            " Document # 7644247:\n",
            "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management [17333874].\n",
            "\n",
            "References:\n",
            "[17333874] Transcutaneous electrical nerve stimulation is widely...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #2:\n",
            "user\n",
            "Question: Is TENS machine effective in pain?\n",
            "Context: Document # 17333874:\n",
            "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
            " Document # 7644247:\n",
            "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Transcutaneous electrical nerve stimulation (TENS) is used for pain management [17333874, 7644247].\n",
            "\n",
            "References:\n",
            "[17333874] Transcutaneous electrical nerve stimulation is widely...\n",
            "[7644247] The hypoalgesic effect of transcutaneous...\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #3:\n",
            "<|im_start|>user\n",
            "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
            "Context: Document # 23526891:\n",
            "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
            " Document # 22328731:\n",
            "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "yes [23526891, 22328731]\n",
            "\n",
            "References:\n",
            "[23526891] Transcriptional enhancers play critical roles in...\n",
            "[22328731] The chemical modification of histones at...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #3:\n",
            "user\n",
            "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
            "Context: Document # 23526891:\n",
            "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
            " Document # 22328731:\n",
            "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Yes. RFECS and ChromaGenSVM are both used for enhancer identification from chromatin state profiles [23526891, 22328731].\n",
            "\n",
            "References:\n",
            "[23526891] Transcriptional enhancers play critical roles in...\n",
            "[22328731] The chemical modification of histones at...\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n",
            "Reference answer #4:\n",
            "<|im_start|>user\n",
            "Question: In which breast cancer patients can palbociclib be used?\n",
            "Context: Document # 26236140:\n",
            "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
            "\n",
            "<|im_end|>\n",
            "<|im_start|>assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Palbociclib is useful for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer [26236140].\n",
            "\n",
            "References:\n",
            "[26236140] Women with hormone receptor-positive, human epidermal...<|im_end|>\n",
            "\n",
            "-----------------------------------\n",
            "Prediction #4:\n",
            "user\n",
            "Question: In which breast cancer patients can palbociclib be used?\n",
            "Context: Document # 26236140:\n",
            "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
            "\n",
            "\n",
            "assistant\n",
            "<think>\n",
            "\n",
            "</think>\n",
            "\n",
            "Palbociclib is used in women with hormone receptor-positive breast cancer [26236140].\n",
            "\n",
            "References:\n",
            "[26236140] Women with hormone receptor-positive, human epidermal...\n",
            "-----------------------------------\n",
            "\n",
            "\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "rows = []\n",
        "\n",
        "for i, prefix in enumerate(sample_prompts):\n",
        "    prefix = prefix[0:512] + '...'\n",
        "    rows.append(row_template.format(prefix, pretrain_outputs[i], posttrain_outputs[i]))\n",
        "\n",
        "display(HTML(table_template.format('\\n'.join(rows))))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "r7M3vYQ3DNLo",
        "outputId": "7ffbe13c-c777-42c0-e933-a3c19a1e7a89"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "<table style=\"border:1px solid black; table-layout: fixed; width: 100%;\" >\n",
              "  <tr>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PREFIX</th>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">PRETRAIN</th>\n",
              "    <th style=\"text-align: center; border:1px solid black; width: 33%;\">SFT</th>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is Alu hypomethylation associated with breast cancer?\n",
              "Context: Document # 24971511:\n",
              "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the chan...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is Alu hypomethylation associated with breast cancer?\n",
              "Context: Document # 24971511:\n",
              "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes, **Alu hypomethylation is associated with breast cancer**, particularly in subtypes like **HER2-enriched breast cancer (IBC)**. Here's a summary of the findings:\n",
              "\n",
              "- **Alu hypomethylation** was **not significantly different** during the progression of breast cancer, but it **tended to decrease** during the transition from **DCIS to IBC**.\n",
              "- **LINE-1 hypomethylation** **significantly decreased** from normal to ADH/FEA, and was **similar** in ADH/FEA, DCIS, and IBC.\n",
              "- In **</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is Alu hypomethylation associated with breast cancer?\n",
              "Context: Document # 24971511:\n",
              "The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes, Alu hypomethylation is an early event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype [24971511].\n",
              "\n",
              "References:\n",
              "[24971511] The changes in DNA methylation status...</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
              "Context: Document # 24056933:\n",
              "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program ...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
              "Context: Document # 24056933:\n",
              "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "The factors that activate zygotic gene expression during the maternal-to-zygotic transition (MZT) in zebrafish are **Nanog**, **Pou5f1 (also called Oct4)**, and **SoxB1**. These factors are conserved in vertebrates and are essential for initiating the zygotic developmental program and clearing the maternal program by activating the microRNA miR-430.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
              "Context: Document # 24056933:\n",
              "After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Maternal Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish [24056933].\n",
              "\n",
              "References:\n",
              "[24056933] After fertilization, maternal factors direct development and...</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is TENS machine effective in pain?\n",
              "Context: Document # 17333874:\n",
              "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
              " Document # 7644247:\n",
              "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was as...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is TENS machine effective in pain?\n",
              "Context: Document # 17333874:\n",
              "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
              " Document # 7644247:\n",
              "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes, TENS machines are considered effective in pain management. According to the context provided, TENS machines are effective when used appropriately, and their effectiveness depends on the correct targeting of the nerve. The study also confirms that TENS can produce a hypoalgesic effect (reduced pain perception) at specific frequencies, with lower frequencies (like 4 Hz) showing the most significant effect. This supports the claim that TENS machines can be effective in managing pain.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is TENS machine effective in pain?\n",
              "Context: Document # 17333874:\n",
              "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. This article, the second in a two-part series, outlines how to set up and use a TENS machine to achieve the most effective results.\n",
              " Document # 7644247:\n",
              "The hypoalgesic effect of transcutaneous electrical nerve stimulation (TENS) at 2 different frequencies was assessed under double-blind conditions using a standardised form of the submaximum effort tourniquet technique. For the purpose of pain induction, 32 healthy naive female subjects attended on 2 occasions, the first during which baseline data were obtained and the second during which the women were randomly allocated to 1 of 4 groups: Control, Placebo, TENS-1 (110 Hz) or TENS-2 (4 Hz). In the treatment groups, 2 hydrogel electrodes were positioned over Erb's point and lateral to C6 and C7 vertebral spines. A TENS machine was applied for 10 min before the cuff was inflated and remained on for the duration of the pain procedure (12 min). Pain was measured using visual analogue scales (VAS) and the McGill Pain Questionnaire (MPQ) to assess 'current pain intensity' and 'worst pain experienced', respectively. Analysis of VAS scores showed significant differences between groups (ANOVA, P = 0.02), with the TENS-2 group showing a greater hypoalgesic effect than the other groups. One-factor ANOVA showed no significant differences in MPQ scores between groups. The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Transcutaneous electrical nerve stimulation (TENS) is used for pain management [17333874, 7644247].\n",
              "\n",
              "References:\n",
              "[17333874] Transcutaneous electrical nerve stimulation is widely...\n",
              "[7644247] The hypoalgesic effect of transcutaneous...</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
              "Context: Document # 23526891:\n",
              "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of ...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
              "Context: Document # 23526891:\n",
              "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
              " Document # 22328731:\n",
              "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "The provided documents discuss two different approaches for identifying enhancers in eukaryotic genomes:\n",
              "\n",
              "1. **RFECS (Random Forest Based Enhancer Identification from Chromatin States)**:\n",
              "   - This algorithm integrates histone modification profiles to identify enhancers. It was tested across two human cell types (embryonic stem cells and lung fibroblasts) and showed improved accuracy and precision compared to previous methods. It also identified a more robust set of three chromatin marks for enhancer prediction.\n",
              "\n",
              "2. **ChromaGenSVM**:\n",
              "   - This method uses support vector machines (SVM) combined with genetic algorithm optimization</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: Is there any algorithm for enhancer identification from chromatin state?\n",
              "Context: Document # 23526891:\n",
              "Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for enhancer prediction.\n",
              " Document # 22328731:\n",
              "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+) T cells to predict 21,000 experimentally supported enhancers within 1.0kb regions and with a precision of 90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Yes. RFECS and ChromaGenSVM are both used for enhancer identification from chromatin state profiles [23526891, 22328731].\n",
              "\n",
              "References:\n",
              "[23526891] Transcriptional enhancers play critical roles in...\n",
              "[22328731] The chemical modification of histones at...</pre></td>\n",
              "  </tr>\n",
              "  <tr>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">`<|im_start|>user\n",
              "Question: In which breast cancer patients can palbociclib be used?\n",
              "Context: Document # 26236140:\n",
              "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
              "\n",
              "<|im_end|>\n",
              "<|im_start|>assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "...`</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: In which breast cancer patients can palbociclib be used?\n",
              "Context: Document # 26236140:\n",
              "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Palbociclib can be used in **breast cancer patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer**. This is the most common subtype of the disease.</pre></td>\n",
              "    <td style=\"border:1px solid black; vertical-align:top;\"><pre style=\"white-space: pre-wrap; word-wrap: break-word; text-align:left; margin: 0;\">user\n",
              "Question: In which breast cancer patients can palbociclib be used?\n",
              "Context: Document # 26236140:\n",
              "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer-the most common subtype-have new options as palbociclib and similar drugs debut. This article outlines the rationale and evidence for their use.\n",
              "\n",
              "\n",
              "assistant\n",
              "<think>\n",
              "\n",
              "</think>\n",
              "\n",
              "Palbociclib is used in women with hormone receptor-positive breast cancer [26236140].\n",
              "\n",
              "References:\n",
              "[26236140] Women with hormone receptor-positive, human epidermal...</pre></td>\n",
              "  </tr>\n",
              "</table>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "And indeed, we have references in the answers now!"
      ],
      "metadata": {
        "id": "RAc-udTpaoQY"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Conclusion\n",
        "\n",
        "We see that the SFT output indeed contains citations and our model has learned to always output `References` section in the end and provide the relevant information that was used for Question-Answering.\n",
        "\n",
        "Just a reminder: here we used **full-precision Full Finetuning**\n",
        "\n",
        "See more methods in the following notebooks!"
      ],
      "metadata": {
        "id": "1QwFjEllF780"
      }
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "hbpec59UBqiM"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}
